data_5zau_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5zau _Structure_validation_residue.Date_analyzed 2019-09-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 120.579 0.228 . . . . 10.0 110.69 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.5 mt -100.43 141.77 32.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -111.18 134.94 52.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.111 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 107' ' ' GLU . 12.6 p -109.42 138.61 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.453 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.84 123.46 26.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.862 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.2 mt -81.32 -34.64 31.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.338 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -133.54 154.99 50.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.259 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.76 145.48 30.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.242 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -150.85 130.0 12.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.53 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -97.06 132.18 43.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.949 -0.759 . . . . 10.0 108.949 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 143.96 57.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.97 0.414 . . . . 10.0 111.396 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -97.01 -12.11 23.68 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.788 -0.642 . . . . 10.0 109.919 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.37 -166.49 2.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.028 -0.987 . . . . 10.0 109.434 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -98.35 -2.99 38.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -78.06 -47.84 17.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.002 -0.999 . . . . 10.0 108.827 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -87.64 155.68 19.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.192 -0.913 . . . . 10.0 108.818 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.1 tp -111.23 139.36 46.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.868 0.366 . . . . 10.0 111.86 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.9 m -81.44 140.04 34.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.665 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -152.2 166.22 32.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.967 0.413 . . . . 10.0 111.007 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -121.61 166.71 13.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.213 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -59.51 122.59 14.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.59 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.08 -1.43 44.2 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.733 -0.746 . . . . 10.0 112.611 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -67.15 140.94 57.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.644 0.259 . . . . 10.0 110.875 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -112.27 124.83 53.32 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -116.94 146.07 43.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.292 0.568 . . . . 10.0 112.356 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -100.14 101.43 12.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.718 -1.216 . . . . 10.0 107.718 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.0 mm -60.77 116.28 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.374 -0.376 . . . . 10.0 111.316 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.8 mt -89.25 -53.51 4.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.307 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -133.25 104.57 6.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.376 -0.375 . . . . 10.0 111.008 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.75 -8.19 44.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.289 0.566 . . . . 10.0 110.497 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 10.57 27.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.215 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.86 -25.12 59.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.913 0.387 . . . . 10.0 110.317 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.42 -127.79 3.18 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.639 -0.584 . . . . 10.0 111.639 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -83.15 -47.74 11.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.471 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 25.8 m95 -88.5 127.68 35.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.531 -0.915 . . . . 10.0 108.531 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -107.52 139.96 41.24 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.835 0.35 . . . . 10.0 111.277 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -85.39 119.41 25.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.177 -1.045 . . . . 10.0 108.177 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.11 162.61 30.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.071 0.463 . . . . 10.0 111.818 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -112.91 122.09 46.62 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.378 -0.828 . . . . 10.0 108.922 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.4 t -62.25 144.34 55.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.883 0.373 . . . . 10.0 110.741 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.75 -16.17 37.19 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.176 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 m -93.05 -50.79 5.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.709 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 64.8 p -88.4 -41.25 12.93 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.284 0.564 . . . . 10.0 111.268 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.89 9.1 62.83 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.751 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.21 162.57 18.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.779 0.323 . . . . 10.0 110.724 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.13 150.97 33.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.463 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 168.79 168.75 31.29 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.911 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -79.79 134.41 36.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.823 0.344 . . . . 10.0 110.821 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 22.8 pt -120.53 137.5 26.31 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.588 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.574 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 37.6 Cg_endo -72.19 121.95 7.97 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.549 2.166 . . . . 10.0 111.437 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -19.55 65.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.843 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 35.7 p-10 -80.63 -21.63 41.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.506 0.193 . . . . 10.0 111.446 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.461 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 4.6 m-85 -93.15 -11.99 31.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.081 0.4 . . . . 10.0 112.081 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.2 m -114.72 159.78 14.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.17 0.509 . . . . 10.0 111.675 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.72 137.59 18.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.716 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.64 137.14 32.25 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.343 2.029 . . . . 10.0 112.142 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.601 -0.714 . . . . 10.0 109.793 179.289 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ttm . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.462 0.173 . . . . 10.0 111.061 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.28 162.24 37.77 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.446 0.641 . . . . 10.0 112.173 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 1.1 m -107.58 118.2 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.316 -0.856 . . . . 10.0 109.746 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.1 134.35 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.821 0.343 . . . . 10.0 111.682 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -98.58 139.25 34.58 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.487 -0.561 . . . . 10.0 109.487 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -148.07 176.35 10.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.85 0.357 . . . . 10.0 110.667 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -123.87 83.55 2.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.815 -0.63 . . . . 10.0 109.76 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -63.77 92.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.765 0.316 . . . . 10.0 110.535 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm 52.02 29.5 6.32 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.688 -0.687 . . . . 10.0 111.608 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.17 -16.65 22.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.839 -0.696 . . . . 10.0 112.806 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -88.83 101.68 14.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.779 0.323 . . . . 10.0 110.732 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -67.52 123.12 19.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.082 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.05 158.76 44.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.747 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -125.12 119.59 29.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.041 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.71 142.43 42.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.804 0.335 . . . . 10.0 110.43 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 1.4 m-20 -60.77 137.86 58.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.351 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.8 tt -60.96 -26.52 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.696 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -10.72 59.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.855 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -105.3 8.18 33.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.69 0.281 . . . . 10.0 111.484 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -90.57 137.89 20.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.792 0.33 . . . . 10.0 110.273 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -88.95 -59.16 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.255 -0.43 . . . . 10.0 111.171 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -136.16 151.85 50.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.634 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.01 127.04 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.178 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 8.1 m -123.43 101.78 7.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.886 0.374 . . . . 10.0 111.398 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 22.3 ttp85 -90.76 137.33 32.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.813 -0.44 . . . . 10.0 109.813 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . 0.41 ' HB2' ' ND2' ' A' ' 136' ' ' ASN . 49.1 t80 -100.91 -20.49 15.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.06 0.457 . . . . 10.0 111.238 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.49 -4.58 37.44 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -135.17 -41.69 0.73 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.565 -0.817 . . . . 10.0 108.971 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -138.81 137.66 36.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.493 -0.776 . . . . 10.0 109.868 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 72.5 mt -102.98 125.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.279 -0.267 . . . . 10.0 110.279 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 17.7 m-85 -117.24 136.17 53.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -151.45 174.02 13.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.0 0.429 . . . . 10.0 111.227 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -130.24 140.88 50.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 10.0 109.805 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -124.41 152.52 43.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.926 0.393 . . . . 10.0 110.832 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.38 98.94 6.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.628 -0.714 . . . . 10.0 109.867 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' B' ' 40' ' ' LYS . 48.9 mt -75.81 144.42 41.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.793 0.33 . . . . 10.0 110.827 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.25 -5.87 87.55 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 116.071 -0.513 . . . . 10.0 112.201 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.3 23.05 10.38 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.899 -0.667 . . . . 10.0 112.441 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.84 43.42 97.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.45 -0.405 . . . . 10.0 112.834 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 86.0 tttt -159.79 95.68 1.61 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.717 0.294 . . . . 10.0 110.815 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -87.73 169.06 6.86 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.002 2.468 . . . . 10.0 111.235 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.63 -173.43 38.51 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.223 -0.989 . . . . 10.0 112.285 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 42.9 m-85 -118.56 166.89 12.17 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.66 138.25 6.42 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.372 -0.918 . . . . 10.0 112.531 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 p -124.33 127.73 73.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.078 0.466 . . . . 10.0 110.392 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.08 123.87 70.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.227 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -71.62 132.61 44.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.365 -0.38 . . . . 10.0 109.977 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -80.79 1.29 31.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.112 0.482 . . . . 10.0 110.791 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -116.3 -35.13 4.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.447 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -101.9 28.3 5.82 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.41 151.18 36.06 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 121.314 -0.154 . . . . 10.0 111.075 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.29 129.25 33.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.256 2.637 . . . . 10.0 112.418 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -64.31 -26.82 68.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.927 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -55.97 -42.62 76.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.971 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 73.8 mt -76.86 -30.67 56.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.729 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 62.1 mt -66.57 -32.09 73.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.413 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -74.42 -7.93 54.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.002 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -98.6 -26.92 14.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.907 -0.588 . . . . 10.0 110.11 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 52.3 mt -72.45 -61.95 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.865 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -101.03 110.33 22.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.208 0.528 . . . . 10.0 109.961 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -107.8 173.84 6.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.481 -0.781 . . . . 10.0 110.073 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -64.12 127.45 31.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.773 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 mttm 60.8 58.29 2.41 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.499 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.283 0 CA-C-N 115.954 -0.567 . . . . 10.0 111.061 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 120.929 0.395 . . . . 10.0 111.058 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.9 mt -92.57 158.84 15.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.09 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -121.08 134.61 55.27 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.2 p -112.27 140.34 32.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.921 0.391 . . . . 10.0 110.527 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.13 123.37 22.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.97 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.6 mt -83.28 -26.09 30.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.547 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.43 -175.3 4.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.922 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.87 149.8 27.05 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.282 0.364 . . . . 10.0 110.391 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -147.63 128.7 14.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.595 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -94.51 122.16 36.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.639 . . . . 10.0 109.403 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.47 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -61.68 144.09 55.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.703 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -97.32 -38.61 9.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.354 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.36 -162.25 1.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.873 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -96.54 -8.58 31.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.911 0.386 . . . . 10.0 110.68 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.48 -38.78 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.232 0.539 . . . . 10.0 110.099 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -93.05 150.55 20.45 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.688 -0.856 . . . . 10.0 108.688 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.2 tp -113.63 142.46 45.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.888 0.375 . . . . 10.0 111.626 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -81.92 148.51 28.7 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.799 179.006 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -154.85 158.96 40.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.102 0.477 . . . . 10.0 111.35 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -113.35 153.14 29.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.053 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -59.56 126.66 28.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.584 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.1 -17.64 29.24 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.884 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -68.4 143.14 55.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.733 0.302 . . . . 10.0 111.035 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -103.26 130.29 50.47 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.444 -0.576 . . . . 10.0 109.444 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -118.87 143.28 47.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.236 0.541 . . . . 10.0 112.089 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -103.19 104.14 14.26 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.69 -0.855 . . . . 10.0 108.69 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.426 HG23 ' HG ' ' A' ' 114' ' ' SER . 20.3 mm -64.13 120.19 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 10.0 111.206 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.8 mt -82.74 -46.44 13.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.194 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -149.06 137.77 21.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.185 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.426 ' HG ' HG23 ' A' ' 111' ' ' ILE . 0.7 OUTLIER -118.12 -12.44 10.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.173 -0.467 . . . . 10.0 111.29 -179.168 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.9 m -86.82 47.21 1.46 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.919 0.39 . . . . 10.0 111.903 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -127.35 -3.72 6.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.97 0.414 . . . . 10.0 110.863 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 139.47 -145.47 16.62 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.014 -0.612 . . . . 10.0 111.729 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.05 -22.41 20.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.031 0.443 . . . . 10.0 110.611 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.434 ' NE1' ' HB3' ' B' ' 31' ' ' PHE . 23.2 m95 -98.38 119.56 37.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.961 -1.125 . . . . 10.0 107.961 177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -103.47 153.92 20.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.284 0.564 . . . . 10.0 112.187 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -90.29 124.6 35.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.672 -1.233 . . . . 10.0 107.672 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.69 146.71 38.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.629 0.728 . . . . 10.0 112.715 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 123' ' ' ARG . 30.0 ttt180 -99.68 122.28 42.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.854 -1.066 . . . . 10.0 109.646 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.7 t -66.79 131.23 45.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.3 mt -78.44 -9.43 59.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.85 0.357 . . . . 10.0 110.427 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.5 m -79.78 -63.65 1.37 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 10.0 111.427 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.3 p -102.09 -25.75 13.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.389 0.514 . . . . 10.0 112.389 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.12 1.59 57.01 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.552 -0.832 . . . . 10.0 111.704 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -69.2 146.33 52.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 10.0 110.846 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.59 178.84 4.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.438 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 143.15 168.87 12.17 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.844 -0.693 . . . . 10.0 111.972 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -84.0 130.43 34.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.842 0.353 . . . . 10.0 110.44 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.8 pt -123.57 146.92 51.47 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.915 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.521 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 48.5 Cg_endo -74.23 115.05 4.18 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.666 2.244 . . . . 10.0 111.779 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.6 m -62.03 -15.06 41.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.945 0.72 . . . . 10.0 112.945 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.521 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 33.7 p-10 -83.41 -8.3 59.41 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.234 -0.291 . . . . 10.0 110.861 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -105.44 -0.16 26.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.167 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.6 m -127.67 156.15 39.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.989 0.423 . . . . 10.0 111.206 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.2 143.05 42.19 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.235 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.85 129.41 19.66 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.617 2.211 . . . . 10.0 112.06 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.29 -0.862 . . . . 10.0 110.261 -179.872 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.469 0.176 . . . . 10.0 110.708 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.4 169.24 25.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.821 0.343 . . . . 10.0 111.148 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.1 p -101.88 145.24 29.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 t -110.02 133.03 56.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.783 -0.451 . . . . 10.0 109.783 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.25 124.21 44.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.457 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 41.3 p90 -128.58 166.72 18.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.958 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -114.31 87.54 2.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.014 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -78.5 90.55 4.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.585 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm 53.54 38.21 27.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.108 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.01 -26.37 20.92 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.675 -0.774 . . . . 10.0 112.813 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -83.59 105.82 14.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.696 0.284 . . . . 10.0 110.882 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 26.7 mt-10 -80.16 116.93 20.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -130.92 157.44 42.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.612 0.244 . . . . 10.0 111.074 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -120.72 113.9 20.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.494 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.42 143.02 39.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.857 -0.423 . . . . 10.0 109.857 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.26 141.69 45.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 10.0 111.314 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 7.4 tt -62.26 -32.68 55.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.174 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 15.2 m -80.98 2.16 28.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.372 -0.376 . . . . 10.0 111.549 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -104.62 12.47 32.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.522 0.677 . . . . 10.0 109.29 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.15 133.86 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.063 -0.972 . . . . 10.0 109.324 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 t -83.76 -73.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.745 0.307 . . . . 10.0 111.568 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -118.85 152.18 36.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.72 0.295 . . . . 10.0 111.354 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.66 129.7 66.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.979 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 1.5 m -134.46 121.4 21.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.901 0.381 . . . . 10.0 111.05 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -120.75 125.47 47.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.814 0.34 . . . . 10.0 110.844 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -89.05 -22.46 22.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.153 0.502 . . . . 10.0 110.684 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.17 -4.47 8.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.865 -0.683 . . . . 10.0 112.01 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -117.14 -57.96 2.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.302 -0.629 . . . . 10.0 109.302 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.68 149.89 52.12 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.6 mt -101.66 124.64 55.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.358 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.434 ' HB3' ' NE1' ' A' ' 119' ' ' TRP . 3.3 m-85 -104.5 132.55 50.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.665 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -152.38 156.65 39.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.938 0.399 . . . . 10.0 111.289 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -110.59 132.17 54.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.059 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -114.62 164.3 14.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.67 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -133.33 142.96 48.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.624 -0.717 . . . . 10.0 109.385 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 35.7 mt -126.5 142.42 51.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.018 0.437 . . . . 10.0 111.288 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.86 -13.48 78.74 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.696 -0.684 . . . . 10.0 112.212 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.52 7.9 37.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.962 -0.637 . . . . 10.0 112.1 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.89 45.46 16.51 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.201 -0.523 . . . . 10.0 112.618 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -160.49 90.45 1.7 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.891 0.377 . . . . 10.0 111.392 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.32 175.03 6.62 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.458 2.105 . . . . 10.0 110.917 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.27 -166.5 36.54 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.881 -1.152 . . . . 10.0 112.462 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -120.65 156.57 31.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.681 0.277 . . . . 10.0 110.45 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.72 155.62 22.74 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.154 -0.778 . . . . 10.0 111.154 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.73 139.79 28.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.111 0.482 . . . . 10.0 111.262 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 20.4 m -132.31 152.48 36.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.763 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' B' ' 50' ' ' ASP . 19.5 t -91.16 141.34 28.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.112 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -82.6 -10.14 59.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.043 0.449 . . . . 10.0 110.636 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.64 -9.18 12.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.89 0.33 . . . . 10.0 111.89 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' B' ' 47' ' ' SER . 24.1 m-20 -120.32 21.9 11.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.901 0.382 . . . . 10.0 111.48 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.71 141.65 17.05 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.164 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.51 142.86 69.78 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.779 2.319 . . . . 10.0 112.297 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -58.06 -30.48 66.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.214 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.4 -45.09 72.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 10.0 111.161 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 mt -71.74 -38.84 70.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 10.0 111.023 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.98 -41.67 97.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.015 -0.539 . . . . 10.0 111.045 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -74.53 -13.65 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.932 -0.577 . . . . 10.0 111.383 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -80.42 -37.11 32.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.018 0.437 . . . . 10.0 109.823 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.44 -47.68 32.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.778 -0.646 . . . . 10.0 111.361 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -88.92 97.71 11.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.065 0.459 . . . . 10.0 110.43 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -104.01 -173.27 2.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.389 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -68.84 140.43 55.22 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 61.5 50.43 4.6 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.552 0.691 . . . . 10.0 109.892 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-N 115.165 -0.925 . . . . 10.0 110.878 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.597 0.237 . . . . 10.0 110.721 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.2 mt -99.8 141.79 32.15 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.932 0.396 . . . . 10.0 110.723 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -119.56 140.35 50.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.76 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.86 140.15 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.959 0.409 . . . . 10.0 110.437 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.34 116.56 12.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.987 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.24 -33.18 72.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.406 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -147.13 173.78 12.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.883 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.19 144.32 27.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -126.78 123.35 37.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.956 0.408 . . . . 10.0 111.112 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -84.93 116.85 23.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.606 -0.725 . . . . 10.0 109.579 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.94 148.67 51.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.092 0.472 . . . . 10.0 111.155 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -115.15 -35.44 4.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.782 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.81 -165.09 1.48 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.551 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -96.0 -11.95 25.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.688 0.28 . . . . 10.0 111.262 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.35 -34.63 31.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.211 0.529 . . . . 10.0 110.611 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -90.23 149.76 22.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.58 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.6 tp -109.68 135.46 50.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.981 0.42 . . . . 10.0 111.916 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.91 147.72 24.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.204 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -156.77 163.59 39.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.779 0.323 . . . . 10.0 111.268 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -110.26 157.05 19.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.08 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -58.5 128.1 35.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.799 0.333 . . . . 10.0 110.419 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.38 -10.0 53.78 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.707 -0.758 . . . . 10.0 112.924 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -70.85 146.73 49.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 10.0 110.781 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -115.62 139.07 50.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.067 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -126.58 150.39 48.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.053 0.454 . . . . 10.0 111.818 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -97.91 111.5 23.78 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.45 119.17 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.336 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.9 mt -102.7 -62.32 1.29 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.579 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -119.54 107.22 13.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.431 . . . . 10.0 110.644 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.29 22.0 12.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.78 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -112.27 -1.08 15.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.783 0.66 . . . . 10.0 112.783 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.72 -37.11 65.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.518 -0.473 . . . . 10.0 110.876 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.74 -133.62 2.89 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.189 -1.005 . . . . 10.0 112.588 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.39 -31.58 29.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.641 0.258 . . . . 10.0 110.947 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.558 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 28.2 m95 -93.16 121.22 34.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -103.17 146.48 28.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.046 0.451 . . . . 10.0 111.634 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -95.23 119.51 33.87 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.01 159.13 42.48 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.291 0.567 . . . . 10.0 111.832 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -104.38 124.15 48.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.245 -0.889 . . . . 10.0 109.433 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.0 t -65.95 136.57 56.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.944 -0.391 . . . . 10.0 109.944 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.34 -2.71 58.81 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.2 m -97.15 -50.31 4.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.2 p -101.24 -28.07 12.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.94 0.4 . . . . 10.0 111.732 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.45 -6.03 77.73 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.977 -0.63 . . . . 10.0 112.233 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -69.03 149.32 48.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.945 0.403 . . . . 10.0 110.882 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.1 m -119.95 125.86 49.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.947 -0.569 . . . . 10.0 111.093 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -163.5 176.11 39.67 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.489 -0.644 . . . . 10.0 111.489 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -81.72 127.86 33.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.839 0.352 . . . . 10.0 110.5 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.0 pt -119.62 142.13 32.27 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.805 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.443 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 28.9 Cg_endo -69.01 110.9 2.51 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.171 1.914 . . . . 10.0 111.184 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 m -59.35 -19.55 47.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.887 -0.597 . . . . 10.0 112.579 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.443 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 30.7 p-10 -81.51 -8.8 59.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 10.0 110.87 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -103.03 -3.5 25.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.312 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.79 157.87 27.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.507 -0.315 . . . . 10.0 111.036 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -138.85 148.37 57.85 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.317 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.38 136.53 55.59 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.546 2.164 . . . . 10.0 112.117 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.567 -0.73 . . . . 10.0 110.396 179.677 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ttt . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.561 0.22 . . . . 10.0 110.538 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.53 145.99 16.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.885 0.374 . . . . 10.0 111.009 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 6.1 m -93.72 119.8 33.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.625 -0.716 . . . . 10.0 109.45 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 32.8 t -86.87 130.34 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.984 0.421 . . . . 10.0 111.291 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -99.69 120.65 40.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.339 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -140.53 -174.22 3.9 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.609 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -125.54 142.97 51.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.068 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -125.52 98.84 5.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.968 0.413 . . . . 10.0 110.171 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm 56.8 31.64 19.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.189 -0.914 . . . . 10.0 112.264 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.45 -56.35 0.72 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.263 -0.97 . . . . 10.0 114.022 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -78.88 158.38 28.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.097 0.449 . . . . 10.0 111.842 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -97.1 141.79 29.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -136.9 152.1 49.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.443 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -126.18 111.9 15.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.21 -0.45 . . . . 10.0 109.796 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -129.59 142.13 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.803 0.335 . . . . 10.0 111.172 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.67 142.37 57.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.647 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 16.5 tt -63.13 -25.83 39.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.232 0.539 . . . . 10.0 110.616 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -11.38 60.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 10.0 111.362 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -99.5 2.68 45.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.122 0.487 . . . . 10.0 110.207 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 61.3 mt -96.91 134.34 34.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.075 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.26 -72.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.031 0.443 . . . . 10.0 110.434 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -120.99 147.02 46.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.096 -0.502 . . . . 10.0 111.155 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 t -124.16 116.01 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.659 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 5.1 m -120.65 112.55 19.02 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.128 0.49 . . . . 10.0 112.266 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.558 ' HD2' ' OE1' ' B' ' 48' ' ' GLU . 37.3 ttp85 -102.9 131.71 49.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.939 -0.393 . . . . 10.0 109.939 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -89.88 -25.48 20.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.311 0.577 . . . . 10.0 110.787 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.07 -4.14 16.3 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.716 -0.954 . . . . 10.0 110.716 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -134.17 -38.44 0.86 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -135.71 143.64 45.5 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.717 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mt -105.22 121.45 57.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -113.16 127.67 56.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.443 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -145.87 167.27 23.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.769 0.318 . . . . 10.0 110.608 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -126.46 129.93 49.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.106 -0.497 . . . . 10.0 109.742 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -119.48 162.99 17.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.224 0.535 . . . . 10.0 111.629 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.8 133.81 50.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.081 -0.963 . . . . 10.0 109.269 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 41.9 mt -112.5 140.01 47.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.815 0.341 . . . . 10.0 110.915 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.2 -7.49 45.07 Favored Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 115.829 -0.623 . . . . 10.0 112.839 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.07 8.89 59.18 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.916 -0.659 . . . . 10.0 111.975 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.1 47.93 16.98 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.913 -0.661 . . . . 10.0 112.372 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -163.02 99.28 1.04 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.552 0.215 . . . . 10.0 111.117 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.04 165.55 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.531 2.154 . . . . 10.0 110.874 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.76 -171.68 29.27 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 119.809 -1.186 . . . . 10.0 113.303 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 1.5 m-85 -124.49 158.42 32.91 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.813 -0.44 . . . . 10.0 109.813 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.69 132.7 6.16 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.627 -0.796 . . . . 10.0 111.584 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.27 125.82 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.254 0.55 . . . . 10.0 110.443 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 t -121.08 136.85 56.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.047 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 28.1 t -83.9 130.72 34.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.933 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.558 ' OE1' ' HD2' ' B' ' 25' ' ' ARG . 5.1 tt0 -93.97 4.44 53.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.338 0.589 . . . . 10.0 109.732 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -98.7 -46.09 5.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.793 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.03 79.85 1.89 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.23 0.538 . . . . 10.0 111.712 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.54 156.22 10.36 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.151 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.33 128.01 25.96 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.618 2.212 . . . . 10.0 112.55 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -63.42 -27.13 69.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.966 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' B' ' 58' ' ' LYS . 0.1 OUTLIER -57.88 -33.17 68.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.492 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.2 -38.18 19.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.252 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 61.9 mt -61.88 -47.08 86.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 10.0 111.142 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -76.83 -5.91 50.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.799 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' B' ' 54' ' ' GLU . 4.0 tttt -92.23 -22.92 19.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 10.0 110.369 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 29.3 mt -82.62 -54.56 5.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.736 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . 0.401 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 31.6 tt0 -92.15 94.16 9.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.103 0.478 . . . . 10.0 110.044 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -86.41 166.67 15.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.69 -0.686 . . . . 10.0 109.827 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -63.57 132.02 49.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.78 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.6 mttt 61.32 49.6 5.28 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.187 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.601 -0.714 . . . . 10.0 110.495 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 120.554 0.216 . . . . 10.0 110.735 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.7 mt -90.39 146.21 24.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.33 -0.396 . . . . 10.0 110.52 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -123.04 145.25 48.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.431 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.01 142.38 38.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.481 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.13 120.64 20.91 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.131 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 50.7 mt -79.74 -32.99 41.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.366 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -144.45 164.28 31.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.734 -0.667 . . . . 10.0 109.748 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.02 152.34 38.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.407 -0.59 . . . . 10.0 109.407 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -119.29 128.92 54.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.896 0.379 . . . . 10.0 111.026 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.79 92.59 6.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.09 -0.505 . . . . 10.0 109.67 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.91 162.8 29.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.56 . . . . 10.0 111.499 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -126.11 -45.64 1.7 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.023 -0.535 . . . . 10.0 110.728 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.23 -177.82 3.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.864 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -87.47 -11.21 49.65 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.891 0.33 . . . . 10.0 111.891 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.96 -39.04 31.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.993 0.425 . . . . 10.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.13 124.0 29.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.117 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.2 tp -77.85 135.13 37.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.996 -0.547 . . . . 10.0 112.204 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.33 120.81 35.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.711 . . . . 10.0 109.897 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -136.55 166.23 24.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.852 0.358 . . . . 10.0 111.29 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -109.78 168.32 9.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.839 -0.619 . . . . 10.0 111.391 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -65.27 134.3 53.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.389 -0.823 . . . . 10.0 111.357 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.41 2.95 88.89 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.118 -0.563 . . . . 10.0 113.725 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -81.41 151.26 28.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.073 0.436 . . . . 10.0 110.968 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -116.43 143.66 45.29 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.06 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.38 158.72 43.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 10.0 110.861 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -97.68 113.99 25.87 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.55 116.77 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.148 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.6 mt -83.96 -63.33 1.37 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.906 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -117.73 98.27 6.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.179 0.514 . . . . 10.0 111.403 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.41 -17.1 35.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.683 -0.689 . . . . 10.0 110.386 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.59 14.36 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.765 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -70.07 -44.39 69.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.314 0.578 . . . . 10.0 110.324 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 153.3 -113.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.452 -0.794 . . . . 10.0 111.185 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.16 -45.68 6.44 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.429 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 29.4 m95 -92.4 110.68 22.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -96.52 150.25 20.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.843 0.354 . . . . 10.0 111.052 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -95.07 123.8 38.75 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.455 -0.943 . . . . 10.0 108.455 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.5 163.99 27.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.958 0.409 . . . . 10.0 111.345 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -114.58 128.4 56.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.834 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.1 t -68.88 147.7 51.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.919 0.39 . . . . 10.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.0 mt -94.52 -3.14 50.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.496 -0.557 . . . . 10.0 109.496 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 m -95.06 -66.36 0.92 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.363 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.0 p -90.18 -20.91 22.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 10.0 111.461 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.94 13.49 79.34 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.783 -0.723 . . . . 10.0 111.895 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.48 153.43 37.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 10.0 110.898 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.9 m -117.6 135.75 53.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.176 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -179.47 176.79 47.95 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.433 -0.889 . . . . 10.0 112.221 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -84.29 138.95 32.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.307 -0.257 . . . . 10.0 110.307 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.2 pt -126.41 139.98 36.04 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.019 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.578 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 37.3 Cg_endo -68.83 121.57 8.46 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.343 2.029 . . . . 10.0 111.415 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 p -66.46 -12.82 59.24 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.551 0.574 . . . . 10.0 112.551 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.578 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 35.4 p-10 -87.58 -8.31 56.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.859 0.361 . . . . 10.0 110.986 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -100.32 -17.66 17.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.021 0.439 . . . . 10.0 110.677 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 22.5 m -115.83 154.05 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.61 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.82 145.24 47.59 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.407 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.46 124.76 12.88 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.219 1.946 . . . . 10.0 111.332 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.052 -0.975 . . . . 10.0 110.293 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 111.239 0.088 . . . . 10.0 111.239 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . 0.424 ' O ' HG23 ' B' ' 17' ' ' ILE . . . -169.66 169.67 8.46 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.683 0.278 . . . . 10.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 2.2 m -107.6 140.2 40.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.699 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 54.6 t -115.05 136.52 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.56 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -105.09 128.4 53.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.093 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -137.71 177.31 7.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.544 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -125.38 89.0 2.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.771 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -78.37 110.72 13.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.084 -0.507 . . . . 10.0 109.866 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm 58.28 24.21 11.28 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.027 0.441 . . . . 10.0 111.017 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.29 -14.7 59.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.821 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.51 127.44 34.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.857 0.361 . . . . 10.0 110.804 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.07 120.72 22.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.3 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -137.61 149.79 46.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.255 -0.429 . . . . 10.0 110.382 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -126.85 115.51 19.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.547 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 64.1 t -125.88 143.8 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.15 -0.477 . . . . 10.0 109.847 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.575 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 56.6 m-20 -64.42 135.04 55.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 10.0 110.076 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.424 HG23 ' O ' ' B' ' 2' ' ' ALA . 15.8 tt -59.94 -26.23 35.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.614 -0.721 . . . . 10.0 111.398 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -10.8 60.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.079 -0.509 . . . . 10.0 111.345 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -100.94 12.6 37.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.132 0.491 . . . . 10.0 110.337 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -99.6 132.22 45.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.049 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.98 -64.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.93 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -137.0 155.87 49.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.326 -0.397 . . . . 10.0 110.723 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.5 t -127.05 142.86 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.923 -0.581 . . . . 10.0 109.644 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 9.3 m -137.81 118.87 14.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.036 0.445 . . . . 10.0 111.577 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.435 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 57.4 ttp85 -111.59 116.12 30.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.11 0.481 . . . . 10.0 110.687 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -84.66 -21.3 30.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.331 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.82 12.63 15.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.556 -0.83 . . . . 10.0 111.497 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -138.56 -51.97 0.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.761 -0.829 . . . . 10.0 108.761 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -136.57 143.28 43.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.783 -1.099 . . . . 10.0 108.85 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 27.8 mt -97.32 122.35 48.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.654 -0.498 . . . . 10.0 109.654 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -113.26 136.78 52.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.521 -0.309 . . . . 10.0 110.508 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -148.28 169.41 20.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.782 0.325 . . . . 10.0 110.646 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -126.81 131.24 51.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.037 -0.528 . . . . 10.0 109.847 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -125.55 165.53 18.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.031 0.443 . . . . 10.0 111.375 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -134.63 122.02 21.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.678 -0.692 . . . . 10.0 110.218 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -90.27 147.48 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 10.0 111.59 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.49 -12.89 70.5 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.933 -0.576 . . . . 10.0 112.549 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.38 13.94 43.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.906 -0.664 . . . . 10.0 112.555 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.31 54.94 7.29 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.702 -0.761 . . . . 10.0 111.966 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -157.59 95.28 2.06 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.648 0.261 . . . . 10.0 110.813 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.72 143.06 18.43 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.346 2.031 . . . . 10.0 110.792 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.93 -173.46 18.92 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.84 -1.172 . . . . 10.0 113.136 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . 0.429 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 7.2 m-85 -128.46 161.11 30.26 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.85 143.74 12.98 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.346 -0.931 . . . . 10.0 112.208 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 2.4 p -131.3 130.37 63.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.995 0.426 . . . . 10.0 110.004 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 26.4 t -122.57 133.95 67.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.848 -0.614 . . . . 10.0 110.134 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.39 136.67 53.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.047 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -87.86 -19.3 27.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.002 0.429 . . . . 10.0 110.946 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -108.35 -36.72 6.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.524 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -96.88 52.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.904 -0.589 . . . . 10.0 111.002 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -169.21 151.92 4.84 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.305 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.29 140.57 59.09 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.485 2.123 . . . . 10.0 111.803 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -60.96 -21.03 63.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.309 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -54.67 -46.15 73.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.252 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.28 -35.41 48.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.782 0.325 . . . . 10.0 110.743 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 30.8 mt -61.55 -43.47 98.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.001 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -74.33 -7.3 52.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.546 . . . . 10.0 111.949 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -91.97 -33.92 14.66 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.842 -0.429 . . . . 10.0 109.842 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 89.5 mt -82.26 -36.9 26.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.943 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . 0.435 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 8.8 tp10 -79.73 94.73 5.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.267 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -105.58 142.79 34.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.182 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -67.47 127.1 31.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 mttt 64.77 65.01 0.63 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.935 0.772 . . . . 10.0 109.845 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.606 -0.724 . . . . 10.0 110.586 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 120.568 0.223 . . . . 10.0 110.774 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.0 mt -93.66 148.13 22.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.021 -0.363 . . . . 10.0 110.021 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -120.59 134.19 55.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.711 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.45 140.29 34.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.026 -0.533 . . . . 10.0 109.95 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.22 124.77 25.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.191 -0.458 . . . . 10.0 111.633 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.6 mt -80.75 -34.12 34.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.172 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -140.71 164.08 31.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.533 -0.758 . . . . 10.0 110.008 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.79 147.41 39.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.829 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -129.48 137.73 51.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 10.0 111.243 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -98.31 130.98 44.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.946 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.54 139.78 31.89 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.22 -0.289 . . . . 10.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -107.89 -28.32 9.69 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.848 -0.341 . . . . 10.0 111.444 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.3 p -132.25 -161.47 1.14 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.993 0.425 . . . . 10.0 110.878 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -102.31 8.72 40.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.482 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.55 -38.83 7.36 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.497 -0.557 . . . . 10.0 109.497 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -89.87 149.46 22.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.748 -0.834 . . . . 10.0 108.748 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.4 tp -117.1 134.4 54.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.089 0.471 . . . . 10.0 111.964 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.67 151.38 26.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.831 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -159.57 170.57 21.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.363 -0.38 . . . . 10.0 110.314 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 59.2 m-70 -113.4 165.28 12.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.252 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -62.32 121.05 12.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.406 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.37 -4.34 33.14 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.958 -0.639 . . . . 10.0 112.122 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 104' ' ' HIS . 3.7 tp10 -66.86 129.32 39.49 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 122.287 0.235 . . . . 10.0 111.225 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -94.19 124.47 38.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -118.72 138.04 52.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.228 0.537 . . . . 10.0 112.088 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -100.52 105.67 17.12 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.388 -0.967 . . . . 10.0 108.388 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.8 mm -65.87 119.31 10.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.057 -0.519 . . . . 10.0 110.848 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -96.29 -38.78 9.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.435 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 121' ' ' GLU . 18.3 t30 -137.23 101.62 4.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.194 0.521 . . . . 10.0 110.255 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.63 -13.44 16.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.17 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.69 3.01 27.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.993 -0.548 . . . . 10.0 111.802 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -65.94 -48.12 72.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 10.0 110.581 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.43 -124.47 1.27 Allowed Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.826 -0.702 . . . . 10.0 111.813 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.417 ' HA ' ' HZ2' ' B' ' 9' ' ' LYS . 46.3 m-20 -76.68 -58.08 3.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.055 -0.35 . . . . 10.0 110.055 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -78.72 137.92 38.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -112.94 150.24 32.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.13 0.49 . . . . 10.0 111.901 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.496 ' HG3' ' CE1' ' A' ' 132' ' ' TYR . 5.3 mt-10 -89.96 112.61 24.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.496 -0.927 . . . . 10.0 108.496 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.69 154.91 44.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.234 0.54 . . . . 10.0 111.908 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 -109.15 132.54 54.02 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.442 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 t -73.78 131.64 41.77 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.725 -0.472 . . . . 10.0 109.725 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.12 -10.75 57.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.208 0.528 . . . . 10.0 110.067 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -62.71 1.41 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.444 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.9 p -89.08 -31.26 18.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.743 0.306 . . . . 10.0 111.796 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.8 -3.0 58.69 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.635 -0.793 . . . . 10.0 112.439 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -69.19 153.55 43.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.74 0.305 . . . . 10.0 111.195 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.4 m -127.37 134.88 49.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.982 -0.554 . . . . 10.0 110.957 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.14 -176.37 44.29 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.851 -0.69 . . . . 10.0 111.945 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.496 ' CE1' ' HG3' ' A' ' 121' ' ' GLU . 41.3 m-85 -83.92 131.32 34.86 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.7 pt -122.55 141.39 34.89 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.041 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.18 111.05 1.32 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.495 2.13 . . . . 10.0 111.428 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.84 -18.86 63.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.693 -0.685 . . . . 10.0 112.232 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -83.07 -13.96 54.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.455 -0.339 . . . . 10.0 111.246 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.91 0.03 43.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.575 -0.284 . . . . 10.0 111.328 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.7 m -123.33 161.23 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.823 0.344 . . . . 10.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.48 146.36 41.68 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.441 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -67.35 135.61 37.29 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.478 2.119 . . . . 10.0 111.599 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.524 -0.751 . . . . 10.0 110.439 -179.74 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ttt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.41 0.148 . . . . 10.0 110.942 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.11 152.59 24.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.866 0.365 . . . . 10.0 111.447 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.66 133.56 36.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.371 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 t -110.74 135.41 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.734 0.302 . . . . 10.0 110.729 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -102.87 126.3 49.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.057 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -128.86 166.43 19.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.502 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -106.66 89.08 2.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.149 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -75.73 86.38 2.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.419 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.417 ' HZ2' ' HA ' ' A' ' 118' ' ' ASP . 17.0 mmtm 54.85 35.36 24.11 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.3 -0.864 . . . . 10.0 111.294 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.48 -29.7 8.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.855 -0.688 . . . . 10.0 112.897 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -87.42 117.22 26.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.757 0.313 . . . . 10.0 111.121 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -83.51 114.34 21.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.998 0.428 . . . . 10.0 109.973 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -125.5 149.31 48.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.166 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -115.58 107.77 15.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.361 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.36 144.13 28.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.206 -0.452 . . . . 10.0 109.915 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.23 139.19 58.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.624 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.4 tt -63.29 -24.04 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.314 0.578 . . . . 10.0 110.732 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -16.01 62.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.932 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -98.93 15.93 24.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.34 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 72.9 mt -103.74 133.77 46.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.942 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.92 -71.62 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.472 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -128.94 147.0 50.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.709 -0.223 . . . . 10.0 110.844 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 27.9 t -125.53 127.69 71.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.1 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 63.1 m -129.8 118.21 21.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.081 0.467 . . . . 10.0 111.913 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 15.8 ttp85 -99.87 148.25 24.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.924 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -122.29 -25.47 4.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.965 0.357 . . . . 10.0 111.965 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.29 18.37 8.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.225 -0.988 . . . . 10.0 110.935 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -148.12 -50.65 0.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -148.7 134.0 18.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.854 -1.067 . . . . 10.0 109.647 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.4 mt -91.69 129.92 41.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.138 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -115.61 135.27 54.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.481 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -150.15 171.08 17.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.673 0.273 . . . . 10.0 110.852 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -121.05 132.9 55.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.239 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -119.17 161.33 20.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.222 0.534 . . . . 10.0 111.455 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -133.09 128.79 36.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.542 -0.754 . . . . 10.0 109.751 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt -113.24 122.16 46.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.751 0.31 . . . . 10.0 110.613 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.2 -15.16 21.42 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.716 -0.675 . . . . 10.0 113.185 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.54 -14.48 67.11 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.286 -0.483 . . . . 10.0 112.437 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.55 40.84 2.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 10.0 113.009 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -159.93 89.9 1.85 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.066 0.46 . . . . 10.0 111.458 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -86.05 160.26 10.14 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.575 2.183 . . . . 10.0 110.836 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.94 -156.43 13.52 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.016 -1.088 . . . . 10.0 112.446 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -124.3 171.36 9.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.225 -0.287 . . . . 10.0 110.225 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.68 141.1 8.73 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.802 -0.713 . . . . 10.0 111.7 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.16 132.71 68.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.279 0.561 . . . . 10.0 111.015 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 71.0 t -128.14 126.09 65.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.476 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 28.7 t -68.84 146.96 52.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.93 7.37 43.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.104 0.478 . . . . 10.0 110.35 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -114.32 -50.86 2.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.936 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -101.49 31.71 3.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.828 0.347 . . . . 10.0 111.919 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . -133.35 149.32 72.12 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.768 -0.196 . . . . 10.0 110.56 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.47 142.56 65.84 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.784 2.323 . . . . 10.0 112.654 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -65.86 -24.36 66.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.771 -0.649 . . . . 10.0 110.31 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -56.69 -30.7 63.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.544 -0.753 . . . . 10.0 110.987 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.66 -37.25 11.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.387 . . . . 10.0 110.392 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 66.0 mt -63.64 -37.87 88.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 10.0 111.436 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -70.89 -16.32 62.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 10.0 111.242 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -86.33 -37.17 18.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 10.0 110.275 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.51 -41.13 80.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.931 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -85.62 100.16 11.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.156 0.503 . . . . 10.0 110.357 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -109.67 157.36 19.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.659 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -69.51 136.19 51.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.65 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 67.04 48.86 1.18 Allowed 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.758 0.662 . . . . 10.0 110.021 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.656 -0.688 . . . . 10.0 110.568 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.1 mt -109.59 145.32 36.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.961 0.41 . . . . 10.0 110.098 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -117.99 137.15 53.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.527 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.97 138.69 31.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.909 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.06 117.67 11.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.542 . . . . 10.0 110.932 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.36 -49.31 67.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.076 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -138.04 170.3 16.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.554 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.72 133.93 47.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.626 -0.509 . . . . 10.0 109.626 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -110.84 120.99 44.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.009 0.433 . . . . 10.0 111.337 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -89.12 120.48 30.55 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.69 155.62 31.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.054 0.454 . . . . 10.0 111.181 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.493 HH22 ' HA ' ' B' ' 64' ' ' LYS . 6.5 ttm180 -110.32 -41.44 4.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.449 -0.796 . . . . 10.0 110.119 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.75 -160.86 0.86 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.072 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.5 -3.29 31.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.094 0.473 . . . . 10.0 110.145 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.58 -44.02 13.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.384 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.58 129.74 34.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.419 -0.81 . . . . 10.0 109.587 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.8 tp -80.68 125.26 29.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.672 -0.694 . . . . 10.0 111.947 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.46 131.49 34.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.402 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -147.26 167.61 23.81 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.983 0.42 . . . . 10.0 111.541 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -106.25 164.01 12.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.849 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.01 132.88 51.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.359 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.82 -5.23 66.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.629 -0.796 . . . . 10.0 113.962 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -78.32 155.04 30.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.07 0.435 . . . . 10.0 111.192 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -122.54 141.68 51.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.898 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.75 155.42 50.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.786 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -99.19 120.5 39.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.8 -0.636 . . . . 10.0 109.621 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.47 120.33 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.053 -0.522 . . . . 10.0 110.889 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.7 mt -93.53 -46.61 7.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.691 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -135.19 103.71 5.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.172 0.51 . . . . 10.0 111.05 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.92 -11.81 27.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.78 -0.645 . . . . 10.0 110.859 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.07 0.16 54.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.398 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.1 -32.9 74.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.218 0.532 . . . . 10.0 110.5 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 144.99 -110.03 0.54 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.913 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.09 -50.86 3.53 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.09 -0.337 . . . . 10.0 110.09 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.459 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 54.2 m95 -82.81 107.11 15.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.751 -1.203 . . . . 10.0 107.751 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -89.18 146.02 25.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.151 0.5 . . . . 10.0 111.553 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -86.69 115.91 24.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.83 154.94 41.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.112 0.482 . . . . 10.0 111.474 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.6 ttp85 -109.6 125.37 52.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.657 -0.701 . . . . 10.0 109.487 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.2 t -61.6 131.06 48.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.577 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.35 -6.22 58.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.832 -0.622 . . . . 10.0 109.783 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.26 -63.02 1.49 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.523 -0.762 . . . . 10.0 109.954 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.7 p -104.24 -61.14 1.48 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.691 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 149.83 -7.98 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.919 -0.582 . . . . 10.0 111.826 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.06 134.36 21.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.088 0.47 . . . . 10.0 111.879 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -116.69 132.45 56.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.306 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.24 -178.25 43.08 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.275 -0.964 . . . . 10.0 112.629 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -78.71 126.44 30.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.17 -0.307 . . . . 10.0 110.17 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.4 pt -112.84 135.69 21.63 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 10.0 111.127 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.453 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 34.8 Cg_endo -69.25 116.57 4.57 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.558 2.172 . . . . 10.0 111.518 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -14.36 60.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.695 -0.684 . . . . 10.0 112.35 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.507 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 38.4 p-10 -89.45 -3.34 58.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.452 -0.34 . . . . 10.0 111.032 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.436 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 11.2 m-85 -113.4 6.48 17.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.704 0.288 . . . . 10.0 111.223 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.5 m -129.64 150.58 34.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.937 0.399 . . . . 10.0 111.196 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.88 145.4 57.3 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.183 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.47 124.72 13.26 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.489 2.126 . . . . 10.0 111.82 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.403 -0.808 . . . . 10.0 110.158 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.638 0.256 . . . . 10.0 110.533 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.27 157.8 23.41 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.9 0.381 . . . . 10.0 110.922 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.9 m -96.74 131.35 43.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.684 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -103.38 138.32 28.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.07 0.462 . . . . 10.0 111.158 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -99.74 127.77 45.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.633 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -135.54 175.96 9.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.846 0.355 . . . . 10.0 111.002 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -120.97 106.48 11.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.571 . . . . 10.0 109.801 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -94.11 95.59 9.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.678 -0.489 . . . . 10.0 109.678 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 59.64 34.65 22.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.773 -0.649 . . . . 10.0 111.053 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.29 -24.82 29.83 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.808 -0.633 . . . . 10.0 112.49 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.96 111.32 18.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.75 0.31 . . . . 10.0 110.914 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -76.35 121.17 22.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.416 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -135.55 162.27 33.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.485 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -126.4 121.95 33.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.561 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 82.1 t -131.94 142.66 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 110.148 -0.315 . . . . 10.0 110.148 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 23.6 m-20 -70.1 141.79 52.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.898 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 tt -61.98 -26.2 39.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.961 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -17.93 64.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.094 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -99.87 3.16 44.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.681 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 65.1 mt -91.91 128.84 43.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.123 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 t -75.09 -63.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.097 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -138.6 152.51 48.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.471 -0.331 . . . . 10.0 110.86 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.446 HG13 ' HB3' ' B' ' 59' ' ' LEU . 18.8 t -131.33 138.49 53.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.3 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 8.7 m -143.09 125.6 15.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.201 0.524 . . . . 10.0 111.25 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.471 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 40.9 ttp85 -105.39 155.64 18.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.939 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -121.77 -34.95 3.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.702 0.287 . . . . 10.0 111.742 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.85 27.23 1.95 Allowed Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 110.241 -1.144 . . . . 10.0 110.241 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -152.64 -57.82 0.14 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.161 -1.052 . . . . 10.0 108.161 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . 0.401 ' HG2' ' HA ' ' B' ' 47' ' ' SER . 42.0 mt-30 -142.93 142.05 31.61 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.667 -1.151 . . . . 10.0 109.569 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -95.46 130.11 44.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 24.8 m-85 -114.23 139.58 49.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.546 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -152.0 160.85 43.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 10.0 111.149 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -123.13 132.92 54.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.362 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -126.12 167.43 15.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.945 0.402 . . . . 10.0 111.491 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -137.66 129.37 28.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.359 -0.837 . . . . 10.0 109.437 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 96.8 mt -101.44 143.85 30.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 10.0 111.077 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.51 -3.21 53.3 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.904 -0.589 . . . . 10.0 112.59 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.92 -8.57 87.55 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.933 -0.651 . . . . 10.0 112.068 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.72 42.5 3.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.265 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -163.77 114.7 0.99 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.711 0.291 . . . . 10.0 110.905 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.06 169.47 8.8 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.737 2.291 . . . . 10.0 111.311 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.51 -177.63 37.3 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.003 -1.094 . . . . 10.0 112.965 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 43.5 m-85 -132.23 164.5 26.23 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.87 150.43 22.09 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.488 -0.863 . . . . 10.0 112.183 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.52 139.2 28.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.101 0.477 . . . . 10.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.22 133.69 55.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.77 -0.65 . . . . 10.0 109.73 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.401 ' HA ' ' HG2' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -80.77 134.21 35.77 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.838 0.351 . . . . 10.0 110.516 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -77.7 41.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.769 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.27 -62.26 0.54 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.509 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -29.53 61.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.864 -0.607 . . . . 10.0 112.033 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.31 136.16 32.07 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.474 -0.33 . . . . 10.0 111.314 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.75 144.17 87.83 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.832 2.355 . . . . 10.0 112.197 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -61.64 -26.04 67.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 10.0 112.074 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -33.57 71.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 10.0 110.064 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 mt -80.96 -39.57 25.82 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.185 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -64.05 -38.64 91.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.62 -0.718 . . . . 10.0 110.962 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -71.93 -15.07 62.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 10.0 111.032 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -81.82 -24.27 35.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.316 0.579 . . . . 10.0 109.47 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . 0.446 ' HB3' HG13 ' B' ' 23' ' ' VAL . 64.0 mt -89.07 -52.5 5.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.33 -0.85 . . . . 10.0 111.352 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . 0.471 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 28.9 tt0 -86.38 106.08 17.17 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.337 0.589 . . . . 10.0 110.228 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -107.25 164.38 12.22 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.333 -0.849 . . . . 10.0 109.21 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -59.2 128.99 39.93 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.181 0.301 . . . . 10.0 110.906 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 66.95 75.88 0.3 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.372 -0.831 . . . . 10.0 110.676 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.493 ' HA ' HH22 ' A' ' 96' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.496 -0.764 . . . . 10.0 110.284 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 121.215 0.531 . . . . 10.0 110.809 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.0 mt -104.13 136.88 42.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.108 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.22 137.04 54.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.935 0.397 . . . . 10.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.16 140.78 31.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.353 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 119.91 17.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.026 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.459 ' O ' ' HE2' ' A' ' 105' ' ' LYS . 71.2 mt -72.0 -36.77 69.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.405 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -141.63 169.92 16.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.789 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.33 149.29 40.68 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -124.08 124.73 43.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.107 0.48 . . . . 10.0 111.985 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.452 ' CD ' ' HZ3' ' B' ' 64' ' ' LYS . 0.1 OUTLIER -96.43 98.12 9.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.308 -0.86 . . . . 10.0 109.097 178.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.49 155.51 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.608 -0.724 . . . . 10.0 112.191 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -114.4 -32.8 5.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.306 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.26 -166.52 1.66 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.272 -0.171 . . . . 10.0 110.844 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.4 -1.21 51.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 10.0 109.908 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.57 -42.45 16.76 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.065 -0.717 . . . . 10.0 109.065 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -91.82 138.41 31.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.946 -1.025 . . . . 10.0 109.894 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.1 tp -100.64 133.16 45.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.914 -0.585 . . . . 10.0 111.633 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.22 147.13 27.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.539 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -152.72 162.66 40.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.646 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -101.47 163.86 12.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.735 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 90' ' ' LEU . 57.7 tttm -60.97 118.71 7.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.767 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.92 -0.25 31.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.678 -0.773 . . . . 10.0 112.641 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.4 141.31 55.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.584 0.23 . . . . 10.0 110.74 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -120.67 134.8 55.26 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -128.29 157.57 40.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.317 0.579 . . . . 10.0 111.919 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -99.88 110.16 22.52 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.935 -1.135 . . . . 10.0 107.935 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.6 mm -64.35 116.64 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.299 -0.409 . . . . 10.0 111.651 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.6 mt -104.12 -57.7 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.563 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -117.65 112.9 21.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.355 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.58 -17.59 3.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.21 0.448 . . . . 10.0 112.21 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.2 m -83.14 -6.26 59.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.032 0.382 . . . . 10.0 112.032 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.11 -53.29 39.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 10.0 110.55 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.409 ' HA3' ' CD1' ' B' ' 43' ' ' PHE . . . -167.17 -159.14 12.25 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.451 -0.66 . . . . 10.0 111.451 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.69 -34.56 74.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.929 0.395 . . . . 10.0 110.689 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -86.07 112.69 21.5 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.781 -0.822 . . . . 10.0 108.781 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -91.17 145.7 24.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.927 -0.578 . . . . 10.0 111.471 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -108.66 115.85 30.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.075 -1.083 . . . . 10.0 108.075 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.1 164.64 26.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.064 0.459 . . . . 10.0 111.903 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.95 127.77 51.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.778 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.7 t -65.72 135.11 54.52 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.311 -0.404 . . . . 10.0 109.919 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.4 mt -82.3 -15.46 52.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.183 0.516 . . . . 10.0 109.806 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.8 m -79.85 -67.94 0.72 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.476 -0.784 . . . . 10.0 111.556 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 p -92.21 -34.68 14.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.151 0.426 . . . . 10.0 112.151 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.3 -4.97 35.45 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.628 -0.796 . . . . 10.0 112.071 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -63.75 141.61 58.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.681 0.277 . . . . 10.0 110.695 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.7 m -117.75 133.13 56.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.859 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -172.86 -178.57 42.99 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.799 -0.715 . . . . 10.0 112.093 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -78.66 131.39 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 10.0 110.498 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.0 pt -123.06 136.71 27.21 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.513 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.66 117.44 4.51 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.46 2.107 . . . . 10.0 111.563 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.72 -19.41 65.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 10.0 112.363 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.417 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 36.0 p-10 -87.05 0.46 55.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.405 -0.361 . . . . 10.0 111.338 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -116.28 -0.08 12.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.697 0.284 . . . . 10.0 111.223 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.35 151.94 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.906 0.384 . . . . 10.0 111.451 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.45 150.17 62.86 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.266 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.14 142.63 97.45 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.686 2.257 . . . . 10.0 112.348 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.459 -0.782 . . . . 10.0 110.809 -179.667 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 20.3 ttt . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.571 0.224 . . . . 10.0 110.667 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.6 161.09 26.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.733 0.302 . . . . 10.0 110.952 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 7.1 m -100.73 133.28 45.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.388 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 21.0 t -115.42 138.8 44.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.002 0.43 . . . . 10.0 111.488 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -96.5 135.01 38.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.853 -0.612 . . . . 10.0 109.678 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.85 -179.51 6.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.816 0.341 . . . . 10.0 110.703 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.424 ' HE2' ' OE2' ' B' ' 12' ' ' GLU . 66.9 mttt -117.53 141.79 47.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.147 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -146.85 110.82 5.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.595 -0.275 . . . . 10.0 110.716 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm 67.5 1.89 2.71 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.937 0.773 . . . . 10.0 111.969 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.77 -52.57 0.82 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.668 -0.777 . . . . 10.0 112.096 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.49 145.35 47.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.866 0.365 . . . . 10.0 110.323 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.424 ' OE2' ' HE2' ' B' ' 7' ' ' LYS . 21.7 mt-10 -90.92 122.46 33.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.811 -0.631 . . . . 10.0 109.866 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -116.33 157.34 25.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.641 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -128.45 118.21 22.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.319 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 46.8 t -134.56 149.38 29.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.487 -0.56 . . . . 10.0 109.487 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 18.8 m-20 -68.26 138.38 55.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.715 0.293 . . . . 10.0 110.518 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 tt -62.54 -24.54 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 2.4 m -72.46 -9.2 58.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.082 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -106.6 11.8 30.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.338 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' B' ' 34' ' ' TYR . 67.6 mt -99.48 137.43 26.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 10.0 109.996 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 6.8 t -77.92 -74.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.777 0.322 . . . . 10.0 111.059 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -126.97 155.17 43.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.423 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.26 125.4 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.34 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -120.05 118.41 30.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.14 0.495 . . . . 10.0 111.464 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 40.5 ttp85 -104.81 144.17 32.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.142 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -115.36 -26.52 7.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.611 0.243 . . . . 10.0 111.131 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.71 14.57 8.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.401 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -145.24 -52.79 0.28 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.818 -0.808 . . . . 10.0 108.818 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -142.47 135.39 28.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.814 -1.085 . . . . 10.0 109.519 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 61.3 mt -93.02 133.52 33.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.212 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 53.3 m-85 -119.89 137.94 53.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.47 174.31 13.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.087 0.47 . . . . 10.0 111.383 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -126.95 126.45 43.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.315 -0.857 . . . . 10.0 109.399 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 20' ' ' ILE . 53.9 p90 -116.12 159.03 22.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 10.0 111.223 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -126.26 115.83 20.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.434 -0.803 . . . . 10.0 109.775 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.41 137.41 32.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.005 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.36 -13.54 58.36 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.912 -0.586 . . . . 10.0 112.807 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.03 2.65 83.39 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.179 -0.534 . . . . 10.0 112.368 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.49 46.02 5.35 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.917 -0.659 . . . . 10.0 112.873 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -152.62 95.3 3.09 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.713 0.292 . . . . 10.0 111.211 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.49 150.88 25.33 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.931 2.421 . . . . 10.0 110.9 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.16 -170.9 22.59 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.044 -1.074 . . . . 10.0 112.885 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . 0.409 ' CD1' ' HA3' ' A' ' 117' ' ' GLY . 24.4 m-85 -126.6 165.8 18.5 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.56 -0.533 . . . . 10.0 109.56 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.45 149.48 20.08 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.251 -0.976 . . . . 10.0 112.553 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.1 p -125.53 138.1 55.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.092 0.473 . . . . 10.0 110.85 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 74.7 t -125.76 118.85 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.002 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 118.74 15.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.572 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.73 -7.93 43.6 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.648 0.61 . . . . 10.0 112.648 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -103.75 -24.18 13.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.84 0.311 . . . . 10.0 111.84 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.38 -42.37 6.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.361 0.504 . . . . 10.0 112.361 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.96 146.81 87.97 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.686 -0.233 . . . . 10.0 111.547 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.63 147.42 91.94 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.693 2.262 . . . . 10.0 111.467 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -60.61 -24.77 65.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -59.11 -44.16 91.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.872 0.368 . . . . 10.0 110.641 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 79.1 mt -72.45 -35.79 68.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.431 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.49 -42.0 92.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.745 -0.661 . . . . 10.0 111.487 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -78.05 -16.92 57.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 10.0 110.909 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -79.46 -45.92 18.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.551 -0.537 . . . . 10.0 109.551 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.79 -47.78 61.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.593 -0.73 . . . . 10.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -82.62 98.74 9.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.007 0.432 . . . . 10.0 110.453 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -96.22 144.2 26.63 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.844 -0.616 . . . . 10.0 109.919 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -61.89 130.88 47.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.968 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 67.58 97.38 0.06 Allowed 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.981 0.8 . . . . 10.0 111.23 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.452 ' HZ3' ' CD ' ' A' ' 94' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.637 -0.697 . . . . 10.0 110.302 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.632 0.253 . . . . 10.0 110.985 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.7 mt -108.49 140.23 42.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.559 -0.291 . . . . 10.0 110.361 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -112.33 130.05 56.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.209 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -109.1 140.38 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.234 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.26 121.36 19.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.84 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.6 -32.67 62.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.338 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.8 168.15 24.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.483 -0.781 . . . . 10.0 109.502 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.77 139.58 40.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.744 -0.465 . . . . 10.0 109.744 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -101.84 128.56 48.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.834 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -77.84 101.37 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.681 -0.69 . . . . 10.0 109.353 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.28 141.37 19.35 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.633 0.583 . . . . 10.0 111.661 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -106.93 -58.5 1.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.661 -0.7 . . . . 10.0 111.03 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 p -131.83 -165.86 1.64 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.958 -0.565 . . . . 10.0 110.346 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -89.32 -6.73 56.47 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.13 -0.693 . . . . 10.0 109.13 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -76.42 -45.14 32.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.045 -0.98 . . . . 10.0 110.006 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -82.5 152.86 25.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.466 -0.788 . . . . 10.0 110.149 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.8 tp -89.82 132.2 35.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.345 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 m -91.15 126.16 36.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.751 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -146.83 165.49 29.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.828 0.346 . . . . 10.0 111.218 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -118.33 166.51 12.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.166 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.2 tttm -66.52 132.25 47.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.942 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.56 -6.16 52.3 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.835 -0.698 . . . . 10.0 112.71 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -81.54 150.35 28.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 10.0 111.415 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -113.16 128.24 56.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.745 -0.662 . . . . 10.0 109.225 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -120.25 144.47 47.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.9 0.381 . . . . 10.0 111.216 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -99.08 110.66 23.22 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 16.9 mm -66.22 118.63 9.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.334 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.13 -37.72 18.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.083 -0.508 . . . . 10.0 109.896 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -153.57 112.37 3.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.968 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.47 2.59 47.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.274 0.559 . . . . 10.0 110.656 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.91 20.07 1.94 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.794 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.61 -42.89 17.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.274 0.559 . . . . 10.0 110.159 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 138.5 -70.79 0.46 Allowed Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.702 -0.681 . . . . 10.0 111.82 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -122.76 -69.0 0.85 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.709 -0.478 . . . . 10.0 109.709 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.489 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 40.0 m95 -78.35 100.84 6.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.444 -0.947 . . . . 10.0 108.444 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -88.34 156.26 19.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.057 -0.52 . . . . 10.0 111.941 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -84.56 122.9 29.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.404 -0.817 . . . . 10.0 109.028 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.25 153.13 43.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.238 0.542 . . . . 10.0 112.107 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -114.06 123.29 49.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.072 -0.967 . . . . 10.0 109.128 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 t -67.22 131.36 45.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.955 0.407 . . . . 10.0 110.016 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.4 mt -83.1 -21.28 33.73 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.31 -55.15 6.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.077 -0.965 . . . . 10.0 111.075 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.4 p -94.58 -67.17 0.87 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.766 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.29 -2.2 3.83 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.824 -0.91 . . . . 10.0 110.824 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -68.66 148.05 50.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.294 -0.453 . . . . 10.0 110.738 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.2 m -120.91 138.71 53.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.233 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.85 -175.05 47.49 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.571 -0.823 . . . . 10.0 112.159 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -88.79 135.7 33.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.615 0.245 . . . . 10.0 110.69 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.0 pt -125.78 143.96 46.84 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.192 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.501 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 56.9 Cg_endo -73.16 121.45 7.25 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.396 2.064 . . . . 10.0 111.347 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.18 -1.65 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.501 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 36.8 p-10 -96.33 0.55 50.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.794 0.33 . . . . 10.0 110.768 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -119.7 1.03 11.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.035 0.445 . . . . 10.0 111.202 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.63 154.33 36.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.37 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.15 147.13 42.83 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.804 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.29 142.85 42.23 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.438 2.092 . . . . 10.0 111.512 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.406 -0.807 . . . . 10.0 110.143 179.947 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.309 0.1 . . . . 10.0 110.828 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.03 171.23 11.26 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.751 0.31 . . . . 10.0 110.883 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m -107.72 129.16 55.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.34 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -102.85 137.39 31.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 10.0 110.722 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -101.94 137.32 40.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 10.0 110.417 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -145.55 168.13 21.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.254 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.45 85.14 2.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -67.77 96.38 0.56 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.356 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt 58.94 26.33 14.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.353 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.26 -27.23 9.66 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.973 -0.632 . . . . 10.0 112.703 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -76.87 114.03 15.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.693 0.283 . . . . 10.0 111.204 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.03 109.75 7.78 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.772 -0.455 . . . . 10.0 109.772 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -131.08 157.38 43.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.55 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -129.42 132.02 46.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.847 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 90.8 t -136.99 147.13 27.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.419 ' HB2' ' HD2' ' B' ' 19' ' ' LYS . 18.1 m-20 -61.16 135.99 57.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 10.0 110.783 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.4 tt -60.6 -31.4 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.492 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -5.49 39.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.165 -0.471 . . . . 10.0 111.584 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.419 ' HD2' ' HB2' ' B' ' 16' ' ' ASP . 80.9 mttt -105.29 9.99 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.21 0.529 . . . . 10.0 110.618 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 78.7 mt -95.55 121.7 46.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.39 -60.0 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.69 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.22 151.53 45.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.852 0.358 . . . . 10.0 111.318 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 t -127.02 138.41 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.278 -0.873 . . . . 10.0 109.564 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -136.91 118.6 15.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.977 0.418 . . . . 10.0 111.04 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 35.1 ttp85 -109.03 141.1 41.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.409 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -115.92 -26.06 7.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.339 -0.391 . . . . 10.0 111.168 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.64 29.76 2.81 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.748 . . . . 10.0 111.452 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -157.52 -53.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -139.23 129.88 25.95 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.283 -0.871 . . . . 10.0 109.806 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mt -88.98 117.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -104.97 139.12 40.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.688 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.81 166.19 32.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.724 0.297 . . . . 10.0 110.939 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -127.63 135.91 50.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.097 -0.501 . . . . 10.0 109.837 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -122.11 165.15 16.53 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.483 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -136.32 121.81 19.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.844 -0.616 . . . . 10.0 110.331 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 66.1 mt -98.11 142.38 29.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.875 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.38 -14.99 62.94 Favored Glycine 0 C--N 1.329 0.148 0 CA-C-N 116.095 -0.502 . . . . 10.0 112.815 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.64 11.94 54.2 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.659 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.3 51.1 6.28 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.889 -0.672 . . . . 10.0 111.766 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 tptt -138.93 90.46 12.2 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 121.072 -0.251 . . . . 10.0 110.987 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -89.05 110.02 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.771 2.314 . . . . 10.0 110.467 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.63 -177.86 15.18 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.124 -1.036 . . . . 10.0 112.897 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 23.0 m-85 -120.8 166.74 13.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.785 -0.45 . . . . 10.0 109.785 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.35 142.8 12.02 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.827 -0.702 . . . . 10.0 112.169 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.68 129.25 51.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.844 0.354 . . . . 10.0 110.43 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -126.07 127.19 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.204 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.15 127.94 34.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.457 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -83.73 26.06 0.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -137.69 -50.54 0.61 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -95.64 19.86 10.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.34 144.14 48.32 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.614 -0.267 . . . . 10.0 110.456 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.41 138.45 47.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.025 2.483 . . . . 10.0 112.248 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -60.7 -27.55 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.982 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.83 -38.1 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.716 0.293 . . . . 10.0 111.134 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.19 -39.85 78.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.382 . . . . 10.0 110.035 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 21.9 mt -67.84 -39.72 83.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.588 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -66.93 -31.61 72.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.266 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.42 -8.6 59.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.003 0.43 . . . . 10.0 110.748 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 25.5 mt -96.09 -45.56 6.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.791 0.293 . . . . 10.0 111.791 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -91.54 131.84 36.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 10.0 111.213 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -123.86 163.57 20.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 10.0 109.487 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -74.35 131.99 41.62 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.893 -0.323 . . . . 10.0 110.613 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 mttp 64.0 62.52 0.87 Allowed 'General case' 0 C--O 1.236 0.38 0 O-C-N 123.921 0.763 . . . . 10.0 110.746 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.449 ' HZ2' ' C ' ' B' ' 64' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.496 -0.764 . . . . 10.0 110.254 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.753 0.311 . . . . 10.0 110.552 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.4 mt -88.09 160.79 17.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.309 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.18 135.92 55.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.505 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 p -111.05 139.29 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.553 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.99 124.63 25.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.162 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.41 ' O ' ' HE2' ' A' ' 105' ' ' LYS . 59.6 mt -83.51 -33.37 25.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.531 . . . . 10.0 110.607 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -139.61 154.57 47.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.962 -0.563 . . . . 10.0 109.812 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.01 150.42 42.43 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.619 -0.512 . . . . 10.0 109.619 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -138.02 133.93 34.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.629 0.252 . . . . 10.0 110.518 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.65 132.45 46.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.15 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.477 ' HA ' ' OD2' ' A' ' 100' ' ' ASP . . . -91.88 148.76 21.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.015 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.419 HH12 ' HD3' ' A' ' 96' ' ' ARG . 5.4 ttm180 -119.8 -21.37 7.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.345 0.593 . . . . 10.0 109.968 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.55 -178.48 4.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.005 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -94.17 8.56 41.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.358 0.599 . . . . 10.0 110.143 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.407 ' CG ' HH12 ' B' ' 33' ' ' ARG . 0.5 OUTLIER -94.69 -44.14 7.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.303 -0.862 . . . . 10.0 109.521 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.477 ' OD2' ' HA ' ' A' ' 95' ' ' ALA . 15.9 p-10 -88.39 151.21 22.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.411 -0.813 . . . . 10.0 109.053 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 tp -112.0 129.12 56.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.984 0.421 . . . . 10.0 112.057 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.469 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -84.28 139.36 32.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.124 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.4 ' CB ' ' HZ ' ' A' ' 109' ' ' PHE . 31.3 p90 -155.2 170.81 20.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.841 0.353 . . . . 10.0 111.225 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -114.91 157.61 23.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.71 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 90' ' ' LEU . 54.8 tttm -62.32 131.99 51.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.664 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.71 -19.73 23.3 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.546 -0.835 . . . . 10.0 112.863 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -77.15 148.98 35.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.98 0.419 . . . . 10.0 110.834 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -114.68 144.09 43.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.122 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.4 ' HZ ' ' CB ' ' A' ' 103' ' ' PHE . 32.1 m-85 -129.51 153.91 47.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.963 0.411 . . . . 10.0 111.306 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -100.1 114.35 27.64 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 46.9 mm -69.35 119.15 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.904 0.383 . . . . 10.0 111.142 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.4 mt -85.37 -52.58 5.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.648 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -135.92 109.1 7.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.877 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.36 -8.08 39.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.225 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.27 21.22 9.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.45 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 119' ' ' TRP . 19.4 tp10 -67.59 -43.39 80.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.645 -0.707 . . . . 10.0 110.356 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 155.28 -106.54 0.3 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.833 -0.698 . . . . 10.0 111.887 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -99.4 -11.44 21.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.213 0.53 . . . . 10.0 109.971 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.472 ' O ' ' HB3' ' A' ' 116' ' ' GLU . 39.9 m95 -124.64 159.71 30.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.155 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -119.85 139.99 51.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.943 0.401 . . . . 10.0 111.88 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -90.23 116.11 27.97 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.786 -1.19 . . . . 10.0 107.786 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.91 160.61 30.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.643 0.735 . . . . 10.0 112.579 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -116.31 128.29 55.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.67 -1.15 . . . . 10.0 109.226 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t -66.43 133.16 49.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.81 0.338 . . . . 10.0 111.101 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.8 mt -92.04 -11.23 36.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.432 0.634 . . . . 10.0 109.362 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -50.47 8.48 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.347 -0.842 . . . . 10.0 110.537 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.0 p -111.05 -55.89 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.099 0.476 . . . . 10.0 111.298 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.1 -8.54 4.44 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.908 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -55.73 146.82 20.18 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.05 0.452 . . . . 10.0 111.843 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.83 142.62 46.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.329 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.92 173.47 42.51 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.419 -0.896 . . . . 10.0 112.076 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -84.79 131.34 34.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.019 0.438 . . . . 10.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.0 pt -115.51 144.53 32.61 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.547 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.465 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 19.6 Cg_exo -63.89 114.53 2.64 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.849 1.7 . . . . 10.0 111.141 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.1 -14.2 15.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.559 -0.746 . . . . 10.0 112.46 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -104.27 12.88 33.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.424 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 134' ' ' PRO . 8.8 m-85 -120.82 3.34 10.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.747 0.308 . . . . 10.0 111.163 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 m -128.84 148.44 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.945 0.402 . . . . 10.0 111.12 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -128.9 141.44 41.71 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.292 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.02 137.02 43.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.654 2.236 . . . . 10.0 111.973 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 64.3 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.397 -0.811 . . . . 10.0 109.785 179.678 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.668 0.271 . . . . 10.0 110.398 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.52 147.58 28.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.863 0.364 . . . . 10.0 110.866 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.8 m -97.84 132.33 43.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.419 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 48.5 t -104.46 131.62 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.867 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -98.42 131.62 44.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.677 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -145.42 -174.07 4.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.742 0.306 . . . . 10.0 110.809 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -130.2 123.96 31.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.895 -0.593 . . . . 10.0 109.841 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . 0.466 ' O ' ' HG2' ' B' ' 11' ' ' GLU . 17.9 t80 -102.17 94.05 5.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.869 0.366 . . . . 10.0 110.122 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 60.44 13.4 4.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.639 -0.71 . . . . 10.0 112.156 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.68 -35.87 2.0 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.38 -0.914 . . . . 10.0 113.159 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' B' ' 8' ' ' TYR . 12.0 pt-20 -82.57 136.66 34.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.159 0.479 . . . . 10.0 111.062 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -83.62 138.59 33.28 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -148.3 150.48 33.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.894 0.378 . . . . 10.0 111.386 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -123.47 110.82 15.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.126 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t -125.44 141.51 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.162 -0.472 . . . . 10.0 109.835 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 29.9 m-20 -66.97 145.25 55.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.117 0.484 . . . . 10.0 111.786 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.6 tt -58.88 -30.14 42.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.401 -0.818 . . . . 10.0 112.318 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 5.8 m -74.04 -10.65 59.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.778 0.323 . . . . 10.0 111.417 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.3 2.58 39.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.237 0.541 . . . . 10.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -99.3 110.48 26.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.537 -0.756 . . . . 10.0 109.289 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.19 -78.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.698 -0.683 . . . . 10.0 112.14 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -114.57 144.8 42.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 10.0 111.202 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 t -131.68 140.93 47.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 56.1 m -144.93 125.87 14.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.216 0.532 . . . . 10.0 111.376 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.435 ' HG3' ' OE1' ' B' ' 48' ' ' GLU . 27.6 ttp85 -108.42 152.59 24.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.373 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -129.63 -18.31 3.53 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.874 -0.33 . . . . 10.0 111.745 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.46 3.14 25.8 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.316 -0.945 . . . . 10.0 111.325 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -128.02 -52.27 1.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.405 -0.591 . . . . 10.0 109.405 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -150.97 143.32 24.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.373 -0.83 . . . . 10.0 109.941 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mt -95.02 132.68 38.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.331 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -118.9 142.68 47.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.308 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -162.14 168.82 21.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.807 0.336 . . . . 10.0 111.193 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . 0.407 HH12 ' CG ' ' A' ' 99' ' ' ASP . 16.1 ttp180 -123.9 133.56 53.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.476 -0.564 . . . . 10.0 109.476 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -113.88 147.54 38.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.977 0.418 . . . . 10.0 110.739 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -122.94 121.76 36.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.641 -0.708 . . . . 10.0 109.531 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt -97.84 136.85 37.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.817 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.3 -18.18 64.88 Favored Glycine 0 C--N 1.33 0.202 0 CA-C-N 116.068 -0.515 . . . . 10.0 112.194 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.57 -8.63 87.56 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.793 -0.718 . . . . 10.0 111.913 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 64.85 1.05 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.76 -0.734 . . . . 10.0 112.471 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -160.34 85.47 1.97 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.047 0.451 . . . . 10.0 110.371 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -84.34 136.07 6.46 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.668 2.245 . . . . 10.0 111.667 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.37 -176.92 29.97 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.532 -0.842 . . . . 10.0 112.101 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -113.13 168.83 9.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.303 -0.258 . . . . 10.0 110.303 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.03 138.77 7.08 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.463 -0.655 . . . . 10.0 111.463 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.44 135.28 64.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.88 0.372 . . . . 10.0 110.424 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 81.1 t -127.67 129.11 70.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.574 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.9 t -75.78 126.98 32.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.226 -0.443 . . . . 10.0 109.903 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.435 ' OE1' ' HG3' ' B' ' 25' ' ' ARG . 52.8 mt-10 -76.45 2.46 13.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.955 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -124.37 -34.71 2.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.595 -0.275 . . . . 10.0 111.497 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -84.47 -24.28 29.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.735 0.302 . . . . 10.0 111.557 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.35 146.87 32.07 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.747 0.308 . . . . 10.0 111.038 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.63 156.23 66.88 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.704 2.269 . . . . 10.0 111.759 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -60.57 -25.96 66.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.375 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . 0.404 ' CD ' ' HZ2' ' B' ' 58' ' ' LYS . 1.3 tm-20 -51.39 -40.85 60.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.666 -0.697 . . . . 10.0 111.385 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.21 -40.53 14.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.027 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 54.8 mt -60.89 -37.18 81.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.7 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -74.52 -11.53 60.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.603 -0.271 . . . . 10.0 111.342 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.404 ' HZ2' ' CD ' ' B' ' 54' ' ' GLU . 53.3 mttp -94.42 -19.16 20.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.097 0.475 . . . . 10.0 110.05 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -95.14 -7.94 37.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.229 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -79.92 71.35 6.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.616 -0.72 . . . . 10.0 109.781 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' B' ' 64' ' ' LYS . 82.3 mttt -72.39 102.71 3.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.589 -0.732 . . . . 10.0 110.076 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -70.68 150.96 45.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.401 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 67.59 33.85 4.86 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.739 0.78 . . . . 10.0 109.791 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' B' ' 61' ' ' LYS . 11.5 tptp . . . . . 0 C--O 1.251 1.172 0 CA-C-N 114.642 -1.163 . . . . 10.0 108.783 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.592 0.234 . . . . 10.0 110.553 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -107.86 137.94 44.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.964 0.411 . . . . 10.0 110.876 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -116.41 142.24 47.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.526 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.6 p -110.47 140.34 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.534 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.76 126.21 30.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.888 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.76 -31.95 35.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.019 0.438 . . . . 10.0 110.164 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -141.29 168.76 19.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.67 -0.696 . . . . 10.0 109.442 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.19 138.83 35.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.336 -0.393 . . . . 10.0 109.946 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -112.65 127.17 56.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.098 0.475 . . . . 10.0 111.67 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -95.94 118.09 31.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.371 -0.974 . . . . 10.0 108.371 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.87 153.26 36.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.98 0.419 . . . . 10.0 111.236 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -118.08 -35.9 3.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.946 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.44 171.79 7.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.985 0.421 . . . . 10.0 110.343 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -84.32 20.01 1.75 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.738 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.74 -36.04 3.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.161 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -83.3 141.05 32.11 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.923 -0.769 . . . . 10.0 108.923 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.0 tp -97.65 126.94 43.24 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.407 0.521 . . . . 10.0 112.407 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.4 146.97 25.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 10.0 109.839 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -155.61 168.39 27.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.674 0.274 . . . . 10.0 111.014 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -105.8 160.6 15.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.916 -0.583 . . . . 10.0 110.434 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -64.9 126.43 27.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.115 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.38 -9.07 38.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.641 -0.79 . . . . 10.0 113.278 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -77.8 151.45 33.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.269 0.534 . . . . 10.0 111.147 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -118.42 133.52 55.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.684 . . . . 10.0 109.971 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.26 152.56 45.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.784 0.326 . . . . 10.0 110.56 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -95.0 115.35 27.31 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.948 -0.76 . . . . 10.0 108.948 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.6 mm -69.5 120.18 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.862 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.1 mt -89.43 -55.93 3.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.148 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.406 ' ND2' ' HG3' ' A' ' 116' ' ' GLU . 66.1 t30 -134.74 108.63 8.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.922 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.34 4.71 41.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.642 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -95.4 8.53 42.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.031 -0.532 . . . . 10.0 111.541 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.406 ' HG3' ' ND2' ' A' ' 113' ' ' ASN . 5.0 mt-10 -95.21 74.55 3.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.312 0.577 . . . . 10.0 110.842 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.459 ' O ' ' HE2' ' B' ' 9' ' ' LYS . . . 68.04 -132.53 28.55 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.776 -0.726 . . . . 10.0 112.127 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -112.32 8.62 19.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.022 0.439 . . . . 10.0 110.798 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -120.44 104.76 10.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.262 -1.014 . . . . 10.0 108.262 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 4.6 m0 -83.35 135.56 34.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.869 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -92.41 112.56 24.55 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.462 -1.31 . . . . 10.0 107.462 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.75 169.26 11.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.012 0.434 . . . . 10.0 111.806 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -120.52 126.04 49.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.544 -0.753 . . . . 10.0 109.765 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.2 t -65.24 135.31 55.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.399 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.02 -12.38 44.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.056 0.455 . . . . 10.0 110.2 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.35 -48.02 11.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.693 -0.685 . . . . 10.0 111.126 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 80.8 p -105.98 -43.61 4.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.995 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.52 3.88 28.75 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.605 -0.807 . . . . 10.0 111.729 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -74.12 144.88 44.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 10.0 110.576 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -118.44 139.5 51.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.921 -0.582 . . . . 10.0 110.811 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.95 177.17 45.69 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.798 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.32 129.41 35.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.7 pt -113.67 136.78 22.03 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.719 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.57 107.16 0.82 Allowed 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.494 2.129 . . . . 10.0 111.752 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -7.69 10.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.791 -0.64 . . . . 10.0 112.227 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -96.11 1.22 52.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.833 0.349 . . . . 10.0 110.701 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -111.5 -14.45 13.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.093 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.6 m -114.1 160.62 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.108 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -143.42 152.66 57.63 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.448 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.12 144.56 87.43 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.272 1.981 . . . . 10.0 111.632 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.416 -0.802 . . . . 10.0 110.176 -179.982 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.524 0.202 . . . . 10.0 110.609 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.01 169.96 23.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.931 0.396 . . . . 10.0 111.48 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 7.4 m -104.95 136.01 45.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.895 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 44.3 t -109.86 132.47 58.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.763 0.316 . . . . 10.0 110.91 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -99.31 127.04 45.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.272 -0.64 . . . . 10.0 109.272 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.468 ' CD2' ' HZ ' ' B' ' 32' ' ' PHE . 41.3 p90 -141.96 175.88 9.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.441 -0.345 . . . . 10.0 111.009 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -109.72 146.91 34.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.88 92.78 2.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 117' ' ' GLY . 5.1 mmtm 61.57 30.35 18.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.287 -0.87 . . . . 10.0 111.668 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.83 -51.88 0.72 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.908 -0.663 . . . . 10.0 113.469 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -74.18 142.66 45.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.959 0.409 . . . . 10.0 111.198 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -92.94 130.49 38.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.953 -0.567 . . . . 10.0 109.79 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.47 157.26 35.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.568 -0.287 . . . . 10.0 110.916 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -129.32 113.28 14.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.549 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.14 149.5 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.273 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 5.1 m-20 -64.99 142.82 58.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.656 -0.247 . . . . 10.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 12.0 tt -65.96 -24.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.48 0.657 . . . . 10.0 110.041 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -4.06 33.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.322 -0.853 . . . . 10.0 111.068 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -110.97 15.08 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.539 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 71.3 mt -95.91 133.15 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.257 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -80.99 -52.58 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.066 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -152.15 155.3 37.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.367 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.59 125.83 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 123.547 0.529 . . . . 10.0 110.464 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 4.2 m -116.82 105.95 12.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.871 0.367 . . . . 10.0 111.453 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.55 ' HD2' ' OE2' ' B' ' 48' ' ' GLU . 0.3 OUTLIER -94.82 136.99 34.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.354 -0.384 . . . . 10.0 110.091 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -116.48 -21.47 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.887 0.375 . . . . 10.0 111.16 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.82 4.59 39.3 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.081 -0.808 . . . . 10.0 111.081 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -134.12 -47.41 0.78 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -149.44 132.69 16.43 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.988 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -87.17 123.65 40.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.245 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.81 132.67 53.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.86 -0.609 . . . . 10.0 109.612 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . 0.468 ' HZ ' ' CD2' ' B' ' 6' ' ' PHE . 43.4 p90 -150.77 169.46 21.61 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.431 -0.508 . . . . 10.0 111.985 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -122.04 138.87 54.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.357 -0.838 . . . . 10.0 109.459 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -133.67 165.65 24.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 10.0 111.697 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.32 121.38 15.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.707 -0.678 . . . . 10.0 110.112 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' B' ' 40' ' ' LYS . 24.9 mt -96.08 129.67 43.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.616 -0.265 . . . . 10.0 110.415 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.6 106.23 1.31 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.095 -0.574 . . . . 10.0 111.869 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.77 -7.83 1.73 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.976 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.54 36.27 3.84 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.52 -0.847 . . . . 10.0 112.991 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 79.5 tttt -135.42 67.72 67.18 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.113 0.457 . . . . 10.0 111.274 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -90.74 171.65 3.35 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.499 2.133 . . . . 10.0 112.015 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.8 -158.73 31.54 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.413 -0.898 . . . . 10.0 112.394 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -121.37 178.33 4.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.515 0.198 . . . . 10.0 110.517 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.51 150.5 19.68 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.654 -0.784 . . . . 10.0 111.957 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.55 130.8 69.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.188 0.518 . . . . 10.0 110.974 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 5.0 t -118.57 122.78 70.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.828 -0.623 . . . . 10.0 109.748 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.7 t -69.77 133.18 47.16 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.154 -0.313 . . . . 10.0 110.154 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.55 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 44.0 mt-10 -87.24 15.95 5.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.944 0.402 . . . . 10.0 110.389 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -122.92 -62.79 1.32 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.605 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.35 36.33 0.69 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 10.0 112.194 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.66 143.72 36.34 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.316 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.75 143.1 85.58 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.618 2.212 . . . . 10.0 112.095 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -59.79 -23.13 63.03 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.582 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -52.93 -50.88 63.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.685 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 75.6 mt -77.2 -34.86 56.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.695 0.283 . . . . 10.0 110.933 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.81 -42.0 98.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.391 -0.368 . . . . 10.0 111.553 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -73.9 -31.48 63.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.008 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -71.59 -33.78 69.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.462 -0.335 . . . . 10.0 110.394 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 20.5 mt -74.46 -44.54 51.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.677 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -79.19 87.43 4.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.177 0.513 . . . . 10.0 110.625 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -89.76 145.45 25.18 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.924 -0.58 . . . . 10.0 109.777 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -68.21 140.52 56.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.522 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.7 mttt 62.31 79.48 0.26 Allowed 'General case' 0 C--O 1.232 0.18 0 O-C-N 123.835 0.71 . . . . 10.0 110.233 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.221 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.833 0.349 . . . . 10.0 110.703 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.06 154.94 24.15 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.747 -0.464 . . . . 10.0 109.747 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -121.65 136.17 54.95 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.2 -0.296 . . . . 10.0 110.2 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.27 138.96 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.61 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.43 122.57 22.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.208 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.2 mt -77.78 -35.12 51.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.801 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -142.78 163.88 31.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 10.0 110.273 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.31 131.41 42.64 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -102.8 123.68 46.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.048 0.452 . . . . 10.0 111.688 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -88.29 105.81 17.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.802 -0.814 . . . . 10.0 108.802 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.99 156.99 37.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.355 0.598 . . . . 10.0 111.96 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -118.46 -44.08 2.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.67 -0.695 . . . . 10.0 111.059 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.89 -160.83 0.89 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.511 -0.313 . . . . 10.0 110.979 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.35 -16.33 19.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.271 0.558 . . . . 10.0 109.54 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.86 -44.74 69.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.159 -0.928 . . . . 10.0 110.26 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.46 146.04 31.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.559 -0.746 . . . . 10.0 109.958 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.7 tp -96.77 124.9 40.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.31 -0.405 . . . . 10.0 111.816 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.24 129.42 34.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.297 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -144.29 164.53 30.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.892 0.377 . . . . 10.0 111.13 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -106.05 160.78 15.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.515 -0.766 . . . . 10.0 110.111 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -65.22 130.75 44.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.588 -0.278 . . . . 10.0 110.755 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.06 -15.34 51.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.681 -0.771 . . . . 10.0 113.175 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -71.43 152.22 43.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.899 0.381 . . . . 10.0 111.102 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -114.03 139.81 48.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.75 -0.659 . . . . 10.0 110.21 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.0 157.64 45.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 10.0 111.018 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -108.94 117.95 35.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.306 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.8 mm -69.09 123.76 23.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.231 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 mt -98.17 -37.86 9.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.483 -0.326 . . . . 10.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -142.38 100.87 3.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.79 0.329 . . . . 10.0 111.364 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.75 -5.5 26.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.447 0.641 . . . . 10.0 110.34 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.78 8.71 24.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.078 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -72.9 -35.61 67.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.705 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 146.63 -127.26 2.68 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.719 -0.673 . . . . 10.0 111.454 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -49.74 22.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.933 0.396 . . . . 10.0 110.186 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.513 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 23.5 m95 -87.69 134.81 33.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.8 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 20.0 m0 -110.69 147.69 33.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.921 0.391 . . . . 10.0 111.18 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -99.03 120.57 39.67 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -139.89 166.37 24.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.846 0.355 . . . . 10.0 111.401 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -116.25 140.12 49.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.1 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.1 t -74.46 148.95 40.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.676 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.18 -24.7 18.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.568 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -45.08 48.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.729 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 p -104.35 -63.7 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.696 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.33 -13.01 5.72 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.748 -0.739 . . . . 10.0 112.037 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -57.15 144.42 34.97 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.858 0.361 . . . . 10.0 111.333 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.2 m -118.47 126.33 51.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.759 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -162.9 -174.58 32.97 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.564 -0.827 . . . . 10.0 111.675 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -82.19 130.1 35.0 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.145 -0.317 . . . . 10.0 110.145 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 pt -121.43 140.8 32.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.797 0.332 . . . . 10.0 110.821 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.56 119.64 6.68 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.666 2.244 . . . . 10.0 111.832 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.69 -18.97 65.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 10.0 111.749 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -88.92 7.09 36.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.389 -0.368 . . . . 10.0 111.422 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -123.85 8.04 8.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.179 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.2 m -131.33 151.72 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.992 0.425 . . . . 10.0 111.576 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -133.68 144.37 51.69 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.294 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.73 134.35 43.5 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.608 2.205 . . . . 10.0 112.41 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.434 -0.794 . . . . 10.0 110.445 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ttt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.525 0.203 . . . . 10.0 110.656 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.02 165.52 27.21 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.592 0.234 . . . . 10.0 110.673 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.92 137.75 32.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.903 -0.589 . . . . 10.0 110.958 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 88.2 t -108.55 128.74 63.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.358 -0.383 . . . . 10.0 110.159 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -93.82 121.95 35.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -132.09 170.97 14.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.486 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -117.44 97.07 5.69 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.193 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -80.98 72.47 8.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm 59.16 66.97 0.96 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.306 -0.861 . . . . 10.0 110.955 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.96 -46.3 2.27 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.832 -0.699 . . . . 10.0 113.02 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.32 117.88 19.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 10.0 111.333 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -88.53 116.36 26.71 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.274 -0.639 . . . . 10.0 109.274 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -124.24 160.1 28.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.885 0.374 . . . . 10.0 111.299 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -127.3 118.05 23.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.515 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.5 144.46 37.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.261 -0.427 . . . . 10.0 109.874 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.83 135.69 57.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.499 -0.318 . . . . 10.0 110.388 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 tt -63.75 -22.42 30.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.298 0.57 . . . . 10.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -9.45 59.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.935 -0.575 . . . . 10.0 111.131 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -101.47 11.23 39.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.303 0.573 . . . . 10.0 110.314 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 78.1 mt -98.73 129.95 48.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.34 -0.845 . . . . 10.0 109.654 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 7.2 t -76.65 -75.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.335 -0.393 . . . . 10.0 111.331 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -120.49 153.41 36.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.796 0.332 . . . . 10.0 110.781 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.34 129.2 56.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.869 -0.605 . . . . 10.0 110.511 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 19.5 m -121.44 112.13 18.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.197 0.522 . . . . 10.0 110.861 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.468 ' HG3' HG12 ' B' ' 30' ' ' ILE . 52.0 ttp85 -100.71 133.72 44.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.314 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -103.65 -19.01 14.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.984 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.96 -18.86 14.18 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.115 -0.794 . . . . 10.0 111.115 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -114.04 -61.4 1.75 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -118.67 143.57 46.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.368 -0.833 . . . . 10.0 109.523 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.468 HG12 ' HG3' ' B' ' 25' ' ' ARG . 1.9 mt -106.14 119.31 55.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.033 -0.531 . . . . 10.0 109.908 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -105.24 135.46 46.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.347 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -151.26 165.84 32.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.861 0.362 . . . . 10.0 111.438 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 133.55 54.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.409 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -123.73 166.2 15.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.517 -0.311 . . . . 10.0 110.699 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -139.6 115.81 10.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.164 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -82.55 145.53 29.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.837 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.47 -18.81 73.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.039 -0.601 . . . . 10.0 112.669 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.34 19.86 7.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.024 -0.608 . . . . 10.0 112.887 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.03 51.7 17.34 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.929 -0.653 . . . . 10.0 112.349 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -150.36 96.04 3.49 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.881 0.372 . . . . 10.0 111.286 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.84 154.13 13.24 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.412 2.074 . . . . 10.0 110.76 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.79 -172.11 31.85 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 119.573 -1.299 . . . . 10.0 113.034 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . 0.513 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 15.6 m-85 -133.07 166.89 21.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.685 -0.487 . . . . 10.0 109.685 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.66 146.43 14.48 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.628 -0.796 . . . . 10.0 111.767 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 3.6 p -129.68 127.63 64.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.303 0.573 . . . . 10.0 110.784 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.58 132.08 67.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.282 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 14.6 t -88.67 125.38 34.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.668 0.27 . . . . 10.0 110.388 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -68.97 -17.28 63.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.046 0.451 . . . . 10.0 111.587 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -100.47 16.75 23.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.671 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -133.26 -53.3 0.9 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.903 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.06 152.64 76.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.024 -0.534 . . . . 10.0 111.371 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.436 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 32.0 Cg_endo -63.4 154.08 70.54 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.82 2.346 . . . . 10.0 112.951 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -57.76 -34.12 69.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.459 -0.791 . . . . 10.0 112.082 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -54.15 -44.97 71.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.961 0.356 . . . . 10.0 111.961 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.6 -39.22 70.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 10.0 110.98 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 18.0 mt -65.21 -43.05 92.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.771 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -69.44 -18.39 63.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.818 -0.628 . . . . 10.0 111.685 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -80.67 -25.42 38.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.893 0.378 . . . . 10.0 110.614 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 82.0 mt -83.67 -42.9 16.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.452 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . 0.443 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 1.1 tp10 -86.64 92.39 8.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 10.0 110.342 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -108.88 -177.65 3.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.404 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -80.18 138.19 36.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.262 -0.273 . . . . 10.0 110.262 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 57.4 39.09 28.47 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.43 0.633 . . . . 10.0 110.018 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-N 115.168 -0.924 . . . . 10.0 110.886 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 120.849 0.357 . . . . 10.0 110.441 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -84.79 129.59 34.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.976 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -121.06 145.42 47.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.762 -0.654 . . . . 10.0 109.673 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.23 139.6 42.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.956 0.407 . . . . 10.0 110.647 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.95 123.52 24.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.894 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.4 mt -71.2 -50.93 27.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.429 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -129.01 178.61 6.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.846 -0.615 . . . . 10.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.06 142.87 28.41 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -126.37 130.2 50.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.996 0.426 . . . . 10.0 110.751 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -93.73 116.99 29.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.521 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 137.85 56.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.144 0.497 . . . . 10.0 111.304 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' B' ' 21' ' ' VAL . 14.6 ttt180 -94.09 -40.7 9.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.455 -0.793 . . . . 10.0 110.306 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.9 p -131.95 -163.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.887 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -93.84 -2.49 53.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.238 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.5 -41.43 16.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.907 -0.588 . . . . 10.0 109.874 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -89.49 154.51 19.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.5 -0.773 . . . . 10.0 109.153 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.3 tp -107.62 134.52 50.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.197 0.443 . . . . 10.0 112.197 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.56 146.36 25.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.528 -0.76 . . . . 10.0 110.555 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -162.65 166.06 24.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.821 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -113.53 168.34 9.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.493 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -61.7 115.54 4.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.852 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.09 -1.2 25.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.637 -0.792 . . . . 10.0 112.696 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -67.99 137.92 55.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 10.0 110.947 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -102.2 130.58 48.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -120.47 144.73 47.83 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.098 0.777 . . . . 10.0 113.098 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -108.28 106.07 16.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.7 114.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.101 0.477 . . . . 10.0 111.578 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 mt -86.0 -48.67 8.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.571 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -138.95 104.41 5.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 10.0 111.182 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -15.45 37.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.281 0.562 . . . . 10.0 110.458 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.87 13.45 5.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.811 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.17 -45.38 73.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 10.0 110.471 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.99 -119.12 0.93 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.2 -0.76 . . . . 10.0 111.2 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -93.51 -27.73 16.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.296 0.569 . . . . 10.0 110.052 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.427 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 29.2 m95 -110.63 114.99 28.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.145 -1.057 . . . . 10.0 108.145 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -95.31 143.12 26.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.164 0.507 . . . . 10.0 111.353 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -90.89 121.64 32.91 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.52 -0.919 . . . . 10.0 108.52 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.14 164.34 27.57 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.815 0.341 . . . . 10.0 111.582 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -112.04 137.64 49.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.522 -0.763 . . . . 10.0 110.708 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.1 t -76.45 141.12 41.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.148 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.8 mt -93.21 2.97 56.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.451 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -105.14 -58.48 1.88 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.888 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.1 p -91.47 -39.14 12.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.218 0.532 . . . . 10.0 110.875 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 103.17 6.96 44.5 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.698 -0.683 . . . . 10.0 111.671 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -73.24 146.11 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.321 . . . . 10.0 110.663 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 91.0 m -126.83 134.5 50.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.366 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.63 -176.0 43.5 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.903 -0.665 . . . . 10.0 111.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -76.26 122.65 24.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.757 0.313 . . . . 10.0 110.181 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.3 pt -114.39 141.15 26.07 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.734 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.38 110.3 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.45 2.1 . . . . 10.0 111.591 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -12.11 22.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.973 -0.558 . . . . 10.0 112.13 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -93.93 0.29 56.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.884 0.373 . . . . 10.0 110.66 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.26 5.07 14.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.915 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.2 m -129.78 153.45 38.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.376 -0.374 . . . . 10.0 110.947 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.57 147.92 61.65 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.214 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.84 130.03 20.98 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.537 2.158 . . . . 10.0 112.083 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.356 -0.831 . . . . 10.0 109.898 179.657 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ttt . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 120.711 0.291 . . . . 10.0 110.68 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.12 168.17 25.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.777 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.44 146.38 27.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.382 -0.372 . . . . 10.0 110.952 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.94 132.12 68.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.155 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -103.22 129.33 50.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.031 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 26.5 p90 -139.19 165.06 28.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.736 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -110.0 77.7 1.07 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.086 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -69.58 99.92 1.36 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.551 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 57.2 32.48 21.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.156 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.88 -28.53 14.95 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.756 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -81.76 113.01 19.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.662 0.231 . . . . 10.0 110.89 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 7.2 mt-10 -74.88 115.71 14.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -125.2 156.01 39.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.857 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -124.36 116.6 22.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.336 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.5 145.03 36.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.577 -0.527 . . . . 10.0 109.577 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.92 138.88 58.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.963 0.411 . . . . 10.0 111.099 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 15.2 tt -63.64 -24.51 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.677 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 8.0 m -77.0 -3.5 39.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.619 -0.719 . . . . 10.0 111.007 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -111.37 13.46 21.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.212 0.529 . . . . 10.0 110.021 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -99.01 126.88 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.732 -0.667 . . . . 10.0 109.767 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 96' ' ' ARG . 3.5 t -75.18 -64.38 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.755 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -134.99 153.46 52.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.593 -0.276 . . . . 10.0 111.121 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -132.96 137.5 53.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.237 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -135.24 121.9 20.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.999 0.428 . . . . 10.0 111.023 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.444 ' HG3' HG12 ' B' ' 30' ' ' ILE . 53.6 ttp85 -109.0 146.12 34.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.257 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -127.19 -15.54 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.958 0.409 . . . . 10.0 111.613 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.76 16.76 23.17 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.39 -0.91 . . . . 10.0 111.072 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -140.9 -53.73 0.48 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -145.5 130.99 18.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.318 -0.855 . . . . 10.0 109.816 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 9.4 mt -86.42 121.26 37.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.67 -0.493 . . . . 10.0 109.67 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -109.06 135.78 49.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.722 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -155.69 169.4 24.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.664 0.269 . . . . 10.0 110.704 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -128.34 135.29 49.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.254 -0.43 . . . . 10.0 109.969 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -114.08 168.01 10.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.755 0.312 . . . . 10.0 110.414 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -138.4 112.45 8.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.935 -0.575 . . . . 10.0 109.859 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 82.7 mt -93.55 132.49 37.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.441 -0.345 . . . . 10.0 110.945 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.2 -11.17 61.01 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.91 -0.586 . . . . 10.0 112.469 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.52 -19.54 68.99 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.359 -0.448 . . . . 10.0 112.217 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.97 43.77 1.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.68 -0.771 . . . . 10.0 112.641 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -170.13 111.07 0.46 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.827 0.346 . . . . 10.0 110.738 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -86.27 179.11 3.71 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.513 2.142 . . . . 10.0 110.883 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.64 172.56 43.86 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.079 -1.058 . . . . 10.0 112.276 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 29.9 m-85 -108.1 168.32 9.38 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.38 144.95 12.7 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.938 -0.649 . . . . 10.0 111.888 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 4.2 p -136.78 131.47 47.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.092 0.472 . . . . 10.0 110.876 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.9 121.98 65.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.855 -0.611 . . . . 10.0 109.934 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.39 101.33 3.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.668 0.27 . . . . 10.0 110.662 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -74.1 65.15 1.11 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.585 0.707 . . . . 10.0 110.417 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -166.24 -50.02 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.885 -1.052 . . . . 10.0 109.21 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.47 -28.33 15.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.054 -0.975 . . . . 10.0 111.249 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.66 153.09 73.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.135 -0.484 . . . . 10.0 111.202 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.03 142.64 94.1 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.701 2.267 . . . . 10.0 111.994 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -60.86 -26.03 67.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.812 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -56.84 -48.51 77.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.807 0.337 . . . . 10.0 110.904 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 99.0 mt -65.62 -32.97 74.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.837 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -71.91 -44.0 64.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.792 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -69.52 -31.89 70.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.854 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -78.48 -23.39 46.45 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.051 -0.26 . . . . 10.0 110.999 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.68 -47.59 11.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.968 0.413 . . . . 10.0 110.391 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -84.74 87.84 7.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.362 0.601 . . . . 10.0 109.938 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.416 ' HB2' ' HB3' ' B' ' 64' ' ' LYS . 46.9 mtmt -93.0 169.78 10.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.18 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.7 mm-40 -76.11 121.37 22.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.7 0.286 . . . . 10.0 110.572 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 mttt 59.24 43.74 16.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.681 -0.691 . . . . 10.0 110.942 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' B' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.581 -0.723 . . . . 10.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.9 mt -88.68 150.8 22.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.982 0.42 . . . . 10.0 110.862 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -122.8 141.21 52.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.806 -0.633 . . . . 10.0 110.196 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.2 p -109.27 140.04 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.613 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.2 123.81 25.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.588 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.8 mt -78.74 -24.47 44.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.28 170.57 22.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.31 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.27 130.25 35.07 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -104.99 132.03 51.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.971 0.415 . . . . 10.0 111.64 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -89.83 118.77 29.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.506 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.12 158.63 24.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.14 0.495 . . . . 10.0 111.57 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -120.01 -44.62 2.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.554 -0.748 . . . . 10.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.89 -167.59 1.61 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.886 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -93.2 -2.62 55.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.1 0.476 . . . . 10.0 110.671 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.16 -37.58 20.01 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.276 0.56 . . . . 10.0 110.021 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -91.28 146.64 23.65 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.397 -0.964 . . . . 10.0 108.397 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.9 tp -111.36 123.49 50.31 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.568 0.581 . . . . 10.0 112.568 -177.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.83 133.4 36.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.938 -0.573 . . . . 10.0 109.731 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -140.39 163.03 33.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.803 0.335 . . . . 10.0 111.342 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -95.75 158.26 15.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.911 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -64.46 124.95 23.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.503 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.25 -3.01 56.58 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.853 -0.689 . . . . 10.0 113.201 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -74.0 154.6 39.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.937 0.398 . . . . 10.0 111.219 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -117.55 141.26 48.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.779 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.06 152.66 51.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 10.0 111.006 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -100.3 115.59 30.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.9 mm -71.96 112.13 7.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.328 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.6 mt -84.57 -40.05 18.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.121 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -140.07 103.39 4.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.72 0.295 . . . . 10.0 111.3 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.2 p -105.01 0.08 27.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.294 0.569 . . . . 10.0 110.552 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.21 10.04 20.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.37 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.1 -58.34 3.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.546 0.689 . . . . 10.0 109.977 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 167.59 -118.75 0.8 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.3 -0.72 . . . . 10.0 111.3 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -76.71 -51.16 11.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.083 -0.339 . . . . 10.0 110.083 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -88.47 134.35 33.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.876 -0.787 . . . . 10.0 108.876 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -115.04 148.51 38.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 10.0 111.045 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -86.97 117.27 25.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.73 156.76 45.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.226 0.536 . . . . 10.0 111.662 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -112.54 126.75 55.68 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.985 -0.746 . . . . 10.0 108.985 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.3 t -62.8 136.63 57.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.387 -0.37 . . . . 10.0 110.181 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.8 mt -84.66 -10.98 56.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.191 0.52 . . . . 10.0 109.829 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.78 -67.92 0.76 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.488 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.7 p -86.86 -46.59 9.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.444 . . . . 10.0 111.476 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 116.35 6.09 15.95 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.895 -0.669 . . . . 10.0 111.865 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -72.21 149.31 44.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.729 0.3 . . . . 10.0 110.759 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -115.71 135.0 54.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.347 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -174.62 179.79 45.71 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.925 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -86.78 136.3 33.04 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.0 -0.37 . . . . 10.0 110.0 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.3 pt -121.15 136.14 25.47 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.08 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.458 ' HG2' ' HB2' ' A' ' 137' ' ' TYR . 19.2 Cg_endo -63.05 122.62 10.92 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.761 2.307 . . . . 10.0 111.869 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -17.74 64.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.85 -0.614 . . . . 10.0 112.238 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.465 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 45.3 p-10 -87.44 -5.79 58.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.959 0.409 . . . . 10.0 111.057 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.458 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 0.8 OUTLIER -105.27 -6.16 19.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.969 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.1 m -124.31 152.38 30.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.125 0.488 . . . . 10.0 111.356 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.61 152.89 67.37 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.545 -0.752 . . . . 10.0 110.163 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.68 156.08 63.35 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.335 2.024 . . . . 10.0 111.622 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.323 -0.846 . . . . 10.0 110.097 179.703 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.732 0.301 . . . . 10.0 110.302 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.1 168.07 13.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.127 0.489 . . . . 10.0 112.23 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.7 m -110.69 145.84 37.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.541 -0.754 . . . . 10.0 109.927 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 45.0 t -111.23 130.3 64.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.717 0.294 . . . . 10.0 111.333 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -103.57 120.49 40.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.662 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -134.33 169.53 17.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.919 0.39 . . . . 10.0 111.259 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -117.37 63.25 0.74 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.522 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -59.32 112.96 1.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.889 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 58.83 21.81 9.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.305 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.4 -5.99 63.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.951 -0.642 . . . . 10.0 112.454 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -94.72 119.08 32.75 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.89 -0.182 . . . . 10.0 110.844 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -72.23 113.98 9.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.946 -0.39 . . . . 10.0 109.946 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt -134.38 153.02 52.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.788 0.327 . . . . 10.0 110.837 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 1.5 mt-30 -124.8 120.28 31.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.165 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.0 t -128.93 143.36 41.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.058 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.18 136.22 57.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.04 -0.356 . . . . 10.0 110.04 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.83 -22.9 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.131 0.491 . . . . 10.0 111.206 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -10.25 57.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.635 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -106.65 16.03 25.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.346 . . . . 10.0 111.072 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 73.2 mt -103.07 133.92 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.083 -0.508 . . . . 10.0 109.765 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.95 -63.12 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.199 -0.455 . . . . 10.0 111.286 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -134.29 152.27 51.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.494 -0.321 . . . . 10.0 110.878 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.51 129.24 70.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.779 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 8.3 m -123.92 127.43 47.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.015 0.436 . . . . 10.0 111.895 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.4 ' HG3' ' OE1' ' B' ' 48' ' ' GLU . 14.4 ttp85 -121.68 144.98 48.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -125.26 -16.64 5.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.675 0.274 . . . . 10.0 111.707 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.31 31.79 4.52 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.307 -0.949 . . . . 10.0 111.064 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 mmtm -155.33 -56.49 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.576 0.75 . . . . 10.0 109.179 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -143.8 138.38 28.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.859 -1.064 . . . . 10.0 109.691 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -95.48 131.81 41.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.808 -0.441 . . . . 10.0 109.808 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.465 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 49.4 m-85 -123.21 141.21 52.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.441 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -153.77 173.21 16.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.5 -0.318 . . . . 10.0 111.13 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -130.88 132.8 45.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.581 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -125.44 164.53 20.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.149 0.5 . . . . 10.0 111.249 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -138.08 125.82 22.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.986 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 54.6 mt -100.7 135.54 41.99 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.16 -27.05 62.11 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.223 -0.513 . . . . 10.0 112.887 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.04 8.54 15.64 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.292 -0.48 . . . . 10.0 112.803 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.73 54.35 3.48 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.368 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -147.74 78.35 9.9 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.919 0.39 . . . . 10.0 110.861 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -85.56 148.53 9.94 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.826 2.35 . . . . 10.0 110.863 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.79 -164.78 26.09 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 119.805 -1.188 . . . . 10.0 112.857 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -122.2 177.55 5.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.842 -0.429 . . . . 10.0 109.842 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.62 139.44 6.63 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.768 -0.73 . . . . 10.0 112.119 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.88 128.83 71.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.12 0.486 . . . . 10.0 110.392 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.93 119.61 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.034 -0.53 . . . . 10.0 109.841 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.0 t -68.68 125.86 27.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.732 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.4 ' OE1' ' HG3' ' B' ' 25' ' ' ARG . 52.2 mt-10 -75.68 -2.08 27.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.006 0.431 . . . . 10.0 110.967 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -111.27 -39.67 4.65 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.287 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -85.52 -27.81 25.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.147 0.425 . . . . 10.0 112.147 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.88 146.25 31.74 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.938 -0.305 . . . . 10.0 111.017 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.12 154.39 57.76 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.711 2.274 . . . . 10.0 111.639 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -63.0 -25.18 68.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.363 -0.381 . . . . 10.0 111.164 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -56.2 -44.14 79.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 10.0 110.61 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mt -69.93 -41.1 75.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.786 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.1 -37.66 88.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.054 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -73.37 -25.25 60.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.161 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -79.75 -36.06 37.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.437 -0.347 . . . . 10.0 110.419 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.68 -45.69 50.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.505 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.99 111.62 19.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.96 0.409 . . . . 10.0 110.48 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.25 165.2 15.14 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.64 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.464 ' OE1' ' HG3' ' B' ' 63' ' ' LYS . 1.0 OUTLIER -58.73 139.22 56.5 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.366 0.416 . . . . 10.0 110.398 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.464 ' HG3' ' OE1' ' B' ' 62' ' ' GLN . 43.6 mttp 63.06 79.98 0.24 Allowed 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 123.718 0.636 . . . . 10.0 110.159 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.262 -0.875 . . . . 10.0 109.997 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.676 0.274 . . . . 10.0 110.397 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.51 133.59 36.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.084 0.468 . . . . 10.0 110.83 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -116.7 140.2 49.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.179 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.48 139.04 39.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.855 0.359 . . . . 10.0 110.439 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.83 121.69 18.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.93 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.01 -40.15 63.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.431 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -143.1 164.05 31.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.186 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.85 147.4 39.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -126.92 126.19 42.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.815 0.341 . . . . 10.0 110.883 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.08 113.92 20.94 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.834 -0.621 . . . . 10.0 109.459 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.31 149.0 49.96 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.47 0.481 . . . . 10.0 111.089 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.69 -37.35 5.69 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.148 -0.478 . . . . 10.0 111.079 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 p -129.37 -164.11 1.37 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.961 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -99.63 6.77 45.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.138 0.494 . . . . 10.0 110.521 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.35 -36.73 11.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.502 -0.772 . . . . 10.0 109.611 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -89.78 145.35 25.25 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.4 tp -98.74 135.25 40.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.187 0.517 . . . . 10.0 112.043 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.94 134.17 33.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.361 -0.836 . . . . 10.0 110.123 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -147.46 164.92 31.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.797 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -118.98 172.27 7.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.929 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -60.02 118.65 6.54 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.383 -0.826 . . . . 10.0 111.359 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.33 -1.84 43.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.476 -0.869 . . . . 10.0 113.351 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.57 133.7 54.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.839 0.352 . . . . 10.0 111.437 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -94.5 121.09 35.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.689 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -115.88 134.49 54.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.66 0.615 . . . . 10.0 112.66 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -102.9 104.37 14.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.904 -1.146 . . . . 10.0 107.904 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.3 mm -62.44 117.62 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.327 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 70.9 mt -94.35 -35.87 12.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.321 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -145.1 99.89 3.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.28 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.79 0.26 46.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.238 0.542 . . . . 10.0 110.252 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -88.3 -0.0 56.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.995 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -63.17 -46.82 85.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.185 0.517 . . . . 10.0 110.333 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.99 -116.75 0.74 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.991 -0.843 . . . . 10.0 110.991 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.78 -28.5 17.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.234 0.54 . . . . 10.0 110.149 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.586 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 17.9 m95 -105.03 110.32 22.67 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.351 -0.981 . . . . 10.0 108.351 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -93.9 154.92 17.45 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.749 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -98.92 122.94 42.82 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -136.3 161.86 34.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.327 0.584 . . . . 10.0 111.602 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -114.03 133.76 55.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.19 -0.914 . . . . 10.0 109.345 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.5 t -69.45 140.82 54.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.954 0.407 . . . . 10.0 110.507 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 99.2 mt -96.84 2.05 51.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.376 0.608 . . . . 10.0 109.848 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.09 -48.84 3.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.492 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 66.4 p -101.06 -42.8 6.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 10.0 110.842 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.69 -0.73 34.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.059 -0.591 . . . . 10.0 112.42 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -67.26 150.23 49.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.736 0.303 . . . . 10.0 110.905 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.2 m -122.77 133.91 54.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.709 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.1 178.83 46.7 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.61 -0.805 . . . . 10.0 111.995 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -81.47 133.48 35.4 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.276 -0.268 . . . . 10.0 110.276 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.8 pt -128.07 145.54 55.77 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.85 0.357 . . . . 10.0 111.426 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.49 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 47.3 Cg_endo -72.08 127.5 12.88 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.577 2.185 . . . . 10.0 111.672 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.0 p -69.81 -16.09 63.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.96 -0.564 . . . . 10.0 112.267 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.49 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 38.0 p-10 -85.55 -0.45 55.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.692 0.282 . . . . 10.0 111.465 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.418 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 1.9 m-85 -115.58 3.91 14.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.53 -0.304 . . . . 10.0 111.246 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.81 144.65 37.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 10.0 111.105 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -132.77 144.01 51.08 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.085 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.3 132.05 26.56 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.536 2.157 . . . . 10.0 112.305 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.1 t . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.151 -0.928 . . . . 10.0 110.121 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.619 0.247 . . . . 10.0 110.747 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' B' ' 16' ' ' ASP . . . -153.76 128.57 9.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.47 -0.332 . . . . 10.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.9 108.18 19.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.608 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.05 130.78 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.62 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -95.32 132.15 40.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.45 -0.341 . . . . 10.0 110.281 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -145.25 170.18 16.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.186 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -120.7 105.82 11.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.16 -0.473 . . . . 10.0 109.788 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -99.99 111.71 24.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.894 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt 54.27 34.13 19.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.69 -0.686 . . . . 10.0 112.13 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.52 4.36 68.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.023 -0.608 . . . . 10.0 113.409 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -109.94 123.18 49.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.884 0.342 . . . . 10.0 110.644 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.14 121.18 22.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -134.44 153.45 51.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.897 0.38 . . . . 10.0 110.972 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.46 114.06 15.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.72 -0.673 . . . . 10.0 109.773 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.04 144.24 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.55 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' B' ' 2' ' ' ALA . 6.9 t70 -64.26 138.27 58.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.387 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 21.4 tt -61.29 -22.58 27.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.935 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -70.71 -19.65 62.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.7 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -93.99 1.01 56.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.133 0.492 . . . . 10.0 110.517 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 70.8 mt -94.2 123.97 46.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.725 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.59 -77.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.549 -0.296 . . . . 10.0 111.383 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -113.13 151.63 30.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.011 0.434 . . . . 10.0 111.308 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 32.3 t -129.32 142.01 45.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.421 -0.808 . . . . 10.0 109.983 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.1 m -134.5 122.89 23.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 10.0 111.402 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.48 ' HD2' ' OE2' ' B' ' 48' ' ' GLU . 0.8 OUTLIER -109.98 143.26 40.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.511 . . . . 10.0 110.164 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -124.35 -20.58 5.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.648 0.24 . . . . 10.0 111.648 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.34 22.18 8.84 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.744 -0.943 . . . . 10.0 110.744 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -146.38 -54.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.721 -0.844 . . . . 10.0 108.721 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -146.88 138.59 24.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.008 -0.997 . . . . 10.0 109.433 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 52.0 mt -94.27 126.89 46.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.971 -0.381 . . . . 10.0 109.971 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 18.9 m-85 -111.19 139.29 46.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.38 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -154.4 171.83 18.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.991 0.424 . . . . 10.0 111.273 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -130.32 135.68 48.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.854 -0.612 . . . . 10.0 109.594 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -121.58 156.83 32.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.065 0.46 . . . . 10.0 111.139 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -127.35 117.39 22.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.419 -0.81 . . . . 10.0 109.32 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.52 139.37 31.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.835 0.35 . . . . 10.0 111.319 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.52 -9.39 61.53 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.588 -0.733 . . . . 10.0 112.095 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.83 -8.17 67.6 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.215 -0.517 . . . . 10.0 111.999 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.64 32.5 7.23 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.951 -0.643 . . . . 10.0 112.149 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -153.64 103.38 2.53 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.682 0.277 . . . . 10.0 111.086 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -86.14 168.93 8.91 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.826 2.35 . . . . 10.0 111.44 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.63 -172.0 36.53 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.115 -1.04 . . . . 10.0 113.143 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 6.6 m-85 -123.63 166.2 15.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.855 -0.424 . . . . 10.0 109.855 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.0 150.57 22.13 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.471 -0.871 . . . . 10.0 112.345 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 p -132.67 132.9 59.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.968 0.413 . . . . 10.0 110.451 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.44 136.38 55.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.441 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 26.9 t -74.11 131.29 41.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.391 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.48 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 45.1 mt-10 -84.45 3.64 35.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.964 0.411 . . . . 10.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -119.43 -44.25 2.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.969 0.414 . . . . 10.0 111.068 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -78.72 -49.43 13.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.634 . . . . 10.0 112.481 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.23 151.13 97.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.34 . . . . 10.0 111.886 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.15 142.22 96.1 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.954 2.436 . . . . 10.0 112.296 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -62.93 -23.08 67.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.626 . . . . 10.0 110.704 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.4 -44.99 80.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.155 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.3 -35.47 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.551 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.0 mt -62.03 -42.94 99.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.872 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -72.63 -17.37 61.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 10.0 111.158 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -85.93 -38.56 17.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.635 -0.506 . . . . 10.0 109.635 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 51.6 mt -68.41 -41.77 79.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.085 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.15 85.74 7.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.545 0.688 . . . . 10.0 109.645 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -81.62 131.18 35.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.307 -0.86 . . . . 10.0 109.761 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' B' ' 63' ' ' LYS . 83.9 mm-40 -58.59 127.18 30.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.816 -0.439 . . . . 10.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' B' ' 62' ' ' GLN . 78.8 mttt 74.24 51.92 0.1 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 124.105 0.878 . . . . 10.0 110.122 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.359 -0.829 . . . . 10.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.683 0.278 . . . . 10.0 111.035 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.3 mt -88.16 161.18 17.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.295 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -131.07 126.03 34.76 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.1 p -108.63 141.05 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.874 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.3 126.5 31.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.317 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 30.0 mt -90.72 -20.62 22.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.013 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.4 159.92 41.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.029 -0.532 . . . . 10.0 109.585 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -85.9 145.4 27.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 10.0 109.868 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -143.37 130.87 21.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.032 0.444 . . . . 10.0 111.41 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.2 124.36 44.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.587 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.83 140.29 58.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.983 0.421 . . . . 10.0 111.234 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -104.86 -23.84 12.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.364 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.1 -166.41 1.79 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.262 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -17.97 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.838 0.351 . . . . 10.0 110.451 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -69.9 -45.55 67.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -87.43 163.26 16.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.615 -0.72 . . . . 10.0 109.61 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.3 tp -130.59 145.46 51.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.757 0.313 . . . . 10.0 111.381 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -81.61 145.77 30.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.829 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -157.23 154.45 29.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -105.17 159.39 15.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.8 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -63.3 116.78 5.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.597 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.5 -4.82 26.42 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.78 -0.724 . . . . 10.0 112.171 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -78.58 150.44 32.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.579 0.228 . . . . 10.0 110.441 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -121.64 143.1 49.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 10.0 110.85 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 159.47 41.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.577 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -103.64 116.38 32.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.045 -0.724 . . . . 10.0 109.045 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.2 mm -68.36 121.13 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.943 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.1 mt -94.73 -40.78 9.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.249 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.587 ' ND2' ' HG3' ' A' ' 116' ' ' GLU . 55.2 t30 -146.39 106.26 3.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.013 0.435 . . . . 10.0 111.24 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.19 0.47 31.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 10.0 110.615 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.18 5.73 47.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.915 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.587 ' HG3' ' ND2' ' A' ' 113' ' ' ASN . 3.4 mt-10 -78.99 -34.47 44.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.689 0.28 . . . . 10.0 111.358 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 156.89 -126.79 1.82 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.349 -0.929 . . . . 10.0 112.37 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -87.42 -43.75 11.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 10.0 110.817 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.414 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 44.2 m95 -88.39 113.35 23.9 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.123 -1.066 . . . . 10.0 108.123 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -95.0 150.78 19.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.181 0.515 . . . . 10.0 112.152 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -88.03 117.07 26.66 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.53 -1.285 . . . . 10.0 107.53 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.3 146.23 49.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.238 0.542 . . . . 10.0 112.228 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -100.39 119.18 38.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.37 -0.832 . . . . 10.0 109.307 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.5 t -60.93 138.22 58.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.847 0.356 . . . . 10.0 110.556 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.0 mt -91.71 2.03 56.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.314 0.578 . . . . 10.0 109.541 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.1 -61.09 1.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.313 -0.858 . . . . 10.0 110.723 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.5 p -100.7 -29.21 12.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.34 . . . . 10.0 111.322 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.25 0.74 54.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.663 -0.779 . . . . 10.0 112.346 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -74.11 154.26 39.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.793 0.33 . . . . 10.0 111.204 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.17 -178.2 3.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.997 -0.547 . . . . 10.0 109.841 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 145.22 168.05 12.69 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.097 -1.049 . . . . 10.0 112.714 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -85.23 124.62 32.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.829 0.347 . . . . 10.0 110.38 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.9 pt -120.48 147.59 45.75 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.382 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.73 125.51 10.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.337 2.025 . . . . 10.0 111.359 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -67.14 -12.64 60.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.326 0.491 . . . . 10.0 112.326 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -96.27 -9.46 30.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.629 0.252 . . . . 10.0 110.814 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -88.04 -12.92 42.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.277 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.9 m -121.42 169.9 12.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.639 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.29 141.13 28.17 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.994 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.69 131.48 21.42 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.459 2.106 . . . . 10.0 112.336 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.3 t . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.111 -0.947 . . . . 10.0 109.713 179.368 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.753 0.311 . . . . 10.0 111.254 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.82 171.93 15.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.802 0.334 . . . . 10.0 110.857 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 142.26 32.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.575 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.04 124.87 63.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.928 0.394 . . . . 10.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . 0.467 ' HZ3' ' CD ' ' B' ' 12' ' ' GLU . 0.9 OUTLIER -100.65 132.49 46.01 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.734 . . . . 10.0 109.417 179.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -149.2 173.62 13.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.857 0.36 . . . . 10.0 110.876 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -119.62 85.41 2.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.911 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -73.93 95.8 2.53 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt 61.82 23.89 14.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.459 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.59 -18.33 32.48 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.537 -0.756 . . . . 10.0 112.114 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.63 113.28 9.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.765 0.317 . . . . 10.0 111.015 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.467 ' CD ' ' HZ3' ' B' ' 5' ' ' LYS . 3.5 mm-40 -73.29 94.76 2.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.938 -0.573 . . . . 10.0 109.523 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -109.76 153.23 24.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.206 0.526 . . . . 10.0 111.974 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -130.9 105.47 7.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -119.93 146.88 24.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.688 0.28 . . . . 10.0 110.674 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.1 139.59 51.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.839 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.407 HD13 ' O ' ' B' ' 58' ' ' LYS . 13.7 tt -65.95 -18.88 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.467 0.651 . . . . 10.0 110.377 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.6 -4.43 59.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.492 -0.777 . . . . 10.0 111.321 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.67 9.09 39.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.071 0.463 . . . . 10.0 110.519 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 81.7 mt -95.51 125.24 48.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.909 -0.587 . . . . 10.0 109.963 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 t -71.84 -60.95 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.088 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -133.86 151.58 51.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.683 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 t -119.46 115.08 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 10.0 109.722 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 13.7 m -117.34 120.41 38.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.035 0.445 . . . . 10.0 111.823 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.409 ' HD2' ' CD ' ' B' ' 48' ' ' GLU . 4.0 ttp85 -109.06 121.71 45.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -83.52 -39.46 20.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.691 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.2 -2.61 5.87 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.73 -0.948 . . . . 10.0 110.73 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -139.5 -40.29 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.04 141.52 36.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.37 -0.832 . . . . 10.0 109.644 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 55.7 mt -96.33 129.79 45.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.686 -0.487 . . . . 10.0 109.686 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -118.78 136.09 54.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.357 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -153.4 171.46 18.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.818 0.342 . . . . 10.0 110.953 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -125.04 133.98 52.73 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -123.46 166.77 14.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.024 0.44 . . . . 10.0 111.152 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -128.33 157.98 39.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.299 -0.864 . . . . 10.0 109.099 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 mt -133.89 145.29 49.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.829 0.347 . . . . 10.0 111.009 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.83 -15.25 66.59 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.939 -0.648 . . . . 10.0 112.592 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.12 4.51 70.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.254 -0.498 . . . . 10.0 112.874 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.58 38.5 32.33 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.771 -0.728 . . . . 10.0 112.885 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -149.17 88.07 5.17 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 122.552 -0.381 . . . . 10.0 110.663 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -74.98 177.9 7.98 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.374 2.049 . . . . 10.0 111.075 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.72 -169.95 37.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.653 -1.26 . . . . 10.0 112.711 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 28.5 m-85 -117.05 160.33 21.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.898 -0.408 . . . . 10.0 109.898 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.02 141.43 12.12 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.669 -0.777 . . . . 10.0 112.237 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 p -135.77 128.79 47.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.95 0.405 . . . . 10.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 t -128.03 129.89 69.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.027 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 30.2 t -74.31 133.87 42.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.409 ' CD ' ' HD2' ' B' ' 25' ' ' ARG . 54.0 mt-10 -81.01 -1.21 43.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.176 0.512 . . . . 10.0 110.437 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -116.39 -49.77 2.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.947 -0.569 . . . . 10.0 110.579 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -90.92 45.37 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.783 -0.644 . . . . 10.0 111.973 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . -162.63 151.06 12.14 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.581 -0.282 . . . . 10.0 110.798 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.24 136.29 74.53 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.86 2.374 . . . . 10.0 112.348 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.84 -29.92 71.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.218 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -59.25 -41.27 88.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.992 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.4 mt -67.55 -36.12 80.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.873 0.368 . . . . 10.0 110.518 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -68.38 -39.8 81.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.136 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -72.49 -21.47 61.2 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.851 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . 0.407 ' O ' HD13 ' B' ' 17' ' ' ILE . 79.3 mttt -81.51 -32.02 32.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.166 -0.679 . . . . 10.0 109.166 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 21.6 mt -75.87 -58.93 2.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.895 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -80.17 115.7 19.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.141 0.496 . . . . 10.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mtmm -129.15 170.31 13.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.731 -0.668 . . . . 10.0 109.547 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -69.49 134.9 49.45 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.347 0.404 . . . . 10.0 110.059 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 66.48 54.8 0.86 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.435 0.636 . . . . 10.0 110.312 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.919 0 CA-C-N 115.56 -0.746 . . . . 10.0 110.539 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 120.903 0.382 . . . . 10.0 110.769 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.72 153.64 20.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -114.68 129.4 56.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.782 0.325 . . . . 10.0 110.509 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.8 142.2 18.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.989 -0.55 . . . . 10.0 110.171 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 130.8 43.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.642 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.9 -45.29 18.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.915 -0.584 . . . . 10.0 109.799 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -137.02 173.56 11.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.657 -0.702 . . . . 10.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.88 141.25 36.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.145 -0.48 . . . . 10.0 109.938 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -131.25 123.55 28.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.73 0.3 . . . . 10.0 111.186 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -92.12 133.44 35.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.52 155.05 20.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.164 0.507 . . . . 10.0 111.991 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.2 ttm-85 -110.6 -36.32 5.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.48 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.77 -159.79 0.9 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.449 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -98.58 -10.36 23.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.92 -50.2 15.65 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.367 -0.833 . . . . 10.0 109.596 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -83.65 134.66 34.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.342 -0.845 . . . . 10.0 108.839 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 tp -97.74 134.1 41.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.189 0.519 . . . . 10.0 112.378 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.23 135.1 34.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.418 -0.81 . . . . 10.0 110.199 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -146.87 158.63 43.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.081 0.467 . . . . 10.0 111.377 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -102.29 164.42 11.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.807 -0.633 . . . . 10.0 111.054 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -62.07 113.41 2.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.738 -0.665 . . . . 10.0 110.5 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.61 -1.32 24.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 10.0 112.783 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.57 147.94 51.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.608 0.242 . . . . 10.0 110.469 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -116.74 131.13 57.03 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.1 -0.333 . . . . 10.0 110.1 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -119.18 142.71 47.74 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.553 0.575 . . . . 10.0 112.553 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -95.0 126.4 40.32 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.477 -0.934 . . . . 10.0 108.477 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.4 mm -70.27 115.17 9.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.262 0.553 . . . . 10.0 112.025 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.1 mt -108.64 -67.09 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.717 -0.674 . . . . 10.0 109.425 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 22.0 t30 -107.38 95.62 5.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.764 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.1 p -99.87 -21.21 15.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.2 0.524 . . . . 10.0 110.813 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.5 m -83.09 20.11 1.3 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.134 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -70.84 -40.22 72.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.139 0.495 . . . . 10.0 109.94 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 137.21 -62.16 0.59 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.597 -0.811 . . . . 10.0 112.321 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.05 -66.11 0.68 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -78.98 115.27 18.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.033 -0.729 . . . . 10.0 109.033 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -90.56 144.42 25.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.98 0.419 . . . . 10.0 111.427 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 113' ' ' ASN . 28.3 tt0 -95.49 109.95 22.08 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.256 -1.016 . . . . 10.0 108.256 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.6 168.8 13.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.929 0.395 . . . . 10.0 111.681 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -119.04 134.55 55.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.1 t -70.45 137.13 50.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.367 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.8 mt -84.91 -10.16 57.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.059 0.457 . . . . 10.0 110.006 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.7 m -94.46 -57.5 2.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.609 -0.723 . . . . 10.0 111.607 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 46.6 p -89.0 -35.62 16.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.865 0.364 . . . . 10.0 111.53 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.78 5.85 58.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.658 -0.782 . . . . 10.0 112.096 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -78.1 146.84 34.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.562 0.22 . . . . 10.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.4 m -119.46 132.78 55.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.342 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -174.53 -178.06 44.14 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.687 -0.768 . . . . 10.0 112.12 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -82.46 132.92 35.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.873 0.368 . . . . 10.0 110.622 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 26.1 pt -122.6 142.65 37.97 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.048 -0.524 . . . . 10.0 110.842 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 133' ' ' ILE . 13.4 Cg_exo -69.15 122.12 8.96 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.61 2.207 . . . . 10.0 111.701 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -18.36 65.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.981 -0.554 . . . . 10.0 112.159 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -88.97 -1.84 58.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.478 -0.328 . . . . 10.0 111.232 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -115.51 5.41 14.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.67 0.271 . . . . 10.0 111.429 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.2 m -132.22 157.42 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.744 0.307 . . . . 10.0 110.78 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.57 143.22 19.36 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.314 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.96 143.29 72.09 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.357 2.038 . . . . 10.0 112.085 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.532 -0.747 . . . . 10.0 110.103 179.55 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.514 0.197 . . . . 10.0 111.033 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.67 168.82 18.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.938 0.399 . . . . 10.0 111.381 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.4 142.23 34.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.32 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.32 137.53 42.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.704 0.288 . . . . 10.0 110.781 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . 0.42 ' HZ1' ' CD ' ' B' ' 12' ' ' GLU . 0.8 OUTLIER -101.73 121.53 42.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.582 -0.525 . . . . 10.0 109.582 179.366 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 33.6 p90 -130.88 171.47 13.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.059 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -114.41 93.0 4.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 10.0 109.998 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.16 94.65 6.69 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.982 -0.287 . . . . 10.0 110.227 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm 55.15 31.98 17.48 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.73 -0.668 . . . . 10.0 111.15 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.01 -24.69 20.74 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.903 -0.665 . . . . 10.0 112.719 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -85.92 108.87 18.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.859 0.33 . . . . 10.0 110.749 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 11.3 mt-10 -82.41 113.4 20.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.984 0.421 . . . . 10.0 110.853 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -132.61 157.09 45.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.391 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -115.9 127.54 55.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.86 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 91.0 t -131.78 147.15 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.33 139.04 57.39 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.683 -0.235 . . . . 10.0 110.556 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 20.6 tt -66.5 -21.11 28.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.381 0.61 . . . . 10.0 109.791 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.09 -15.17 60.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.538 -0.755 . . . . 10.0 110.663 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -95.37 0.49 53.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.158 0.504 . . . . 10.0 110.235 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mt -102.61 106.82 20.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.009 -0.541 . . . . 10.0 109.861 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -65.14 -78.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.774 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -110.1 141.41 43.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.042 0.449 . . . . 10.0 111.756 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 58.7 t -125.79 114.89 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.327 -0.852 . . . . 10.0 109.247 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 30.1 m -103.93 116.85 33.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.363 0.602 . . . . 10.0 111.973 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 33.8 ttp85 -107.56 137.72 45.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.593 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -111.79 -20.19 12.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.747 0.308 . . . . 10.0 111.678 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.1 -0.49 31.46 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.986 -0.846 . . . . 10.0 110.986 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -134.12 -42.25 0.81 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.158 -0.521 . . . . 10.0 109.89 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -147.82 133.78 19.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.205 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 68.0 mt -94.13 133.96 33.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.501 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -127.59 120.71 28.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.14 -0.482 . . . . 10.0 109.785 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -136.28 168.02 20.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.89 0.376 . . . . 10.0 111.336 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -122.96 126.46 47.24 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.933 -0.766 . . . . 10.0 108.933 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -122.02 156.65 33.04 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.072 0.463 . . . . 10.0 111.57 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -104.99 151.73 23.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.364 -0.834 . . . . 10.0 109.819 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 13.1 mt -135.88 133.93 38.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.781 0.324 . . . . 10.0 111.102 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.06 -10.69 69.13 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.764 -0.653 . . . . 10.0 112.624 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.94 -15.36 74.01 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.969 -0.634 . . . . 10.0 111.773 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.65 -3.02 45.71 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.749 -0.739 . . . . 10.0 112.991 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -131.56 94.32 26.34 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.728 0.299 . . . . 10.0 111.212 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.22 179.67 6.22 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.529 2.153 . . . . 10.0 111.096 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.1 -165.1 28.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.951 -1.119 . . . . 10.0 112.902 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -117.34 157.87 25.39 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.76 132.25 6.98 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.483 -0.865 . . . . 10.0 112.087 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.9 125.12 73.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.307 0.575 . . . . 10.0 110.617 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 91.6 t -126.84 120.95 57.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.766 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -71.84 129.87 39.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.311 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -86.75 18.38 3.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.101 0.477 . . . . 10.0 110.053 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -136.89 -39.27 0.62 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.866 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -94.23 7.67 44.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.631 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.02 153.64 81.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 122.348 -0.22 . . . . 10.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.82 149.58 90.39 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.851 2.367 . . . . 10.0 112.679 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -65.88 -23.3 66.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.735 -0.666 . . . . 10.0 111.307 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -54.76 -39.18 68.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 10.0 110.925 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.82 -37.38 30.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.649 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 28.2 mt -62.88 -42.08 99.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 10.0 111.122 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -66.71 -28.98 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.563 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -79.29 -29.85 42.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.783 0.325 . . . . 10.0 111.229 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 14.5 mt -85.07 -14.46 47.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.969 0.414 . . . . 10.0 110.929 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -70.63 90.88 0.77 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.345 0.593 . . . . 10.0 111.049 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -88.25 100.04 12.68 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.179 -0.675 . . . . 10.0 109.179 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -57.4 116.92 3.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.795 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 91.3 mttt 60.27 81.4 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.134 0.896 . . . . 10.0 110.674 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.401 -0.809 . . . . 10.0 110.284 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 120.718 0.294 . . . . 10.0 110.95 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.7 mt -87.96 155.59 19.76 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.846 -0.428 . . . . 10.0 109.846 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -116.9 136.45 52.94 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.514 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.7 p -111.29 140.29 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.64 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.98 123.67 22.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.559 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.78 -35.61 57.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.563 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.52 169.96 16.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.803 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -76.68 104.69 7.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.656 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.444 ' CE1' HG22 ' B' ' 24' ' ' THR . 86.8 t80 -81.58 128.2 33.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.003 0.43 . . . . 10.0 111.17 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -99.24 115.38 28.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.652 -0.703 . . . . 10.0 109.772 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.0 172.67 7.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.53 -0.304 . . . . 10.0 110.647 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -136.81 -41.63 0.6 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.572 -0.285 . . . . 10.0 111.087 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -172.92 2.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.58 -0.282 . . . . 10.0 110.608 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -92.35 -14.65 28.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.72 0.295 . . . . 10.0 111.336 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -43.75 34.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.023 0.44 . . . . 10.0 110.068 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.15 120.2 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.802 . . . . 10.0 109.762 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.4 tp -78.54 136.82 37.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 10.0 111.943 -178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -95.0 124.73 39.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.435 -0.802 . . . . 10.0 109.698 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.59 155.01 45.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 10.0 111.805 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -94.43 158.29 15.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.358 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.36 133.18 53.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.817 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.9 -9.56 65.91 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.733 -0.746 . . . . 10.0 113.585 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.56 149.2 45.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.16 0.48 . . . . 10.0 111.094 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -110.66 137.71 47.99 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.093 -0.503 . . . . 10.0 109.928 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.66 155.92 45.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.936 0.398 . . . . 10.0 111.313 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -107.78 114.47 28.44 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 mm -71.21 118.04 15.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.474 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.91 -38.62 12.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.553 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -136.02 117.29 14.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.317 -0.401 . . . . 10.0 111.049 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.5 -15.05 15.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.128 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.5 m -83.19 13.04 4.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.42 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -76.8 -30.65 56.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.253 0.549 . . . . 10.0 110.483 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 128.73 -110.49 1.11 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.72 -0.673 . . . . 10.0 111.79 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.17 -57.43 2.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.277 0.56 . . . . 10.0 110.002 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -82.73 114.89 21.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.735 . . . . 10.0 109.026 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -93.61 144.15 25.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.972 0.415 . . . . 10.0 111.492 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.95 113.88 20.85 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.323 -0.991 . . . . 10.0 108.323 177.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.08 154.65 51.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.057 0.456 . . . . 10.0 111.613 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -111.8 128.18 56.03 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.219 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.2 t -69.22 134.26 48.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.135 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.3 mt -85.31 -3.25 58.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 10.0 109.941 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.55 -61.64 1.65 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.683 -0.689 . . . . 10.0 111.119 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 26.0 p -94.37 -21.71 18.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 10.0 111.723 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.22 15.43 66.82 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.665 -0.779 . . . . 10.0 112.071 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -91.34 154.83 18.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.669 0.271 . . . . 10.0 111.013 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.09 155.93 22.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.527 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.69 172.54 38.49 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.825 -0.702 . . . . 10.0 111.572 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -88.94 127.32 35.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.842 0.353 . . . . 10.0 110.351 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.7 pt -120.67 144.64 39.17 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.982 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.531 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 46.4 Cg_endo -73.04 131.35 16.65 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.448 2.099 . . . . 10.0 111.447 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 p -73.74 -1.65 20.07 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.605 0.595 . . . . 10.0 112.605 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.531 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 28.1 p-10 -105.15 13.79 30.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.848 0.356 . . . . 10.0 111.01 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.458 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 5.5 m-85 -126.4 7.87 7.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.686 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.7 m -133.15 155.86 41.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.893 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -135.4 144.16 48.35 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.19 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 13.8 Cg_exo -69.6 132.08 22.83 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.563 2.175 . . . . 10.0 111.686 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.666 -0.683 . . . . 10.0 110.522 -179.94 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ttt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.439 0.161 . . . . 10.0 111.067 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.05 130.68 7.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.773 0.32 . . . . 10.0 110.918 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.39 112.76 19.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.436 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 23.9 t -89.28 129.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.821 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -97.55 119.1 35.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.62 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -131.67 147.04 52.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.56 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -89.97 109.97 20.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.266 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -111.59 105.82 14.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.42 -0.355 . . . . 10.0 111.08 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt 56.67 38.15 29.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.666 -0.697 . . . . 10.0 111.878 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.4 -0.11 85.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.721 -0.752 . . . . 10.0 112.811 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . 0.406 ' CB ' ' HE2' ' B' ' 13' ' ' LYS . 49.4 mt-10 -111.87 117.34 32.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.728 0.264 . . . . 10.0 110.495 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -74.09 112.88 10.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.008 -0.367 . . . . 10.0 110.008 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.406 ' HE2' ' CB ' ' B' ' 11' ' ' GLU . 51.7 mmtt -109.68 147.4 33.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.159 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 8.4 pt20 -130.3 109.26 10.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.516 -0.55 . . . . 10.0 109.516 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.41 142.5 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.503 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -64.78 143.5 57.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.809 -0.441 . . . . 10.0 109.809 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 14.8 tt -56.41 -21.66 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.716 -0.675 . . . . 10.0 112.72 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.24 -14.22 47.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.392 0.516 . . . . 10.0 112.392 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -95.14 16.13 17.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.267 0.556 . . . . 10.0 111.461 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 47.5 mt -105.69 133.6 49.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.546 -0.752 . . . . 10.0 109.284 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.39 -72.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.563 -0.29 . . . . 10.0 110.833 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -133.44 154.77 50.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.601 -0.272 . . . . 10.0 110.3 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.36 126.33 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.402 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' THR . . . . . 0.444 HG22 ' CE1' ' A' ' 93' ' ' TYR . 1.3 m -125.49 127.66 46.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.024 0.44 . . . . 10.0 110.67 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 48.2 ttp85 -108.46 138.48 44.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.496 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -101.44 -17.21 16.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.197 0.522 . . . . 10.0 111.354 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 14.18 24.56 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.101 -0.8 . . . . 10.0 111.101 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -146.86 -51.87 0.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.484 -0.932 . . . . 10.0 108.484 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -130.13 148.8 52.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.514 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mt -105.31 124.8 60.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.805 -0.443 . . . . 10.0 109.805 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -114.03 127.57 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.33 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -146.4 175.26 10.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.856 0.36 . . . . 10.0 111.033 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -136.95 128.41 28.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.903 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -111.01 158.2 19.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.718 0.295 . . . . 10.0 110.725 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -131.56 107.67 9.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.594 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -95.14 143.18 26.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.532 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.47 12.23 47.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.039 -0.601 . . . . 10.0 112.508 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.88 16.63 60.0 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.986 -0.626 . . . . 10.0 111.698 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.35 31.88 63.02 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.124 -0.56 . . . . 10.0 112.197 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -149.41 92.11 4.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.792 0.329 . . . . 10.0 111.492 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -90.49 177.88 2.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.781 2.32 . . . . 10.0 110.678 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.46 -172.25 45.29 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 119.979 -1.105 . . . . 10.0 112.807 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -117.38 -178.96 3.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.654 0.264 . . . . 10.0 110.406 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.35 143.17 10.05 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.465 -0.654 . . . . 10.0 111.465 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.02 125.16 28.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.089 0.471 . . . . 10.0 110.604 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 t -129.47 143.49 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.312 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.3 t -96.59 137.62 35.39 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.953 -0.388 . . . . 10.0 109.953 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -72.46 -12.28 61.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.737 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -100.31 -13.03 18.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.863 0.363 . . . . 10.0 110.744 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.13 -54.5 3.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.218 -0.447 . . . . 10.0 111.459 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -89.78 143.55 30.4 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.499 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.427 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 26.0 Cg_exo -62.74 155.74 57.51 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.601 2.201 . . . . 10.0 111.823 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.89 -27.4 63.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.261 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -53.18 -44.05 67.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.68 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 70.2 mt -80.16 -37.46 33.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.958 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 40.8 mt -60.84 -40.67 93.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.565 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -70.63 -22.63 62.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.034 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -75.76 -26.88 57.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.232 0.539 . . . . 10.0 110.037 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.87 -30.61 17.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.121 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.82 94.93 1.86 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.21 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -95.14 130.86 41.69 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.483 -0.78 . . . . 10.0 110.306 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -64.55 124.31 21.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.62 77.73 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.89 0.744 . . . . 10.0 110.045 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.379 -0.819 . . . . 10.0 110.301 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.713 0.292 . . . . 10.0 110.904 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.8 mt -113.21 154.49 26.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.257 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -113.82 125.27 53.89 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.86 142.24 17.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.442 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.14 123.8 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.423 -0.353 . . . . 10.0 110.675 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.25 -37.41 53.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.04 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -146.0 158.21 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.524 -0.762 . . . . 10.0 109.503 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.42 146.43 54.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.238 0.336 . . . . 10.0 110.272 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -127.66 131.86 49.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.947 0.403 . . . . 10.0 111.02 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -95.28 128.43 42.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.462 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.92 137.84 54.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 10.0 110.731 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -113.22 -31.85 6.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.272 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.3 -163.97 1.46 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.401 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -93.11 -19.1 21.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.835 0.35 . . . . 10.0 111.053 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.46 -37.09 60.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.857 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -93.56 151.54 19.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.254 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.9 tp -120.36 134.85 55.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.424 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.9 p -79.3 153.06 30.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.886 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -158.45 160.2 36.53 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.426 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -101.95 156.0 17.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.475 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -62.76 123.37 18.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.87 -12.24 22.63 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.767 -0.73 . . . . 10.0 112.95 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -72.15 150.12 44.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 10.0 111.472 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -111.47 137.32 49.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.349 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -124.39 150.94 45.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.218 0.532 . . . . 10.0 111.936 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -106.98 103.67 13.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.038 -0.983 . . . . 10.0 108.709 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.1 mm -64.45 124.82 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.39 -0.368 . . . . 10.0 111.038 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.81 -39.85 8.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.295 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -130.96 122.56 27.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.36 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.3 p -133.65 19.09 3.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.243 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.76 -6.99 10.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.359 0.503 . . . . 10.0 112.359 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -84.29 -109.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.494 0.188 . . . . 10.0 110.598 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.506 ' HA2' ' OH ' ' B' ' 8' ' ' TYR . . . -73.19 -164.35 8.55 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.77 -0.729 . . . . 10.0 112.143 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -95.65 4.25 53.23 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.667 0.746 . . . . 10.0 110.044 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -105.06 155.73 18.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.513 -1.292 . . . . 10.0 107.513 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -106.45 129.57 54.4 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.084 -0.647 . . . . 10.0 112.671 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.26 115.03 27.16 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.16 -1.422 . . . . 10.0 107.16 177.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -137.33 161.83 35.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.442 0.639 . . . . 10.0 112.668 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 123' ' ' ARG . 31.4 ttp180 -106.78 120.93 43.33 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.117 -0.947 . . . . 10.0 109.318 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.2 t -69.67 134.73 49.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.9 mt -78.52 -11.05 59.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.864 0.364 . . . . 10.0 110.214 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -82.91 -56.61 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.558 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 p -92.76 -32.67 14.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.359 -0.382 . . . . 10.0 112.027 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.89 20.74 49.24 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.645 -0.788 . . . . 10.0 111.6 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -109.92 159.55 17.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.772 -0.214 . . . . 10.0 110.937 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.37 -179.48 4.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.705 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.58 157.32 7.73 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.185 -0.531 . . . . 10.0 111.778 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -80.76 116.38 20.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 37.6 pt -99.59 140.92 21.96 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.727 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 133' ' ' ILE . 27.0 Cg_exo -61.01 117.87 4.68 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.44 2.093 . . . . 10.0 111.465 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -6.5 11.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 10.0 112.538 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -107.18 3.63 25.86 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.743 0.275 . . . . 10.0 111.743 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.97 3.79 14.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.818 0.342 . . . . 10.0 111.036 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.51 159.15 43.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.929 0.395 . . . . 10.0 111.037 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.7 141.23 34.5 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.725 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.87 130.29 13.27 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.441 2.094 . . . . 10.0 111.875 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.386 -0.816 . . . . 10.0 109.968 179.945 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ttt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.438 0.161 . . . . 10.0 110.605 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.04 169.53 24.35 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.618 0.247 . . . . 10.0 110.957 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.95 139.53 30.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.802 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -102.94 130.28 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.718 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -94.02 118.64 31.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.072 -0.513 . . . . 10.0 109.953 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -136.54 178.34 7.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.569 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . 0.4 ' HE2' ' OE2' ' B' ' 12' ' ' GLU . 66.6 mttt -123.1 137.94 54.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.871 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . 0.506 ' OH ' ' HA2' ' A' ' 117' ' ' GLY . 77.2 t80 -134.95 115.84 14.03 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.082 -0.71 . . . . 10.0 109.082 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm 59.34 24.02 12.53 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.512 0.507 . . . . 10.0 111.384 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.89 -0.6 67.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.905 -0.664 . . . . 10.0 112.77 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -103.13 136.13 43.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.686 -0.302 . . . . 10.0 110.426 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.4 ' OE2' ' HE2' ' B' ' 7' ' ' LYS . 20.3 mt-10 -86.52 126.19 34.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.54 -0.3 . . . . 10.0 110.238 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -139.11 153.38 48.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.616 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -125.7 124.52 41.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.412 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.2 t -134.62 146.83 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.079 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.71 140.44 56.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.623 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 tt -64.57 -26.57 40.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.912 -0.586 . . . . 10.0 110.6 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.91 -11.84 60.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.213 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -99.4 3.56 45.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.031 0.443 . . . . 10.0 110.482 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.4 mt -95.3 127.76 47.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.62 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.41 -88.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.339 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -100.11 149.86 23.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 10.0 110.93 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.1 t -127.12 116.1 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.715 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 1.2 m -108.72 104.22 13.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.142 0.496 . . . . 10.0 111.528 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -100.47 146.61 26.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.78 -0.646 . . . . 10.0 109.966 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -138.08 5.13 2.53 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.088 0.47 . . . . 10.0 111.165 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.47 20.55 68.84 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.569 -0.824 . . . . 10.0 111.281 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -138.83 -59.7 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.057 -0.72 . . . . 10.0 109.057 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -145.74 134.24 22.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.04 -0.982 . . . . 10.0 109.557 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 89.8 mt -91.37 117.94 35.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 123.302 0.376 . . . . 10.0 110.352 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -107.14 135.53 48.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.707 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -152.76 173.52 15.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.03 0.443 . . . . 10.0 111.388 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -131.91 141.65 49.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.496 -0.775 . . . . 10.0 109.668 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -133.36 173.72 11.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.82 0.343 . . . . 10.0 110.462 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -142.93 127.39 17.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.088 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt -100.51 142.2 32.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.723 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.97 -21.05 60.82 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 116.056 -0.52 . . . . 10.0 113.258 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.93 -3.7 75.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.911 -0.661 . . . . 10.0 112.38 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.43 34.41 8.62 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.914 -0.66 . . . . 10.0 112.052 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -125.43 77.36 68.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.739 0.305 . . . . 10.0 111.243 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.89 148.66 17.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.551 2.168 . . . . 10.0 111.442 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.86 -174.0 39.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.011 -1.09 . . . . 10.0 112.728 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -112.84 174.57 5.83 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.962 -0.384 . . . . 10.0 109.962 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.53 151.58 22.13 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.107 -0.797 . . . . 10.0 111.107 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.8 p -135.78 137.75 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.253 0.549 . . . . 10.0 111.263 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.36 132.97 70.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.782 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 13.6 t -73.5 128.44 35.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.591 -0.277 . . . . 10.0 110.358 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -84.97 6.94 22.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.929 0.395 . . . . 10.0 110.792 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -120.22 -39.47 2.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.269 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.66 -50.87 7.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.93 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.15 146.57 98.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.861 -0.609 . . . . 10.0 111.332 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.23 148.72 84.76 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.54 2.16 . . . . 10.0 112.364 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -60.66 -26.84 67.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.058 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -53.33 -42.48 66.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.159 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 90.2 mt -74.44 -36.39 63.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 10.0 110.695 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 35.6 mt -65.72 -36.97 85.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.626 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -71.9 -14.49 61.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.111 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -96.26 -37.54 10.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.097 0.475 . . . . 10.0 109.831 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -70.53 -35.03 72.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.113 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -74.44 89.94 2.16 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.132 0.492 . . . . 10.0 110.35 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -70.23 109.17 4.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -50.85 123.38 8.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.293 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 65.64 58.58 0.8 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.346 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.533 -0.746 . . . . 10.0 110.622 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.856 0.36 . . . . 10.0 110.637 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.0 mt -81.6 128.1 33.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.278 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -117.82 127.42 53.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.656 -0.702 . . . . 10.0 109.478 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 p -99.79 135.06 36.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.891 0.377 . . . . 10.0 110.432 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.43 118.95 13.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.688 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.4 mt -70.14 -31.48 69.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.673 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -151.3 -178.2 6.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.064 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -87.47 159.99 18.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.16 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -141.12 125.61 17.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.858 0.361 . . . . 10.0 110.789 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -87.86 114.19 24.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.723 -0.672 . . . . 10.0 109.712 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.09 155.69 24.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.255 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -119.02 -20.03 8.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.885 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.6 -160.04 1.01 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.581 -0.282 . . . . 10.0 110.802 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -101.75 -19.88 15.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.983 0.42 . . . . 10.0 110.575 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.99 -48.03 59.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.516 -0.766 . . . . 10.0 109.418 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.83 129.04 34.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.279 -0.873 . . . . 10.0 109.362 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.48 138.69 31.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.903 -0.59 . . . . 10.0 112.319 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -92.2 136.82 32.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.615 -0.513 . . . . 10.0 109.615 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -153.54 178.46 9.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.821 0.343 . . . . 10.0 111.025 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.88 173.87 10.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.98 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -63.57 122.56 16.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.778 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.99 -4.13 33.85 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.836 -0.697 . . . . 10.0 112.524 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -66.33 131.93 47.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.741 0.305 . . . . 10.0 110.856 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -102.1 118.64 37.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.87 -0.419 . . . . 10.0 109.87 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -112.17 142.77 44.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.501 0.556 . . . . 10.0 112.501 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -108.22 104.3 13.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.513 -1.291 . . . . 10.0 107.513 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.64 123.96 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.522 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -102.82 -51.54 3.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.436 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -133.85 114.46 13.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.78 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -129.8 9.39 5.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.451 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.58 -0.98 51.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.435 -0.802 . . . . 10.0 111.897 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -87.72 -91.55 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.887 -0.325 . . . . 10.0 110.221 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.77 -162.57 28.96 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.603 -0.808 . . . . 10.0 111.627 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.53 -28.2 41.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.869 0.366 . . . . 10.0 110.19 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -81.32 145.59 30.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.551 -1.278 . . . . 10.0 107.551 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -106.6 142.5 36.15 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.794 0.665 . . . . 10.0 112.794 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.32 118.17 30.96 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 177.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.96 163.39 33.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.292 0.568 . . . . 10.0 111.64 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -114.79 138.32 50.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.423 -0.808 . . . . 10.0 110.08 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.9 t -73.22 133.49 44.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.273 -0.422 . . . . 10.0 110.434 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.6 mt -92.22 5.85 48.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 10.0 109.956 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.19 -51.11 3.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.703 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.0 p -103.73 -39.39 6.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.033 0.444 . . . . 10.0 110.83 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.7 -2.59 29.03 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.931 -0.652 . . . . 10.0 111.766 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -66.14 142.39 57.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.623 0.249 . . . . 10.0 110.826 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.5 m -117.58 144.6 44.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.539 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.02 179.01 42.68 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.173 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -85.22 135.96 33.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.896 0.379 . . . . 10.0 110.205 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.2 pt -122.47 145.48 44.82 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.294 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.431 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 31.9 Cg_endo -67.44 121.14 8.22 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.776 2.318 . . . . 10.0 111.497 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -4.93 14.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.628 -0.714 . . . . 10.0 112.736 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.431 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 36.0 p-10 -101.57 6.24 42.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.754 0.311 . . . . 10.0 110.977 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -124.96 14.12 8.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.298 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.29 146.52 30.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.471 -0.331 . . . . 10.0 110.755 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -130.9 142.97 47.49 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.557 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.23 131.71 19.67 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.356 2.038 . . . . 10.0 112.323 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.453 -0.784 . . . . 10.0 109.915 179.818 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.779 0.323 . . . . 10.0 110.405 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.74 151.07 26.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.747 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.3 m -94.98 123.16 38.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.242 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 20.6 t -98.75 132.96 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.999 0.428 . . . . 10.0 111.241 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -102.73 111.85 24.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.597 -0.729 . . . . 10.0 109.094 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -130.16 -174.41 3.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.441 . . . . 10.0 111.104 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -110.62 148.6 31.86 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.171 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.17 103.43 4.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.159 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 tptt 58.67 30.77 20.36 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.7 0.625 . . . . 10.0 110.703 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.49 -31.79 8.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.29 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -75.74 168.97 19.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.806 0.336 . . . . 10.0 110.515 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -114.37 129.73 56.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -132.64 148.1 52.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.833 0.349 . . . . 10.0 111.27 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -117.01 109.57 17.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.963 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 94.6 t -129.0 139.38 52.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 110.148 -0.315 . . . . 10.0 110.148 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 31.0 m-20 -66.9 141.17 57.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.861 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.08 -23.52 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.039 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.67 0.25 18.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.147 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -114.61 9.65 16.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.468 . . . . 10.0 110.244 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 63.9 mt -97.3 132.49 41.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.157 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 t -79.15 -59.99 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.367 -0.379 . . . . 10.0 111.658 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -141.03 155.14 46.23 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.245 -0.284 . . . . 10.0 110.824 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 68.1 t -123.54 122.91 66.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 O-C-N 123.512 0.508 . . . . 10.0 110.59 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 7.3 m -113.53 107.37 15.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.888 0.375 . . . . 10.0 110.969 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.474 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 8.0 ttp85 -102.65 149.9 23.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.254 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -125.84 -22.71 4.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.508 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.04 16.8 14.13 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.958 -0.857 . . . . 10.0 110.958 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -144.38 -51.34 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -145.08 136.02 24.7 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.384 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 52.7 mt -93.88 128.26 45.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.571 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -119.16 130.52 55.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -143.8 172.02 13.41 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.71 -0.396 . . . . 10.0 111.677 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -128.98 136.41 50.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.706 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -131.11 166.84 20.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.891 0.377 . . . . 10.0 111.287 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -132.33 114.74 14.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.539 -0.755 . . . . 10.0 109.729 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 88.1 mt -88.0 135.6 33.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.979 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.75 -8.74 35.33 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.819 -0.628 . . . . 10.0 112.815 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.87 -11.76 83.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.979 -0.629 . . . . 10.0 112.258 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.05 16.34 19.25 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.92 -0.657 . . . . 10.0 112.702 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -138.2 104.03 8.0 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 120.885 -0.326 . . . . 10.0 111.62 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.47 171.42 7.44 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.733 2.289 . . . . 10.0 111.18 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.42 -173.76 44.87 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.66 -1.257 . . . . 10.0 112.966 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -113.42 169.51 8.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.537 0.208 . . . . 10.0 110.497 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.23 151.53 23.48 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.151 -0.547 . . . . 10.0 111.823 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.7 p -136.27 140.12 44.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 10.0 111.517 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.78 135.46 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.901 -0.59 . . . . 10.0 109.557 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.3 t -76.02 134.89 40.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.745 0.307 . . . . 10.0 110.714 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.465 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 45.0 mt-10 -89.79 8.95 29.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 10.0 110.048 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -132.22 -42.77 0.97 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.733 -0.667 . . . . 10.0 111.665 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.21 34.23 1.81 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.208 0.447 . . . . 10.0 112.208 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.98 154.66 34.55 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.705 -0.225 . . . . 10.0 110.574 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -59.48 134.71 60.03 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.77 2.313 . . . . 10.0 111.356 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -67.97 -16.65 64.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.219 -0.446 . . . . 10.0 112.165 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -59.61 -44.4 93.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.409 . . . . 10.0 110.366 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.97 -39.23 83.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.526 . . . . 10.0 110.008 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.9 -41.0 95.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.741 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -62.5 -38.12 88.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.323 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.69 -35.86 44.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.956 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.28 -56.33 22.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.857 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . 0.474 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 40.6 tt0 -86.81 89.77 8.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.335 0.588 . . . . 10.0 110.944 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -78.58 148.74 33.19 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -64.7 138.91 58.67 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.1 mttt 72.04 54.64 0.18 Allowed 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.983 0.802 . . . . 10.0 110.245 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.662 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 120.678 0.275 . . . . 10.0 110.507 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 73.1 mt -92.15 150.85 20.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -119.37 137.53 53.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.853 0.358 . . . . 10.0 110.942 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -111.86 140.01 33.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.335 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.74 122.8 22.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.921 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.9 mt -79.13 -38.32 36.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.462 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -134.19 161.39 35.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.36 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -77.23 121.54 23.81 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -112.22 117.92 33.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.075 0.464 . . . . 10.0 110.431 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -94.46 120.52 34.82 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.906 -0.588 . . . . 10.0 109.486 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.428 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -73.48 156.61 38.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.969 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.1 ttm105 -123.28 -26.42 4.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.85 -0.614 . . . . 10.0 110.676 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.48 -168.51 1.5 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.297 -0.41 . . . . 10.0 111.022 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -97.8 -3.17 39.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.018 0.437 . . . . 10.0 111.14 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.52 -43.29 9.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.04 -0.527 . . . . 10.0 110.385 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -81.16 147.43 30.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.552 -0.749 . . . . 10.0 109.91 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 62.2 tp -103.84 131.39 51.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.337 -0.392 . . . . 10.0 112.009 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.428 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -85.37 135.8 33.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.877 178.713 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -155.58 165.46 36.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.775 0.322 . . . . 10.0 110.664 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 36.5 m170 -110.22 165.23 11.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.959 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -61.82 126.1 26.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.558 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.35 -4.21 43.99 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.675 -0.774 . . . . 10.0 112.146 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 2.5 tp10 -68.11 148.12 51.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 122.204 0.202 . . . . 10.0 110.922 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -119.1 133.52 55.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.662 -0.495 . . . . 10.0 109.662 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 107' ' ' GLU . 0.4 OUTLIER -130.53 155.46 46.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.125 0.488 . . . . 10.0 111.582 -179.156 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -109.45 114.11 27.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.2 mm -63.2 128.77 25.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.143 -0.48 . . . . 10.0 111.065 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.03 -44.33 4.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.917 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' A' ' 116' ' ' GLU . 30.1 t30 -138.81 108.55 6.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.812 0.339 . . . . 10.0 111.131 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.72 -11.32 19.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.163 0.506 . . . . 10.0 110.73 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.6 8.79 15.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.069 -0.514 . . . . 10.0 111.446 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.413 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 7.2 tp10 -77.98 -20.14 53.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.013 0.435 . . . . 10.0 110.806 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.34 -139.99 9.61 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.818 -0.706 . . . . 10.0 111.499 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.11 -35.28 49.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.98 -0.378 . . . . 10.0 109.98 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.453 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 20.4 m95 -92.18 126.01 37.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -103.55 146.99 27.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.882 0.372 . . . . 10.0 111.228 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -97.11 122.17 39.82 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.735 -0.839 . . . . 10.0 108.735 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.74 162.46 32.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.953 0.406 . . . . 10.0 111.543 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -109.53 128.08 54.93 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.453 -0.794 . . . . 10.0 109.599 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.3 t -67.3 134.16 51.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.163 -0.472 . . . . 10.0 109.749 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.9 mt -83.73 -10.66 57.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.864 0.364 . . . . 10.0 110.105 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.12 -62.77 1.37 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.761 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.2 p -87.36 -35.73 18.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.037 0.446 . . . . 10.0 111.546 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.89 2.01 52.17 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.72 -0.753 . . . . 10.0 111.87 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.99 144.7 48.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.802 0.334 . . . . 10.0 111.248 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.7 m -117.76 135.64 53.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.288 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -178.68 178.44 48.71 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.445 -0.883 . . . . 10.0 112.106 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -79.79 126.09 30.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.965 0.412 . . . . 10.0 109.971 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 31.2 pt -115.67 139.83 25.28 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.797 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.07 112.58 1.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.453 2.102 . . . . 10.0 111.34 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.67 -18.21 61.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.056 -0.52 . . . . 10.0 112.134 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -92.57 5.69 49.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.621 -0.263 . . . . 10.0 111.494 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -119.25 4.82 11.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.914 0.388 . . . . 10.0 110.748 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.93 149.07 32.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.152 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.431 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -129.39 142.65 45.96 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.218 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 6.7 Cg_exo -73.84 135.73 21.9 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.437 2.092 . . . . 10.0 111.773 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.367 -0.825 . . . . 10.0 110.682 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ttt . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.348 0.118 . . . . 10.0 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.35 174.08 13.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.75 0.309 . . . . 10.0 111.153 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 2.1 m -108.59 131.56 54.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.47 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.86 125.06 48.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.892 0.377 . . . . 10.0 110.893 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -103.86 111.44 23.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.272 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -121.94 176.99 5.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.978 -0.556 . . . . 10.0 111.036 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -121.06 94.72 4.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.469 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -80.88 92.02 6.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.059 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm 56.24 43.9 25.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.42 -0.809 . . . . 10.0 111.893 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.6 -16.43 59.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.852 -0.69 . . . . 10.0 113.586 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -94.75 117.79 30.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.168 0.484 . . . . 10.0 111.314 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -76.81 117.26 18.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -132.37 137.97 47.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.855 0.359 . . . . 10.0 110.877 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -112.48 116.28 30.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.137 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.3 t -124.08 140.34 47.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.775 -0.454 . . . . 10.0 109.775 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -57.51 137.21 56.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.594 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.8 tt -60.12 -26.94 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.983 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.27 2.16 16.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.434 -0.348 . . . . 10.0 111.821 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' B' ' 35' ' ' ASP . 95.4 mttt -112.01 8.27 20.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.775 0.321 . . . . 10.0 111.088 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -92.2 119.97 40.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.78 -70.32 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.888 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -128.49 148.98 50.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.73 0.3 . . . . 10.0 111.145 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.21 132.37 68.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.481 -0.781 . . . . 10.0 110.297 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 28.7 m -132.22 115.4 15.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.037 0.446 . . . . 10.0 110.851 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.547 ' HD2' ' OE1' ' B' ' 48' ' ' GLU . 68.5 ttp85 -116.32 144.26 44.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.309 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -119.89 7.62 10.97 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.132 0.491 . . . . 10.0 111.607 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.487 ' H ' ' HG2' ' B' ' 25' ' ' ARG . . . 90.53 16.56 54.89 Favored Glycine 0 C--O 1.231 -0.077 0 C-N-CA 120.462 -0.875 . . . . 10.0 112.203 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -140.0 -60.92 0.53 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.48 0.657 . . . . 10.0 109.343 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -131.46 147.05 52.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.162 -0.926 . . . . 10.0 109.699 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 61.7 mt -101.57 111.96 33.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.681 -0.69 . . . . 10.0 110.089 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -103.02 126.95 50.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.089 -0.505 . . . . 10.0 109.676 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -152.45 172.96 15.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.01 0.433 . . . . 10.0 111.133 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -129.16 134.41 48.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.785 -0.643 . . . . 10.0 109.739 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -110.98 168.83 9.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.239 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' B' ' 19' ' ' LYS . 21.8 t70 -131.65 153.09 50.32 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.312 -0.625 . . . . 10.0 109.312 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 51.0 mt -138.55 139.29 38.62 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.189 -0.3 . . . . 10.0 110.189 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.97 -20.93 60.68 Favored Glycine 0 C--N 1.33 0.218 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.33 -18.49 71.49 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.749 -0.54 . . . . 10.0 111.749 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.07 29.38 6.45 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.972 -0.632 . . . . 10.0 112.795 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -130.41 85.91 55.06 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.883 0.341 . . . . 10.0 111.56 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -91.33 76.94 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.138 2.559 . . . . 10.0 111.997 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.58 -167.47 43.69 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.927 -0.654 . . . . 10.0 113.027 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 62.1 m-85 -111.65 172.34 6.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.852 0.358 . . . . 10.0 110.727 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.22 151.59 23.05 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.358 -0.697 . . . . 10.0 111.358 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 14.6 p -141.57 140.49 31.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.13 0.49 . . . . 10.0 110.984 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.57 147.77 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.559 . . . . 10.0 109.651 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 22.2 t -93.0 136.67 33.05 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.168 -0.308 . . . . 10.0 110.168 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' GLU . . . . . 0.547 ' OE1' ' HD2' ' B' ' 25' ' ' ARG . 19.6 tt0 -80.66 -10.17 59.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.979 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -110.99 -26.01 9.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.157 0.428 . . . . 10.0 112.157 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -97.83 -15.16 20.37 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.465 0.543 . . . . 10.0 112.465 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.29 151.34 41.42 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.451 0.167 . . . . 10.0 111.226 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.436 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 25.7 Cg_exo -63.5 147.78 92.96 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.713 2.275 . . . . 10.0 111.836 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -64.31 -21.95 66.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.969 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.96 -45.93 71.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.918 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.2 mt -78.61 -36.26 44.42 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.898 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 36.4 mt -61.91 -39.38 91.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.203 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -69.08 -16.58 63.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 10.0 111.771 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -90.28 -20.24 23.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.167 0.508 . . . . 10.0 110.173 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 21.3 mt -93.08 -37.98 11.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.751 -0.659 . . . . 10.0 110.141 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -79.66 85.3 5.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.563 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -91.32 163.59 14.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.968 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -81.74 126.48 31.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 63.36 36.91 11.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.236 0.541 . . . . 10.0 109.736 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.174 -0.921 . . . . 10.0 111.673 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 120.579 0.228 . . . . 10.0 110.69 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.5 mt -100.43 141.77 32.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -111.18 134.94 52.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.111 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 107' ' ' GLU . 12.6 p -109.42 138.61 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.453 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.84 123.46 26.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.862 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.2 mt -81.32 -34.64 31.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.338 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -133.54 154.99 50.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.259 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.76 145.48 30.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.242 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -150.85 130.0 12.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.53 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -97.06 132.18 43.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.949 -0.759 . . . . 10.0 108.949 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 143.96 57.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.97 0.414 . . . . 10.0 111.396 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -97.01 -12.11 23.68 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.788 -0.642 . . . . 10.0 109.919 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.37 -166.49 2.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.028 -0.987 . . . . 10.0 109.434 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -98.35 -2.99 38.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -78.06 -47.84 17.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.002 -0.999 . . . . 10.0 108.827 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -87.64 155.68 19.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.192 -0.913 . . . . 10.0 108.818 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.1 tp -111.23 139.36 46.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.868 0.366 . . . . 10.0 111.86 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.9 m -81.44 140.04 34.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.665 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -152.2 166.22 32.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.967 0.413 . . . . 10.0 111.007 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -121.61 166.71 13.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.213 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -59.51 122.59 14.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.59 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.08 -1.43 44.2 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.733 -0.746 . . . . 10.0 112.611 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -67.15 140.94 57.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.644 0.259 . . . . 10.0 110.875 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -112.27 124.83 53.32 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -116.94 146.07 43.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.292 0.568 . . . . 10.0 112.356 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -100.14 101.43 12.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.718 -1.216 . . . . 10.0 107.718 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.0 mm -60.77 116.28 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.374 -0.376 . . . . 10.0 111.316 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.8 mt -89.25 -53.51 4.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.307 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -133.25 104.57 6.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.376 -0.375 . . . . 10.0 111.008 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.75 -8.19 44.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.289 0.566 . . . . 10.0 110.497 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 10.57 27.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.215 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.86 -25.12 59.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.913 0.387 . . . . 10.0 110.317 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.42 -127.79 3.18 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.639 -0.584 . . . . 10.0 111.639 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -83.15 -47.74 11.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.471 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 25.8 m95 -88.5 127.68 35.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.531 -0.915 . . . . 10.0 108.531 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -107.52 139.96 41.24 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.835 0.35 . . . . 10.0 111.277 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -85.39 119.41 25.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.177 -1.045 . . . . 10.0 108.177 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.11 162.61 30.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.071 0.463 . . . . 10.0 111.818 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -112.91 122.09 46.62 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.378 -0.828 . . . . 10.0 108.922 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.4 t -62.25 144.34 55.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.883 0.373 . . . . 10.0 110.741 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.75 -16.17 37.19 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.176 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 m -93.05 -50.79 5.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.709 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 64.8 p -88.4 -41.25 12.93 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.284 0.564 . . . . 10.0 111.268 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.89 9.1 62.83 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.751 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.21 162.57 18.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.779 0.323 . . . . 10.0 110.724 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.13 150.97 33.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.463 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 168.79 168.75 31.29 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.911 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -79.79 134.41 36.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.823 0.344 . . . . 10.0 110.821 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 22.8 pt -120.53 137.5 26.31 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.588 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.574 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 37.6 Cg_endo -72.19 121.95 7.97 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.549 2.166 . . . . 10.0 111.437 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -19.55 65.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.843 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 35.7 p-10 -80.63 -21.63 41.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.506 0.193 . . . . 10.0 111.446 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.461 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 4.6 m-85 -93.15 -11.99 31.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.081 0.4 . . . . 10.0 112.081 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.2 m -114.72 159.78 14.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.17 0.509 . . . . 10.0 111.675 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.72 137.59 18.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.716 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.64 137.14 32.25 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.343 2.029 . . . . 10.0 112.142 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.601 -0.714 . . . . 10.0 109.793 179.289 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ttm . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.462 0.173 . . . . 10.0 111.061 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.28 162.24 37.77 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.446 0.641 . . . . 10.0 112.173 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 1.1 m -107.58 118.2 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.316 -0.856 . . . . 10.0 109.746 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.1 134.35 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.821 0.343 . . . . 10.0 111.682 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -98.58 139.25 34.58 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.487 -0.561 . . . . 10.0 109.487 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -148.07 176.35 10.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.85 0.357 . . . . 10.0 110.667 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -123.87 83.55 2.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.815 -0.63 . . . . 10.0 109.76 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -63.77 92.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.765 0.316 . . . . 10.0 110.535 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm 52.02 29.5 6.32 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.688 -0.687 . . . . 10.0 111.608 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.17 -16.65 22.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.839 -0.696 . . . . 10.0 112.806 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -88.83 101.68 14.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.779 0.323 . . . . 10.0 110.732 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -67.52 123.12 19.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.082 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.05 158.76 44.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.747 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -125.12 119.59 29.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.041 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.71 142.43 42.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.804 0.335 . . . . 10.0 110.43 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 1.4 m-20 -60.77 137.86 58.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.351 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.8 tt -60.96 -26.52 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.696 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -10.72 59.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.855 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -105.3 8.18 33.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.69 0.281 . . . . 10.0 111.484 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -90.57 137.89 20.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.792 0.33 . . . . 10.0 110.273 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -88.95 -59.16 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.255 -0.43 . . . . 10.0 111.171 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -136.16 151.85 50.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.634 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.01 127.04 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.178 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 8.1 m -123.43 101.78 7.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.886 0.374 . . . . 10.0 111.398 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 22.3 ttp85 -90.76 137.33 32.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.813 -0.44 . . . . 10.0 109.813 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . 0.41 ' HB2' ' ND2' ' A' ' 136' ' ' ASN . 49.1 t80 -100.91 -20.49 15.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.06 0.457 . . . . 10.0 111.238 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.49 -4.58 37.44 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -135.17 -41.69 0.73 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.565 -0.817 . . . . 10.0 108.971 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -138.81 137.66 36.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.493 -0.776 . . . . 10.0 109.868 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 72.5 mt -102.98 125.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.279 -0.267 . . . . 10.0 110.279 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 17.7 m-85 -117.24 136.17 53.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -151.45 174.02 13.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.0 0.429 . . . . 10.0 111.227 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -130.24 140.88 50.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 10.0 109.805 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -124.41 152.52 43.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.926 0.393 . . . . 10.0 110.832 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.38 98.94 6.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.628 -0.714 . . . . 10.0 109.867 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' B' ' 40' ' ' LYS . 48.9 mt -75.81 144.42 41.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.793 0.33 . . . . 10.0 110.827 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.25 -5.87 87.55 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 116.071 -0.513 . . . . 10.0 112.201 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.3 23.05 10.38 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.899 -0.667 . . . . 10.0 112.441 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.84 43.42 97.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.45 -0.405 . . . . 10.0 112.834 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 86.0 tttt -159.79 95.68 1.61 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.717 0.294 . . . . 10.0 110.815 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -87.73 169.06 6.86 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.002 2.468 . . . . 10.0 111.235 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.63 -173.43 38.51 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.223 -0.989 . . . . 10.0 112.285 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 42.9 m-85 -118.56 166.89 12.17 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.66 138.25 6.42 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.372 -0.918 . . . . 10.0 112.531 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 p -124.33 127.73 73.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.078 0.466 . . . . 10.0 110.392 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.08 123.87 70.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.227 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -71.62 132.61 44.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.365 -0.38 . . . . 10.0 109.977 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -80.79 1.29 31.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.112 0.482 . . . . 10.0 110.791 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -116.3 -35.13 4.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.447 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -101.9 28.3 5.82 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.41 151.18 36.06 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 121.314 -0.154 . . . . 10.0 111.075 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.29 129.25 33.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.256 2.637 . . . . 10.0 112.418 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -64.31 -26.82 68.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.927 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -55.97 -42.62 76.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.971 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 73.8 mt -76.86 -30.67 56.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.729 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 62.1 mt -66.57 -32.09 73.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.413 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -74.42 -7.93 54.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.002 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -98.6 -26.92 14.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.907 -0.588 . . . . 10.0 110.11 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 52.3 mt -72.45 -61.95 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.865 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -101.03 110.33 22.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.208 0.528 . . . . 10.0 109.961 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -107.8 173.84 6.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.481 -0.781 . . . . 10.0 110.073 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -64.12 127.45 31.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.773 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 mttm 60.8 58.29 2.41 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.499 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.283 0 CA-C-N 115.954 -0.567 . . . . 10.0 111.061 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 120.929 0.395 . . . . 10.0 111.058 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.9 mt -92.57 158.84 15.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.09 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -121.08 134.61 55.27 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.2 p -112.27 140.34 32.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.921 0.391 . . . . 10.0 110.527 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.13 123.37 22.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.97 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 82.6 mt -83.28 -26.09 30.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.547 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.43 -175.3 4.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.922 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.87 149.8 27.05 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.282 0.364 . . . . 10.0 110.391 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -147.63 128.7 14.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.595 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -94.51 122.16 36.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.639 . . . . 10.0 109.403 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.47 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -61.68 144.09 55.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.703 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -97.32 -38.61 9.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.354 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.36 -162.25 1.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.873 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -96.54 -8.58 31.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.911 0.386 . . . . 10.0 110.68 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.48 -38.78 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.232 0.539 . . . . 10.0 110.099 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -93.05 150.55 20.45 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.688 -0.856 . . . . 10.0 108.688 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.2 tp -113.63 142.46 45.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.888 0.375 . . . . 10.0 111.626 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -81.92 148.51 28.7 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.799 179.006 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -154.85 158.96 40.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.102 0.477 . . . . 10.0 111.35 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -113.35 153.14 29.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.053 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -59.56 126.66 28.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.584 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.1 -17.64 29.24 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.884 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -68.4 143.14 55.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.733 0.302 . . . . 10.0 111.035 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -103.26 130.29 50.47 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.444 -0.576 . . . . 10.0 109.444 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -118.87 143.28 47.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.236 0.541 . . . . 10.0 112.089 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -103.19 104.14 14.26 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.69 -0.855 . . . . 10.0 108.69 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.426 HG23 ' HG ' ' A' ' 114' ' ' SER . 20.3 mm -64.13 120.19 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 10.0 111.206 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.8 mt -82.74 -46.44 13.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.194 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -149.06 137.77 21.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.185 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.426 ' HG ' HG23 ' A' ' 111' ' ' ILE . 0.7 OUTLIER -118.12 -12.44 10.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.173 -0.467 . . . . 10.0 111.29 -179.168 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.9 m -86.82 47.21 1.46 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.919 0.39 . . . . 10.0 111.903 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -127.35 -3.72 6.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.97 0.414 . . . . 10.0 110.863 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 139.47 -145.47 16.62 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.014 -0.612 . . . . 10.0 111.729 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.05 -22.41 20.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.031 0.443 . . . . 10.0 110.611 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.434 ' NE1' ' HB3' ' B' ' 31' ' ' PHE . 23.2 m95 -98.38 119.56 37.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.961 -1.125 . . . . 10.0 107.961 177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -103.47 153.92 20.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.284 0.564 . . . . 10.0 112.187 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -90.29 124.6 35.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.672 -1.233 . . . . 10.0 107.672 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.69 146.71 38.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.629 0.728 . . . . 10.0 112.715 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 123' ' ' ARG . 30.0 ttt180 -99.68 122.28 42.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.854 -1.066 . . . . 10.0 109.646 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.7 t -66.79 131.23 45.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.3 mt -78.44 -9.43 59.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.85 0.357 . . . . 10.0 110.427 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.5 m -79.78 -63.65 1.37 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 10.0 111.427 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.3 p -102.09 -25.75 13.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.389 0.514 . . . . 10.0 112.389 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.12 1.59 57.01 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.552 -0.832 . . . . 10.0 111.704 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -69.2 146.33 52.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 10.0 110.846 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.59 178.84 4.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.438 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 143.15 168.87 12.17 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.844 -0.693 . . . . 10.0 111.972 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -84.0 130.43 34.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.842 0.353 . . . . 10.0 110.44 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.8 pt -123.57 146.92 51.47 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.915 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.521 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 48.5 Cg_endo -74.23 115.05 4.18 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.666 2.244 . . . . 10.0 111.779 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.6 m -62.03 -15.06 41.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.945 0.72 . . . . 10.0 112.945 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.521 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 33.7 p-10 -83.41 -8.3 59.41 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.234 -0.291 . . . . 10.0 110.861 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -105.44 -0.16 26.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.167 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.6 m -127.67 156.15 39.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.989 0.423 . . . . 10.0 111.206 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.2 143.05 42.19 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.235 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.85 129.41 19.66 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.617 2.211 . . . . 10.0 112.06 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.29 -0.862 . . . . 10.0 110.261 -179.872 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.469 0.176 . . . . 10.0 110.708 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.4 169.24 25.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.821 0.343 . . . . 10.0 111.148 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.1 p -101.88 145.24 29.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 t -110.02 133.03 56.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.783 -0.451 . . . . 10.0 109.783 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.25 124.21 44.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.457 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 41.3 p90 -128.58 166.72 18.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.958 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -114.31 87.54 2.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.014 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -78.5 90.55 4.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.585 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm 53.54 38.21 27.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.108 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.01 -26.37 20.92 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.675 -0.774 . . . . 10.0 112.813 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -83.59 105.82 14.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.696 0.284 . . . . 10.0 110.882 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 26.7 mt-10 -80.16 116.93 20.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -130.92 157.44 42.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.612 0.244 . . . . 10.0 111.074 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -120.72 113.9 20.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.494 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 48.8 t -124.42 143.02 39.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.857 -0.423 . . . . 10.0 109.857 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.26 141.69 45.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 10.0 111.314 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 7.4 tt -62.26 -32.68 55.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.174 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 15.2 m -80.98 2.16 28.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.372 -0.376 . . . . 10.0 111.549 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -104.62 12.47 32.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.522 0.677 . . . . 10.0 109.29 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.15 133.86 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.063 -0.972 . . . . 10.0 109.324 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 t -83.76 -73.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.745 0.307 . . . . 10.0 111.568 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -118.85 152.18 36.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.72 0.295 . . . . 10.0 111.354 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.66 129.7 66.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.979 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 1.5 m -134.46 121.4 21.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.901 0.381 . . . . 10.0 111.05 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -120.75 125.47 47.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.814 0.34 . . . . 10.0 110.844 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -89.05 -22.46 22.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.153 0.502 . . . . 10.0 110.684 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.17 -4.47 8.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.865 -0.683 . . . . 10.0 112.01 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -117.14 -57.96 2.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.302 -0.629 . . . . 10.0 109.302 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.68 149.89 52.12 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.6 mt -101.66 124.64 55.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.358 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.434 ' HB3' ' NE1' ' A' ' 119' ' ' TRP . 3.3 m-85 -104.5 132.55 50.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.665 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -152.38 156.65 39.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.938 0.399 . . . . 10.0 111.289 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -110.59 132.17 54.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.059 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -114.62 164.3 14.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.67 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -133.33 142.96 48.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.624 -0.717 . . . . 10.0 109.385 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 35.7 mt -126.5 142.42 51.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.018 0.437 . . . . 10.0 111.288 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.86 -13.48 78.74 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.696 -0.684 . . . . 10.0 112.212 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.52 7.9 37.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.962 -0.637 . . . . 10.0 112.1 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.89 45.46 16.51 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.201 -0.523 . . . . 10.0 112.618 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -160.49 90.45 1.7 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.891 0.377 . . . . 10.0 111.392 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.32 175.03 6.62 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.458 2.105 . . . . 10.0 110.917 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.27 -166.5 36.54 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.881 -1.152 . . . . 10.0 112.462 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -120.65 156.57 31.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.681 0.277 . . . . 10.0 110.45 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.72 155.62 22.74 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.154 -0.778 . . . . 10.0 111.154 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.73 139.79 28.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.111 0.482 . . . . 10.0 111.262 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 20.4 m -132.31 152.48 36.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.763 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' B' ' 50' ' ' ASP . 19.5 t -91.16 141.34 28.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.112 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -82.6 -10.14 59.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.043 0.449 . . . . 10.0 110.636 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.64 -9.18 12.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.89 0.33 . . . . 10.0 111.89 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' B' ' 47' ' ' SER . 24.1 m-20 -120.32 21.9 11.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.901 0.382 . . . . 10.0 111.48 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.71 141.65 17.05 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.164 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.51 142.86 69.78 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.779 2.319 . . . . 10.0 112.297 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -58.06 -30.48 66.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.214 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.4 -45.09 72.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 10.0 111.161 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 mt -71.74 -38.84 70.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 10.0 111.023 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.98 -41.67 97.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.015 -0.539 . . . . 10.0 111.045 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -74.53 -13.65 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.932 -0.577 . . . . 10.0 111.383 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -80.42 -37.11 32.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.018 0.437 . . . . 10.0 109.823 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.44 -47.68 32.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.778 -0.646 . . . . 10.0 111.361 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -88.92 97.71 11.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.065 0.459 . . . . 10.0 110.43 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -104.01 -173.27 2.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.389 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -68.84 140.43 55.22 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 61.5 50.43 4.6 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.552 0.691 . . . . 10.0 109.892 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-N 115.165 -0.925 . . . . 10.0 110.878 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.597 0.237 . . . . 10.0 110.721 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.2 mt -99.8 141.79 32.15 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.932 0.396 . . . . 10.0 110.723 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -119.56 140.35 50.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.76 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.86 140.15 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.959 0.409 . . . . 10.0 110.437 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.34 116.56 12.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.987 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.24 -33.18 72.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.406 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -147.13 173.78 12.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.883 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.19 144.32 27.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -126.78 123.35 37.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.956 0.408 . . . . 10.0 111.112 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -84.93 116.85 23.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.606 -0.725 . . . . 10.0 109.579 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.94 148.67 51.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.092 0.472 . . . . 10.0 111.155 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -115.15 -35.44 4.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.782 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.81 -165.09 1.48 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.551 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -96.0 -11.95 25.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.688 0.28 . . . . 10.0 111.262 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.35 -34.63 31.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.211 0.529 . . . . 10.0 110.611 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -90.23 149.76 22.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.58 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.6 tp -109.68 135.46 50.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.981 0.42 . . . . 10.0 111.916 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.91 147.72 24.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.204 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -156.77 163.59 39.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.779 0.323 . . . . 10.0 111.268 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -110.26 157.05 19.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.08 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -58.5 128.1 35.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.799 0.333 . . . . 10.0 110.419 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.38 -10.0 53.78 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.707 -0.758 . . . . 10.0 112.924 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -70.85 146.73 49.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 10.0 110.781 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -115.62 139.07 50.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.067 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -126.58 150.39 48.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.053 0.454 . . . . 10.0 111.818 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -97.91 111.5 23.78 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.45 119.17 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.336 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.9 mt -102.7 -62.32 1.29 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.579 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -119.54 107.22 13.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.431 . . . . 10.0 110.644 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.29 22.0 12.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.78 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -112.27 -1.08 15.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.783 0.66 . . . . 10.0 112.783 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.72 -37.11 65.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.518 -0.473 . . . . 10.0 110.876 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.74 -133.62 2.89 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.189 -1.005 . . . . 10.0 112.588 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.39 -31.58 29.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.641 0.258 . . . . 10.0 110.947 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.558 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 28.2 m95 -93.16 121.22 34.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -103.17 146.48 28.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.046 0.451 . . . . 10.0 111.634 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -95.23 119.51 33.87 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.01 159.13 42.48 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.291 0.567 . . . . 10.0 111.832 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -104.38 124.15 48.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.245 -0.889 . . . . 10.0 109.433 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.0 t -65.95 136.57 56.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.944 -0.391 . . . . 10.0 109.944 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.34 -2.71 58.81 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.2 m -97.15 -50.31 4.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.2 p -101.24 -28.07 12.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.94 0.4 . . . . 10.0 111.732 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.45 -6.03 77.73 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.977 -0.63 . . . . 10.0 112.233 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -69.03 149.32 48.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.945 0.403 . . . . 10.0 110.882 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.1 m -119.95 125.86 49.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.947 -0.569 . . . . 10.0 111.093 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -163.5 176.11 39.67 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.489 -0.644 . . . . 10.0 111.489 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -81.72 127.86 33.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.839 0.352 . . . . 10.0 110.5 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.0 pt -119.62 142.13 32.27 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.805 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.443 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 28.9 Cg_endo -69.01 110.9 2.51 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.171 1.914 . . . . 10.0 111.184 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 m -59.35 -19.55 47.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.887 -0.597 . . . . 10.0 112.579 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.443 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 30.7 p-10 -81.51 -8.8 59.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 10.0 110.87 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -103.03 -3.5 25.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.312 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.79 157.87 27.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.507 -0.315 . . . . 10.0 111.036 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -138.85 148.37 57.85 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.317 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.38 136.53 55.59 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.546 2.164 . . . . 10.0 112.117 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.567 -0.73 . . . . 10.0 110.396 179.677 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ttt . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.561 0.22 . . . . 10.0 110.538 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.53 145.99 16.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.885 0.374 . . . . 10.0 111.009 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 6.1 m -93.72 119.8 33.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.625 -0.716 . . . . 10.0 109.45 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 32.8 t -86.87 130.34 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.984 0.421 . . . . 10.0 111.291 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -99.69 120.65 40.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.339 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -140.53 -174.22 3.9 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.609 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -125.54 142.97 51.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.068 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -125.52 98.84 5.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.968 0.413 . . . . 10.0 110.171 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm 56.8 31.64 19.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.189 -0.914 . . . . 10.0 112.264 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.45 -56.35 0.72 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.263 -0.97 . . . . 10.0 114.022 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -78.88 158.38 28.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.097 0.449 . . . . 10.0 111.842 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -97.1 141.79 29.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -136.9 152.1 49.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.443 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -126.18 111.9 15.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.21 -0.45 . . . . 10.0 109.796 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -129.59 142.13 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.803 0.335 . . . . 10.0 111.172 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.67 142.37 57.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.647 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 16.5 tt -63.13 -25.83 39.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.232 0.539 . . . . 10.0 110.616 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -11.38 60.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 10.0 111.362 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -99.5 2.68 45.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.122 0.487 . . . . 10.0 110.207 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 61.3 mt -96.91 134.34 34.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.075 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.26 -72.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.031 0.443 . . . . 10.0 110.434 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -120.99 147.02 46.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.096 -0.502 . . . . 10.0 111.155 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 t -124.16 116.01 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.659 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 5.1 m -120.65 112.55 19.02 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.128 0.49 . . . . 10.0 112.266 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.558 ' HD2' ' OE1' ' B' ' 48' ' ' GLU . 37.3 ttp85 -102.9 131.71 49.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.939 -0.393 . . . . 10.0 109.939 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -89.88 -25.48 20.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.311 0.577 . . . . 10.0 110.787 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.07 -4.14 16.3 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.716 -0.954 . . . . 10.0 110.716 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -134.17 -38.44 0.86 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -135.71 143.64 45.5 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.717 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mt -105.22 121.45 57.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -113.16 127.67 56.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.443 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -145.87 167.27 23.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.769 0.318 . . . . 10.0 110.608 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -126.46 129.93 49.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.106 -0.497 . . . . 10.0 109.742 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -119.48 162.99 17.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.224 0.535 . . . . 10.0 111.629 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.8 133.81 50.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.081 -0.963 . . . . 10.0 109.269 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 41.9 mt -112.5 140.01 47.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.815 0.341 . . . . 10.0 110.915 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.2 -7.49 45.07 Favored Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 115.829 -0.623 . . . . 10.0 112.839 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.07 8.89 59.18 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.916 -0.659 . . . . 10.0 111.975 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.1 47.93 16.98 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.913 -0.661 . . . . 10.0 112.372 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -163.02 99.28 1.04 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.552 0.215 . . . . 10.0 111.117 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.04 165.55 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.531 2.154 . . . . 10.0 110.874 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.76 -171.68 29.27 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 119.809 -1.186 . . . . 10.0 113.303 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 1.5 m-85 -124.49 158.42 32.91 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.813 -0.44 . . . . 10.0 109.813 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.69 132.7 6.16 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.627 -0.796 . . . . 10.0 111.584 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.27 125.82 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.254 0.55 . . . . 10.0 110.443 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 t -121.08 136.85 56.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.047 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 28.1 t -83.9 130.72 34.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.933 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.558 ' OE1' ' HD2' ' B' ' 25' ' ' ARG . 5.1 tt0 -93.97 4.44 53.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.338 0.589 . . . . 10.0 109.732 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -98.7 -46.09 5.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.793 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.03 79.85 1.89 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.23 0.538 . . . . 10.0 111.712 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.54 156.22 10.36 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.151 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.33 128.01 25.96 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.618 2.212 . . . . 10.0 112.55 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -63.42 -27.13 69.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.966 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' B' ' 58' ' ' LYS . 0.1 OUTLIER -57.88 -33.17 68.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.492 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.2 -38.18 19.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.252 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 61.9 mt -61.88 -47.08 86.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 10.0 111.142 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -76.83 -5.91 50.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.799 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' B' ' 54' ' ' GLU . 4.0 tttt -92.23 -22.92 19.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 10.0 110.369 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 29.3 mt -82.62 -54.56 5.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.736 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . 0.401 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 31.6 tt0 -92.15 94.16 9.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.103 0.478 . . . . 10.0 110.044 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -86.41 166.67 15.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.69 -0.686 . . . . 10.0 109.827 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -63.57 132.02 49.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.78 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.6 mttt 61.32 49.6 5.28 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.187 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.601 -0.714 . . . . 10.0 110.495 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 120.554 0.216 . . . . 10.0 110.735 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.7 mt -90.39 146.21 24.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.33 -0.396 . . . . 10.0 110.52 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -123.04 145.25 48.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.431 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.01 142.38 38.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.481 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.13 120.64 20.91 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.131 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 50.7 mt -79.74 -32.99 41.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.366 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -144.45 164.28 31.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.734 -0.667 . . . . 10.0 109.748 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.02 152.34 38.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.407 -0.59 . . . . 10.0 109.407 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -119.29 128.92 54.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.896 0.379 . . . . 10.0 111.026 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.79 92.59 6.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.09 -0.505 . . . . 10.0 109.67 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.91 162.8 29.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.56 . . . . 10.0 111.499 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -126.11 -45.64 1.7 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.023 -0.535 . . . . 10.0 110.728 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.23 -177.82 3.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.864 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -87.47 -11.21 49.65 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.891 0.33 . . . . 10.0 111.891 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.96 -39.04 31.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.993 0.425 . . . . 10.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.13 124.0 29.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.117 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.2 tp -77.85 135.13 37.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.996 -0.547 . . . . 10.0 112.204 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.33 120.81 35.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.711 . . . . 10.0 109.897 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -136.55 166.23 24.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.852 0.358 . . . . 10.0 111.29 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -109.78 168.32 9.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.839 -0.619 . . . . 10.0 111.391 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -65.27 134.3 53.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.389 -0.823 . . . . 10.0 111.357 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.41 2.95 88.89 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.118 -0.563 . . . . 10.0 113.725 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -81.41 151.26 28.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.073 0.436 . . . . 10.0 110.968 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -116.43 143.66 45.29 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.06 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.38 158.72 43.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 10.0 110.861 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -97.68 113.99 25.87 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.55 116.77 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.148 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.6 mt -83.96 -63.33 1.37 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.906 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -117.73 98.27 6.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.179 0.514 . . . . 10.0 111.403 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.41 -17.1 35.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.683 -0.689 . . . . 10.0 110.386 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.59 14.36 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.765 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -70.07 -44.39 69.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.314 0.578 . . . . 10.0 110.324 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 153.3 -113.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.452 -0.794 . . . . 10.0 111.185 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.16 -45.68 6.44 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.429 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 29.4 m95 -92.4 110.68 22.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -96.52 150.25 20.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.843 0.354 . . . . 10.0 111.052 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -95.07 123.8 38.75 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.455 -0.943 . . . . 10.0 108.455 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.5 163.99 27.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.958 0.409 . . . . 10.0 111.345 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -114.58 128.4 56.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.834 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.1 t -68.88 147.7 51.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.919 0.39 . . . . 10.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.0 mt -94.52 -3.14 50.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.496 -0.557 . . . . 10.0 109.496 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 m -95.06 -66.36 0.92 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.363 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.0 p -90.18 -20.91 22.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 10.0 111.461 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.94 13.49 79.34 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.783 -0.723 . . . . 10.0 111.895 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.48 153.43 37.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 10.0 110.898 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.9 m -117.6 135.75 53.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.176 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -179.47 176.79 47.95 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.433 -0.889 . . . . 10.0 112.221 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -84.29 138.95 32.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.307 -0.257 . . . . 10.0 110.307 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.2 pt -126.41 139.98 36.04 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.019 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.578 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 37.3 Cg_endo -68.83 121.57 8.46 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.343 2.029 . . . . 10.0 111.415 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 p -66.46 -12.82 59.24 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.551 0.574 . . . . 10.0 112.551 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.578 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 35.4 p-10 -87.58 -8.31 56.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.859 0.361 . . . . 10.0 110.986 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -100.32 -17.66 17.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.021 0.439 . . . . 10.0 110.677 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 22.5 m -115.83 154.05 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.61 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.82 145.24 47.59 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.407 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.46 124.76 12.88 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.219 1.946 . . . . 10.0 111.332 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.052 -0.975 . . . . 10.0 110.293 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 111.239 0.088 . . . . 10.0 111.239 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.424 ' O ' HG23 ' B' ' 17' ' ' ILE . . . -169.66 169.67 8.46 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.683 0.278 . . . . 10.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 2.2 m -107.6 140.2 40.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.699 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 54.6 t -115.05 136.52 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.56 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -105.09 128.4 53.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.093 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -137.71 177.31 7.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.544 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -125.38 89.0 2.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.771 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -78.37 110.72 13.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.084 -0.507 . . . . 10.0 109.866 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm 58.28 24.21 11.28 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.027 0.441 . . . . 10.0 111.017 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.29 -14.7 59.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.821 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.51 127.44 34.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.857 0.361 . . . . 10.0 110.804 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.07 120.72 22.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.3 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -137.61 149.79 46.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.255 -0.429 . . . . 10.0 110.382 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -126.85 115.51 19.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.547 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 64.1 t -125.88 143.8 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.15 -0.477 . . . . 10.0 109.847 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.575 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 56.6 m-20 -64.42 135.04 55.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 10.0 110.076 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.424 HG23 ' O ' ' B' ' 2' ' ' ALA . 15.8 tt -59.94 -26.23 35.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.614 -0.721 . . . . 10.0 111.398 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -10.8 60.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.079 -0.509 . . . . 10.0 111.345 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -100.94 12.6 37.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.132 0.491 . . . . 10.0 110.337 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -99.6 132.22 45.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.049 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.98 -64.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.93 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -137.0 155.87 49.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.326 -0.397 . . . . 10.0 110.723 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.5 t -127.05 142.86 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.923 -0.581 . . . . 10.0 109.644 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 9.3 m -137.81 118.87 14.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.036 0.445 . . . . 10.0 111.577 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.435 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 57.4 ttp85 -111.59 116.12 30.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.11 0.481 . . . . 10.0 110.687 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -84.66 -21.3 30.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.331 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.82 12.63 15.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.556 -0.83 . . . . 10.0 111.497 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -138.56 -51.97 0.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.761 -0.829 . . . . 10.0 108.761 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -136.57 143.28 43.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.783 -1.099 . . . . 10.0 108.85 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 27.8 mt -97.32 122.35 48.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.654 -0.498 . . . . 10.0 109.654 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -113.26 136.78 52.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.521 -0.309 . . . . 10.0 110.508 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -148.28 169.41 20.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.782 0.325 . . . . 10.0 110.646 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -126.81 131.24 51.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.037 -0.528 . . . . 10.0 109.847 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -125.55 165.53 18.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.031 0.443 . . . . 10.0 111.375 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -134.63 122.02 21.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.678 -0.692 . . . . 10.0 110.218 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -90.27 147.48 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 10.0 111.59 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.49 -12.89 70.5 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.933 -0.576 . . . . 10.0 112.549 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.38 13.94 43.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.906 -0.664 . . . . 10.0 112.555 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.31 54.94 7.29 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.702 -0.761 . . . . 10.0 111.966 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -157.59 95.28 2.06 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.648 0.261 . . . . 10.0 110.813 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.72 143.06 18.43 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.346 2.031 . . . . 10.0 110.792 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.93 -173.46 18.92 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.84 -1.172 . . . . 10.0 113.136 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . 0.429 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 7.2 m-85 -128.46 161.11 30.26 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.85 143.74 12.98 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.346 -0.931 . . . . 10.0 112.208 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 2.4 p -131.3 130.37 63.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.995 0.426 . . . . 10.0 110.004 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 26.4 t -122.57 133.95 67.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.848 -0.614 . . . . 10.0 110.134 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.39 136.67 53.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.047 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -87.86 -19.3 27.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.002 0.429 . . . . 10.0 110.946 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -108.35 -36.72 6.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.524 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -96.88 52.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.904 -0.589 . . . . 10.0 111.002 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -169.21 151.92 4.84 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.305 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.29 140.57 59.09 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.485 2.123 . . . . 10.0 111.803 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -60.96 -21.03 63.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.309 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -54.67 -46.15 73.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.252 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.28 -35.41 48.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.782 0.325 . . . . 10.0 110.743 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 30.8 mt -61.55 -43.47 98.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.001 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -74.33 -7.3 52.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.546 . . . . 10.0 111.949 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -91.97 -33.92 14.66 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.842 -0.429 . . . . 10.0 109.842 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 89.5 mt -82.26 -36.9 26.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.943 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . 0.435 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 8.8 tp10 -79.73 94.73 5.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.267 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -105.58 142.79 34.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.182 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -67.47 127.1 31.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 mttt 64.77 65.01 0.63 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.935 0.772 . . . . 10.0 109.845 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.606 -0.724 . . . . 10.0 110.586 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 120.568 0.223 . . . . 10.0 110.774 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.0 mt -93.66 148.13 22.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.021 -0.363 . . . . 10.0 110.021 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -120.59 134.19 55.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.711 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.45 140.29 34.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.026 -0.533 . . . . 10.0 109.95 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.22 124.77 25.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.191 -0.458 . . . . 10.0 111.633 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.6 mt -80.75 -34.12 34.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.172 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -140.71 164.08 31.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.533 -0.758 . . . . 10.0 110.008 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.79 147.41 39.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.829 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -129.48 137.73 51.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 10.0 111.243 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -98.31 130.98 44.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.946 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.54 139.78 31.89 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.22 -0.289 . . . . 10.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -107.89 -28.32 9.69 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.848 -0.341 . . . . 10.0 111.444 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.3 p -132.25 -161.47 1.14 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.993 0.425 . . . . 10.0 110.878 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -102.31 8.72 40.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.482 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.55 -38.83 7.36 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.497 -0.557 . . . . 10.0 109.497 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -89.87 149.46 22.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.748 -0.834 . . . . 10.0 108.748 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.4 tp -117.1 134.4 54.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.089 0.471 . . . . 10.0 111.964 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.67 151.38 26.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.831 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -159.57 170.57 21.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.363 -0.38 . . . . 10.0 110.314 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 59.2 m-70 -113.4 165.28 12.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.252 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -62.32 121.05 12.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.406 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.37 -4.34 33.14 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.958 -0.639 . . . . 10.0 112.122 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 104' ' ' HIS . 3.7 tp10 -66.86 129.32 39.49 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 122.287 0.235 . . . . 10.0 111.225 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -94.19 124.47 38.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -118.72 138.04 52.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.228 0.537 . . . . 10.0 112.088 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -100.52 105.67 17.12 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.388 -0.967 . . . . 10.0 108.388 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.8 mm -65.87 119.31 10.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.057 -0.519 . . . . 10.0 110.848 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -96.29 -38.78 9.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.435 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 121' ' ' GLU . 18.3 t30 -137.23 101.62 4.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.194 0.521 . . . . 10.0 110.255 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.63 -13.44 16.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.17 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.69 3.01 27.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.993 -0.548 . . . . 10.0 111.802 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -65.94 -48.12 72.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 10.0 110.581 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.43 -124.47 1.27 Allowed Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.826 -0.702 . . . . 10.0 111.813 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.417 ' HA ' ' HZ2' ' B' ' 9' ' ' LYS . 46.3 m-20 -76.68 -58.08 3.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.055 -0.35 . . . . 10.0 110.055 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.4 m95 -78.72 137.92 38.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -112.94 150.24 32.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.13 0.49 . . . . 10.0 111.901 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.496 ' HG3' ' CE1' ' A' ' 132' ' ' TYR . 5.3 mt-10 -89.96 112.61 24.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.496 -0.927 . . . . 10.0 108.496 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.69 154.91 44.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.234 0.54 . . . . 10.0 111.908 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 -109.15 132.54 54.02 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.442 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 t -73.78 131.64 41.77 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.725 -0.472 . . . . 10.0 109.725 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.12 -10.75 57.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.208 0.528 . . . . 10.0 110.067 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -62.71 1.41 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.444 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.9 p -89.08 -31.26 18.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.743 0.306 . . . . 10.0 111.796 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.8 -3.0 58.69 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.635 -0.793 . . . . 10.0 112.439 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -69.19 153.55 43.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.74 0.305 . . . . 10.0 111.195 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.4 m -127.37 134.88 49.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.982 -0.554 . . . . 10.0 110.957 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.14 -176.37 44.29 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.851 -0.69 . . . . 10.0 111.945 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.496 ' CE1' ' HG3' ' A' ' 121' ' ' GLU . 41.3 m-85 -83.92 131.32 34.86 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.7 pt -122.55 141.39 34.89 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.041 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.18 111.05 1.32 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.495 2.13 . . . . 10.0 111.428 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.84 -18.86 63.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.693 -0.685 . . . . 10.0 112.232 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -83.07 -13.96 54.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.455 -0.339 . . . . 10.0 111.246 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.91 0.03 43.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.575 -0.284 . . . . 10.0 111.328 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.7 m -123.33 161.23 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.823 0.344 . . . . 10.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.48 146.36 41.68 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.441 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -67.35 135.61 37.29 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.478 2.119 . . . . 10.0 111.599 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.524 -0.751 . . . . 10.0 110.439 -179.74 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ttt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.41 0.148 . . . . 10.0 110.942 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.11 152.59 24.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.866 0.365 . . . . 10.0 111.447 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.66 133.56 36.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.371 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 t -110.74 135.41 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.734 0.302 . . . . 10.0 110.729 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -102.87 126.3 49.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.057 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -128.86 166.43 19.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.502 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -106.66 89.08 2.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.149 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -75.73 86.38 2.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.419 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.417 ' HZ2' ' HA ' ' A' ' 118' ' ' ASP . 17.0 mmtm 54.85 35.36 24.11 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.3 -0.864 . . . . 10.0 111.294 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.48 -29.7 8.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.855 -0.688 . . . . 10.0 112.897 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -87.42 117.22 26.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.757 0.313 . . . . 10.0 111.121 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -83.51 114.34 21.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.998 0.428 . . . . 10.0 109.973 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -125.5 149.31 48.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.166 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -115.58 107.77 15.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.361 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.36 144.13 28.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.206 -0.452 . . . . 10.0 109.915 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.23 139.19 58.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.624 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.4 tt -63.29 -24.04 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.314 0.578 . . . . 10.0 110.732 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -16.01 62.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.932 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -98.93 15.93 24.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.34 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 72.9 mt -103.74 133.77 46.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.942 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.92 -71.62 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.472 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -128.94 147.0 50.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.709 -0.223 . . . . 10.0 110.844 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 27.9 t -125.53 127.69 71.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.1 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 63.1 m -129.8 118.21 21.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.081 0.467 . . . . 10.0 111.913 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 15.8 ttp85 -99.87 148.25 24.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.924 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -122.29 -25.47 4.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.965 0.357 . . . . 10.0 111.965 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.29 18.37 8.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.225 -0.988 . . . . 10.0 110.935 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -148.12 -50.65 0.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -148.7 134.0 18.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.854 -1.067 . . . . 10.0 109.647 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.4 mt -91.69 129.92 41.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.138 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -115.61 135.27 54.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.481 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -150.15 171.08 17.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.673 0.273 . . . . 10.0 110.852 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -121.05 132.9 55.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.239 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -119.17 161.33 20.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.222 0.534 . . . . 10.0 111.455 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -133.09 128.79 36.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.542 -0.754 . . . . 10.0 109.751 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt -113.24 122.16 46.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.751 0.31 . . . . 10.0 110.613 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.2 -15.16 21.42 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.716 -0.675 . . . . 10.0 113.185 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.54 -14.48 67.11 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.286 -0.483 . . . . 10.0 112.437 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.55 40.84 2.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 10.0 113.009 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -159.93 89.9 1.85 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.066 0.46 . . . . 10.0 111.458 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -86.05 160.26 10.14 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.575 2.183 . . . . 10.0 110.836 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.94 -156.43 13.52 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.016 -1.088 . . . . 10.0 112.446 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -124.3 171.36 9.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.225 -0.287 . . . . 10.0 110.225 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.68 141.1 8.73 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.802 -0.713 . . . . 10.0 111.7 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.16 132.71 68.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.279 0.561 . . . . 10.0 111.015 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 71.0 t -128.14 126.09 65.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.476 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 28.7 t -68.84 146.96 52.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.93 7.37 43.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.104 0.478 . . . . 10.0 110.35 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -114.32 -50.86 2.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.936 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -101.49 31.71 3.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.828 0.347 . . . . 10.0 111.919 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . -133.35 149.32 72.12 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.768 -0.196 . . . . 10.0 110.56 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.47 142.56 65.84 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.784 2.323 . . . . 10.0 112.654 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -65.86 -24.36 66.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.771 -0.649 . . . . 10.0 110.31 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -56.69 -30.7 63.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.544 -0.753 . . . . 10.0 110.987 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.66 -37.25 11.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.387 . . . . 10.0 110.392 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 66.0 mt -63.64 -37.87 88.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 10.0 111.436 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -70.89 -16.32 62.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 10.0 111.242 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -86.33 -37.17 18.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 10.0 110.275 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.51 -41.13 80.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.931 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -85.62 100.16 11.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.156 0.503 . . . . 10.0 110.357 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -109.67 157.36 19.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.659 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -69.51 136.19 51.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.65 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 67.04 48.86 1.18 Allowed 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.758 0.662 . . . . 10.0 110.021 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.656 -0.688 . . . . 10.0 110.568 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.1 mt -109.59 145.32 36.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.961 0.41 . . . . 10.0 110.098 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -117.99 137.15 53.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.527 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.97 138.69 31.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.909 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.06 117.67 11.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.542 . . . . 10.0 110.932 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.36 -49.31 67.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.076 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -138.04 170.3 16.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.554 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.72 133.93 47.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.626 -0.509 . . . . 10.0 109.626 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -110.84 120.99 44.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.009 0.433 . . . . 10.0 111.337 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -89.12 120.48 30.55 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.69 155.62 31.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.054 0.454 . . . . 10.0 111.181 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.493 HH22 ' HA ' ' B' ' 64' ' ' LYS . 6.5 ttm180 -110.32 -41.44 4.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.449 -0.796 . . . . 10.0 110.119 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.75 -160.86 0.86 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.072 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.5 -3.29 31.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.094 0.473 . . . . 10.0 110.145 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.58 -44.02 13.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.384 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.58 129.74 34.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.419 -0.81 . . . . 10.0 109.587 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.8 tp -80.68 125.26 29.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.672 -0.694 . . . . 10.0 111.947 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.46 131.49 34.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.402 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -147.26 167.61 23.81 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.983 0.42 . . . . 10.0 111.541 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -106.25 164.01 12.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.849 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.01 132.88 51.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.359 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.82 -5.23 66.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.629 -0.796 . . . . 10.0 113.962 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -78.32 155.04 30.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.07 0.435 . . . . 10.0 111.192 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -122.54 141.68 51.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.898 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.75 155.42 50.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.786 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -99.19 120.5 39.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.8 -0.636 . . . . 10.0 109.621 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.47 120.33 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.053 -0.522 . . . . 10.0 110.889 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.7 mt -93.53 -46.61 7.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.691 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -135.19 103.71 5.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.172 0.51 . . . . 10.0 111.05 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.92 -11.81 27.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.78 -0.645 . . . . 10.0 110.859 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.07 0.16 54.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.398 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.1 -32.9 74.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.218 0.532 . . . . 10.0 110.5 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 144.99 -110.03 0.54 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.913 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.09 -50.86 3.53 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.09 -0.337 . . . . 10.0 110.09 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.459 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 54.2 m95 -82.81 107.11 15.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.751 -1.203 . . . . 10.0 107.751 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -89.18 146.02 25.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.151 0.5 . . . . 10.0 111.553 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -86.69 115.91 24.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.83 154.94 41.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.112 0.482 . . . . 10.0 111.474 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.6 ttp85 -109.6 125.37 52.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.657 -0.701 . . . . 10.0 109.487 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.2 t -61.6 131.06 48.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.577 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.35 -6.22 58.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.832 -0.622 . . . . 10.0 109.783 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.26 -63.02 1.49 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.523 -0.762 . . . . 10.0 109.954 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.7 p -104.24 -61.14 1.48 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.691 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 149.83 -7.98 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.919 -0.582 . . . . 10.0 111.826 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.06 134.36 21.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.088 0.47 . . . . 10.0 111.879 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -116.69 132.45 56.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.306 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.24 -178.25 43.08 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.275 -0.964 . . . . 10.0 112.629 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -78.71 126.44 30.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.17 -0.307 . . . . 10.0 110.17 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.4 pt -112.84 135.69 21.63 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 10.0 111.127 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.453 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 34.8 Cg_endo -69.25 116.57 4.57 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.558 2.172 . . . . 10.0 111.518 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -14.36 60.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.695 -0.684 . . . . 10.0 112.35 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.507 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 38.4 p-10 -89.45 -3.34 58.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.452 -0.34 . . . . 10.0 111.032 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.436 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 11.2 m-85 -113.4 6.48 17.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.704 0.288 . . . . 10.0 111.223 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.5 m -129.64 150.58 34.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.937 0.399 . . . . 10.0 111.196 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.88 145.4 57.3 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.183 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.47 124.72 13.26 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.489 2.126 . . . . 10.0 111.82 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.403 -0.808 . . . . 10.0 110.158 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.638 0.256 . . . . 10.0 110.533 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.27 157.8 23.41 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.9 0.381 . . . . 10.0 110.922 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.9 m -96.74 131.35 43.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.684 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -103.38 138.32 28.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.07 0.462 . . . . 10.0 111.158 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -99.74 127.77 45.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.633 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -135.54 175.96 9.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.846 0.355 . . . . 10.0 111.002 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -120.97 106.48 11.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.571 . . . . 10.0 109.801 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -94.11 95.59 9.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.678 -0.489 . . . . 10.0 109.678 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 59.64 34.65 22.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.773 -0.649 . . . . 10.0 111.053 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.29 -24.82 29.83 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.808 -0.633 . . . . 10.0 112.49 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.96 111.32 18.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.75 0.31 . . . . 10.0 110.914 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -76.35 121.17 22.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.416 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -135.55 162.27 33.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.485 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -126.4 121.95 33.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.561 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 82.1 t -131.94 142.66 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 110.148 -0.315 . . . . 10.0 110.148 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 23.6 m-20 -70.1 141.79 52.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.898 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 tt -61.98 -26.2 39.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.961 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -17.93 64.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.094 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -99.87 3.16 44.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.681 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 65.1 mt -91.91 128.84 43.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.123 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 t -75.09 -63.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.097 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -138.6 152.51 48.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.471 -0.331 . . . . 10.0 110.86 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.446 HG13 ' HB3' ' B' ' 59' ' ' LEU . 18.8 t -131.33 138.49 53.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.3 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 8.7 m -143.09 125.6 15.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.201 0.524 . . . . 10.0 111.25 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.471 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 40.9 ttp85 -105.39 155.64 18.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.939 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -121.77 -34.95 3.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.702 0.287 . . . . 10.0 111.742 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.85 27.23 1.95 Allowed Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 110.241 -1.144 . . . . 10.0 110.241 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -152.64 -57.82 0.14 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.161 -1.052 . . . . 10.0 108.161 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . 0.401 ' HG2' ' HA ' ' B' ' 47' ' ' SER . 42.0 mt-30 -142.93 142.05 31.61 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.667 -1.151 . . . . 10.0 109.569 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -95.46 130.11 44.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 24.8 m-85 -114.23 139.58 49.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.546 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -152.0 160.85 43.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 10.0 111.149 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -123.13 132.92 54.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.362 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -126.12 167.43 15.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.945 0.402 . . . . 10.0 111.491 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -137.66 129.37 28.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.359 -0.837 . . . . 10.0 109.437 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 96.8 mt -101.44 143.85 30.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 10.0 111.077 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.51 -3.21 53.3 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.904 -0.589 . . . . 10.0 112.59 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.92 -8.57 87.55 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.933 -0.651 . . . . 10.0 112.068 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.72 42.5 3.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.265 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -163.77 114.7 0.99 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.711 0.291 . . . . 10.0 110.905 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.06 169.47 8.8 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.737 2.291 . . . . 10.0 111.311 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.51 -177.63 37.3 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.003 -1.094 . . . . 10.0 112.965 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 43.5 m-85 -132.23 164.5 26.23 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.87 150.43 22.09 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.488 -0.863 . . . . 10.0 112.183 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.52 139.2 28.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.101 0.477 . . . . 10.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.22 133.69 55.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.77 -0.65 . . . . 10.0 109.73 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.401 ' HA ' ' HG2' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -80.77 134.21 35.77 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.838 0.351 . . . . 10.0 110.516 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -77.7 41.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.769 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.27 -62.26 0.54 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.509 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -29.53 61.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.864 -0.607 . . . . 10.0 112.033 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.31 136.16 32.07 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.474 -0.33 . . . . 10.0 111.314 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.75 144.17 87.83 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.832 2.355 . . . . 10.0 112.197 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -61.64 -26.04 67.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 10.0 112.074 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -33.57 71.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 10.0 110.064 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 mt -80.96 -39.57 25.82 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.185 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -64.05 -38.64 91.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.62 -0.718 . . . . 10.0 110.962 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -71.93 -15.07 62.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 10.0 111.032 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -81.82 -24.27 35.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.316 0.579 . . . . 10.0 109.47 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.446 ' HB3' HG13 ' B' ' 23' ' ' VAL . 64.0 mt -89.07 -52.5 5.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.33 -0.85 . . . . 10.0 111.352 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . 0.471 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 28.9 tt0 -86.38 106.08 17.17 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.337 0.589 . . . . 10.0 110.228 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -107.25 164.38 12.22 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.333 -0.849 . . . . 10.0 109.21 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -59.2 128.99 39.93 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.181 0.301 . . . . 10.0 110.906 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 66.95 75.88 0.3 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.372 -0.831 . . . . 10.0 110.676 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.493 ' HA ' HH22 ' A' ' 96' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.496 -0.764 . . . . 10.0 110.284 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 121.215 0.531 . . . . 10.0 110.809 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.0 mt -104.13 136.88 42.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.108 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.22 137.04 54.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.935 0.397 . . . . 10.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.16 140.78 31.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.353 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 119.91 17.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.026 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.459 ' O ' ' HE2' ' A' ' 105' ' ' LYS . 71.2 mt -72.0 -36.77 69.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.405 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -141.63 169.92 16.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.789 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.33 149.29 40.68 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -124.08 124.73 43.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.107 0.48 . . . . 10.0 111.985 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.452 ' CD ' ' HZ3' ' B' ' 64' ' ' LYS . 0.1 OUTLIER -96.43 98.12 9.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.308 -0.86 . . . . 10.0 109.097 178.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.49 155.51 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.608 -0.724 . . . . 10.0 112.191 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -114.4 -32.8 5.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.306 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.26 -166.52 1.66 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.272 -0.171 . . . . 10.0 110.844 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.4 -1.21 51.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 10.0 109.908 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.57 -42.45 16.76 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.065 -0.717 . . . . 10.0 109.065 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -91.82 138.41 31.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.946 -1.025 . . . . 10.0 109.894 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.1 tp -100.64 133.16 45.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.914 -0.585 . . . . 10.0 111.633 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.22 147.13 27.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.539 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -152.72 162.66 40.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.646 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -101.47 163.86 12.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.735 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 90' ' ' LEU . 57.7 tttm -60.97 118.71 7.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.767 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.92 -0.25 31.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.678 -0.773 . . . . 10.0 112.641 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.4 141.31 55.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.584 0.23 . . . . 10.0 110.74 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -120.67 134.8 55.26 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -128.29 157.57 40.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.317 0.579 . . . . 10.0 111.919 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -99.88 110.16 22.52 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.935 -1.135 . . . . 10.0 107.935 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.6 mm -64.35 116.64 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.299 -0.409 . . . . 10.0 111.651 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.6 mt -104.12 -57.7 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.563 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -117.65 112.9 21.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.355 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.58 -17.59 3.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.21 0.448 . . . . 10.0 112.21 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.2 m -83.14 -6.26 59.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.032 0.382 . . . . 10.0 112.032 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.11 -53.29 39.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 10.0 110.55 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.409 ' HA3' ' CD1' ' B' ' 43' ' ' PHE . . . -167.17 -159.14 12.25 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.451 -0.66 . . . . 10.0 111.451 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.69 -34.56 74.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.929 0.395 . . . . 10.0 110.689 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -86.07 112.69 21.5 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.781 -0.822 . . . . 10.0 108.781 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -91.17 145.7 24.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.927 -0.578 . . . . 10.0 111.471 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -108.66 115.85 30.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.075 -1.083 . . . . 10.0 108.075 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.1 164.64 26.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.064 0.459 . . . . 10.0 111.903 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.95 127.77 51.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.778 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.7 t -65.72 135.11 54.52 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.311 -0.404 . . . . 10.0 109.919 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.4 mt -82.3 -15.46 52.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.183 0.516 . . . . 10.0 109.806 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.8 m -79.85 -67.94 0.72 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.476 -0.784 . . . . 10.0 111.556 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 p -92.21 -34.68 14.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.151 0.426 . . . . 10.0 112.151 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.3 -4.97 35.45 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.628 -0.796 . . . . 10.0 112.071 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -63.75 141.61 58.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.681 0.277 . . . . 10.0 110.695 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.7 m -117.75 133.13 56.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.859 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -172.86 -178.57 42.99 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.799 -0.715 . . . . 10.0 112.093 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -78.66 131.39 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 10.0 110.498 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.0 pt -123.06 136.71 27.21 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.513 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -64.66 117.44 4.51 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.46 2.107 . . . . 10.0 111.563 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.72 -19.41 65.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 10.0 112.363 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.417 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 36.0 p-10 -87.05 0.46 55.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.405 -0.361 . . . . 10.0 111.338 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -116.28 -0.08 12.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.697 0.284 . . . . 10.0 111.223 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.35 151.94 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.906 0.384 . . . . 10.0 111.451 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.45 150.17 62.86 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.266 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.14 142.63 97.45 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.686 2.257 . . . . 10.0 112.348 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.459 -0.782 . . . . 10.0 110.809 -179.667 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 20.3 ttt . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.571 0.224 . . . . 10.0 110.667 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.6 161.09 26.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.733 0.302 . . . . 10.0 110.952 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 7.1 m -100.73 133.28 45.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.388 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 21.0 t -115.42 138.8 44.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.002 0.43 . . . . 10.0 111.488 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -96.5 135.01 38.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.853 -0.612 . . . . 10.0 109.678 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.85 -179.51 6.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.816 0.341 . . . . 10.0 110.703 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.424 ' HE2' ' OE2' ' B' ' 12' ' ' GLU . 66.9 mttt -117.53 141.79 47.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.147 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -146.85 110.82 5.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.595 -0.275 . . . . 10.0 110.716 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm 67.5 1.89 2.71 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.937 0.773 . . . . 10.0 111.969 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.77 -52.57 0.82 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.668 -0.777 . . . . 10.0 112.096 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.49 145.35 47.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.866 0.365 . . . . 10.0 110.323 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.424 ' OE2' ' HE2' ' B' ' 7' ' ' LYS . 21.7 mt-10 -90.92 122.46 33.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.811 -0.631 . . . . 10.0 109.866 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -116.33 157.34 25.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.641 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -128.45 118.21 22.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.319 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 46.8 t -134.56 149.38 29.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.487 -0.56 . . . . 10.0 109.487 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 18.8 m-20 -68.26 138.38 55.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.715 0.293 . . . . 10.0 110.518 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 tt -62.54 -24.54 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 2.4 m -72.46 -9.2 58.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.082 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -106.6 11.8 30.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.338 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' B' ' 34' ' ' TYR . 67.6 mt -99.48 137.43 26.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 10.0 109.996 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 6.8 t -77.92 -74.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.777 0.322 . . . . 10.0 111.059 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -126.97 155.17 43.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.423 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.26 125.4 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.34 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -120.05 118.41 30.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.14 0.495 . . . . 10.0 111.464 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 40.5 ttp85 -104.81 144.17 32.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.142 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -115.36 -26.52 7.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.611 0.243 . . . . 10.0 111.131 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.71 14.57 8.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.401 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -145.24 -52.79 0.28 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.818 -0.808 . . . . 10.0 108.818 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -142.47 135.39 28.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.814 -1.085 . . . . 10.0 109.519 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 61.3 mt -93.02 133.52 33.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.212 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.417 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 53.3 m-85 -119.89 137.94 53.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.47 174.31 13.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.087 0.47 . . . . 10.0 111.383 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -126.95 126.45 43.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.315 -0.857 . . . . 10.0 109.399 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' B' ' 20' ' ' ILE . 53.9 p90 -116.12 159.03 22.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 10.0 111.223 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -126.26 115.83 20.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.434 -0.803 . . . . 10.0 109.775 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.41 137.41 32.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.005 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.36 -13.54 58.36 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.912 -0.586 . . . . 10.0 112.807 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.03 2.65 83.39 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.179 -0.534 . . . . 10.0 112.368 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.49 46.02 5.35 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.917 -0.659 . . . . 10.0 112.873 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -152.62 95.3 3.09 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.713 0.292 . . . . 10.0 111.211 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.49 150.88 25.33 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.931 2.421 . . . . 10.0 110.9 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.16 -170.9 22.59 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.044 -1.074 . . . . 10.0 112.885 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . 0.409 ' CD1' ' HA3' ' A' ' 117' ' ' GLY . 24.4 m-85 -126.6 165.8 18.5 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.56 -0.533 . . . . 10.0 109.56 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.45 149.48 20.08 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.251 -0.976 . . . . 10.0 112.553 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.1 p -125.53 138.1 55.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.092 0.473 . . . . 10.0 110.85 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 74.7 t -125.76 118.85 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.002 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 118.74 15.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.572 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.73 -7.93 43.6 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.648 0.61 . . . . 10.0 112.648 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -103.75 -24.18 13.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.84 0.311 . . . . 10.0 111.84 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.38 -42.37 6.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.361 0.504 . . . . 10.0 112.361 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.96 146.81 87.97 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.686 -0.233 . . . . 10.0 111.547 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.63 147.42 91.94 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.693 2.262 . . . . 10.0 111.467 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -60.61 -24.77 65.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -59.11 -44.16 91.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.872 0.368 . . . . 10.0 110.641 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 79.1 mt -72.45 -35.79 68.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.431 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.49 -42.0 92.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.745 -0.661 . . . . 10.0 111.487 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -78.05 -16.92 57.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 10.0 110.909 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -79.46 -45.92 18.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.551 -0.537 . . . . 10.0 109.551 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.79 -47.78 61.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.593 -0.73 . . . . 10.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -82.62 98.74 9.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.007 0.432 . . . . 10.0 110.453 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -96.22 144.2 26.63 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.844 -0.616 . . . . 10.0 109.919 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -61.89 130.88 47.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.968 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 67.58 97.38 0.06 Allowed 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.981 0.8 . . . . 10.0 111.23 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.452 ' HZ3' ' CD ' ' A' ' 94' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.637 -0.697 . . . . 10.0 110.302 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.632 0.253 . . . . 10.0 110.985 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.7 mt -108.49 140.23 42.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.559 -0.291 . . . . 10.0 110.361 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -112.33 130.05 56.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.209 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -109.1 140.38 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.234 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.26 121.36 19.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.84 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.6 -32.67 62.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.338 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.8 168.15 24.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.483 -0.781 . . . . 10.0 109.502 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.77 139.58 40.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.744 -0.465 . . . . 10.0 109.744 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -101.84 128.56 48.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.834 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -77.84 101.37 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.681 -0.69 . . . . 10.0 109.353 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.28 141.37 19.35 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.633 0.583 . . . . 10.0 111.661 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -106.93 -58.5 1.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.661 -0.7 . . . . 10.0 111.03 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 p -131.83 -165.86 1.64 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.958 -0.565 . . . . 10.0 110.346 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -89.32 -6.73 56.47 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.13 -0.693 . . . . 10.0 109.13 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -76.42 -45.14 32.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.045 -0.98 . . . . 10.0 110.006 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -82.5 152.86 25.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.466 -0.788 . . . . 10.0 110.149 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.8 tp -89.82 132.2 35.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.345 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 m -91.15 126.16 36.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.751 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -146.83 165.49 29.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.828 0.346 . . . . 10.0 111.218 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -118.33 166.51 12.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.166 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.2 tttm -66.52 132.25 47.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.942 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.56 -6.16 52.3 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.835 -0.698 . . . . 10.0 112.71 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -81.54 150.35 28.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 10.0 111.415 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -113.16 128.24 56.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.745 -0.662 . . . . 10.0 109.225 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -120.25 144.47 47.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.9 0.381 . . . . 10.0 111.216 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -99.08 110.66 23.22 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 16.9 mm -66.22 118.63 9.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.334 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.13 -37.72 18.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.083 -0.508 . . . . 10.0 109.896 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -153.57 112.37 3.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.968 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.47 2.59 47.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.274 0.559 . . . . 10.0 110.656 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.91 20.07 1.94 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.794 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.61 -42.89 17.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.274 0.559 . . . . 10.0 110.159 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 138.5 -70.79 0.46 Allowed Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.702 -0.681 . . . . 10.0 111.82 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -122.76 -69.0 0.85 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.709 -0.478 . . . . 10.0 109.709 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.489 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 40.0 m95 -78.35 100.84 6.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.444 -0.947 . . . . 10.0 108.444 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -88.34 156.26 19.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.057 -0.52 . . . . 10.0 111.941 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -84.56 122.9 29.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.404 -0.817 . . . . 10.0 109.028 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.25 153.13 43.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.238 0.542 . . . . 10.0 112.107 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -114.06 123.29 49.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.072 -0.967 . . . . 10.0 109.128 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 t -67.22 131.36 45.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.955 0.407 . . . . 10.0 110.016 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.4 mt -83.1 -21.28 33.73 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.31 -55.15 6.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.077 -0.965 . . . . 10.0 111.075 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.4 p -94.58 -67.17 0.87 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.766 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.29 -2.2 3.83 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.824 -0.91 . . . . 10.0 110.824 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -68.66 148.05 50.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.294 -0.453 . . . . 10.0 110.738 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.2 m -120.91 138.71 53.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.233 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.85 -175.05 47.49 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.571 -0.823 . . . . 10.0 112.159 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -88.79 135.7 33.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.615 0.245 . . . . 10.0 110.69 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.0 pt -125.78 143.96 46.84 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.192 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.501 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 56.9 Cg_endo -73.16 121.45 7.25 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.396 2.064 . . . . 10.0 111.347 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.18 -1.65 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.501 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 36.8 p-10 -96.33 0.55 50.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.794 0.33 . . . . 10.0 110.768 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -119.7 1.03 11.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.035 0.445 . . . . 10.0 111.202 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.63 154.33 36.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.37 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.15 147.13 42.83 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.804 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.29 142.85 42.23 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.438 2.092 . . . . 10.0 111.512 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.406 -0.807 . . . . 10.0 110.143 179.947 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.309 0.1 . . . . 10.0 110.828 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.03 171.23 11.26 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.751 0.31 . . . . 10.0 110.883 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m -107.72 129.16 55.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.34 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -102.85 137.39 31.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 10.0 110.722 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -101.94 137.32 40.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 10.0 110.417 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -145.55 168.13 21.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.254 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.45 85.14 2.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -67.77 96.38 0.56 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.356 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt 58.94 26.33 14.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.353 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.26 -27.23 9.66 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.973 -0.632 . . . . 10.0 112.703 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -76.87 114.03 15.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.693 0.283 . . . . 10.0 111.204 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.03 109.75 7.78 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.772 -0.455 . . . . 10.0 109.772 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -131.08 157.38 43.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.55 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -129.42 132.02 46.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.847 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 90.8 t -136.99 147.13 27.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.419 ' HB2' ' HD2' ' B' ' 19' ' ' LYS . 18.1 m-20 -61.16 135.99 57.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 10.0 110.783 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.4 tt -60.6 -31.4 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.492 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -5.49 39.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.165 -0.471 . . . . 10.0 111.584 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.419 ' HD2' ' HB2' ' B' ' 16' ' ' ASP . 80.9 mttt -105.29 9.99 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.21 0.529 . . . . 10.0 110.618 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 78.7 mt -95.55 121.7 46.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.39 -60.0 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.69 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.22 151.53 45.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.852 0.358 . . . . 10.0 111.318 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 t -127.02 138.41 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.278 -0.873 . . . . 10.0 109.564 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -136.91 118.6 15.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.977 0.418 . . . . 10.0 111.04 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 35.1 ttp85 -109.03 141.1 41.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.409 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -115.92 -26.06 7.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.339 -0.391 . . . . 10.0 111.168 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.64 29.76 2.81 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.748 . . . . 10.0 111.452 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -157.52 -53.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -139.23 129.88 25.95 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.283 -0.871 . . . . 10.0 109.806 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mt -88.98 117.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -104.97 139.12 40.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.688 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.81 166.19 32.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.724 0.297 . . . . 10.0 110.939 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -127.63 135.91 50.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.097 -0.501 . . . . 10.0 109.837 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -122.11 165.15 16.53 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.483 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -136.32 121.81 19.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.844 -0.616 . . . . 10.0 110.331 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 66.1 mt -98.11 142.38 29.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.875 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.38 -14.99 62.94 Favored Glycine 0 C--N 1.329 0.148 0 CA-C-N 116.095 -0.502 . . . . 10.0 112.815 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.64 11.94 54.2 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.659 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.3 51.1 6.28 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.889 -0.672 . . . . 10.0 111.766 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 tptt -138.93 90.46 12.2 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 121.072 -0.251 . . . . 10.0 110.987 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -89.05 110.02 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.771 2.314 . . . . 10.0 110.467 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.63 -177.86 15.18 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.124 -1.036 . . . . 10.0 112.897 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 23.0 m-85 -120.8 166.74 13.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.785 -0.45 . . . . 10.0 109.785 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.35 142.8 12.02 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.827 -0.702 . . . . 10.0 112.169 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.68 129.25 51.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.844 0.354 . . . . 10.0 110.43 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -126.07 127.19 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.204 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.15 127.94 34.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.457 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -83.73 26.06 0.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -137.69 -50.54 0.61 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -95.64 19.86 10.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.34 144.14 48.32 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.614 -0.267 . . . . 10.0 110.456 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.41 138.45 47.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.025 2.483 . . . . 10.0 112.248 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -60.7 -27.55 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.982 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.83 -38.1 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.716 0.293 . . . . 10.0 111.134 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.19 -39.85 78.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.382 . . . . 10.0 110.035 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 21.9 mt -67.84 -39.72 83.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.588 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -66.93 -31.61 72.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.266 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.42 -8.6 59.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.003 0.43 . . . . 10.0 110.748 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 25.5 mt -96.09 -45.56 6.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.791 0.293 . . . . 10.0 111.791 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -91.54 131.84 36.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 10.0 111.213 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -123.86 163.57 20.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 10.0 109.487 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -74.35 131.99 41.62 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.893 -0.323 . . . . 10.0 110.613 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 mttp 64.0 62.52 0.87 Allowed 'General case' 0 C--O 1.236 0.38 0 O-C-N 123.921 0.763 . . . . 10.0 110.746 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.449 ' HZ2' ' C ' ' B' ' 64' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.496 -0.764 . . . . 10.0 110.254 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.753 0.311 . . . . 10.0 110.552 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.4 mt -88.09 160.79 17.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.309 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.18 135.92 55.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.505 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 p -111.05 139.29 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.553 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.99 124.63 25.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.162 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.41 ' O ' ' HE2' ' A' ' 105' ' ' LYS . 59.6 mt -83.51 -33.37 25.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.531 . . . . 10.0 110.607 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -139.61 154.57 47.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.962 -0.563 . . . . 10.0 109.812 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.01 150.42 42.43 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.619 -0.512 . . . . 10.0 109.619 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -138.02 133.93 34.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.629 0.252 . . . . 10.0 110.518 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.65 132.45 46.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.15 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.477 ' HA ' ' OD2' ' A' ' 100' ' ' ASP . . . -91.88 148.76 21.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.015 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.419 HH12 ' HD3' ' A' ' 96' ' ' ARG . 5.4 ttm180 -119.8 -21.37 7.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.345 0.593 . . . . 10.0 109.968 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.55 -178.48 4.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.005 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -94.17 8.56 41.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.358 0.599 . . . . 10.0 110.143 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.407 ' CG ' HH12 ' B' ' 33' ' ' ARG . 0.5 OUTLIER -94.69 -44.14 7.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.303 -0.862 . . . . 10.0 109.521 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.477 ' OD2' ' HA ' ' A' ' 95' ' ' ALA . 15.9 p-10 -88.39 151.21 22.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.411 -0.813 . . . . 10.0 109.053 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 tp -112.0 129.12 56.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.984 0.421 . . . . 10.0 112.057 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.469 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -84.28 139.36 32.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.124 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.4 ' CB ' ' HZ ' ' A' ' 109' ' ' PHE . 31.3 p90 -155.2 170.81 20.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.841 0.353 . . . . 10.0 111.225 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -114.91 157.61 23.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.71 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 90' ' ' LEU . 54.8 tttm -62.32 131.99 51.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.664 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.71 -19.73 23.3 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.546 -0.835 . . . . 10.0 112.863 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -77.15 148.98 35.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.98 0.419 . . . . 10.0 110.834 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -114.68 144.09 43.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.122 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.4 ' HZ ' ' CB ' ' A' ' 103' ' ' PHE . 32.1 m-85 -129.51 153.91 47.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.963 0.411 . . . . 10.0 111.306 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -100.1 114.35 27.64 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 46.9 mm -69.35 119.15 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.904 0.383 . . . . 10.0 111.142 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.4 mt -85.37 -52.58 5.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.648 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -135.92 109.1 7.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.877 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.36 -8.08 39.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.225 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.27 21.22 9.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.45 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 119' ' ' TRP . 19.4 tp10 -67.59 -43.39 80.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.645 -0.707 . . . . 10.0 110.356 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 155.28 -106.54 0.3 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.833 -0.698 . . . . 10.0 111.887 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -99.4 -11.44 21.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.213 0.53 . . . . 10.0 109.971 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.472 ' O ' ' HB3' ' A' ' 116' ' ' GLU . 39.9 m95 -124.64 159.71 30.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.155 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -119.85 139.99 51.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.943 0.401 . . . . 10.0 111.88 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -90.23 116.11 27.97 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.786 -1.19 . . . . 10.0 107.786 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.91 160.61 30.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.643 0.735 . . . . 10.0 112.579 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -116.31 128.29 55.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.67 -1.15 . . . . 10.0 109.226 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t -66.43 133.16 49.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.81 0.338 . . . . 10.0 111.101 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.8 mt -92.04 -11.23 36.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.432 0.634 . . . . 10.0 109.362 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -50.47 8.48 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.347 -0.842 . . . . 10.0 110.537 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.0 p -111.05 -55.89 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.099 0.476 . . . . 10.0 111.298 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.1 -8.54 4.44 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.908 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -55.73 146.82 20.18 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.05 0.452 . . . . 10.0 111.843 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.83 142.62 46.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.329 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.92 173.47 42.51 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.419 -0.896 . . . . 10.0 112.076 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -84.79 131.34 34.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.019 0.438 . . . . 10.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.0 pt -115.51 144.53 32.61 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.547 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.465 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 19.6 Cg_exo -63.89 114.53 2.64 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.849 1.7 . . . . 10.0 111.141 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.1 -14.2 15.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.559 -0.746 . . . . 10.0 112.46 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -104.27 12.88 33.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.424 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 134' ' ' PRO . 8.8 m-85 -120.82 3.34 10.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.747 0.308 . . . . 10.0 111.163 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 m -128.84 148.44 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.945 0.402 . . . . 10.0 111.12 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -128.9 141.44 41.71 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.292 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.02 137.02 43.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.654 2.236 . . . . 10.0 111.973 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 64.3 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.397 -0.811 . . . . 10.0 109.785 179.678 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.668 0.271 . . . . 10.0 110.398 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.52 147.58 28.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.863 0.364 . . . . 10.0 110.866 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.8 m -97.84 132.33 43.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.419 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 48.5 t -104.46 131.62 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.867 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -98.42 131.62 44.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.677 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -145.42 -174.07 4.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.742 0.306 . . . . 10.0 110.809 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -130.2 123.96 31.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.895 -0.593 . . . . 10.0 109.841 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . 0.466 ' O ' ' HG2' ' B' ' 11' ' ' GLU . 17.9 t80 -102.17 94.05 5.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.869 0.366 . . . . 10.0 110.122 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 60.44 13.4 4.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.639 -0.71 . . . . 10.0 112.156 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.68 -35.87 2.0 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.38 -0.914 . . . . 10.0 113.159 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' B' ' 8' ' ' TYR . 12.0 pt-20 -82.57 136.66 34.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.159 0.479 . . . . 10.0 111.062 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -83.62 138.59 33.28 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -148.3 150.48 33.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.894 0.378 . . . . 10.0 111.386 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -123.47 110.82 15.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.126 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.2 t -125.44 141.51 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.162 -0.472 . . . . 10.0 109.835 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.528 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 29.9 m-20 -66.97 145.25 55.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.117 0.484 . . . . 10.0 111.786 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.6 tt -58.88 -30.14 42.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.401 -0.818 . . . . 10.0 112.318 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 5.8 m -74.04 -10.65 59.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.778 0.323 . . . . 10.0 111.417 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.3 2.58 39.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.237 0.541 . . . . 10.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -99.3 110.48 26.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.537 -0.756 . . . . 10.0 109.289 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.19 -78.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.698 -0.683 . . . . 10.0 112.14 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -114.57 144.8 42.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 10.0 111.202 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 t -131.68 140.93 47.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 56.1 m -144.93 125.87 14.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.216 0.532 . . . . 10.0 111.376 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.435 ' HG3' ' OE1' ' B' ' 48' ' ' GLU . 27.6 ttp85 -108.42 152.59 24.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.373 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -129.63 -18.31 3.53 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.874 -0.33 . . . . 10.0 111.745 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.46 3.14 25.8 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.316 -0.945 . . . . 10.0 111.325 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -128.02 -52.27 1.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.405 -0.591 . . . . 10.0 109.405 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -150.97 143.32 24.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.373 -0.83 . . . . 10.0 109.941 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mt -95.02 132.68 38.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.331 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -118.9 142.68 47.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.308 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -162.14 168.82 21.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.807 0.336 . . . . 10.0 111.193 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . 0.407 HH12 ' CG ' ' A' ' 99' ' ' ASP . 16.1 ttp180 -123.9 133.56 53.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.476 -0.564 . . . . 10.0 109.476 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -113.88 147.54 38.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.977 0.418 . . . . 10.0 110.739 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -122.94 121.76 36.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.641 -0.708 . . . . 10.0 109.531 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 96.5 mt -97.84 136.85 37.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.817 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.3 -18.18 64.88 Favored Glycine 0 C--N 1.33 0.202 0 CA-C-N 116.068 -0.515 . . . . 10.0 112.194 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.57 -8.63 87.56 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.793 -0.718 . . . . 10.0 111.913 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 64.85 1.05 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.76 -0.734 . . . . 10.0 112.471 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -160.34 85.47 1.97 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.047 0.451 . . . . 10.0 110.371 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -84.34 136.07 6.46 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.668 2.245 . . . . 10.0 111.667 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.37 -176.92 29.97 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.532 -0.842 . . . . 10.0 112.101 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -113.13 168.83 9.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.303 -0.258 . . . . 10.0 110.303 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.03 138.77 7.08 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.463 -0.655 . . . . 10.0 111.463 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.44 135.28 64.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.88 0.372 . . . . 10.0 110.424 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 81.1 t -127.67 129.11 70.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.574 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.9 t -75.78 126.98 32.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.226 -0.443 . . . . 10.0 109.903 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.435 ' OE1' ' HG3' ' B' ' 25' ' ' ARG . 52.8 mt-10 -76.45 2.46 13.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.955 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -124.37 -34.71 2.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.595 -0.275 . . . . 10.0 111.497 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -84.47 -24.28 29.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.735 0.302 . . . . 10.0 111.557 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.35 146.87 32.07 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.747 0.308 . . . . 10.0 111.038 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.63 156.23 66.88 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.704 2.269 . . . . 10.0 111.759 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -60.57 -25.96 66.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.375 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . 0.404 ' CD ' ' HZ2' ' B' ' 58' ' ' LYS . 1.3 tm-20 -51.39 -40.85 60.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.666 -0.697 . . . . 10.0 111.385 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.21 -40.53 14.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.027 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 54.8 mt -60.89 -37.18 81.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.7 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -74.52 -11.53 60.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.603 -0.271 . . . . 10.0 111.342 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.404 ' HZ2' ' CD ' ' B' ' 54' ' ' GLU . 53.3 mttp -94.42 -19.16 20.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.097 0.475 . . . . 10.0 110.05 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -95.14 -7.94 37.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.229 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -79.92 71.35 6.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.616 -0.72 . . . . 10.0 109.781 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' B' ' 64' ' ' LYS . 82.3 mttt -72.39 102.71 3.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.589 -0.732 . . . . 10.0 110.076 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -70.68 150.96 45.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.401 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 67.59 33.85 4.86 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.739 0.78 . . . . 10.0 109.791 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' B' ' 61' ' ' LYS . 11.5 tptp . . . . . 0 C--O 1.251 1.172 0 CA-C-N 114.642 -1.163 . . . . 10.0 108.783 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.592 0.234 . . . . 10.0 110.553 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -107.86 137.94 44.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.964 0.411 . . . . 10.0 110.876 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -116.41 142.24 47.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.526 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.6 p -110.47 140.34 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.534 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.76 126.21 30.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.888 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.76 -31.95 35.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.019 0.438 . . . . 10.0 110.164 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -141.29 168.76 19.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.67 -0.696 . . . . 10.0 109.442 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.19 138.83 35.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.336 -0.393 . . . . 10.0 109.946 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -112.65 127.17 56.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.098 0.475 . . . . 10.0 111.67 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -95.94 118.09 31.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.371 -0.974 . . . . 10.0 108.371 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.87 153.26 36.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.98 0.419 . . . . 10.0 111.236 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -118.08 -35.9 3.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.946 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.44 171.79 7.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.985 0.421 . . . . 10.0 110.343 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -84.32 20.01 1.75 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.738 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.74 -36.04 3.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.161 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -83.3 141.05 32.11 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.923 -0.769 . . . . 10.0 108.923 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.0 tp -97.65 126.94 43.24 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.407 0.521 . . . . 10.0 112.407 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.4 146.97 25.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 10.0 109.839 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -155.61 168.39 27.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.674 0.274 . . . . 10.0 111.014 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -105.8 160.6 15.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.916 -0.583 . . . . 10.0 110.434 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -64.9 126.43 27.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.115 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.38 -9.07 38.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.641 -0.79 . . . . 10.0 113.278 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -77.8 151.45 33.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.269 0.534 . . . . 10.0 111.147 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -118.42 133.52 55.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.684 . . . . 10.0 109.971 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.26 152.56 45.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.784 0.326 . . . . 10.0 110.56 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -95.0 115.35 27.31 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.948 -0.76 . . . . 10.0 108.948 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.6 mm -69.5 120.18 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.862 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.1 mt -89.43 -55.93 3.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.148 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.406 ' ND2' ' HG3' ' A' ' 116' ' ' GLU . 66.1 t30 -134.74 108.63 8.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.922 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.34 4.71 41.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.642 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -95.4 8.53 42.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.031 -0.532 . . . . 10.0 111.541 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.406 ' HG3' ' ND2' ' A' ' 113' ' ' ASN . 5.0 mt-10 -95.21 74.55 3.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.312 0.577 . . . . 10.0 110.842 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.459 ' O ' ' HE2' ' B' ' 9' ' ' LYS . . . 68.04 -132.53 28.55 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.776 -0.726 . . . . 10.0 112.127 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -112.32 8.62 19.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.022 0.439 . . . . 10.0 110.798 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -120.44 104.76 10.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.262 -1.014 . . . . 10.0 108.262 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 4.6 m0 -83.35 135.56 34.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.869 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -92.41 112.56 24.55 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.462 -1.31 . . . . 10.0 107.462 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.75 169.26 11.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.012 0.434 . . . . 10.0 111.806 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -120.52 126.04 49.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.544 -0.753 . . . . 10.0 109.765 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.2 t -65.24 135.31 55.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.399 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.02 -12.38 44.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.056 0.455 . . . . 10.0 110.2 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.35 -48.02 11.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.693 -0.685 . . . . 10.0 111.126 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 80.8 p -105.98 -43.61 4.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.995 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.52 3.88 28.75 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.605 -0.807 . . . . 10.0 111.729 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -74.12 144.88 44.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 10.0 110.576 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -118.44 139.5 51.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.921 -0.582 . . . . 10.0 110.811 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.95 177.17 45.69 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.798 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.32 129.41 35.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.7 pt -113.67 136.78 22.03 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.719 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.57 107.16 0.82 Allowed 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.494 2.129 . . . . 10.0 111.752 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -7.69 10.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.791 -0.64 . . . . 10.0 112.227 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -96.11 1.22 52.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.833 0.349 . . . . 10.0 110.701 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -111.5 -14.45 13.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.093 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.6 m -114.1 160.62 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.108 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -143.42 152.66 57.63 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.448 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.12 144.56 87.43 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.272 1.981 . . . . 10.0 111.632 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.416 -0.802 . . . . 10.0 110.176 -179.982 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.524 0.202 . . . . 10.0 110.609 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.01 169.96 23.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.931 0.396 . . . . 10.0 111.48 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 7.4 m -104.95 136.01 45.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.895 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 44.3 t -109.86 132.47 58.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.763 0.316 . . . . 10.0 110.91 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -99.31 127.04 45.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.272 -0.64 . . . . 10.0 109.272 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.468 ' CD2' ' HZ ' ' B' ' 32' ' ' PHE . 41.3 p90 -141.96 175.88 9.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.441 -0.345 . . . . 10.0 111.009 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -109.72 146.91 34.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.88 92.78 2.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 117' ' ' GLY . 5.1 mmtm 61.57 30.35 18.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.287 -0.87 . . . . 10.0 111.668 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.83 -51.88 0.72 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.908 -0.663 . . . . 10.0 113.469 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -74.18 142.66 45.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.959 0.409 . . . . 10.0 111.198 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -92.94 130.49 38.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.953 -0.567 . . . . 10.0 109.79 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.47 157.26 35.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.568 -0.287 . . . . 10.0 110.916 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -129.32 113.28 14.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.549 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.14 149.5 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.273 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 5.1 m-20 -64.99 142.82 58.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.656 -0.247 . . . . 10.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 12.0 tt -65.96 -24.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.48 0.657 . . . . 10.0 110.041 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -4.06 33.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.322 -0.853 . . . . 10.0 111.068 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -110.97 15.08 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.539 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 71.3 mt -95.91 133.15 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.257 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -80.99 -52.58 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.066 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -152.15 155.3 37.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.367 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.59 125.83 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 123.547 0.529 . . . . 10.0 110.464 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 4.2 m -116.82 105.95 12.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.871 0.367 . . . . 10.0 111.453 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.55 ' HD2' ' OE2' ' B' ' 48' ' ' GLU . 0.3 OUTLIER -94.82 136.99 34.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.354 -0.384 . . . . 10.0 110.091 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -116.48 -21.47 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.887 0.375 . . . . 10.0 111.16 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.82 4.59 39.3 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.081 -0.808 . . . . 10.0 111.081 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -134.12 -47.41 0.78 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -149.44 132.69 16.43 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.988 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -87.17 123.65 40.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.245 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.81 132.67 53.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.86 -0.609 . . . . 10.0 109.612 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . 0.468 ' HZ ' ' CD2' ' B' ' 6' ' ' PHE . 43.4 p90 -150.77 169.46 21.61 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.431 -0.508 . . . . 10.0 111.985 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -122.04 138.87 54.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.357 -0.838 . . . . 10.0 109.459 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -133.67 165.65 24.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 10.0 111.697 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.32 121.38 15.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.707 -0.678 . . . . 10.0 110.112 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' B' ' 40' ' ' LYS . 24.9 mt -96.08 129.67 43.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.616 -0.265 . . . . 10.0 110.415 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.6 106.23 1.31 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.095 -0.574 . . . . 10.0 111.869 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.77 -7.83 1.73 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.976 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.54 36.27 3.84 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.52 -0.847 . . . . 10.0 112.991 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 79.5 tttt -135.42 67.72 67.18 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.113 0.457 . . . . 10.0 111.274 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -90.74 171.65 3.35 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.499 2.133 . . . . 10.0 112.015 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.8 -158.73 31.54 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.413 -0.898 . . . . 10.0 112.394 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -121.37 178.33 4.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.515 0.198 . . . . 10.0 110.517 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.51 150.5 19.68 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.654 -0.784 . . . . 10.0 111.957 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.55 130.8 69.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.188 0.518 . . . . 10.0 110.974 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 5.0 t -118.57 122.78 70.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.828 -0.623 . . . . 10.0 109.748 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.7 t -69.77 133.18 47.16 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.154 -0.313 . . . . 10.0 110.154 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.55 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 44.0 mt-10 -87.24 15.95 5.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.944 0.402 . . . . 10.0 110.389 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -122.92 -62.79 1.32 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.605 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.35 36.33 0.69 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 10.0 112.194 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.66 143.72 36.34 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.316 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.75 143.1 85.58 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.618 2.212 . . . . 10.0 112.095 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -59.79 -23.13 63.03 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.582 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -52.93 -50.88 63.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.685 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 75.6 mt -77.2 -34.86 56.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.695 0.283 . . . . 10.0 110.933 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.81 -42.0 98.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.391 -0.368 . . . . 10.0 111.553 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -73.9 -31.48 63.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.008 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -71.59 -33.78 69.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.462 -0.335 . . . . 10.0 110.394 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 20.5 mt -74.46 -44.54 51.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.677 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -79.19 87.43 4.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.177 0.513 . . . . 10.0 110.625 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -89.76 145.45 25.18 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.924 -0.58 . . . . 10.0 109.777 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -68.21 140.52 56.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.522 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.7 mttt 62.31 79.48 0.26 Allowed 'General case' 0 C--O 1.232 0.18 0 O-C-N 123.835 0.71 . . . . 10.0 110.233 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.221 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.833 0.349 . . . . 10.0 110.703 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.06 154.94 24.15 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.747 -0.464 . . . . 10.0 109.747 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -121.65 136.17 54.95 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.2 -0.296 . . . . 10.0 110.2 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.27 138.96 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.61 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.43 122.57 22.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.208 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.2 mt -77.78 -35.12 51.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.801 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -142.78 163.88 31.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 10.0 110.273 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.31 131.41 42.64 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -102.8 123.68 46.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.048 0.452 . . . . 10.0 111.688 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -88.29 105.81 17.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.802 -0.814 . . . . 10.0 108.802 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.99 156.99 37.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.355 0.598 . . . . 10.0 111.96 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -118.46 -44.08 2.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.67 -0.695 . . . . 10.0 111.059 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.89 -160.83 0.89 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.511 -0.313 . . . . 10.0 110.979 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.35 -16.33 19.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.271 0.558 . . . . 10.0 109.54 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.86 -44.74 69.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.159 -0.928 . . . . 10.0 110.26 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.46 146.04 31.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.559 -0.746 . . . . 10.0 109.958 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.7 tp -96.77 124.9 40.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.31 -0.405 . . . . 10.0 111.816 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.24 129.42 34.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.297 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -144.29 164.53 30.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.892 0.377 . . . . 10.0 111.13 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -106.05 160.78 15.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.515 -0.766 . . . . 10.0 110.111 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -65.22 130.75 44.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.588 -0.278 . . . . 10.0 110.755 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.06 -15.34 51.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.681 -0.771 . . . . 10.0 113.175 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -71.43 152.22 43.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.899 0.381 . . . . 10.0 111.102 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -114.03 139.81 48.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.75 -0.659 . . . . 10.0 110.21 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.0 157.64 45.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 10.0 111.018 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -108.94 117.95 35.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.306 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.8 mm -69.09 123.76 23.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.231 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 mt -98.17 -37.86 9.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.483 -0.326 . . . . 10.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -142.38 100.87 3.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.79 0.329 . . . . 10.0 111.364 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.75 -5.5 26.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.447 0.641 . . . . 10.0 110.34 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.78 8.71 24.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.078 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -72.9 -35.61 67.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.705 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 146.63 -127.26 2.68 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.719 -0.673 . . . . 10.0 111.454 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -49.74 22.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.933 0.396 . . . . 10.0 110.186 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.513 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 23.5 m95 -87.69 134.81 33.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.8 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 20.0 m0 -110.69 147.69 33.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.921 0.391 . . . . 10.0 111.18 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -99.03 120.57 39.67 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -139.89 166.37 24.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.846 0.355 . . . . 10.0 111.401 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -116.25 140.12 49.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.1 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.1 t -74.46 148.95 40.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.676 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.18 -24.7 18.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.568 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -45.08 48.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.729 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 p -104.35 -63.7 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.696 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.33 -13.01 5.72 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.748 -0.739 . . . . 10.0 112.037 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -57.15 144.42 34.97 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.858 0.361 . . . . 10.0 111.333 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.2 m -118.47 126.33 51.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.759 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -162.9 -174.58 32.97 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.564 -0.827 . . . . 10.0 111.675 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -82.19 130.1 35.0 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.145 -0.317 . . . . 10.0 110.145 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 pt -121.43 140.8 32.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.797 0.332 . . . . 10.0 110.821 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.56 119.64 6.68 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.666 2.244 . . . . 10.0 111.832 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.69 -18.97 65.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 10.0 111.749 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -88.92 7.09 36.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.389 -0.368 . . . . 10.0 111.422 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -123.85 8.04 8.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.179 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.2 m -131.33 151.72 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.992 0.425 . . . . 10.0 111.576 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -133.68 144.37 51.69 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.294 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.73 134.35 43.5 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.608 2.205 . . . . 10.0 112.41 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.434 -0.794 . . . . 10.0 110.445 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ttt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.525 0.203 . . . . 10.0 110.656 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.02 165.52 27.21 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.592 0.234 . . . . 10.0 110.673 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.92 137.75 32.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.903 -0.589 . . . . 10.0 110.958 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 88.2 t -108.55 128.74 63.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.358 -0.383 . . . . 10.0 110.159 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -93.82 121.95 35.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -132.09 170.97 14.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.486 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -117.44 97.07 5.69 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.193 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -80.98 72.47 8.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm 59.16 66.97 0.96 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.306 -0.861 . . . . 10.0 110.955 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.96 -46.3 2.27 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.832 -0.699 . . . . 10.0 113.02 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.32 117.88 19.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 10.0 111.333 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -88.53 116.36 26.71 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.274 -0.639 . . . . 10.0 109.274 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -124.24 160.1 28.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.885 0.374 . . . . 10.0 111.299 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -127.3 118.05 23.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.515 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.5 144.46 37.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.261 -0.427 . . . . 10.0 109.874 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.83 135.69 57.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.499 -0.318 . . . . 10.0 110.388 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 tt -63.75 -22.42 30.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.298 0.57 . . . . 10.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -9.45 59.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.935 -0.575 . . . . 10.0 111.131 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -101.47 11.23 39.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.303 0.573 . . . . 10.0 110.314 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 78.1 mt -98.73 129.95 48.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.34 -0.845 . . . . 10.0 109.654 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 7.2 t -76.65 -75.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.335 -0.393 . . . . 10.0 111.331 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -120.49 153.41 36.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.796 0.332 . . . . 10.0 110.781 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.34 129.2 56.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.869 -0.605 . . . . 10.0 110.511 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 19.5 m -121.44 112.13 18.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.197 0.522 . . . . 10.0 110.861 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.468 ' HG3' HG12 ' B' ' 30' ' ' ILE . 52.0 ttp85 -100.71 133.72 44.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.314 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -103.65 -19.01 14.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.984 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.96 -18.86 14.18 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.115 -0.794 . . . . 10.0 111.115 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -114.04 -61.4 1.75 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -118.67 143.57 46.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.368 -0.833 . . . . 10.0 109.523 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.468 HG12 ' HG3' ' B' ' 25' ' ' ARG . 1.9 mt -106.14 119.31 55.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.033 -0.531 . . . . 10.0 109.908 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -105.24 135.46 46.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.347 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -151.26 165.84 32.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.861 0.362 . . . . 10.0 111.438 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 133.55 54.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.409 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -123.73 166.2 15.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.517 -0.311 . . . . 10.0 110.699 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -139.6 115.81 10.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.164 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -82.55 145.53 29.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.837 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.47 -18.81 73.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.039 -0.601 . . . . 10.0 112.669 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.34 19.86 7.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.024 -0.608 . . . . 10.0 112.887 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.03 51.7 17.34 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.929 -0.653 . . . . 10.0 112.349 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -150.36 96.04 3.49 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.881 0.372 . . . . 10.0 111.286 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.84 154.13 13.24 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.412 2.074 . . . . 10.0 110.76 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.79 -172.11 31.85 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 119.573 -1.299 . . . . 10.0 113.034 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . 0.513 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 15.6 m-85 -133.07 166.89 21.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.685 -0.487 . . . . 10.0 109.685 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.66 146.43 14.48 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.628 -0.796 . . . . 10.0 111.767 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 3.6 p -129.68 127.63 64.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.303 0.573 . . . . 10.0 110.784 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.58 132.08 67.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.282 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 14.6 t -88.67 125.38 34.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.668 0.27 . . . . 10.0 110.388 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -68.97 -17.28 63.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.046 0.451 . . . . 10.0 111.587 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -100.47 16.75 23.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.671 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -133.26 -53.3 0.9 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.903 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.06 152.64 76.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.024 -0.534 . . . . 10.0 111.371 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.436 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 32.0 Cg_endo -63.4 154.08 70.54 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.82 2.346 . . . . 10.0 112.951 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -57.76 -34.12 69.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.459 -0.791 . . . . 10.0 112.082 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -54.15 -44.97 71.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.961 0.356 . . . . 10.0 111.961 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.6 -39.22 70.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 10.0 110.98 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 18.0 mt -65.21 -43.05 92.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.771 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -69.44 -18.39 63.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.818 -0.628 . . . . 10.0 111.685 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -80.67 -25.42 38.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.893 0.378 . . . . 10.0 110.614 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 82.0 mt -83.67 -42.9 16.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.452 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . 0.443 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 1.1 tp10 -86.64 92.39 8.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 10.0 110.342 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -108.88 -177.65 3.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.404 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -80.18 138.19 36.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.262 -0.273 . . . . 10.0 110.262 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 57.4 39.09 28.47 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.43 0.633 . . . . 10.0 110.018 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-N 115.168 -0.924 . . . . 10.0 110.886 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 120.849 0.357 . . . . 10.0 110.441 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -84.79 129.59 34.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.976 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -121.06 145.42 47.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.762 -0.654 . . . . 10.0 109.673 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.23 139.6 42.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.956 0.407 . . . . 10.0 110.647 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.95 123.52 24.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.894 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.4 mt -71.2 -50.93 27.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.429 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -129.01 178.61 6.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.846 -0.615 . . . . 10.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.06 142.87 28.41 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -126.37 130.2 50.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.996 0.426 . . . . 10.0 110.751 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -93.73 116.99 29.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.521 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 137.85 56.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.144 0.497 . . . . 10.0 111.304 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.462 ' HD3' ' O ' ' B' ' 21' ' ' VAL . 14.6 ttt180 -94.09 -40.7 9.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.455 -0.793 . . . . 10.0 110.306 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.9 p -131.95 -163.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.887 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -93.84 -2.49 53.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.238 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.5 -41.43 16.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.907 -0.588 . . . . 10.0 109.874 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -89.49 154.51 19.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.5 -0.773 . . . . 10.0 109.153 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.3 tp -107.62 134.52 50.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.197 0.443 . . . . 10.0 112.197 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.56 146.36 25.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.528 -0.76 . . . . 10.0 110.555 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -162.65 166.06 24.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.821 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -113.53 168.34 9.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.493 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -61.7 115.54 4.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.852 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.09 -1.2 25.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.637 -0.792 . . . . 10.0 112.696 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -67.99 137.92 55.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 10.0 110.947 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -102.2 130.58 48.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -120.47 144.73 47.83 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.098 0.777 . . . . 10.0 113.098 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -108.28 106.07 16.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.7 114.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.101 0.477 . . . . 10.0 111.578 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 mt -86.0 -48.67 8.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.571 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -138.95 104.41 5.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 10.0 111.182 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -15.45 37.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.281 0.562 . . . . 10.0 110.458 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.87 13.45 5.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.811 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.17 -45.38 73.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 10.0 110.471 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.99 -119.12 0.93 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.2 -0.76 . . . . 10.0 111.2 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -93.51 -27.73 16.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.296 0.569 . . . . 10.0 110.052 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.427 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 29.2 m95 -110.63 114.99 28.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.145 -1.057 . . . . 10.0 108.145 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -95.31 143.12 26.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.164 0.507 . . . . 10.0 111.353 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -90.89 121.64 32.91 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.52 -0.919 . . . . 10.0 108.52 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.14 164.34 27.57 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.815 0.341 . . . . 10.0 111.582 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -112.04 137.64 49.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.522 -0.763 . . . . 10.0 110.708 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.1 t -76.45 141.12 41.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.148 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.8 mt -93.21 2.97 56.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.451 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -105.14 -58.48 1.88 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.888 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.1 p -91.47 -39.14 12.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.218 0.532 . . . . 10.0 110.875 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 103.17 6.96 44.5 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.698 -0.683 . . . . 10.0 111.671 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -73.24 146.11 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.321 . . . . 10.0 110.663 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 91.0 m -126.83 134.5 50.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.366 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.63 -176.0 43.5 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.903 -0.665 . . . . 10.0 111.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -76.26 122.65 24.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.757 0.313 . . . . 10.0 110.181 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.3 pt -114.39 141.15 26.07 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.734 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.38 110.3 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.45 2.1 . . . . 10.0 111.591 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -12.11 22.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.973 -0.558 . . . . 10.0 112.13 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -93.93 0.29 56.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.884 0.373 . . . . 10.0 110.66 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.26 5.07 14.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.915 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.2 m -129.78 153.45 38.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.376 -0.374 . . . . 10.0 110.947 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.57 147.92 61.65 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.214 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.84 130.03 20.98 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.537 2.158 . . . . 10.0 112.083 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.356 -0.831 . . . . 10.0 109.898 179.657 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ttt . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 120.711 0.291 . . . . 10.0 110.68 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.12 168.17 25.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.777 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.44 146.38 27.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.382 -0.372 . . . . 10.0 110.952 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.94 132.12 68.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.155 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -103.22 129.33 50.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.031 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 26.5 p90 -139.19 165.06 28.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.736 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -110.0 77.7 1.07 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.086 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -69.58 99.92 1.36 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.551 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 57.2 32.48 21.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.156 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.88 -28.53 14.95 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.756 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -81.76 113.01 19.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.662 0.231 . . . . 10.0 110.89 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 7.2 mt-10 -74.88 115.71 14.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -125.2 156.01 39.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.857 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -124.36 116.6 22.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.336 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.5 145.03 36.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.577 -0.527 . . . . 10.0 109.577 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -61.92 138.88 58.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.963 0.411 . . . . 10.0 111.099 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 15.2 tt -63.64 -24.51 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.677 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 8.0 m -77.0 -3.5 39.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.619 -0.719 . . . . 10.0 111.007 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -111.37 13.46 21.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.212 0.529 . . . . 10.0 110.021 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -99.01 126.88 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.732 -0.667 . . . . 10.0 109.767 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 96' ' ' ARG . 3.5 t -75.18 -64.38 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.755 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -134.99 153.46 52.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.593 -0.276 . . . . 10.0 111.121 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -132.96 137.5 53.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.237 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -135.24 121.9 20.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.999 0.428 . . . . 10.0 111.023 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.444 ' HG3' HG12 ' B' ' 30' ' ' ILE . 53.6 ttp85 -109.0 146.12 34.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.257 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -127.19 -15.54 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.958 0.409 . . . . 10.0 111.613 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.76 16.76 23.17 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.39 -0.91 . . . . 10.0 111.072 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -140.9 -53.73 0.48 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -145.5 130.99 18.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.318 -0.855 . . . . 10.0 109.816 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 9.4 mt -86.42 121.26 37.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.67 -0.493 . . . . 10.0 109.67 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -109.06 135.78 49.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.722 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -155.69 169.4 24.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.664 0.269 . . . . 10.0 110.704 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -128.34 135.29 49.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.254 -0.43 . . . . 10.0 109.969 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -114.08 168.01 10.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.755 0.312 . . . . 10.0 110.414 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -138.4 112.45 8.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.935 -0.575 . . . . 10.0 109.859 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 82.7 mt -93.55 132.49 37.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.441 -0.345 . . . . 10.0 110.945 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.2 -11.17 61.01 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.91 -0.586 . . . . 10.0 112.469 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.52 -19.54 68.99 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.359 -0.448 . . . . 10.0 112.217 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.97 43.77 1.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.68 -0.771 . . . . 10.0 112.641 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -170.13 111.07 0.46 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.827 0.346 . . . . 10.0 110.738 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -86.27 179.11 3.71 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.513 2.142 . . . . 10.0 110.883 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.64 172.56 43.86 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.079 -1.058 . . . . 10.0 112.276 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 29.9 m-85 -108.1 168.32 9.38 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.38 144.95 12.7 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.938 -0.649 . . . . 10.0 111.888 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 4.2 p -136.78 131.47 47.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.092 0.472 . . . . 10.0 110.876 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.9 121.98 65.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.855 -0.611 . . . . 10.0 109.934 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.39 101.33 3.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.668 0.27 . . . . 10.0 110.662 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -74.1 65.15 1.11 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.585 0.707 . . . . 10.0 110.417 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -166.24 -50.02 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.885 -1.052 . . . . 10.0 109.21 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.47 -28.33 15.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.054 -0.975 . . . . 10.0 111.249 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.66 153.09 73.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.135 -0.484 . . . . 10.0 111.202 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.03 142.64 94.1 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.701 2.267 . . . . 10.0 111.994 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -60.86 -26.03 67.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.812 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -56.84 -48.51 77.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.807 0.337 . . . . 10.0 110.904 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 99.0 mt -65.62 -32.97 74.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.837 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -71.91 -44.0 64.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.792 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -69.52 -31.89 70.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.854 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -78.48 -23.39 46.45 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.051 -0.26 . . . . 10.0 110.999 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.68 -47.59 11.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.968 0.413 . . . . 10.0 110.391 179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -84.74 87.84 7.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.362 0.601 . . . . 10.0 109.938 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.416 ' HB2' ' HB3' ' B' ' 64' ' ' LYS . 46.9 mtmt -93.0 169.78 10.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.18 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.7 mm-40 -76.11 121.37 22.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.7 0.286 . . . . 10.0 110.572 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 mttt 59.24 43.74 16.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.681 -0.691 . . . . 10.0 110.942 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.416 ' HB3' ' HB2' ' B' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.581 -0.723 . . . . 10.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.9 mt -88.68 150.8 22.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.982 0.42 . . . . 10.0 110.862 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -122.8 141.21 52.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.806 -0.633 . . . . 10.0 110.196 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.2 p -109.27 140.04 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.613 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.2 123.81 25.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.588 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.8 mt -78.74 -24.47 44.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.28 170.57 22.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.31 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.27 130.25 35.07 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -104.99 132.03 51.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.971 0.415 . . . . 10.0 111.64 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -89.83 118.77 29.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.506 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.12 158.63 24.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.14 0.495 . . . . 10.0 111.57 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -120.01 -44.62 2.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.554 -0.748 . . . . 10.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.89 -167.59 1.61 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.886 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -93.2 -2.62 55.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.1 0.476 . . . . 10.0 110.671 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.16 -37.58 20.01 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.276 0.56 . . . . 10.0 110.021 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -91.28 146.64 23.65 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.397 -0.964 . . . . 10.0 108.397 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.9 tp -111.36 123.49 50.31 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.568 0.581 . . . . 10.0 112.568 -177.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.83 133.4 36.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.938 -0.573 . . . . 10.0 109.731 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -140.39 163.03 33.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.803 0.335 . . . . 10.0 111.342 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -95.75 158.26 15.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.911 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -64.46 124.95 23.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.503 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.25 -3.01 56.58 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.853 -0.689 . . . . 10.0 113.201 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -74.0 154.6 39.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.937 0.398 . . . . 10.0 111.219 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -117.55 141.26 48.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.779 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.06 152.66 51.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 10.0 111.006 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -100.3 115.59 30.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 10.9 mm -71.96 112.13 7.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.328 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.6 mt -84.57 -40.05 18.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.121 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -140.07 103.39 4.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.72 0.295 . . . . 10.0 111.3 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.2 p -105.01 0.08 27.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.294 0.569 . . . . 10.0 110.552 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.21 10.04 20.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.37 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.1 -58.34 3.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.546 0.689 . . . . 10.0 109.977 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 167.59 -118.75 0.8 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.3 -0.72 . . . . 10.0 111.3 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -76.71 -51.16 11.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.083 -0.339 . . . . 10.0 110.083 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -88.47 134.35 33.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.876 -0.787 . . . . 10.0 108.876 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -115.04 148.51 38.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 10.0 111.045 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -86.97 117.27 25.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.73 156.76 45.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.226 0.536 . . . . 10.0 111.662 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -112.54 126.75 55.68 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.985 -0.746 . . . . 10.0 108.985 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.3 t -62.8 136.63 57.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.387 -0.37 . . . . 10.0 110.181 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 83.8 mt -84.66 -10.98 56.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.191 0.52 . . . . 10.0 109.829 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.78 -67.92 0.76 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.488 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.7 p -86.86 -46.59 9.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.444 . . . . 10.0 111.476 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 116.35 6.09 15.95 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.895 -0.669 . . . . 10.0 111.865 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -72.21 149.31 44.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.729 0.3 . . . . 10.0 110.759 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -115.71 135.0 54.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.347 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -174.62 179.79 45.71 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.925 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -86.78 136.3 33.04 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.0 -0.37 . . . . 10.0 110.0 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.3 pt -121.15 136.14 25.47 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.08 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.458 ' HG2' ' HB2' ' A' ' 137' ' ' TYR . 19.2 Cg_endo -63.05 122.62 10.92 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.761 2.307 . . . . 10.0 111.869 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -17.74 64.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.85 -0.614 . . . . 10.0 112.238 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.465 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 45.3 p-10 -87.44 -5.79 58.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.959 0.409 . . . . 10.0 111.057 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.458 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 0.8 OUTLIER -105.27 -6.16 19.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.969 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.1 m -124.31 152.38 30.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.125 0.488 . . . . 10.0 111.356 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.61 152.89 67.37 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.545 -0.752 . . . . 10.0 110.163 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.68 156.08 63.35 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.335 2.024 . . . . 10.0 111.622 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.323 -0.846 . . . . 10.0 110.097 179.703 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.732 0.301 . . . . 10.0 110.302 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.1 168.07 13.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.127 0.489 . . . . 10.0 112.23 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.7 m -110.69 145.84 37.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.541 -0.754 . . . . 10.0 109.927 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 45.0 t -111.23 130.3 64.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.717 0.294 . . . . 10.0 111.333 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -103.57 120.49 40.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.662 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -134.33 169.53 17.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.919 0.39 . . . . 10.0 111.259 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -117.37 63.25 0.74 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.522 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -59.32 112.96 1.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.889 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 58.83 21.81 9.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.305 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.4 -5.99 63.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.951 -0.642 . . . . 10.0 112.454 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -94.72 119.08 32.75 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.89 -0.182 . . . . 10.0 110.844 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -72.23 113.98 9.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.946 -0.39 . . . . 10.0 109.946 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt -134.38 153.02 52.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.788 0.327 . . . . 10.0 110.837 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 1.5 mt-30 -124.8 120.28 31.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.165 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.0 t -128.93 143.36 41.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.058 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.18 136.22 57.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.04 -0.356 . . . . 10.0 110.04 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.83 -22.9 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.131 0.491 . . . . 10.0 111.206 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -10.25 57.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.635 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -106.65 16.03 25.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.346 . . . . 10.0 111.072 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 73.2 mt -103.07 133.92 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.083 -0.508 . . . . 10.0 109.765 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.95 -63.12 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.199 -0.455 . . . . 10.0 111.286 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -134.29 152.27 51.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.494 -0.321 . . . . 10.0 110.878 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.51 129.24 70.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.779 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 8.3 m -123.92 127.43 47.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.015 0.436 . . . . 10.0 111.895 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.4 ' HG3' ' OE1' ' B' ' 48' ' ' GLU . 14.4 ttp85 -121.68 144.98 48.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -125.26 -16.64 5.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.675 0.274 . . . . 10.0 111.707 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.31 31.79 4.52 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.307 -0.949 . . . . 10.0 111.064 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 mmtm -155.33 -56.49 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.576 0.75 . . . . 10.0 109.179 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -143.8 138.38 28.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.859 -1.064 . . . . 10.0 109.691 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -95.48 131.81 41.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.808 -0.441 . . . . 10.0 109.808 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.465 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 49.4 m-85 -123.21 141.21 52.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.441 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -153.77 173.21 16.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.5 -0.318 . . . . 10.0 111.13 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -130.88 132.8 45.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.581 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -125.44 164.53 20.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.149 0.5 . . . . 10.0 111.249 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -138.08 125.82 22.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.986 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 54.6 mt -100.7 135.54 41.99 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.16 -27.05 62.11 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.223 -0.513 . . . . 10.0 112.887 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.04 8.54 15.64 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.292 -0.48 . . . . 10.0 112.803 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.73 54.35 3.48 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.368 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -147.74 78.35 9.9 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.919 0.39 . . . . 10.0 110.861 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -85.56 148.53 9.94 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.826 2.35 . . . . 10.0 110.863 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.79 -164.78 26.09 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 119.805 -1.188 . . . . 10.0 112.857 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -122.2 177.55 5.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.842 -0.429 . . . . 10.0 109.842 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.62 139.44 6.63 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.768 -0.73 . . . . 10.0 112.119 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.88 128.83 71.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.12 0.486 . . . . 10.0 110.392 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.93 119.61 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.034 -0.53 . . . . 10.0 109.841 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.0 t -68.68 125.86 27.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.732 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.4 ' OE1' ' HG3' ' B' ' 25' ' ' ARG . 52.2 mt-10 -75.68 -2.08 27.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.006 0.431 . . . . 10.0 110.967 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -111.27 -39.67 4.65 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.287 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -85.52 -27.81 25.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.147 0.425 . . . . 10.0 112.147 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.88 146.25 31.74 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.938 -0.305 . . . . 10.0 111.017 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.12 154.39 57.76 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.711 2.274 . . . . 10.0 111.639 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -63.0 -25.18 68.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.363 -0.381 . . . . 10.0 111.164 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -56.2 -44.14 79.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 10.0 110.61 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mt -69.93 -41.1 75.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.786 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.1 -37.66 88.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.054 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -73.37 -25.25 60.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.161 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -79.75 -36.06 37.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.437 -0.347 . . . . 10.0 110.419 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.68 -45.69 50.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.505 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.99 111.62 19.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.96 0.409 . . . . 10.0 110.48 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.25 165.2 15.14 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.64 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.464 ' OE1' ' HG3' ' B' ' 63' ' ' LYS . 1.0 OUTLIER -58.73 139.22 56.5 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.366 0.416 . . . . 10.0 110.398 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.464 ' HG3' ' OE1' ' B' ' 62' ' ' GLN . 43.6 mttp 63.06 79.98 0.24 Allowed 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 123.718 0.636 . . . . 10.0 110.159 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.262 -0.875 . . . . 10.0 109.997 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.676 0.274 . . . . 10.0 110.397 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.51 133.59 36.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.084 0.468 . . . . 10.0 110.83 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -116.7 140.2 49.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.179 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.48 139.04 39.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.855 0.359 . . . . 10.0 110.439 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.83 121.69 18.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.93 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.01 -40.15 63.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.431 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -143.1 164.05 31.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.186 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.85 147.4 39.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -126.92 126.19 42.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.815 0.341 . . . . 10.0 110.883 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.08 113.92 20.94 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.834 -0.621 . . . . 10.0 109.459 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.31 149.0 49.96 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.47 0.481 . . . . 10.0 111.089 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.69 -37.35 5.69 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.148 -0.478 . . . . 10.0 111.079 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 p -129.37 -164.11 1.37 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.961 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -99.63 6.77 45.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.138 0.494 . . . . 10.0 110.521 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.35 -36.73 11.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.502 -0.772 . . . . 10.0 109.611 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -89.78 145.35 25.25 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.4 tp -98.74 135.25 40.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.187 0.517 . . . . 10.0 112.043 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.94 134.17 33.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.361 -0.836 . . . . 10.0 110.123 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -147.46 164.92 31.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.797 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -118.98 172.27 7.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.929 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -60.02 118.65 6.54 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.383 -0.826 . . . . 10.0 111.359 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.33 -1.84 43.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.476 -0.869 . . . . 10.0 113.351 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.57 133.7 54.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.839 0.352 . . . . 10.0 111.437 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -94.5 121.09 35.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.689 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -115.88 134.49 54.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.66 0.615 . . . . 10.0 112.66 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -102.9 104.37 14.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.904 -1.146 . . . . 10.0 107.904 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.3 mm -62.44 117.62 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.327 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 70.9 mt -94.35 -35.87 12.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.321 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -145.1 99.89 3.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.28 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.79 0.26 46.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.238 0.542 . . . . 10.0 110.252 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -88.3 -0.0 56.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.995 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -63.17 -46.82 85.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.185 0.517 . . . . 10.0 110.333 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.99 -116.75 0.74 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.991 -0.843 . . . . 10.0 110.991 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.78 -28.5 17.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.234 0.54 . . . . 10.0 110.149 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.586 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 17.9 m95 -105.03 110.32 22.67 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.351 -0.981 . . . . 10.0 108.351 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -93.9 154.92 17.45 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.749 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -98.92 122.94 42.82 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -136.3 161.86 34.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.327 0.584 . . . . 10.0 111.602 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -114.03 133.76 55.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.19 -0.914 . . . . 10.0 109.345 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.5 t -69.45 140.82 54.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.954 0.407 . . . . 10.0 110.507 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 99.2 mt -96.84 2.05 51.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.376 0.608 . . . . 10.0 109.848 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.09 -48.84 3.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.492 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 66.4 p -101.06 -42.8 6.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 10.0 110.842 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.69 -0.73 34.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.059 -0.591 . . . . 10.0 112.42 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -67.26 150.23 49.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.736 0.303 . . . . 10.0 110.905 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.2 m -122.77 133.91 54.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.709 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.1 178.83 46.7 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.61 -0.805 . . . . 10.0 111.995 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -81.47 133.48 35.4 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.276 -0.268 . . . . 10.0 110.276 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.8 pt -128.07 145.54 55.77 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.85 0.357 . . . . 10.0 111.426 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.49 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 47.3 Cg_endo -72.08 127.5 12.88 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.577 2.185 . . . . 10.0 111.672 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.0 p -69.81 -16.09 63.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.96 -0.564 . . . . 10.0 112.267 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.49 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 38.0 p-10 -85.55 -0.45 55.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.692 0.282 . . . . 10.0 111.465 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.418 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 1.9 m-85 -115.58 3.91 14.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.53 -0.304 . . . . 10.0 111.246 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.81 144.65 37.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 10.0 111.105 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -132.77 144.01 51.08 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.085 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.3 132.05 26.56 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.536 2.157 . . . . 10.0 112.305 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.1 t . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.151 -0.928 . . . . 10.0 110.121 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.619 0.247 . . . . 10.0 110.747 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' B' ' 16' ' ' ASP . . . -153.76 128.57 9.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.47 -0.332 . . . . 10.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.9 108.18 19.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.608 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.05 130.78 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.62 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -95.32 132.15 40.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.45 -0.341 . . . . 10.0 110.281 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -145.25 170.18 16.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.186 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -120.7 105.82 11.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.16 -0.473 . . . . 10.0 109.788 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -99.99 111.71 24.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.894 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt 54.27 34.13 19.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.69 -0.686 . . . . 10.0 112.13 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.52 4.36 68.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.023 -0.608 . . . . 10.0 113.409 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -109.94 123.18 49.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.884 0.342 . . . . 10.0 110.644 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -76.14 121.18 22.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -134.44 153.45 51.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.897 0.38 . . . . 10.0 110.972 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.46 114.06 15.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.72 -0.673 . . . . 10.0 109.773 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.04 144.24 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.55 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' B' ' 2' ' ' ALA . 6.9 t70 -64.26 138.27 58.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.387 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 21.4 tt -61.29 -22.58 27.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.935 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -70.71 -19.65 62.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.7 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -93.99 1.01 56.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.133 0.492 . . . . 10.0 110.517 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 70.8 mt -94.2 123.97 46.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.725 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.59 -77.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.549 -0.296 . . . . 10.0 111.383 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -113.13 151.63 30.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.011 0.434 . . . . 10.0 111.308 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 32.3 t -129.32 142.01 45.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.421 -0.808 . . . . 10.0 109.983 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.1 m -134.5 122.89 23.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 10.0 111.402 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.48 ' HD2' ' OE2' ' B' ' 48' ' ' GLU . 0.8 OUTLIER -109.98 143.26 40.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.511 . . . . 10.0 110.164 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -124.35 -20.58 5.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.648 0.24 . . . . 10.0 111.648 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.34 22.18 8.84 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.744 -0.943 . . . . 10.0 110.744 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -146.38 -54.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.721 -0.844 . . . . 10.0 108.721 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -146.88 138.59 24.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.008 -0.997 . . . . 10.0 109.433 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 52.0 mt -94.27 126.89 46.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.971 -0.381 . . . . 10.0 109.971 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 18.9 m-85 -111.19 139.29 46.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.38 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -154.4 171.83 18.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.991 0.424 . . . . 10.0 111.273 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -130.32 135.68 48.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.854 -0.612 . . . . 10.0 109.594 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -121.58 156.83 32.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.065 0.46 . . . . 10.0 111.139 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -127.35 117.39 22.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.419 -0.81 . . . . 10.0 109.32 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.52 139.37 31.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.835 0.35 . . . . 10.0 111.319 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.52 -9.39 61.53 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.588 -0.733 . . . . 10.0 112.095 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.83 -8.17 67.6 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.215 -0.517 . . . . 10.0 111.999 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.64 32.5 7.23 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.951 -0.643 . . . . 10.0 112.149 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -153.64 103.38 2.53 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.682 0.277 . . . . 10.0 111.086 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -86.14 168.93 8.91 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.826 2.35 . . . . 10.0 111.44 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.63 -172.0 36.53 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.115 -1.04 . . . . 10.0 113.143 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 6.6 m-85 -123.63 166.2 15.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.855 -0.424 . . . . 10.0 109.855 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.0 150.57 22.13 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.471 -0.871 . . . . 10.0 112.345 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 p -132.67 132.9 59.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.968 0.413 . . . . 10.0 110.451 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.44 136.38 55.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.441 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 26.9 t -74.11 131.29 41.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.391 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.48 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 45.1 mt-10 -84.45 3.64 35.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.964 0.411 . . . . 10.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -119.43 -44.25 2.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.969 0.414 . . . . 10.0 111.068 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -78.72 -49.43 13.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.634 . . . . 10.0 112.481 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.23 151.13 97.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.34 . . . . 10.0 111.886 -178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.15 142.22 96.1 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.954 2.436 . . . . 10.0 112.296 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -62.93 -23.08 67.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.626 . . . . 10.0 110.704 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.4 -44.99 80.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.155 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.3 -35.47 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.551 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.0 mt -62.03 -42.94 99.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.872 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -72.63 -17.37 61.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 10.0 111.158 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -85.93 -38.56 17.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.635 -0.506 . . . . 10.0 109.635 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 51.6 mt -68.41 -41.77 79.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.085 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.15 85.74 7.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.545 0.688 . . . . 10.0 109.645 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -81.62 131.18 35.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.307 -0.86 . . . . 10.0 109.761 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' B' ' 63' ' ' LYS . 83.9 mm-40 -58.59 127.18 30.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.816 -0.439 . . . . 10.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' B' ' 62' ' ' GLN . 78.8 mttt 74.24 51.92 0.1 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 124.105 0.878 . . . . 10.0 110.122 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.359 -0.829 . . . . 10.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.683 0.278 . . . . 10.0 111.035 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.3 mt -88.16 161.18 17.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.295 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -131.07 126.03 34.76 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.1 p -108.63 141.05 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.874 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.3 126.5 31.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.317 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 30.0 mt -90.72 -20.62 22.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.013 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.4 159.92 41.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.029 -0.532 . . . . 10.0 109.585 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -85.9 145.4 27.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 10.0 109.868 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -143.37 130.87 21.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.032 0.444 . . . . 10.0 111.41 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.2 124.36 44.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.587 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.83 140.29 58.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.983 0.421 . . . . 10.0 111.234 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -104.86 -23.84 12.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.364 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.1 -166.41 1.79 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.262 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -17.97 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.838 0.351 . . . . 10.0 110.451 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -69.9 -45.55 67.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -87.43 163.26 16.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.615 -0.72 . . . . 10.0 109.61 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.3 tp -130.59 145.46 51.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.757 0.313 . . . . 10.0 111.381 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -81.61 145.77 30.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.829 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -157.23 154.45 29.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -105.17 159.39 15.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.8 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -63.3 116.78 5.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.597 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.5 -4.82 26.42 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.78 -0.724 . . . . 10.0 112.171 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -78.58 150.44 32.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.579 0.228 . . . . 10.0 110.441 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -121.64 143.1 49.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 10.0 110.85 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 159.47 41.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.577 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -103.64 116.38 32.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.045 -0.724 . . . . 10.0 109.045 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.2 mm -68.36 121.13 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.943 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.1 mt -94.73 -40.78 9.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.249 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.587 ' ND2' ' HG3' ' A' ' 116' ' ' GLU . 55.2 t30 -146.39 106.26 3.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.013 0.435 . . . . 10.0 111.24 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.19 0.47 31.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 10.0 110.615 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.18 5.73 47.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.915 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.587 ' HG3' ' ND2' ' A' ' 113' ' ' ASN . 3.4 mt-10 -78.99 -34.47 44.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.689 0.28 . . . . 10.0 111.358 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 156.89 -126.79 1.82 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.349 -0.929 . . . . 10.0 112.37 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -87.42 -43.75 11.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 10.0 110.817 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.414 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 44.2 m95 -88.39 113.35 23.9 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.123 -1.066 . . . . 10.0 108.123 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -95.0 150.78 19.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.181 0.515 . . . . 10.0 112.152 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -88.03 117.07 26.66 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.53 -1.285 . . . . 10.0 107.53 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.3 146.23 49.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.238 0.542 . . . . 10.0 112.228 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -100.39 119.18 38.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.37 -0.832 . . . . 10.0 109.307 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.5 t -60.93 138.22 58.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.847 0.356 . . . . 10.0 110.556 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.0 mt -91.71 2.03 56.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.314 0.578 . . . . 10.0 109.541 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.1 -61.09 1.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.313 -0.858 . . . . 10.0 110.723 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.5 p -100.7 -29.21 12.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.34 . . . . 10.0 111.322 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.25 0.74 54.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.663 -0.779 . . . . 10.0 112.346 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -74.11 154.26 39.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.793 0.33 . . . . 10.0 111.204 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.17 -178.2 3.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.997 -0.547 . . . . 10.0 109.841 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 145.22 168.05 12.69 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.097 -1.049 . . . . 10.0 112.714 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -85.23 124.62 32.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.829 0.347 . . . . 10.0 110.38 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.9 pt -120.48 147.59 45.75 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.382 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.73 125.51 10.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.337 2.025 . . . . 10.0 111.359 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -67.14 -12.64 60.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.326 0.491 . . . . 10.0 112.326 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -96.27 -9.46 30.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.629 0.252 . . . . 10.0 110.814 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -88.04 -12.92 42.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.277 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.9 m -121.42 169.9 12.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.639 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.29 141.13 28.17 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.994 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.69 131.48 21.42 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.459 2.106 . . . . 10.0 112.336 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.3 t . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.111 -0.947 . . . . 10.0 109.713 179.368 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.753 0.311 . . . . 10.0 111.254 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.82 171.93 15.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.802 0.334 . . . . 10.0 110.857 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 142.26 32.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.575 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.04 124.87 63.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.928 0.394 . . . . 10.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . 0.467 ' HZ3' ' CD ' ' B' ' 12' ' ' GLU . 0.9 OUTLIER -100.65 132.49 46.01 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.734 . . . . 10.0 109.417 179.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -149.2 173.62 13.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.857 0.36 . . . . 10.0 110.876 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -119.62 85.41 2.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.911 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -73.93 95.8 2.53 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt 61.82 23.89 14.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.459 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.59 -18.33 32.48 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.537 -0.756 . . . . 10.0 112.114 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.63 113.28 9.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.765 0.317 . . . . 10.0 111.015 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.467 ' CD ' ' HZ3' ' B' ' 5' ' ' LYS . 3.5 mm-40 -73.29 94.76 2.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.938 -0.573 . . . . 10.0 109.523 178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -109.76 153.23 24.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.206 0.526 . . . . 10.0 111.974 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -130.9 105.47 7.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -119.93 146.88 24.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.688 0.28 . . . . 10.0 110.674 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.1 139.59 51.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.839 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.407 HD13 ' O ' ' B' ' 58' ' ' LYS . 13.7 tt -65.95 -18.88 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.467 0.651 . . . . 10.0 110.377 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.6 -4.43 59.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.492 -0.777 . . . . 10.0 111.321 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.67 9.09 39.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.071 0.463 . . . . 10.0 110.519 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 81.7 mt -95.51 125.24 48.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.909 -0.587 . . . . 10.0 109.963 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 t -71.84 -60.95 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.088 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -133.86 151.58 51.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.683 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 t -119.46 115.08 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 10.0 109.722 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 13.7 m -117.34 120.41 38.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.035 0.445 . . . . 10.0 111.823 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.409 ' HD2' ' CD ' ' B' ' 48' ' ' GLU . 4.0 ttp85 -109.06 121.71 45.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -83.52 -39.46 20.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.691 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.2 -2.61 5.87 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.73 -0.948 . . . . 10.0 110.73 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -139.5 -40.29 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.04 141.52 36.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.37 -0.832 . . . . 10.0 109.644 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 55.7 mt -96.33 129.79 45.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.686 -0.487 . . . . 10.0 109.686 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -118.78 136.09 54.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.357 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -153.4 171.46 18.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.818 0.342 . . . . 10.0 110.953 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -125.04 133.98 52.73 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -123.46 166.77 14.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.024 0.44 . . . . 10.0 111.152 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -128.33 157.98 39.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.299 -0.864 . . . . 10.0 109.099 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 mt -133.89 145.29 49.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.829 0.347 . . . . 10.0 111.009 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.83 -15.25 66.59 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.939 -0.648 . . . . 10.0 112.592 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.12 4.51 70.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.254 -0.498 . . . . 10.0 112.874 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.58 38.5 32.33 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.771 -0.728 . . . . 10.0 112.885 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -149.17 88.07 5.17 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 122.552 -0.381 . . . . 10.0 110.663 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -74.98 177.9 7.98 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.374 2.049 . . . . 10.0 111.075 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.72 -169.95 37.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.653 -1.26 . . . . 10.0 112.711 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 28.5 m-85 -117.05 160.33 21.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.898 -0.408 . . . . 10.0 109.898 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.02 141.43 12.12 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.669 -0.777 . . . . 10.0 112.237 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 p -135.77 128.79 47.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.95 0.405 . . . . 10.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 t -128.03 129.89 69.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.027 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 51' ' ' ALA . 30.2 t -74.31 133.87 42.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.409 ' CD ' ' HD2' ' B' ' 25' ' ' ARG . 54.0 mt-10 -81.01 -1.21 43.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.176 0.512 . . . . 10.0 110.437 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -116.39 -49.77 2.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.947 -0.569 . . . . 10.0 110.579 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -90.92 45.37 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.783 -0.644 . . . . 10.0 111.973 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' B' ' 47' ' ' SER . . . -162.63 151.06 12.14 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.581 -0.282 . . . . 10.0 110.798 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.24 136.29 74.53 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.86 2.374 . . . . 10.0 112.348 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.84 -29.92 71.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.218 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -59.25 -41.27 88.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.992 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.4 mt -67.55 -36.12 80.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.873 0.368 . . . . 10.0 110.518 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -68.38 -39.8 81.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.136 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -72.49 -21.47 61.2 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.851 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . 0.407 ' O ' HD13 ' B' ' 17' ' ' ILE . 79.3 mttt -81.51 -32.02 32.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.166 -0.679 . . . . 10.0 109.166 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 21.6 mt -75.87 -58.93 2.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.895 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -80.17 115.7 19.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.141 0.496 . . . . 10.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mtmm -129.15 170.31 13.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.731 -0.668 . . . . 10.0 109.547 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -69.49 134.9 49.45 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.347 0.404 . . . . 10.0 110.059 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 66.48 54.8 0.86 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.435 0.636 . . . . 10.0 110.312 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.919 0 CA-C-N 115.56 -0.746 . . . . 10.0 110.539 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 120.903 0.382 . . . . 10.0 110.769 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.72 153.64 20.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -114.68 129.4 56.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.782 0.325 . . . . 10.0 110.509 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.8 142.2 18.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.989 -0.55 . . . . 10.0 110.171 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 130.8 43.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.642 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.9 -45.29 18.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.915 -0.584 . . . . 10.0 109.799 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -137.02 173.56 11.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.657 -0.702 . . . . 10.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.88 141.25 36.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.145 -0.48 . . . . 10.0 109.938 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -131.25 123.55 28.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.73 0.3 . . . . 10.0 111.186 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -92.12 133.44 35.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.52 155.05 20.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.164 0.507 . . . . 10.0 111.991 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.2 ttm-85 -110.6 -36.32 5.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.48 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.77 -159.79 0.9 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.449 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -98.58 -10.36 23.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.92 -50.2 15.65 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.367 -0.833 . . . . 10.0 109.596 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -83.65 134.66 34.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.342 -0.845 . . . . 10.0 108.839 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 tp -97.74 134.1 41.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.189 0.519 . . . . 10.0 112.378 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.23 135.1 34.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.418 -0.81 . . . . 10.0 110.199 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -146.87 158.63 43.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.081 0.467 . . . . 10.0 111.377 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -102.29 164.42 11.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.807 -0.633 . . . . 10.0 111.054 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -62.07 113.41 2.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.738 -0.665 . . . . 10.0 110.5 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.61 -1.32 24.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 10.0 112.783 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.57 147.94 51.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.608 0.242 . . . . 10.0 110.469 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -116.74 131.13 57.03 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.1 -0.333 . . . . 10.0 110.1 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -119.18 142.71 47.74 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.553 0.575 . . . . 10.0 112.553 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -95.0 126.4 40.32 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.477 -0.934 . . . . 10.0 108.477 177.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.4 mm -70.27 115.17 9.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.262 0.553 . . . . 10.0 112.025 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 27.1 mt -108.64 -67.09 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.717 -0.674 . . . . 10.0 109.425 178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 22.0 t30 -107.38 95.62 5.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.764 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.1 p -99.87 -21.21 15.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.2 0.524 . . . . 10.0 110.813 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.5 m -83.09 20.11 1.3 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.134 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -70.84 -40.22 72.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.139 0.495 . . . . 10.0 109.94 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 137.21 -62.16 0.59 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.597 -0.811 . . . . 10.0 112.321 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.05 -66.11 0.68 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 24.4 m95 -78.98 115.27 18.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.033 -0.729 . . . . 10.0 109.033 178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -90.56 144.42 25.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.98 0.419 . . . . 10.0 111.427 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 113' ' ' ASN . 28.3 tt0 -95.49 109.95 22.08 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.256 -1.016 . . . . 10.0 108.256 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.6 168.8 13.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.929 0.395 . . . . 10.0 111.681 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -119.04 134.55 55.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.1 t -70.45 137.13 50.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.367 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.8 mt -84.91 -10.16 57.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.059 0.457 . . . . 10.0 110.006 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.7 m -94.46 -57.5 2.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.609 -0.723 . . . . 10.0 111.607 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 46.6 p -89.0 -35.62 16.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.865 0.364 . . . . 10.0 111.53 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.78 5.85 58.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.658 -0.782 . . . . 10.0 112.096 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -78.1 146.84 34.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.562 0.22 . . . . 10.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.4 m -119.46 132.78 55.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.342 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -174.53 -178.06 44.14 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.687 -0.768 . . . . 10.0 112.12 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -82.46 132.92 35.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.873 0.368 . . . . 10.0 110.622 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 26.1 pt -122.6 142.65 37.97 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.048 -0.524 . . . . 10.0 110.842 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 133' ' ' ILE . 13.4 Cg_exo -69.15 122.12 8.96 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.61 2.207 . . . . 10.0 111.701 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -18.36 65.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.981 -0.554 . . . . 10.0 112.159 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -88.97 -1.84 58.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.478 -0.328 . . . . 10.0 111.232 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -115.51 5.41 14.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.67 0.271 . . . . 10.0 111.429 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.2 m -132.22 157.42 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.744 0.307 . . . . 10.0 110.78 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.57 143.22 19.36 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.314 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.96 143.29 72.09 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.357 2.038 . . . . 10.0 112.085 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.532 -0.747 . . . . 10.0 110.103 179.55 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.514 0.197 . . . . 10.0 111.033 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.67 168.82 18.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.938 0.399 . . . . 10.0 111.381 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.4 142.23 34.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.32 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.32 137.53 42.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.704 0.288 . . . . 10.0 110.781 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . 0.42 ' HZ1' ' CD ' ' B' ' 12' ' ' GLU . 0.8 OUTLIER -101.73 121.53 42.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.582 -0.525 . . . . 10.0 109.582 179.366 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 33.6 p90 -130.88 171.47 13.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.059 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -114.41 93.0 4.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 10.0 109.998 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.16 94.65 6.69 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.982 -0.287 . . . . 10.0 110.227 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm 55.15 31.98 17.48 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.73 -0.668 . . . . 10.0 111.15 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.01 -24.69 20.74 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.903 -0.665 . . . . 10.0 112.719 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -85.92 108.87 18.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.859 0.33 . . . . 10.0 110.749 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 11.3 mt-10 -82.41 113.4 20.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.984 0.421 . . . . 10.0 110.853 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -132.61 157.09 45.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.391 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -115.9 127.54 55.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.86 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 91.0 t -131.78 147.15 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.33 139.04 57.39 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.683 -0.235 . . . . 10.0 110.556 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 20.6 tt -66.5 -21.11 28.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.381 0.61 . . . . 10.0 109.791 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.09 -15.17 60.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.538 -0.755 . . . . 10.0 110.663 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -95.37 0.49 53.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.158 0.504 . . . . 10.0 110.235 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mt -102.61 106.82 20.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.009 -0.541 . . . . 10.0 109.861 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -65.14 -78.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.774 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -110.1 141.41 43.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.042 0.449 . . . . 10.0 111.756 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 58.7 t -125.79 114.89 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.327 -0.852 . . . . 10.0 109.247 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 30.1 m -103.93 116.85 33.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.363 0.602 . . . . 10.0 111.973 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 33.8 ttp85 -107.56 137.72 45.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.593 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -111.79 -20.19 12.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.747 0.308 . . . . 10.0 111.678 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.1 -0.49 31.46 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.986 -0.846 . . . . 10.0 110.986 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -134.12 -42.25 0.81 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.158 -0.521 . . . . 10.0 109.89 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -147.82 133.78 19.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.205 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 68.0 mt -94.13 133.96 33.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.501 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -127.59 120.71 28.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.14 -0.482 . . . . 10.0 109.785 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -136.28 168.02 20.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.89 0.376 . . . . 10.0 111.336 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -122.96 126.46 47.24 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.933 -0.766 . . . . 10.0 108.933 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -122.02 156.65 33.04 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.072 0.463 . . . . 10.0 111.57 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -104.99 151.73 23.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.364 -0.834 . . . . 10.0 109.819 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 13.1 mt -135.88 133.93 38.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.781 0.324 . . . . 10.0 111.102 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.06 -10.69 69.13 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.764 -0.653 . . . . 10.0 112.624 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.94 -15.36 74.01 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.969 -0.634 . . . . 10.0 111.773 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.65 -3.02 45.71 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.749 -0.739 . . . . 10.0 112.991 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -131.56 94.32 26.34 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.728 0.299 . . . . 10.0 111.212 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.22 179.67 6.22 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.529 2.153 . . . . 10.0 111.096 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.1 -165.1 28.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.951 -1.119 . . . . 10.0 112.902 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -117.34 157.87 25.39 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.76 132.25 6.98 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.483 -0.865 . . . . 10.0 112.087 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.9 125.12 73.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.307 0.575 . . . . 10.0 110.617 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 91.6 t -126.84 120.95 57.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.766 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -71.84 129.87 39.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.311 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -86.75 18.38 3.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.101 0.477 . . . . 10.0 110.053 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -136.89 -39.27 0.62 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.866 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -94.23 7.67 44.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.631 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.02 153.64 81.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 122.348 -0.22 . . . . 10.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.82 149.58 90.39 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.851 2.367 . . . . 10.0 112.679 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -65.88 -23.3 66.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.735 -0.666 . . . . 10.0 111.307 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -54.76 -39.18 68.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 10.0 110.925 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.82 -37.38 30.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.649 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 28.2 mt -62.88 -42.08 99.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 10.0 111.122 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -66.71 -28.98 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.563 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -79.29 -29.85 42.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.783 0.325 . . . . 10.0 111.229 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 14.5 mt -85.07 -14.46 47.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.969 0.414 . . . . 10.0 110.929 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -70.63 90.88 0.77 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.345 0.593 . . . . 10.0 111.049 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -88.25 100.04 12.68 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.179 -0.675 . . . . 10.0 109.179 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -57.4 116.92 3.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.795 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 91.3 mttt 60.27 81.4 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.134 0.896 . . . . 10.0 110.674 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.401 -0.809 . . . . 10.0 110.284 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 120.718 0.294 . . . . 10.0 110.95 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.7 mt -87.96 155.59 19.76 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.846 -0.428 . . . . 10.0 109.846 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -116.9 136.45 52.94 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.514 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.7 p -111.29 140.29 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.64 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.98 123.67 22.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.559 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.78 -35.61 57.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.563 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.52 169.96 16.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.803 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -76.68 104.69 7.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.656 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.444 ' CE1' HG22 ' B' ' 24' ' ' THR . 86.8 t80 -81.58 128.2 33.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.003 0.43 . . . . 10.0 111.17 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -99.24 115.38 28.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.652 -0.703 . . . . 10.0 109.772 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.0 172.67 7.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.53 -0.304 . . . . 10.0 110.647 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -136.81 -41.63 0.6 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.572 -0.285 . . . . 10.0 111.087 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -172.92 2.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.58 -0.282 . . . . 10.0 110.608 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -92.35 -14.65 28.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.72 0.295 . . . . 10.0 111.336 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -43.75 34.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.023 0.44 . . . . 10.0 110.068 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.15 120.2 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.802 . . . . 10.0 109.762 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.4 tp -78.54 136.82 37.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 10.0 111.943 -178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -95.0 124.73 39.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.435 -0.802 . . . . 10.0 109.698 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.59 155.01 45.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 10.0 111.805 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -94.43 158.29 15.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.358 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.36 133.18 53.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.817 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.9 -9.56 65.91 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.733 -0.746 . . . . 10.0 113.585 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.56 149.2 45.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.16 0.48 . . . . 10.0 111.094 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -110.66 137.71 47.99 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.093 -0.503 . . . . 10.0 109.928 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.66 155.92 45.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.936 0.398 . . . . 10.0 111.313 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -107.78 114.47 28.44 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 mm -71.21 118.04 15.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.474 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.91 -38.62 12.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.553 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -136.02 117.29 14.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.317 -0.401 . . . . 10.0 111.049 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.5 -15.05 15.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.128 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.5 m -83.19 13.04 4.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.42 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -76.8 -30.65 56.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.253 0.549 . . . . 10.0 110.483 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 128.73 -110.49 1.11 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.72 -0.673 . . . . 10.0 111.79 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.17 -57.43 2.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.277 0.56 . . . . 10.0 110.002 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -82.73 114.89 21.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.735 . . . . 10.0 109.026 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -93.61 144.15 25.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.972 0.415 . . . . 10.0 111.492 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.95 113.88 20.85 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.323 -0.991 . . . . 10.0 108.323 177.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.08 154.65 51.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.057 0.456 . . . . 10.0 111.613 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -111.8 128.18 56.03 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.219 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.2 t -69.22 134.26 48.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.135 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.3 mt -85.31 -3.25 58.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 10.0 109.941 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.55 -61.64 1.65 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.683 -0.689 . . . . 10.0 111.119 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 26.0 p -94.37 -21.71 18.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 10.0 111.723 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.22 15.43 66.82 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.665 -0.779 . . . . 10.0 112.071 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -91.34 154.83 18.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.669 0.271 . . . . 10.0 111.013 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.09 155.93 22.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.527 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.69 172.54 38.49 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.825 -0.702 . . . . 10.0 111.572 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -88.94 127.32 35.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.842 0.353 . . . . 10.0 110.351 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.7 pt -120.67 144.64 39.17 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.982 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.531 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 46.4 Cg_endo -73.04 131.35 16.65 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.448 2.099 . . . . 10.0 111.447 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 p -73.74 -1.65 20.07 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.605 0.595 . . . . 10.0 112.605 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.531 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 28.1 p-10 -105.15 13.79 30.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.848 0.356 . . . . 10.0 111.01 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.458 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 5.5 m-85 -126.4 7.87 7.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.686 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.7 m -133.15 155.86 41.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.893 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -135.4 144.16 48.35 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.19 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 13.8 Cg_exo -69.6 132.08 22.83 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.563 2.175 . . . . 10.0 111.686 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.666 -0.683 . . . . 10.0 110.522 -179.94 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ttt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.439 0.161 . . . . 10.0 111.067 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.05 130.68 7.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.773 0.32 . . . . 10.0 110.918 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.39 112.76 19.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.436 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 23.9 t -89.28 129.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.821 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -97.55 119.1 35.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.62 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -131.67 147.04 52.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.56 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -89.97 109.97 20.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.266 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -111.59 105.82 14.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.42 -0.355 . . . . 10.0 111.08 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt 56.67 38.15 29.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.666 -0.697 . . . . 10.0 111.878 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.4 -0.11 85.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.721 -0.752 . . . . 10.0 112.811 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . 0.406 ' CB ' ' HE2' ' B' ' 13' ' ' LYS . 49.4 mt-10 -111.87 117.34 32.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.728 0.264 . . . . 10.0 110.495 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -74.09 112.88 10.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.008 -0.367 . . . . 10.0 110.008 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.406 ' HE2' ' CB ' ' B' ' 11' ' ' GLU . 51.7 mmtt -109.68 147.4 33.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.159 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 8.4 pt20 -130.3 109.26 10.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.516 -0.55 . . . . 10.0 109.516 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.41 142.5 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.503 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -64.78 143.5 57.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.809 -0.441 . . . . 10.0 109.809 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 14.8 tt -56.41 -21.66 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.716 -0.675 . . . . 10.0 112.72 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.24 -14.22 47.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.392 0.516 . . . . 10.0 112.392 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -95.14 16.13 17.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.267 0.556 . . . . 10.0 111.461 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 47.5 mt -105.69 133.6 49.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.546 -0.752 . . . . 10.0 109.284 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.39 -72.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.563 -0.29 . . . . 10.0 110.833 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -133.44 154.77 50.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.601 -0.272 . . . . 10.0 110.3 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.36 126.33 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.402 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' THR . . . . . 0.444 HG22 ' CE1' ' A' ' 93' ' ' TYR . 1.3 m -125.49 127.66 46.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.024 0.44 . . . . 10.0 110.67 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 48.2 ttp85 -108.46 138.48 44.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.496 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -101.44 -17.21 16.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.197 0.522 . . . . 10.0 111.354 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 14.18 24.56 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.101 -0.8 . . . . 10.0 111.101 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -146.86 -51.87 0.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.484 -0.932 . . . . 10.0 108.484 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -130.13 148.8 52.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.514 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mt -105.31 124.8 60.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.805 -0.443 . . . . 10.0 109.805 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -114.03 127.57 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.33 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -146.4 175.26 10.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.856 0.36 . . . . 10.0 111.033 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -136.95 128.41 28.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.903 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -111.01 158.2 19.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.718 0.295 . . . . 10.0 110.725 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -131.56 107.67 9.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.594 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -95.14 143.18 26.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.532 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.47 12.23 47.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.039 -0.601 . . . . 10.0 112.508 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.88 16.63 60.0 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.986 -0.626 . . . . 10.0 111.698 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.35 31.88 63.02 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.124 -0.56 . . . . 10.0 112.197 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -149.41 92.11 4.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.792 0.329 . . . . 10.0 111.492 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -90.49 177.88 2.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.781 2.32 . . . . 10.0 110.678 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.46 -172.25 45.29 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 119.979 -1.105 . . . . 10.0 112.807 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -117.38 -178.96 3.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.654 0.264 . . . . 10.0 110.406 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.35 143.17 10.05 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.465 -0.654 . . . . 10.0 111.465 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.02 125.16 28.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.089 0.471 . . . . 10.0 110.604 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 t -129.47 143.49 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.312 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.3 t -96.59 137.62 35.39 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.953 -0.388 . . . . 10.0 109.953 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -72.46 -12.28 61.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.737 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -100.31 -13.03 18.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.863 0.363 . . . . 10.0 110.744 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.13 -54.5 3.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.218 -0.447 . . . . 10.0 111.459 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -89.78 143.55 30.4 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.499 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.427 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 26.0 Cg_exo -62.74 155.74 57.51 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.601 2.201 . . . . 10.0 111.823 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.89 -27.4 63.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.261 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -53.18 -44.05 67.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.68 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 70.2 mt -80.16 -37.46 33.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.958 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 40.8 mt -60.84 -40.67 93.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.565 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -70.63 -22.63 62.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.034 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -75.76 -26.88 57.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.232 0.539 . . . . 10.0 110.037 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.87 -30.61 17.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.121 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.82 94.93 1.86 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.21 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -95.14 130.86 41.69 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.483 -0.78 . . . . 10.0 110.306 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -64.55 124.31 21.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.62 77.73 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.89 0.744 . . . . 10.0 110.045 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.379 -0.819 . . . . 10.0 110.301 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.713 0.292 . . . . 10.0 110.904 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.8 mt -113.21 154.49 26.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.257 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -113.82 125.27 53.89 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.86 142.24 17.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.442 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.14 123.8 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.423 -0.353 . . . . 10.0 110.675 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.25 -37.41 53.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.04 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -146.0 158.21 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.524 -0.762 . . . . 10.0 109.503 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.42 146.43 54.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.238 0.336 . . . . 10.0 110.272 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -127.66 131.86 49.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.947 0.403 . . . . 10.0 111.02 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -95.28 128.43 42.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.462 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.92 137.84 54.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 10.0 110.731 -179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -113.22 -31.85 6.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.272 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.3 -163.97 1.46 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.401 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -93.11 -19.1 21.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.835 0.35 . . . . 10.0 111.053 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.46 -37.09 60.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.857 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -93.56 151.54 19.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.254 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.9 tp -120.36 134.85 55.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.424 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.9 p -79.3 153.06 30.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.886 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -158.45 160.2 36.53 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.426 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -101.95 156.0 17.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.475 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -62.76 123.37 18.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.87 -12.24 22.63 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.767 -0.73 . . . . 10.0 112.95 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -72.15 150.12 44.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 10.0 111.472 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -111.47 137.32 49.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.349 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -124.39 150.94 45.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.218 0.532 . . . . 10.0 111.936 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -106.98 103.67 13.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.038 -0.983 . . . . 10.0 108.709 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.1 mm -64.45 124.82 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.39 -0.368 . . . . 10.0 111.038 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.81 -39.85 8.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.295 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -130.96 122.56 27.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.36 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.3 p -133.65 19.09 3.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.243 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.76 -6.99 10.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.359 0.503 . . . . 10.0 112.359 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -84.29 -109.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.494 0.188 . . . . 10.0 110.598 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.506 ' HA2' ' OH ' ' B' ' 8' ' ' TYR . . . -73.19 -164.35 8.55 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.77 -0.729 . . . . 10.0 112.143 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -95.65 4.25 53.23 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.667 0.746 . . . . 10.0 110.044 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -105.06 155.73 18.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.513 -1.292 . . . . 10.0 107.513 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -106.45 129.57 54.4 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.084 -0.647 . . . . 10.0 112.671 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.26 115.03 27.16 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.16 -1.422 . . . . 10.0 107.16 177.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -137.33 161.83 35.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.442 0.639 . . . . 10.0 112.668 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 123' ' ' ARG . 31.4 ttp180 -106.78 120.93 43.33 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.117 -0.947 . . . . 10.0 109.318 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.2 t -69.67 134.73 49.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.9 mt -78.52 -11.05 59.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.864 0.364 . . . . 10.0 110.214 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -82.91 -56.61 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.558 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 p -92.76 -32.67 14.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.359 -0.382 . . . . 10.0 112.027 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.89 20.74 49.24 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.645 -0.788 . . . . 10.0 111.6 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -109.92 159.55 17.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.772 -0.214 . . . . 10.0 110.937 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.37 -179.48 4.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.705 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.58 157.32 7.73 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.185 -0.531 . . . . 10.0 111.778 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -80.76 116.38 20.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 37.6 pt -99.59 140.92 21.96 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.727 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 133' ' ' ILE . 27.0 Cg_exo -61.01 117.87 4.68 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.44 2.093 . . . . 10.0 111.465 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -6.5 11.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 10.0 112.538 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -107.18 3.63 25.86 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.743 0.275 . . . . 10.0 111.743 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.97 3.79 14.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.818 0.342 . . . . 10.0 111.036 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 20.5 m -132.51 159.15 43.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.929 0.395 . . . . 10.0 111.037 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.7 141.23 34.5 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.725 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.87 130.29 13.27 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.441 2.094 . . . . 10.0 111.875 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.386 -0.816 . . . . 10.0 109.968 179.945 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ttt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.438 0.161 . . . . 10.0 110.605 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.04 169.53 24.35 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.618 0.247 . . . . 10.0 110.957 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.95 139.53 30.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.802 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -102.94 130.28 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.718 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -94.02 118.64 31.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.072 -0.513 . . . . 10.0 109.953 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -136.54 178.34 7.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.569 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . 0.4 ' HE2' ' OE2' ' B' ' 12' ' ' GLU . 66.6 mttt -123.1 137.94 54.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.871 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . 0.506 ' OH ' ' HA2' ' A' ' 117' ' ' GLY . 77.2 t80 -134.95 115.84 14.03 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.082 -0.71 . . . . 10.0 109.082 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm 59.34 24.02 12.53 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.512 0.507 . . . . 10.0 111.384 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.89 -0.6 67.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.905 -0.664 . . . . 10.0 112.77 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -103.13 136.13 43.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.686 -0.302 . . . . 10.0 110.426 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.4 ' OE2' ' HE2' ' B' ' 7' ' ' LYS . 20.3 mt-10 -86.52 126.19 34.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.54 -0.3 . . . . 10.0 110.238 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -139.11 153.38 48.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.616 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -125.7 124.52 41.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.412 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.2 t -134.62 146.83 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.079 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.71 140.44 56.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.623 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 tt -64.57 -26.57 40.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.912 -0.586 . . . . 10.0 110.6 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.91 -11.84 60.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.213 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -99.4 3.56 45.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.031 0.443 . . . . 10.0 110.482 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.4 mt -95.3 127.76 47.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.62 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.41 -88.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.339 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -100.11 149.86 23.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 10.0 110.93 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.1 t -127.12 116.1 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.715 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 1.2 m -108.72 104.22 13.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.142 0.496 . . . . 10.0 111.528 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -100.47 146.61 26.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.78 -0.646 . . . . 10.0 109.966 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -138.08 5.13 2.53 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.088 0.47 . . . . 10.0 111.165 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.47 20.55 68.84 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.569 -0.824 . . . . 10.0 111.281 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -138.83 -59.7 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.057 -0.72 . . . . 10.0 109.057 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -145.74 134.24 22.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.04 -0.982 . . . . 10.0 109.557 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 89.8 mt -91.37 117.94 35.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 123.302 0.376 . . . . 10.0 110.352 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -107.14 135.53 48.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.707 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -152.76 173.52 15.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.03 0.443 . . . . 10.0 111.388 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -131.91 141.65 49.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.496 -0.775 . . . . 10.0 109.668 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -133.36 173.72 11.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.82 0.343 . . . . 10.0 110.462 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -142.93 127.39 17.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.088 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt -100.51 142.2 32.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.723 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.97 -21.05 60.82 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 116.056 -0.52 . . . . 10.0 113.258 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.93 -3.7 75.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.911 -0.661 . . . . 10.0 112.38 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.43 34.41 8.62 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.914 -0.66 . . . . 10.0 112.052 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -125.43 77.36 68.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.739 0.305 . . . . 10.0 111.243 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.89 148.66 17.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.551 2.168 . . . . 10.0 111.442 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.86 -174.0 39.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.011 -1.09 . . . . 10.0 112.728 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -112.84 174.57 5.83 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.962 -0.384 . . . . 10.0 109.962 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.53 151.58 22.13 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.107 -0.797 . . . . 10.0 111.107 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.8 p -135.78 137.75 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.253 0.549 . . . . 10.0 111.263 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.36 132.97 70.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.782 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 13.6 t -73.5 128.44 35.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.591 -0.277 . . . . 10.0 110.358 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -84.97 6.94 22.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.929 0.395 . . . . 10.0 110.792 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -120.22 -39.47 2.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.269 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.66 -50.87 7.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.93 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.15 146.57 98.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.861 -0.609 . . . . 10.0 111.332 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.23 148.72 84.76 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.54 2.16 . . . . 10.0 112.364 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -60.66 -26.84 67.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.058 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -53.33 -42.48 66.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.159 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 90.2 mt -74.44 -36.39 63.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 10.0 110.695 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 35.6 mt -65.72 -36.97 85.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.626 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -71.9 -14.49 61.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.111 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -96.26 -37.54 10.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.097 0.475 . . . . 10.0 109.831 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -70.53 -35.03 72.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.113 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -74.44 89.94 2.16 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.132 0.492 . . . . 10.0 110.35 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -70.23 109.17 4.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -50.85 123.38 8.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.293 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 65.64 58.58 0.8 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.346 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.533 -0.746 . . . . 10.0 110.622 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.856 0.36 . . . . 10.0 110.637 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.0 mt -81.6 128.1 33.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.278 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -117.82 127.42 53.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.656 -0.702 . . . . 10.0 109.478 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 p -99.79 135.06 36.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.891 0.377 . . . . 10.0 110.432 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.43 118.95 13.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.688 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.4 mt -70.14 -31.48 69.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.673 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -151.3 -178.2 6.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.064 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -87.47 159.99 18.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.16 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -141.12 125.61 17.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.858 0.361 . . . . 10.0 110.789 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -87.86 114.19 24.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.723 -0.672 . . . . 10.0 109.712 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.09 155.69 24.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.255 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -119.02 -20.03 8.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.885 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.6 -160.04 1.01 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.581 -0.282 . . . . 10.0 110.802 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -101.75 -19.88 15.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.983 0.42 . . . . 10.0 110.575 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.99 -48.03 59.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.516 -0.766 . . . . 10.0 109.418 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.83 129.04 34.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.279 -0.873 . . . . 10.0 109.362 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.48 138.69 31.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.903 -0.59 . . . . 10.0 112.319 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -92.2 136.82 32.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.615 -0.513 . . . . 10.0 109.615 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -153.54 178.46 9.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.821 0.343 . . . . 10.0 111.025 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.88 173.87 10.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.98 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -63.57 122.56 16.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.778 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.99 -4.13 33.85 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.836 -0.697 . . . . 10.0 112.524 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -66.33 131.93 47.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.741 0.305 . . . . 10.0 110.856 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -102.1 118.64 37.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.87 -0.419 . . . . 10.0 109.87 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -112.17 142.77 44.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.501 0.556 . . . . 10.0 112.501 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -108.22 104.3 13.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.513 -1.291 . . . . 10.0 107.513 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.64 123.96 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.522 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -102.82 -51.54 3.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.436 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -133.85 114.46 13.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.78 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -129.8 9.39 5.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.451 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.58 -0.98 51.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.435 -0.802 . . . . 10.0 111.897 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -87.72 -91.55 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.887 -0.325 . . . . 10.0 110.221 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.77 -162.57 28.96 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.603 -0.808 . . . . 10.0 111.627 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.53 -28.2 41.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.869 0.366 . . . . 10.0 110.19 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -81.32 145.59 30.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.551 -1.278 . . . . 10.0 107.551 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -106.6 142.5 36.15 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.794 0.665 . . . . 10.0 112.794 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.32 118.17 30.96 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 177.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.96 163.39 33.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.292 0.568 . . . . 10.0 111.64 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -114.79 138.32 50.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.423 -0.808 . . . . 10.0 110.08 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.9 t -73.22 133.49 44.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.273 -0.422 . . . . 10.0 110.434 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.6 mt -92.22 5.85 48.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 10.0 109.956 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.19 -51.11 3.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.703 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.0 p -103.73 -39.39 6.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.033 0.444 . . . . 10.0 110.83 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.7 -2.59 29.03 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.931 -0.652 . . . . 10.0 111.766 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -66.14 142.39 57.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.623 0.249 . . . . 10.0 110.826 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.5 m -117.58 144.6 44.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.539 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.02 179.01 42.68 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.173 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -85.22 135.96 33.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.896 0.379 . . . . 10.0 110.205 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.2 pt -122.47 145.48 44.82 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.294 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.431 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 31.9 Cg_endo -67.44 121.14 8.22 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.776 2.318 . . . . 10.0 111.497 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -4.93 14.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.628 -0.714 . . . . 10.0 112.736 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.431 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 36.0 p-10 -101.57 6.24 42.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.754 0.311 . . . . 10.0 110.977 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -124.96 14.12 8.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.298 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.29 146.52 30.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.471 -0.331 . . . . 10.0 110.755 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -130.9 142.97 47.49 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.557 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.23 131.71 19.67 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.356 2.038 . . . . 10.0 112.323 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.453 -0.784 . . . . 10.0 109.915 179.818 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.779 0.323 . . . . 10.0 110.405 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.74 151.07 26.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.747 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.3 m -94.98 123.16 38.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.242 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 20.6 t -98.75 132.96 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.999 0.428 . . . . 10.0 111.241 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -102.73 111.85 24.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.597 -0.729 . . . . 10.0 109.094 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -130.16 -174.41 3.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.441 . . . . 10.0 111.104 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -110.62 148.6 31.86 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.171 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.17 103.43 4.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.159 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 tptt 58.67 30.77 20.36 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.7 0.625 . . . . 10.0 110.703 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.49 -31.79 8.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.29 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -75.74 168.97 19.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.806 0.336 . . . . 10.0 110.515 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -114.37 129.73 56.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -132.64 148.1 52.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.833 0.349 . . . . 10.0 111.27 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -117.01 109.57 17.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.963 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 94.6 t -129.0 139.38 52.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 110.148 -0.315 . . . . 10.0 110.148 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . 0.523 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 31.0 m-20 -66.9 141.17 57.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.861 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.08 -23.52 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.039 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.67 0.25 18.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.147 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -114.61 9.65 16.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.468 . . . . 10.0 110.244 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 63.9 mt -97.3 132.49 41.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.157 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 t -79.15 -59.99 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.367 -0.379 . . . . 10.0 111.658 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -141.03 155.14 46.23 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.245 -0.284 . . . . 10.0 110.824 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 68.1 t -123.54 122.91 66.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 O-C-N 123.512 0.508 . . . . 10.0 110.59 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 7.3 m -113.53 107.37 15.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.888 0.375 . . . . 10.0 110.969 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.474 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 8.0 ttp85 -102.65 149.9 23.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.254 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -125.84 -22.71 4.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.508 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.04 16.8 14.13 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.958 -0.857 . . . . 10.0 110.958 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -144.38 -51.34 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -145.08 136.02 24.7 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.384 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 52.7 mt -93.88 128.26 45.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.571 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -119.16 130.52 55.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -143.8 172.02 13.41 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.71 -0.396 . . . . 10.0 111.677 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -128.98 136.41 50.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.706 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -131.11 166.84 20.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.891 0.377 . . . . 10.0 111.287 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -132.33 114.74 14.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.539 -0.755 . . . . 10.0 109.729 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 88.1 mt -88.0 135.6 33.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.979 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.75 -8.74 35.33 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.819 -0.628 . . . . 10.0 112.815 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.87 -11.76 83.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.979 -0.629 . . . . 10.0 112.258 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.05 16.34 19.25 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.92 -0.657 . . . . 10.0 112.702 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -138.2 104.03 8.0 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 120.885 -0.326 . . . . 10.0 111.62 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.47 171.42 7.44 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.733 2.289 . . . . 10.0 111.18 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.42 -173.76 44.87 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.66 -1.257 . . . . 10.0 112.966 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -113.42 169.51 8.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.537 0.208 . . . . 10.0 110.497 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.23 151.53 23.48 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.151 -0.547 . . . . 10.0 111.823 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.7 p -136.27 140.12 44.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 10.0 111.517 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.78 135.46 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.901 -0.59 . . . . 10.0 109.557 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.3 t -76.02 134.89 40.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.745 0.307 . . . . 10.0 110.714 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.465 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 45.0 mt-10 -89.79 8.95 29.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 10.0 110.048 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -132.22 -42.77 0.97 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.733 -0.667 . . . . 10.0 111.665 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.21 34.23 1.81 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.208 0.447 . . . . 10.0 112.208 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.98 154.66 34.55 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.705 -0.225 . . . . 10.0 110.574 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -59.48 134.71 60.03 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.77 2.313 . . . . 10.0 111.356 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -67.97 -16.65 64.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.219 -0.446 . . . . 10.0 112.165 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -59.61 -44.4 93.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.409 . . . . 10.0 110.366 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.97 -39.23 83.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.526 . . . . 10.0 110.008 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.9 -41.0 95.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.741 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -62.5 -38.12 88.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.323 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.69 -35.86 44.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.956 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.28 -56.33 22.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.857 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . 0.474 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 40.6 tt0 -86.81 89.77 8.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.335 0.588 . . . . 10.0 110.944 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -78.58 148.74 33.19 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -64.7 138.91 58.67 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.1 mttt 72.04 54.64 0.18 Allowed 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.983 0.802 . . . . 10.0 110.245 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.662 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 120.678 0.275 . . . . 10.0 110.507 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 73.1 mt -92.15 150.85 20.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -119.37 137.53 53.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.853 0.358 . . . . 10.0 110.942 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -111.86 140.01 33.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.335 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.74 122.8 22.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.921 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.9 mt -79.13 -38.32 36.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.462 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -134.19 161.39 35.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.36 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -77.23 121.54 23.81 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -112.22 117.92 33.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.075 0.464 . . . . 10.0 110.431 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -94.46 120.52 34.82 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.906 -0.588 . . . . 10.0 109.486 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.428 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -73.48 156.61 38.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.969 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.1 ttm105 -123.28 -26.42 4.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.85 -0.614 . . . . 10.0 110.676 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.48 -168.51 1.5 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.297 -0.41 . . . . 10.0 111.022 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -97.8 -3.17 39.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.018 0.437 . . . . 10.0 111.14 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.52 -43.29 9.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.04 -0.527 . . . . 10.0 110.385 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -81.16 147.43 30.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.552 -0.749 . . . . 10.0 109.91 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 62.2 tp -103.84 131.39 51.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.337 -0.392 . . . . 10.0 112.009 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.428 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -85.37 135.8 33.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.877 178.713 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -155.58 165.46 36.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.775 0.322 . . . . 10.0 110.664 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 36.5 m170 -110.22 165.23 11.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.959 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -61.82 126.1 26.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.558 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.35 -4.21 43.99 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.675 -0.774 . . . . 10.0 112.146 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 2.5 tp10 -68.11 148.12 51.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 122.204 0.202 . . . . 10.0 110.922 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -119.1 133.52 55.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.662 -0.495 . . . . 10.0 109.662 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.485 ' CZ ' ' HB3' ' A' ' 107' ' ' GLU . 0.4 OUTLIER -130.53 155.46 46.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.125 0.488 . . . . 10.0 111.582 -179.156 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -109.45 114.11 27.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.2 mm -63.2 128.77 25.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.143 -0.48 . . . . 10.0 111.065 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.03 -44.33 4.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.917 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' A' ' 116' ' ' GLU . 30.1 t30 -138.81 108.55 6.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.812 0.339 . . . . 10.0 111.131 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.72 -11.32 19.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.163 0.506 . . . . 10.0 110.73 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.6 8.79 15.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.069 -0.514 . . . . 10.0 111.446 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.413 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 7.2 tp10 -77.98 -20.14 53.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.013 0.435 . . . . 10.0 110.806 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.34 -139.99 9.61 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.818 -0.706 . . . . 10.0 111.499 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.11 -35.28 49.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.98 -0.378 . . . . 10.0 109.98 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.453 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 20.4 m95 -92.18 126.01 37.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -103.55 146.99 27.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.882 0.372 . . . . 10.0 111.228 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -97.11 122.17 39.82 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.735 -0.839 . . . . 10.0 108.735 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.74 162.46 32.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.953 0.406 . . . . 10.0 111.543 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -109.53 128.08 54.93 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.453 -0.794 . . . . 10.0 109.599 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.3 t -67.3 134.16 51.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.163 -0.472 . . . . 10.0 109.749 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.9 mt -83.73 -10.66 57.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.864 0.364 . . . . 10.0 110.105 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.12 -62.77 1.37 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.761 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.2 p -87.36 -35.73 18.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.037 0.446 . . . . 10.0 111.546 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.89 2.01 52.17 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.72 -0.753 . . . . 10.0 111.87 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.99 144.7 48.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.802 0.334 . . . . 10.0 111.248 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.7 m -117.76 135.64 53.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.288 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -178.68 178.44 48.71 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.445 -0.883 . . . . 10.0 112.106 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -79.79 126.09 30.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.965 0.412 . . . . 10.0 109.971 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 31.2 pt -115.67 139.83 25.28 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.797 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.07 112.58 1.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.453 2.102 . . . . 10.0 111.34 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.67 -18.21 61.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.056 -0.52 . . . . 10.0 112.134 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -92.57 5.69 49.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.621 -0.263 . . . . 10.0 111.494 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -119.25 4.82 11.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.914 0.388 . . . . 10.0 110.748 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.93 149.07 32.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.152 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.431 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -129.39 142.65 45.96 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.218 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 6.7 Cg_exo -73.84 135.73 21.9 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.437 2.092 . . . . 10.0 111.773 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.367 -0.825 . . . . 10.0 110.682 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ttt . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.348 0.118 . . . . 10.0 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.35 174.08 13.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.75 0.309 . . . . 10.0 111.153 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 2.1 m -108.59 131.56 54.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.47 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.86 125.06 48.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.892 0.377 . . . . 10.0 110.893 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -103.86 111.44 23.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.272 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -121.94 176.99 5.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.978 -0.556 . . . . 10.0 111.036 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -121.06 94.72 4.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.469 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -80.88 92.02 6.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.059 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm 56.24 43.9 25.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.42 -0.809 . . . . 10.0 111.893 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.6 -16.43 59.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.852 -0.69 . . . . 10.0 113.586 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -94.75 117.79 30.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.168 0.484 . . . . 10.0 111.314 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -76.81 117.26 18.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -132.37 137.97 47.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.855 0.359 . . . . 10.0 110.877 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -112.48 116.28 30.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.137 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.3 t -124.08 140.34 47.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.775 -0.454 . . . . 10.0 109.775 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -57.51 137.21 56.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.594 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.8 tt -60.12 -26.94 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.983 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.27 2.16 16.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.434 -0.348 . . . . 10.0 111.821 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' B' ' 35' ' ' ASP . 95.4 mttt -112.01 8.27 20.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.775 0.321 . . . . 10.0 111.088 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -92.2 119.97 40.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.78 -70.32 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.888 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -128.49 148.98 50.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.73 0.3 . . . . 10.0 111.145 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.21 132.37 68.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.481 -0.781 . . . . 10.0 110.297 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 28.7 m -132.22 115.4 15.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.037 0.446 . . . . 10.0 110.851 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.547 ' HD2' ' OE1' ' B' ' 48' ' ' GLU . 68.5 ttp85 -116.32 144.26 44.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.309 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -119.89 7.62 10.97 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.132 0.491 . . . . 10.0 111.607 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.487 ' H ' ' HG2' ' B' ' 25' ' ' ARG . . . 90.53 16.56 54.89 Favored Glycine 0 C--O 1.231 -0.077 0 C-N-CA 120.462 -0.875 . . . . 10.0 112.203 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -140.0 -60.92 0.53 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.48 0.657 . . . . 10.0 109.343 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -131.46 147.05 52.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.162 -0.926 . . . . 10.0 109.699 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 61.7 mt -101.57 111.96 33.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.681 -0.69 . . . . 10.0 110.089 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -103.02 126.95 50.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.089 -0.505 . . . . 10.0 109.676 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -152.45 172.96 15.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.01 0.433 . . . . 10.0 111.133 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -129.16 134.41 48.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.785 -0.643 . . . . 10.0 109.739 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -110.98 168.83 9.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.239 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' B' ' 19' ' ' LYS . 21.8 t70 -131.65 153.09 50.32 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.312 -0.625 . . . . 10.0 109.312 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 51.0 mt -138.55 139.29 38.62 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.189 -0.3 . . . . 10.0 110.189 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.97 -20.93 60.68 Favored Glycine 0 C--N 1.33 0.218 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.33 -18.49 71.49 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.749 -0.54 . . . . 10.0 111.749 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.07 29.38 6.45 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.972 -0.632 . . . . 10.0 112.795 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -130.41 85.91 55.06 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.883 0.341 . . . . 10.0 111.56 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -91.33 76.94 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.138 2.559 . . . . 10.0 111.997 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.58 -167.47 43.69 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.927 -0.654 . . . . 10.0 113.027 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 62.1 m-85 -111.65 172.34 6.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.852 0.358 . . . . 10.0 110.727 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.22 151.59 23.05 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.358 -0.697 . . . . 10.0 111.358 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 14.6 p -141.57 140.49 31.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.13 0.49 . . . . 10.0 110.984 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.57 147.77 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.559 . . . . 10.0 109.651 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 22.2 t -93.0 136.67 33.05 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.168 -0.308 . . . . 10.0 110.168 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . 0.547 ' OE1' ' HD2' ' B' ' 25' ' ' ARG . 19.6 tt0 -80.66 -10.17 59.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.979 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -110.99 -26.01 9.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.157 0.428 . . . . 10.0 112.157 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -97.83 -15.16 20.37 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.465 0.543 . . . . 10.0 112.465 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.29 151.34 41.42 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.451 0.167 . . . . 10.0 111.226 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.436 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 25.7 Cg_exo -63.5 147.78 92.96 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.713 2.275 . . . . 10.0 111.836 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -64.31 -21.95 66.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.969 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.96 -45.93 71.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.918 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.2 mt -78.61 -36.26 44.42 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.898 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 36.4 mt -61.91 -39.38 91.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.203 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -69.08 -16.58 63.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 10.0 111.771 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -90.28 -20.24 23.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.167 0.508 . . . . 10.0 110.173 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 21.3 mt -93.08 -37.98 11.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.751 -0.659 . . . . 10.0 110.141 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -79.66 85.3 5.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.563 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -91.32 163.59 14.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.968 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -81.74 126.48 31.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 63.36 36.91 11.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.236 0.541 . . . . 10.0 109.736 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.174 -0.921 . . . . 10.0 111.673 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 120.579 0.228 . . . . 10.0 110.69 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.5 mt -100.43 141.77 32.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -111.18 134.94 52.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.111 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 107' ' ' GLU . 12.6 p -109.42 138.61 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.453 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.84 123.46 26.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.862 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.2 mt -81.32 -34.64 31.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.338 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -133.54 154.99 50.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.259 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.76 145.48 30.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.242 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -150.85 130.0 12.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.53 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -97.06 132.18 43.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.949 -0.759 . . . . 10.0 108.949 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 143.96 57.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.97 0.414 . . . . 10.0 111.396 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -97.01 -12.11 23.68 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.788 -0.642 . . . . 10.0 109.919 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.37 -166.49 2.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.028 -0.987 . . . . 10.0 109.434 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -98.35 -2.99 38.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -78.06 -47.84 17.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.002 -0.999 . . . . 10.0 108.827 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -87.64 155.68 19.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.192 -0.913 . . . . 10.0 108.818 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.1 tp -111.23 139.36 46.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.868 0.366 . . . . 10.0 111.86 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.9 m -81.44 140.04 34.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.665 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -152.2 166.22 32.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.967 0.413 . . . . 10.0 111.007 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -121.61 166.71 13.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.213 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -59.51 122.59 14.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.59 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.08 -1.43 44.2 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.733 -0.746 . . . . 10.0 112.611 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -67.15 140.94 57.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.644 0.259 . . . . 10.0 110.875 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -112.27 124.83 53.32 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 107' ' ' GLU . 25.6 m-85 -116.94 146.07 43.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.292 0.568 . . . . 10.0 112.356 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -100.14 101.43 12.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.718 -1.216 . . . . 10.0 107.718 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.0 mm -60.77 116.28 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.374 -0.376 . . . . 10.0 111.316 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.8 mt -89.25 -53.51 4.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.307 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -133.25 104.57 6.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.376 -0.375 . . . . 10.0 111.008 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.75 -8.19 44.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.289 0.566 . . . . 10.0 110.497 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 10.57 27.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.215 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.86 -25.12 59.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.913 0.387 . . . . 10.0 110.317 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.42 -127.79 3.18 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.639 -0.584 . . . . 10.0 111.639 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -83.15 -47.74 11.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.484 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 25.8 m95 -88.5 127.68 35.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.531 -0.915 . . . . 10.0 108.531 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -107.52 139.96 41.24 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.835 0.35 . . . . 10.0 111.277 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -85.39 119.41 25.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.177 -1.045 . . . . 10.0 108.177 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.11 162.61 30.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.071 0.463 . . . . 10.0 111.818 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -112.91 122.09 46.62 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.378 -0.828 . . . . 10.0 108.922 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.4 t -62.25 144.34 55.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.883 0.373 . . . . 10.0 110.741 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.75 -16.17 37.19 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.176 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 m -93.05 -50.79 5.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.709 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 64.8 p -88.4 -41.25 12.93 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.284 0.564 . . . . 10.0 111.268 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.89 9.1 62.83 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.751 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.21 162.57 18.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.779 0.323 . . . . 10.0 110.724 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.13 150.97 33.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.463 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 168.79 168.75 31.29 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.911 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -79.79 134.41 36.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.823 0.344 . . . . 10.0 110.821 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 22.8 pt -120.53 137.5 26.31 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.588 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.581 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 37.6 Cg_endo -72.19 121.95 7.97 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.549 2.166 . . . . 10.0 111.437 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -19.55 65.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.843 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.581 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 35.7 p-10 -80.63 -21.63 41.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.506 0.193 . . . . 10.0 111.446 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.473 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 4.6 m-85 -93.15 -11.99 31.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.081 0.4 . . . . 10.0 112.081 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.2 m -114.72 159.78 14.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.17 0.509 . . . . 10.0 111.675 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.72 137.59 18.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.716 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.64 137.14 32.25 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.343 2.029 . . . . 10.0 112.142 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.601 -0.714 . . . . 10.0 109.793 179.289 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ttm . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.462 0.173 . . . . 10.0 111.061 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.28 162.24 37.77 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.446 0.641 . . . . 10.0 112.173 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 1.1 m -107.58 118.2 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.316 -0.856 . . . . 10.0 109.746 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.1 134.35 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.821 0.343 . . . . 10.0 111.682 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -98.58 139.25 34.58 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.487 -0.561 . . . . 10.0 109.487 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -148.07 176.35 10.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.85 0.357 . . . . 10.0 110.667 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -123.87 83.55 2.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.815 -0.63 . . . . 10.0 109.76 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -63.77 92.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.765 0.316 . . . . 10.0 110.535 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm 52.02 29.5 6.32 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.688 -0.687 . . . . 10.0 111.608 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.17 -16.65 22.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.839 -0.696 . . . . 10.0 112.806 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -88.83 101.68 14.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.779 0.323 . . . . 10.0 110.732 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -67.52 123.12 19.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.082 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.05 158.76 44.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.747 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -125.12 119.59 29.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.041 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.71 142.43 42.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.804 0.335 . . . . 10.0 110.43 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 1.4 m-20 -60.77 137.86 58.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.351 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.8 tt -60.96 -26.52 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.696 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -10.72 59.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.855 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -105.3 8.18 33.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.69 0.281 . . . . 10.0 111.484 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -90.57 137.89 20.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.792 0.33 . . . . 10.0 110.273 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -88.95 -59.16 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.255 -0.43 . . . . 10.0 111.171 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -136.16 151.85 50.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.634 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.01 127.04 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.178 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' THR . . . . . 0.405 ' HG1' ' HH2' ' A' ' 119' ' ' TRP . 8.1 m -123.43 101.78 7.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.886 0.374 . . . . 10.0 111.398 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.409 ' HG3' HG12 ' B' ' 30' ' ' ILE . 22.3 ttp85 -90.76 137.33 32.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.813 -0.44 . . . . 10.0 109.813 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.431 ' HB2' ' ND2' ' A' ' 136' ' ' ASN . 49.1 t80 -100.91 -20.49 15.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.06 0.457 . . . . 10.0 111.238 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.49 -4.58 37.44 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -135.17 -41.69 0.73 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.565 -0.817 . . . . 10.0 108.971 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -138.81 137.66 36.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.493 -0.776 . . . . 10.0 109.868 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.409 HG12 ' HG3' ' B' ' 25' ' ' ARG . 72.5 mt -102.98 125.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.279 -0.267 . . . . 10.0 110.279 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 17.7 m-85 -117.24 136.17 53.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -151.45 174.02 13.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.0 0.429 . . . . 10.0 111.227 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -130.24 140.88 50.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 10.0 109.805 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -124.41 152.52 43.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.926 0.393 . . . . 10.0 110.832 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.38 98.94 6.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.628 -0.714 . . . . 10.0 109.867 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' B' ' 40' ' ' LYS . 48.9 mt -75.81 144.42 41.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.793 0.33 . . . . 10.0 110.827 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.25 -5.87 87.55 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 116.071 -0.513 . . . . 10.0 112.201 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.3 23.05 10.38 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.899 -0.667 . . . . 10.0 112.441 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.84 43.42 97.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.45 -0.405 . . . . 10.0 112.834 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 86.0 tttt -159.79 95.68 1.61 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.717 0.294 . . . . 10.0 110.815 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -87.73 169.06 6.86 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.002 2.468 . . . . 10.0 111.235 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.63 -173.43 38.51 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.223 -0.989 . . . . 10.0 112.285 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 42.9 m-85 -118.56 166.89 12.17 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.66 138.25 6.42 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.372 -0.918 . . . . 10.0 112.531 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 p -124.33 127.73 73.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.078 0.466 . . . . 10.0 110.392 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.08 123.87 70.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.227 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -71.62 132.61 44.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.365 -0.38 . . . . 10.0 109.977 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -80.79 1.29 31.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.112 0.482 . . . . 10.0 110.791 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -116.3 -35.13 4.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.447 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -101.9 28.3 5.82 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.41 151.18 36.06 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 121.314 -0.154 . . . . 10.0 111.075 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.29 129.25 33.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.256 2.637 . . . . 10.0 112.418 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.449 ' HA ' HD12 ' B' ' 56' ' ' LEU . 97.3 mttt -64.31 -26.82 68.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.927 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -55.97 -42.62 76.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.971 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 73.8 mt -76.86 -30.67 56.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.729 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' B' ' 53' ' ' LYS . 62.1 mt -66.57 -32.09 73.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.413 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -74.42 -7.93 54.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.002 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -98.6 -26.92 14.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.907 -0.588 . . . . 10.0 110.11 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 52.3 mt -72.45 -61.95 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.865 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -101.03 110.33 22.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.208 0.528 . . . . 10.0 109.961 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -107.8 173.84 6.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.481 -0.781 . . . . 10.0 110.073 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -64.12 127.45 31.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.773 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 mttm 60.8 58.29 2.41 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.499 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.283 0 CA-C-N 115.954 -0.567 . . . . 10.0 111.061 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 120.929 0.395 . . . . 10.0 111.058 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.9 mt -92.57 158.84 15.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.09 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -121.08 134.61 55.27 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.2 p -112.27 140.34 32.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.921 0.391 . . . . 10.0 110.527 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 138' ' ' VAL . . . -72.13 123.37 22.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.97 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 139' ' ' ALA . 82.6 mt -83.28 -26.09 30.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.547 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.43 -175.3 4.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.922 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.87 149.8 27.05 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.282 0.364 . . . . 10.0 110.391 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -147.63 128.7 14.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.595 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -94.51 122.16 36.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.639 . . . . 10.0 109.403 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.507 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -61.68 144.09 55.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.703 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -97.32 -38.61 9.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.354 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -124.36 -162.25 1.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.873 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' H ' ' HB ' ' A' ' 97' ' ' THR . 1.6 pt-20 -96.54 -8.58 31.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.911 0.386 . . . . 10.0 110.68 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.48 -38.78 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.232 0.539 . . . . 10.0 110.099 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -93.05 150.55 20.45 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.688 -0.856 . . . . 10.0 108.688 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.2 tp -113.63 142.46 45.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.888 0.375 . . . . 10.0 111.626 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -81.92 148.51 28.7 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.799 179.006 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -154.85 158.96 40.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.102 0.477 . . . . 10.0 111.35 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -113.35 153.14 29.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.053 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -59.56 126.66 28.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.584 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.1 -17.64 29.24 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.884 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -68.4 143.14 55.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.733 0.302 . . . . 10.0 111.035 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -103.26 130.29 50.47 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.444 -0.576 . . . . 10.0 109.444 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -118.87 143.28 47.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.236 0.541 . . . . 10.0 112.089 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -103.19 104.14 14.26 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.69 -0.855 . . . . 10.0 108.69 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' A' ' 122' ' ' ALA . 20.3 mm -64.13 120.19 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 10.0 111.206 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.8 mt -82.74 -46.44 13.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.194 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -149.06 137.77 21.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.185 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.12 -12.44 10.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.173 -0.467 . . . . 10.0 111.29 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.9 m -86.82 47.21 1.46 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.919 0.39 . . . . 10.0 111.903 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -127.35 -3.72 6.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.97 0.414 . . . . 10.0 110.863 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 139.47 -145.47 16.62 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.014 -0.612 . . . . 10.0 111.729 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.05 -22.41 20.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.031 0.443 . . . . 10.0 110.611 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' B' ' 31' ' ' PHE . 23.2 m95 -98.38 119.56 37.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.961 -1.125 . . . . 10.0 107.961 177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -103.47 153.92 20.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.284 0.564 . . . . 10.0 112.187 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -90.29 124.6 35.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.672 -1.233 . . . . 10.0 107.672 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -140.69 146.71 38.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.629 0.728 . . . . 10.0 112.715 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 123' ' ' ARG . 30.0 ttt180 -99.68 122.28 42.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.854 -1.066 . . . . 10.0 109.646 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.7 t -66.79 131.23 45.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.3 mt -78.44 -9.43 59.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.85 0.357 . . . . 10.0 110.427 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.5 m -79.78 -63.65 1.37 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 10.0 111.427 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.3 p -102.09 -25.75 13.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.389 0.514 . . . . 10.0 112.389 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.12 1.59 57.01 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.552 -0.832 . . . . 10.0 111.704 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -69.2 146.33 52.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 10.0 110.846 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.59 178.84 4.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.438 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 143.15 168.87 12.17 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.844 -0.693 . . . . 10.0 111.972 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -84.0 130.43 34.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.842 0.353 . . . . 10.0 110.44 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.8 pt -123.57 146.92 51.47 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.915 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.526 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 48.5 Cg_endo -74.23 115.05 4.18 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.666 2.244 . . . . 10.0 111.779 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.6 m -62.03 -15.06 41.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.945 0.72 . . . . 10.0 112.945 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 33.7 p-10 -83.41 -8.3 59.41 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.234 -0.291 . . . . 10.0 110.861 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.402 ' CE1' HG22 ' B' ' 24' ' ' THR . 2.5 m-85 -105.44 -0.16 26.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.167 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 89' ' ' ALA . 4.6 m -127.67 156.15 39.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.989 0.423 . . . . 10.0 111.206 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 90' ' ' LEU . . . -136.2 143.05 42.19 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.235 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.85 129.41 19.66 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.617 2.211 . . . . 10.0 112.06 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.29 -0.862 . . . . 10.0 110.261 -179.872 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.469 0.176 . . . . 10.0 110.708 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.4 169.24 25.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.821 0.343 . . . . 10.0 111.148 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.1 p -101.88 145.24 29.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 t -110.02 133.03 56.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.783 -0.451 . . . . 10.0 109.783 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.25 124.21 44.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.457 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 41.3 p90 -128.58 166.72 18.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.958 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -114.31 87.54 2.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.014 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -78.5 90.55 4.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.585 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm 53.54 38.21 27.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.108 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.01 -26.37 20.92 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.675 -0.774 . . . . 10.0 112.813 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -83.59 105.82 14.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.696 0.284 . . . . 10.0 110.882 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 26.7 mt-10 -80.16 116.93 20.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -130.92 157.44 42.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.612 0.244 . . . . 10.0 111.074 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -120.72 113.9 20.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.494 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' VAL . . . . . 0.497 HG11 ' HB2' ' B' ' 34' ' ' TYR . 48.8 t -124.42 143.02 39.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.857 -0.423 . . . . 10.0 109.857 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.26 141.69 45.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 10.0 111.314 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 7.4 tt -62.26 -32.68 55.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.174 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 15.2 m -80.98 2.16 28.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.372 -0.376 . . . . 10.0 111.549 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -104.62 12.47 32.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.522 0.677 . . . . 10.0 109.29 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.15 133.86 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.063 -0.972 . . . . 10.0 109.324 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 t -83.76 -73.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.745 0.307 . . . . 10.0 111.568 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -118.85 152.18 36.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.72 0.295 . . . . 10.0 111.354 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.66 129.7 66.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.979 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' THR . . . . . 0.402 HG22 ' CE1' ' A' ' 137' ' ' TYR . 1.5 m -134.46 121.4 21.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.901 0.381 . . . . 10.0 111.05 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -120.75 125.47 47.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.814 0.34 . . . . 10.0 110.844 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -89.05 -22.46 22.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.153 0.502 . . . . 10.0 110.684 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.17 -4.47 8.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.865 -0.683 . . . . 10.0 112.01 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -117.14 -57.96 2.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.302 -0.629 . . . . 10.0 109.302 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.68 149.89 52.12 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.6 mt -101.66 124.64 55.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.358 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.443 ' HB3' ' NE1' ' A' ' 119' ' ' TRP . 3.3 m-85 -104.5 132.55 50.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.665 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -152.38 156.65 39.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.938 0.399 . . . . 10.0 111.289 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -110.59 132.17 54.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.059 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.497 ' HB2' HG11 ' B' ' 15' ' ' VAL . 19.2 p90 -114.62 164.3 14.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.67 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -133.33 142.96 48.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.624 -0.717 . . . . 10.0 109.385 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 35.7 mt -126.5 142.42 51.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.018 0.437 . . . . 10.0 111.288 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.86 -13.48 78.74 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.696 -0.684 . . . . 10.0 112.212 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.52 7.9 37.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.962 -0.637 . . . . 10.0 112.1 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.89 45.46 16.51 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.201 -0.523 . . . . 10.0 112.618 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -160.49 90.45 1.7 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.891 0.377 . . . . 10.0 111.392 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.32 175.03 6.62 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.458 2.105 . . . . 10.0 110.917 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.27 -166.5 36.54 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.881 -1.152 . . . . 10.0 112.462 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -120.65 156.57 31.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.681 0.277 . . . . 10.0 110.45 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.72 155.62 22.74 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.154 -0.778 . . . . 10.0 111.154 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.73 139.79 28.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.111 0.482 . . . . 10.0 111.262 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 20.4 m -132.31 152.48 36.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.763 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.416 ' HB3' ' HB2' ' B' ' 50' ' ' ASP . 19.5 t -91.16 141.34 28.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.112 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -82.6 -10.14 59.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.043 0.449 . . . . 10.0 110.636 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.64 -9.18 12.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.89 0.33 . . . . 10.0 111.89 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ASP . . . . . 0.416 ' HB2' ' HB3' ' B' ' 47' ' ' SER . 24.1 m-20 -120.32 21.9 11.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.901 0.382 . . . . 10.0 111.48 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.71 141.65 17.05 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.164 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.51 142.86 69.78 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.779 2.319 . . . . 10.0 112.297 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -58.06 -30.48 66.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.214 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.4 -45.09 72.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 10.0 111.161 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 mt -71.74 -38.84 70.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 10.0 111.023 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.98 -41.67 97.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.015 -0.539 . . . . 10.0 111.045 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -74.53 -13.65 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.932 -0.577 . . . . 10.0 111.383 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -80.42 -37.11 32.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.018 0.437 . . . . 10.0 109.823 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.44 -47.68 32.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.778 -0.646 . . . . 10.0 111.361 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -88.92 97.71 11.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.065 0.459 . . . . 10.0 110.43 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -104.01 -173.27 2.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.389 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -68.84 140.43 55.22 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 61.5 50.43 4.6 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.552 0.691 . . . . 10.0 109.892 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-N 115.165 -0.925 . . . . 10.0 110.878 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.597 0.237 . . . . 10.0 110.721 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.2 mt -99.8 141.79 32.15 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.932 0.396 . . . . 10.0 110.723 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -119.56 140.35 50.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.76 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.86 140.15 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.959 0.409 . . . . 10.0 110.437 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.34 116.56 12.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.987 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.24 -33.18 72.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.406 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -147.13 173.78 12.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.883 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.19 144.32 27.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -126.78 123.35 37.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.956 0.408 . . . . 10.0 111.112 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -84.93 116.85 23.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.606 -0.725 . . . . 10.0 109.579 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.94 148.67 51.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.092 0.472 . . . . 10.0 111.155 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -115.15 -35.44 4.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.782 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.81 -165.09 1.48 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.551 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -96.0 -11.95 25.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.688 0.28 . . . . 10.0 111.262 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.35 -34.63 31.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.211 0.529 . . . . 10.0 110.611 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -90.23 149.76 22.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.58 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.6 tp -109.68 135.46 50.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.981 0.42 . . . . 10.0 111.916 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.91 147.72 24.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.204 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -156.77 163.59 39.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.779 0.323 . . . . 10.0 111.268 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -110.26 157.05 19.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.08 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -58.5 128.1 35.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.799 0.333 . . . . 10.0 110.419 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.38 -10.0 53.78 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.707 -0.758 . . . . 10.0 112.924 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -70.85 146.73 49.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 10.0 110.781 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -115.62 139.07 50.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.067 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -126.58 150.39 48.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.053 0.454 . . . . 10.0 111.818 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -97.91 111.5 23.78 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.45 119.17 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.336 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.9 mt -102.7 -62.32 1.29 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.579 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -119.54 107.22 13.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.431 . . . . 10.0 110.644 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.29 22.0 12.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.78 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -112.27 -1.08 15.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.783 0.66 . . . . 10.0 112.783 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.72 -37.11 65.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.518 -0.473 . . . . 10.0 110.876 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.74 -133.62 2.89 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.189 -1.005 . . . . 10.0 112.588 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.39 -31.58 29.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.641 0.258 . . . . 10.0 110.947 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.558 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 28.2 m95 -93.16 121.22 34.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -103.17 146.48 28.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.046 0.451 . . . . 10.0 111.634 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -95.23 119.51 33.87 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.01 159.13 42.48 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.291 0.567 . . . . 10.0 111.832 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -104.38 124.15 48.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.245 -0.889 . . . . 10.0 109.433 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.0 t -65.95 136.57 56.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.944 -0.391 . . . . 10.0 109.944 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.34 -2.71 58.81 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.2 m -97.15 -50.31 4.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.2 p -101.24 -28.07 12.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.94 0.4 . . . . 10.0 111.732 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.45 -6.03 77.73 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.977 -0.63 . . . . 10.0 112.233 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -69.03 149.32 48.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.945 0.403 . . . . 10.0 110.882 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.1 m -119.95 125.86 49.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.947 -0.569 . . . . 10.0 111.093 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -163.5 176.11 39.67 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.489 -0.644 . . . . 10.0 111.489 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -81.72 127.86 33.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.839 0.352 . . . . 10.0 110.5 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.0 pt -119.62 142.13 32.27 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.805 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.447 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 28.9 Cg_endo -69.01 110.9 2.51 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.171 1.914 . . . . 10.0 111.184 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 m -59.35 -19.55 47.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.887 -0.597 . . . . 10.0 112.579 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 30.7 p-10 -81.51 -8.8 59.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 10.0 110.87 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -103.03 -3.5 25.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.312 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.79 157.87 27.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.507 -0.315 . . . . 10.0 111.036 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -138.85 148.37 57.85 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.317 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 24.3 Cg_exo -63.38 136.53 55.59 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.546 2.164 . . . . 10.0 112.117 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.567 -0.73 . . . . 10.0 110.396 179.677 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ttt . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.561 0.22 . . . . 10.0 110.538 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.53 145.99 16.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.885 0.374 . . . . 10.0 111.009 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 6.1 m -93.72 119.8 33.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.625 -0.716 . . . . 10.0 109.45 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 32.8 t -86.87 130.34 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.984 0.421 . . . . 10.0 111.291 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -99.69 120.65 40.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.339 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -140.53 -174.22 3.9 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.609 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -125.54 142.97 51.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.068 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -125.52 98.84 5.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.968 0.413 . . . . 10.0 110.171 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm 56.8 31.64 19.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.189 -0.914 . . . . 10.0 112.264 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.45 -56.35 0.72 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.263 -0.97 . . . . 10.0 114.022 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -78.88 158.38 28.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.097 0.449 . . . . 10.0 111.842 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -97.1 141.79 29.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -136.9 152.1 49.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.443 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -126.18 111.9 15.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.21 -0.45 . . . . 10.0 109.796 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -129.59 142.13 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.803 0.335 . . . . 10.0 111.172 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.67 142.37 57.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.647 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 16.5 tt -63.13 -25.83 39.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.232 0.539 . . . . 10.0 110.616 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -11.38 60.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 10.0 111.362 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -99.5 2.68 45.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.122 0.487 . . . . 10.0 110.207 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 61.3 mt -96.91 134.34 34.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.075 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.26 -72.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.031 0.443 . . . . 10.0 110.434 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -120.99 147.02 46.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.096 -0.502 . . . . 10.0 111.155 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 t -124.16 116.01 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.659 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 5.1 m -120.65 112.55 19.02 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.128 0.49 . . . . 10.0 112.266 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.557 ' HD2' ' OE1' ' B' ' 48' ' ' GLU . 37.3 ttp85 -102.9 131.71 49.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.939 -0.393 . . . . 10.0 109.939 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -89.88 -25.48 20.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.311 0.577 . . . . 10.0 110.787 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.07 -4.14 16.3 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.716 -0.954 . . . . 10.0 110.716 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -134.17 -38.44 0.86 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -135.71 143.64 45.5 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.717 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mt -105.22 121.45 57.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -113.16 127.67 56.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.443 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -145.87 167.27 23.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.769 0.318 . . . . 10.0 110.608 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' ' 33' ' ' ARG . 6.2 ttt180 -126.46 129.93 49.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.106 -0.497 . . . . 10.0 109.742 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -119.48 162.99 17.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.224 0.535 . . . . 10.0 111.629 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.8 133.81 50.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.081 -0.963 . . . . 10.0 109.269 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 41.9 mt -112.5 140.01 47.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.815 0.341 . . . . 10.0 110.915 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.2 -7.49 45.07 Favored Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 115.829 -0.623 . . . . 10.0 112.839 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.07 8.89 59.18 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.916 -0.659 . . . . 10.0 111.975 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.1 47.93 16.98 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.913 -0.661 . . . . 10.0 112.372 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -163.02 99.28 1.04 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.552 0.215 . . . . 10.0 111.117 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.04 165.55 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.531 2.154 . . . . 10.0 110.874 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.76 -171.68 29.27 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 119.809 -1.186 . . . . 10.0 113.303 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 1.5 m-85 -124.49 158.42 32.91 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.813 -0.44 . . . . 10.0 109.813 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.69 132.7 6.16 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.627 -0.796 . . . . 10.0 111.584 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.27 125.82 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.254 0.55 . . . . 10.0 110.443 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 t -121.08 136.85 56.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.047 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 28.1 t -83.9 130.72 34.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.933 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.557 ' OE1' ' HD2' ' B' ' 25' ' ' ARG . 5.1 tt0 -93.97 4.44 53.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.338 0.589 . . . . 10.0 109.732 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -98.7 -46.09 5.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.793 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.03 79.85 1.89 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.23 0.538 . . . . 10.0 111.712 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.54 156.22 10.36 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.151 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.33 128.01 25.96 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.618 2.212 . . . . 10.0 112.55 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -63.42 -27.13 69.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.966 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' B' ' 58' ' ' LYS . 0.1 OUTLIER -57.88 -33.17 68.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.492 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.2 -38.18 19.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.252 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 61.9 mt -61.88 -47.08 86.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 10.0 111.142 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -76.83 -5.91 50.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.799 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' B' ' 54' ' ' GLU . 4.0 tttt -92.23 -22.92 19.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 10.0 110.369 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 29.3 mt -82.62 -54.56 5.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.736 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' GLU . . . . . 0.425 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 31.6 tt0 -92.15 94.16 9.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.103 0.478 . . . . 10.0 110.044 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -86.41 166.67 15.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.69 -0.686 . . . . 10.0 109.827 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -63.57 132.02 49.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.78 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.6 mttt 61.32 49.6 5.28 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.187 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.601 -0.714 . . . . 10.0 110.495 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 120.554 0.216 . . . . 10.0 110.735 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.7 mt -90.39 146.21 24.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.33 -0.396 . . . . 10.0 110.52 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -123.04 145.25 48.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.431 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.01 142.38 38.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.481 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.13 120.64 20.91 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.131 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 139' ' ' ALA . 50.7 mt -79.74 -32.99 41.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.366 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -144.45 164.28 31.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.734 -0.667 . . . . 10.0 109.748 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.02 152.34 38.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.407 -0.59 . . . . 10.0 109.407 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -119.29 128.92 54.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.896 0.379 . . . . 10.0 111.026 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.79 92.59 6.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.09 -0.505 . . . . 10.0 109.67 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.91 162.8 29.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.56 . . . . 10.0 111.499 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -126.11 -45.64 1.7 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.023 -0.535 . . . . 10.0 110.728 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.23 -177.82 3.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.864 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -87.47 -11.21 49.65 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.891 0.33 . . . . 10.0 111.891 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.96 -39.04 31.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.993 0.425 . . . . 10.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.13 124.0 29.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.117 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.2 tp -77.85 135.13 37.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.996 -0.547 . . . . 10.0 112.204 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.33 120.81 35.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.711 . . . . 10.0 109.897 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -136.55 166.23 24.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.852 0.358 . . . . 10.0 111.29 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -109.78 168.32 9.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.839 -0.619 . . . . 10.0 111.391 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -65.27 134.3 53.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.389 -0.823 . . . . 10.0 111.357 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.41 2.95 88.89 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.118 -0.563 . . . . 10.0 113.725 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -81.41 151.26 28.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.073 0.436 . . . . 10.0 110.968 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -116.43 143.66 45.29 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.06 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.38 158.72 43.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 10.0 110.861 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -97.68 113.99 25.87 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.55 116.77 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.148 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.6 mt -83.96 -63.33 1.37 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.906 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -117.73 98.27 6.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.179 0.514 . . . . 10.0 111.403 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.41 -17.1 35.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.683 -0.689 . . . . 10.0 110.386 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.59 14.36 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.765 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -70.07 -44.39 69.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.314 0.578 . . . . 10.0 110.324 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 153.3 -113.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.452 -0.794 . . . . 10.0 111.185 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.16 -45.68 6.44 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.435 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 29.4 m95 -92.4 110.68 22.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -96.52 150.25 20.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.843 0.354 . . . . 10.0 111.052 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -95.07 123.8 38.75 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.455 -0.943 . . . . 10.0 108.455 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.5 163.99 27.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.958 0.409 . . . . 10.0 111.345 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -114.58 128.4 56.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.834 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.1 t -68.88 147.7 51.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.919 0.39 . . . . 10.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.0 mt -94.52 -3.14 50.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.496 -0.557 . . . . 10.0 109.496 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 m -95.06 -66.36 0.92 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.363 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.0 p -90.18 -20.91 22.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 10.0 111.461 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.94 13.49 79.34 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.783 -0.723 . . . . 10.0 111.895 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.48 153.43 37.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 10.0 110.898 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.9 m -117.6 135.75 53.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.176 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -179.47 176.79 47.95 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.433 -0.889 . . . . 10.0 112.221 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -84.29 138.95 32.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.307 -0.257 . . . . 10.0 110.307 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.2 pt -126.41 139.98 36.04 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.019 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.589 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 37.3 Cg_endo -68.83 121.57 8.46 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.343 2.029 . . . . 10.0 111.415 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 p -66.46 -12.82 59.24 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.551 0.574 . . . . 10.0 112.551 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.589 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 35.4 p-10 -87.58 -8.31 56.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.859 0.361 . . . . 10.0 110.986 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -100.32 -17.66 17.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.021 0.439 . . . . 10.0 110.677 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 22.5 m -115.83 154.05 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.61 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 90' ' ' LEU . . . -137.82 145.24 47.59 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.407 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.46 124.76 12.88 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.219 1.946 . . . . 10.0 111.332 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.052 -0.975 . . . . 10.0 110.293 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 111.239 0.088 . . . . 10.0 111.239 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' ALA . . . . . 0.431 ' O ' HG22 ' B' ' 17' ' ' ILE . . . -169.66 169.67 8.46 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.683 0.278 . . . . 10.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 2.2 m -107.6 140.2 40.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.699 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 54.6 t -115.05 136.52 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.56 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -105.09 128.4 53.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.093 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -137.71 177.31 7.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.544 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -125.38 89.0 2.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.771 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -78.37 110.72 13.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.084 -0.507 . . . . 10.0 109.866 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm 58.28 24.21 11.28 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.027 0.441 . . . . 10.0 111.017 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.29 -14.7 59.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.821 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.51 127.44 34.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.857 0.361 . . . . 10.0 110.804 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.07 120.72 22.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.3 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -137.61 149.79 46.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.255 -0.429 . . . . 10.0 110.382 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -126.85 115.51 19.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.547 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 64.1 t -125.88 143.8 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.15 -0.477 . . . . 10.0 109.847 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 56.6 m-20 -64.42 135.04 55.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 10.0 110.076 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.431 HG22 ' O ' ' B' ' 2' ' ' ALA . 15.8 tt -59.94 -26.23 35.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.614 -0.721 . . . . 10.0 111.398 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -10.8 60.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.079 -0.509 . . . . 10.0 111.345 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -100.94 12.6 37.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.132 0.491 . . . . 10.0 110.337 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -99.6 132.22 45.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.049 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.98 -64.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.93 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -137.0 155.87 49.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.326 -0.397 . . . . 10.0 110.723 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' B' ' 59' ' ' LEU . 22.5 t -127.05 142.86 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.923 -0.581 . . . . 10.0 109.644 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 9.3 m -137.81 118.87 14.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.036 0.445 . . . . 10.0 111.577 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.462 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 57.4 ttp85 -111.59 116.12 30.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.11 0.481 . . . . 10.0 110.687 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -84.66 -21.3 30.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.331 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.82 12.63 15.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.556 -0.83 . . . . 10.0 111.497 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -138.56 -51.97 0.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.761 -0.829 . . . . 10.0 108.761 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -136.57 143.28 43.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.783 -1.099 . . . . 10.0 108.85 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 27.8 mt -97.32 122.35 48.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.654 -0.498 . . . . 10.0 109.654 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -113.26 136.78 52.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.521 -0.309 . . . . 10.0 110.508 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -148.28 169.41 20.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.782 0.325 . . . . 10.0 110.646 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -126.81 131.24 51.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.037 -0.528 . . . . 10.0 109.847 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -125.55 165.53 18.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.031 0.443 . . . . 10.0 111.375 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -134.63 122.02 21.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.678 -0.692 . . . . 10.0 110.218 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -90.27 147.48 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 10.0 111.59 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.49 -12.89 70.5 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.933 -0.576 . . . . 10.0 112.549 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.38 13.94 43.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.906 -0.664 . . . . 10.0 112.555 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.31 54.94 7.29 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.702 -0.761 . . . . 10.0 111.966 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -157.59 95.28 2.06 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.648 0.261 . . . . 10.0 110.813 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.72 143.06 18.43 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.346 2.031 . . . . 10.0 110.792 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.93 -173.46 18.92 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.84 -1.172 . . . . 10.0 113.136 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 7.2 m-85 -128.46 161.11 30.26 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.85 143.74 12.98 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.346 -0.931 . . . . 10.0 112.208 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 2.4 p -131.3 130.37 63.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.995 0.426 . . . . 10.0 110.004 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 26.4 t -122.57 133.95 67.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.848 -0.614 . . . . 10.0 110.134 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.39 136.67 53.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.047 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -87.86 -19.3 27.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.002 0.429 . . . . 10.0 110.946 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -108.35 -36.72 6.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.524 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -96.88 52.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.904 -0.589 . . . . 10.0 111.002 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -169.21 151.92 4.84 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.305 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.29 140.57 59.09 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.485 2.123 . . . . 10.0 111.803 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -60.96 -21.03 63.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.309 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -54.67 -46.15 73.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.252 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.28 -35.41 48.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.782 0.325 . . . . 10.0 110.743 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 30.8 mt -61.55 -43.47 98.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.001 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -74.33 -7.3 52.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.546 . . . . 10.0 111.949 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -91.97 -33.92 14.66 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.842 -0.429 . . . . 10.0 109.842 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.464 ' HB3' HG11 ' B' ' 23' ' ' VAL . 89.5 mt -82.26 -36.9 26.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.943 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' GLU . . . . . 0.462 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 8.8 tp10 -79.73 94.73 5.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.267 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -105.58 142.79 34.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.182 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -67.47 127.1 31.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 mttt 64.77 65.01 0.63 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.935 0.772 . . . . 10.0 109.845 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' B' ' 23' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.606 -0.724 . . . . 10.0 110.586 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 120.568 0.223 . . . . 10.0 110.774 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.0 mt -93.66 148.13 22.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.021 -0.363 . . . . 10.0 110.021 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -120.59 134.19 55.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.711 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.45 140.29 34.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.026 -0.533 . . . . 10.0 109.95 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 138' ' ' VAL . . . -71.22 124.77 25.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.191 -0.458 . . . . 10.0 111.633 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.6 mt -80.75 -34.12 34.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.172 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -140.71 164.08 31.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.533 -0.758 . . . . 10.0 110.008 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.79 147.41 39.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.829 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -129.48 137.73 51.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 10.0 111.243 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -98.31 130.98 44.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.946 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.411 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . . . -84.54 139.78 31.89 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.22 -0.289 . . . . 10.0 110.22 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -107.89 -28.32 9.69 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.848 -0.341 . . . . 10.0 111.444 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.3 p -132.25 -161.47 1.14 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.993 0.425 . . . . 10.0 110.878 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -102.31 8.72 40.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.482 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.55 -38.83 7.36 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.497 -0.557 . . . . 10.0 109.497 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 95' ' ' ALA . 16.3 p-10 -89.87 149.46 22.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.748 -0.834 . . . . 10.0 108.748 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.4 tp -117.1 134.4 54.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.089 0.471 . . . . 10.0 111.964 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.67 151.38 26.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.831 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -159.57 170.57 21.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.363 -0.38 . . . . 10.0 110.314 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.428 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 59.2 m-70 -113.4 165.28 12.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.252 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -62.32 121.05 12.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.406 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.37 -4.34 33.14 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.958 -0.639 . . . . 10.0 112.122 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 104' ' ' HIS . 3.7 tp10 -66.86 129.32 39.49 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 122.287 0.235 . . . . 10.0 111.225 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -94.19 124.47 38.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -118.72 138.04 52.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.228 0.537 . . . . 10.0 112.088 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -100.52 105.67 17.12 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.388 -0.967 . . . . 10.0 108.388 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.8 mm -65.87 119.31 10.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.057 -0.519 . . . . 10.0 110.848 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -96.29 -38.78 9.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.435 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 121' ' ' GLU . 18.3 t30 -137.23 101.62 4.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.194 0.521 . . . . 10.0 110.255 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.63 -13.44 16.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.17 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.69 3.01 27.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.993 -0.548 . . . . 10.0 111.802 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -65.94 -48.12 72.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 10.0 110.581 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.43 -124.47 1.27 Allowed Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.826 -0.702 . . . . 10.0 111.813 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -76.68 -58.08 3.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.055 -0.35 . . . . 10.0 110.055 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.406 ' NE1' ' HB3' ' B' ' 31' ' ' PHE . 29.4 m95 -78.72 137.92 38.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -112.94 150.24 32.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.13 0.49 . . . . 10.0 111.901 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 113' ' ' ASN . 5.3 mt-10 -89.96 112.61 24.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.496 -0.927 . . . . 10.0 108.496 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.69 154.91 44.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.234 0.54 . . . . 10.0 111.908 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 123' ' ' ARG . 36.2 ttt-85 -109.15 132.54 54.02 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.442 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 t -73.78 131.64 41.77 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.725 -0.472 . . . . 10.0 109.725 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.12 -10.75 57.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.208 0.528 . . . . 10.0 110.067 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -62.71 1.41 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.444 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.9 p -89.08 -31.26 18.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.743 0.306 . . . . 10.0 111.796 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.8 -3.0 58.69 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.635 -0.793 . . . . 10.0 112.439 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -69.19 153.55 43.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.74 0.305 . . . . 10.0 111.195 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.4 m -127.37 134.88 49.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.982 -0.554 . . . . 10.0 110.957 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.14 -176.37 44.29 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.851 -0.69 . . . . 10.0 111.945 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.502 ' CE1' ' HG3' ' A' ' 121' ' ' GLU . 41.3 m-85 -83.92 131.32 34.86 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.7 pt -122.55 141.39 34.89 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.041 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.18 111.05 1.32 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.495 2.13 . . . . 10.0 111.428 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.84 -18.86 63.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.693 -0.685 . . . . 10.0 112.232 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -83.07 -13.96 54.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.455 -0.339 . . . . 10.0 111.246 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.91 0.03 43.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.575 -0.284 . . . . 10.0 111.328 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 89' ' ' ALA . 15.7 m -123.33 161.23 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.823 0.344 . . . . 10.0 110.932 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -141.48 146.36 41.68 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.441 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 15.1 Cg_exo -67.35 135.61 37.29 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.478 2.119 . . . . 10.0 111.599 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.524 -0.751 . . . . 10.0 110.439 -179.74 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ttt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.41 0.148 . . . . 10.0 110.942 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.11 152.59 24.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.866 0.365 . . . . 10.0 111.447 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.66 133.56 36.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.371 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 t -110.74 135.41 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.734 0.302 . . . . 10.0 110.729 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -102.87 126.3 49.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.057 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -128.86 166.43 19.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.502 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.427 ' HG2' ' HG2' ' B' ' 12' ' ' GLU . 88.9 mttt -106.66 89.08 2.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.149 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -75.73 86.38 2.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.419 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm 54.85 35.36 24.11 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.3 -0.864 . . . . 10.0 111.294 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.48 -29.7 8.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.855 -0.688 . . . . 10.0 112.897 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -87.42 117.22 26.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.757 0.313 . . . . 10.0 111.121 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' B' ' 7' ' ' LYS . 34.8 mt-10 -83.51 114.34 21.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.998 0.428 . . . . 10.0 109.973 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -125.5 149.31 48.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.166 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -115.58 107.77 15.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.361 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.36 144.13 28.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.206 -0.452 . . . . 10.0 109.915 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.23 139.19 58.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.624 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.4 tt -63.29 -24.04 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.314 0.578 . . . . 10.0 110.732 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -16.01 62.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.932 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -98.93 15.93 24.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.34 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 72.9 mt -103.74 133.77 46.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.942 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.92 -71.62 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.472 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -128.94 147.0 50.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.709 -0.223 . . . . 10.0 110.844 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 27.9 t -125.53 127.69 71.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.1 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 63.1 m -129.8 118.21 21.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.081 0.467 . . . . 10.0 111.913 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 15.8 ttp85 -99.87 148.25 24.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.924 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -122.29 -25.47 4.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.965 0.357 . . . . 10.0 111.965 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.29 18.37 8.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.225 -0.988 . . . . 10.0 110.935 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -148.12 -50.65 0.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -148.7 134.0 18.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.854 -1.067 . . . . 10.0 109.647 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.4 mt -91.69 129.92 41.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.138 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.406 ' HB3' ' NE1' ' A' ' 119' ' ' TRP . 16.9 m-85 -115.61 135.27 54.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.481 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -150.15 171.08 17.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.673 0.273 . . . . 10.0 110.852 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -121.05 132.9 55.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.239 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -119.17 161.33 20.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.222 0.534 . . . . 10.0 111.455 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -133.09 128.79 36.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.542 -0.754 . . . . 10.0 109.751 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt -113.24 122.16 46.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.751 0.31 . . . . 10.0 110.613 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.2 -15.16 21.42 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.716 -0.675 . . . . 10.0 113.185 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.54 -14.48 67.11 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.286 -0.483 . . . . 10.0 112.437 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.55 40.84 2.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 10.0 113.009 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -159.93 89.9 1.85 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.066 0.46 . . . . 10.0 111.458 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -86.05 160.26 10.14 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.575 2.183 . . . . 10.0 110.836 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.94 -156.43 13.52 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.016 -1.088 . . . . 10.0 112.446 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -124.3 171.36 9.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.225 -0.287 . . . . 10.0 110.225 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.68 141.1 8.73 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.802 -0.713 . . . . 10.0 111.7 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.16 132.71 68.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.279 0.561 . . . . 10.0 111.015 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 71.0 t -128.14 126.09 65.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.476 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' B' ' 51' ' ' ALA . 28.7 t -68.84 146.96 52.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.93 7.37 43.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.104 0.478 . . . . 10.0 110.35 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -114.32 -50.86 2.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.936 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -101.49 31.71 3.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.828 0.347 . . . . 10.0 111.919 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -133.35 149.32 72.12 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.768 -0.196 . . . . 10.0 110.56 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 16.9 Cg_exo -66.47 142.56 65.84 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.784 2.323 . . . . 10.0 112.654 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -65.86 -24.36 66.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.771 -0.649 . . . . 10.0 110.31 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -56.69 -30.7 63.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.544 -0.753 . . . . 10.0 110.987 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.66 -37.25 11.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.387 . . . . 10.0 110.392 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 66.0 mt -63.64 -37.87 88.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 10.0 111.436 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -70.89 -16.32 62.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 10.0 111.242 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -86.33 -37.17 18.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 10.0 110.275 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.51 -41.13 80.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.931 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -85.62 100.16 11.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.156 0.503 . . . . 10.0 110.357 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -109.67 157.36 19.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.659 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -69.51 136.19 51.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.65 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 67.04 48.86 1.18 Allowed 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.758 0.662 . . . . 10.0 110.021 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.656 -0.688 . . . . 10.0 110.568 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.1 mt -109.59 145.32 36.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.961 0.41 . . . . 10.0 110.098 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -117.99 137.15 53.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.527 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.97 138.69 31.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.909 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.06 117.67 11.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.542 . . . . 10.0 110.932 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.36 -49.31 67.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.076 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -138.04 170.3 16.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.554 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.72 133.93 47.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.626 -0.509 . . . . 10.0 109.626 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.487 ' CE1' HG21 ' B' ' 24' ' ' THR . 32.6 t80 -110.84 120.99 44.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.009 0.433 . . . . 10.0 111.337 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -89.12 120.48 30.55 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.69 155.62 31.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.054 0.454 . . . . 10.0 111.181 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.514 HH21 ' HA ' ' B' ' 64' ' ' LYS . 6.5 ttm180 -110.32 -41.44 4.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.449 -0.796 . . . . 10.0 110.119 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.75 -160.86 0.86 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.072 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.5 -3.29 31.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.094 0.473 . . . . 10.0 110.145 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.58 -44.02 13.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.384 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.58 129.74 34.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.419 -0.81 . . . . 10.0 109.587 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.8 tp -80.68 125.26 29.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.672 -0.694 . . . . 10.0 111.947 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.46 131.49 34.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.402 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -147.26 167.61 23.81 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.983 0.42 . . . . 10.0 111.541 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -106.25 164.01 12.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.849 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.01 132.88 51.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.359 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.82 -5.23 66.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.629 -0.796 . . . . 10.0 113.962 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -78.32 155.04 30.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.07 0.435 . . . . 10.0 111.192 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -122.54 141.68 51.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.898 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.75 155.42 50.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.786 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -99.19 120.5 39.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.8 -0.636 . . . . 10.0 109.621 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.47 120.33 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.053 -0.522 . . . . 10.0 110.889 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.7 mt -93.53 -46.61 7.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.691 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -135.19 103.71 5.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.172 0.51 . . . . 10.0 111.05 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.92 -11.81 27.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.78 -0.645 . . . . 10.0 110.859 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.07 0.16 54.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.398 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.1 -32.9 74.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.218 0.532 . . . . 10.0 110.5 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 144.99 -110.03 0.54 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.913 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.09 -50.86 3.53 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.09 -0.337 . . . . 10.0 110.09 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.472 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 54.2 m95 -82.81 107.11 15.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.751 -1.203 . . . . 10.0 107.751 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -89.18 146.02 25.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.151 0.5 . . . . 10.0 111.553 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -86.69 115.91 24.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.83 154.94 41.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.112 0.482 . . . . 10.0 111.474 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.6 ttp85 -109.6 125.37 52.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.657 -0.701 . . . . 10.0 109.487 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.2 t -61.6 131.06 48.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.577 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.35 -6.22 58.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.832 -0.622 . . . . 10.0 109.783 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.26 -63.02 1.49 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.523 -0.762 . . . . 10.0 109.954 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.7 p -104.24 -61.14 1.48 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.691 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 149.83 -7.98 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.919 -0.582 . . . . 10.0 111.826 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.06 134.36 21.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.088 0.47 . . . . 10.0 111.879 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -116.69 132.45 56.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.306 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.24 -178.25 43.08 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.275 -0.964 . . . . 10.0 112.629 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -78.71 126.44 30.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.17 -0.307 . . . . 10.0 110.17 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.4 pt -112.84 135.69 21.63 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 10.0 111.127 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.454 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 34.8 Cg_endo -69.25 116.57 4.57 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.558 2.172 . . . . 10.0 111.518 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -14.36 60.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.695 -0.684 . . . . 10.0 112.35 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.513 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 38.4 p-10 -89.45 -3.34 58.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.452 -0.34 . . . . 10.0 111.032 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.448 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 11.2 m-85 -113.4 6.48 17.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.704 0.288 . . . . 10.0 111.223 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.5 m -129.64 150.58 34.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.937 0.399 . . . . 10.0 111.196 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.88 145.4 57.3 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.183 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.47 124.72 13.26 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.489 2.126 . . . . 10.0 111.82 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.403 -0.808 . . . . 10.0 110.158 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.638 0.256 . . . . 10.0 110.533 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.27 157.8 23.41 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.9 0.381 . . . . 10.0 110.922 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.9 m -96.74 131.35 43.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.684 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -103.38 138.32 28.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.07 0.462 . . . . 10.0 111.158 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -99.74 127.77 45.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.633 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -135.54 175.96 9.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.846 0.355 . . . . 10.0 111.002 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -120.97 106.48 11.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.571 . . . . 10.0 109.801 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -94.11 95.59 9.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.678 -0.489 . . . . 10.0 109.678 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 59.64 34.65 22.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.773 -0.649 . . . . 10.0 111.053 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.29 -24.82 29.83 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.808 -0.633 . . . . 10.0 112.49 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.96 111.32 18.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.75 0.31 . . . . 10.0 110.914 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -76.35 121.17 22.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.416 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -135.55 162.27 33.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.485 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -126.4 121.95 33.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.561 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 82.1 t -131.94 142.66 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 110.148 -0.315 . . . . 10.0 110.148 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 23.6 m-20 -70.1 141.79 52.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.898 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 tt -61.98 -26.2 39.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.961 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -17.93 64.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.094 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -99.87 3.16 44.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.681 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 65.1 mt -91.91 128.84 43.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.123 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 t -75.09 -63.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.097 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -138.6 152.51 48.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.471 -0.331 . . . . 10.0 110.86 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' B' ' 59' ' ' LEU . 18.8 t -131.33 138.49 53.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.3 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' THR . . . . . 0.487 HG21 ' CE1' ' A' ' 93' ' ' TYR . 8.7 m -143.09 125.6 15.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.201 0.524 . . . . 10.0 111.25 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.499 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 40.9 ttp85 -105.39 155.64 18.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.939 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -121.77 -34.95 3.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.702 0.287 . . . . 10.0 111.742 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.85 27.23 1.95 Allowed Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 110.241 -1.144 . . . . 10.0 110.241 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -152.64 -57.82 0.14 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.161 -1.052 . . . . 10.0 108.161 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' B' ' 47' ' ' SER . 42.0 mt-30 -142.93 142.05 31.61 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.667 -1.151 . . . . 10.0 109.569 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -95.46 130.11 44.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 24.8 m-85 -114.23 139.58 49.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.546 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' PHE . . . . . 0.417 ' N ' ' HE1' ' A' ' 119' ' ' TRP . 42.8 p90 -152.0 160.85 43.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 10.0 111.149 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -123.13 132.92 54.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.362 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -126.12 167.43 15.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.945 0.402 . . . . 10.0 111.491 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -137.66 129.37 28.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.359 -0.837 . . . . 10.0 109.437 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 96.8 mt -101.44 143.85 30.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 10.0 111.077 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.51 -3.21 53.3 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.904 -0.589 . . . . 10.0 112.59 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.92 -8.57 87.55 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.933 -0.651 . . . . 10.0 112.068 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.72 42.5 3.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.265 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -163.77 114.7 0.99 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.711 0.291 . . . . 10.0 110.905 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.06 169.47 8.8 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.737 2.291 . . . . 10.0 111.311 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.51 -177.63 37.3 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.003 -1.094 . . . . 10.0 112.965 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 43.5 m-85 -132.23 164.5 26.23 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.87 150.43 22.09 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.488 -0.863 . . . . 10.0 112.183 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.52 139.2 28.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.101 0.477 . . . . 10.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.22 133.69 55.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.77 -0.65 . . . . 10.0 109.73 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.416 ' HA ' ' HG2' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -80.77 134.21 35.77 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.838 0.351 . . . . 10.0 110.516 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -77.7 41.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.769 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.27 -62.26 0.54 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.509 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -29.53 61.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.864 -0.607 . . . . 10.0 112.033 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -88.31 136.16 32.07 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.474 -0.33 . . . . 10.0 111.314 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 52.9 Cg_exo -56.75 144.17 87.83 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.832 2.355 . . . . 10.0 112.197 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -61.64 -26.04 67.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 10.0 112.074 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -33.57 71.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 10.0 110.064 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 mt -80.96 -39.57 25.82 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.185 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -64.05 -38.64 91.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.62 -0.718 . . . . 10.0 110.962 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -71.93 -15.07 62.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 10.0 111.032 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -81.82 -24.27 35.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.316 0.579 . . . . 10.0 109.47 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.479 ' HB3' HG11 ' B' ' 23' ' ' VAL . 64.0 mt -89.07 -52.5 5.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.33 -0.85 . . . . 10.0 111.352 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' GLU . . . . . 0.499 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 28.9 tt0 -86.38 106.08 17.17 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.337 0.589 . . . . 10.0 110.228 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -107.25 164.38 12.22 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.333 -0.849 . . . . 10.0 109.21 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -59.2 128.99 39.93 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.181 0.301 . . . . 10.0 110.906 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 66.95 75.88 0.3 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.372 -0.831 . . . . 10.0 110.676 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.514 ' HA ' HH21 ' A' ' 96' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.496 -0.764 . . . . 10.0 110.284 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 121.215 0.531 . . . . 10.0 110.809 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.0 mt -104.13 136.88 42.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.108 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.22 137.04 54.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.935 0.397 . . . . 10.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.16 140.78 31.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.353 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 119.91 17.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.026 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.462 ' O ' ' HE2' ' A' ' 105' ' ' LYS . 71.2 mt -72.0 -36.77 69.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.405 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -141.63 169.92 16.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.789 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.33 149.29 40.68 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -124.08 124.73 43.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.107 0.48 . . . . 10.0 111.985 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.43 98.12 9.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.308 -0.86 . . . . 10.0 109.097 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.49 155.51 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.608 -0.724 . . . . 10.0 112.191 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -114.4 -32.8 5.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.306 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.26 -166.52 1.66 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.272 -0.171 . . . . 10.0 110.844 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.4 -1.21 51.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 10.0 109.908 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.57 -42.45 16.76 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.065 -0.717 . . . . 10.0 109.065 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -91.82 138.41 31.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.946 -1.025 . . . . 10.0 109.894 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.1 tp -100.64 133.16 45.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.914 -0.585 . . . . 10.0 111.633 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.22 147.13 27.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.539 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -152.72 162.66 40.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.646 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -101.47 163.86 12.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.735 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 90' ' ' LEU . 57.7 tttm -60.97 118.71 7.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.767 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.92 -0.25 31.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.678 -0.773 . . . . 10.0 112.641 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 2.3 tp10 -68.4 141.31 55.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.584 0.23 . . . . 10.0 110.74 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -120.67 134.8 55.26 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 107' ' ' GLU . 0.5 OUTLIER -128.29 157.57 40.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.317 0.579 . . . . 10.0 111.919 -178.308 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -99.88 110.16 22.52 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.935 -1.135 . . . . 10.0 107.935 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.6 mm -64.35 116.64 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.299 -0.409 . . . . 10.0 111.651 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.6 mt -104.12 -57.7 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.563 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -117.65 112.9 21.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.355 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.58 -17.59 3.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.21 0.448 . . . . 10.0 112.21 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.2 m -83.14 -6.26 59.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.032 0.382 . . . . 10.0 112.032 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.11 -53.29 39.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 10.0 110.55 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.421 ' HA3' ' CD1' ' B' ' 43' ' ' PHE . . . -167.17 -159.14 12.25 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.451 -0.66 . . . . 10.0 111.451 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.69 -34.56 74.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.929 0.395 . . . . 10.0 110.689 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -86.07 112.69 21.5 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.781 -0.822 . . . . 10.0 108.781 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -91.17 145.7 24.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.927 -0.578 . . . . 10.0 111.471 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -108.66 115.85 30.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.075 -1.083 . . . . 10.0 108.075 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.1 164.64 26.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.064 0.459 . . . . 10.0 111.903 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.95 127.77 51.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.778 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.7 t -65.72 135.11 54.52 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.311 -0.404 . . . . 10.0 109.919 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.4 mt -82.3 -15.46 52.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.183 0.516 . . . . 10.0 109.806 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.8 m -79.85 -67.94 0.72 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.476 -0.784 . . . . 10.0 111.556 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 p -92.21 -34.68 14.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.151 0.426 . . . . 10.0 112.151 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.3 -4.97 35.45 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.628 -0.796 . . . . 10.0 112.071 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -63.75 141.61 58.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.681 0.277 . . . . 10.0 110.695 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.7 m -117.75 133.13 56.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.859 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -172.86 -178.57 42.99 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.799 -0.715 . . . . 10.0 112.093 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -78.66 131.39 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 10.0 110.498 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.0 pt -123.06 136.71 27.21 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.513 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 137' ' ' TYR . 26.4 Cg_endo -64.66 117.44 4.51 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.46 2.107 . . . . 10.0 111.563 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.72 -19.41 65.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 10.0 112.363 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.424 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 36.0 p-10 -87.05 0.46 55.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.405 -0.361 . . . . 10.0 111.338 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 13.2 m-85 -116.28 -0.08 12.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.697 0.284 . . . . 10.0 111.223 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.35 151.94 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.906 0.384 . . . . 10.0 111.451 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.45 150.17 62.86 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.266 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.14 142.63 97.45 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.686 2.257 . . . . 10.0 112.348 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.459 -0.782 . . . . 10.0 110.809 -179.667 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 20.3 ttt . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.571 0.224 . . . . 10.0 110.667 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.6 161.09 26.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.733 0.302 . . . . 10.0 110.952 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 7.1 m -100.73 133.28 45.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.388 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 21.0 t -115.42 138.8 44.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.002 0.43 . . . . 10.0 111.488 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -96.5 135.01 38.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.853 -0.612 . . . . 10.0 109.678 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.85 -179.51 6.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.816 0.341 . . . . 10.0 110.703 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.442 ' HE2' ' OE2' ' B' ' 12' ' ' GLU . 66.9 mttt -117.53 141.79 47.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.147 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -146.85 110.82 5.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.595 -0.275 . . . . 10.0 110.716 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm 67.5 1.89 2.71 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.937 0.773 . . . . 10.0 111.969 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.77 -52.57 0.82 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.668 -0.777 . . . . 10.0 112.096 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.49 145.35 47.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.866 0.365 . . . . 10.0 110.323 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.442 ' OE2' ' HE2' ' B' ' 7' ' ' LYS . 21.7 mt-10 -90.92 122.46 33.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.811 -0.631 . . . . 10.0 109.866 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -116.33 157.34 25.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.641 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -128.45 118.21 22.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.319 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 46.8 t -134.56 149.38 29.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.487 -0.56 . . . . 10.0 109.487 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 18.8 m-20 -68.26 138.38 55.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.715 0.293 . . . . 10.0 110.518 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 tt -62.54 -24.54 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 2.4 m -72.46 -9.2 58.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.082 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -106.6 11.8 30.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.338 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' B' ' 34' ' ' TYR . 67.6 mt -99.48 137.43 26.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 10.0 109.996 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 6.8 t -77.92 -74.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.777 0.322 . . . . 10.0 111.059 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -126.97 155.17 43.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.423 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.26 125.4 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.34 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -120.05 118.41 30.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.14 0.495 . . . . 10.0 111.464 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 40.5 ttp85 -104.81 144.17 32.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.142 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -115.36 -26.52 7.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.611 0.243 . . . . 10.0 111.131 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.71 14.57 8.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.401 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -145.24 -52.79 0.28 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.818 -0.808 . . . . 10.0 108.818 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -142.47 135.39 28.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.814 -1.085 . . . . 10.0 109.519 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 61.3 mt -93.02 133.52 33.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.212 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 53.3 m-85 -119.89 137.94 53.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.47 174.31 13.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.087 0.47 . . . . 10.0 111.383 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -126.95 126.45 43.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.315 -0.857 . . . . 10.0 109.399 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' B' ' 20' ' ' ILE . 53.9 p90 -116.12 159.03 22.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 10.0 111.223 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -126.26 115.83 20.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.434 -0.803 . . . . 10.0 109.775 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.41 137.41 32.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.005 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.36 -13.54 58.36 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.912 -0.586 . . . . 10.0 112.807 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.03 2.65 83.39 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.179 -0.534 . . . . 10.0 112.368 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.49 46.02 5.35 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.917 -0.659 . . . . 10.0 112.873 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -152.62 95.3 3.09 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.713 0.292 . . . . 10.0 111.211 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.49 150.88 25.33 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.931 2.421 . . . . 10.0 110.9 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.16 -170.9 22.59 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.044 -1.074 . . . . 10.0 112.885 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' PHE . . . . . 0.421 ' CD1' ' HA3' ' A' ' 117' ' ' GLY . 24.4 m-85 -126.6 165.8 18.5 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.56 -0.533 . . . . 10.0 109.56 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.45 149.48 20.08 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.251 -0.976 . . . . 10.0 112.553 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.1 p -125.53 138.1 55.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.092 0.473 . . . . 10.0 110.85 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 74.7 t -125.76 118.85 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.002 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 118.74 15.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.572 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.73 -7.93 43.6 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.648 0.61 . . . . 10.0 112.648 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -103.75 -24.18 13.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.84 0.311 . . . . 10.0 111.84 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.38 -42.37 6.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.361 0.504 . . . . 10.0 112.361 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.96 146.81 87.97 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.686 -0.233 . . . . 10.0 111.547 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.63 147.42 91.94 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.693 2.262 . . . . 10.0 111.467 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -60.61 -24.77 65.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -59.11 -44.16 91.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.872 0.368 . . . . 10.0 110.641 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 79.1 mt -72.45 -35.79 68.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.431 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.49 -42.0 92.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.745 -0.661 . . . . 10.0 111.487 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -78.05 -16.92 57.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 10.0 110.909 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -79.46 -45.92 18.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.551 -0.537 . . . . 10.0 109.551 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.79 -47.78 61.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.593 -0.73 . . . . 10.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -82.62 98.74 9.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.007 0.432 . . . . 10.0 110.453 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -96.22 144.2 26.63 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.844 -0.616 . . . . 10.0 109.919 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -61.89 130.88 47.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.968 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 67.58 97.38 0.06 Allowed 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.981 0.8 . . . . 10.0 111.23 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.637 -0.697 . . . . 10.0 110.302 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.632 0.253 . . . . 10.0 110.985 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.7 mt -108.49 140.23 42.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.559 -0.291 . . . . 10.0 110.361 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -112.33 130.05 56.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.209 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -109.1 140.38 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.234 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.26 121.36 19.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.84 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.6 -32.67 62.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.338 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.8 168.15 24.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.483 -0.781 . . . . 10.0 109.502 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.77 139.58 40.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.744 -0.465 . . . . 10.0 109.744 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -101.84 128.56 48.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.834 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -77.84 101.37 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.681 -0.69 . . . . 10.0 109.353 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.28 141.37 19.35 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.633 0.583 . . . . 10.0 111.661 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -106.93 -58.5 1.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.661 -0.7 . . . . 10.0 111.03 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 p -131.83 -165.86 1.64 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.958 -0.565 . . . . 10.0 110.346 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -89.32 -6.73 56.47 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.13 -0.693 . . . . 10.0 109.13 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -76.42 -45.14 32.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.045 -0.98 . . . . 10.0 110.006 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -82.5 152.86 25.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.466 -0.788 . . . . 10.0 110.149 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.406 HD11 ' HB2' ' A' ' 129' ' ' GLU . 22.8 tp -89.82 132.2 35.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.345 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 m -91.15 126.16 36.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.751 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -146.83 165.49 29.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.828 0.346 . . . . 10.0 111.218 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -118.33 166.51 12.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.166 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.2 tttm -66.52 132.25 47.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.942 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.56 -6.16 52.3 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.835 -0.698 . . . . 10.0 112.71 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -81.54 150.35 28.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 10.0 111.415 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -113.16 128.24 56.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.745 -0.662 . . . . 10.0 109.225 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -120.25 144.47 47.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.9 0.381 . . . . 10.0 111.216 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -99.08 110.66 23.22 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 16.9 mm -66.22 118.63 9.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.334 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.13 -37.72 18.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.083 -0.508 . . . . 10.0 109.896 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -153.57 112.37 3.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.968 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.47 2.59 47.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.274 0.559 . . . . 10.0 110.656 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.91 20.07 1.94 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.794 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.61 -42.89 17.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.274 0.559 . . . . 10.0 110.159 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 138.5 -70.79 0.46 Allowed Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.702 -0.681 . . . . 10.0 111.82 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -122.76 -69.0 0.85 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.709 -0.478 . . . . 10.0 109.709 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.499 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 40.0 m95 -78.35 100.84 6.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.444 -0.947 . . . . 10.0 108.444 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -88.34 156.26 19.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.057 -0.52 . . . . 10.0 111.941 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -84.56 122.9 29.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.404 -0.817 . . . . 10.0 109.028 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.25 153.13 43.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.238 0.542 . . . . 10.0 112.107 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -114.06 123.29 49.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.072 -0.967 . . . . 10.0 109.128 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 t -67.22 131.36 45.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.955 0.407 . . . . 10.0 110.016 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.4 mt -83.1 -21.28 33.73 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.31 -55.15 6.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.077 -0.965 . . . . 10.0 111.075 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.4 p -94.58 -67.17 0.87 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.766 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.29 -2.2 3.83 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.824 -0.91 . . . . 10.0 110.824 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.406 ' HB2' HD11 ' A' ' 101' ' ' LEU . 40.8 mt-10 -68.66 148.05 50.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.294 -0.453 . . . . 10.0 110.738 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.2 m -120.91 138.71 53.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.233 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.85 -175.05 47.49 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.571 -0.823 . . . . 10.0 112.159 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -88.79 135.7 33.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.615 0.245 . . . . 10.0 110.69 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.0 pt -125.78 143.96 46.84 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.192 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.513 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 56.9 Cg_endo -73.16 121.45 7.25 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.396 2.064 . . . . 10.0 111.347 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.18 -1.65 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.513 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 36.8 p-10 -96.33 0.55 50.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.794 0.33 . . . . 10.0 110.768 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -119.7 1.03 11.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.035 0.445 . . . . 10.0 111.202 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.63 154.33 36.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.37 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.15 147.13 42.83 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.804 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.29 142.85 42.23 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.438 2.092 . . . . 10.0 111.512 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.406 -0.807 . . . . 10.0 110.143 179.947 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.309 0.1 . . . . 10.0 110.828 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.03 171.23 11.26 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.751 0.31 . . . . 10.0 110.883 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m -107.72 129.16 55.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.34 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -102.85 137.39 31.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 10.0 110.722 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -101.94 137.32 40.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 10.0 110.417 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -145.55 168.13 21.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.254 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.45 85.14 2.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -67.77 96.38 0.56 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.356 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt 58.94 26.33 14.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.353 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.26 -27.23 9.66 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.973 -0.632 . . . . 10.0 112.703 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -76.87 114.03 15.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.693 0.283 . . . . 10.0 111.204 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.03 109.75 7.78 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.772 -0.455 . . . . 10.0 109.772 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -131.08 157.38 43.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.55 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -129.42 132.02 46.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.847 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 90.8 t -136.99 147.13 27.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.413 ' HB2' ' HD2' ' B' ' 19' ' ' LYS . 18.1 m-20 -61.16 135.99 57.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 10.0 110.783 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.4 tt -60.6 -31.4 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.492 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -5.49 39.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.165 -0.471 . . . . 10.0 111.584 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.413 ' HD2' ' HB2' ' B' ' 16' ' ' ASP . 80.9 mttt -105.29 9.99 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.21 0.529 . . . . 10.0 110.618 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 78.7 mt -95.55 121.7 46.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.39 -60.0 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.69 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.22 151.53 45.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.852 0.358 . . . . 10.0 111.318 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 t -127.02 138.41 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.278 -0.873 . . . . 10.0 109.564 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -136.91 118.6 15.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.977 0.418 . . . . 10.0 111.04 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 35.1 ttp85 -109.03 141.1 41.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.409 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -115.92 -26.06 7.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.339 -0.391 . . . . 10.0 111.168 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.64 29.76 2.81 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.748 . . . . 10.0 111.452 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -157.52 -53.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -139.23 129.88 25.95 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.283 -0.871 . . . . 10.0 109.806 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mt -88.98 117.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -104.97 139.12 40.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.688 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.81 166.19 32.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.724 0.297 . . . . 10.0 110.939 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -127.63 135.91 50.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.097 -0.501 . . . . 10.0 109.837 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -122.11 165.15 16.53 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.483 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -136.32 121.81 19.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.844 -0.616 . . . . 10.0 110.331 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 66.1 mt -98.11 142.38 29.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.875 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.38 -14.99 62.94 Favored Glycine 0 C--N 1.329 0.148 0 CA-C-N 116.095 -0.502 . . . . 10.0 112.815 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.64 11.94 54.2 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.659 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.3 51.1 6.28 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.889 -0.672 . . . . 10.0 111.766 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 tptt -138.93 90.46 12.2 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 121.072 -0.251 . . . . 10.0 110.987 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -89.05 110.02 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.771 2.314 . . . . 10.0 110.467 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.63 -177.86 15.18 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.124 -1.036 . . . . 10.0 112.897 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 23.0 m-85 -120.8 166.74 13.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.785 -0.45 . . . . 10.0 109.785 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.35 142.8 12.02 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.827 -0.702 . . . . 10.0 112.169 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.68 129.25 51.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.844 0.354 . . . . 10.0 110.43 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -126.07 127.19 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.204 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.15 127.94 34.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.457 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -83.73 26.06 0.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -137.69 -50.54 0.61 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -95.64 19.86 10.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.34 144.14 48.32 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.614 -0.267 . . . . 10.0 110.456 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.41 138.45 47.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.025 2.483 . . . . 10.0 112.248 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -60.7 -27.55 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.982 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.83 -38.1 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.716 0.293 . . . . 10.0 111.134 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.19 -39.85 78.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.382 . . . . 10.0 110.035 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 21.9 mt -67.84 -39.72 83.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.588 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -66.93 -31.61 72.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.266 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.42 -8.6 59.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.003 0.43 . . . . 10.0 110.748 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 25.5 mt -96.09 -45.56 6.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.791 0.293 . . . . 10.0 111.791 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -91.54 131.84 36.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 10.0 111.213 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -123.86 163.57 20.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 10.0 109.487 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -74.35 131.99 41.62 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.893 -0.323 . . . . 10.0 110.613 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 mttp 64.0 62.52 0.87 Allowed 'General case' 0 C--O 1.236 0.38 0 O-C-N 123.921 0.763 . . . . 10.0 110.746 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.496 -0.764 . . . . 10.0 110.254 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.753 0.311 . . . . 10.0 110.552 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.4 mt -88.09 160.79 17.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.309 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.18 135.92 55.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.505 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 p -111.05 139.29 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.553 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.99 124.63 25.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.162 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.411 ' O ' ' HE2' ' A' ' 105' ' ' LYS . 59.6 mt -83.51 -33.37 25.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.531 . . . . 10.0 110.607 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -139.61 154.57 47.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.962 -0.563 . . . . 10.0 109.812 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.01 150.42 42.43 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.619 -0.512 . . . . 10.0 109.619 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -138.02 133.93 34.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.629 0.252 . . . . 10.0 110.518 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.65 132.45 46.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.15 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.497 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -91.88 148.76 21.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.015 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 96' ' ' ARG . 5.4 ttm180 -119.8 -21.37 7.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.345 0.593 . . . . 10.0 109.968 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.55 -178.48 4.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.005 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -94.17 8.56 41.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.358 0.599 . . . . 10.0 110.143 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.69 -44.14 7.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.303 -0.862 . . . . 10.0 109.521 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 95' ' ' ALA . 15.9 p-10 -88.39 151.21 22.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.411 -0.813 . . . . 10.0 109.053 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 tp -112.0 129.12 56.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.984 0.421 . . . . 10.0 112.057 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.497 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -84.28 139.36 32.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.124 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.402 ' CB ' ' HZ ' ' A' ' 109' ' ' PHE . 31.3 p90 -155.2 170.81 20.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.841 0.353 . . . . 10.0 111.225 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -114.91 157.61 23.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.71 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 90' ' ' LEU . 54.8 tttm -62.32 131.99 51.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.664 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.71 -19.73 23.3 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.546 -0.835 . . . . 10.0 112.863 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -77.15 148.98 35.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.98 0.419 . . . . 10.0 110.834 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -114.68 144.09 43.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.122 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.402 ' HZ ' ' CB ' ' A' ' 103' ' ' PHE . 32.1 m-85 -129.51 153.91 47.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.963 0.411 . . . . 10.0 111.306 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -100.1 114.35 27.64 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 46.9 mm -69.35 119.15 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.904 0.383 . . . . 10.0 111.142 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.4 mt -85.37 -52.58 5.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.648 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -135.92 109.1 7.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.877 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.36 -8.08 39.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.225 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.27 21.22 9.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.45 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 119' ' ' TRP . 19.4 tp10 -67.59 -43.39 80.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.645 -0.707 . . . . 10.0 110.356 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 155.28 -106.54 0.3 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.833 -0.698 . . . . 10.0 111.887 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -99.4 -11.44 21.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.213 0.53 . . . . 10.0 109.971 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.482 ' O ' ' HB3' ' A' ' 116' ' ' GLU . 39.9 m95 -124.64 159.71 30.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.155 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -119.85 139.99 51.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.943 0.401 . . . . 10.0 111.88 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -90.23 116.11 27.97 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.786 -1.19 . . . . 10.0 107.786 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.91 160.61 30.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.643 0.735 . . . . 10.0 112.579 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -116.31 128.29 55.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.67 -1.15 . . . . 10.0 109.226 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t -66.43 133.16 49.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.81 0.338 . . . . 10.0 111.101 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.8 mt -92.04 -11.23 36.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.432 0.634 . . . . 10.0 109.362 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -50.47 8.48 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.347 -0.842 . . . . 10.0 110.537 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.0 p -111.05 -55.89 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.099 0.476 . . . . 10.0 111.298 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.1 -8.54 4.44 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.908 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -55.73 146.82 20.18 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.05 0.452 . . . . 10.0 111.843 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.83 142.62 46.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.329 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.92 173.47 42.51 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.419 -0.896 . . . . 10.0 112.076 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -84.79 131.34 34.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.019 0.438 . . . . 10.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.0 pt -115.51 144.53 32.61 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.547 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.469 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 19.6 Cg_exo -63.89 114.53 2.64 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.849 1.7 . . . . 10.0 111.141 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.1 -14.2 15.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.559 -0.746 . . . . 10.0 112.46 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.405 ' ND2' ' HB2' ' B' ' 26' ' ' TYR . 23.0 p-10 -104.27 12.88 33.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.424 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 134' ' ' PRO . 8.8 m-85 -120.82 3.34 10.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.747 0.308 . . . . 10.0 111.163 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 m -128.84 148.44 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.945 0.402 . . . . 10.0 111.12 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -128.9 141.44 41.71 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.292 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.02 137.02 43.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.654 2.236 . . . . 10.0 111.973 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 64.3 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.397 -0.811 . . . . 10.0 109.785 179.678 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.668 0.271 . . . . 10.0 110.398 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.52 147.58 28.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.863 0.364 . . . . 10.0 110.866 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.8 m -97.84 132.33 43.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.419 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 48.5 t -104.46 131.62 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.867 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -98.42 131.62 44.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.677 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -145.42 -174.07 4.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.742 0.306 . . . . 10.0 110.809 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -130.2 123.96 31.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.895 -0.593 . . . . 10.0 109.841 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' TYR . . . . . 0.481 ' O ' ' HG2' ' B' ' 11' ' ' GLU . 17.9 t80 -102.17 94.05 5.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.869 0.366 . . . . 10.0 110.122 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 60.44 13.4 4.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.639 -0.71 . . . . 10.0 112.156 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.68 -35.87 2.0 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.38 -0.914 . . . . 10.0 113.159 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' B' ' 8' ' ' TYR . 12.0 pt-20 -82.57 136.66 34.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.159 0.479 . . . . 10.0 111.062 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -83.62 138.59 33.28 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -148.3 150.48 33.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.894 0.378 . . . . 10.0 111.386 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -123.47 110.82 15.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.126 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' VAL . . . . . 0.436 HG11 ' HB2' ' B' ' 34' ' ' TYR . 60.2 t -125.44 141.51 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.162 -0.472 . . . . 10.0 109.835 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 29.9 m-20 -66.97 145.25 55.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.117 0.484 . . . . 10.0 111.786 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.6 tt -58.88 -30.14 42.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.401 -0.818 . . . . 10.0 112.318 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 5.8 m -74.04 -10.65 59.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.778 0.323 . . . . 10.0 111.417 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.3 2.58 39.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.237 0.541 . . . . 10.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -99.3 110.48 26.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.537 -0.756 . . . . 10.0 109.289 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.422 ' H ' HG23 ' B' ' 21' ' ' VAL . 2.9 t -62.19 -78.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.698 -0.683 . . . . 10.0 112.14 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -114.57 144.8 42.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 10.0 111.202 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 t -131.68 140.93 47.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 56.1 m -144.93 125.87 14.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.216 0.532 . . . . 10.0 111.376 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.452 ' HG3' ' OE1' ' B' ' 48' ' ' GLU . 27.6 ttp85 -108.42 152.59 24.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.373 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' TYR . . . . . 0.405 ' HB2' ' ND2' ' A' ' 136' ' ' ASN . 19.2 t80 -129.63 -18.31 3.53 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.874 -0.33 . . . . 10.0 111.745 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.46 3.14 25.8 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.316 -0.945 . . . . 10.0 111.325 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -128.02 -52.27 1.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.405 -0.591 . . . . 10.0 109.405 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -150.97 143.32 24.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.373 -0.83 . . . . 10.0 109.941 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mt -95.02 132.68 38.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.331 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -118.9 142.68 47.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.308 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -162.14 168.82 21.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.807 0.336 . . . . 10.0 111.193 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -123.9 133.56 53.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.476 -0.564 . . . . 10.0 109.476 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' TYR . . . . . 0.436 ' HB2' HG11 ' B' ' 15' ' ' VAL . 51.4 p90 -113.88 147.54 38.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.977 0.418 . . . . 10.0 110.739 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -122.94 121.76 36.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.641 -0.708 . . . . 10.0 109.531 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' B' ' 40' ' ' LYS . 96.5 mt -97.84 136.85 37.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.817 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.3 -18.18 64.88 Favored Glycine 0 C--N 1.33 0.202 0 CA-C-N 116.068 -0.515 . . . . 10.0 112.194 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.57 -8.63 87.56 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.793 -0.718 . . . . 10.0 111.913 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 64.85 1.05 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.76 -0.734 . . . . 10.0 112.471 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' LYS . . . . . 0.533 ' HB3' HD12 ' B' ' 36' ' ' LEU . 36.8 tttp -160.34 85.47 1.97 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.047 0.451 . . . . 10.0 110.371 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -84.34 136.07 6.46 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.668 2.245 . . . . 10.0 111.667 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.37 -176.92 29.97 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.532 -0.842 . . . . 10.0 112.101 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -113.13 168.83 9.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.303 -0.258 . . . . 10.0 110.303 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.03 138.77 7.08 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.463 -0.655 . . . . 10.0 111.463 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.44 135.28 64.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.88 0.372 . . . . 10.0 110.424 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 81.1 t -127.67 129.11 70.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.574 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.9 t -75.78 126.98 32.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.226 -0.443 . . . . 10.0 109.903 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' B' ' 25' ' ' ARG . 52.8 mt-10 -76.45 2.46 13.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.955 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -124.37 -34.71 2.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.595 -0.275 . . . . 10.0 111.497 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -84.47 -24.28 29.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.735 0.302 . . . . 10.0 111.557 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.35 146.87 32.07 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.747 0.308 . . . . 10.0 111.038 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.63 156.23 66.88 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.704 2.269 . . . . 10.0 111.759 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.401 ' HD3' HD12 ' B' ' 56' ' ' LEU . 74.3 mmtt -60.57 -25.96 66.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.375 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -51.39 -40.85 60.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.666 -0.697 . . . . 10.0 111.385 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.21 -40.53 14.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.027 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.401 HD12 ' HD3' ' B' ' 53' ' ' LYS . 54.8 mt -60.89 -37.18 81.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.7 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -74.52 -11.53 60.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.603 -0.271 . . . . 10.0 111.342 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -94.42 -19.16 20.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.097 0.475 . . . . 10.0 110.05 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -95.14 -7.94 37.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.229 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -79.92 71.35 6.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.616 -0.72 . . . . 10.0 109.781 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' B' ' 64' ' ' LYS . 82.3 mttt -72.39 102.71 3.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.589 -0.732 . . . . 10.0 110.076 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -70.68 150.96 45.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.401 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 67.59 33.85 4.86 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.739 0.78 . . . . 10.0 109.791 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' B' ' 61' ' ' LYS . 11.5 tptp . . . . . 0 C--O 1.251 1.172 0 CA-C-N 114.642 -1.163 . . . . 10.0 108.783 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.592 0.234 . . . . 10.0 110.553 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -107.86 137.94 44.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.964 0.411 . . . . 10.0 110.876 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -116.41 142.24 47.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.526 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.6 p -110.47 140.34 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.534 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.76 126.21 30.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.888 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.76 -31.95 35.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.019 0.438 . . . . 10.0 110.164 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -141.29 168.76 19.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.67 -0.696 . . . . 10.0 109.442 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.19 138.83 35.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.336 -0.393 . . . . 10.0 109.946 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -112.65 127.17 56.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.098 0.475 . . . . 10.0 111.67 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -95.94 118.09 31.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.371 -0.974 . . . . 10.0 108.371 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.87 153.26 36.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.98 0.419 . . . . 10.0 111.236 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -118.08 -35.9 3.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.946 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.44 171.79 7.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.985 0.421 . . . . 10.0 110.343 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -84.32 20.01 1.75 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.738 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.74 -36.04 3.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.161 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -83.3 141.05 32.11 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.923 -0.769 . . . . 10.0 108.923 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.0 tp -97.65 126.94 43.24 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.407 0.521 . . . . 10.0 112.407 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.4 146.97 25.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 10.0 109.839 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -155.61 168.39 27.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.674 0.274 . . . . 10.0 111.014 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -105.8 160.6 15.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.916 -0.583 . . . . 10.0 110.434 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -64.9 126.43 27.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.115 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.38 -9.07 38.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.641 -0.79 . . . . 10.0 113.278 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -77.8 151.45 33.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.269 0.534 . . . . 10.0 111.147 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -118.42 133.52 55.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.684 . . . . 10.0 109.971 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.26 152.56 45.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.784 0.326 . . . . 10.0 110.56 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -95.0 115.35 27.31 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.948 -0.76 . . . . 10.0 108.948 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.6 mm -69.5 120.18 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.862 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.1 mt -89.43 -55.93 3.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.148 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -134.74 108.63 8.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.34 4.71 41.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.642 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -95.4 8.53 42.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.031 -0.532 . . . . 10.0 111.541 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.21 74.55 3.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.312 0.577 . . . . 10.0 110.842 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.473 ' O ' ' HE2' ' B' ' 9' ' ' LYS . . . 68.04 -132.53 28.55 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.776 -0.726 . . . . 10.0 112.127 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -112.32 8.62 19.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.022 0.439 . . . . 10.0 110.798 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -120.44 104.76 10.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.262 -1.014 . . . . 10.0 108.262 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 4.6 m0 -83.35 135.56 34.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.869 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -92.41 112.56 24.55 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.462 -1.31 . . . . 10.0 107.462 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.75 169.26 11.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.012 0.434 . . . . 10.0 111.806 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -120.52 126.04 49.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.544 -0.753 . . . . 10.0 109.765 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.2 t -65.24 135.31 55.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.399 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.02 -12.38 44.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.056 0.455 . . . . 10.0 110.2 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.35 -48.02 11.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.693 -0.685 . . . . 10.0 111.126 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 80.8 p -105.98 -43.61 4.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.995 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.52 3.88 28.75 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.605 -0.807 . . . . 10.0 111.729 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -74.12 144.88 44.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 10.0 110.576 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -118.44 139.5 51.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.921 -0.582 . . . . 10.0 110.811 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.95 177.17 45.69 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.798 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.32 129.41 35.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.7 pt -113.67 136.78 22.03 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.719 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.57 107.16 0.82 Allowed 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.494 2.129 . . . . 10.0 111.752 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -7.69 10.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.791 -0.64 . . . . 10.0 112.227 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -96.11 1.22 52.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.833 0.349 . . . . 10.0 110.701 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -111.5 -14.45 13.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.093 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.6 m -114.1 160.62 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.108 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -143.42 152.66 57.63 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.448 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.12 144.56 87.43 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.272 1.981 . . . . 10.0 111.632 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.416 -0.802 . . . . 10.0 110.176 -179.982 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.524 0.202 . . . . 10.0 110.609 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.01 169.96 23.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.931 0.396 . . . . 10.0 111.48 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 7.4 m -104.95 136.01 45.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.895 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 44.3 t -109.86 132.47 58.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.763 0.316 . . . . 10.0 110.91 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -99.31 127.04 45.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.272 -0.64 . . . . 10.0 109.272 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.468 ' CD2' ' HZ ' ' B' ' 32' ' ' PHE . 41.3 p90 -141.96 175.88 9.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.441 -0.345 . . . . 10.0 111.009 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -109.72 146.91 34.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.88 92.78 2.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.473 ' HE2' ' O ' ' A' ' 117' ' ' GLY . 5.1 mmtm 61.57 30.35 18.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.287 -0.87 . . . . 10.0 111.668 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.83 -51.88 0.72 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.908 -0.663 . . . . 10.0 113.469 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -74.18 142.66 45.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.959 0.409 . . . . 10.0 111.198 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -92.94 130.49 38.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.953 -0.567 . . . . 10.0 109.79 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.47 157.26 35.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.568 -0.287 . . . . 10.0 110.916 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -129.32 113.28 14.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.549 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.14 149.5 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.273 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 5.1 m-20 -64.99 142.82 58.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.656 -0.247 . . . . 10.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 12.0 tt -65.96 -24.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.48 0.657 . . . . 10.0 110.041 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -4.06 33.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.322 -0.853 . . . . 10.0 111.068 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -110.97 15.08 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.539 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 71.3 mt -95.91 133.15 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.257 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -80.99 -52.58 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.066 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -152.15 155.3 37.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.367 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.59 125.83 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 123.547 0.529 . . . . 10.0 110.464 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 4.2 m -116.82 105.95 12.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.871 0.367 . . . . 10.0 111.453 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.552 ' HD2' ' OE2' ' B' ' 48' ' ' GLU . 0.3 OUTLIER -94.82 136.99 34.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.354 -0.384 . . . . 10.0 110.091 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -116.48 -21.47 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.887 0.375 . . . . 10.0 111.16 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.82 4.59 39.3 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.081 -0.808 . . . . 10.0 111.081 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -134.12 -47.41 0.78 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -149.44 132.69 16.43 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.988 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -87.17 123.65 40.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.245 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.81 132.67 53.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.86 -0.609 . . . . 10.0 109.612 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' PHE . . . . . 0.468 ' HZ ' ' CD2' ' B' ' 6' ' ' PHE . 43.4 p90 -150.77 169.46 21.61 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.431 -0.508 . . . . 10.0 111.985 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -122.04 138.87 54.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.357 -0.838 . . . . 10.0 109.459 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -133.67 165.65 24.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 10.0 111.697 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.32 121.38 15.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.707 -0.678 . . . . 10.0 110.112 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' B' ' 40' ' ' LYS . 24.9 mt -96.08 129.67 43.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.616 -0.265 . . . . 10.0 110.415 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.6 106.23 1.31 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.095 -0.574 . . . . 10.0 111.869 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.77 -7.83 1.73 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.976 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.54 36.27 3.84 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.52 -0.847 . . . . 10.0 112.991 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 79.5 tttt -135.42 67.72 67.18 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.113 0.457 . . . . 10.0 111.274 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -90.74 171.65 3.35 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.499 2.133 . . . . 10.0 112.015 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.8 -158.73 31.54 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.413 -0.898 . . . . 10.0 112.394 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -121.37 178.33 4.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.515 0.198 . . . . 10.0 110.517 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.51 150.5 19.68 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.654 -0.784 . . . . 10.0 111.957 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.55 130.8 69.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.188 0.518 . . . . 10.0 110.974 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 5.0 t -118.57 122.78 70.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.828 -0.623 . . . . 10.0 109.748 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.7 t -69.77 133.18 47.16 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.154 -0.313 . . . . 10.0 110.154 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.552 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 44.0 mt-10 -87.24 15.95 5.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.944 0.402 . . . . 10.0 110.389 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -122.92 -62.79 1.32 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.605 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.35 36.33 0.69 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 10.0 112.194 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.66 143.72 36.34 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.316 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.75 143.1 85.58 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.618 2.212 . . . . 10.0 112.095 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -59.79 -23.13 63.03 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.582 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -52.93 -50.88 63.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.685 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 75.6 mt -77.2 -34.86 56.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.695 0.283 . . . . 10.0 110.933 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.81 -42.0 98.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.391 -0.368 . . . . 10.0 111.553 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -73.9 -31.48 63.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.008 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -71.59 -33.78 69.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.462 -0.335 . . . . 10.0 110.394 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 20.5 mt -74.46 -44.54 51.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.677 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -79.19 87.43 4.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.177 0.513 . . . . 10.0 110.625 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -89.76 145.45 25.18 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.924 -0.58 . . . . 10.0 109.777 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -68.21 140.52 56.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.522 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.7 mttt 62.31 79.48 0.26 Allowed 'General case' 0 C--O 1.232 0.18 0 O-C-N 123.835 0.71 . . . . 10.0 110.233 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.221 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.833 0.349 . . . . 10.0 110.703 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.06 154.94 24.15 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.747 -0.464 . . . . 10.0 109.747 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -121.65 136.17 54.95 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.2 -0.296 . . . . 10.0 110.2 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.27 138.96 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.61 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.43 122.57 22.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.208 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.2 mt -77.78 -35.12 51.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.801 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -142.78 163.88 31.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 10.0 110.273 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.31 131.41 42.64 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -102.8 123.68 46.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.048 0.452 . . . . 10.0 111.688 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -88.29 105.81 17.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.802 -0.814 . . . . 10.0 108.802 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.99 156.99 37.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.355 0.598 . . . . 10.0 111.96 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -118.46 -44.08 2.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.67 -0.695 . . . . 10.0 111.059 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -121.89 -160.83 0.89 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.511 -0.313 . . . . 10.0 110.979 -178.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.404 ' H ' ' HB ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -98.35 -16.33 19.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.271 0.558 . . . . 10.0 109.54 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.86 -44.74 69.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.159 -0.928 . . . . 10.0 110.26 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.46 146.04 31.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.559 -0.746 . . . . 10.0 109.958 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.7 tp -96.77 124.9 40.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.31 -0.405 . . . . 10.0 111.816 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.24 129.42 34.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.297 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -144.29 164.53 30.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.892 0.377 . . . . 10.0 111.13 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -106.05 160.78 15.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.515 -0.766 . . . . 10.0 110.111 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -65.22 130.75 44.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.588 -0.278 . . . . 10.0 110.755 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.06 -15.34 51.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.681 -0.771 . . . . 10.0 113.175 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -71.43 152.22 43.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.899 0.381 . . . . 10.0 111.102 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -114.03 139.81 48.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.75 -0.659 . . . . 10.0 110.21 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.0 157.64 45.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 10.0 111.018 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -108.94 117.95 35.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.306 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.423 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . 23.8 mm -69.09 123.76 23.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.231 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 mt -98.17 -37.86 9.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.483 -0.326 . . . . 10.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -142.38 100.87 3.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.79 0.329 . . . . 10.0 111.364 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.75 -5.5 26.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.447 0.641 . . . . 10.0 110.34 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.78 8.71 24.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.078 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -72.9 -35.61 67.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.705 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 146.63 -127.26 2.68 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.719 -0.673 . . . . 10.0 111.454 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -49.74 22.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.933 0.396 . . . . 10.0 110.186 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.522 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 23.5 m95 -87.69 134.81 33.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.8 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 20.0 m0 -110.69 147.69 33.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.921 0.391 . . . . 10.0 111.18 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -99.03 120.57 39.67 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.423 ' HB2' ' HA ' ' A' ' 111' ' ' ILE . . . -139.89 166.37 24.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.846 0.355 . . . . 10.0 111.401 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -116.25 140.12 49.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.1 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.1 t -74.46 148.95 40.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.676 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.18 -24.7 18.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.568 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -45.08 48.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.729 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 p -104.35 -63.7 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.696 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.33 -13.01 5.72 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.748 -0.739 . . . . 10.0 112.037 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -57.15 144.42 34.97 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.858 0.361 . . . . 10.0 111.333 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.2 m -118.47 126.33 51.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.759 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -162.9 -174.58 32.97 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.564 -0.827 . . . . 10.0 111.675 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -82.19 130.1 35.0 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.145 -0.317 . . . . 10.0 110.145 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 pt -121.43 140.8 32.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.797 0.332 . . . . 10.0 110.821 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.56 119.64 6.68 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.666 2.244 . . . . 10.0 111.832 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.69 -18.97 65.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 10.0 111.749 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -88.92 7.09 36.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.389 -0.368 . . . . 10.0 111.422 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -123.85 8.04 8.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.179 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.2 m -131.33 151.72 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.992 0.425 . . . . 10.0 111.576 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -133.68 144.37 51.69 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.294 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.73 134.35 43.5 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.608 2.205 . . . . 10.0 112.41 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.434 -0.794 . . . . 10.0 110.445 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ttt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.525 0.203 . . . . 10.0 110.656 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.02 165.52 27.21 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.592 0.234 . . . . 10.0 110.673 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.92 137.75 32.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.903 -0.589 . . . . 10.0 110.958 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 88.2 t -108.55 128.74 63.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.358 -0.383 . . . . 10.0 110.159 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -93.82 121.95 35.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -132.09 170.97 14.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.486 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -117.44 97.07 5.69 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.193 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -80.98 72.47 8.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm 59.16 66.97 0.96 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.306 -0.861 . . . . 10.0 110.955 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.96 -46.3 2.27 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.832 -0.699 . . . . 10.0 113.02 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.32 117.88 19.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 10.0 111.333 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -88.53 116.36 26.71 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.274 -0.639 . . . . 10.0 109.274 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -124.24 160.1 28.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.885 0.374 . . . . 10.0 111.299 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -127.3 118.05 23.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.515 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.5 144.46 37.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.261 -0.427 . . . . 10.0 109.874 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.83 135.69 57.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.499 -0.318 . . . . 10.0 110.388 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 tt -63.75 -22.42 30.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.298 0.57 . . . . 10.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -9.45 59.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.935 -0.575 . . . . 10.0 111.131 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -101.47 11.23 39.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.303 0.573 . . . . 10.0 110.314 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 78.1 mt -98.73 129.95 48.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.34 -0.845 . . . . 10.0 109.654 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 7.2 t -76.65 -75.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.335 -0.393 . . . . 10.0 111.331 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -120.49 153.41 36.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.796 0.332 . . . . 10.0 110.781 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.34 129.2 56.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.869 -0.605 . . . . 10.0 110.511 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 19.5 m -121.44 112.13 18.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.197 0.522 . . . . 10.0 110.861 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.483 ' HG3' HG12 ' B' ' 30' ' ' ILE . 52.0 ttp85 -100.71 133.72 44.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.314 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -103.65 -19.01 14.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.984 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.96 -18.86 14.18 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.115 -0.794 . . . . 10.0 111.115 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -114.04 -61.4 1.75 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -118.67 143.57 46.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.368 -0.833 . . . . 10.0 109.523 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.483 HG12 ' HG3' ' B' ' 25' ' ' ARG . 1.9 mt -106.14 119.31 55.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.033 -0.531 . . . . 10.0 109.908 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -105.24 135.46 46.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.347 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -151.26 165.84 32.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.861 0.362 . . . . 10.0 111.438 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 133.55 54.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.409 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -123.73 166.2 15.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.517 -0.311 . . . . 10.0 110.699 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -139.6 115.81 10.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.164 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -82.55 145.53 29.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.837 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.47 -18.81 73.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.039 -0.601 . . . . 10.0 112.669 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.34 19.86 7.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.024 -0.608 . . . . 10.0 112.887 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.03 51.7 17.34 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.929 -0.653 . . . . 10.0 112.349 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -150.36 96.04 3.49 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.881 0.372 . . . . 10.0 111.286 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.84 154.13 13.24 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.412 2.074 . . . . 10.0 110.76 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.79 -172.11 31.85 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 119.573 -1.299 . . . . 10.0 113.034 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' PHE . . . . . 0.522 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 15.6 m-85 -133.07 166.89 21.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.685 -0.487 . . . . 10.0 109.685 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.66 146.43 14.48 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.628 -0.796 . . . . 10.0 111.767 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 3.6 p -129.68 127.63 64.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.303 0.573 . . . . 10.0 110.784 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.58 132.08 67.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.282 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 14.6 t -88.67 125.38 34.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.668 0.27 . . . . 10.0 110.388 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -68.97 -17.28 63.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.046 0.451 . . . . 10.0 111.587 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -100.47 16.75 23.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.671 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -133.26 -53.3 0.9 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.903 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.06 152.64 76.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.024 -0.534 . . . . 10.0 111.371 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.442 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 32.0 Cg_endo -63.4 154.08 70.54 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.82 2.346 . . . . 10.0 112.951 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -57.76 -34.12 69.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.459 -0.791 . . . . 10.0 112.082 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -54.15 -44.97 71.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.961 0.356 . . . . 10.0 111.961 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.6 -39.22 70.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 10.0 110.98 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 18.0 mt -65.21 -43.05 92.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.771 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -69.44 -18.39 63.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.818 -0.628 . . . . 10.0 111.685 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -80.67 -25.42 38.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.893 0.378 . . . . 10.0 110.614 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 82.0 mt -83.67 -42.9 16.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.452 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' GLU . . . . . 0.471 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 1.1 tp10 -86.64 92.39 8.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 10.0 110.342 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -108.88 -177.65 3.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.404 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -80.18 138.19 36.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.262 -0.273 . . . . 10.0 110.262 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 57.4 39.09 28.47 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.43 0.633 . . . . 10.0 110.018 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-N 115.168 -0.924 . . . . 10.0 110.886 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 120.849 0.357 . . . . 10.0 110.441 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -84.79 129.59 34.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.976 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -121.06 145.42 47.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.762 -0.654 . . . . 10.0 109.673 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.23 139.6 42.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.956 0.407 . . . . 10.0 110.647 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.95 123.52 24.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.894 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.4 mt -71.2 -50.93 27.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.429 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -129.01 178.61 6.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.846 -0.615 . . . . 10.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.06 142.87 28.41 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -126.37 130.2 50.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.996 0.426 . . . . 10.0 110.751 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -93.73 116.99 29.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.521 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 137.85 56.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.144 0.497 . . . . 10.0 111.304 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' B' ' 21' ' ' VAL . 14.6 ttt180 -94.09 -40.7 9.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.455 -0.793 . . . . 10.0 110.306 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.9 p -131.95 -163.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.887 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -93.84 -2.49 53.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.238 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.5 -41.43 16.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.907 -0.588 . . . . 10.0 109.874 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -89.49 154.51 19.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.5 -0.773 . . . . 10.0 109.153 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.3 tp -107.62 134.52 50.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.197 0.443 . . . . 10.0 112.197 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.56 146.36 25.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.528 -0.76 . . . . 10.0 110.555 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -162.65 166.06 24.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.821 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -113.53 168.34 9.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.493 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -61.7 115.54 4.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.852 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.09 -1.2 25.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.637 -0.792 . . . . 10.0 112.696 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -67.99 137.92 55.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 10.0 110.947 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -102.2 130.58 48.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -120.47 144.73 47.83 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.098 0.777 . . . . 10.0 113.098 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -108.28 106.07 16.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.7 114.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.101 0.477 . . . . 10.0 111.578 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 mt -86.0 -48.67 8.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.571 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -138.95 104.41 5.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 10.0 111.182 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -15.45 37.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.281 0.562 . . . . 10.0 110.458 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.87 13.45 5.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.811 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.17 -45.38 73.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 10.0 110.471 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.99 -119.12 0.93 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.2 -0.76 . . . . 10.0 111.2 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -93.51 -27.73 16.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.296 0.569 . . . . 10.0 110.052 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.442 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 29.2 m95 -110.63 114.99 28.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.145 -1.057 . . . . 10.0 108.145 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -95.31 143.12 26.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.164 0.507 . . . . 10.0 111.353 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -90.89 121.64 32.91 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.52 -0.919 . . . . 10.0 108.52 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.14 164.34 27.57 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.815 0.341 . . . . 10.0 111.582 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -112.04 137.64 49.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.522 -0.763 . . . . 10.0 110.708 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.1 t -76.45 141.12 41.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.148 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.8 mt -93.21 2.97 56.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.451 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -105.14 -58.48 1.88 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.888 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.1 p -91.47 -39.14 12.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.218 0.532 . . . . 10.0 110.875 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 103.17 6.96 44.5 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.698 -0.683 . . . . 10.0 111.671 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -73.24 146.11 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.321 . . . . 10.0 110.663 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 91.0 m -126.83 134.5 50.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.366 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.63 -176.0 43.5 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.903 -0.665 . . . . 10.0 111.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -76.26 122.65 24.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.757 0.313 . . . . 10.0 110.181 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.3 pt -114.39 141.15 26.07 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.734 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.38 110.3 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.45 2.1 . . . . 10.0 111.591 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -12.11 22.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.973 -0.558 . . . . 10.0 112.13 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -93.93 0.29 56.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.884 0.373 . . . . 10.0 110.66 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.26 5.07 14.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.915 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.2 m -129.78 153.45 38.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.376 -0.374 . . . . 10.0 110.947 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.57 147.92 61.65 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.214 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.84 130.03 20.98 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.537 2.158 . . . . 10.0 112.083 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.356 -0.831 . . . . 10.0 109.898 179.657 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ttt . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 120.711 0.291 . . . . 10.0 110.68 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.12 168.17 25.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.777 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 0.1 OUTLIER -101.44 146.38 27.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.382 -0.372 . . . . 10.0 110.952 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.94 132.12 68.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.155 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -103.22 129.33 50.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.031 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 26.5 p90 -139.19 165.06 28.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.736 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -110.0 77.7 1.07 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.086 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -69.58 99.92 1.36 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.551 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 57.2 32.48 21.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.156 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.88 -28.53 14.95 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.756 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -81.76 113.01 19.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.662 0.231 . . . . 10.0 110.89 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 7.2 mt-10 -74.88 115.71 14.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -125.2 156.01 39.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.857 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -124.36 116.6 22.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.336 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.5 145.03 36.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.577 -0.527 . . . . 10.0 109.577 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 11.5 m-20 -61.92 138.88 58.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.963 0.411 . . . . 10.0 111.099 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 15.2 tt -63.64 -24.51 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.677 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 8.0 m -77.0 -3.5 39.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.619 -0.719 . . . . 10.0 111.007 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -111.37 13.46 21.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.212 0.529 . . . . 10.0 110.021 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -99.01 126.88 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.732 -0.667 . . . . 10.0 109.767 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' VAL . . . . . 0.479 ' O ' ' HD3' ' A' ' 96' ' ' ARG . 3.5 t -75.18 -64.38 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.755 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -134.99 153.46 52.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.593 -0.276 . . . . 10.0 111.121 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -132.96 137.5 53.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.237 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -135.24 121.9 20.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.999 0.428 . . . . 10.0 111.023 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.46 ' HG3' HG12 ' B' ' 30' ' ' ILE . 53.6 ttp85 -109.0 146.12 34.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.257 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -127.19 -15.54 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.958 0.409 . . . . 10.0 111.613 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.76 16.76 23.17 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.39 -0.91 . . . . 10.0 111.072 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -140.9 -53.73 0.48 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -145.5 130.99 18.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.318 -0.855 . . . . 10.0 109.816 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 9.4 mt -86.42 121.26 37.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.67 -0.493 . . . . 10.0 109.67 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -109.06 135.78 49.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.722 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' PHE . . . . . 0.419 ' N ' ' HE1' ' A' ' 119' ' ' TRP . 51.2 p90 -155.69 169.4 24.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.664 0.269 . . . . 10.0 110.704 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -128.34 135.29 49.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.254 -0.43 . . . . 10.0 109.969 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -114.08 168.01 10.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.755 0.312 . . . . 10.0 110.414 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -138.4 112.45 8.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.935 -0.575 . . . . 10.0 109.859 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 82.7 mt -93.55 132.49 37.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.441 -0.345 . . . . 10.0 110.945 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.2 -11.17 61.01 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.91 -0.586 . . . . 10.0 112.469 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.52 -19.54 68.99 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.359 -0.448 . . . . 10.0 112.217 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.97 43.77 1.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.68 -0.771 . . . . 10.0 112.641 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -170.13 111.07 0.46 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.827 0.346 . . . . 10.0 110.738 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -86.27 179.11 3.71 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.513 2.142 . . . . 10.0 110.883 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.64 172.56 43.86 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.079 -1.058 . . . . 10.0 112.276 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 29.9 m-85 -108.1 168.32 9.38 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.38 144.95 12.7 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.938 -0.649 . . . . 10.0 111.888 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 4.2 p -136.78 131.47 47.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.092 0.472 . . . . 10.0 110.876 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.9 121.98 65.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.855 -0.611 . . . . 10.0 109.934 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.39 101.33 3.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.668 0.27 . . . . 10.0 110.662 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -74.1 65.15 1.11 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.585 0.707 . . . . 10.0 110.417 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -166.24 -50.02 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.885 -1.052 . . . . 10.0 109.21 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.47 -28.33 15.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.054 -0.975 . . . . 10.0 111.249 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.66 153.09 73.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.135 -0.484 . . . . 10.0 111.202 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.03 142.64 94.1 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.701 2.267 . . . . 10.0 111.994 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -60.86 -26.03 67.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.812 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -56.84 -48.51 77.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.807 0.337 . . . . 10.0 110.904 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 99.0 mt -65.62 -32.97 74.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.837 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -71.91 -44.0 64.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.792 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -69.52 -31.89 70.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.854 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -78.48 -23.39 46.45 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.051 -0.26 . . . . 10.0 110.999 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' B' ' 59' ' ' LEU . 13.0 mt -83.68 -47.59 11.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.968 0.413 . . . . 10.0 110.391 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' GLU . . . . . 0.415 ' OE1' ' HE3' ' B' ' 64' ' ' LYS . 2.9 tp10 -84.74 87.84 7.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.362 0.601 . . . . 10.0 109.938 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' B' ' 64' ' ' LYS . 46.9 mtmt -93.0 169.78 10.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.18 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.7 mm-40 -76.11 121.37 22.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.7 0.286 . . . . 10.0 110.572 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 mttt 59.24 43.74 16.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.681 -0.691 . . . . 10.0 110.942 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' B' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.581 -0.723 . . . . 10.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.9 mt -88.68 150.8 22.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.982 0.42 . . . . 10.0 110.862 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -122.8 141.21 52.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.806 -0.633 . . . . 10.0 110.196 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.2 p -109.27 140.04 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.613 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.2 123.81 25.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.588 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.8 mt -78.74 -24.47 44.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.28 170.57 22.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.31 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.27 130.25 35.07 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -104.99 132.03 51.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.971 0.415 . . . . 10.0 111.64 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -89.83 118.77 29.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.506 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.12 158.63 24.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.14 0.495 . . . . 10.0 111.57 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -120.01 -44.62 2.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.554 -0.748 . . . . 10.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.89 -167.59 1.61 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.886 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -93.2 -2.62 55.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.1 0.476 . . . . 10.0 110.671 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.16 -37.58 20.01 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.276 0.56 . . . . 10.0 110.021 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -91.28 146.64 23.65 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.397 -0.964 . . . . 10.0 108.397 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.9 tp -111.36 123.49 50.31 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.568 0.581 . . . . 10.0 112.568 -177.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.83 133.4 36.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.938 -0.573 . . . . 10.0 109.731 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -140.39 163.03 33.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.803 0.335 . . . . 10.0 111.342 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -95.75 158.26 15.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.911 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -64.46 124.95 23.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.503 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.25 -3.01 56.58 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.853 -0.689 . . . . 10.0 113.201 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -74.0 154.6 39.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.937 0.398 . . . . 10.0 111.219 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -117.55 141.26 48.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.779 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.06 152.66 51.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 10.0 111.006 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.405 ' HB2' HD21 ' A' ' 125' ' ' LEU . 5.9 tp-100 -100.3 115.59 30.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.432 HG21 ' HB3' ' A' ' 114' ' ' SER . 10.9 mm -71.96 112.13 7.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.328 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.6 mt -84.57 -40.05 18.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.121 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -140.07 103.39 4.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.72 0.295 . . . . 10.0 111.3 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.432 ' HB3' HG21 ' A' ' 111' ' ' ILE . 2.2 p -105.01 0.08 27.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.294 0.569 . . . . 10.0 110.552 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.21 10.04 20.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.37 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.1 -58.34 3.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.546 0.689 . . . . 10.0 109.977 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 167.59 -118.75 0.8 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.3 -0.72 . . . . 10.0 111.3 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -76.71 -51.16 11.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.083 -0.339 . . . . 10.0 110.083 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -88.47 134.35 33.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.876 -0.787 . . . . 10.0 108.876 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -115.04 148.51 38.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 10.0 111.045 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -86.97 117.27 25.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.73 156.76 45.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.226 0.536 . . . . 10.0 111.662 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -112.54 126.75 55.68 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.985 -0.746 . . . . 10.0 108.985 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.3 t -62.8 136.63 57.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.387 -0.37 . . . . 10.0 110.181 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 110' ' ' GLN . 83.8 mt -84.66 -10.98 56.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.191 0.52 . . . . 10.0 109.829 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.78 -67.92 0.76 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.488 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.7 p -86.86 -46.59 9.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.444 . . . . 10.0 111.476 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 116.35 6.09 15.95 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.895 -0.669 . . . . 10.0 111.865 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -72.21 149.31 44.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.729 0.3 . . . . 10.0 110.759 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -115.71 135.0 54.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.347 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -174.62 179.79 45.71 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.925 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -86.78 136.3 33.04 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.0 -0.37 . . . . 10.0 110.0 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.3 pt -121.15 136.14 25.47 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.08 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 137' ' ' TYR . 19.2 Cg_endo -63.05 122.62 10.92 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.761 2.307 . . . . 10.0 111.869 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -17.74 64.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.85 -0.614 . . . . 10.0 112.238 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.472 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 45.3 p-10 -87.44 -5.79 58.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.959 0.409 . . . . 10.0 111.057 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.476 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 0.8 OUTLIER -105.27 -6.16 19.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.969 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.1 m -124.31 152.38 30.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.125 0.488 . . . . 10.0 111.356 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.61 152.89 67.37 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.545 -0.752 . . . . 10.0 110.163 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.68 156.08 63.35 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.335 2.024 . . . . 10.0 111.622 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.323 -0.846 . . . . 10.0 110.097 179.703 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.732 0.301 . . . . 10.0 110.302 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.1 168.07 13.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.127 0.489 . . . . 10.0 112.23 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.7 m -110.69 145.84 37.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.541 -0.754 . . . . 10.0 109.927 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 45.0 t -111.23 130.3 64.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.717 0.294 . . . . 10.0 111.333 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -103.57 120.49 40.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.662 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -134.33 169.53 17.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.919 0.39 . . . . 10.0 111.259 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.41 ' HG3' ' HG2' ' B' ' 12' ' ' GLU . 1.7 mttt -117.37 63.25 0.74 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.522 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -59.32 112.96 1.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.889 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 58.83 21.81 9.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.305 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.4 -5.99 63.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.951 -0.642 . . . . 10.0 112.454 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -94.72 119.08 32.75 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.89 -0.182 . . . . 10.0 110.844 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.41 ' HG2' ' HG3' ' B' ' 7' ' ' LYS . 2.9 mt-10 -72.23 113.98 9.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.946 -0.39 . . . . 10.0 109.946 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt -134.38 153.02 52.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.788 0.327 . . . . 10.0 110.837 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 1.5 mt-30 -124.8 120.28 31.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.165 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.0 t -128.93 143.36 41.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.058 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.18 136.22 57.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.04 -0.356 . . . . 10.0 110.04 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.83 -22.9 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.131 0.491 . . . . 10.0 111.206 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -10.25 57.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.635 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -106.65 16.03 25.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.346 . . . . 10.0 111.072 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 73.2 mt -103.07 133.92 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.083 -0.508 . . . . 10.0 109.765 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.95 -63.12 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.199 -0.455 . . . . 10.0 111.286 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -134.29 152.27 51.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.494 -0.321 . . . . 10.0 110.878 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.51 129.24 70.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.779 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 8.3 m -123.92 127.43 47.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.015 0.436 . . . . 10.0 111.895 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.412 ' HG3' ' OE1' ' B' ' 48' ' ' GLU . 14.4 ttp85 -121.68 144.98 48.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -125.26 -16.64 5.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.675 0.274 . . . . 10.0 111.707 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.31 31.79 4.52 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.307 -0.949 . . . . 10.0 111.064 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 mmtm -155.33 -56.49 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.576 0.75 . . . . 10.0 109.179 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -143.8 138.38 28.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.859 -1.064 . . . . 10.0 109.691 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -95.48 131.81 41.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.808 -0.441 . . . . 10.0 109.808 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 49.4 m-85 -123.21 141.21 52.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.441 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -153.77 173.21 16.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.5 -0.318 . . . . 10.0 111.13 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -130.88 132.8 45.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.581 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -125.44 164.53 20.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.149 0.5 . . . . 10.0 111.249 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -138.08 125.82 22.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.986 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 54.6 mt -100.7 135.54 41.99 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.16 -27.05 62.11 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.223 -0.513 . . . . 10.0 112.887 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.04 8.54 15.64 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.292 -0.48 . . . . 10.0 112.803 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.73 54.35 3.48 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.368 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -147.74 78.35 9.9 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.919 0.39 . . . . 10.0 110.861 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -85.56 148.53 9.94 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.826 2.35 . . . . 10.0 110.863 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.79 -164.78 26.09 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 119.805 -1.188 . . . . 10.0 112.857 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -122.2 177.55 5.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.842 -0.429 . . . . 10.0 109.842 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.62 139.44 6.63 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.768 -0.73 . . . . 10.0 112.119 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.88 128.83 71.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.12 0.486 . . . . 10.0 110.392 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.93 119.61 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.034 -0.53 . . . . 10.0 109.841 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.0 t -68.68 125.86 27.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.732 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.412 ' OE1' ' HG3' ' B' ' 25' ' ' ARG . 52.2 mt-10 -75.68 -2.08 27.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.006 0.431 . . . . 10.0 110.967 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -111.27 -39.67 4.65 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.287 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -85.52 -27.81 25.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.147 0.425 . . . . 10.0 112.147 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.88 146.25 31.74 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.938 -0.305 . . . . 10.0 111.017 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.12 154.39 57.76 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.711 2.274 . . . . 10.0 111.639 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -63.0 -25.18 68.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.363 -0.381 . . . . 10.0 111.164 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -56.2 -44.14 79.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 10.0 110.61 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mt -69.93 -41.1 75.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.786 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.1 -37.66 88.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.054 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -73.37 -25.25 60.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.161 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -79.75 -36.06 37.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.437 -0.347 . . . . 10.0 110.419 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.68 -45.69 50.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.505 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.99 111.62 19.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.96 0.409 . . . . 10.0 110.48 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.25 165.2 15.14 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.64 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.474 ' OE1' ' HG3' ' B' ' 63' ' ' LYS . 1.0 OUTLIER -58.73 139.22 56.5 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.366 0.416 . . . . 10.0 110.398 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.474 ' HG3' ' OE1' ' B' ' 62' ' ' GLN . 43.6 mttp 63.06 79.98 0.24 Allowed 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 123.718 0.636 . . . . 10.0 110.159 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.262 -0.875 . . . . 10.0 109.997 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.676 0.274 . . . . 10.0 110.397 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.51 133.59 36.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.084 0.468 . . . . 10.0 110.83 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -116.7 140.2 49.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.179 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.48 139.04 39.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.855 0.359 . . . . 10.0 110.439 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.83 121.69 18.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.93 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.01 -40.15 63.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.431 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -143.1 164.05 31.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.186 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.85 147.4 39.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -126.92 126.19 42.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.815 0.341 . . . . 10.0 110.883 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.08 113.92 20.94 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.834 -0.621 . . . . 10.0 109.459 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.31 149.0 49.96 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.47 0.481 . . . . 10.0 111.089 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.405 ' HE ' ' C ' ' B' ' 64' ' ' LYS . 0.0 OUTLIER -109.69 -37.35 5.69 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.148 -0.478 . . . . 10.0 111.079 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 p -129.37 -164.11 1.37 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.961 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 98' ' ' GLU . 1.3 pp20? -99.63 6.77 45.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.138 0.494 . . . . 10.0 110.521 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.35 -36.73 11.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.502 -0.772 . . . . 10.0 109.611 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -89.78 145.35 25.25 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 129' ' ' GLU . 9.4 tp -98.74 135.25 40.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.187 0.517 . . . . 10.0 112.043 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.94 134.17 33.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.361 -0.836 . . . . 10.0 110.123 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -147.46 164.92 31.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.797 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -118.98 172.27 7.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.929 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -60.02 118.65 6.54 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.383 -0.826 . . . . 10.0 111.359 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.33 -1.84 43.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.476 -0.869 . . . . 10.0 113.351 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.57 133.7 54.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.839 0.352 . . . . 10.0 111.437 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -94.5 121.09 35.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.689 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -115.88 134.49 54.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.66 0.615 . . . . 10.0 112.66 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -102.9 104.37 14.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.904 -1.146 . . . . 10.0 107.904 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.3 mm -62.44 117.62 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.327 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 123' ' ' ARG . 70.9 mt -94.35 -35.87 12.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.321 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -145.1 99.89 3.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.28 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.79 0.26 46.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.238 0.542 . . . . 10.0 110.252 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -88.3 -0.0 56.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.995 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -63.17 -46.82 85.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.185 0.517 . . . . 10.0 110.333 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.99 -116.75 0.74 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.991 -0.843 . . . . 10.0 110.991 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.78 -28.5 17.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.234 0.54 . . . . 10.0 110.149 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.595 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 17.9 m95 -105.03 110.32 22.67 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.351 -0.981 . . . . 10.0 108.351 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -93.9 154.92 17.45 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.749 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -98.92 122.94 42.82 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -136.3 161.86 34.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.327 0.584 . . . . 10.0 111.602 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.416 ' HB2' HD11 ' A' ' 112' ' ' LEU . 6.0 ttp180 -114.03 133.76 55.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.19 -0.914 . . . . 10.0 109.345 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.5 t -69.45 140.82 54.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.954 0.407 . . . . 10.0 110.507 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 99.2 mt -96.84 2.05 51.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.376 0.608 . . . . 10.0 109.848 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.09 -48.84 3.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.492 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 66.4 p -101.06 -42.8 6.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 10.0 110.842 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.69 -0.73 34.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.059 -0.591 . . . . 10.0 112.42 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 101' ' ' LEU . 32.1 mt-10 -67.26 150.23 49.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.736 0.303 . . . . 10.0 110.905 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.2 m -122.77 133.91 54.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.709 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.1 178.83 46.7 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.61 -0.805 . . . . 10.0 111.995 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -81.47 133.48 35.4 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.276 -0.268 . . . . 10.0 110.276 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.8 pt -128.07 145.54 55.77 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.85 0.357 . . . . 10.0 111.426 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.498 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 47.3 Cg_endo -72.08 127.5 12.88 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.577 2.185 . . . . 10.0 111.672 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.0 p -69.81 -16.09 63.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.96 -0.564 . . . . 10.0 112.267 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.498 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 38.0 p-10 -85.55 -0.45 55.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.692 0.282 . . . . 10.0 111.465 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.433 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 1.9 m-85 -115.58 3.91 14.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.53 -0.304 . . . . 10.0 111.246 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.81 144.65 37.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 10.0 111.105 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -132.77 144.01 51.08 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.085 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.3 132.05 26.56 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.536 2.157 . . . . 10.0 112.305 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.1 t . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.151 -0.928 . . . . 10.0 110.121 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.619 0.247 . . . . 10.0 110.747 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' B' ' 16' ' ' ASP . . . -153.76 128.57 9.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.47 -0.332 . . . . 10.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.9 108.18 19.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.608 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.05 130.78 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.62 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -95.32 132.15 40.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.45 -0.341 . . . . 10.0 110.281 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -145.25 170.18 16.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.186 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.416 ' HG2' ' HG2' ' B' ' 12' ' ' GLU . 98.9 mttt -120.7 105.82 11.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.16 -0.473 . . . . 10.0 109.788 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -99.99 111.71 24.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.894 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt 54.27 34.13 19.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.69 -0.686 . . . . 10.0 112.13 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.52 4.36 68.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.023 -0.608 . . . . 10.0 113.409 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -109.94 123.18 49.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.884 0.342 . . . . 10.0 110.644 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' B' ' 7' ' ' LYS . 39.0 mt-10 -76.14 121.18 22.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -134.44 153.45 51.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.897 0.38 . . . . 10.0 110.972 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.46 114.06 15.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.72 -0.673 . . . . 10.0 109.773 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.04 144.24 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.55 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' B' ' 2' ' ' ALA . 6.9 t70 -64.26 138.27 58.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.387 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' B' ' 20' ' ' ILE . 21.4 tt -61.29 -22.58 27.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.935 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -70.71 -19.65 62.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.7 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -93.99 1.01 56.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.133 0.492 . . . . 10.0 110.517 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' B' ' 17' ' ' ILE . 70.8 mt -94.2 123.97 46.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.725 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.59 -77.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.549 -0.296 . . . . 10.0 111.383 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -113.13 151.63 30.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.011 0.434 . . . . 10.0 111.308 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 32.3 t -129.32 142.01 45.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.421 -0.808 . . . . 10.0 109.983 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.1 m -134.5 122.89 23.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 10.0 111.402 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.48 ' HD2' ' OE2' ' B' ' 48' ' ' GLU . 0.8 OUTLIER -109.98 143.26 40.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.511 . . . . 10.0 110.164 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -124.35 -20.58 5.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.648 0.24 . . . . 10.0 111.648 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.34 22.18 8.84 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.744 -0.943 . . . . 10.0 110.744 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -146.38 -54.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.721 -0.844 . . . . 10.0 108.721 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -146.88 138.59 24.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.008 -0.997 . . . . 10.0 109.433 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 52.0 mt -94.27 126.89 46.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.971 -0.381 . . . . 10.0 109.971 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 18.9 m-85 -111.19 139.29 46.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.38 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -154.4 171.83 18.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.991 0.424 . . . . 10.0 111.273 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -130.32 135.68 48.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.854 -0.612 . . . . 10.0 109.594 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -121.58 156.83 32.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.065 0.46 . . . . 10.0 111.139 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -127.35 117.39 22.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.419 -0.81 . . . . 10.0 109.32 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.52 139.37 31.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.835 0.35 . . . . 10.0 111.319 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.52 -9.39 61.53 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.588 -0.733 . . . . 10.0 112.095 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.83 -8.17 67.6 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.215 -0.517 . . . . 10.0 111.999 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.64 32.5 7.23 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.951 -0.643 . . . . 10.0 112.149 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -153.64 103.38 2.53 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.682 0.277 . . . . 10.0 111.086 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -86.14 168.93 8.91 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.826 2.35 . . . . 10.0 111.44 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.63 -172.0 36.53 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.115 -1.04 . . . . 10.0 113.143 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 6.6 m-85 -123.63 166.2 15.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.855 -0.424 . . . . 10.0 109.855 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.0 150.57 22.13 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.471 -0.871 . . . . 10.0 112.345 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 p -132.67 132.9 59.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.968 0.413 . . . . 10.0 110.451 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.44 136.38 55.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.441 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 26.9 t -74.11 131.29 41.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.391 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.48 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 45.1 mt-10 -84.45 3.64 35.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.964 0.411 . . . . 10.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -119.43 -44.25 2.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.969 0.414 . . . . 10.0 111.068 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -78.72 -49.43 13.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.634 . . . . 10.0 112.481 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -67.23 151.13 97.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.34 . . . . 10.0 111.886 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 32.2 Cg_exo -61.15 142.22 96.1 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.954 2.436 . . . . 10.0 112.296 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -62.93 -23.08 67.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.626 . . . . 10.0 110.704 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.4 -44.99 80.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.155 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.3 -35.47 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.551 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.0 mt -62.03 -42.94 99.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.872 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -72.63 -17.37 61.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 10.0 111.158 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -85.93 -38.56 17.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.635 -0.506 . . . . 10.0 109.635 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 51.6 mt -68.41 -41.77 79.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.085 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.15 85.74 7.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.545 0.688 . . . . 10.0 109.645 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -81.62 131.18 35.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.307 -0.86 . . . . 10.0 109.761 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' B' ' 63' ' ' LYS . 83.9 mm-40 -58.59 127.18 30.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.816 -0.439 . . . . 10.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' B' ' 62' ' ' GLN . 78.8 mttt 74.24 51.92 0.1 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 124.105 0.878 . . . . 10.0 110.122 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.405 ' C ' ' HE ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.359 -0.829 . . . . 10.0 110.945 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.683 0.278 . . . . 10.0 111.035 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.3 mt -88.16 161.18 17.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.295 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -131.07 126.03 34.76 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.1 p -108.63 141.05 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.874 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.3 126.5 31.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.317 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 139' ' ' ALA . 30.0 mt -90.72 -20.62 22.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.013 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.4 159.92 41.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.029 -0.532 . . . . 10.0 109.585 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -85.9 145.4 27.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 10.0 109.868 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -143.37 130.87 21.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.032 0.444 . . . . 10.0 111.41 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.2 124.36 44.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.587 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.83 140.29 58.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.983 0.421 . . . . 10.0 111.234 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -104.86 -23.84 12.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.364 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.1 -166.41 1.79 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.262 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -17.97 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.838 0.351 . . . . 10.0 110.451 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -69.9 -45.55 67.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -87.43 163.26 16.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.615 -0.72 . . . . 10.0 109.61 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.3 tp -130.59 145.46 51.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.757 0.313 . . . . 10.0 111.381 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -81.61 145.77 30.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.829 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -157.23 154.45 29.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -105.17 159.39 15.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.8 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -63.3 116.78 5.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.597 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.5 -4.82 26.42 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.78 -0.724 . . . . 10.0 112.171 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -78.58 150.44 32.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.579 0.228 . . . . 10.0 110.441 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -121.64 143.1 49.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 10.0 110.85 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 159.47 41.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.577 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -103.64 116.38 32.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.045 -0.724 . . . . 10.0 109.045 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.2 mm -68.36 121.13 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.943 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.1 mt -94.73 -40.78 9.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.249 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.586 ' ND2' ' HG3' ' A' ' 116' ' ' GLU . 55.2 t30 -146.39 106.26 3.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.013 0.435 . . . . 10.0 111.24 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.19 0.47 31.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 10.0 110.615 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.18 5.73 47.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.915 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.586 ' HG3' ' ND2' ' A' ' 113' ' ' ASN . 3.4 mt-10 -78.99 -34.47 44.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.689 0.28 . . . . 10.0 111.358 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 156.89 -126.79 1.82 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.349 -0.929 . . . . 10.0 112.37 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -87.42 -43.75 11.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 10.0 110.817 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.424 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 44.2 m95 -88.39 113.35 23.9 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.123 -1.066 . . . . 10.0 108.123 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -95.0 150.78 19.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.181 0.515 . . . . 10.0 112.152 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -88.03 117.07 26.66 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.53 -1.285 . . . . 10.0 107.53 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.3 146.23 49.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.238 0.542 . . . . 10.0 112.228 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -100.39 119.18 38.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.37 -0.832 . . . . 10.0 109.307 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.5 t -60.93 138.22 58.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.847 0.356 . . . . 10.0 110.556 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.0 mt -91.71 2.03 56.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.314 0.578 . . . . 10.0 109.541 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.1 -61.09 1.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.313 -0.858 . . . . 10.0 110.723 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.5 p -100.7 -29.21 12.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.34 . . . . 10.0 111.322 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.25 0.74 54.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.663 -0.779 . . . . 10.0 112.346 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -74.11 154.26 39.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.793 0.33 . . . . 10.0 111.204 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.17 -178.2 3.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.997 -0.547 . . . . 10.0 109.841 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 145.22 168.05 12.69 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.097 -1.049 . . . . 10.0 112.714 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -85.23 124.62 32.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.829 0.347 . . . . 10.0 110.38 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.9 pt -120.48 147.59 45.75 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.382 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.73 125.51 10.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.337 2.025 . . . . 10.0 111.359 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -67.14 -12.64 60.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.326 0.491 . . . . 10.0 112.326 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -96.27 -9.46 30.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.629 0.252 . . . . 10.0 110.814 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -88.04 -12.92 42.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.277 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.9 m -121.42 169.9 12.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.639 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.519 ' HB2' HD11 ' A' ' 90' ' ' LEU . . . -139.29 141.13 28.17 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.994 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.69 131.48 21.42 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.459 2.106 . . . . 10.0 112.336 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.3 t . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.111 -0.947 . . . . 10.0 109.713 179.368 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.403 ' HB3' HG21 ' B' ' 17' ' ' ILE . 7.9 ttt . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.753 0.311 . . . . 10.0 111.254 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.82 171.93 15.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.802 0.334 . . . . 10.0 110.857 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 142.26 32.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.575 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.04 124.87 63.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.928 0.394 . . . . 10.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.65 132.49 46.01 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.734 . . . . 10.0 109.417 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -149.2 173.62 13.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.857 0.36 . . . . 10.0 110.876 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -119.62 85.41 2.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.911 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -73.93 95.8 2.53 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt 61.82 23.89 14.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.459 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.59 -18.33 32.48 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.537 -0.756 . . . . 10.0 112.114 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.63 113.28 9.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.765 0.317 . . . . 10.0 111.015 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -73.29 94.76 2.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.938 -0.573 . . . . 10.0 109.523 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -109.76 153.23 24.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.206 0.526 . . . . 10.0 111.974 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -130.9 105.47 7.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -119.93 146.88 24.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.688 0.28 . . . . 10.0 110.674 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.1 139.59 51.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.839 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.419 HD11 ' O ' ' B' ' 58' ' ' LYS . 13.7 tt -65.95 -18.88 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.467 0.651 . . . . 10.0 110.377 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.6 -4.43 59.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.492 -0.777 . . . . 10.0 111.321 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.67 9.09 39.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.071 0.463 . . . . 10.0 110.519 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 81.7 mt -95.51 125.24 48.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.909 -0.587 . . . . 10.0 109.963 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 t -71.84 -60.95 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.088 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -133.86 151.58 51.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.683 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 t -119.46 115.08 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 10.0 109.722 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 13.7 m -117.34 120.41 38.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.035 0.445 . . . . 10.0 111.823 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.413 ' HD2' ' CD ' ' B' ' 48' ' ' GLU . 4.0 ttp85 -109.06 121.71 45.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -83.52 -39.46 20.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.691 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.2 -2.61 5.87 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.73 -0.948 . . . . 10.0 110.73 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -139.5 -40.29 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.04 141.52 36.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.37 -0.832 . . . . 10.0 109.644 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 55.7 mt -96.33 129.79 45.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.686 -0.487 . . . . 10.0 109.686 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -118.78 136.09 54.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.357 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -153.4 171.46 18.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.818 0.342 . . . . 10.0 110.953 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -125.04 133.98 52.73 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -123.46 166.77 14.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.024 0.44 . . . . 10.0 111.152 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -128.33 157.98 39.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.299 -0.864 . . . . 10.0 109.099 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 mt -133.89 145.29 49.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.829 0.347 . . . . 10.0 111.009 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.83 -15.25 66.59 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.939 -0.648 . . . . 10.0 112.592 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.12 4.51 70.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.254 -0.498 . . . . 10.0 112.874 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.58 38.5 32.33 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.771 -0.728 . . . . 10.0 112.885 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -149.17 88.07 5.17 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 122.552 -0.381 . . . . 10.0 110.663 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -74.98 177.9 7.98 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.374 2.049 . . . . 10.0 111.075 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.72 -169.95 37.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.653 -1.26 . . . . 10.0 112.711 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 28.5 m-85 -117.05 160.33 21.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.898 -0.408 . . . . 10.0 109.898 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.02 141.43 12.12 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.669 -0.777 . . . . 10.0 112.237 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 p -135.77 128.79 47.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.95 0.405 . . . . 10.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 t -128.03 129.89 69.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.027 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' B' ' 51' ' ' ALA . 30.2 t -74.31 133.87 42.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.413 ' CD ' ' HD2' ' B' ' 25' ' ' ARG . 54.0 mt-10 -81.01 -1.21 43.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.176 0.512 . . . . 10.0 110.437 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -116.39 -49.77 2.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.947 -0.569 . . . . 10.0 110.579 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -90.92 45.37 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.783 -0.644 . . . . 10.0 111.973 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' B' ' 47' ' ' SER . . . -162.63 151.06 12.14 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.581 -0.282 . . . . 10.0 110.798 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.24 136.29 74.53 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.86 2.374 . . . . 10.0 112.348 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.84 -29.92 71.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.218 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -59.25 -41.27 88.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.992 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.4 mt -67.55 -36.12 80.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.873 0.368 . . . . 10.0 110.518 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -68.38 -39.8 81.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.136 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -72.49 -21.47 61.2 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.851 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' LYS . . . . . 0.419 ' O ' HD11 ' B' ' 17' ' ' ILE . 79.3 mttt -81.51 -32.02 32.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.166 -0.679 . . . . 10.0 109.166 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 21.6 mt -75.87 -58.93 2.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.895 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -80.17 115.7 19.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.141 0.496 . . . . 10.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mtmm -129.15 170.31 13.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.731 -0.668 . . . . 10.0 109.547 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -69.49 134.9 49.45 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.347 0.404 . . . . 10.0 110.059 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 66.48 54.8 0.86 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.435 0.636 . . . . 10.0 110.312 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.919 0 CA-C-N 115.56 -0.746 . . . . 10.0 110.539 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 120.903 0.382 . . . . 10.0 110.769 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.72 153.64 20.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -114.68 129.4 56.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.782 0.325 . . . . 10.0 110.509 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.8 142.2 18.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.989 -0.55 . . . . 10.0 110.171 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 130.8 43.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.642 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.9 -45.29 18.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.915 -0.584 . . . . 10.0 109.799 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -137.02 173.56 11.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.657 -0.702 . . . . 10.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.88 141.25 36.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.145 -0.48 . . . . 10.0 109.938 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -131.25 123.55 28.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.73 0.3 . . . . 10.0 111.186 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -92.12 133.44 35.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.52 155.05 20.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.164 0.507 . . . . 10.0 111.991 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.2 ttm-85 -110.6 -36.32 5.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.48 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.77 -159.79 0.9 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.449 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -98.58 -10.36 23.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.92 -50.2 15.65 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.367 -0.833 . . . . 10.0 109.596 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -83.65 134.66 34.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.342 -0.845 . . . . 10.0 108.839 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 tp -97.74 134.1 41.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.189 0.519 . . . . 10.0 112.378 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.23 135.1 34.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.418 -0.81 . . . . 10.0 110.199 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -146.87 158.63 43.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.081 0.467 . . . . 10.0 111.377 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -102.29 164.42 11.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.807 -0.633 . . . . 10.0 111.054 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -62.07 113.41 2.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.738 -0.665 . . . . 10.0 110.5 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.61 -1.32 24.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 10.0 112.783 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.57 147.94 51.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.608 0.242 . . . . 10.0 110.469 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -116.74 131.13 57.03 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.1 -0.333 . . . . 10.0 110.1 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -119.18 142.71 47.74 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.553 0.575 . . . . 10.0 112.553 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.641 ' HB2' HD21 ' A' ' 125' ' ' LEU . 6.0 tp-100 -95.0 126.4 40.32 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.477 -0.934 . . . . 10.0 108.477 177.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.4 mm -70.27 115.17 9.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.262 0.553 . . . . 10.0 112.025 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 123' ' ' ARG . 27.1 mt -108.64 -67.09 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.717 -0.674 . . . . 10.0 109.425 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 22.0 t30 -107.38 95.62 5.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.764 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.1 p -99.87 -21.21 15.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.2 0.524 . . . . 10.0 110.813 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.5 m -83.09 20.11 1.3 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.134 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -70.84 -40.22 72.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.139 0.495 . . . . 10.0 109.94 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 137.21 -62.16 0.59 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.597 -0.811 . . . . 10.0 112.321 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.05 -66.11 0.68 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.472 ' HH2' ' HG1' ' B' ' 24' ' ' THR . 24.4 m95 -78.98 115.27 18.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.033 -0.729 . . . . 10.0 109.033 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -90.56 144.42 25.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.98 0.419 . . . . 10.0 111.427 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 113' ' ' ASN . 28.3 tt0 -95.49 109.95 22.08 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.256 -1.016 . . . . 10.0 108.256 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.6 168.8 13.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.929 0.395 . . . . 10.0 111.681 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.484 ' HB2' HD11 ' A' ' 112' ' ' LEU . 69.9 ttp85 -119.04 134.55 55.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.1 t -70.45 137.13 50.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.367 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 110' ' ' GLN . 43.8 mt -84.91 -10.16 57.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.059 0.457 . . . . 10.0 110.006 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.7 m -94.46 -57.5 2.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.609 -0.723 . . . . 10.0 111.607 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 46.6 p -89.0 -35.62 16.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.865 0.364 . . . . 10.0 111.53 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.78 5.85 58.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.658 -0.782 . . . . 10.0 112.096 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -78.1 146.84 34.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.562 0.22 . . . . 10.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.4 m -119.46 132.78 55.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.342 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -174.53 -178.06 44.14 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.687 -0.768 . . . . 10.0 112.12 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -82.46 132.92 35.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.873 0.368 . . . . 10.0 110.622 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 26.1 pt -122.6 142.65 37.97 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.048 -0.524 . . . . 10.0 110.842 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 133' ' ' ILE . 13.4 Cg_exo -69.15 122.12 8.96 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.61 2.207 . . . . 10.0 111.701 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -18.36 65.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.981 -0.554 . . . . 10.0 112.159 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -88.97 -1.84 58.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.478 -0.328 . . . . 10.0 111.232 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -115.51 5.41 14.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.67 0.271 . . . . 10.0 111.429 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.2 m -132.22 157.42 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.744 0.307 . . . . 10.0 110.78 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.57 143.22 19.36 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.314 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.96 143.29 72.09 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.357 2.038 . . . . 10.0 112.085 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.532 -0.747 . . . . 10.0 110.103 179.55 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.514 0.197 . . . . 10.0 111.033 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.67 168.82 18.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.938 0.399 . . . . 10.0 111.381 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.4 142.23 34.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.32 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 21.2 t -110.32 137.53 42.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.704 0.288 . . . . 10.0 110.781 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.73 121.53 42.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.582 -0.525 . . . . 10.0 109.582 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 33.6 p90 -130.88 171.47 13.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.059 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -114.41 93.0 4.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 10.0 109.998 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.16 94.65 6.69 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.982 -0.287 . . . . 10.0 110.227 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm 55.15 31.98 17.48 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.73 -0.668 . . . . 10.0 111.15 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.01 -24.69 20.74 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.903 -0.665 . . . . 10.0 112.719 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -85.92 108.87 18.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.859 0.33 . . . . 10.0 110.749 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 11.3 mt-10 -82.41 113.4 20.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.984 0.421 . . . . 10.0 110.853 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -132.61 157.09 45.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.391 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 52.4 mt-30 -115.9 127.54 55.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.86 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 91.0 t -131.78 147.15 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.33 139.04 57.39 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.683 -0.235 . . . . 10.0 110.556 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 20.6 tt -66.5 -21.11 28.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.381 0.61 . . . . 10.0 109.791 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.09 -15.17 60.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.538 -0.755 . . . . 10.0 110.663 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -95.37 0.49 53.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.158 0.504 . . . . 10.0 110.235 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mt -102.61 106.82 20.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.009 -0.541 . . . . 10.0 109.861 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -65.14 -78.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.774 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -110.1 141.41 43.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.042 0.449 . . . . 10.0 111.756 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.418 ' O ' ' HD3' ' B' ' 64' ' ' LYS . 58.7 t -125.79 114.89 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.327 -0.852 . . . . 10.0 109.247 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' THR . . . . . 0.472 ' HG1' ' HH2' ' A' ' 119' ' ' TRP . 30.1 m -103.93 116.85 33.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.363 0.602 . . . . 10.0 111.973 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 33.8 ttp85 -107.56 137.72 45.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.593 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -111.79 -20.19 12.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.747 0.308 . . . . 10.0 111.678 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.1 -0.49 31.46 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.986 -0.846 . . . . 10.0 110.986 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -134.12 -42.25 0.81 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.158 -0.521 . . . . 10.0 109.89 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -147.82 133.78 19.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.205 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 68.0 mt -94.13 133.96 33.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.501 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -127.59 120.71 28.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.14 -0.482 . . . . 10.0 109.785 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -136.28 168.02 20.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.89 0.376 . . . . 10.0 111.336 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -122.96 126.46 47.24 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.933 -0.766 . . . . 10.0 108.933 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -122.02 156.65 33.04 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.072 0.463 . . . . 10.0 111.57 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -104.99 151.73 23.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.364 -0.834 . . . . 10.0 109.819 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 13.1 mt -135.88 133.93 38.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.781 0.324 . . . . 10.0 111.102 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.06 -10.69 69.13 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.764 -0.653 . . . . 10.0 112.624 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.94 -15.36 74.01 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.969 -0.634 . . . . 10.0 111.773 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.65 -3.02 45.71 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.749 -0.739 . . . . 10.0 112.991 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -131.56 94.32 26.34 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.728 0.299 . . . . 10.0 111.212 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.22 179.67 6.22 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.529 2.153 . . . . 10.0 111.096 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.1 -165.1 28.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.951 -1.119 . . . . 10.0 112.902 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -117.34 157.87 25.39 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.76 132.25 6.98 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.483 -0.865 . . . . 10.0 112.087 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.9 125.12 73.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.307 0.575 . . . . 10.0 110.617 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 91.6 t -126.84 120.95 57.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.766 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -71.84 129.87 39.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.311 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -86.75 18.38 3.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.101 0.477 . . . . 10.0 110.053 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -136.89 -39.27 0.62 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.866 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -94.23 7.67 44.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.631 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.02 153.64 81.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 122.348 -0.22 . . . . 10.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.82 149.58 90.39 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.851 2.367 . . . . 10.0 112.679 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -65.88 -23.3 66.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.735 -0.666 . . . . 10.0 111.307 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -54.76 -39.18 68.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 10.0 110.925 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.82 -37.38 30.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.649 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 28.2 mt -62.88 -42.08 99.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 10.0 111.122 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -66.71 -28.98 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.563 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -79.29 -29.85 42.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.783 0.325 . . . . 10.0 111.229 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 14.5 mt -85.07 -14.46 47.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.969 0.414 . . . . 10.0 110.929 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -70.63 90.88 0.77 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.345 0.593 . . . . 10.0 111.049 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -88.25 100.04 12.68 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.179 -0.675 . . . . 10.0 109.179 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -57.4 116.92 3.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.795 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 91.3 mttt 60.27 81.4 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.134 0.896 . . . . 10.0 110.674 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.418 ' HD3' ' O ' ' B' ' 23' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.401 -0.809 . . . . 10.0 110.284 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 120.718 0.294 . . . . 10.0 110.95 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.7 mt -87.96 155.59 19.76 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.846 -0.428 . . . . 10.0 109.846 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -116.9 136.45 52.94 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.514 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.7 p -111.29 140.29 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.64 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.98 123.67 22.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.559 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.78 -35.61 57.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.563 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.52 169.96 16.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.803 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -76.68 104.69 7.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.656 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.546 ' CE1' HG21 ' B' ' 24' ' ' THR . 86.8 t80 -81.58 128.2 33.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.003 0.43 . . . . 10.0 111.17 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -99.24 115.38 28.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.652 -0.703 . . . . 10.0 109.772 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.0 172.67 7.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.53 -0.304 . . . . 10.0 110.647 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -136.81 -41.63 0.6 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.572 -0.285 . . . . 10.0 111.087 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -172.92 2.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.58 -0.282 . . . . 10.0 110.608 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -92.35 -14.65 28.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.72 0.295 . . . . 10.0 111.336 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -43.75 34.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.023 0.44 . . . . 10.0 110.068 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.15 120.2 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.802 . . . . 10.0 109.762 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.4 tp -78.54 136.82 37.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 10.0 111.943 -178.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -95.0 124.73 39.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.435 -0.802 . . . . 10.0 109.698 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.59 155.01 45.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 10.0 111.805 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -94.43 158.29 15.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.358 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.36 133.18 53.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.817 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.9 -9.56 65.91 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.733 -0.746 . . . . 10.0 113.585 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.56 149.2 45.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.16 0.48 . . . . 10.0 111.094 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -110.66 137.71 47.99 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.093 -0.503 . . . . 10.0 109.928 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.66 155.92 45.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.936 0.398 . . . . 10.0 111.313 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -107.78 114.47 28.44 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 mm -71.21 118.04 15.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.474 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.91 -38.62 12.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.553 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -136.02 117.29 14.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.317 -0.401 . . . . 10.0 111.049 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.5 -15.05 15.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.128 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.5 m -83.19 13.04 4.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.42 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -76.8 -30.65 56.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.253 0.549 . . . . 10.0 110.483 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 128.73 -110.49 1.11 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.72 -0.673 . . . . 10.0 111.79 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.17 -57.43 2.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.277 0.56 . . . . 10.0 110.002 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -82.73 114.89 21.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.735 . . . . 10.0 109.026 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -93.61 144.15 25.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.972 0.415 . . . . 10.0 111.492 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.95 113.88 20.85 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.323 -0.991 . . . . 10.0 108.323 177.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.08 154.65 51.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.057 0.456 . . . . 10.0 111.613 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -111.8 128.18 56.03 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.219 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.2 t -69.22 134.26 48.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.135 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.3 mt -85.31 -3.25 58.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 10.0 109.941 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.55 -61.64 1.65 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.683 -0.689 . . . . 10.0 111.119 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 26.0 p -94.37 -21.71 18.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 10.0 111.723 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.22 15.43 66.82 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.665 -0.779 . . . . 10.0 112.071 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -91.34 154.83 18.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.669 0.271 . . . . 10.0 111.013 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.09 155.93 22.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.527 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.69 172.54 38.49 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.825 -0.702 . . . . 10.0 111.572 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -88.94 127.32 35.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.842 0.353 . . . . 10.0 110.351 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.7 pt -120.67 144.64 39.17 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.982 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.543 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 46.4 Cg_endo -73.04 131.35 16.65 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.448 2.099 . . . . 10.0 111.447 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 p -73.74 -1.65 20.07 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.605 0.595 . . . . 10.0 112.605 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.543 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 28.1 p-10 -105.15 13.79 30.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.848 0.356 . . . . 10.0 111.01 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.464 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 5.5 m-85 -126.4 7.87 7.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.686 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.7 m -133.15 155.86 41.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.893 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -135.4 144.16 48.35 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.19 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 13.8 Cg_exo -69.6 132.08 22.83 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.563 2.175 . . . . 10.0 111.686 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.666 -0.683 . . . . 10.0 110.522 -179.94 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ttt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.439 0.161 . . . . 10.0 111.067 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.05 130.68 7.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.773 0.32 . . . . 10.0 110.918 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.39 112.76 19.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.436 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 23.9 t -89.28 129.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.821 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -97.55 119.1 35.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.62 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -131.67 147.04 52.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.56 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -89.97 109.97 20.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.266 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -111.59 105.82 14.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.42 -0.355 . . . . 10.0 111.08 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt 56.67 38.15 29.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.666 -0.697 . . . . 10.0 111.878 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.4 -0.11 85.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.721 -0.752 . . . . 10.0 112.811 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' GLU . . . . . 0.415 ' CB ' ' HE2' ' B' ' 13' ' ' LYS . 49.4 mt-10 -111.87 117.34 32.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.728 0.264 . . . . 10.0 110.495 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -74.09 112.88 10.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.008 -0.367 . . . . 10.0 110.008 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.415 ' HE2' ' CB ' ' B' ' 11' ' ' GLU . 51.7 mmtt -109.68 147.4 33.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.159 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 8.4 pt20 -130.3 109.26 10.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.516 -0.55 . . . . 10.0 109.516 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.41 142.5 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.503 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -64.78 143.5 57.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.809 -0.441 . . . . 10.0 109.809 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 14.8 tt -56.41 -21.66 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.716 -0.675 . . . . 10.0 112.72 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.24 -14.22 47.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.392 0.516 . . . . 10.0 112.392 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -95.14 16.13 17.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.267 0.556 . . . . 10.0 111.461 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 47.5 mt -105.69 133.6 49.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.546 -0.752 . . . . 10.0 109.284 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.39 -72.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.563 -0.29 . . . . 10.0 110.833 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -133.44 154.77 50.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.601 -0.272 . . . . 10.0 110.3 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.36 126.33 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.402 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' THR . . . . . 0.546 HG21 ' CE1' ' A' ' 93' ' ' TYR . 1.3 m -125.49 127.66 46.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.024 0.44 . . . . 10.0 110.67 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 48.2 ttp85 -108.46 138.48 44.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.496 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -101.44 -17.21 16.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.197 0.522 . . . . 10.0 111.354 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 14.18 24.56 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.101 -0.8 . . . . 10.0 111.101 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -146.86 -51.87 0.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.484 -0.932 . . . . 10.0 108.484 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -130.13 148.8 52.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.514 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mt -105.31 124.8 60.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.805 -0.443 . . . . 10.0 109.805 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -114.03 127.57 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.33 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -146.4 175.26 10.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.856 0.36 . . . . 10.0 111.033 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -136.95 128.41 28.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.903 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -111.01 158.2 19.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.718 0.295 . . . . 10.0 110.725 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -131.56 107.67 9.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.594 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -95.14 143.18 26.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.532 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.47 12.23 47.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.039 -0.601 . . . . 10.0 112.508 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.88 16.63 60.0 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.986 -0.626 . . . . 10.0 111.698 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.35 31.88 63.02 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.124 -0.56 . . . . 10.0 112.197 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -149.41 92.11 4.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.792 0.329 . . . . 10.0 111.492 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -90.49 177.88 2.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.781 2.32 . . . . 10.0 110.678 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.46 -172.25 45.29 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 119.979 -1.105 . . . . 10.0 112.807 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -117.38 -178.96 3.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.654 0.264 . . . . 10.0 110.406 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.35 143.17 10.05 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.465 -0.654 . . . . 10.0 111.465 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.02 125.16 28.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.089 0.471 . . . . 10.0 110.604 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 t -129.47 143.49 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.312 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.3 t -96.59 137.62 35.39 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.953 -0.388 . . . . 10.0 109.953 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -72.46 -12.28 61.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.737 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -100.31 -13.03 18.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.863 0.363 . . . . 10.0 110.744 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.13 -54.5 3.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.218 -0.447 . . . . 10.0 111.459 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -89.78 143.55 30.4 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.499 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.432 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 26.0 Cg_exo -62.74 155.74 57.51 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.601 2.201 . . . . 10.0 111.823 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.89 -27.4 63.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.261 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -53.18 -44.05 67.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.68 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 70.2 mt -80.16 -37.46 33.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.958 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 40.8 mt -60.84 -40.67 93.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.565 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -70.63 -22.63 62.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.034 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -75.76 -26.88 57.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.232 0.539 . . . . 10.0 110.037 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.87 -30.61 17.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.121 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.82 94.93 1.86 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.21 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -95.14 130.86 41.69 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.483 -0.78 . . . . 10.0 110.306 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -64.55 124.31 21.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.62 77.73 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.89 0.744 . . . . 10.0 110.045 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.379 -0.819 . . . . 10.0 110.301 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.713 0.292 . . . . 10.0 110.904 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.8 mt -113.21 154.49 26.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.257 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -113.82 125.27 53.89 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.86 142.24 17.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.442 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.417 ' HA ' HG12 ' A' ' 138' ' ' VAL . . . -74.14 123.8 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.423 -0.353 . . . . 10.0 110.675 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.25 -37.41 53.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.04 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -146.0 158.21 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.524 -0.762 . . . . 10.0 109.503 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.42 146.43 54.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.238 0.336 . . . . 10.0 110.272 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -127.66 131.86 49.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.947 0.403 . . . . 10.0 111.02 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -95.28 128.43 42.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.462 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.402 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -68.92 137.84 54.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 10.0 110.731 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -113.22 -31.85 6.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.272 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.3 -163.97 1.46 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.401 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -93.11 -19.1 21.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.835 0.35 . . . . 10.0 111.053 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.46 -37.09 60.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.857 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -93.56 151.54 19.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.254 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.9 tp -120.36 134.85 55.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.424 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 2.9 p -79.3 153.06 30.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.886 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -158.45 160.2 36.53 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.426 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -101.95 156.0 17.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.475 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -62.76 123.37 18.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.87 -12.24 22.63 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.767 -0.73 . . . . 10.0 112.95 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -72.15 150.12 44.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 10.0 111.472 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -111.47 137.32 49.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.349 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -124.39 150.94 45.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.218 0.532 . . . . 10.0 111.936 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -106.98 103.67 13.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.038 -0.983 . . . . 10.0 108.709 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 122' ' ' ALA . 26.1 mm -64.45 124.82 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.39 -0.368 . . . . 10.0 111.038 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.81 -39.85 8.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.295 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -130.96 122.56 27.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.36 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.3 p -133.65 19.09 3.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.243 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.76 -6.99 10.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.359 0.503 . . . . 10.0 112.359 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -84.29 -109.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.494 0.188 . . . . 10.0 110.598 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.518 ' HA2' ' OH ' ' B' ' 8' ' ' TYR . . . -73.19 -164.35 8.55 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.77 -0.729 . . . . 10.0 112.143 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -95.65 4.25 53.23 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.667 0.746 . . . . 10.0 110.044 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -105.06 155.73 18.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.513 -1.292 . . . . 10.0 107.513 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -106.45 129.57 54.4 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.084 -0.647 . . . . 10.0 112.671 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.26 115.03 27.16 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.16 -1.422 . . . . 10.0 107.16 177.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.551 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -137.33 161.83 35.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.442 0.639 . . . . 10.0 112.668 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 123' ' ' ARG . 31.4 ttp180 -106.78 120.93 43.33 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.117 -0.947 . . . . 10.0 109.318 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.2 t -69.67 134.73 49.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.9 mt -78.52 -11.05 59.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.864 0.364 . . . . 10.0 110.214 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -82.91 -56.61 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.558 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 p -92.76 -32.67 14.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.359 -0.382 . . . . 10.0 112.027 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.89 20.74 49.24 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.645 -0.788 . . . . 10.0 111.6 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -109.92 159.55 17.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.772 -0.214 . . . . 10.0 110.937 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.37 -179.48 4.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.705 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.58 157.32 7.73 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.185 -0.531 . . . . 10.0 111.778 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -80.76 116.38 20.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 37.6 pt -99.59 140.92 21.96 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.727 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 133' ' ' ILE . 27.0 Cg_exo -61.01 117.87 4.68 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.44 2.093 . . . . 10.0 111.465 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -6.5 11.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 10.0 112.538 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -107.18 3.63 25.86 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.743 0.275 . . . . 10.0 111.743 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.97 3.79 14.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.818 0.342 . . . . 10.0 111.036 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 89' ' ' ALA . 20.5 m -132.51 159.15 43.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.929 0.395 . . . . 10.0 111.037 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.7 141.23 34.5 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.725 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.87 130.29 13.27 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.441 2.094 . . . . 10.0 111.875 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.386 -0.816 . . . . 10.0 109.968 179.945 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ttt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.438 0.161 . . . . 10.0 110.605 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.04 169.53 24.35 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.618 0.247 . . . . 10.0 110.957 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.95 139.53 30.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.802 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -102.94 130.28 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.718 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -94.02 118.64 31.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.072 -0.513 . . . . 10.0 109.953 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -136.54 178.34 7.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.569 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' LYS . . . . . 0.421 ' HE2' ' OE2' ' B' ' 12' ' ' GLU . 66.6 mttt -123.1 137.94 54.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.871 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 8' ' ' TYR . . . . . 0.518 ' OH ' ' HA2' ' A' ' 117' ' ' GLY . 77.2 t80 -134.95 115.84 14.03 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.082 -0.71 . . . . 10.0 109.082 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm 59.34 24.02 12.53 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.512 0.507 . . . . 10.0 111.384 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.89 -0.6 67.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.905 -0.664 . . . . 10.0 112.77 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -103.13 136.13 43.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.686 -0.302 . . . . 10.0 110.426 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.421 ' OE2' ' HE2' ' B' ' 7' ' ' LYS . 20.3 mt-10 -86.52 126.19 34.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.54 -0.3 . . . . 10.0 110.238 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -139.11 153.38 48.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.616 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -125.7 124.52 41.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.412 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.2 t -134.62 146.83 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.079 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.71 140.44 56.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.623 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 tt -64.57 -26.57 40.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.912 -0.586 . . . . 10.0 110.6 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.91 -11.84 60.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.213 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -99.4 3.56 45.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.031 0.443 . . . . 10.0 110.482 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.4 mt -95.3 127.76 47.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.62 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.41 -88.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.339 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -100.11 149.86 23.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 10.0 110.93 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.1 t -127.12 116.1 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.715 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 1.2 m -108.72 104.22 13.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.142 0.496 . . . . 10.0 111.528 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -100.47 146.61 26.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.78 -0.646 . . . . 10.0 109.966 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -138.08 5.13 2.53 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.088 0.47 . . . . 10.0 111.165 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.47 20.55 68.84 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.569 -0.824 . . . . 10.0 111.281 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -138.83 -59.7 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.057 -0.72 . . . . 10.0 109.057 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -145.74 134.24 22.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.04 -0.982 . . . . 10.0 109.557 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 89.8 mt -91.37 117.94 35.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 123.302 0.376 . . . . 10.0 110.352 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -107.14 135.53 48.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.707 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -152.76 173.52 15.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.03 0.443 . . . . 10.0 111.388 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -131.91 141.65 49.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.496 -0.775 . . . . 10.0 109.668 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -133.36 173.72 11.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.82 0.343 . . . . 10.0 110.462 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -142.93 127.39 17.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.088 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt -100.51 142.2 32.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.723 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.97 -21.05 60.82 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 116.056 -0.52 . . . . 10.0 113.258 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.93 -3.7 75.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.911 -0.661 . . . . 10.0 112.38 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.43 34.41 8.62 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.914 -0.66 . . . . 10.0 112.052 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -125.43 77.36 68.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.739 0.305 . . . . 10.0 111.243 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.89 148.66 17.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.551 2.168 . . . . 10.0 111.442 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.86 -174.0 39.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.011 -1.09 . . . . 10.0 112.728 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -112.84 174.57 5.83 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.962 -0.384 . . . . 10.0 109.962 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.53 151.58 22.13 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.107 -0.797 . . . . 10.0 111.107 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.8 p -135.78 137.75 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.253 0.549 . . . . 10.0 111.263 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.36 132.97 70.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.782 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 13.6 t -73.5 128.44 35.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.591 -0.277 . . . . 10.0 110.358 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -84.97 6.94 22.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.929 0.395 . . . . 10.0 110.792 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -120.22 -39.47 2.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.269 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.66 -50.87 7.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.93 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -67.15 146.57 98.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.861 -0.609 . . . . 10.0 111.332 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 31.8 Cg_exo -59.23 148.72 84.76 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.54 2.16 . . . . 10.0 112.364 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -60.66 -26.84 67.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.058 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -53.33 -42.48 66.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.159 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 90.2 mt -74.44 -36.39 63.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 10.0 110.695 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 35.6 mt -65.72 -36.97 85.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.626 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -71.9 -14.49 61.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.111 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -96.26 -37.54 10.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.097 0.475 . . . . 10.0 109.831 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -70.53 -35.03 72.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.113 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -74.44 89.94 2.16 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.132 0.492 . . . . 10.0 110.35 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -70.23 109.17 4.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -50.85 123.38 8.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.293 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 65.64 58.58 0.8 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.346 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.533 -0.746 . . . . 10.0 110.622 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.856 0.36 . . . . 10.0 110.637 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.0 mt -81.6 128.1 33.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.278 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -117.82 127.42 53.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.656 -0.702 . . . . 10.0 109.478 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 p -99.79 135.06 36.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.891 0.377 . . . . 10.0 110.432 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.43 118.95 13.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.688 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.4 mt -70.14 -31.48 69.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.673 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -151.3 -178.2 6.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.064 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -87.47 159.99 18.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.16 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -141.12 125.61 17.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.858 0.361 . . . . 10.0 110.789 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -87.86 114.19 24.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.723 -0.672 . . . . 10.0 109.712 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.09 155.69 24.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.255 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -119.02 -20.03 8.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.885 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.6 -160.04 1.01 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.581 -0.282 . . . . 10.0 110.802 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -101.75 -19.88 15.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.983 0.42 . . . . 10.0 110.575 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.99 -48.03 59.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.516 -0.766 . . . . 10.0 109.418 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.83 129.04 34.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.279 -0.873 . . . . 10.0 109.362 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.48 138.69 31.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.903 -0.59 . . . . 10.0 112.319 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -92.2 136.82 32.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.615 -0.513 . . . . 10.0 109.615 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -153.54 178.46 9.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.821 0.343 . . . . 10.0 111.025 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.88 173.87 10.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.98 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -63.57 122.56 16.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.778 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.99 -4.13 33.85 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.836 -0.697 . . . . 10.0 112.524 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -66.33 131.93 47.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.741 0.305 . . . . 10.0 110.856 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -102.1 118.64 37.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.87 -0.419 . . . . 10.0 109.87 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -112.17 142.77 44.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.501 0.556 . . . . 10.0 112.501 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -108.22 104.3 13.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.513 -1.291 . . . . 10.0 107.513 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.64 123.96 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.522 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -102.82 -51.54 3.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.436 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -133.85 114.46 13.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.78 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -129.8 9.39 5.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.451 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.58 -0.98 51.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.435 -0.802 . . . . 10.0 111.897 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -87.72 -91.55 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.887 -0.325 . . . . 10.0 110.221 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.77 -162.57 28.96 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.603 -0.808 . . . . 10.0 111.627 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.53 -28.2 41.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.869 0.366 . . . . 10.0 110.19 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -81.32 145.59 30.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.551 -1.278 . . . . 10.0 107.551 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -106.6 142.5 36.15 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.794 0.665 . . . . 10.0 112.794 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.32 118.17 30.96 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 177.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.96 163.39 33.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.292 0.568 . . . . 10.0 111.64 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -114.79 138.32 50.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.423 -0.808 . . . . 10.0 110.08 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.9 t -73.22 133.49 44.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.273 -0.422 . . . . 10.0 110.434 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.6 mt -92.22 5.85 48.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 10.0 109.956 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.19 -51.11 3.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.703 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.0 p -103.73 -39.39 6.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.033 0.444 . . . . 10.0 110.83 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.7 -2.59 29.03 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.931 -0.652 . . . . 10.0 111.766 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -66.14 142.39 57.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.623 0.249 . . . . 10.0 110.826 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.5 m -117.58 144.6 44.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.539 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.02 179.01 42.68 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.173 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -85.22 135.96 33.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.896 0.379 . . . . 10.0 110.205 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.2 pt -122.47 145.48 44.82 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.294 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.444 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 31.9 Cg_endo -67.44 121.14 8.22 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.776 2.318 . . . . 10.0 111.497 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -4.93 14.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.628 -0.714 . . . . 10.0 112.736 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.444 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 36.0 p-10 -101.57 6.24 42.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.754 0.311 . . . . 10.0 110.977 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -124.96 14.12 8.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.298 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.29 146.52 30.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.471 -0.331 . . . . 10.0 110.755 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -130.9 142.97 47.49 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.557 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.23 131.71 19.67 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.356 2.038 . . . . 10.0 112.323 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.453 -0.784 . . . . 10.0 109.915 179.818 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.779 0.323 . . . . 10.0 110.405 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.74 151.07 26.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.747 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.3 m -94.98 123.16 38.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.242 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 20.6 t -98.75 132.96 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.999 0.428 . . . . 10.0 111.241 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -102.73 111.85 24.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.597 -0.729 . . . . 10.0 109.094 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -130.16 -174.41 3.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.441 . . . . 10.0 111.104 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -110.62 148.6 31.86 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.171 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.17 103.43 4.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.159 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 tptt 58.67 30.77 20.36 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.7 0.625 . . . . 10.0 110.703 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.49 -31.79 8.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.29 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -75.74 168.97 19.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.806 0.336 . . . . 10.0 110.515 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -114.37 129.73 56.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -132.64 148.1 52.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.833 0.349 . . . . 10.0 111.27 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -117.01 109.57 17.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.963 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 94.6 t -129.0 139.38 52.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 110.148 -0.315 . . . . 10.0 110.148 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 31.0 m-20 -66.9 141.17 57.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.861 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.08 -23.52 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.039 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.67 0.25 18.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.147 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -114.61 9.65 16.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.468 . . . . 10.0 110.244 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 63.9 mt -97.3 132.49 41.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.157 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 t -79.15 -59.99 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.367 -0.379 . . . . 10.0 111.658 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -141.03 155.14 46.23 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.245 -0.284 . . . . 10.0 110.824 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 68.1 t -123.54 122.91 66.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 O-C-N 123.512 0.508 . . . . 10.0 110.59 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 7.3 m -113.53 107.37 15.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.888 0.375 . . . . 10.0 110.969 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.496 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 8.0 ttp85 -102.65 149.9 23.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.254 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -125.84 -22.71 4.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.508 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.04 16.8 14.13 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.958 -0.857 . . . . 10.0 110.958 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -144.38 -51.34 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -145.08 136.02 24.7 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.384 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 52.7 mt -93.88 128.26 45.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.571 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 29.4 m-85 -119.16 130.52 55.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -143.8 172.02 13.41 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.71 -0.396 . . . . 10.0 111.677 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -128.98 136.41 50.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.706 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -131.11 166.84 20.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.891 0.377 . . . . 10.0 111.287 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -132.33 114.74 14.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.539 -0.755 . . . . 10.0 109.729 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 88.1 mt -88.0 135.6 33.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.979 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.75 -8.74 35.33 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.819 -0.628 . . . . 10.0 112.815 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.87 -11.76 83.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.979 -0.629 . . . . 10.0 112.258 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.05 16.34 19.25 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.92 -0.657 . . . . 10.0 112.702 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -138.2 104.03 8.0 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 120.885 -0.326 . . . . 10.0 111.62 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.47 171.42 7.44 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.733 2.289 . . . . 10.0 111.18 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.42 -173.76 44.87 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.66 -1.257 . . . . 10.0 112.966 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -113.42 169.51 8.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.537 0.208 . . . . 10.0 110.497 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.23 151.53 23.48 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.151 -0.547 . . . . 10.0 111.823 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.7 p -136.27 140.12 44.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 10.0 111.517 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.78 135.46 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.901 -0.59 . . . . 10.0 109.557 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.3 t -76.02 134.89 40.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.745 0.307 . . . . 10.0 110.714 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.459 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 45.0 mt-10 -89.79 8.95 29.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 10.0 110.048 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -132.22 -42.77 0.97 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.733 -0.667 . . . . 10.0 111.665 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.21 34.23 1.81 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.208 0.447 . . . . 10.0 112.208 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.98 154.66 34.55 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.705 -0.225 . . . . 10.0 110.574 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -59.48 134.71 60.03 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.77 2.313 . . . . 10.0 111.356 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -67.97 -16.65 64.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.219 -0.446 . . . . 10.0 112.165 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -59.61 -44.4 93.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.409 . . . . 10.0 110.366 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.97 -39.23 83.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.526 . . . . 10.0 110.008 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.9 -41.0 95.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.741 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -62.5 -38.12 88.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.323 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.69 -35.86 44.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.956 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.28 -56.33 22.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.857 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' GLU . . . . . 0.496 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 40.6 tt0 -86.81 89.77 8.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.335 0.588 . . . . 10.0 110.944 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -78.58 148.74 33.19 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -64.7 138.91 58.67 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.1 mttt 72.04 54.64 0.18 Allowed 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.983 0.802 . . . . 10.0 110.245 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.662 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 120.678 0.275 . . . . 10.0 110.507 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 73.1 mt -92.15 150.85 20.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -119.37 137.53 53.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.853 0.358 . . . . 10.0 110.942 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -111.86 140.01 33.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.335 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.74 122.8 22.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.921 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.9 mt -79.13 -38.32 36.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.462 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -134.19 161.39 35.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.36 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -77.23 121.54 23.81 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -112.22 117.92 33.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.075 0.464 . . . . 10.0 110.431 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -94.46 120.52 34.82 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.906 -0.588 . . . . 10.0 109.486 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.471 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -73.48 156.61 38.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.969 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.1 ttm105 -123.28 -26.42 4.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.85 -0.614 . . . . 10.0 110.676 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.48 -168.51 1.5 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.297 -0.41 . . . . 10.0 111.022 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -97.8 -3.17 39.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.018 0.437 . . . . 10.0 111.14 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.52 -43.29 9.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.04 -0.527 . . . . 10.0 110.385 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -81.16 147.43 30.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.552 -0.749 . . . . 10.0 109.91 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 62.2 tp -103.84 131.39 51.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.337 -0.392 . . . . 10.0 112.009 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.471 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -85.37 135.8 33.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.877 178.713 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -155.58 165.46 36.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.775 0.322 . . . . 10.0 110.664 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.493 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 36.5 m170 -110.22 165.23 11.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.959 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -61.82 126.1 26.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.558 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.35 -4.21 43.99 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.675 -0.774 . . . . 10.0 112.146 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 2.5 tp10 -68.11 148.12 51.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 122.204 0.202 . . . . 10.0 110.922 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -119.1 133.52 55.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.662 -0.495 . . . . 10.0 109.662 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 107' ' ' GLU . 0.4 OUTLIER -130.53 155.46 46.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.125 0.488 . . . . 10.0 111.582 -179.156 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -109.45 114.11 27.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.2 mm -63.2 128.77 25.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.143 -0.48 . . . . 10.0 111.065 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.03 -44.33 4.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.917 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 116' ' ' GLU . 30.1 t30 -138.81 108.55 6.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.812 0.339 . . . . 10.0 111.131 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.72 -11.32 19.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.163 0.506 . . . . 10.0 110.73 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.6 8.79 15.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.069 -0.514 . . . . 10.0 111.446 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.407 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 7.2 tp10 -77.98 -20.14 53.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.013 0.435 . . . . 10.0 110.806 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.34 -139.99 9.61 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.818 -0.706 . . . . 10.0 111.499 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.11 -35.28 49.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.98 -0.378 . . . . 10.0 109.98 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.466 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 20.4 m95 -92.18 126.01 37.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -103.55 146.99 27.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.882 0.372 . . . . 10.0 111.228 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -97.11 122.17 39.82 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.735 -0.839 . . . . 10.0 108.735 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.74 162.46 32.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.953 0.406 . . . . 10.0 111.543 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 123' ' ' ARG . 13.1 ttt-85 -109.53 128.08 54.93 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.453 -0.794 . . . . 10.0 109.599 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.3 t -67.3 134.16 51.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.163 -0.472 . . . . 10.0 109.749 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.9 mt -83.73 -10.66 57.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.864 0.364 . . . . 10.0 110.105 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.12 -62.77 1.37 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.761 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.2 p -87.36 -35.73 18.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.037 0.446 . . . . 10.0 111.546 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.89 2.01 52.17 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.72 -0.753 . . . . 10.0 111.87 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.99 144.7 48.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.802 0.334 . . . . 10.0 111.248 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.7 m -117.76 135.64 53.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.288 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -178.68 178.44 48.71 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.445 -0.883 . . . . 10.0 112.106 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -79.79 126.09 30.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.965 0.412 . . . . 10.0 109.971 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 31.2 pt -115.67 139.83 25.28 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.797 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.07 112.58 1.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.453 2.102 . . . . 10.0 111.34 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.67 -18.21 61.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.056 -0.52 . . . . 10.0 112.134 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -92.57 5.69 49.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.621 -0.263 . . . . 10.0 111.494 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -119.25 4.82 11.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.914 0.388 . . . . 10.0 110.748 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.93 149.07 32.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.152 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -129.39 142.65 45.96 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.218 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 6.7 Cg_exo -73.84 135.73 21.9 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.437 2.092 . . . . 10.0 111.773 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.367 -0.825 . . . . 10.0 110.682 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ttt . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.348 0.118 . . . . 10.0 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.35 174.08 13.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.75 0.309 . . . . 10.0 111.153 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 2.1 m -108.59 131.56 54.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.47 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.86 125.06 48.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.892 0.377 . . . . 10.0 110.893 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -103.86 111.44 23.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.272 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -121.94 176.99 5.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.978 -0.556 . . . . 10.0 111.036 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -121.06 94.72 4.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.469 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -80.88 92.02 6.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.059 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm 56.24 43.9 25.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.42 -0.809 . . . . 10.0 111.893 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.6 -16.43 59.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.852 -0.69 . . . . 10.0 113.586 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -94.75 117.79 30.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.168 0.484 . . . . 10.0 111.314 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -76.81 117.26 18.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -132.37 137.97 47.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.855 0.359 . . . . 10.0 110.877 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -112.48 116.28 30.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.137 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.3 t -124.08 140.34 47.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.775 -0.454 . . . . 10.0 109.775 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -57.51 137.21 56.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.594 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.8 tt -60.12 -26.94 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.983 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.27 2.16 16.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.434 -0.348 . . . . 10.0 111.821 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' B' ' 35' ' ' ASP . 95.4 mttt -112.01 8.27 20.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.775 0.321 . . . . 10.0 111.088 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -92.2 119.97 40.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.78 -70.32 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.888 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -128.49 148.98 50.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.73 0.3 . . . . 10.0 111.145 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.21 132.37 68.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.481 -0.781 . . . . 10.0 110.297 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 28.7 m -132.22 115.4 15.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.037 0.446 . . . . 10.0 110.851 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.546 ' HD2' ' OE1' ' B' ' 48' ' ' GLU . 68.5 ttp85 -116.32 144.26 44.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.309 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -119.89 7.62 10.97 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.132 0.491 . . . . 10.0 111.607 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.542 ' H ' ' HG2' ' B' ' 25' ' ' ARG . . . 90.53 16.56 54.89 Favored Glycine 0 C--O 1.231 -0.077 0 C-N-CA 120.462 -0.875 . . . . 10.0 112.203 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -140.0 -60.92 0.53 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.48 0.657 . . . . 10.0 109.343 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -131.46 147.05 52.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.162 -0.926 . . . . 10.0 109.699 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 61.7 mt -101.57 111.96 33.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.681 -0.69 . . . . 10.0 110.089 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -103.02 126.95 50.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.089 -0.505 . . . . 10.0 109.676 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -152.45 172.96 15.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.01 0.433 . . . . 10.0 111.133 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -129.16 134.41 48.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.785 -0.643 . . . . 10.0 109.739 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -110.98 168.83 9.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.239 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' B' ' 19' ' ' LYS . 21.8 t70 -131.65 153.09 50.32 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.312 -0.625 . . . . 10.0 109.312 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 51.0 mt -138.55 139.29 38.62 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.189 -0.3 . . . . 10.0 110.189 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.97 -20.93 60.68 Favored Glycine 0 C--N 1.33 0.218 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.33 -18.49 71.49 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.749 -0.54 . . . . 10.0 111.749 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.07 29.38 6.45 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.972 -0.632 . . . . 10.0 112.795 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -130.41 85.91 55.06 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.883 0.341 . . . . 10.0 111.56 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -91.33 76.94 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.138 2.559 . . . . 10.0 111.997 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.58 -167.47 43.69 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.927 -0.654 . . . . 10.0 113.027 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 62.1 m-85 -111.65 172.34 6.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.852 0.358 . . . . 10.0 110.727 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.22 151.59 23.05 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.358 -0.697 . . . . 10.0 111.358 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 14.6 p -141.57 140.49 31.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.13 0.49 . . . . 10.0 110.984 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.57 147.77 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.559 . . . . 10.0 109.651 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 22.2 t -93.0 136.67 33.05 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.168 -0.308 . . . . 10.0 110.168 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' GLU . . . . . 0.546 ' OE1' ' HD2' ' B' ' 25' ' ' ARG . 19.6 tt0 -80.66 -10.17 59.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.979 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -110.99 -26.01 9.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.157 0.428 . . . . 10.0 112.157 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -97.83 -15.16 20.37 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.465 0.543 . . . . 10.0 112.465 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.29 151.34 41.42 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.451 0.167 . . . . 10.0 111.226 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 25.7 Cg_exo -63.5 147.78 92.96 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.713 2.275 . . . . 10.0 111.836 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -64.31 -21.95 66.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.969 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.96 -45.93 71.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.918 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.2 mt -78.61 -36.26 44.42 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.898 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 36.4 mt -61.91 -39.38 91.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.203 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -69.08 -16.58 63.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 10.0 111.771 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -90.28 -20.24 23.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.167 0.508 . . . . 10.0 110.173 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 21.3 mt -93.08 -37.98 11.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.751 -0.659 . . . . 10.0 110.141 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -79.66 85.3 5.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.563 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' B' ' 64' ' ' LYS . 86.4 mttt -91.32 163.59 14.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.968 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -81.74 126.48 31.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 63.36 36.91 11.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.236 0.541 . . . . 10.0 109.736 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.174 -0.921 . . . . 10.0 111.673 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 120.579 0.228 . . . . 10.0 110.69 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.5 mt -100.43 141.77 32.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -111.18 134.94 52.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.111 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 107' ' ' GLU . 12.6 p -109.42 138.61 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.453 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.84 123.46 26.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.862 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.2 mt -81.32 -34.64 31.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.338 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -133.54 154.99 50.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.259 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.76 145.48 30.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.242 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -150.85 130.0 12.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.53 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -97.06 132.18 43.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.949 -0.759 . . . . 10.0 108.949 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 143.96 57.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.97 0.414 . . . . 10.0 111.396 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -97.01 -12.11 23.68 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.788 -0.642 . . . . 10.0 109.919 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.37 -166.49 2.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.028 -0.987 . . . . 10.0 109.434 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -98.35 -2.99 38.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -78.06 -47.84 17.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.002 -0.999 . . . . 10.0 108.827 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -87.64 155.68 19.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.192 -0.913 . . . . 10.0 108.818 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.1 tp -111.23 139.36 46.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.868 0.366 . . . . 10.0 111.86 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.9 m -81.44 140.04 34.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.665 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -152.2 166.22 32.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.967 0.413 . . . . 10.0 111.007 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -121.61 166.71 13.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.213 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -59.51 122.59 14.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.59 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.08 -1.43 44.2 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.733 -0.746 . . . . 10.0 112.611 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -67.15 140.94 57.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.644 0.259 . . . . 10.0 110.875 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -112.27 124.83 53.32 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 107' ' ' GLU . 25.6 m-85 -116.94 146.07 43.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.292 0.568 . . . . 10.0 112.356 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -100.14 101.43 12.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.718 -1.216 . . . . 10.0 107.718 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.0 mm -60.77 116.28 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.374 -0.376 . . . . 10.0 111.316 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.8 mt -89.25 -53.51 4.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.307 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -133.25 104.57 6.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.376 -0.375 . . . . 10.0 111.008 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.75 -8.19 44.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.289 0.566 . . . . 10.0 110.497 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 10.57 27.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.215 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.86 -25.12 59.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.913 0.387 . . . . 10.0 110.317 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.42 -127.79 3.18 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.639 -0.584 . . . . 10.0 111.639 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -83.15 -47.74 11.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.484 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 25.8 m95 -88.5 127.68 35.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.531 -0.915 . . . . 10.0 108.531 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -107.52 139.96 41.24 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.835 0.35 . . . . 10.0 111.277 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -85.39 119.41 25.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.177 -1.045 . . . . 10.0 108.177 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.11 162.61 30.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.071 0.463 . . . . 10.0 111.818 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -112.91 122.09 46.62 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.378 -0.828 . . . . 10.0 108.922 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.4 t -62.25 144.34 55.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.883 0.373 . . . . 10.0 110.741 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.75 -16.17 37.19 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.176 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 m -93.05 -50.79 5.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.709 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 64.8 p -88.4 -41.25 12.93 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.284 0.564 . . . . 10.0 111.268 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.89 9.1 62.83 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.751 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.21 162.57 18.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.779 0.323 . . . . 10.0 110.724 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.13 150.97 33.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.463 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 168.79 168.75 31.29 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.911 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -79.79 134.41 36.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.823 0.344 . . . . 10.0 110.821 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 22.8 pt -120.53 137.5 26.31 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.588 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.581 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 37.6 Cg_endo -72.19 121.95 7.97 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.549 2.166 . . . . 10.0 111.437 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -19.55 65.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.843 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.581 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 35.7 p-10 -80.63 -21.63 41.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.506 0.193 . . . . 10.0 111.446 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.473 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 4.6 m-85 -93.15 -11.99 31.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.081 0.4 . . . . 10.0 112.081 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.2 m -114.72 159.78 14.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.17 0.509 . . . . 10.0 111.675 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.72 137.59 18.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.716 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.64 137.14 32.25 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.343 2.029 . . . . 10.0 112.142 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.601 -0.714 . . . . 10.0 109.793 179.289 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ttm . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.462 0.173 . . . . 10.0 111.061 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.28 162.24 37.77 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.446 0.641 . . . . 10.0 112.173 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 1.1 m -107.58 118.2 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.316 -0.856 . . . . 10.0 109.746 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.1 134.35 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.821 0.343 . . . . 10.0 111.682 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -98.58 139.25 34.58 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.487 -0.561 . . . . 10.0 109.487 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -148.07 176.35 10.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.85 0.357 . . . . 10.0 110.667 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -123.87 83.55 2.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.815 -0.63 . . . . 10.0 109.76 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -63.77 92.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.765 0.316 . . . . 10.0 110.535 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm 52.02 29.5 6.32 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.688 -0.687 . . . . 10.0 111.608 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.17 -16.65 22.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.839 -0.696 . . . . 10.0 112.806 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -88.83 101.68 14.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.779 0.323 . . . . 10.0 110.732 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -67.52 123.12 19.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.082 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.05 158.76 44.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.747 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -125.12 119.59 29.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.041 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.71 142.43 42.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.804 0.335 . . . . 10.0 110.43 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 1.4 m-20 -60.77 137.86 58.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.351 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.8 tt -60.96 -26.52 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.696 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -10.72 59.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.855 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -105.3 8.18 33.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.69 0.281 . . . . 10.0 111.484 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -90.57 137.89 20.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.792 0.33 . . . . 10.0 110.273 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -88.95 -59.16 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.255 -0.43 . . . . 10.0 111.171 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -136.16 151.85 50.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.634 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.01 127.04 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.178 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' THR . . . . . 0.405 ' HG1' ' HH2' ' A' ' 119' ' ' TRP . 8.1 m -123.43 101.78 7.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.886 0.374 . . . . 10.0 111.398 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.409 ' HG3' HG12 ' B' ' 30' ' ' ILE . 22.3 ttp85 -90.76 137.33 32.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.813 -0.44 . . . . 10.0 109.813 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.431 ' HB2' ' ND2' ' A' ' 136' ' ' ASN . 49.1 t80 -100.91 -20.49 15.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.06 0.457 . . . . 10.0 111.238 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.49 -4.58 37.44 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -135.17 -41.69 0.73 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.565 -0.817 . . . . 10.0 108.971 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -138.81 137.66 36.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.493 -0.776 . . . . 10.0 109.868 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.409 HG12 ' HG3' ' B' ' 25' ' ' ARG . 72.5 mt -102.98 125.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.279 -0.267 . . . . 10.0 110.279 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 17.7 m-85 -117.24 136.17 53.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -151.45 174.02 13.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.0 0.429 . . . . 10.0 111.227 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -130.24 140.88 50.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 10.0 109.805 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -124.41 152.52 43.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.926 0.393 . . . . 10.0 110.832 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.38 98.94 6.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.628 -0.714 . . . . 10.0 109.867 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' B' ' 40' ' ' LYS . 48.9 mt -75.81 144.42 41.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.793 0.33 . . . . 10.0 110.827 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.25 -5.87 87.55 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 116.071 -0.513 . . . . 10.0 112.201 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.3 23.05 10.38 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.899 -0.667 . . . . 10.0 112.441 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.84 43.42 97.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.45 -0.405 . . . . 10.0 112.834 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 86.0 tttt -159.79 95.68 1.61 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.717 0.294 . . . . 10.0 110.815 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -87.73 169.06 6.86 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.002 2.468 . . . . 10.0 111.235 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.63 -173.43 38.51 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.223 -0.989 . . . . 10.0 112.285 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 42.9 m-85 -118.56 166.89 12.17 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.66 138.25 6.42 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.372 -0.918 . . . . 10.0 112.531 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 p -124.33 127.73 73.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.078 0.466 . . . . 10.0 110.392 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.08 123.87 70.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.227 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -71.62 132.61 44.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.365 -0.38 . . . . 10.0 109.977 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -80.79 1.29 31.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.112 0.482 . . . . 10.0 110.791 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -116.3 -35.13 4.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.447 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -101.9 28.3 5.82 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.41 151.18 36.06 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 121.314 -0.154 . . . . 10.0 111.075 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.29 129.25 33.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.256 2.637 . . . . 10.0 112.418 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.449 ' HA ' HD12 ' B' ' 56' ' ' LEU . 97.3 mttt -64.31 -26.82 68.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.927 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -55.97 -42.62 76.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.971 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 73.8 mt -76.86 -30.67 56.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.729 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' B' ' 53' ' ' LYS . 62.1 mt -66.57 -32.09 73.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.413 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -74.42 -7.93 54.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.002 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -98.6 -26.92 14.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.907 -0.588 . . . . 10.0 110.11 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 52.3 mt -72.45 -61.95 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.865 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -101.03 110.33 22.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.208 0.528 . . . . 10.0 109.961 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -107.8 173.84 6.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.481 -0.781 . . . . 10.0 110.073 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -64.12 127.45 31.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.773 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 mttm 60.8 58.29 2.41 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.499 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.283 0 CA-C-N 115.954 -0.567 . . . . 10.0 111.061 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 120.929 0.395 . . . . 10.0 111.058 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.9 mt -92.57 158.84 15.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.09 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -121.08 134.61 55.27 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.2 p -112.27 140.34 32.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.921 0.391 . . . . 10.0 110.527 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 138' ' ' VAL . . . -72.13 123.37 22.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.97 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 139' ' ' ALA . 82.6 mt -83.28 -26.09 30.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.547 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.43 -175.3 4.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.922 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.87 149.8 27.05 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.282 0.364 . . . . 10.0 110.391 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -147.63 128.7 14.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.595 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -94.51 122.16 36.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.639 . . . . 10.0 109.403 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.507 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -61.68 144.09 55.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.703 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -97.32 -38.61 9.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.354 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -124.36 -162.25 1.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.873 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' H ' ' HB ' ' A' ' 97' ' ' THR . 1.6 pt-20 -96.54 -8.58 31.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.911 0.386 . . . . 10.0 110.68 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.48 -38.78 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.232 0.539 . . . . 10.0 110.099 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -93.05 150.55 20.45 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.688 -0.856 . . . . 10.0 108.688 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.2 tp -113.63 142.46 45.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.888 0.375 . . . . 10.0 111.626 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -81.92 148.51 28.7 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.799 179.006 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -154.85 158.96 40.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.102 0.477 . . . . 10.0 111.35 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -113.35 153.14 29.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.053 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -59.56 126.66 28.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.584 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.1 -17.64 29.24 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.884 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -68.4 143.14 55.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.733 0.302 . . . . 10.0 111.035 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -103.26 130.29 50.47 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.444 -0.576 . . . . 10.0 109.444 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -118.87 143.28 47.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.236 0.541 . . . . 10.0 112.089 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -103.19 104.14 14.26 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.69 -0.855 . . . . 10.0 108.69 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' A' ' 122' ' ' ALA . 20.3 mm -64.13 120.19 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 10.0 111.206 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.8 mt -82.74 -46.44 13.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.194 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -149.06 137.77 21.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.185 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.12 -12.44 10.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.173 -0.467 . . . . 10.0 111.29 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.9 m -86.82 47.21 1.46 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.919 0.39 . . . . 10.0 111.903 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -127.35 -3.72 6.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.97 0.414 . . . . 10.0 110.863 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 139.47 -145.47 16.62 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.014 -0.612 . . . . 10.0 111.729 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.05 -22.41 20.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.031 0.443 . . . . 10.0 110.611 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' B' ' 31' ' ' PHE . 23.2 m95 -98.38 119.56 37.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.961 -1.125 . . . . 10.0 107.961 177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -103.47 153.92 20.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.284 0.564 . . . . 10.0 112.187 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -90.29 124.6 35.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.672 -1.233 . . . . 10.0 107.672 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -140.69 146.71 38.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.629 0.728 . . . . 10.0 112.715 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 123' ' ' ARG . 30.0 ttt180 -99.68 122.28 42.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.854 -1.066 . . . . 10.0 109.646 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.7 t -66.79 131.23 45.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.3 mt -78.44 -9.43 59.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.85 0.357 . . . . 10.0 110.427 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.5 m -79.78 -63.65 1.37 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 10.0 111.427 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.3 p -102.09 -25.75 13.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.389 0.514 . . . . 10.0 112.389 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.12 1.59 57.01 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.552 -0.832 . . . . 10.0 111.704 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -69.2 146.33 52.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 10.0 110.846 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.59 178.84 4.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.438 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 143.15 168.87 12.17 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.844 -0.693 . . . . 10.0 111.972 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -84.0 130.43 34.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.842 0.353 . . . . 10.0 110.44 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.8 pt -123.57 146.92 51.47 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.915 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.526 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 48.5 Cg_endo -74.23 115.05 4.18 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.666 2.244 . . . . 10.0 111.779 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.6 m -62.03 -15.06 41.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.945 0.72 . . . . 10.0 112.945 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 33.7 p-10 -83.41 -8.3 59.41 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.234 -0.291 . . . . 10.0 110.861 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.402 ' CE1' HG22 ' B' ' 24' ' ' THR . 2.5 m-85 -105.44 -0.16 26.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.167 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 89' ' ' ALA . 4.6 m -127.67 156.15 39.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.989 0.423 . . . . 10.0 111.206 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 90' ' ' LEU . . . -136.2 143.05 42.19 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.235 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.85 129.41 19.66 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.617 2.211 . . . . 10.0 112.06 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.29 -0.862 . . . . 10.0 110.261 -179.872 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.469 0.176 . . . . 10.0 110.708 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.4 169.24 25.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.821 0.343 . . . . 10.0 111.148 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.1 p -101.88 145.24 29.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 t -110.02 133.03 56.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.783 -0.451 . . . . 10.0 109.783 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.25 124.21 44.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.457 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 41.3 p90 -128.58 166.72 18.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.958 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -114.31 87.54 2.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.014 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -78.5 90.55 4.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.585 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm 53.54 38.21 27.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.108 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.01 -26.37 20.92 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.675 -0.774 . . . . 10.0 112.813 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -83.59 105.82 14.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.696 0.284 . . . . 10.0 110.882 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 26.7 mt-10 -80.16 116.93 20.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -130.92 157.44 42.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.612 0.244 . . . . 10.0 111.074 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -120.72 113.9 20.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.494 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' VAL . . . . . 0.497 HG11 ' HB2' ' B' ' 34' ' ' TYR . 48.8 t -124.42 143.02 39.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.857 -0.423 . . . . 10.0 109.857 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.26 141.69 45.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 10.0 111.314 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 7.4 tt -62.26 -32.68 55.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.174 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 15.2 m -80.98 2.16 28.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.372 -0.376 . . . . 10.0 111.549 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -104.62 12.47 32.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.522 0.677 . . . . 10.0 109.29 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.15 133.86 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.063 -0.972 . . . . 10.0 109.324 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 t -83.76 -73.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.745 0.307 . . . . 10.0 111.568 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -118.85 152.18 36.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.72 0.295 . . . . 10.0 111.354 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.66 129.7 66.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.979 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' THR . . . . . 0.402 HG22 ' CE1' ' A' ' 137' ' ' TYR . 1.5 m -134.46 121.4 21.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.901 0.381 . . . . 10.0 111.05 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -120.75 125.47 47.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.814 0.34 . . . . 10.0 110.844 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -89.05 -22.46 22.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.153 0.502 . . . . 10.0 110.684 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.17 -4.47 8.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.865 -0.683 . . . . 10.0 112.01 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -117.14 -57.96 2.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.302 -0.629 . . . . 10.0 109.302 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.68 149.89 52.12 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.6 mt -101.66 124.64 55.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.358 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.443 ' HB3' ' NE1' ' A' ' 119' ' ' TRP . 3.3 m-85 -104.5 132.55 50.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.665 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -152.38 156.65 39.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.938 0.399 . . . . 10.0 111.289 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -110.59 132.17 54.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.059 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.497 ' HB2' HG11 ' B' ' 15' ' ' VAL . 19.2 p90 -114.62 164.3 14.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.67 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -133.33 142.96 48.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.624 -0.717 . . . . 10.0 109.385 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 35.7 mt -126.5 142.42 51.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.018 0.437 . . . . 10.0 111.288 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.86 -13.48 78.74 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.696 -0.684 . . . . 10.0 112.212 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.52 7.9 37.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.962 -0.637 . . . . 10.0 112.1 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.89 45.46 16.51 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.201 -0.523 . . . . 10.0 112.618 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -160.49 90.45 1.7 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.891 0.377 . . . . 10.0 111.392 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.32 175.03 6.62 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.458 2.105 . . . . 10.0 110.917 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.27 -166.5 36.54 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.881 -1.152 . . . . 10.0 112.462 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -120.65 156.57 31.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.681 0.277 . . . . 10.0 110.45 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.72 155.62 22.74 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.154 -0.778 . . . . 10.0 111.154 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.73 139.79 28.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.111 0.482 . . . . 10.0 111.262 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 20.4 m -132.31 152.48 36.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.763 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.416 ' HB3' ' HB2' ' B' ' 50' ' ' ASP . 19.5 t -91.16 141.34 28.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.112 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -82.6 -10.14 59.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.043 0.449 . . . . 10.0 110.636 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.64 -9.18 12.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.89 0.33 . . . . 10.0 111.89 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ASP . . . . . 0.416 ' HB2' ' HB3' ' B' ' 47' ' ' SER . 24.1 m-20 -120.32 21.9 11.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.901 0.382 . . . . 10.0 111.48 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.71 141.65 17.05 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.164 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.51 142.86 69.78 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.779 2.319 . . . . 10.0 112.297 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -58.06 -30.48 66.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.214 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.4 -45.09 72.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 10.0 111.161 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 mt -71.74 -38.84 70.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 10.0 111.023 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.98 -41.67 97.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.015 -0.539 . . . . 10.0 111.045 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -74.53 -13.65 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.932 -0.577 . . . . 10.0 111.383 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -80.42 -37.11 32.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.018 0.437 . . . . 10.0 109.823 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.44 -47.68 32.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.778 -0.646 . . . . 10.0 111.361 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -88.92 97.71 11.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.065 0.459 . . . . 10.0 110.43 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -104.01 -173.27 2.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.389 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -68.84 140.43 55.22 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 61.5 50.43 4.6 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.552 0.691 . . . . 10.0 109.892 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-N 115.165 -0.925 . . . . 10.0 110.878 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.597 0.237 . . . . 10.0 110.721 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.2 mt -99.8 141.79 32.15 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.932 0.396 . . . . 10.0 110.723 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -119.56 140.35 50.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.76 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.86 140.15 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.959 0.409 . . . . 10.0 110.437 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.34 116.56 12.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.987 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.24 -33.18 72.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.406 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -147.13 173.78 12.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.883 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.19 144.32 27.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -126.78 123.35 37.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.956 0.408 . . . . 10.0 111.112 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -84.93 116.85 23.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.606 -0.725 . . . . 10.0 109.579 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.94 148.67 51.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.092 0.472 . . . . 10.0 111.155 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -115.15 -35.44 4.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.782 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.81 -165.09 1.48 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.551 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -96.0 -11.95 25.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.688 0.28 . . . . 10.0 111.262 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.35 -34.63 31.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.211 0.529 . . . . 10.0 110.611 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -90.23 149.76 22.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.58 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.6 tp -109.68 135.46 50.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.981 0.42 . . . . 10.0 111.916 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.91 147.72 24.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.204 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -156.77 163.59 39.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.779 0.323 . . . . 10.0 111.268 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -110.26 157.05 19.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.08 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -58.5 128.1 35.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.799 0.333 . . . . 10.0 110.419 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.38 -10.0 53.78 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.707 -0.758 . . . . 10.0 112.924 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -70.85 146.73 49.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 10.0 110.781 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -115.62 139.07 50.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.067 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -126.58 150.39 48.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.053 0.454 . . . . 10.0 111.818 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -97.91 111.5 23.78 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.45 119.17 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.336 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.9 mt -102.7 -62.32 1.29 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.579 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -119.54 107.22 13.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.431 . . . . 10.0 110.644 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.29 22.0 12.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.78 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -112.27 -1.08 15.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.783 0.66 . . . . 10.0 112.783 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.72 -37.11 65.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.518 -0.473 . . . . 10.0 110.876 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.74 -133.62 2.89 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.189 -1.005 . . . . 10.0 112.588 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.39 -31.58 29.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.641 0.258 . . . . 10.0 110.947 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.558 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 28.2 m95 -93.16 121.22 34.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -103.17 146.48 28.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.046 0.451 . . . . 10.0 111.634 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -95.23 119.51 33.87 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.01 159.13 42.48 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.291 0.567 . . . . 10.0 111.832 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -104.38 124.15 48.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.245 -0.889 . . . . 10.0 109.433 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.0 t -65.95 136.57 56.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.944 -0.391 . . . . 10.0 109.944 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.34 -2.71 58.81 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.2 m -97.15 -50.31 4.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.2 p -101.24 -28.07 12.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.94 0.4 . . . . 10.0 111.732 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.45 -6.03 77.73 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.977 -0.63 . . . . 10.0 112.233 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -69.03 149.32 48.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.945 0.403 . . . . 10.0 110.882 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.1 m -119.95 125.86 49.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.947 -0.569 . . . . 10.0 111.093 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -163.5 176.11 39.67 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.489 -0.644 . . . . 10.0 111.489 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -81.72 127.86 33.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.839 0.352 . . . . 10.0 110.5 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.0 pt -119.62 142.13 32.27 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.805 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.447 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 28.9 Cg_endo -69.01 110.9 2.51 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.171 1.914 . . . . 10.0 111.184 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 m -59.35 -19.55 47.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.887 -0.597 . . . . 10.0 112.579 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 30.7 p-10 -81.51 -8.8 59.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 10.0 110.87 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -103.03 -3.5 25.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.312 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.79 157.87 27.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.507 -0.315 . . . . 10.0 111.036 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -138.85 148.37 57.85 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.317 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 24.3 Cg_exo -63.38 136.53 55.59 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.546 2.164 . . . . 10.0 112.117 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.567 -0.73 . . . . 10.0 110.396 179.677 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ttt . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.561 0.22 . . . . 10.0 110.538 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.53 145.99 16.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.885 0.374 . . . . 10.0 111.009 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 6.1 m -93.72 119.8 33.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.625 -0.716 . . . . 10.0 109.45 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 32.8 t -86.87 130.34 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.984 0.421 . . . . 10.0 111.291 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -99.69 120.65 40.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.339 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -140.53 -174.22 3.9 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.609 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -125.54 142.97 51.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.068 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -125.52 98.84 5.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.968 0.413 . . . . 10.0 110.171 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm 56.8 31.64 19.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.189 -0.914 . . . . 10.0 112.264 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.45 -56.35 0.72 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.263 -0.97 . . . . 10.0 114.022 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -78.88 158.38 28.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.097 0.449 . . . . 10.0 111.842 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -97.1 141.79 29.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -136.9 152.1 49.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.443 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -126.18 111.9 15.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.21 -0.45 . . . . 10.0 109.796 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -129.59 142.13 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.803 0.335 . . . . 10.0 111.172 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.67 142.37 57.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.647 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 16.5 tt -63.13 -25.83 39.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.232 0.539 . . . . 10.0 110.616 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -11.38 60.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 10.0 111.362 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -99.5 2.68 45.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.122 0.487 . . . . 10.0 110.207 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 61.3 mt -96.91 134.34 34.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.075 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.26 -72.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.031 0.443 . . . . 10.0 110.434 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -120.99 147.02 46.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.096 -0.502 . . . . 10.0 111.155 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 t -124.16 116.01 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.659 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 5.1 m -120.65 112.55 19.02 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.128 0.49 . . . . 10.0 112.266 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.557 ' HD2' ' OE1' ' B' ' 48' ' ' GLU . 37.3 ttp85 -102.9 131.71 49.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.939 -0.393 . . . . 10.0 109.939 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -89.88 -25.48 20.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.311 0.577 . . . . 10.0 110.787 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.07 -4.14 16.3 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.716 -0.954 . . . . 10.0 110.716 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -134.17 -38.44 0.86 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -135.71 143.64 45.5 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.717 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mt -105.22 121.45 57.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -113.16 127.67 56.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.443 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -145.87 167.27 23.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.769 0.318 . . . . 10.0 110.608 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' ' 33' ' ' ARG . 6.2 ttt180 -126.46 129.93 49.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.106 -0.497 . . . . 10.0 109.742 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -119.48 162.99 17.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.224 0.535 . . . . 10.0 111.629 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.8 133.81 50.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.081 -0.963 . . . . 10.0 109.269 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 41.9 mt -112.5 140.01 47.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.815 0.341 . . . . 10.0 110.915 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.2 -7.49 45.07 Favored Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 115.829 -0.623 . . . . 10.0 112.839 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.07 8.89 59.18 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.916 -0.659 . . . . 10.0 111.975 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.1 47.93 16.98 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.913 -0.661 . . . . 10.0 112.372 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -163.02 99.28 1.04 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.552 0.215 . . . . 10.0 111.117 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.04 165.55 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.531 2.154 . . . . 10.0 110.874 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.76 -171.68 29.27 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 119.809 -1.186 . . . . 10.0 113.303 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 1.5 m-85 -124.49 158.42 32.91 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.813 -0.44 . . . . 10.0 109.813 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.69 132.7 6.16 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.627 -0.796 . . . . 10.0 111.584 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.27 125.82 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.254 0.55 . . . . 10.0 110.443 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 t -121.08 136.85 56.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.047 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 28.1 t -83.9 130.72 34.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.933 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.557 ' OE1' ' HD2' ' B' ' 25' ' ' ARG . 5.1 tt0 -93.97 4.44 53.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.338 0.589 . . . . 10.0 109.732 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -98.7 -46.09 5.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.793 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.03 79.85 1.89 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.23 0.538 . . . . 10.0 111.712 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.54 156.22 10.36 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.151 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.33 128.01 25.96 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.618 2.212 . . . . 10.0 112.55 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -63.42 -27.13 69.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.966 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' B' ' 58' ' ' LYS . 0.1 OUTLIER -57.88 -33.17 68.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.492 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.2 -38.18 19.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.252 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 61.9 mt -61.88 -47.08 86.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 10.0 111.142 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -76.83 -5.91 50.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.799 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' B' ' 54' ' ' GLU . 4.0 tttt -92.23 -22.92 19.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 10.0 110.369 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 29.3 mt -82.62 -54.56 5.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.736 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' GLU . . . . . 0.425 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 31.6 tt0 -92.15 94.16 9.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.103 0.478 . . . . 10.0 110.044 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -86.41 166.67 15.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.69 -0.686 . . . . 10.0 109.827 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -63.57 132.02 49.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.78 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.6 mttt 61.32 49.6 5.28 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.187 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.601 -0.714 . . . . 10.0 110.495 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 120.554 0.216 . . . . 10.0 110.735 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.7 mt -90.39 146.21 24.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.33 -0.396 . . . . 10.0 110.52 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -123.04 145.25 48.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.431 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.01 142.38 38.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.481 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.13 120.64 20.91 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.131 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 139' ' ' ALA . 50.7 mt -79.74 -32.99 41.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.366 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -144.45 164.28 31.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.734 -0.667 . . . . 10.0 109.748 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.02 152.34 38.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.407 -0.59 . . . . 10.0 109.407 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -119.29 128.92 54.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.896 0.379 . . . . 10.0 111.026 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.79 92.59 6.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.09 -0.505 . . . . 10.0 109.67 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.91 162.8 29.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.56 . . . . 10.0 111.499 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -126.11 -45.64 1.7 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.023 -0.535 . . . . 10.0 110.728 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.23 -177.82 3.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.864 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -87.47 -11.21 49.65 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.891 0.33 . . . . 10.0 111.891 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.96 -39.04 31.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.993 0.425 . . . . 10.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.13 124.0 29.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.117 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.2 tp -77.85 135.13 37.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.996 -0.547 . . . . 10.0 112.204 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.33 120.81 35.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.711 . . . . 10.0 109.897 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -136.55 166.23 24.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.852 0.358 . . . . 10.0 111.29 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -109.78 168.32 9.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.839 -0.619 . . . . 10.0 111.391 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -65.27 134.3 53.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.389 -0.823 . . . . 10.0 111.357 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.41 2.95 88.89 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.118 -0.563 . . . . 10.0 113.725 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -81.41 151.26 28.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.073 0.436 . . . . 10.0 110.968 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -116.43 143.66 45.29 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.06 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.38 158.72 43.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 10.0 110.861 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -97.68 113.99 25.87 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.55 116.77 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.148 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.6 mt -83.96 -63.33 1.37 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.906 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -117.73 98.27 6.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.179 0.514 . . . . 10.0 111.403 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.41 -17.1 35.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.683 -0.689 . . . . 10.0 110.386 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.59 14.36 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.765 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -70.07 -44.39 69.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.314 0.578 . . . . 10.0 110.324 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 153.3 -113.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.452 -0.794 . . . . 10.0 111.185 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.16 -45.68 6.44 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.435 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 29.4 m95 -92.4 110.68 22.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -96.52 150.25 20.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.843 0.354 . . . . 10.0 111.052 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -95.07 123.8 38.75 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.455 -0.943 . . . . 10.0 108.455 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.5 163.99 27.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.958 0.409 . . . . 10.0 111.345 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -114.58 128.4 56.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.834 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.1 t -68.88 147.7 51.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.919 0.39 . . . . 10.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.0 mt -94.52 -3.14 50.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.496 -0.557 . . . . 10.0 109.496 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 m -95.06 -66.36 0.92 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.363 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.0 p -90.18 -20.91 22.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 10.0 111.461 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.94 13.49 79.34 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.783 -0.723 . . . . 10.0 111.895 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.48 153.43 37.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 10.0 110.898 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.9 m -117.6 135.75 53.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.176 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -179.47 176.79 47.95 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.433 -0.889 . . . . 10.0 112.221 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -84.29 138.95 32.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.307 -0.257 . . . . 10.0 110.307 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.2 pt -126.41 139.98 36.04 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.019 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.589 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 37.3 Cg_endo -68.83 121.57 8.46 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.343 2.029 . . . . 10.0 111.415 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 p -66.46 -12.82 59.24 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.551 0.574 . . . . 10.0 112.551 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.589 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 35.4 p-10 -87.58 -8.31 56.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.859 0.361 . . . . 10.0 110.986 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -100.32 -17.66 17.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.021 0.439 . . . . 10.0 110.677 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 22.5 m -115.83 154.05 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.61 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 90' ' ' LEU . . . -137.82 145.24 47.59 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.407 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.46 124.76 12.88 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.219 1.946 . . . . 10.0 111.332 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.052 -0.975 . . . . 10.0 110.293 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 111.239 0.088 . . . . 10.0 111.239 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.431 ' O ' HG22 ' B' ' 17' ' ' ILE . . . -169.66 169.67 8.46 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.683 0.278 . . . . 10.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 2.2 m -107.6 140.2 40.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.699 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 54.6 t -115.05 136.52 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.56 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -105.09 128.4 53.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.093 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -137.71 177.31 7.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.544 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -125.38 89.0 2.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.771 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -78.37 110.72 13.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.084 -0.507 . . . . 10.0 109.866 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm 58.28 24.21 11.28 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.027 0.441 . . . . 10.0 111.017 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.29 -14.7 59.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.821 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.51 127.44 34.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.857 0.361 . . . . 10.0 110.804 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.07 120.72 22.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.3 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -137.61 149.79 46.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.255 -0.429 . . . . 10.0 110.382 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -126.85 115.51 19.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.547 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 64.1 t -125.88 143.8 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.15 -0.477 . . . . 10.0 109.847 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 56.6 m-20 -64.42 135.04 55.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 10.0 110.076 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.431 HG22 ' O ' ' B' ' 2' ' ' ALA . 15.8 tt -59.94 -26.23 35.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.614 -0.721 . . . . 10.0 111.398 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -10.8 60.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.079 -0.509 . . . . 10.0 111.345 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -100.94 12.6 37.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.132 0.491 . . . . 10.0 110.337 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -99.6 132.22 45.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.049 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.98 -64.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.93 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -137.0 155.87 49.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.326 -0.397 . . . . 10.0 110.723 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' B' ' 59' ' ' LEU . 22.5 t -127.05 142.86 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.923 -0.581 . . . . 10.0 109.644 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 9.3 m -137.81 118.87 14.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.036 0.445 . . . . 10.0 111.577 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.462 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 57.4 ttp85 -111.59 116.12 30.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.11 0.481 . . . . 10.0 110.687 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -84.66 -21.3 30.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.331 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.82 12.63 15.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.556 -0.83 . . . . 10.0 111.497 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -138.56 -51.97 0.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.761 -0.829 . . . . 10.0 108.761 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -136.57 143.28 43.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.783 -1.099 . . . . 10.0 108.85 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 27.8 mt -97.32 122.35 48.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.654 -0.498 . . . . 10.0 109.654 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -113.26 136.78 52.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.521 -0.309 . . . . 10.0 110.508 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -148.28 169.41 20.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.782 0.325 . . . . 10.0 110.646 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -126.81 131.24 51.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.037 -0.528 . . . . 10.0 109.847 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -125.55 165.53 18.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.031 0.443 . . . . 10.0 111.375 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -134.63 122.02 21.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.678 -0.692 . . . . 10.0 110.218 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -90.27 147.48 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 10.0 111.59 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.49 -12.89 70.5 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.933 -0.576 . . . . 10.0 112.549 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.38 13.94 43.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.906 -0.664 . . . . 10.0 112.555 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.31 54.94 7.29 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.702 -0.761 . . . . 10.0 111.966 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -157.59 95.28 2.06 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.648 0.261 . . . . 10.0 110.813 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.72 143.06 18.43 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.346 2.031 . . . . 10.0 110.792 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.93 -173.46 18.92 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.84 -1.172 . . . . 10.0 113.136 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 7.2 m-85 -128.46 161.11 30.26 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.85 143.74 12.98 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.346 -0.931 . . . . 10.0 112.208 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 2.4 p -131.3 130.37 63.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.995 0.426 . . . . 10.0 110.004 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 26.4 t -122.57 133.95 67.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.848 -0.614 . . . . 10.0 110.134 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.39 136.67 53.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.047 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -87.86 -19.3 27.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.002 0.429 . . . . 10.0 110.946 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -108.35 -36.72 6.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.524 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -96.88 52.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.904 -0.589 . . . . 10.0 111.002 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -169.21 151.92 4.84 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.305 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.29 140.57 59.09 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.485 2.123 . . . . 10.0 111.803 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -60.96 -21.03 63.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.309 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -54.67 -46.15 73.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.252 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.28 -35.41 48.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.782 0.325 . . . . 10.0 110.743 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 30.8 mt -61.55 -43.47 98.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.001 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -74.33 -7.3 52.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.546 . . . . 10.0 111.949 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -91.97 -33.92 14.66 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.842 -0.429 . . . . 10.0 109.842 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.464 ' HB3' HG11 ' B' ' 23' ' ' VAL . 89.5 mt -82.26 -36.9 26.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.943 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' GLU . . . . . 0.462 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 8.8 tp10 -79.73 94.73 5.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.267 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -105.58 142.79 34.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.182 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -67.47 127.1 31.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 mttt 64.77 65.01 0.63 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.935 0.772 . . . . 10.0 109.845 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' B' ' 23' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.606 -0.724 . . . . 10.0 110.586 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 120.568 0.223 . . . . 10.0 110.774 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.0 mt -93.66 148.13 22.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.021 -0.363 . . . . 10.0 110.021 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -120.59 134.19 55.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.711 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.45 140.29 34.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.026 -0.533 . . . . 10.0 109.95 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 138' ' ' VAL . . . -71.22 124.77 25.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.191 -0.458 . . . . 10.0 111.633 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.6 mt -80.75 -34.12 34.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.172 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -140.71 164.08 31.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.533 -0.758 . . . . 10.0 110.008 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.79 147.41 39.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.829 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -129.48 137.73 51.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 10.0 111.243 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -98.31 130.98 44.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.946 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.411 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . . . -84.54 139.78 31.89 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.22 -0.289 . . . . 10.0 110.22 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -107.89 -28.32 9.69 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.848 -0.341 . . . . 10.0 111.444 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.3 p -132.25 -161.47 1.14 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.993 0.425 . . . . 10.0 110.878 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -102.31 8.72 40.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.482 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.55 -38.83 7.36 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.497 -0.557 . . . . 10.0 109.497 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 95' ' ' ALA . 16.3 p-10 -89.87 149.46 22.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.748 -0.834 . . . . 10.0 108.748 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.4 tp -117.1 134.4 54.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.089 0.471 . . . . 10.0 111.964 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.67 151.38 26.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.831 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -159.57 170.57 21.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.363 -0.38 . . . . 10.0 110.314 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.428 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 59.2 m-70 -113.4 165.28 12.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.252 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -62.32 121.05 12.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.406 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.37 -4.34 33.14 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.958 -0.639 . . . . 10.0 112.122 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 104' ' ' HIS . 3.7 tp10 -66.86 129.32 39.49 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 122.287 0.235 . . . . 10.0 111.225 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -94.19 124.47 38.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -118.72 138.04 52.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.228 0.537 . . . . 10.0 112.088 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -100.52 105.67 17.12 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.388 -0.967 . . . . 10.0 108.388 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.8 mm -65.87 119.31 10.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.057 -0.519 . . . . 10.0 110.848 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -96.29 -38.78 9.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.435 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 121' ' ' GLU . 18.3 t30 -137.23 101.62 4.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.194 0.521 . . . . 10.0 110.255 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.63 -13.44 16.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.17 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.69 3.01 27.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.993 -0.548 . . . . 10.0 111.802 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -65.94 -48.12 72.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 10.0 110.581 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.43 -124.47 1.27 Allowed Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.826 -0.702 . . . . 10.0 111.813 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -76.68 -58.08 3.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.055 -0.35 . . . . 10.0 110.055 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.406 ' NE1' ' HB3' ' B' ' 31' ' ' PHE . 29.4 m95 -78.72 137.92 38.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -112.94 150.24 32.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.13 0.49 . . . . 10.0 111.901 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 113' ' ' ASN . 5.3 mt-10 -89.96 112.61 24.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.496 -0.927 . . . . 10.0 108.496 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.69 154.91 44.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.234 0.54 . . . . 10.0 111.908 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 123' ' ' ARG . 36.2 ttt-85 -109.15 132.54 54.02 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.442 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 t -73.78 131.64 41.77 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.725 -0.472 . . . . 10.0 109.725 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.12 -10.75 57.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.208 0.528 . . . . 10.0 110.067 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -62.71 1.41 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.444 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.9 p -89.08 -31.26 18.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.743 0.306 . . . . 10.0 111.796 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.8 -3.0 58.69 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.635 -0.793 . . . . 10.0 112.439 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -69.19 153.55 43.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.74 0.305 . . . . 10.0 111.195 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.4 m -127.37 134.88 49.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.982 -0.554 . . . . 10.0 110.957 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.14 -176.37 44.29 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.851 -0.69 . . . . 10.0 111.945 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.502 ' CE1' ' HG3' ' A' ' 121' ' ' GLU . 41.3 m-85 -83.92 131.32 34.86 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.7 pt -122.55 141.39 34.89 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.041 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.18 111.05 1.32 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.495 2.13 . . . . 10.0 111.428 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.84 -18.86 63.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.693 -0.685 . . . . 10.0 112.232 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -83.07 -13.96 54.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.455 -0.339 . . . . 10.0 111.246 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.91 0.03 43.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.575 -0.284 . . . . 10.0 111.328 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 89' ' ' ALA . 15.7 m -123.33 161.23 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.823 0.344 . . . . 10.0 110.932 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -141.48 146.36 41.68 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.441 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 15.1 Cg_exo -67.35 135.61 37.29 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.478 2.119 . . . . 10.0 111.599 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.524 -0.751 . . . . 10.0 110.439 -179.74 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ttt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.41 0.148 . . . . 10.0 110.942 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.11 152.59 24.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.866 0.365 . . . . 10.0 111.447 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.66 133.56 36.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.371 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 t -110.74 135.41 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.734 0.302 . . . . 10.0 110.729 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -102.87 126.3 49.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.057 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -128.86 166.43 19.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.502 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.427 ' HG2' ' HG2' ' B' ' 12' ' ' GLU . 88.9 mttt -106.66 89.08 2.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.149 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -75.73 86.38 2.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.419 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm 54.85 35.36 24.11 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.3 -0.864 . . . . 10.0 111.294 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.48 -29.7 8.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.855 -0.688 . . . . 10.0 112.897 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -87.42 117.22 26.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.757 0.313 . . . . 10.0 111.121 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' B' ' 7' ' ' LYS . 34.8 mt-10 -83.51 114.34 21.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.998 0.428 . . . . 10.0 109.973 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -125.5 149.31 48.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.166 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -115.58 107.77 15.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.361 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.36 144.13 28.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.206 -0.452 . . . . 10.0 109.915 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.23 139.19 58.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.624 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.4 tt -63.29 -24.04 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.314 0.578 . . . . 10.0 110.732 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -16.01 62.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.932 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -98.93 15.93 24.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.34 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 72.9 mt -103.74 133.77 46.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.942 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.92 -71.62 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.472 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -128.94 147.0 50.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.709 -0.223 . . . . 10.0 110.844 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 27.9 t -125.53 127.69 71.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.1 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 63.1 m -129.8 118.21 21.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.081 0.467 . . . . 10.0 111.913 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 15.8 ttp85 -99.87 148.25 24.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.924 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -122.29 -25.47 4.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.965 0.357 . . . . 10.0 111.965 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.29 18.37 8.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.225 -0.988 . . . . 10.0 110.935 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -148.12 -50.65 0.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -148.7 134.0 18.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.854 -1.067 . . . . 10.0 109.647 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.4 mt -91.69 129.92 41.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.138 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.406 ' HB3' ' NE1' ' A' ' 119' ' ' TRP . 16.9 m-85 -115.61 135.27 54.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.481 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -150.15 171.08 17.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.673 0.273 . . . . 10.0 110.852 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -121.05 132.9 55.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.239 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -119.17 161.33 20.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.222 0.534 . . . . 10.0 111.455 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -133.09 128.79 36.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.542 -0.754 . . . . 10.0 109.751 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt -113.24 122.16 46.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.751 0.31 . . . . 10.0 110.613 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.2 -15.16 21.42 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.716 -0.675 . . . . 10.0 113.185 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.54 -14.48 67.11 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.286 -0.483 . . . . 10.0 112.437 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.55 40.84 2.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 10.0 113.009 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -159.93 89.9 1.85 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.066 0.46 . . . . 10.0 111.458 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -86.05 160.26 10.14 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.575 2.183 . . . . 10.0 110.836 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.94 -156.43 13.52 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.016 -1.088 . . . . 10.0 112.446 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -124.3 171.36 9.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.225 -0.287 . . . . 10.0 110.225 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.68 141.1 8.73 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.802 -0.713 . . . . 10.0 111.7 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.16 132.71 68.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.279 0.561 . . . . 10.0 111.015 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 71.0 t -128.14 126.09 65.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.476 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' B' ' 51' ' ' ALA . 28.7 t -68.84 146.96 52.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.93 7.37 43.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.104 0.478 . . . . 10.0 110.35 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -114.32 -50.86 2.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.936 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -101.49 31.71 3.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.828 0.347 . . . . 10.0 111.919 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -133.35 149.32 72.12 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.768 -0.196 . . . . 10.0 110.56 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 16.9 Cg_exo -66.47 142.56 65.84 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.784 2.323 . . . . 10.0 112.654 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -65.86 -24.36 66.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.771 -0.649 . . . . 10.0 110.31 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -56.69 -30.7 63.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.544 -0.753 . . . . 10.0 110.987 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.66 -37.25 11.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.387 . . . . 10.0 110.392 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 66.0 mt -63.64 -37.87 88.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 10.0 111.436 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -70.89 -16.32 62.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 10.0 111.242 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -86.33 -37.17 18.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 10.0 110.275 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.51 -41.13 80.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.931 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -85.62 100.16 11.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.156 0.503 . . . . 10.0 110.357 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -109.67 157.36 19.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.659 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -69.51 136.19 51.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.65 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 67.04 48.86 1.18 Allowed 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.758 0.662 . . . . 10.0 110.021 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.656 -0.688 . . . . 10.0 110.568 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.1 mt -109.59 145.32 36.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.961 0.41 . . . . 10.0 110.098 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -117.99 137.15 53.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.527 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.97 138.69 31.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.909 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.06 117.67 11.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.542 . . . . 10.0 110.932 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.36 -49.31 67.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.076 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -138.04 170.3 16.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.554 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.72 133.93 47.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.626 -0.509 . . . . 10.0 109.626 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.487 ' CE1' HG21 ' B' ' 24' ' ' THR . 32.6 t80 -110.84 120.99 44.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.009 0.433 . . . . 10.0 111.337 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -89.12 120.48 30.55 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.69 155.62 31.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.054 0.454 . . . . 10.0 111.181 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.514 HH21 ' HA ' ' B' ' 64' ' ' LYS . 6.5 ttm180 -110.32 -41.44 4.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.449 -0.796 . . . . 10.0 110.119 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.75 -160.86 0.86 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.072 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.5 -3.29 31.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.094 0.473 . . . . 10.0 110.145 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.58 -44.02 13.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.384 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.58 129.74 34.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.419 -0.81 . . . . 10.0 109.587 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.8 tp -80.68 125.26 29.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.672 -0.694 . . . . 10.0 111.947 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.46 131.49 34.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.402 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -147.26 167.61 23.81 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.983 0.42 . . . . 10.0 111.541 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -106.25 164.01 12.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.849 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.01 132.88 51.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.359 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.82 -5.23 66.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.629 -0.796 . . . . 10.0 113.962 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -78.32 155.04 30.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.07 0.435 . . . . 10.0 111.192 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -122.54 141.68 51.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.898 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.75 155.42 50.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.786 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -99.19 120.5 39.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.8 -0.636 . . . . 10.0 109.621 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.47 120.33 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.053 -0.522 . . . . 10.0 110.889 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.7 mt -93.53 -46.61 7.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.691 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -135.19 103.71 5.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.172 0.51 . . . . 10.0 111.05 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.92 -11.81 27.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.78 -0.645 . . . . 10.0 110.859 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.07 0.16 54.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.398 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.1 -32.9 74.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.218 0.532 . . . . 10.0 110.5 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 144.99 -110.03 0.54 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.913 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.09 -50.86 3.53 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.09 -0.337 . . . . 10.0 110.09 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.472 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 54.2 m95 -82.81 107.11 15.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.751 -1.203 . . . . 10.0 107.751 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -89.18 146.02 25.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.151 0.5 . . . . 10.0 111.553 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -86.69 115.91 24.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.83 154.94 41.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.112 0.482 . . . . 10.0 111.474 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.6 ttp85 -109.6 125.37 52.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.657 -0.701 . . . . 10.0 109.487 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.2 t -61.6 131.06 48.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.577 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.35 -6.22 58.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.832 -0.622 . . . . 10.0 109.783 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.26 -63.02 1.49 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.523 -0.762 . . . . 10.0 109.954 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.7 p -104.24 -61.14 1.48 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.691 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 149.83 -7.98 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.919 -0.582 . . . . 10.0 111.826 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.06 134.36 21.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.088 0.47 . . . . 10.0 111.879 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -116.69 132.45 56.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.306 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.24 -178.25 43.08 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.275 -0.964 . . . . 10.0 112.629 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -78.71 126.44 30.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.17 -0.307 . . . . 10.0 110.17 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.4 pt -112.84 135.69 21.63 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 10.0 111.127 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.454 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 34.8 Cg_endo -69.25 116.57 4.57 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.558 2.172 . . . . 10.0 111.518 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -14.36 60.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.695 -0.684 . . . . 10.0 112.35 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.513 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 38.4 p-10 -89.45 -3.34 58.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.452 -0.34 . . . . 10.0 111.032 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.448 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 11.2 m-85 -113.4 6.48 17.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.704 0.288 . . . . 10.0 111.223 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.5 m -129.64 150.58 34.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.937 0.399 . . . . 10.0 111.196 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.88 145.4 57.3 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.183 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.47 124.72 13.26 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.489 2.126 . . . . 10.0 111.82 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.403 -0.808 . . . . 10.0 110.158 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.638 0.256 . . . . 10.0 110.533 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.27 157.8 23.41 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.9 0.381 . . . . 10.0 110.922 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.9 m -96.74 131.35 43.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.684 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -103.38 138.32 28.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.07 0.462 . . . . 10.0 111.158 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -99.74 127.77 45.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.633 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -135.54 175.96 9.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.846 0.355 . . . . 10.0 111.002 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -120.97 106.48 11.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.571 . . . . 10.0 109.801 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -94.11 95.59 9.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.678 -0.489 . . . . 10.0 109.678 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 59.64 34.65 22.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.773 -0.649 . . . . 10.0 111.053 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.29 -24.82 29.83 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.808 -0.633 . . . . 10.0 112.49 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.96 111.32 18.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.75 0.31 . . . . 10.0 110.914 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -76.35 121.17 22.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.416 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -135.55 162.27 33.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.485 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -126.4 121.95 33.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.561 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 82.1 t -131.94 142.66 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 110.148 -0.315 . . . . 10.0 110.148 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 23.6 m-20 -70.1 141.79 52.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.898 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 tt -61.98 -26.2 39.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.961 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -17.93 64.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.094 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -99.87 3.16 44.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.681 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 65.1 mt -91.91 128.84 43.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.123 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 t -75.09 -63.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.097 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -138.6 152.51 48.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.471 -0.331 . . . . 10.0 110.86 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' B' ' 59' ' ' LEU . 18.8 t -131.33 138.49 53.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.3 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' THR . . . . . 0.487 HG21 ' CE1' ' A' ' 93' ' ' TYR . 8.7 m -143.09 125.6 15.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.201 0.524 . . . . 10.0 111.25 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.499 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 40.9 ttp85 -105.39 155.64 18.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.939 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -121.77 -34.95 3.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.702 0.287 . . . . 10.0 111.742 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.85 27.23 1.95 Allowed Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 110.241 -1.144 . . . . 10.0 110.241 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -152.64 -57.82 0.14 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.161 -1.052 . . . . 10.0 108.161 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' B' ' 47' ' ' SER . 42.0 mt-30 -142.93 142.05 31.61 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.667 -1.151 . . . . 10.0 109.569 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -95.46 130.11 44.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 24.8 m-85 -114.23 139.58 49.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.546 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' PHE . . . . . 0.417 ' N ' ' HE1' ' A' ' 119' ' ' TRP . 42.8 p90 -152.0 160.85 43.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 10.0 111.149 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -123.13 132.92 54.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.362 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -126.12 167.43 15.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.945 0.402 . . . . 10.0 111.491 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -137.66 129.37 28.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.359 -0.837 . . . . 10.0 109.437 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 96.8 mt -101.44 143.85 30.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 10.0 111.077 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.51 -3.21 53.3 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.904 -0.589 . . . . 10.0 112.59 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.92 -8.57 87.55 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.933 -0.651 . . . . 10.0 112.068 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.72 42.5 3.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.265 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -163.77 114.7 0.99 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.711 0.291 . . . . 10.0 110.905 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.06 169.47 8.8 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.737 2.291 . . . . 10.0 111.311 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.51 -177.63 37.3 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.003 -1.094 . . . . 10.0 112.965 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 43.5 m-85 -132.23 164.5 26.23 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.87 150.43 22.09 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.488 -0.863 . . . . 10.0 112.183 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.52 139.2 28.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.101 0.477 . . . . 10.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.22 133.69 55.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.77 -0.65 . . . . 10.0 109.73 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.416 ' HA ' ' HG2' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -80.77 134.21 35.77 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.838 0.351 . . . . 10.0 110.516 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -77.7 41.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.769 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.27 -62.26 0.54 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.509 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -29.53 61.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.864 -0.607 . . . . 10.0 112.033 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -88.31 136.16 32.07 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.474 -0.33 . . . . 10.0 111.314 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 52.9 Cg_exo -56.75 144.17 87.83 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.832 2.355 . . . . 10.0 112.197 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -61.64 -26.04 67.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 10.0 112.074 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -33.57 71.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 10.0 110.064 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 mt -80.96 -39.57 25.82 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.185 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -64.05 -38.64 91.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.62 -0.718 . . . . 10.0 110.962 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -71.93 -15.07 62.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 10.0 111.032 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -81.82 -24.27 35.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.316 0.579 . . . . 10.0 109.47 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.479 ' HB3' HG11 ' B' ' 23' ' ' VAL . 64.0 mt -89.07 -52.5 5.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.33 -0.85 . . . . 10.0 111.352 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' GLU . . . . . 0.499 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 28.9 tt0 -86.38 106.08 17.17 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.337 0.589 . . . . 10.0 110.228 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -107.25 164.38 12.22 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.333 -0.849 . . . . 10.0 109.21 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -59.2 128.99 39.93 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.181 0.301 . . . . 10.0 110.906 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 66.95 75.88 0.3 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.372 -0.831 . . . . 10.0 110.676 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.514 ' HA ' HH21 ' A' ' 96' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.496 -0.764 . . . . 10.0 110.284 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 121.215 0.531 . . . . 10.0 110.809 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.0 mt -104.13 136.88 42.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.108 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.22 137.04 54.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.935 0.397 . . . . 10.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.16 140.78 31.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.353 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 119.91 17.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.026 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.462 ' O ' ' HE2' ' A' ' 105' ' ' LYS . 71.2 mt -72.0 -36.77 69.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.405 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -141.63 169.92 16.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.789 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.33 149.29 40.68 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -124.08 124.73 43.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.107 0.48 . . . . 10.0 111.985 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.43 98.12 9.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.308 -0.86 . . . . 10.0 109.097 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.49 155.51 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.608 -0.724 . . . . 10.0 112.191 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -114.4 -32.8 5.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.306 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.26 -166.52 1.66 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.272 -0.171 . . . . 10.0 110.844 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.4 -1.21 51.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 10.0 109.908 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.57 -42.45 16.76 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.065 -0.717 . . . . 10.0 109.065 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -91.82 138.41 31.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.946 -1.025 . . . . 10.0 109.894 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.1 tp -100.64 133.16 45.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.914 -0.585 . . . . 10.0 111.633 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.22 147.13 27.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.539 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -152.72 162.66 40.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.646 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -101.47 163.86 12.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.735 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 90' ' ' LEU . 57.7 tttm -60.97 118.71 7.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.767 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.92 -0.25 31.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.678 -0.773 . . . . 10.0 112.641 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 2.3 tp10 -68.4 141.31 55.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.584 0.23 . . . . 10.0 110.74 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -120.67 134.8 55.26 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 107' ' ' GLU . 0.5 OUTLIER -128.29 157.57 40.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.317 0.579 . . . . 10.0 111.919 -178.308 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -99.88 110.16 22.52 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.935 -1.135 . . . . 10.0 107.935 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.6 mm -64.35 116.64 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.299 -0.409 . . . . 10.0 111.651 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.6 mt -104.12 -57.7 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.563 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -117.65 112.9 21.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.355 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.58 -17.59 3.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.21 0.448 . . . . 10.0 112.21 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.2 m -83.14 -6.26 59.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.032 0.382 . . . . 10.0 112.032 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.11 -53.29 39.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 10.0 110.55 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.421 ' HA3' ' CD1' ' B' ' 43' ' ' PHE . . . -167.17 -159.14 12.25 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.451 -0.66 . . . . 10.0 111.451 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.69 -34.56 74.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.929 0.395 . . . . 10.0 110.689 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -86.07 112.69 21.5 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.781 -0.822 . . . . 10.0 108.781 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -91.17 145.7 24.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.927 -0.578 . . . . 10.0 111.471 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -108.66 115.85 30.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.075 -1.083 . . . . 10.0 108.075 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.1 164.64 26.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.064 0.459 . . . . 10.0 111.903 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.95 127.77 51.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.778 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.7 t -65.72 135.11 54.52 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.311 -0.404 . . . . 10.0 109.919 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.4 mt -82.3 -15.46 52.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.183 0.516 . . . . 10.0 109.806 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.8 m -79.85 -67.94 0.72 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.476 -0.784 . . . . 10.0 111.556 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 p -92.21 -34.68 14.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.151 0.426 . . . . 10.0 112.151 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.3 -4.97 35.45 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.628 -0.796 . . . . 10.0 112.071 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -63.75 141.61 58.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.681 0.277 . . . . 10.0 110.695 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.7 m -117.75 133.13 56.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.859 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -172.86 -178.57 42.99 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.799 -0.715 . . . . 10.0 112.093 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -78.66 131.39 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 10.0 110.498 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.0 pt -123.06 136.71 27.21 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.513 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 137' ' ' TYR . 26.4 Cg_endo -64.66 117.44 4.51 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.46 2.107 . . . . 10.0 111.563 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.72 -19.41 65.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 10.0 112.363 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.424 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 36.0 p-10 -87.05 0.46 55.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.405 -0.361 . . . . 10.0 111.338 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 13.2 m-85 -116.28 -0.08 12.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.697 0.284 . . . . 10.0 111.223 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.35 151.94 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.906 0.384 . . . . 10.0 111.451 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.45 150.17 62.86 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.266 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.14 142.63 97.45 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.686 2.257 . . . . 10.0 112.348 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.459 -0.782 . . . . 10.0 110.809 -179.667 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 20.3 ttt . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.571 0.224 . . . . 10.0 110.667 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.6 161.09 26.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.733 0.302 . . . . 10.0 110.952 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 7.1 m -100.73 133.28 45.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.388 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 21.0 t -115.42 138.8 44.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.002 0.43 . . . . 10.0 111.488 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -96.5 135.01 38.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.853 -0.612 . . . . 10.0 109.678 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.85 -179.51 6.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.816 0.341 . . . . 10.0 110.703 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.442 ' HE2' ' OE2' ' B' ' 12' ' ' GLU . 66.9 mttt -117.53 141.79 47.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.147 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -146.85 110.82 5.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.595 -0.275 . . . . 10.0 110.716 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm 67.5 1.89 2.71 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.937 0.773 . . . . 10.0 111.969 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.77 -52.57 0.82 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.668 -0.777 . . . . 10.0 112.096 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.49 145.35 47.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.866 0.365 . . . . 10.0 110.323 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.442 ' OE2' ' HE2' ' B' ' 7' ' ' LYS . 21.7 mt-10 -90.92 122.46 33.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.811 -0.631 . . . . 10.0 109.866 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -116.33 157.34 25.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.641 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -128.45 118.21 22.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.319 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 46.8 t -134.56 149.38 29.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.487 -0.56 . . . . 10.0 109.487 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 18.8 m-20 -68.26 138.38 55.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.715 0.293 . . . . 10.0 110.518 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 tt -62.54 -24.54 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 2.4 m -72.46 -9.2 58.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.082 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -106.6 11.8 30.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.338 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' B' ' 34' ' ' TYR . 67.6 mt -99.48 137.43 26.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 10.0 109.996 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 6.8 t -77.92 -74.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.777 0.322 . . . . 10.0 111.059 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -126.97 155.17 43.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.423 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.26 125.4 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.34 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -120.05 118.41 30.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.14 0.495 . . . . 10.0 111.464 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 40.5 ttp85 -104.81 144.17 32.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.142 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -115.36 -26.52 7.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.611 0.243 . . . . 10.0 111.131 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.71 14.57 8.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.401 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -145.24 -52.79 0.28 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.818 -0.808 . . . . 10.0 108.818 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -142.47 135.39 28.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.814 -1.085 . . . . 10.0 109.519 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 61.3 mt -93.02 133.52 33.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.212 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 53.3 m-85 -119.89 137.94 53.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.47 174.31 13.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.087 0.47 . . . . 10.0 111.383 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -126.95 126.45 43.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.315 -0.857 . . . . 10.0 109.399 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' B' ' 20' ' ' ILE . 53.9 p90 -116.12 159.03 22.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 10.0 111.223 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -126.26 115.83 20.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.434 -0.803 . . . . 10.0 109.775 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.41 137.41 32.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.005 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.36 -13.54 58.36 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.912 -0.586 . . . . 10.0 112.807 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.03 2.65 83.39 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.179 -0.534 . . . . 10.0 112.368 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.49 46.02 5.35 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.917 -0.659 . . . . 10.0 112.873 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -152.62 95.3 3.09 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.713 0.292 . . . . 10.0 111.211 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.49 150.88 25.33 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.931 2.421 . . . . 10.0 110.9 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.16 -170.9 22.59 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.044 -1.074 . . . . 10.0 112.885 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' PHE . . . . . 0.421 ' CD1' ' HA3' ' A' ' 117' ' ' GLY . 24.4 m-85 -126.6 165.8 18.5 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.56 -0.533 . . . . 10.0 109.56 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.45 149.48 20.08 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.251 -0.976 . . . . 10.0 112.553 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.1 p -125.53 138.1 55.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.092 0.473 . . . . 10.0 110.85 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 74.7 t -125.76 118.85 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.002 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 118.74 15.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.572 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.73 -7.93 43.6 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.648 0.61 . . . . 10.0 112.648 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -103.75 -24.18 13.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.84 0.311 . . . . 10.0 111.84 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.38 -42.37 6.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.361 0.504 . . . . 10.0 112.361 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.96 146.81 87.97 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.686 -0.233 . . . . 10.0 111.547 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.63 147.42 91.94 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.693 2.262 . . . . 10.0 111.467 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -60.61 -24.77 65.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -59.11 -44.16 91.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.872 0.368 . . . . 10.0 110.641 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 79.1 mt -72.45 -35.79 68.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.431 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.49 -42.0 92.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.745 -0.661 . . . . 10.0 111.487 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -78.05 -16.92 57.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 10.0 110.909 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -79.46 -45.92 18.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.551 -0.537 . . . . 10.0 109.551 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.79 -47.78 61.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.593 -0.73 . . . . 10.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -82.62 98.74 9.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.007 0.432 . . . . 10.0 110.453 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -96.22 144.2 26.63 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.844 -0.616 . . . . 10.0 109.919 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -61.89 130.88 47.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.968 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 67.58 97.38 0.06 Allowed 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.981 0.8 . . . . 10.0 111.23 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.637 -0.697 . . . . 10.0 110.302 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.632 0.253 . . . . 10.0 110.985 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.7 mt -108.49 140.23 42.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.559 -0.291 . . . . 10.0 110.361 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -112.33 130.05 56.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.209 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -109.1 140.38 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.234 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.26 121.36 19.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.84 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.6 -32.67 62.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.338 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.8 168.15 24.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.483 -0.781 . . . . 10.0 109.502 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.77 139.58 40.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.744 -0.465 . . . . 10.0 109.744 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -101.84 128.56 48.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.834 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -77.84 101.37 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.681 -0.69 . . . . 10.0 109.353 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.28 141.37 19.35 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.633 0.583 . . . . 10.0 111.661 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -106.93 -58.5 1.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.661 -0.7 . . . . 10.0 111.03 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 p -131.83 -165.86 1.64 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.958 -0.565 . . . . 10.0 110.346 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -89.32 -6.73 56.47 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.13 -0.693 . . . . 10.0 109.13 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -76.42 -45.14 32.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.045 -0.98 . . . . 10.0 110.006 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -82.5 152.86 25.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.466 -0.788 . . . . 10.0 110.149 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.406 HD11 ' HB2' ' A' ' 129' ' ' GLU . 22.8 tp -89.82 132.2 35.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.345 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 m -91.15 126.16 36.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.751 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -146.83 165.49 29.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.828 0.346 . . . . 10.0 111.218 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -118.33 166.51 12.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.166 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.2 tttm -66.52 132.25 47.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.942 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.56 -6.16 52.3 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.835 -0.698 . . . . 10.0 112.71 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -81.54 150.35 28.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 10.0 111.415 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -113.16 128.24 56.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.745 -0.662 . . . . 10.0 109.225 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -120.25 144.47 47.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.9 0.381 . . . . 10.0 111.216 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -99.08 110.66 23.22 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 16.9 mm -66.22 118.63 9.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.334 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.13 -37.72 18.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.083 -0.508 . . . . 10.0 109.896 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -153.57 112.37 3.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.968 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.47 2.59 47.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.274 0.559 . . . . 10.0 110.656 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.91 20.07 1.94 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.794 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.61 -42.89 17.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.274 0.559 . . . . 10.0 110.159 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 138.5 -70.79 0.46 Allowed Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.702 -0.681 . . . . 10.0 111.82 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -122.76 -69.0 0.85 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.709 -0.478 . . . . 10.0 109.709 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.499 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 40.0 m95 -78.35 100.84 6.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.444 -0.947 . . . . 10.0 108.444 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -88.34 156.26 19.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.057 -0.52 . . . . 10.0 111.941 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -84.56 122.9 29.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.404 -0.817 . . . . 10.0 109.028 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.25 153.13 43.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.238 0.542 . . . . 10.0 112.107 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -114.06 123.29 49.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.072 -0.967 . . . . 10.0 109.128 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 t -67.22 131.36 45.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.955 0.407 . . . . 10.0 110.016 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.4 mt -83.1 -21.28 33.73 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.31 -55.15 6.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.077 -0.965 . . . . 10.0 111.075 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.4 p -94.58 -67.17 0.87 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.766 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.29 -2.2 3.83 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.824 -0.91 . . . . 10.0 110.824 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.406 ' HB2' HD11 ' A' ' 101' ' ' LEU . 40.8 mt-10 -68.66 148.05 50.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.294 -0.453 . . . . 10.0 110.738 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.2 m -120.91 138.71 53.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.233 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.85 -175.05 47.49 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.571 -0.823 . . . . 10.0 112.159 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -88.79 135.7 33.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.615 0.245 . . . . 10.0 110.69 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.0 pt -125.78 143.96 46.84 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.192 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.513 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 56.9 Cg_endo -73.16 121.45 7.25 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.396 2.064 . . . . 10.0 111.347 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.18 -1.65 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.513 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 36.8 p-10 -96.33 0.55 50.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.794 0.33 . . . . 10.0 110.768 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -119.7 1.03 11.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.035 0.445 . . . . 10.0 111.202 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.63 154.33 36.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.37 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.15 147.13 42.83 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.804 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.29 142.85 42.23 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.438 2.092 . . . . 10.0 111.512 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.406 -0.807 . . . . 10.0 110.143 179.947 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.309 0.1 . . . . 10.0 110.828 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.03 171.23 11.26 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.751 0.31 . . . . 10.0 110.883 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m -107.72 129.16 55.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.34 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -102.85 137.39 31.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 10.0 110.722 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -101.94 137.32 40.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 10.0 110.417 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -145.55 168.13 21.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.254 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.45 85.14 2.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -67.77 96.38 0.56 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.356 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt 58.94 26.33 14.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.353 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.26 -27.23 9.66 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.973 -0.632 . . . . 10.0 112.703 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -76.87 114.03 15.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.693 0.283 . . . . 10.0 111.204 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.03 109.75 7.78 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.772 -0.455 . . . . 10.0 109.772 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -131.08 157.38 43.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.55 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -129.42 132.02 46.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.847 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 90.8 t -136.99 147.13 27.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.413 ' HB2' ' HD2' ' B' ' 19' ' ' LYS . 18.1 m-20 -61.16 135.99 57.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 10.0 110.783 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.4 tt -60.6 -31.4 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.492 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -5.49 39.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.165 -0.471 . . . . 10.0 111.584 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.413 ' HD2' ' HB2' ' B' ' 16' ' ' ASP . 80.9 mttt -105.29 9.99 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.21 0.529 . . . . 10.0 110.618 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 78.7 mt -95.55 121.7 46.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.39 -60.0 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.69 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.22 151.53 45.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.852 0.358 . . . . 10.0 111.318 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 t -127.02 138.41 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.278 -0.873 . . . . 10.0 109.564 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -136.91 118.6 15.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.977 0.418 . . . . 10.0 111.04 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 35.1 ttp85 -109.03 141.1 41.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.409 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -115.92 -26.06 7.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.339 -0.391 . . . . 10.0 111.168 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.64 29.76 2.81 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.748 . . . . 10.0 111.452 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -157.52 -53.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -139.23 129.88 25.95 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.283 -0.871 . . . . 10.0 109.806 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mt -88.98 117.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -104.97 139.12 40.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.688 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.81 166.19 32.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.724 0.297 . . . . 10.0 110.939 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -127.63 135.91 50.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.097 -0.501 . . . . 10.0 109.837 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -122.11 165.15 16.53 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.483 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -136.32 121.81 19.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.844 -0.616 . . . . 10.0 110.331 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 66.1 mt -98.11 142.38 29.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.875 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.38 -14.99 62.94 Favored Glycine 0 C--N 1.329 0.148 0 CA-C-N 116.095 -0.502 . . . . 10.0 112.815 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.64 11.94 54.2 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.659 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.3 51.1 6.28 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.889 -0.672 . . . . 10.0 111.766 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 tptt -138.93 90.46 12.2 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 121.072 -0.251 . . . . 10.0 110.987 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -89.05 110.02 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.771 2.314 . . . . 10.0 110.467 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.63 -177.86 15.18 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.124 -1.036 . . . . 10.0 112.897 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 23.0 m-85 -120.8 166.74 13.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.785 -0.45 . . . . 10.0 109.785 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.35 142.8 12.02 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.827 -0.702 . . . . 10.0 112.169 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.68 129.25 51.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.844 0.354 . . . . 10.0 110.43 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -126.07 127.19 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.204 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.15 127.94 34.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.457 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -83.73 26.06 0.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -137.69 -50.54 0.61 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -95.64 19.86 10.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.34 144.14 48.32 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.614 -0.267 . . . . 10.0 110.456 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.41 138.45 47.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.025 2.483 . . . . 10.0 112.248 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -60.7 -27.55 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.982 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.83 -38.1 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.716 0.293 . . . . 10.0 111.134 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.19 -39.85 78.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.382 . . . . 10.0 110.035 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 21.9 mt -67.84 -39.72 83.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.588 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -66.93 -31.61 72.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.266 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.42 -8.6 59.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.003 0.43 . . . . 10.0 110.748 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 25.5 mt -96.09 -45.56 6.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.791 0.293 . . . . 10.0 111.791 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -91.54 131.84 36.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 10.0 111.213 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -123.86 163.57 20.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 10.0 109.487 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -74.35 131.99 41.62 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.893 -0.323 . . . . 10.0 110.613 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 mttp 64.0 62.52 0.87 Allowed 'General case' 0 C--O 1.236 0.38 0 O-C-N 123.921 0.763 . . . . 10.0 110.746 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.496 -0.764 . . . . 10.0 110.254 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.753 0.311 . . . . 10.0 110.552 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.4 mt -88.09 160.79 17.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.309 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.18 135.92 55.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.505 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 p -111.05 139.29 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.553 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.99 124.63 25.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.162 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.411 ' O ' ' HE2' ' A' ' 105' ' ' LYS . 59.6 mt -83.51 -33.37 25.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.531 . . . . 10.0 110.607 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -139.61 154.57 47.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.962 -0.563 . . . . 10.0 109.812 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.01 150.42 42.43 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.619 -0.512 . . . . 10.0 109.619 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -138.02 133.93 34.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.629 0.252 . . . . 10.0 110.518 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.65 132.45 46.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.15 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.497 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -91.88 148.76 21.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.015 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 96' ' ' ARG . 5.4 ttm180 -119.8 -21.37 7.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.345 0.593 . . . . 10.0 109.968 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.55 -178.48 4.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.005 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -94.17 8.56 41.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.358 0.599 . . . . 10.0 110.143 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.69 -44.14 7.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.303 -0.862 . . . . 10.0 109.521 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 95' ' ' ALA . 15.9 p-10 -88.39 151.21 22.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.411 -0.813 . . . . 10.0 109.053 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 tp -112.0 129.12 56.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.984 0.421 . . . . 10.0 112.057 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.497 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -84.28 139.36 32.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.124 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.402 ' CB ' ' HZ ' ' A' ' 109' ' ' PHE . 31.3 p90 -155.2 170.81 20.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.841 0.353 . . . . 10.0 111.225 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -114.91 157.61 23.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.71 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 90' ' ' LEU . 54.8 tttm -62.32 131.99 51.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.664 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.71 -19.73 23.3 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.546 -0.835 . . . . 10.0 112.863 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -77.15 148.98 35.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.98 0.419 . . . . 10.0 110.834 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -114.68 144.09 43.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.122 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.402 ' HZ ' ' CB ' ' A' ' 103' ' ' PHE . 32.1 m-85 -129.51 153.91 47.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.963 0.411 . . . . 10.0 111.306 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -100.1 114.35 27.64 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 46.9 mm -69.35 119.15 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.904 0.383 . . . . 10.0 111.142 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.4 mt -85.37 -52.58 5.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.648 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -135.92 109.1 7.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.877 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.36 -8.08 39.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.225 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.27 21.22 9.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.45 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 119' ' ' TRP . 19.4 tp10 -67.59 -43.39 80.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.645 -0.707 . . . . 10.0 110.356 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 155.28 -106.54 0.3 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.833 -0.698 . . . . 10.0 111.887 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -99.4 -11.44 21.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.213 0.53 . . . . 10.0 109.971 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.482 ' O ' ' HB3' ' A' ' 116' ' ' GLU . 39.9 m95 -124.64 159.71 30.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.155 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -119.85 139.99 51.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.943 0.401 . . . . 10.0 111.88 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -90.23 116.11 27.97 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.786 -1.19 . . . . 10.0 107.786 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.91 160.61 30.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.643 0.735 . . . . 10.0 112.579 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -116.31 128.29 55.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.67 -1.15 . . . . 10.0 109.226 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t -66.43 133.16 49.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.81 0.338 . . . . 10.0 111.101 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.8 mt -92.04 -11.23 36.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.432 0.634 . . . . 10.0 109.362 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -50.47 8.48 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.347 -0.842 . . . . 10.0 110.537 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.0 p -111.05 -55.89 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.099 0.476 . . . . 10.0 111.298 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.1 -8.54 4.44 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.908 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -55.73 146.82 20.18 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.05 0.452 . . . . 10.0 111.843 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.83 142.62 46.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.329 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.92 173.47 42.51 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.419 -0.896 . . . . 10.0 112.076 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -84.79 131.34 34.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.019 0.438 . . . . 10.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.0 pt -115.51 144.53 32.61 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.547 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.469 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 19.6 Cg_exo -63.89 114.53 2.64 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.849 1.7 . . . . 10.0 111.141 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.1 -14.2 15.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.559 -0.746 . . . . 10.0 112.46 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.405 ' ND2' ' HB2' ' B' ' 26' ' ' TYR . 23.0 p-10 -104.27 12.88 33.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.424 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 134' ' ' PRO . 8.8 m-85 -120.82 3.34 10.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.747 0.308 . . . . 10.0 111.163 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 m -128.84 148.44 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.945 0.402 . . . . 10.0 111.12 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -128.9 141.44 41.71 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.292 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.02 137.02 43.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.654 2.236 . . . . 10.0 111.973 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 64.3 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.397 -0.811 . . . . 10.0 109.785 179.678 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.668 0.271 . . . . 10.0 110.398 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.52 147.58 28.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.863 0.364 . . . . 10.0 110.866 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.8 m -97.84 132.33 43.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.419 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 48.5 t -104.46 131.62 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.867 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -98.42 131.62 44.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.677 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -145.42 -174.07 4.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.742 0.306 . . . . 10.0 110.809 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -130.2 123.96 31.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.895 -0.593 . . . . 10.0 109.841 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' TYR . . . . . 0.481 ' O ' ' HG2' ' B' ' 11' ' ' GLU . 17.9 t80 -102.17 94.05 5.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.869 0.366 . . . . 10.0 110.122 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 60.44 13.4 4.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.639 -0.71 . . . . 10.0 112.156 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.68 -35.87 2.0 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.38 -0.914 . . . . 10.0 113.159 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' B' ' 8' ' ' TYR . 12.0 pt-20 -82.57 136.66 34.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.159 0.479 . . . . 10.0 111.062 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -83.62 138.59 33.28 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -148.3 150.48 33.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.894 0.378 . . . . 10.0 111.386 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -123.47 110.82 15.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.126 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' VAL . . . . . 0.436 HG11 ' HB2' ' B' ' 34' ' ' TYR . 60.2 t -125.44 141.51 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.162 -0.472 . . . . 10.0 109.835 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 29.9 m-20 -66.97 145.25 55.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.117 0.484 . . . . 10.0 111.786 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.6 tt -58.88 -30.14 42.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.401 -0.818 . . . . 10.0 112.318 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 5.8 m -74.04 -10.65 59.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.778 0.323 . . . . 10.0 111.417 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.3 2.58 39.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.237 0.541 . . . . 10.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -99.3 110.48 26.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.537 -0.756 . . . . 10.0 109.289 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.422 ' H ' HG23 ' B' ' 21' ' ' VAL . 2.9 t -62.19 -78.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.698 -0.683 . . . . 10.0 112.14 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -114.57 144.8 42.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 10.0 111.202 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 t -131.68 140.93 47.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 56.1 m -144.93 125.87 14.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.216 0.532 . . . . 10.0 111.376 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.452 ' HG3' ' OE1' ' B' ' 48' ' ' GLU . 27.6 ttp85 -108.42 152.59 24.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.373 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' TYR . . . . . 0.405 ' HB2' ' ND2' ' A' ' 136' ' ' ASN . 19.2 t80 -129.63 -18.31 3.53 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.874 -0.33 . . . . 10.0 111.745 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.46 3.14 25.8 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.316 -0.945 . . . . 10.0 111.325 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -128.02 -52.27 1.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.405 -0.591 . . . . 10.0 109.405 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -150.97 143.32 24.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.373 -0.83 . . . . 10.0 109.941 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mt -95.02 132.68 38.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.331 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -118.9 142.68 47.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.308 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -162.14 168.82 21.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.807 0.336 . . . . 10.0 111.193 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -123.9 133.56 53.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.476 -0.564 . . . . 10.0 109.476 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.436 ' HB2' HG11 ' B' ' 15' ' ' VAL . 51.4 p90 -113.88 147.54 38.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.977 0.418 . . . . 10.0 110.739 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -122.94 121.76 36.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.641 -0.708 . . . . 10.0 109.531 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' B' ' 40' ' ' LYS . 96.5 mt -97.84 136.85 37.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.817 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.3 -18.18 64.88 Favored Glycine 0 C--N 1.33 0.202 0 CA-C-N 116.068 -0.515 . . . . 10.0 112.194 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.57 -8.63 87.56 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.793 -0.718 . . . . 10.0 111.913 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 64.85 1.05 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.76 -0.734 . . . . 10.0 112.471 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' LYS . . . . . 0.533 ' HB3' HD12 ' B' ' 36' ' ' LEU . 36.8 tttp -160.34 85.47 1.97 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.047 0.451 . . . . 10.0 110.371 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -84.34 136.07 6.46 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.668 2.245 . . . . 10.0 111.667 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.37 -176.92 29.97 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.532 -0.842 . . . . 10.0 112.101 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -113.13 168.83 9.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.303 -0.258 . . . . 10.0 110.303 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.03 138.77 7.08 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.463 -0.655 . . . . 10.0 111.463 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.44 135.28 64.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.88 0.372 . . . . 10.0 110.424 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 81.1 t -127.67 129.11 70.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.574 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.9 t -75.78 126.98 32.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.226 -0.443 . . . . 10.0 109.903 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' B' ' 25' ' ' ARG . 52.8 mt-10 -76.45 2.46 13.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.955 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -124.37 -34.71 2.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.595 -0.275 . . . . 10.0 111.497 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -84.47 -24.28 29.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.735 0.302 . . . . 10.0 111.557 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.35 146.87 32.07 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.747 0.308 . . . . 10.0 111.038 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.63 156.23 66.88 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.704 2.269 . . . . 10.0 111.759 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.401 ' HD3' HD12 ' B' ' 56' ' ' LEU . 74.3 mmtt -60.57 -25.96 66.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.375 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -51.39 -40.85 60.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.666 -0.697 . . . . 10.0 111.385 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.21 -40.53 14.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.027 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.401 HD12 ' HD3' ' B' ' 53' ' ' LYS . 54.8 mt -60.89 -37.18 81.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.7 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -74.52 -11.53 60.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.603 -0.271 . . . . 10.0 111.342 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -94.42 -19.16 20.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.097 0.475 . . . . 10.0 110.05 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -95.14 -7.94 37.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.229 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -79.92 71.35 6.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.616 -0.72 . . . . 10.0 109.781 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' B' ' 64' ' ' LYS . 82.3 mttt -72.39 102.71 3.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.589 -0.732 . . . . 10.0 110.076 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -70.68 150.96 45.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.401 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 67.59 33.85 4.86 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.739 0.78 . . . . 10.0 109.791 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' B' ' 61' ' ' LYS . 11.5 tptp . . . . . 0 C--O 1.251 1.172 0 CA-C-N 114.642 -1.163 . . . . 10.0 108.783 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.592 0.234 . . . . 10.0 110.553 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -107.86 137.94 44.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.964 0.411 . . . . 10.0 110.876 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -116.41 142.24 47.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.526 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.6 p -110.47 140.34 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.534 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.76 126.21 30.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.888 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.76 -31.95 35.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.019 0.438 . . . . 10.0 110.164 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -141.29 168.76 19.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.67 -0.696 . . . . 10.0 109.442 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.19 138.83 35.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.336 -0.393 . . . . 10.0 109.946 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -112.65 127.17 56.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.098 0.475 . . . . 10.0 111.67 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -95.94 118.09 31.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.371 -0.974 . . . . 10.0 108.371 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.87 153.26 36.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.98 0.419 . . . . 10.0 111.236 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -118.08 -35.9 3.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.946 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.44 171.79 7.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.985 0.421 . . . . 10.0 110.343 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -84.32 20.01 1.75 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.738 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.74 -36.04 3.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.161 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -83.3 141.05 32.11 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.923 -0.769 . . . . 10.0 108.923 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.0 tp -97.65 126.94 43.24 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.407 0.521 . . . . 10.0 112.407 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.4 146.97 25.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 10.0 109.839 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -155.61 168.39 27.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.674 0.274 . . . . 10.0 111.014 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -105.8 160.6 15.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.916 -0.583 . . . . 10.0 110.434 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -64.9 126.43 27.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.115 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.38 -9.07 38.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.641 -0.79 . . . . 10.0 113.278 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -77.8 151.45 33.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.269 0.534 . . . . 10.0 111.147 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -118.42 133.52 55.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.684 . . . . 10.0 109.971 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.26 152.56 45.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.784 0.326 . . . . 10.0 110.56 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -95.0 115.35 27.31 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.948 -0.76 . . . . 10.0 108.948 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.6 mm -69.5 120.18 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.862 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.1 mt -89.43 -55.93 3.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.148 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -134.74 108.63 8.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.34 4.71 41.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.642 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -95.4 8.53 42.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.031 -0.532 . . . . 10.0 111.541 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.21 74.55 3.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.312 0.577 . . . . 10.0 110.842 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.473 ' O ' ' HE2' ' B' ' 9' ' ' LYS . . . 68.04 -132.53 28.55 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.776 -0.726 . . . . 10.0 112.127 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -112.32 8.62 19.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.022 0.439 . . . . 10.0 110.798 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -120.44 104.76 10.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.262 -1.014 . . . . 10.0 108.262 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 4.6 m0 -83.35 135.56 34.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.869 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -92.41 112.56 24.55 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.462 -1.31 . . . . 10.0 107.462 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.75 169.26 11.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.012 0.434 . . . . 10.0 111.806 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -120.52 126.04 49.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.544 -0.753 . . . . 10.0 109.765 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.2 t -65.24 135.31 55.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.399 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.02 -12.38 44.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.056 0.455 . . . . 10.0 110.2 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.35 -48.02 11.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.693 -0.685 . . . . 10.0 111.126 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 80.8 p -105.98 -43.61 4.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.995 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.52 3.88 28.75 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.605 -0.807 . . . . 10.0 111.729 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -74.12 144.88 44.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 10.0 110.576 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -118.44 139.5 51.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.921 -0.582 . . . . 10.0 110.811 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.95 177.17 45.69 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.798 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.32 129.41 35.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.7 pt -113.67 136.78 22.03 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.719 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.57 107.16 0.82 Allowed 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.494 2.129 . . . . 10.0 111.752 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -7.69 10.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.791 -0.64 . . . . 10.0 112.227 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -96.11 1.22 52.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.833 0.349 . . . . 10.0 110.701 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -111.5 -14.45 13.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.093 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.6 m -114.1 160.62 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.108 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -143.42 152.66 57.63 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.448 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.12 144.56 87.43 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.272 1.981 . . . . 10.0 111.632 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.416 -0.802 . . . . 10.0 110.176 -179.982 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.524 0.202 . . . . 10.0 110.609 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.01 169.96 23.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.931 0.396 . . . . 10.0 111.48 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 7.4 m -104.95 136.01 45.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.895 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 44.3 t -109.86 132.47 58.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.763 0.316 . . . . 10.0 110.91 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -99.31 127.04 45.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.272 -0.64 . . . . 10.0 109.272 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.468 ' CD2' ' HZ ' ' B' ' 32' ' ' PHE . 41.3 p90 -141.96 175.88 9.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.441 -0.345 . . . . 10.0 111.009 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -109.72 146.91 34.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.88 92.78 2.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.473 ' HE2' ' O ' ' A' ' 117' ' ' GLY . 5.1 mmtm 61.57 30.35 18.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.287 -0.87 . . . . 10.0 111.668 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.83 -51.88 0.72 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.908 -0.663 . . . . 10.0 113.469 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -74.18 142.66 45.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.959 0.409 . . . . 10.0 111.198 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -92.94 130.49 38.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.953 -0.567 . . . . 10.0 109.79 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.47 157.26 35.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.568 -0.287 . . . . 10.0 110.916 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -129.32 113.28 14.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.549 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.14 149.5 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.273 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 5.1 m-20 -64.99 142.82 58.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.656 -0.247 . . . . 10.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 12.0 tt -65.96 -24.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.48 0.657 . . . . 10.0 110.041 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -4.06 33.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.322 -0.853 . . . . 10.0 111.068 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -110.97 15.08 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.539 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 71.3 mt -95.91 133.15 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.257 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -80.99 -52.58 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.066 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -152.15 155.3 37.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.367 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.59 125.83 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 123.547 0.529 . . . . 10.0 110.464 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 4.2 m -116.82 105.95 12.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.871 0.367 . . . . 10.0 111.453 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.552 ' HD2' ' OE2' ' B' ' 48' ' ' GLU . 0.3 OUTLIER -94.82 136.99 34.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.354 -0.384 . . . . 10.0 110.091 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -116.48 -21.47 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.887 0.375 . . . . 10.0 111.16 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.82 4.59 39.3 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.081 -0.808 . . . . 10.0 111.081 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -134.12 -47.41 0.78 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -149.44 132.69 16.43 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.988 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -87.17 123.65 40.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.245 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.81 132.67 53.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.86 -0.609 . . . . 10.0 109.612 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' PHE . . . . . 0.468 ' HZ ' ' CD2' ' B' ' 6' ' ' PHE . 43.4 p90 -150.77 169.46 21.61 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.431 -0.508 . . . . 10.0 111.985 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -122.04 138.87 54.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.357 -0.838 . . . . 10.0 109.459 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -133.67 165.65 24.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 10.0 111.697 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.32 121.38 15.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.707 -0.678 . . . . 10.0 110.112 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' B' ' 40' ' ' LYS . 24.9 mt -96.08 129.67 43.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.616 -0.265 . . . . 10.0 110.415 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.6 106.23 1.31 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.095 -0.574 . . . . 10.0 111.869 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.77 -7.83 1.73 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.976 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.54 36.27 3.84 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.52 -0.847 . . . . 10.0 112.991 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 79.5 tttt -135.42 67.72 67.18 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.113 0.457 . . . . 10.0 111.274 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -90.74 171.65 3.35 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.499 2.133 . . . . 10.0 112.015 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.8 -158.73 31.54 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.413 -0.898 . . . . 10.0 112.394 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -121.37 178.33 4.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.515 0.198 . . . . 10.0 110.517 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.51 150.5 19.68 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.654 -0.784 . . . . 10.0 111.957 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.55 130.8 69.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.188 0.518 . . . . 10.0 110.974 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 5.0 t -118.57 122.78 70.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.828 -0.623 . . . . 10.0 109.748 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.7 t -69.77 133.18 47.16 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.154 -0.313 . . . . 10.0 110.154 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.552 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 44.0 mt-10 -87.24 15.95 5.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.944 0.402 . . . . 10.0 110.389 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -122.92 -62.79 1.32 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.605 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.35 36.33 0.69 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 10.0 112.194 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.66 143.72 36.34 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.316 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.75 143.1 85.58 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.618 2.212 . . . . 10.0 112.095 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -59.79 -23.13 63.03 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.582 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -52.93 -50.88 63.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.685 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 75.6 mt -77.2 -34.86 56.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.695 0.283 . . . . 10.0 110.933 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.81 -42.0 98.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.391 -0.368 . . . . 10.0 111.553 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -73.9 -31.48 63.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.008 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -71.59 -33.78 69.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.462 -0.335 . . . . 10.0 110.394 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 20.5 mt -74.46 -44.54 51.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.677 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -79.19 87.43 4.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.177 0.513 . . . . 10.0 110.625 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -89.76 145.45 25.18 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.924 -0.58 . . . . 10.0 109.777 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -68.21 140.52 56.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.522 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.7 mttt 62.31 79.48 0.26 Allowed 'General case' 0 C--O 1.232 0.18 0 O-C-N 123.835 0.71 . . . . 10.0 110.233 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.221 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.833 0.349 . . . . 10.0 110.703 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.06 154.94 24.15 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.747 -0.464 . . . . 10.0 109.747 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -121.65 136.17 54.95 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.2 -0.296 . . . . 10.0 110.2 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.27 138.96 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.61 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.43 122.57 22.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.208 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.2 mt -77.78 -35.12 51.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.801 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -142.78 163.88 31.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 10.0 110.273 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.31 131.41 42.64 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -102.8 123.68 46.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.048 0.452 . . . . 10.0 111.688 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -88.29 105.81 17.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.802 -0.814 . . . . 10.0 108.802 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.99 156.99 37.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.355 0.598 . . . . 10.0 111.96 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -118.46 -44.08 2.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.67 -0.695 . . . . 10.0 111.059 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -121.89 -160.83 0.89 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.511 -0.313 . . . . 10.0 110.979 -178.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.404 ' H ' ' HB ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -98.35 -16.33 19.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.271 0.558 . . . . 10.0 109.54 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.86 -44.74 69.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.159 -0.928 . . . . 10.0 110.26 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.46 146.04 31.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.559 -0.746 . . . . 10.0 109.958 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.7 tp -96.77 124.9 40.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.31 -0.405 . . . . 10.0 111.816 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.24 129.42 34.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.297 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -144.29 164.53 30.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.892 0.377 . . . . 10.0 111.13 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -106.05 160.78 15.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.515 -0.766 . . . . 10.0 110.111 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -65.22 130.75 44.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.588 -0.278 . . . . 10.0 110.755 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.06 -15.34 51.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.681 -0.771 . . . . 10.0 113.175 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -71.43 152.22 43.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.899 0.381 . . . . 10.0 111.102 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -114.03 139.81 48.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.75 -0.659 . . . . 10.0 110.21 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.0 157.64 45.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 10.0 111.018 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -108.94 117.95 35.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.306 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.423 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . 23.8 mm -69.09 123.76 23.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.231 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 mt -98.17 -37.86 9.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.483 -0.326 . . . . 10.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -142.38 100.87 3.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.79 0.329 . . . . 10.0 111.364 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.75 -5.5 26.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.447 0.641 . . . . 10.0 110.34 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.78 8.71 24.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.078 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -72.9 -35.61 67.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.705 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 146.63 -127.26 2.68 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.719 -0.673 . . . . 10.0 111.454 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -49.74 22.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.933 0.396 . . . . 10.0 110.186 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.522 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 23.5 m95 -87.69 134.81 33.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.8 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 20.0 m0 -110.69 147.69 33.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.921 0.391 . . . . 10.0 111.18 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -99.03 120.57 39.67 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.423 ' HB2' ' HA ' ' A' ' 111' ' ' ILE . . . -139.89 166.37 24.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.846 0.355 . . . . 10.0 111.401 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -116.25 140.12 49.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.1 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.1 t -74.46 148.95 40.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.676 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.18 -24.7 18.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.568 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -45.08 48.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.729 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 p -104.35 -63.7 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.696 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.33 -13.01 5.72 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.748 -0.739 . . . . 10.0 112.037 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -57.15 144.42 34.97 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.858 0.361 . . . . 10.0 111.333 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.2 m -118.47 126.33 51.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.759 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -162.9 -174.58 32.97 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.564 -0.827 . . . . 10.0 111.675 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -82.19 130.1 35.0 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.145 -0.317 . . . . 10.0 110.145 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 pt -121.43 140.8 32.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.797 0.332 . . . . 10.0 110.821 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.56 119.64 6.68 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.666 2.244 . . . . 10.0 111.832 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.69 -18.97 65.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 10.0 111.749 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -88.92 7.09 36.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.389 -0.368 . . . . 10.0 111.422 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -123.85 8.04 8.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.179 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.2 m -131.33 151.72 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.992 0.425 . . . . 10.0 111.576 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -133.68 144.37 51.69 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.294 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.73 134.35 43.5 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.608 2.205 . . . . 10.0 112.41 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.434 -0.794 . . . . 10.0 110.445 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ttt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.525 0.203 . . . . 10.0 110.656 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.02 165.52 27.21 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.592 0.234 . . . . 10.0 110.673 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.92 137.75 32.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.903 -0.589 . . . . 10.0 110.958 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 88.2 t -108.55 128.74 63.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.358 -0.383 . . . . 10.0 110.159 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -93.82 121.95 35.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -132.09 170.97 14.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.486 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -117.44 97.07 5.69 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.193 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -80.98 72.47 8.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm 59.16 66.97 0.96 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.306 -0.861 . . . . 10.0 110.955 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.96 -46.3 2.27 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.832 -0.699 . . . . 10.0 113.02 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.32 117.88 19.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 10.0 111.333 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -88.53 116.36 26.71 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.274 -0.639 . . . . 10.0 109.274 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -124.24 160.1 28.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.885 0.374 . . . . 10.0 111.299 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -127.3 118.05 23.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.515 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.5 144.46 37.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.261 -0.427 . . . . 10.0 109.874 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.83 135.69 57.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.499 -0.318 . . . . 10.0 110.388 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 tt -63.75 -22.42 30.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.298 0.57 . . . . 10.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -9.45 59.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.935 -0.575 . . . . 10.0 111.131 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -101.47 11.23 39.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.303 0.573 . . . . 10.0 110.314 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 78.1 mt -98.73 129.95 48.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.34 -0.845 . . . . 10.0 109.654 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 7.2 t -76.65 -75.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.335 -0.393 . . . . 10.0 111.331 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -120.49 153.41 36.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.796 0.332 . . . . 10.0 110.781 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.34 129.2 56.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.869 -0.605 . . . . 10.0 110.511 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 19.5 m -121.44 112.13 18.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.197 0.522 . . . . 10.0 110.861 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.483 ' HG3' HG12 ' B' ' 30' ' ' ILE . 52.0 ttp85 -100.71 133.72 44.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.314 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -103.65 -19.01 14.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.984 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.96 -18.86 14.18 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.115 -0.794 . . . . 10.0 111.115 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -114.04 -61.4 1.75 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -118.67 143.57 46.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.368 -0.833 . . . . 10.0 109.523 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.483 HG12 ' HG3' ' B' ' 25' ' ' ARG . 1.9 mt -106.14 119.31 55.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.033 -0.531 . . . . 10.0 109.908 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -105.24 135.46 46.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.347 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -151.26 165.84 32.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.861 0.362 . . . . 10.0 111.438 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 133.55 54.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.409 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -123.73 166.2 15.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.517 -0.311 . . . . 10.0 110.699 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -139.6 115.81 10.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.164 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -82.55 145.53 29.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.837 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.47 -18.81 73.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.039 -0.601 . . . . 10.0 112.669 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.34 19.86 7.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.024 -0.608 . . . . 10.0 112.887 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.03 51.7 17.34 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.929 -0.653 . . . . 10.0 112.349 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -150.36 96.04 3.49 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.881 0.372 . . . . 10.0 111.286 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.84 154.13 13.24 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.412 2.074 . . . . 10.0 110.76 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.79 -172.11 31.85 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 119.573 -1.299 . . . . 10.0 113.034 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' PHE . . . . . 0.522 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 15.6 m-85 -133.07 166.89 21.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.685 -0.487 . . . . 10.0 109.685 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.66 146.43 14.48 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.628 -0.796 . . . . 10.0 111.767 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 3.6 p -129.68 127.63 64.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.303 0.573 . . . . 10.0 110.784 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.58 132.08 67.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.282 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 14.6 t -88.67 125.38 34.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.668 0.27 . . . . 10.0 110.388 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -68.97 -17.28 63.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.046 0.451 . . . . 10.0 111.587 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -100.47 16.75 23.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.671 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -133.26 -53.3 0.9 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.903 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.06 152.64 76.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.024 -0.534 . . . . 10.0 111.371 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.442 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 32.0 Cg_endo -63.4 154.08 70.54 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.82 2.346 . . . . 10.0 112.951 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -57.76 -34.12 69.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.459 -0.791 . . . . 10.0 112.082 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -54.15 -44.97 71.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.961 0.356 . . . . 10.0 111.961 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.6 -39.22 70.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 10.0 110.98 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 18.0 mt -65.21 -43.05 92.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.771 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -69.44 -18.39 63.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.818 -0.628 . . . . 10.0 111.685 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -80.67 -25.42 38.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.893 0.378 . . . . 10.0 110.614 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 82.0 mt -83.67 -42.9 16.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.452 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' GLU . . . . . 0.471 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 1.1 tp10 -86.64 92.39 8.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 10.0 110.342 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -108.88 -177.65 3.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.404 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -80.18 138.19 36.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.262 -0.273 . . . . 10.0 110.262 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 57.4 39.09 28.47 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.43 0.633 . . . . 10.0 110.018 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-N 115.168 -0.924 . . . . 10.0 110.886 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 120.849 0.357 . . . . 10.0 110.441 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -84.79 129.59 34.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.976 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -121.06 145.42 47.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.762 -0.654 . . . . 10.0 109.673 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.23 139.6 42.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.956 0.407 . . . . 10.0 110.647 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.95 123.52 24.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.894 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.4 mt -71.2 -50.93 27.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.429 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -129.01 178.61 6.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.846 -0.615 . . . . 10.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.06 142.87 28.41 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -126.37 130.2 50.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.996 0.426 . . . . 10.0 110.751 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -93.73 116.99 29.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.521 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 137.85 56.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.144 0.497 . . . . 10.0 111.304 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' B' ' 21' ' ' VAL . 14.6 ttt180 -94.09 -40.7 9.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.455 -0.793 . . . . 10.0 110.306 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.9 p -131.95 -163.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.887 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -93.84 -2.49 53.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.238 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.5 -41.43 16.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.907 -0.588 . . . . 10.0 109.874 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -89.49 154.51 19.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.5 -0.773 . . . . 10.0 109.153 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.3 tp -107.62 134.52 50.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.197 0.443 . . . . 10.0 112.197 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.56 146.36 25.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.528 -0.76 . . . . 10.0 110.555 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -162.65 166.06 24.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.821 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -113.53 168.34 9.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.493 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -61.7 115.54 4.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.852 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.09 -1.2 25.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.637 -0.792 . . . . 10.0 112.696 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -67.99 137.92 55.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 10.0 110.947 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -102.2 130.58 48.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -120.47 144.73 47.83 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.098 0.777 . . . . 10.0 113.098 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -108.28 106.07 16.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.7 114.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.101 0.477 . . . . 10.0 111.578 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 mt -86.0 -48.67 8.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.571 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -138.95 104.41 5.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 10.0 111.182 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -15.45 37.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.281 0.562 . . . . 10.0 110.458 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.87 13.45 5.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.811 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.17 -45.38 73.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 10.0 110.471 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.99 -119.12 0.93 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.2 -0.76 . . . . 10.0 111.2 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -93.51 -27.73 16.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.296 0.569 . . . . 10.0 110.052 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.442 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 29.2 m95 -110.63 114.99 28.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.145 -1.057 . . . . 10.0 108.145 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -95.31 143.12 26.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.164 0.507 . . . . 10.0 111.353 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -90.89 121.64 32.91 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.52 -0.919 . . . . 10.0 108.52 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.14 164.34 27.57 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.815 0.341 . . . . 10.0 111.582 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -112.04 137.64 49.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.522 -0.763 . . . . 10.0 110.708 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.1 t -76.45 141.12 41.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.148 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.8 mt -93.21 2.97 56.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.451 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -105.14 -58.48 1.88 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.888 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.1 p -91.47 -39.14 12.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.218 0.532 . . . . 10.0 110.875 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 103.17 6.96 44.5 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.698 -0.683 . . . . 10.0 111.671 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -73.24 146.11 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.321 . . . . 10.0 110.663 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 91.0 m -126.83 134.5 50.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.366 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.63 -176.0 43.5 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.903 -0.665 . . . . 10.0 111.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -76.26 122.65 24.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.757 0.313 . . . . 10.0 110.181 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.3 pt -114.39 141.15 26.07 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.734 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.38 110.3 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.45 2.1 . . . . 10.0 111.591 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -12.11 22.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.973 -0.558 . . . . 10.0 112.13 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -93.93 0.29 56.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.884 0.373 . . . . 10.0 110.66 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.26 5.07 14.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.915 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.2 m -129.78 153.45 38.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.376 -0.374 . . . . 10.0 110.947 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.57 147.92 61.65 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.214 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.84 130.03 20.98 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.537 2.158 . . . . 10.0 112.083 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.356 -0.831 . . . . 10.0 109.898 179.657 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ttt . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 120.711 0.291 . . . . 10.0 110.68 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.12 168.17 25.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.777 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 0.1 OUTLIER -101.44 146.38 27.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.382 -0.372 . . . . 10.0 110.952 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.94 132.12 68.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.155 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -103.22 129.33 50.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.031 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 26.5 p90 -139.19 165.06 28.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.736 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -110.0 77.7 1.07 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.086 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -69.58 99.92 1.36 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.551 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 57.2 32.48 21.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.156 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.88 -28.53 14.95 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.756 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -81.76 113.01 19.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.662 0.231 . . . . 10.0 110.89 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 7.2 mt-10 -74.88 115.71 14.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -125.2 156.01 39.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.857 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -124.36 116.6 22.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.336 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.5 145.03 36.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.577 -0.527 . . . . 10.0 109.577 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 11.5 m-20 -61.92 138.88 58.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.963 0.411 . . . . 10.0 111.099 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 15.2 tt -63.64 -24.51 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.677 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 8.0 m -77.0 -3.5 39.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.619 -0.719 . . . . 10.0 111.007 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -111.37 13.46 21.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.212 0.529 . . . . 10.0 110.021 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -99.01 126.88 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.732 -0.667 . . . . 10.0 109.767 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' VAL . . . . . 0.479 ' O ' ' HD3' ' A' ' 96' ' ' ARG . 3.5 t -75.18 -64.38 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.755 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -134.99 153.46 52.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.593 -0.276 . . . . 10.0 111.121 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -132.96 137.5 53.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.237 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -135.24 121.9 20.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.999 0.428 . . . . 10.0 111.023 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.46 ' HG3' HG12 ' B' ' 30' ' ' ILE . 53.6 ttp85 -109.0 146.12 34.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.257 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -127.19 -15.54 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.958 0.409 . . . . 10.0 111.613 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.76 16.76 23.17 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.39 -0.91 . . . . 10.0 111.072 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -140.9 -53.73 0.48 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -145.5 130.99 18.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.318 -0.855 . . . . 10.0 109.816 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 9.4 mt -86.42 121.26 37.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.67 -0.493 . . . . 10.0 109.67 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -109.06 135.78 49.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.722 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' PHE . . . . . 0.419 ' N ' ' HE1' ' A' ' 119' ' ' TRP . 51.2 p90 -155.69 169.4 24.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.664 0.269 . . . . 10.0 110.704 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -128.34 135.29 49.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.254 -0.43 . . . . 10.0 109.969 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -114.08 168.01 10.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.755 0.312 . . . . 10.0 110.414 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -138.4 112.45 8.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.935 -0.575 . . . . 10.0 109.859 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 82.7 mt -93.55 132.49 37.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.441 -0.345 . . . . 10.0 110.945 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.2 -11.17 61.01 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.91 -0.586 . . . . 10.0 112.469 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.52 -19.54 68.99 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.359 -0.448 . . . . 10.0 112.217 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.97 43.77 1.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.68 -0.771 . . . . 10.0 112.641 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -170.13 111.07 0.46 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.827 0.346 . . . . 10.0 110.738 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -86.27 179.11 3.71 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.513 2.142 . . . . 10.0 110.883 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.64 172.56 43.86 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.079 -1.058 . . . . 10.0 112.276 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 29.9 m-85 -108.1 168.32 9.38 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.38 144.95 12.7 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.938 -0.649 . . . . 10.0 111.888 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 4.2 p -136.78 131.47 47.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.092 0.472 . . . . 10.0 110.876 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.9 121.98 65.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.855 -0.611 . . . . 10.0 109.934 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.39 101.33 3.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.668 0.27 . . . . 10.0 110.662 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -74.1 65.15 1.11 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.585 0.707 . . . . 10.0 110.417 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -166.24 -50.02 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.885 -1.052 . . . . 10.0 109.21 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.47 -28.33 15.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.054 -0.975 . . . . 10.0 111.249 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.66 153.09 73.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.135 -0.484 . . . . 10.0 111.202 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.03 142.64 94.1 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.701 2.267 . . . . 10.0 111.994 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -60.86 -26.03 67.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.812 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -56.84 -48.51 77.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.807 0.337 . . . . 10.0 110.904 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 99.0 mt -65.62 -32.97 74.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.837 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -71.91 -44.0 64.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.792 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -69.52 -31.89 70.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.854 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -78.48 -23.39 46.45 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.051 -0.26 . . . . 10.0 110.999 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' B' ' 59' ' ' LEU . 13.0 mt -83.68 -47.59 11.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.968 0.413 . . . . 10.0 110.391 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' GLU . . . . . 0.415 ' OE1' ' HE3' ' B' ' 64' ' ' LYS . 2.9 tp10 -84.74 87.84 7.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.362 0.601 . . . . 10.0 109.938 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' B' ' 64' ' ' LYS . 46.9 mtmt -93.0 169.78 10.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.18 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.7 mm-40 -76.11 121.37 22.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.7 0.286 . . . . 10.0 110.572 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 mttt 59.24 43.74 16.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.681 -0.691 . . . . 10.0 110.942 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' B' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.581 -0.723 . . . . 10.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.9 mt -88.68 150.8 22.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.982 0.42 . . . . 10.0 110.862 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -122.8 141.21 52.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.806 -0.633 . . . . 10.0 110.196 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.2 p -109.27 140.04 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.613 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.2 123.81 25.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.588 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.8 mt -78.74 -24.47 44.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.28 170.57 22.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.31 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.27 130.25 35.07 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -104.99 132.03 51.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.971 0.415 . . . . 10.0 111.64 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -89.83 118.77 29.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.506 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.12 158.63 24.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.14 0.495 . . . . 10.0 111.57 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -120.01 -44.62 2.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.554 -0.748 . . . . 10.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.89 -167.59 1.61 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.886 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -93.2 -2.62 55.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.1 0.476 . . . . 10.0 110.671 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.16 -37.58 20.01 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.276 0.56 . . . . 10.0 110.021 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -91.28 146.64 23.65 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.397 -0.964 . . . . 10.0 108.397 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.9 tp -111.36 123.49 50.31 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.568 0.581 . . . . 10.0 112.568 -177.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.83 133.4 36.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.938 -0.573 . . . . 10.0 109.731 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -140.39 163.03 33.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.803 0.335 . . . . 10.0 111.342 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -95.75 158.26 15.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.911 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -64.46 124.95 23.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.503 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.25 -3.01 56.58 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.853 -0.689 . . . . 10.0 113.201 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -74.0 154.6 39.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.937 0.398 . . . . 10.0 111.219 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -117.55 141.26 48.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.779 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.06 152.66 51.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 10.0 111.006 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.405 ' HB2' HD21 ' A' ' 125' ' ' LEU . 5.9 tp-100 -100.3 115.59 30.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.432 HG21 ' HB3' ' A' ' 114' ' ' SER . 10.9 mm -71.96 112.13 7.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.328 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.6 mt -84.57 -40.05 18.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.121 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -140.07 103.39 4.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.72 0.295 . . . . 10.0 111.3 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.432 ' HB3' HG21 ' A' ' 111' ' ' ILE . 2.2 p -105.01 0.08 27.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.294 0.569 . . . . 10.0 110.552 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.21 10.04 20.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.37 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.1 -58.34 3.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.546 0.689 . . . . 10.0 109.977 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 167.59 -118.75 0.8 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.3 -0.72 . . . . 10.0 111.3 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -76.71 -51.16 11.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.083 -0.339 . . . . 10.0 110.083 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -88.47 134.35 33.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.876 -0.787 . . . . 10.0 108.876 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -115.04 148.51 38.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 10.0 111.045 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -86.97 117.27 25.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.73 156.76 45.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.226 0.536 . . . . 10.0 111.662 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -112.54 126.75 55.68 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.985 -0.746 . . . . 10.0 108.985 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.3 t -62.8 136.63 57.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.387 -0.37 . . . . 10.0 110.181 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 110' ' ' GLN . 83.8 mt -84.66 -10.98 56.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.191 0.52 . . . . 10.0 109.829 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.78 -67.92 0.76 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.488 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.7 p -86.86 -46.59 9.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.444 . . . . 10.0 111.476 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 116.35 6.09 15.95 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.895 -0.669 . . . . 10.0 111.865 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -72.21 149.31 44.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.729 0.3 . . . . 10.0 110.759 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -115.71 135.0 54.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.347 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -174.62 179.79 45.71 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.925 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -86.78 136.3 33.04 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.0 -0.37 . . . . 10.0 110.0 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.3 pt -121.15 136.14 25.47 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.08 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 137' ' ' TYR . 19.2 Cg_endo -63.05 122.62 10.92 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.761 2.307 . . . . 10.0 111.869 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -17.74 64.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.85 -0.614 . . . . 10.0 112.238 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.472 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 45.3 p-10 -87.44 -5.79 58.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.959 0.409 . . . . 10.0 111.057 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.476 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 0.8 OUTLIER -105.27 -6.16 19.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.969 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.1 m -124.31 152.38 30.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.125 0.488 . . . . 10.0 111.356 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.61 152.89 67.37 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.545 -0.752 . . . . 10.0 110.163 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.68 156.08 63.35 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.335 2.024 . . . . 10.0 111.622 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.323 -0.846 . . . . 10.0 110.097 179.703 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.732 0.301 . . . . 10.0 110.302 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.1 168.07 13.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.127 0.489 . . . . 10.0 112.23 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.7 m -110.69 145.84 37.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.541 -0.754 . . . . 10.0 109.927 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 45.0 t -111.23 130.3 64.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.717 0.294 . . . . 10.0 111.333 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -103.57 120.49 40.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.662 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -134.33 169.53 17.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.919 0.39 . . . . 10.0 111.259 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.41 ' HG3' ' HG2' ' B' ' 12' ' ' GLU . 1.7 mttt -117.37 63.25 0.74 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.522 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -59.32 112.96 1.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.889 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 58.83 21.81 9.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.305 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.4 -5.99 63.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.951 -0.642 . . . . 10.0 112.454 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -94.72 119.08 32.75 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.89 -0.182 . . . . 10.0 110.844 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.41 ' HG2' ' HG3' ' B' ' 7' ' ' LYS . 2.9 mt-10 -72.23 113.98 9.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.946 -0.39 . . . . 10.0 109.946 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt -134.38 153.02 52.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.788 0.327 . . . . 10.0 110.837 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 1.5 mt-30 -124.8 120.28 31.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.165 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.0 t -128.93 143.36 41.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.058 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.18 136.22 57.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.04 -0.356 . . . . 10.0 110.04 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.83 -22.9 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.131 0.491 . . . . 10.0 111.206 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -10.25 57.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.635 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -106.65 16.03 25.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.346 . . . . 10.0 111.072 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 73.2 mt -103.07 133.92 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.083 -0.508 . . . . 10.0 109.765 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.95 -63.12 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.199 -0.455 . . . . 10.0 111.286 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -134.29 152.27 51.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.494 -0.321 . . . . 10.0 110.878 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.51 129.24 70.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.779 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 8.3 m -123.92 127.43 47.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.015 0.436 . . . . 10.0 111.895 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.412 ' HG3' ' OE1' ' B' ' 48' ' ' GLU . 14.4 ttp85 -121.68 144.98 48.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -125.26 -16.64 5.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.675 0.274 . . . . 10.0 111.707 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.31 31.79 4.52 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.307 -0.949 . . . . 10.0 111.064 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 mmtm -155.33 -56.49 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.576 0.75 . . . . 10.0 109.179 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -143.8 138.38 28.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.859 -1.064 . . . . 10.0 109.691 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -95.48 131.81 41.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.808 -0.441 . . . . 10.0 109.808 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 49.4 m-85 -123.21 141.21 52.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.441 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -153.77 173.21 16.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.5 -0.318 . . . . 10.0 111.13 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -130.88 132.8 45.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.581 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -125.44 164.53 20.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.149 0.5 . . . . 10.0 111.249 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -138.08 125.82 22.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.986 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 54.6 mt -100.7 135.54 41.99 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.16 -27.05 62.11 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.223 -0.513 . . . . 10.0 112.887 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.04 8.54 15.64 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.292 -0.48 . . . . 10.0 112.803 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.73 54.35 3.48 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.368 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -147.74 78.35 9.9 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.919 0.39 . . . . 10.0 110.861 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -85.56 148.53 9.94 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.826 2.35 . . . . 10.0 110.863 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.79 -164.78 26.09 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 119.805 -1.188 . . . . 10.0 112.857 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -122.2 177.55 5.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.842 -0.429 . . . . 10.0 109.842 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.62 139.44 6.63 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.768 -0.73 . . . . 10.0 112.119 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.88 128.83 71.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.12 0.486 . . . . 10.0 110.392 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.93 119.61 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.034 -0.53 . . . . 10.0 109.841 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.0 t -68.68 125.86 27.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.732 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.412 ' OE1' ' HG3' ' B' ' 25' ' ' ARG . 52.2 mt-10 -75.68 -2.08 27.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.006 0.431 . . . . 10.0 110.967 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -111.27 -39.67 4.65 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.287 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -85.52 -27.81 25.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.147 0.425 . . . . 10.0 112.147 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.88 146.25 31.74 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.938 -0.305 . . . . 10.0 111.017 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.12 154.39 57.76 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.711 2.274 . . . . 10.0 111.639 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -63.0 -25.18 68.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.363 -0.381 . . . . 10.0 111.164 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -56.2 -44.14 79.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 10.0 110.61 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mt -69.93 -41.1 75.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.786 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.1 -37.66 88.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.054 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -73.37 -25.25 60.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.161 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -79.75 -36.06 37.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.437 -0.347 . . . . 10.0 110.419 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.68 -45.69 50.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.505 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.99 111.62 19.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.96 0.409 . . . . 10.0 110.48 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.25 165.2 15.14 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.64 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.474 ' OE1' ' HG3' ' B' ' 63' ' ' LYS . 1.0 OUTLIER -58.73 139.22 56.5 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.366 0.416 . . . . 10.0 110.398 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.474 ' HG3' ' OE1' ' B' ' 62' ' ' GLN . 43.6 mttp 63.06 79.98 0.24 Allowed 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 123.718 0.636 . . . . 10.0 110.159 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.262 -0.875 . . . . 10.0 109.997 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.676 0.274 . . . . 10.0 110.397 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.51 133.59 36.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.084 0.468 . . . . 10.0 110.83 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -116.7 140.2 49.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.179 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.48 139.04 39.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.855 0.359 . . . . 10.0 110.439 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.83 121.69 18.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.93 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.01 -40.15 63.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.431 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -143.1 164.05 31.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.186 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.85 147.4 39.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -126.92 126.19 42.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.815 0.341 . . . . 10.0 110.883 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.08 113.92 20.94 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.834 -0.621 . . . . 10.0 109.459 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.31 149.0 49.96 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.47 0.481 . . . . 10.0 111.089 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.405 ' HE ' ' C ' ' B' ' 64' ' ' LYS . 0.0 OUTLIER -109.69 -37.35 5.69 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.148 -0.478 . . . . 10.0 111.079 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 p -129.37 -164.11 1.37 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.961 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 98' ' ' GLU . 1.3 pp20? -99.63 6.77 45.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.138 0.494 . . . . 10.0 110.521 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.35 -36.73 11.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.502 -0.772 . . . . 10.0 109.611 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -89.78 145.35 25.25 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 129' ' ' GLU . 9.4 tp -98.74 135.25 40.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.187 0.517 . . . . 10.0 112.043 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.94 134.17 33.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.361 -0.836 . . . . 10.0 110.123 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -147.46 164.92 31.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.797 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -118.98 172.27 7.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.929 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -60.02 118.65 6.54 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.383 -0.826 . . . . 10.0 111.359 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.33 -1.84 43.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.476 -0.869 . . . . 10.0 113.351 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.57 133.7 54.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.839 0.352 . . . . 10.0 111.437 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -94.5 121.09 35.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.689 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -115.88 134.49 54.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.66 0.615 . . . . 10.0 112.66 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -102.9 104.37 14.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.904 -1.146 . . . . 10.0 107.904 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.3 mm -62.44 117.62 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.327 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 123' ' ' ARG . 70.9 mt -94.35 -35.87 12.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.321 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -145.1 99.89 3.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.28 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.79 0.26 46.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.238 0.542 . . . . 10.0 110.252 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -88.3 -0.0 56.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.995 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -63.17 -46.82 85.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.185 0.517 . . . . 10.0 110.333 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.99 -116.75 0.74 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.991 -0.843 . . . . 10.0 110.991 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.78 -28.5 17.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.234 0.54 . . . . 10.0 110.149 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.595 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 17.9 m95 -105.03 110.32 22.67 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.351 -0.981 . . . . 10.0 108.351 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -93.9 154.92 17.45 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.749 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -98.92 122.94 42.82 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -136.3 161.86 34.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.327 0.584 . . . . 10.0 111.602 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.416 ' HB2' HD11 ' A' ' 112' ' ' LEU . 6.0 ttp180 -114.03 133.76 55.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.19 -0.914 . . . . 10.0 109.345 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.5 t -69.45 140.82 54.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.954 0.407 . . . . 10.0 110.507 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 99.2 mt -96.84 2.05 51.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.376 0.608 . . . . 10.0 109.848 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.09 -48.84 3.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.492 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 66.4 p -101.06 -42.8 6.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 10.0 110.842 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.69 -0.73 34.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.059 -0.591 . . . . 10.0 112.42 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 101' ' ' LEU . 32.1 mt-10 -67.26 150.23 49.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.736 0.303 . . . . 10.0 110.905 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.2 m -122.77 133.91 54.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.709 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.1 178.83 46.7 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.61 -0.805 . . . . 10.0 111.995 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -81.47 133.48 35.4 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.276 -0.268 . . . . 10.0 110.276 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.8 pt -128.07 145.54 55.77 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.85 0.357 . . . . 10.0 111.426 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.498 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 47.3 Cg_endo -72.08 127.5 12.88 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.577 2.185 . . . . 10.0 111.672 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.0 p -69.81 -16.09 63.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.96 -0.564 . . . . 10.0 112.267 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.498 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 38.0 p-10 -85.55 -0.45 55.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.692 0.282 . . . . 10.0 111.465 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.433 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 1.9 m-85 -115.58 3.91 14.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.53 -0.304 . . . . 10.0 111.246 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.81 144.65 37.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 10.0 111.105 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -132.77 144.01 51.08 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.085 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.3 132.05 26.56 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.536 2.157 . . . . 10.0 112.305 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.1 t . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.151 -0.928 . . . . 10.0 110.121 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.619 0.247 . . . . 10.0 110.747 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' B' ' 16' ' ' ASP . . . -153.76 128.57 9.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.47 -0.332 . . . . 10.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.9 108.18 19.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.608 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.05 130.78 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.62 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -95.32 132.15 40.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.45 -0.341 . . . . 10.0 110.281 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -145.25 170.18 16.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.186 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.416 ' HG2' ' HG2' ' B' ' 12' ' ' GLU . 98.9 mttt -120.7 105.82 11.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.16 -0.473 . . . . 10.0 109.788 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -99.99 111.71 24.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.894 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt 54.27 34.13 19.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.69 -0.686 . . . . 10.0 112.13 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.52 4.36 68.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.023 -0.608 . . . . 10.0 113.409 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -109.94 123.18 49.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.884 0.342 . . . . 10.0 110.644 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' B' ' 7' ' ' LYS . 39.0 mt-10 -76.14 121.18 22.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -134.44 153.45 51.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.897 0.38 . . . . 10.0 110.972 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.46 114.06 15.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.72 -0.673 . . . . 10.0 109.773 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.04 144.24 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.55 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' B' ' 2' ' ' ALA . 6.9 t70 -64.26 138.27 58.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.387 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' B' ' 20' ' ' ILE . 21.4 tt -61.29 -22.58 27.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.935 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -70.71 -19.65 62.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.7 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -93.99 1.01 56.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.133 0.492 . . . . 10.0 110.517 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' B' ' 17' ' ' ILE . 70.8 mt -94.2 123.97 46.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.725 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.59 -77.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.549 -0.296 . . . . 10.0 111.383 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -113.13 151.63 30.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.011 0.434 . . . . 10.0 111.308 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 32.3 t -129.32 142.01 45.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.421 -0.808 . . . . 10.0 109.983 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.1 m -134.5 122.89 23.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 10.0 111.402 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.48 ' HD2' ' OE2' ' B' ' 48' ' ' GLU . 0.8 OUTLIER -109.98 143.26 40.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.511 . . . . 10.0 110.164 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -124.35 -20.58 5.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.648 0.24 . . . . 10.0 111.648 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.34 22.18 8.84 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.744 -0.943 . . . . 10.0 110.744 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -146.38 -54.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.721 -0.844 . . . . 10.0 108.721 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -146.88 138.59 24.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.008 -0.997 . . . . 10.0 109.433 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 52.0 mt -94.27 126.89 46.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.971 -0.381 . . . . 10.0 109.971 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 18.9 m-85 -111.19 139.29 46.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.38 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -154.4 171.83 18.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.991 0.424 . . . . 10.0 111.273 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -130.32 135.68 48.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.854 -0.612 . . . . 10.0 109.594 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -121.58 156.83 32.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.065 0.46 . . . . 10.0 111.139 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -127.35 117.39 22.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.419 -0.81 . . . . 10.0 109.32 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.52 139.37 31.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.835 0.35 . . . . 10.0 111.319 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.52 -9.39 61.53 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.588 -0.733 . . . . 10.0 112.095 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.83 -8.17 67.6 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.215 -0.517 . . . . 10.0 111.999 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.64 32.5 7.23 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.951 -0.643 . . . . 10.0 112.149 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -153.64 103.38 2.53 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.682 0.277 . . . . 10.0 111.086 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -86.14 168.93 8.91 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.826 2.35 . . . . 10.0 111.44 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.63 -172.0 36.53 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.115 -1.04 . . . . 10.0 113.143 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 6.6 m-85 -123.63 166.2 15.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.855 -0.424 . . . . 10.0 109.855 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.0 150.57 22.13 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.471 -0.871 . . . . 10.0 112.345 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 p -132.67 132.9 59.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.968 0.413 . . . . 10.0 110.451 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.44 136.38 55.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.441 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 26.9 t -74.11 131.29 41.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.391 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.48 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 45.1 mt-10 -84.45 3.64 35.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.964 0.411 . . . . 10.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -119.43 -44.25 2.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.969 0.414 . . . . 10.0 111.068 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -78.72 -49.43 13.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.634 . . . . 10.0 112.481 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -67.23 151.13 97.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.34 . . . . 10.0 111.886 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 32.2 Cg_exo -61.15 142.22 96.1 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.954 2.436 . . . . 10.0 112.296 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -62.93 -23.08 67.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.626 . . . . 10.0 110.704 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.4 -44.99 80.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.155 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.3 -35.47 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.551 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.0 mt -62.03 -42.94 99.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.872 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -72.63 -17.37 61.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 10.0 111.158 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -85.93 -38.56 17.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.635 -0.506 . . . . 10.0 109.635 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 51.6 mt -68.41 -41.77 79.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.085 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.15 85.74 7.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.545 0.688 . . . . 10.0 109.645 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -81.62 131.18 35.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.307 -0.86 . . . . 10.0 109.761 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' B' ' 63' ' ' LYS . 83.9 mm-40 -58.59 127.18 30.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.816 -0.439 . . . . 10.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' B' ' 62' ' ' GLN . 78.8 mttt 74.24 51.92 0.1 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 124.105 0.878 . . . . 10.0 110.122 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.405 ' C ' ' HE ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.359 -0.829 . . . . 10.0 110.945 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.683 0.278 . . . . 10.0 111.035 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.3 mt -88.16 161.18 17.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.295 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -131.07 126.03 34.76 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.1 p -108.63 141.05 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.874 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.3 126.5 31.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.317 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 139' ' ' ALA . 30.0 mt -90.72 -20.62 22.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.013 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.4 159.92 41.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.029 -0.532 . . . . 10.0 109.585 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -85.9 145.4 27.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 10.0 109.868 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -143.37 130.87 21.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.032 0.444 . . . . 10.0 111.41 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.2 124.36 44.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.587 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.83 140.29 58.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.983 0.421 . . . . 10.0 111.234 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -104.86 -23.84 12.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.364 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.1 -166.41 1.79 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.262 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -17.97 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.838 0.351 . . . . 10.0 110.451 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -69.9 -45.55 67.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -87.43 163.26 16.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.615 -0.72 . . . . 10.0 109.61 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.3 tp -130.59 145.46 51.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.757 0.313 . . . . 10.0 111.381 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -81.61 145.77 30.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.829 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -157.23 154.45 29.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -105.17 159.39 15.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.8 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -63.3 116.78 5.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.597 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.5 -4.82 26.42 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.78 -0.724 . . . . 10.0 112.171 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -78.58 150.44 32.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.579 0.228 . . . . 10.0 110.441 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -121.64 143.1 49.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 10.0 110.85 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 159.47 41.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.577 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -103.64 116.38 32.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.045 -0.724 . . . . 10.0 109.045 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.2 mm -68.36 121.13 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.943 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.1 mt -94.73 -40.78 9.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.249 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.586 ' ND2' ' HG3' ' A' ' 116' ' ' GLU . 55.2 t30 -146.39 106.26 3.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.013 0.435 . . . . 10.0 111.24 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.19 0.47 31.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 10.0 110.615 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.18 5.73 47.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.915 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.586 ' HG3' ' ND2' ' A' ' 113' ' ' ASN . 3.4 mt-10 -78.99 -34.47 44.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.689 0.28 . . . . 10.0 111.358 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 156.89 -126.79 1.82 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.349 -0.929 . . . . 10.0 112.37 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -87.42 -43.75 11.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 10.0 110.817 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.424 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 44.2 m95 -88.39 113.35 23.9 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.123 -1.066 . . . . 10.0 108.123 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -95.0 150.78 19.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.181 0.515 . . . . 10.0 112.152 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -88.03 117.07 26.66 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.53 -1.285 . . . . 10.0 107.53 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.3 146.23 49.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.238 0.542 . . . . 10.0 112.228 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -100.39 119.18 38.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.37 -0.832 . . . . 10.0 109.307 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.5 t -60.93 138.22 58.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.847 0.356 . . . . 10.0 110.556 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.0 mt -91.71 2.03 56.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.314 0.578 . . . . 10.0 109.541 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.1 -61.09 1.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.313 -0.858 . . . . 10.0 110.723 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.5 p -100.7 -29.21 12.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.34 . . . . 10.0 111.322 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.25 0.74 54.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.663 -0.779 . . . . 10.0 112.346 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -74.11 154.26 39.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.793 0.33 . . . . 10.0 111.204 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.17 -178.2 3.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.997 -0.547 . . . . 10.0 109.841 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 145.22 168.05 12.69 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.097 -1.049 . . . . 10.0 112.714 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -85.23 124.62 32.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.829 0.347 . . . . 10.0 110.38 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.9 pt -120.48 147.59 45.75 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.382 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.73 125.51 10.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.337 2.025 . . . . 10.0 111.359 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -67.14 -12.64 60.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.326 0.491 . . . . 10.0 112.326 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -96.27 -9.46 30.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.629 0.252 . . . . 10.0 110.814 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -88.04 -12.92 42.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.277 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.9 m -121.42 169.9 12.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.639 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.519 ' HB2' HD11 ' A' ' 90' ' ' LEU . . . -139.29 141.13 28.17 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.994 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.69 131.48 21.42 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.459 2.106 . . . . 10.0 112.336 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.3 t . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.111 -0.947 . . . . 10.0 109.713 179.368 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.403 ' HB3' HG21 ' B' ' 17' ' ' ILE . 7.9 ttt . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.753 0.311 . . . . 10.0 111.254 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.82 171.93 15.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.802 0.334 . . . . 10.0 110.857 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 142.26 32.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.575 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.04 124.87 63.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.928 0.394 . . . . 10.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.65 132.49 46.01 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.734 . . . . 10.0 109.417 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -149.2 173.62 13.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.857 0.36 . . . . 10.0 110.876 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -119.62 85.41 2.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.911 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -73.93 95.8 2.53 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt 61.82 23.89 14.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.459 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.59 -18.33 32.48 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.537 -0.756 . . . . 10.0 112.114 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.63 113.28 9.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.765 0.317 . . . . 10.0 111.015 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -73.29 94.76 2.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.938 -0.573 . . . . 10.0 109.523 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -109.76 153.23 24.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.206 0.526 . . . . 10.0 111.974 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -130.9 105.47 7.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -119.93 146.88 24.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.688 0.28 . . . . 10.0 110.674 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.1 139.59 51.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.839 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.419 HD11 ' O ' ' B' ' 58' ' ' LYS . 13.7 tt -65.95 -18.88 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.467 0.651 . . . . 10.0 110.377 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.6 -4.43 59.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.492 -0.777 . . . . 10.0 111.321 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.67 9.09 39.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.071 0.463 . . . . 10.0 110.519 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 81.7 mt -95.51 125.24 48.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.909 -0.587 . . . . 10.0 109.963 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 t -71.84 -60.95 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.088 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -133.86 151.58 51.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.683 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 t -119.46 115.08 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 10.0 109.722 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 13.7 m -117.34 120.41 38.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.035 0.445 . . . . 10.0 111.823 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.413 ' HD2' ' CD ' ' B' ' 48' ' ' GLU . 4.0 ttp85 -109.06 121.71 45.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -83.52 -39.46 20.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.691 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.2 -2.61 5.87 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.73 -0.948 . . . . 10.0 110.73 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -139.5 -40.29 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.04 141.52 36.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.37 -0.832 . . . . 10.0 109.644 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 55.7 mt -96.33 129.79 45.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.686 -0.487 . . . . 10.0 109.686 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -118.78 136.09 54.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.357 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -153.4 171.46 18.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.818 0.342 . . . . 10.0 110.953 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -125.04 133.98 52.73 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -123.46 166.77 14.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.024 0.44 . . . . 10.0 111.152 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -128.33 157.98 39.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.299 -0.864 . . . . 10.0 109.099 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 mt -133.89 145.29 49.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.829 0.347 . . . . 10.0 111.009 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.83 -15.25 66.59 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.939 -0.648 . . . . 10.0 112.592 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.12 4.51 70.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.254 -0.498 . . . . 10.0 112.874 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.58 38.5 32.33 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.771 -0.728 . . . . 10.0 112.885 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -149.17 88.07 5.17 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 122.552 -0.381 . . . . 10.0 110.663 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -74.98 177.9 7.98 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.374 2.049 . . . . 10.0 111.075 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.72 -169.95 37.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.653 -1.26 . . . . 10.0 112.711 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 28.5 m-85 -117.05 160.33 21.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.898 -0.408 . . . . 10.0 109.898 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.02 141.43 12.12 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.669 -0.777 . . . . 10.0 112.237 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 p -135.77 128.79 47.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.95 0.405 . . . . 10.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 t -128.03 129.89 69.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.027 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' B' ' 51' ' ' ALA . 30.2 t -74.31 133.87 42.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.413 ' CD ' ' HD2' ' B' ' 25' ' ' ARG . 54.0 mt-10 -81.01 -1.21 43.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.176 0.512 . . . . 10.0 110.437 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -116.39 -49.77 2.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.947 -0.569 . . . . 10.0 110.579 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -90.92 45.37 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.783 -0.644 . . . . 10.0 111.973 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' B' ' 47' ' ' SER . . . -162.63 151.06 12.14 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.581 -0.282 . . . . 10.0 110.798 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.24 136.29 74.53 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.86 2.374 . . . . 10.0 112.348 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.84 -29.92 71.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.218 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -59.25 -41.27 88.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.992 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.4 mt -67.55 -36.12 80.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.873 0.368 . . . . 10.0 110.518 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -68.38 -39.8 81.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.136 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -72.49 -21.47 61.2 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.851 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' LYS . . . . . 0.419 ' O ' HD11 ' B' ' 17' ' ' ILE . 79.3 mttt -81.51 -32.02 32.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.166 -0.679 . . . . 10.0 109.166 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 21.6 mt -75.87 -58.93 2.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.895 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -80.17 115.7 19.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.141 0.496 . . . . 10.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mtmm -129.15 170.31 13.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.731 -0.668 . . . . 10.0 109.547 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -69.49 134.9 49.45 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.347 0.404 . . . . 10.0 110.059 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 66.48 54.8 0.86 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.435 0.636 . . . . 10.0 110.312 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.919 0 CA-C-N 115.56 -0.746 . . . . 10.0 110.539 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 120.903 0.382 . . . . 10.0 110.769 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.72 153.64 20.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -114.68 129.4 56.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.782 0.325 . . . . 10.0 110.509 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.8 142.2 18.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.989 -0.55 . . . . 10.0 110.171 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 130.8 43.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.642 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.9 -45.29 18.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.915 -0.584 . . . . 10.0 109.799 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -137.02 173.56 11.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.657 -0.702 . . . . 10.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.88 141.25 36.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.145 -0.48 . . . . 10.0 109.938 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -131.25 123.55 28.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.73 0.3 . . . . 10.0 111.186 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -92.12 133.44 35.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.52 155.05 20.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.164 0.507 . . . . 10.0 111.991 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.2 ttm-85 -110.6 -36.32 5.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.48 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.77 -159.79 0.9 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.449 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -98.58 -10.36 23.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.92 -50.2 15.65 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.367 -0.833 . . . . 10.0 109.596 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -83.65 134.66 34.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.342 -0.845 . . . . 10.0 108.839 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 tp -97.74 134.1 41.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.189 0.519 . . . . 10.0 112.378 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.23 135.1 34.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.418 -0.81 . . . . 10.0 110.199 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -146.87 158.63 43.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.081 0.467 . . . . 10.0 111.377 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -102.29 164.42 11.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.807 -0.633 . . . . 10.0 111.054 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -62.07 113.41 2.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.738 -0.665 . . . . 10.0 110.5 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.61 -1.32 24.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 10.0 112.783 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.57 147.94 51.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.608 0.242 . . . . 10.0 110.469 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -116.74 131.13 57.03 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.1 -0.333 . . . . 10.0 110.1 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -119.18 142.71 47.74 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.553 0.575 . . . . 10.0 112.553 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.641 ' HB2' HD21 ' A' ' 125' ' ' LEU . 6.0 tp-100 -95.0 126.4 40.32 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.477 -0.934 . . . . 10.0 108.477 177.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.4 mm -70.27 115.17 9.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.262 0.553 . . . . 10.0 112.025 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 123' ' ' ARG . 27.1 mt -108.64 -67.09 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.717 -0.674 . . . . 10.0 109.425 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 22.0 t30 -107.38 95.62 5.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.764 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.1 p -99.87 -21.21 15.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.2 0.524 . . . . 10.0 110.813 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.5 m -83.09 20.11 1.3 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.134 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -70.84 -40.22 72.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.139 0.495 . . . . 10.0 109.94 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 137.21 -62.16 0.59 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.597 -0.811 . . . . 10.0 112.321 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.05 -66.11 0.68 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.472 ' HH2' ' HG1' ' B' ' 24' ' ' THR . 24.4 m95 -78.98 115.27 18.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.033 -0.729 . . . . 10.0 109.033 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -90.56 144.42 25.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.98 0.419 . . . . 10.0 111.427 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 113' ' ' ASN . 28.3 tt0 -95.49 109.95 22.08 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.256 -1.016 . . . . 10.0 108.256 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.6 168.8 13.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.929 0.395 . . . . 10.0 111.681 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.484 ' HB2' HD11 ' A' ' 112' ' ' LEU . 69.9 ttp85 -119.04 134.55 55.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.1 t -70.45 137.13 50.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.367 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 110' ' ' GLN . 43.8 mt -84.91 -10.16 57.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.059 0.457 . . . . 10.0 110.006 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.7 m -94.46 -57.5 2.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.609 -0.723 . . . . 10.0 111.607 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 46.6 p -89.0 -35.62 16.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.865 0.364 . . . . 10.0 111.53 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.78 5.85 58.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.658 -0.782 . . . . 10.0 112.096 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -78.1 146.84 34.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.562 0.22 . . . . 10.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.4 m -119.46 132.78 55.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.342 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -174.53 -178.06 44.14 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.687 -0.768 . . . . 10.0 112.12 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -82.46 132.92 35.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.873 0.368 . . . . 10.0 110.622 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 26.1 pt -122.6 142.65 37.97 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.048 -0.524 . . . . 10.0 110.842 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 133' ' ' ILE . 13.4 Cg_exo -69.15 122.12 8.96 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.61 2.207 . . . . 10.0 111.701 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -18.36 65.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.981 -0.554 . . . . 10.0 112.159 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -88.97 -1.84 58.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.478 -0.328 . . . . 10.0 111.232 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -115.51 5.41 14.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.67 0.271 . . . . 10.0 111.429 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.2 m -132.22 157.42 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.744 0.307 . . . . 10.0 110.78 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.57 143.22 19.36 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.314 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.96 143.29 72.09 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.357 2.038 . . . . 10.0 112.085 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.532 -0.747 . . . . 10.0 110.103 179.55 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.514 0.197 . . . . 10.0 111.033 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.67 168.82 18.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.938 0.399 . . . . 10.0 111.381 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.4 142.23 34.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.32 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 21.2 t -110.32 137.53 42.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.704 0.288 . . . . 10.0 110.781 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.73 121.53 42.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.582 -0.525 . . . . 10.0 109.582 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 33.6 p90 -130.88 171.47 13.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.059 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -114.41 93.0 4.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 10.0 109.998 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.16 94.65 6.69 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.982 -0.287 . . . . 10.0 110.227 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm 55.15 31.98 17.48 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.73 -0.668 . . . . 10.0 111.15 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.01 -24.69 20.74 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.903 -0.665 . . . . 10.0 112.719 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -85.92 108.87 18.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.859 0.33 . . . . 10.0 110.749 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 11.3 mt-10 -82.41 113.4 20.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.984 0.421 . . . . 10.0 110.853 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -132.61 157.09 45.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.391 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 52.4 mt-30 -115.9 127.54 55.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.86 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 91.0 t -131.78 147.15 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.33 139.04 57.39 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.683 -0.235 . . . . 10.0 110.556 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 20.6 tt -66.5 -21.11 28.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.381 0.61 . . . . 10.0 109.791 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.09 -15.17 60.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.538 -0.755 . . . . 10.0 110.663 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -95.37 0.49 53.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.158 0.504 . . . . 10.0 110.235 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mt -102.61 106.82 20.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.009 -0.541 . . . . 10.0 109.861 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -65.14 -78.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.774 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -110.1 141.41 43.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.042 0.449 . . . . 10.0 111.756 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.418 ' O ' ' HD3' ' B' ' 64' ' ' LYS . 58.7 t -125.79 114.89 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.327 -0.852 . . . . 10.0 109.247 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' THR . . . . . 0.472 ' HG1' ' HH2' ' A' ' 119' ' ' TRP . 30.1 m -103.93 116.85 33.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.363 0.602 . . . . 10.0 111.973 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 33.8 ttp85 -107.56 137.72 45.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.593 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -111.79 -20.19 12.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.747 0.308 . . . . 10.0 111.678 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.1 -0.49 31.46 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.986 -0.846 . . . . 10.0 110.986 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -134.12 -42.25 0.81 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.158 -0.521 . . . . 10.0 109.89 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -147.82 133.78 19.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.205 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 68.0 mt -94.13 133.96 33.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.501 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -127.59 120.71 28.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.14 -0.482 . . . . 10.0 109.785 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -136.28 168.02 20.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.89 0.376 . . . . 10.0 111.336 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -122.96 126.46 47.24 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.933 -0.766 . . . . 10.0 108.933 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -122.02 156.65 33.04 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.072 0.463 . . . . 10.0 111.57 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -104.99 151.73 23.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.364 -0.834 . . . . 10.0 109.819 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 13.1 mt -135.88 133.93 38.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.781 0.324 . . . . 10.0 111.102 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.06 -10.69 69.13 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.764 -0.653 . . . . 10.0 112.624 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.94 -15.36 74.01 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.969 -0.634 . . . . 10.0 111.773 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.65 -3.02 45.71 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.749 -0.739 . . . . 10.0 112.991 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -131.56 94.32 26.34 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.728 0.299 . . . . 10.0 111.212 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.22 179.67 6.22 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.529 2.153 . . . . 10.0 111.096 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.1 -165.1 28.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.951 -1.119 . . . . 10.0 112.902 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -117.34 157.87 25.39 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.76 132.25 6.98 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.483 -0.865 . . . . 10.0 112.087 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.9 125.12 73.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.307 0.575 . . . . 10.0 110.617 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 91.6 t -126.84 120.95 57.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.766 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -71.84 129.87 39.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.311 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -86.75 18.38 3.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.101 0.477 . . . . 10.0 110.053 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -136.89 -39.27 0.62 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.866 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -94.23 7.67 44.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.631 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.02 153.64 81.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 122.348 -0.22 . . . . 10.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.82 149.58 90.39 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.851 2.367 . . . . 10.0 112.679 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -65.88 -23.3 66.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.735 -0.666 . . . . 10.0 111.307 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -54.76 -39.18 68.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 10.0 110.925 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.82 -37.38 30.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.649 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 28.2 mt -62.88 -42.08 99.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 10.0 111.122 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -66.71 -28.98 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.563 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -79.29 -29.85 42.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.783 0.325 . . . . 10.0 111.229 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 14.5 mt -85.07 -14.46 47.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.969 0.414 . . . . 10.0 110.929 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -70.63 90.88 0.77 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.345 0.593 . . . . 10.0 111.049 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -88.25 100.04 12.68 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.179 -0.675 . . . . 10.0 109.179 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -57.4 116.92 3.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.795 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 91.3 mttt 60.27 81.4 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.134 0.896 . . . . 10.0 110.674 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.418 ' HD3' ' O ' ' B' ' 23' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.401 -0.809 . . . . 10.0 110.284 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 120.718 0.294 . . . . 10.0 110.95 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.7 mt -87.96 155.59 19.76 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.846 -0.428 . . . . 10.0 109.846 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -116.9 136.45 52.94 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.514 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.7 p -111.29 140.29 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.64 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.98 123.67 22.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.559 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.78 -35.61 57.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.563 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.52 169.96 16.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.803 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -76.68 104.69 7.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.656 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.546 ' CE1' HG21 ' B' ' 24' ' ' THR . 86.8 t80 -81.58 128.2 33.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.003 0.43 . . . . 10.0 111.17 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -99.24 115.38 28.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.652 -0.703 . . . . 10.0 109.772 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.0 172.67 7.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.53 -0.304 . . . . 10.0 110.647 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -136.81 -41.63 0.6 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.572 -0.285 . . . . 10.0 111.087 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -172.92 2.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.58 -0.282 . . . . 10.0 110.608 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -92.35 -14.65 28.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.72 0.295 . . . . 10.0 111.336 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -43.75 34.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.023 0.44 . . . . 10.0 110.068 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.15 120.2 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.802 . . . . 10.0 109.762 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.4 tp -78.54 136.82 37.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 10.0 111.943 -178.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -95.0 124.73 39.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.435 -0.802 . . . . 10.0 109.698 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.59 155.01 45.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 10.0 111.805 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -94.43 158.29 15.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.358 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.36 133.18 53.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.817 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.9 -9.56 65.91 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.733 -0.746 . . . . 10.0 113.585 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.56 149.2 45.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.16 0.48 . . . . 10.0 111.094 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -110.66 137.71 47.99 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.093 -0.503 . . . . 10.0 109.928 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.66 155.92 45.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.936 0.398 . . . . 10.0 111.313 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -107.78 114.47 28.44 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 mm -71.21 118.04 15.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.474 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.91 -38.62 12.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.553 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -136.02 117.29 14.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.317 -0.401 . . . . 10.0 111.049 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.5 -15.05 15.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.128 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.5 m -83.19 13.04 4.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.42 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -76.8 -30.65 56.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.253 0.549 . . . . 10.0 110.483 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 128.73 -110.49 1.11 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.72 -0.673 . . . . 10.0 111.79 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.17 -57.43 2.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.277 0.56 . . . . 10.0 110.002 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -82.73 114.89 21.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.735 . . . . 10.0 109.026 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -93.61 144.15 25.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.972 0.415 . . . . 10.0 111.492 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.95 113.88 20.85 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.323 -0.991 . . . . 10.0 108.323 177.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.08 154.65 51.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.057 0.456 . . . . 10.0 111.613 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -111.8 128.18 56.03 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.219 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.2 t -69.22 134.26 48.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.135 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.3 mt -85.31 -3.25 58.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 10.0 109.941 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.55 -61.64 1.65 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.683 -0.689 . . . . 10.0 111.119 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 26.0 p -94.37 -21.71 18.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 10.0 111.723 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.22 15.43 66.82 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.665 -0.779 . . . . 10.0 112.071 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -91.34 154.83 18.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.669 0.271 . . . . 10.0 111.013 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.09 155.93 22.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.527 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.69 172.54 38.49 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.825 -0.702 . . . . 10.0 111.572 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -88.94 127.32 35.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.842 0.353 . . . . 10.0 110.351 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.7 pt -120.67 144.64 39.17 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.982 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.543 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 46.4 Cg_endo -73.04 131.35 16.65 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.448 2.099 . . . . 10.0 111.447 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 p -73.74 -1.65 20.07 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.605 0.595 . . . . 10.0 112.605 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.543 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 28.1 p-10 -105.15 13.79 30.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.848 0.356 . . . . 10.0 111.01 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.464 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 5.5 m-85 -126.4 7.87 7.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.686 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.7 m -133.15 155.86 41.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.893 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -135.4 144.16 48.35 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.19 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 13.8 Cg_exo -69.6 132.08 22.83 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.563 2.175 . . . . 10.0 111.686 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.666 -0.683 . . . . 10.0 110.522 -179.94 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ttt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.439 0.161 . . . . 10.0 111.067 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.05 130.68 7.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.773 0.32 . . . . 10.0 110.918 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.39 112.76 19.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.436 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 23.9 t -89.28 129.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.821 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -97.55 119.1 35.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.62 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -131.67 147.04 52.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.56 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -89.97 109.97 20.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.266 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -111.59 105.82 14.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.42 -0.355 . . . . 10.0 111.08 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt 56.67 38.15 29.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.666 -0.697 . . . . 10.0 111.878 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.4 -0.11 85.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.721 -0.752 . . . . 10.0 112.811 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' GLU . . . . . 0.415 ' CB ' ' HE2' ' B' ' 13' ' ' LYS . 49.4 mt-10 -111.87 117.34 32.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.728 0.264 . . . . 10.0 110.495 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -74.09 112.88 10.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.008 -0.367 . . . . 10.0 110.008 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.415 ' HE2' ' CB ' ' B' ' 11' ' ' GLU . 51.7 mmtt -109.68 147.4 33.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.159 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 8.4 pt20 -130.3 109.26 10.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.516 -0.55 . . . . 10.0 109.516 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.41 142.5 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.503 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -64.78 143.5 57.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.809 -0.441 . . . . 10.0 109.809 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 14.8 tt -56.41 -21.66 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.716 -0.675 . . . . 10.0 112.72 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.24 -14.22 47.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.392 0.516 . . . . 10.0 112.392 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -95.14 16.13 17.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.267 0.556 . . . . 10.0 111.461 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 47.5 mt -105.69 133.6 49.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.546 -0.752 . . . . 10.0 109.284 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.39 -72.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.563 -0.29 . . . . 10.0 110.833 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -133.44 154.77 50.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.601 -0.272 . . . . 10.0 110.3 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.36 126.33 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.402 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' THR . . . . . 0.546 HG21 ' CE1' ' A' ' 93' ' ' TYR . 1.3 m -125.49 127.66 46.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.024 0.44 . . . . 10.0 110.67 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 48.2 ttp85 -108.46 138.48 44.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.496 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -101.44 -17.21 16.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.197 0.522 . . . . 10.0 111.354 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 14.18 24.56 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.101 -0.8 . . . . 10.0 111.101 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -146.86 -51.87 0.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.484 -0.932 . . . . 10.0 108.484 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -130.13 148.8 52.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.514 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mt -105.31 124.8 60.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.805 -0.443 . . . . 10.0 109.805 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -114.03 127.57 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.33 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -146.4 175.26 10.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.856 0.36 . . . . 10.0 111.033 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -136.95 128.41 28.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.903 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -111.01 158.2 19.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.718 0.295 . . . . 10.0 110.725 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -131.56 107.67 9.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.594 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -95.14 143.18 26.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.532 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.47 12.23 47.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.039 -0.601 . . . . 10.0 112.508 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.88 16.63 60.0 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.986 -0.626 . . . . 10.0 111.698 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.35 31.88 63.02 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.124 -0.56 . . . . 10.0 112.197 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -149.41 92.11 4.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.792 0.329 . . . . 10.0 111.492 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -90.49 177.88 2.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.781 2.32 . . . . 10.0 110.678 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.46 -172.25 45.29 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 119.979 -1.105 . . . . 10.0 112.807 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -117.38 -178.96 3.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.654 0.264 . . . . 10.0 110.406 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.35 143.17 10.05 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.465 -0.654 . . . . 10.0 111.465 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.02 125.16 28.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.089 0.471 . . . . 10.0 110.604 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 t -129.47 143.49 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.312 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.3 t -96.59 137.62 35.39 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.953 -0.388 . . . . 10.0 109.953 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -72.46 -12.28 61.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.737 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -100.31 -13.03 18.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.863 0.363 . . . . 10.0 110.744 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.13 -54.5 3.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.218 -0.447 . . . . 10.0 111.459 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -89.78 143.55 30.4 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.499 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.432 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 26.0 Cg_exo -62.74 155.74 57.51 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.601 2.201 . . . . 10.0 111.823 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.89 -27.4 63.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.261 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -53.18 -44.05 67.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.68 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 70.2 mt -80.16 -37.46 33.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.958 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 40.8 mt -60.84 -40.67 93.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.565 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -70.63 -22.63 62.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.034 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -75.76 -26.88 57.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.232 0.539 . . . . 10.0 110.037 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.87 -30.61 17.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.121 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.82 94.93 1.86 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.21 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -95.14 130.86 41.69 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.483 -0.78 . . . . 10.0 110.306 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -64.55 124.31 21.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.62 77.73 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.89 0.744 . . . . 10.0 110.045 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.379 -0.819 . . . . 10.0 110.301 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.713 0.292 . . . . 10.0 110.904 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.8 mt -113.21 154.49 26.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.257 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -113.82 125.27 53.89 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.86 142.24 17.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.442 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.417 ' HA ' HG12 ' A' ' 138' ' ' VAL . . . -74.14 123.8 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.423 -0.353 . . . . 10.0 110.675 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.25 -37.41 53.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.04 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -146.0 158.21 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.524 -0.762 . . . . 10.0 109.503 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.42 146.43 54.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.238 0.336 . . . . 10.0 110.272 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -127.66 131.86 49.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.947 0.403 . . . . 10.0 111.02 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -95.28 128.43 42.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.462 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.402 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -68.92 137.84 54.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 10.0 110.731 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -113.22 -31.85 6.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.272 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.3 -163.97 1.46 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.401 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -93.11 -19.1 21.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.835 0.35 . . . . 10.0 111.053 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.46 -37.09 60.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.857 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -93.56 151.54 19.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.254 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.9 tp -120.36 134.85 55.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.424 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 2.9 p -79.3 153.06 30.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.886 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -158.45 160.2 36.53 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.426 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -101.95 156.0 17.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.475 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -62.76 123.37 18.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.87 -12.24 22.63 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.767 -0.73 . . . . 10.0 112.95 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -72.15 150.12 44.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 10.0 111.472 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -111.47 137.32 49.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.349 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -124.39 150.94 45.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.218 0.532 . . . . 10.0 111.936 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -106.98 103.67 13.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.038 -0.983 . . . . 10.0 108.709 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 122' ' ' ALA . 26.1 mm -64.45 124.82 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.39 -0.368 . . . . 10.0 111.038 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.81 -39.85 8.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.295 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -130.96 122.56 27.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.36 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.3 p -133.65 19.09 3.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.243 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.76 -6.99 10.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.359 0.503 . . . . 10.0 112.359 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -84.29 -109.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.494 0.188 . . . . 10.0 110.598 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.518 ' HA2' ' OH ' ' B' ' 8' ' ' TYR . . . -73.19 -164.35 8.55 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.77 -0.729 . . . . 10.0 112.143 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -95.65 4.25 53.23 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.667 0.746 . . . . 10.0 110.044 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -105.06 155.73 18.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.513 -1.292 . . . . 10.0 107.513 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -106.45 129.57 54.4 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.084 -0.647 . . . . 10.0 112.671 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.26 115.03 27.16 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.16 -1.422 . . . . 10.0 107.16 177.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.551 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -137.33 161.83 35.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.442 0.639 . . . . 10.0 112.668 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 123' ' ' ARG . 31.4 ttp180 -106.78 120.93 43.33 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.117 -0.947 . . . . 10.0 109.318 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.2 t -69.67 134.73 49.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.9 mt -78.52 -11.05 59.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.864 0.364 . . . . 10.0 110.214 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -82.91 -56.61 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.558 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 p -92.76 -32.67 14.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.359 -0.382 . . . . 10.0 112.027 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.89 20.74 49.24 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.645 -0.788 . . . . 10.0 111.6 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -109.92 159.55 17.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.772 -0.214 . . . . 10.0 110.937 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.37 -179.48 4.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.705 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.58 157.32 7.73 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.185 -0.531 . . . . 10.0 111.778 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -80.76 116.38 20.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 37.6 pt -99.59 140.92 21.96 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.727 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 133' ' ' ILE . 27.0 Cg_exo -61.01 117.87 4.68 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.44 2.093 . . . . 10.0 111.465 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -6.5 11.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 10.0 112.538 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -107.18 3.63 25.86 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.743 0.275 . . . . 10.0 111.743 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.97 3.79 14.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.818 0.342 . . . . 10.0 111.036 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 89' ' ' ALA . 20.5 m -132.51 159.15 43.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.929 0.395 . . . . 10.0 111.037 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.7 141.23 34.5 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.725 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.87 130.29 13.27 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.441 2.094 . . . . 10.0 111.875 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.386 -0.816 . . . . 10.0 109.968 179.945 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ttt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.438 0.161 . . . . 10.0 110.605 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.04 169.53 24.35 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.618 0.247 . . . . 10.0 110.957 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.95 139.53 30.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.802 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -102.94 130.28 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.718 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -94.02 118.64 31.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.072 -0.513 . . . . 10.0 109.953 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -136.54 178.34 7.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.569 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' LYS . . . . . 0.421 ' HE2' ' OE2' ' B' ' 12' ' ' GLU . 66.6 mttt -123.1 137.94 54.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.871 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' TYR . . . . . 0.518 ' OH ' ' HA2' ' A' ' 117' ' ' GLY . 77.2 t80 -134.95 115.84 14.03 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.082 -0.71 . . . . 10.0 109.082 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm 59.34 24.02 12.53 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.512 0.507 . . . . 10.0 111.384 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.89 -0.6 67.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.905 -0.664 . . . . 10.0 112.77 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -103.13 136.13 43.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.686 -0.302 . . . . 10.0 110.426 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.421 ' OE2' ' HE2' ' B' ' 7' ' ' LYS . 20.3 mt-10 -86.52 126.19 34.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.54 -0.3 . . . . 10.0 110.238 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -139.11 153.38 48.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.616 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -125.7 124.52 41.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.412 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.2 t -134.62 146.83 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.079 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.71 140.44 56.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.623 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 tt -64.57 -26.57 40.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.912 -0.586 . . . . 10.0 110.6 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.91 -11.84 60.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.213 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -99.4 3.56 45.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.031 0.443 . . . . 10.0 110.482 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.4 mt -95.3 127.76 47.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.62 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.41 -88.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.339 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -100.11 149.86 23.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 10.0 110.93 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.1 t -127.12 116.1 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.715 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 1.2 m -108.72 104.22 13.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.142 0.496 . . . . 10.0 111.528 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -100.47 146.61 26.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.78 -0.646 . . . . 10.0 109.966 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -138.08 5.13 2.53 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.088 0.47 . . . . 10.0 111.165 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.47 20.55 68.84 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.569 -0.824 . . . . 10.0 111.281 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -138.83 -59.7 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.057 -0.72 . . . . 10.0 109.057 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -145.74 134.24 22.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.04 -0.982 . . . . 10.0 109.557 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 89.8 mt -91.37 117.94 35.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 123.302 0.376 . . . . 10.0 110.352 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -107.14 135.53 48.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.707 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -152.76 173.52 15.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.03 0.443 . . . . 10.0 111.388 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -131.91 141.65 49.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.496 -0.775 . . . . 10.0 109.668 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -133.36 173.72 11.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.82 0.343 . . . . 10.0 110.462 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -142.93 127.39 17.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.088 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt -100.51 142.2 32.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.723 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.97 -21.05 60.82 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 116.056 -0.52 . . . . 10.0 113.258 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.93 -3.7 75.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.911 -0.661 . . . . 10.0 112.38 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.43 34.41 8.62 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.914 -0.66 . . . . 10.0 112.052 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -125.43 77.36 68.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.739 0.305 . . . . 10.0 111.243 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.89 148.66 17.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.551 2.168 . . . . 10.0 111.442 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.86 -174.0 39.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.011 -1.09 . . . . 10.0 112.728 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -112.84 174.57 5.83 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.962 -0.384 . . . . 10.0 109.962 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.53 151.58 22.13 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.107 -0.797 . . . . 10.0 111.107 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.8 p -135.78 137.75 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.253 0.549 . . . . 10.0 111.263 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.36 132.97 70.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.782 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 13.6 t -73.5 128.44 35.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.591 -0.277 . . . . 10.0 110.358 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -84.97 6.94 22.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.929 0.395 . . . . 10.0 110.792 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -120.22 -39.47 2.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.269 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.66 -50.87 7.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.93 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -67.15 146.57 98.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.861 -0.609 . . . . 10.0 111.332 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 31.8 Cg_exo -59.23 148.72 84.76 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.54 2.16 . . . . 10.0 112.364 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -60.66 -26.84 67.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.058 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -53.33 -42.48 66.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.159 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 90.2 mt -74.44 -36.39 63.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 10.0 110.695 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 35.6 mt -65.72 -36.97 85.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.626 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -71.9 -14.49 61.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.111 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -96.26 -37.54 10.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.097 0.475 . . . . 10.0 109.831 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -70.53 -35.03 72.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.113 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -74.44 89.94 2.16 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.132 0.492 . . . . 10.0 110.35 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -70.23 109.17 4.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -50.85 123.38 8.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.293 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 65.64 58.58 0.8 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.346 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.533 -0.746 . . . . 10.0 110.622 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.856 0.36 . . . . 10.0 110.637 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.0 mt -81.6 128.1 33.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.278 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -117.82 127.42 53.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.656 -0.702 . . . . 10.0 109.478 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 p -99.79 135.06 36.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.891 0.377 . . . . 10.0 110.432 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.43 118.95 13.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.688 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.4 mt -70.14 -31.48 69.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.673 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -151.3 -178.2 6.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.064 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -87.47 159.99 18.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.16 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -141.12 125.61 17.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.858 0.361 . . . . 10.0 110.789 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -87.86 114.19 24.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.723 -0.672 . . . . 10.0 109.712 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.09 155.69 24.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.255 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -119.02 -20.03 8.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.885 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.6 -160.04 1.01 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.581 -0.282 . . . . 10.0 110.802 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -101.75 -19.88 15.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.983 0.42 . . . . 10.0 110.575 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.99 -48.03 59.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.516 -0.766 . . . . 10.0 109.418 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.83 129.04 34.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.279 -0.873 . . . . 10.0 109.362 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.48 138.69 31.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.903 -0.59 . . . . 10.0 112.319 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -92.2 136.82 32.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.615 -0.513 . . . . 10.0 109.615 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -153.54 178.46 9.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.821 0.343 . . . . 10.0 111.025 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.88 173.87 10.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.98 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -63.57 122.56 16.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.778 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.99 -4.13 33.85 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.836 -0.697 . . . . 10.0 112.524 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -66.33 131.93 47.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.741 0.305 . . . . 10.0 110.856 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -102.1 118.64 37.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.87 -0.419 . . . . 10.0 109.87 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -112.17 142.77 44.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.501 0.556 . . . . 10.0 112.501 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -108.22 104.3 13.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.513 -1.291 . . . . 10.0 107.513 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.64 123.96 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.522 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -102.82 -51.54 3.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.436 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -133.85 114.46 13.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.78 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -129.8 9.39 5.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.451 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.58 -0.98 51.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.435 -0.802 . . . . 10.0 111.897 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -87.72 -91.55 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.887 -0.325 . . . . 10.0 110.221 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.77 -162.57 28.96 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.603 -0.808 . . . . 10.0 111.627 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.53 -28.2 41.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.869 0.366 . . . . 10.0 110.19 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -81.32 145.59 30.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.551 -1.278 . . . . 10.0 107.551 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -106.6 142.5 36.15 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.794 0.665 . . . . 10.0 112.794 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.32 118.17 30.96 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 177.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.96 163.39 33.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.292 0.568 . . . . 10.0 111.64 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -114.79 138.32 50.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.423 -0.808 . . . . 10.0 110.08 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.9 t -73.22 133.49 44.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.273 -0.422 . . . . 10.0 110.434 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.6 mt -92.22 5.85 48.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 10.0 109.956 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.19 -51.11 3.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.703 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.0 p -103.73 -39.39 6.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.033 0.444 . . . . 10.0 110.83 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.7 -2.59 29.03 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.931 -0.652 . . . . 10.0 111.766 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -66.14 142.39 57.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.623 0.249 . . . . 10.0 110.826 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.5 m -117.58 144.6 44.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.539 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.02 179.01 42.68 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.173 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -85.22 135.96 33.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.896 0.379 . . . . 10.0 110.205 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.2 pt -122.47 145.48 44.82 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.294 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.444 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 31.9 Cg_endo -67.44 121.14 8.22 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.776 2.318 . . . . 10.0 111.497 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -4.93 14.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.628 -0.714 . . . . 10.0 112.736 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.444 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 36.0 p-10 -101.57 6.24 42.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.754 0.311 . . . . 10.0 110.977 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -124.96 14.12 8.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.298 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.29 146.52 30.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.471 -0.331 . . . . 10.0 110.755 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -130.9 142.97 47.49 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.557 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.23 131.71 19.67 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.356 2.038 . . . . 10.0 112.323 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.453 -0.784 . . . . 10.0 109.915 179.818 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.779 0.323 . . . . 10.0 110.405 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.74 151.07 26.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.747 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.3 m -94.98 123.16 38.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.242 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 20.6 t -98.75 132.96 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.999 0.428 . . . . 10.0 111.241 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -102.73 111.85 24.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.597 -0.729 . . . . 10.0 109.094 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -130.16 -174.41 3.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.441 . . . . 10.0 111.104 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -110.62 148.6 31.86 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.171 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.17 103.43 4.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.159 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 tptt 58.67 30.77 20.36 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.7 0.625 . . . . 10.0 110.703 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.49 -31.79 8.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.29 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -75.74 168.97 19.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.806 0.336 . . . . 10.0 110.515 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -114.37 129.73 56.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -132.64 148.1 52.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.833 0.349 . . . . 10.0 111.27 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -117.01 109.57 17.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.963 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 94.6 t -129.0 139.38 52.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 110.148 -0.315 . . . . 10.0 110.148 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 31.0 m-20 -66.9 141.17 57.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.861 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.08 -23.52 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.039 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.67 0.25 18.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.147 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -114.61 9.65 16.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.468 . . . . 10.0 110.244 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 63.9 mt -97.3 132.49 41.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.157 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 t -79.15 -59.99 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.367 -0.379 . . . . 10.0 111.658 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -141.03 155.14 46.23 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.245 -0.284 . . . . 10.0 110.824 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 68.1 t -123.54 122.91 66.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 O-C-N 123.512 0.508 . . . . 10.0 110.59 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 7.3 m -113.53 107.37 15.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.888 0.375 . . . . 10.0 110.969 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.496 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 8.0 ttp85 -102.65 149.9 23.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.254 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -125.84 -22.71 4.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.508 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.04 16.8 14.13 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.958 -0.857 . . . . 10.0 110.958 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -144.38 -51.34 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -145.08 136.02 24.7 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.384 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 52.7 mt -93.88 128.26 45.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.571 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 29.4 m-85 -119.16 130.52 55.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -143.8 172.02 13.41 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.71 -0.396 . . . . 10.0 111.677 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -128.98 136.41 50.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.706 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -131.11 166.84 20.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.891 0.377 . . . . 10.0 111.287 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -132.33 114.74 14.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.539 -0.755 . . . . 10.0 109.729 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 88.1 mt -88.0 135.6 33.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.979 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.75 -8.74 35.33 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.819 -0.628 . . . . 10.0 112.815 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.87 -11.76 83.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.979 -0.629 . . . . 10.0 112.258 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.05 16.34 19.25 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.92 -0.657 . . . . 10.0 112.702 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -138.2 104.03 8.0 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 120.885 -0.326 . . . . 10.0 111.62 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.47 171.42 7.44 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.733 2.289 . . . . 10.0 111.18 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.42 -173.76 44.87 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.66 -1.257 . . . . 10.0 112.966 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -113.42 169.51 8.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.537 0.208 . . . . 10.0 110.497 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.23 151.53 23.48 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.151 -0.547 . . . . 10.0 111.823 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.7 p -136.27 140.12 44.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 10.0 111.517 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.78 135.46 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.901 -0.59 . . . . 10.0 109.557 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.3 t -76.02 134.89 40.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.745 0.307 . . . . 10.0 110.714 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.459 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 45.0 mt-10 -89.79 8.95 29.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 10.0 110.048 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -132.22 -42.77 0.97 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.733 -0.667 . . . . 10.0 111.665 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.21 34.23 1.81 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.208 0.447 . . . . 10.0 112.208 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.98 154.66 34.55 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.705 -0.225 . . . . 10.0 110.574 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -59.48 134.71 60.03 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.77 2.313 . . . . 10.0 111.356 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -67.97 -16.65 64.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.219 -0.446 . . . . 10.0 112.165 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -59.61 -44.4 93.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.409 . . . . 10.0 110.366 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.97 -39.23 83.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.526 . . . . 10.0 110.008 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.9 -41.0 95.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.741 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -62.5 -38.12 88.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.323 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.69 -35.86 44.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.956 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.28 -56.33 22.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.857 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' GLU . . . . . 0.496 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 40.6 tt0 -86.81 89.77 8.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.335 0.588 . . . . 10.0 110.944 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -78.58 148.74 33.19 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -64.7 138.91 58.67 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.1 mttt 72.04 54.64 0.18 Allowed 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.983 0.802 . . . . 10.0 110.245 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.662 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 120.678 0.275 . . . . 10.0 110.507 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 73.1 mt -92.15 150.85 20.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -119.37 137.53 53.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.853 0.358 . . . . 10.0 110.942 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -111.86 140.01 33.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.335 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.74 122.8 22.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.921 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.9 mt -79.13 -38.32 36.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.462 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -134.19 161.39 35.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.36 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -77.23 121.54 23.81 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -112.22 117.92 33.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.075 0.464 . . . . 10.0 110.431 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -94.46 120.52 34.82 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.906 -0.588 . . . . 10.0 109.486 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.471 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -73.48 156.61 38.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.969 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.1 ttm105 -123.28 -26.42 4.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.85 -0.614 . . . . 10.0 110.676 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.48 -168.51 1.5 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.297 -0.41 . . . . 10.0 111.022 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -97.8 -3.17 39.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.018 0.437 . . . . 10.0 111.14 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.52 -43.29 9.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.04 -0.527 . . . . 10.0 110.385 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -81.16 147.43 30.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.552 -0.749 . . . . 10.0 109.91 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 62.2 tp -103.84 131.39 51.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.337 -0.392 . . . . 10.0 112.009 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.471 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -85.37 135.8 33.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.877 178.713 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -155.58 165.46 36.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.775 0.322 . . . . 10.0 110.664 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.493 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 36.5 m170 -110.22 165.23 11.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.959 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -61.82 126.1 26.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.558 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.35 -4.21 43.99 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.675 -0.774 . . . . 10.0 112.146 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 2.5 tp10 -68.11 148.12 51.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 122.204 0.202 . . . . 10.0 110.922 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -119.1 133.52 55.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.662 -0.495 . . . . 10.0 109.662 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 107' ' ' GLU . 0.4 OUTLIER -130.53 155.46 46.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.125 0.488 . . . . 10.0 111.582 -179.156 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -109.45 114.11 27.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.2 mm -63.2 128.77 25.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.143 -0.48 . . . . 10.0 111.065 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.03 -44.33 4.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.917 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 116' ' ' GLU . 30.1 t30 -138.81 108.55 6.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.812 0.339 . . . . 10.0 111.131 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.72 -11.32 19.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.163 0.506 . . . . 10.0 110.73 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.6 8.79 15.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.069 -0.514 . . . . 10.0 111.446 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.407 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 7.2 tp10 -77.98 -20.14 53.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.013 0.435 . . . . 10.0 110.806 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.34 -139.99 9.61 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.818 -0.706 . . . . 10.0 111.499 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.11 -35.28 49.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.98 -0.378 . . . . 10.0 109.98 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.466 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 20.4 m95 -92.18 126.01 37.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -103.55 146.99 27.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.882 0.372 . . . . 10.0 111.228 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -97.11 122.17 39.82 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.735 -0.839 . . . . 10.0 108.735 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.74 162.46 32.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.953 0.406 . . . . 10.0 111.543 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 123' ' ' ARG . 13.1 ttt-85 -109.53 128.08 54.93 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.453 -0.794 . . . . 10.0 109.599 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.3 t -67.3 134.16 51.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.163 -0.472 . . . . 10.0 109.749 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.9 mt -83.73 -10.66 57.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.864 0.364 . . . . 10.0 110.105 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.12 -62.77 1.37 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.761 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.2 p -87.36 -35.73 18.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.037 0.446 . . . . 10.0 111.546 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.89 2.01 52.17 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.72 -0.753 . . . . 10.0 111.87 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.99 144.7 48.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.802 0.334 . . . . 10.0 111.248 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.7 m -117.76 135.64 53.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.288 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -178.68 178.44 48.71 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.445 -0.883 . . . . 10.0 112.106 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -79.79 126.09 30.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.965 0.412 . . . . 10.0 109.971 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 31.2 pt -115.67 139.83 25.28 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.797 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.07 112.58 1.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.453 2.102 . . . . 10.0 111.34 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.67 -18.21 61.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.056 -0.52 . . . . 10.0 112.134 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -92.57 5.69 49.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.621 -0.263 . . . . 10.0 111.494 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -119.25 4.82 11.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.914 0.388 . . . . 10.0 110.748 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.93 149.07 32.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.152 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -129.39 142.65 45.96 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.218 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 6.7 Cg_exo -73.84 135.73 21.9 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.437 2.092 . . . . 10.0 111.773 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.367 -0.825 . . . . 10.0 110.682 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ttt . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.348 0.118 . . . . 10.0 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.35 174.08 13.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.75 0.309 . . . . 10.0 111.153 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 2.1 m -108.59 131.56 54.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.47 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.86 125.06 48.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.892 0.377 . . . . 10.0 110.893 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -103.86 111.44 23.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.272 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -121.94 176.99 5.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.978 -0.556 . . . . 10.0 111.036 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -121.06 94.72 4.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.469 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -80.88 92.02 6.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.059 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm 56.24 43.9 25.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.42 -0.809 . . . . 10.0 111.893 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.6 -16.43 59.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.852 -0.69 . . . . 10.0 113.586 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -94.75 117.79 30.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.168 0.484 . . . . 10.0 111.314 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -76.81 117.26 18.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -132.37 137.97 47.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.855 0.359 . . . . 10.0 110.877 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -112.48 116.28 30.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.137 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.3 t -124.08 140.34 47.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.775 -0.454 . . . . 10.0 109.775 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -57.51 137.21 56.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.594 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.8 tt -60.12 -26.94 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.983 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.27 2.16 16.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.434 -0.348 . . . . 10.0 111.821 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' B' ' 35' ' ' ASP . 95.4 mttt -112.01 8.27 20.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.775 0.321 . . . . 10.0 111.088 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -92.2 119.97 40.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.78 -70.32 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.888 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -128.49 148.98 50.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.73 0.3 . . . . 10.0 111.145 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.21 132.37 68.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.481 -0.781 . . . . 10.0 110.297 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 28.7 m -132.22 115.4 15.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.037 0.446 . . . . 10.0 110.851 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.546 ' HD2' ' OE1' ' B' ' 48' ' ' GLU . 68.5 ttp85 -116.32 144.26 44.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.309 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -119.89 7.62 10.97 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.132 0.491 . . . . 10.0 111.607 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.542 ' H ' ' HG2' ' B' ' 25' ' ' ARG . . . 90.53 16.56 54.89 Favored Glycine 0 C--O 1.231 -0.077 0 C-N-CA 120.462 -0.875 . . . . 10.0 112.203 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -140.0 -60.92 0.53 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.48 0.657 . . . . 10.0 109.343 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -131.46 147.05 52.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.162 -0.926 . . . . 10.0 109.699 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 61.7 mt -101.57 111.96 33.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.681 -0.69 . . . . 10.0 110.089 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -103.02 126.95 50.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.089 -0.505 . . . . 10.0 109.676 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -152.45 172.96 15.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.01 0.433 . . . . 10.0 111.133 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -129.16 134.41 48.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.785 -0.643 . . . . 10.0 109.739 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -110.98 168.83 9.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.239 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' B' ' 19' ' ' LYS . 21.8 t70 -131.65 153.09 50.32 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.312 -0.625 . . . . 10.0 109.312 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 51.0 mt -138.55 139.29 38.62 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.189 -0.3 . . . . 10.0 110.189 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.97 -20.93 60.68 Favored Glycine 0 C--N 1.33 0.218 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.33 -18.49 71.49 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.749 -0.54 . . . . 10.0 111.749 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.07 29.38 6.45 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.972 -0.632 . . . . 10.0 112.795 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -130.41 85.91 55.06 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.883 0.341 . . . . 10.0 111.56 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -91.33 76.94 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.138 2.559 . . . . 10.0 111.997 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.58 -167.47 43.69 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.927 -0.654 . . . . 10.0 113.027 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 62.1 m-85 -111.65 172.34 6.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.852 0.358 . . . . 10.0 110.727 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.22 151.59 23.05 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.358 -0.697 . . . . 10.0 111.358 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 14.6 p -141.57 140.49 31.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.13 0.49 . . . . 10.0 110.984 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.57 147.77 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.559 . . . . 10.0 109.651 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 22.2 t -93.0 136.67 33.05 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.168 -0.308 . . . . 10.0 110.168 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.546 ' OE1' ' HD2' ' B' ' 25' ' ' ARG . 19.6 tt0 -80.66 -10.17 59.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.979 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -110.99 -26.01 9.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.157 0.428 . . . . 10.0 112.157 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -97.83 -15.16 20.37 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.465 0.543 . . . . 10.0 112.465 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.29 151.34 41.42 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.451 0.167 . . . . 10.0 111.226 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 25.7 Cg_exo -63.5 147.78 92.96 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.713 2.275 . . . . 10.0 111.836 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -64.31 -21.95 66.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.969 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.96 -45.93 71.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.918 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.2 mt -78.61 -36.26 44.42 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.898 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 36.4 mt -61.91 -39.38 91.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.203 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -69.08 -16.58 63.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 10.0 111.771 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -90.28 -20.24 23.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.167 0.508 . . . . 10.0 110.173 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 21.3 mt -93.08 -37.98 11.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.751 -0.659 . . . . 10.0 110.141 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -79.66 85.3 5.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.563 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' B' ' 64' ' ' LYS . 86.4 mttt -91.32 163.59 14.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.968 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -81.74 126.48 31.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 63.36 36.91 11.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.236 0.541 . . . . 10.0 109.736 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.174 -0.921 . . . . 10.0 111.673 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 120.579 0.228 . . . . 10.0 110.69 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.5 mt -100.43 141.77 32.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -111.18 134.94 52.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.111 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 107' ' ' GLU . 12.6 p -109.42 138.61 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.453 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.84 123.46 26.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.862 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.2 mt -81.32 -34.64 31.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.338 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -133.54 154.99 50.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.259 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.76 145.48 30.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.242 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -150.85 130.0 12.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.53 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -97.06 132.18 43.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.949 -0.759 . . . . 10.0 108.949 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 143.96 57.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.97 0.414 . . . . 10.0 111.396 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -97.01 -12.11 23.68 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.788 -0.642 . . . . 10.0 109.919 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.37 -166.49 2.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.028 -0.987 . . . . 10.0 109.434 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -98.35 -2.99 38.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -78.06 -47.84 17.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.002 -0.999 . . . . 10.0 108.827 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -87.64 155.68 19.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.192 -0.913 . . . . 10.0 108.818 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.1 tp -111.23 139.36 46.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.868 0.366 . . . . 10.0 111.86 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.9 m -81.44 140.04 34.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.665 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -152.2 166.22 32.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.967 0.413 . . . . 10.0 111.007 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -121.61 166.71 13.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.213 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -59.51 122.59 14.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.59 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.08 -1.43 44.2 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.733 -0.746 . . . . 10.0 112.611 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -67.15 140.94 57.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.644 0.259 . . . . 10.0 110.875 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -112.27 124.83 53.32 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 107' ' ' GLU . 25.6 m-85 -116.94 146.07 43.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.292 0.568 . . . . 10.0 112.356 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -100.14 101.43 12.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.718 -1.216 . . . . 10.0 107.718 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.0 mm -60.77 116.28 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.374 -0.376 . . . . 10.0 111.316 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.8 mt -89.25 -53.51 4.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.307 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -133.25 104.57 6.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.376 -0.375 . . . . 10.0 111.008 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.75 -8.19 44.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.289 0.566 . . . . 10.0 110.497 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 10.57 27.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.215 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.86 -25.12 59.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.913 0.387 . . . . 10.0 110.317 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.42 -127.79 3.18 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.639 -0.584 . . . . 10.0 111.639 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -83.15 -47.74 11.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.484 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 25.8 m95 -88.5 127.68 35.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.531 -0.915 . . . . 10.0 108.531 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -107.52 139.96 41.24 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.835 0.35 . . . . 10.0 111.277 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -85.39 119.41 25.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.177 -1.045 . . . . 10.0 108.177 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.11 162.61 30.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.071 0.463 . . . . 10.0 111.818 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -112.91 122.09 46.62 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.378 -0.828 . . . . 10.0 108.922 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.4 t -62.25 144.34 55.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.883 0.373 . . . . 10.0 110.741 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.75 -16.17 37.19 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.176 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 m -93.05 -50.79 5.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.709 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 64.8 p -88.4 -41.25 12.93 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.284 0.564 . . . . 10.0 111.268 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.89 9.1 62.83 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.751 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.21 162.57 18.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.779 0.323 . . . . 10.0 110.724 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.13 150.97 33.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.463 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 168.79 168.75 31.29 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.911 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -79.79 134.41 36.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.823 0.344 . . . . 10.0 110.821 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 22.8 pt -120.53 137.5 26.31 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.588 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.581 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 37.6 Cg_endo -72.19 121.95 7.97 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.549 2.166 . . . . 10.0 111.437 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -19.55 65.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.843 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.581 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 35.7 p-10 -80.63 -21.63 41.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.506 0.193 . . . . 10.0 111.446 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.473 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 4.6 m-85 -93.15 -11.99 31.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.081 0.4 . . . . 10.0 112.081 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.2 m -114.72 159.78 14.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.17 0.509 . . . . 10.0 111.675 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.72 137.59 18.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.716 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.64 137.14 32.25 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.343 2.029 . . . . 10.0 112.142 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.601 -0.714 . . . . 10.0 109.793 179.289 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ttm . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.462 0.173 . . . . 10.0 111.061 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.28 162.24 37.77 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.446 0.641 . . . . 10.0 112.173 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 1.1 m -107.58 118.2 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.316 -0.856 . . . . 10.0 109.746 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.1 134.35 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.821 0.343 . . . . 10.0 111.682 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -98.58 139.25 34.58 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.487 -0.561 . . . . 10.0 109.487 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -148.07 176.35 10.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.85 0.357 . . . . 10.0 110.667 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -123.87 83.55 2.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.815 -0.63 . . . . 10.0 109.76 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -63.77 92.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.765 0.316 . . . . 10.0 110.535 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm 52.02 29.5 6.32 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.688 -0.687 . . . . 10.0 111.608 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.17 -16.65 22.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.839 -0.696 . . . . 10.0 112.806 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -88.83 101.68 14.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.779 0.323 . . . . 10.0 110.732 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -67.52 123.12 19.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.082 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.05 158.76 44.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.747 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -125.12 119.59 29.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.041 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.71 142.43 42.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.804 0.335 . . . . 10.0 110.43 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 1.4 m-20 -60.77 137.86 58.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.351 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.8 tt -60.96 -26.52 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.696 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -10.72 59.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.855 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -105.3 8.18 33.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.69 0.281 . . . . 10.0 111.484 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -90.57 137.89 20.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.792 0.33 . . . . 10.0 110.273 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -88.95 -59.16 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.255 -0.43 . . . . 10.0 111.171 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -136.16 151.85 50.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.634 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.01 127.04 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.178 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . 0.405 ' HG1' ' HH2' ' A' ' 119' ' ' TRP . 8.1 m -123.43 101.78 7.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.886 0.374 . . . . 10.0 111.398 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.409 ' HG3' HG12 ' B' ' 30' ' ' ILE . 22.3 ttp85 -90.76 137.33 32.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.813 -0.44 . . . . 10.0 109.813 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.431 ' HB2' ' ND2' ' A' ' 136' ' ' ASN . 49.1 t80 -100.91 -20.49 15.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.06 0.457 . . . . 10.0 111.238 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.49 -4.58 37.44 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -135.17 -41.69 0.73 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.565 -0.817 . . . . 10.0 108.971 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -138.81 137.66 36.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.493 -0.776 . . . . 10.0 109.868 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.409 HG12 ' HG3' ' B' ' 25' ' ' ARG . 72.5 mt -102.98 125.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.279 -0.267 . . . . 10.0 110.279 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 17.7 m-85 -117.24 136.17 53.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -151.45 174.02 13.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.0 0.429 . . . . 10.0 111.227 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -130.24 140.88 50.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 10.0 109.805 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -124.41 152.52 43.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.926 0.393 . . . . 10.0 110.832 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.38 98.94 6.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.628 -0.714 . . . . 10.0 109.867 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' B' ' 40' ' ' LYS . 48.9 mt -75.81 144.42 41.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.793 0.33 . . . . 10.0 110.827 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.25 -5.87 87.55 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 116.071 -0.513 . . . . 10.0 112.201 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.3 23.05 10.38 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.899 -0.667 . . . . 10.0 112.441 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.84 43.42 97.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.45 -0.405 . . . . 10.0 112.834 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 86.0 tttt -159.79 95.68 1.61 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.717 0.294 . . . . 10.0 110.815 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -87.73 169.06 6.86 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.002 2.468 . . . . 10.0 111.235 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.63 -173.43 38.51 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.223 -0.989 . . . . 10.0 112.285 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 42.9 m-85 -118.56 166.89 12.17 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.66 138.25 6.42 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.372 -0.918 . . . . 10.0 112.531 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 p -124.33 127.73 73.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.078 0.466 . . . . 10.0 110.392 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.08 123.87 70.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.227 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -71.62 132.61 44.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.365 -0.38 . . . . 10.0 109.977 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -80.79 1.29 31.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.112 0.482 . . . . 10.0 110.791 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -116.3 -35.13 4.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.447 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -101.9 28.3 5.82 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.41 151.18 36.06 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 121.314 -0.154 . . . . 10.0 111.075 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.29 129.25 33.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.256 2.637 . . . . 10.0 112.418 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.449 ' HA ' HD12 ' B' ' 56' ' ' LEU . 97.3 mttt -64.31 -26.82 68.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.927 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -55.97 -42.62 76.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.971 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 73.8 mt -76.86 -30.67 56.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.729 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' B' ' 53' ' ' LYS . 62.1 mt -66.57 -32.09 73.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.413 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -74.42 -7.93 54.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.002 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -98.6 -26.92 14.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.907 -0.588 . . . . 10.0 110.11 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 52.3 mt -72.45 -61.95 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.865 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -101.03 110.33 22.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.208 0.528 . . . . 10.0 109.961 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -107.8 173.84 6.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.481 -0.781 . . . . 10.0 110.073 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -64.12 127.45 31.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.773 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 mttm 60.8 58.29 2.41 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.499 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.283 0 CA-C-N 115.954 -0.567 . . . . 10.0 111.061 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 120.929 0.395 . . . . 10.0 111.058 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.9 mt -92.57 158.84 15.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.09 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -121.08 134.61 55.27 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.2 p -112.27 140.34 32.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.921 0.391 . . . . 10.0 110.527 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 138' ' ' VAL . . . -72.13 123.37 22.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.97 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 139' ' ' ALA . 82.6 mt -83.28 -26.09 30.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.547 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.43 -175.3 4.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.922 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.87 149.8 27.05 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.282 0.364 . . . . 10.0 110.391 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -147.63 128.7 14.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.595 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -94.51 122.16 36.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.639 . . . . 10.0 109.403 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.507 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -61.68 144.09 55.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.703 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -97.32 -38.61 9.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.354 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -124.36 -162.25 1.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.873 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' H ' ' HB ' ' A' ' 97' ' ' THR . 1.6 pt-20 -96.54 -8.58 31.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.911 0.386 . . . . 10.0 110.68 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.48 -38.78 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.232 0.539 . . . . 10.0 110.099 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -93.05 150.55 20.45 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.688 -0.856 . . . . 10.0 108.688 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.2 tp -113.63 142.46 45.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.888 0.375 . . . . 10.0 111.626 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -81.92 148.51 28.7 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.799 179.006 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -154.85 158.96 40.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.102 0.477 . . . . 10.0 111.35 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -113.35 153.14 29.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.053 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -59.56 126.66 28.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.584 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.1 -17.64 29.24 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.884 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -68.4 143.14 55.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.733 0.302 . . . . 10.0 111.035 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -103.26 130.29 50.47 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.444 -0.576 . . . . 10.0 109.444 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -118.87 143.28 47.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.236 0.541 . . . . 10.0 112.089 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -103.19 104.14 14.26 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.69 -0.855 . . . . 10.0 108.69 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' A' ' 122' ' ' ALA . 20.3 mm -64.13 120.19 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 10.0 111.206 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.8 mt -82.74 -46.44 13.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.194 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -149.06 137.77 21.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.185 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.12 -12.44 10.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.173 -0.467 . . . . 10.0 111.29 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.9 m -86.82 47.21 1.46 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.919 0.39 . . . . 10.0 111.903 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -127.35 -3.72 6.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.97 0.414 . . . . 10.0 110.863 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 139.47 -145.47 16.62 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.014 -0.612 . . . . 10.0 111.729 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.05 -22.41 20.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.031 0.443 . . . . 10.0 110.611 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' B' ' 31' ' ' PHE . 23.2 m95 -98.38 119.56 37.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.961 -1.125 . . . . 10.0 107.961 177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -103.47 153.92 20.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.284 0.564 . . . . 10.0 112.187 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -90.29 124.6 35.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.672 -1.233 . . . . 10.0 107.672 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -140.69 146.71 38.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.629 0.728 . . . . 10.0 112.715 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 123' ' ' ARG . 30.0 ttt180 -99.68 122.28 42.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.854 -1.066 . . . . 10.0 109.646 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.7 t -66.79 131.23 45.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.3 mt -78.44 -9.43 59.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.85 0.357 . . . . 10.0 110.427 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.5 m -79.78 -63.65 1.37 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 10.0 111.427 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.3 p -102.09 -25.75 13.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.389 0.514 . . . . 10.0 112.389 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.12 1.59 57.01 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.552 -0.832 . . . . 10.0 111.704 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -69.2 146.33 52.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 10.0 110.846 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.59 178.84 4.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.438 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 143.15 168.87 12.17 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.844 -0.693 . . . . 10.0 111.972 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -84.0 130.43 34.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.842 0.353 . . . . 10.0 110.44 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.8 pt -123.57 146.92 51.47 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.915 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.526 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 48.5 Cg_endo -74.23 115.05 4.18 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.666 2.244 . . . . 10.0 111.779 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.6 m -62.03 -15.06 41.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.945 0.72 . . . . 10.0 112.945 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 33.7 p-10 -83.41 -8.3 59.41 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.234 -0.291 . . . . 10.0 110.861 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.402 ' CE1' HG22 ' B' ' 24' ' ' THR . 2.5 m-85 -105.44 -0.16 26.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.167 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 89' ' ' ALA . 4.6 m -127.67 156.15 39.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.989 0.423 . . . . 10.0 111.206 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 90' ' ' LEU . . . -136.2 143.05 42.19 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.235 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.85 129.41 19.66 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.617 2.211 . . . . 10.0 112.06 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.29 -0.862 . . . . 10.0 110.261 -179.872 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.469 0.176 . . . . 10.0 110.708 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.4 169.24 25.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.821 0.343 . . . . 10.0 111.148 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.1 p -101.88 145.24 29.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 t -110.02 133.03 56.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.783 -0.451 . . . . 10.0 109.783 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.25 124.21 44.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.457 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 41.3 p90 -128.58 166.72 18.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.958 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -114.31 87.54 2.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.014 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -78.5 90.55 4.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.585 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm 53.54 38.21 27.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.108 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.01 -26.37 20.92 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.675 -0.774 . . . . 10.0 112.813 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -83.59 105.82 14.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.696 0.284 . . . . 10.0 110.882 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 26.7 mt-10 -80.16 116.93 20.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -130.92 157.44 42.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.612 0.244 . . . . 10.0 111.074 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -120.72 113.9 20.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.494 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . 0.497 HG11 ' HB2' ' B' ' 34' ' ' TYR . 48.8 t -124.42 143.02 39.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.857 -0.423 . . . . 10.0 109.857 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.26 141.69 45.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 10.0 111.314 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 7.4 tt -62.26 -32.68 55.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.174 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 15.2 m -80.98 2.16 28.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.372 -0.376 . . . . 10.0 111.549 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -104.62 12.47 32.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.522 0.677 . . . . 10.0 109.29 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.15 133.86 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.063 -0.972 . . . . 10.0 109.324 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 t -83.76 -73.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.745 0.307 . . . . 10.0 111.568 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -118.85 152.18 36.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.72 0.295 . . . . 10.0 111.354 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.66 129.7 66.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.979 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . 0.402 HG22 ' CE1' ' A' ' 137' ' ' TYR . 1.5 m -134.46 121.4 21.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.901 0.381 . . . . 10.0 111.05 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -120.75 125.47 47.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.814 0.34 . . . . 10.0 110.844 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -89.05 -22.46 22.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.153 0.502 . . . . 10.0 110.684 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.17 -4.47 8.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.865 -0.683 . . . . 10.0 112.01 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -117.14 -57.96 2.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.302 -0.629 . . . . 10.0 109.302 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.68 149.89 52.12 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.6 mt -101.66 124.64 55.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.358 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.443 ' HB3' ' NE1' ' A' ' 119' ' ' TRP . 3.3 m-85 -104.5 132.55 50.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.665 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -152.38 156.65 39.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.938 0.399 . . . . 10.0 111.289 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -110.59 132.17 54.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.059 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.497 ' HB2' HG11 ' B' ' 15' ' ' VAL . 19.2 p90 -114.62 164.3 14.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.67 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -133.33 142.96 48.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.624 -0.717 . . . . 10.0 109.385 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 35.7 mt -126.5 142.42 51.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.018 0.437 . . . . 10.0 111.288 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.86 -13.48 78.74 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.696 -0.684 . . . . 10.0 112.212 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.52 7.9 37.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.962 -0.637 . . . . 10.0 112.1 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.89 45.46 16.51 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.201 -0.523 . . . . 10.0 112.618 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -160.49 90.45 1.7 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.891 0.377 . . . . 10.0 111.392 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.32 175.03 6.62 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.458 2.105 . . . . 10.0 110.917 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.27 -166.5 36.54 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.881 -1.152 . . . . 10.0 112.462 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -120.65 156.57 31.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.681 0.277 . . . . 10.0 110.45 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.72 155.62 22.74 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.154 -0.778 . . . . 10.0 111.154 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.73 139.79 28.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.111 0.482 . . . . 10.0 111.262 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 20.4 m -132.31 152.48 36.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.763 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.416 ' HB3' ' HB2' ' B' ' 50' ' ' ASP . 19.5 t -91.16 141.34 28.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.112 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -82.6 -10.14 59.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.043 0.449 . . . . 10.0 110.636 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.64 -9.18 12.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.89 0.33 . . . . 10.0 111.89 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . 0.416 ' HB2' ' HB3' ' B' ' 47' ' ' SER . 24.1 m-20 -120.32 21.9 11.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.901 0.382 . . . . 10.0 111.48 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.71 141.65 17.05 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.164 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.51 142.86 69.78 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.779 2.319 . . . . 10.0 112.297 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -58.06 -30.48 66.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.214 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.4 -45.09 72.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 10.0 111.161 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 mt -71.74 -38.84 70.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 10.0 111.023 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.98 -41.67 97.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.015 -0.539 . . . . 10.0 111.045 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -74.53 -13.65 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.932 -0.577 . . . . 10.0 111.383 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -80.42 -37.11 32.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.018 0.437 . . . . 10.0 109.823 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.44 -47.68 32.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.778 -0.646 . . . . 10.0 111.361 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -88.92 97.71 11.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.065 0.459 . . . . 10.0 110.43 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -104.01 -173.27 2.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.389 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -68.84 140.43 55.22 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 61.5 50.43 4.6 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.552 0.691 . . . . 10.0 109.892 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-N 115.165 -0.925 . . . . 10.0 110.878 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.597 0.237 . . . . 10.0 110.721 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.2 mt -99.8 141.79 32.15 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.932 0.396 . . . . 10.0 110.723 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -119.56 140.35 50.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.76 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.86 140.15 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.959 0.409 . . . . 10.0 110.437 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.34 116.56 12.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.987 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.24 -33.18 72.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.406 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -147.13 173.78 12.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.883 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.19 144.32 27.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -126.78 123.35 37.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.956 0.408 . . . . 10.0 111.112 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -84.93 116.85 23.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.606 -0.725 . . . . 10.0 109.579 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.94 148.67 51.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.092 0.472 . . . . 10.0 111.155 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -115.15 -35.44 4.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.782 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.81 -165.09 1.48 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.551 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -96.0 -11.95 25.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.688 0.28 . . . . 10.0 111.262 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.35 -34.63 31.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.211 0.529 . . . . 10.0 110.611 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -90.23 149.76 22.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.58 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.6 tp -109.68 135.46 50.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.981 0.42 . . . . 10.0 111.916 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.91 147.72 24.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.204 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -156.77 163.59 39.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.779 0.323 . . . . 10.0 111.268 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -110.26 157.05 19.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.08 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -58.5 128.1 35.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.799 0.333 . . . . 10.0 110.419 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.38 -10.0 53.78 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.707 -0.758 . . . . 10.0 112.924 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -70.85 146.73 49.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 10.0 110.781 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -115.62 139.07 50.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.067 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -126.58 150.39 48.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.053 0.454 . . . . 10.0 111.818 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -97.91 111.5 23.78 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.45 119.17 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.336 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.9 mt -102.7 -62.32 1.29 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.579 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -119.54 107.22 13.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.431 . . . . 10.0 110.644 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.29 22.0 12.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.78 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -112.27 -1.08 15.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.783 0.66 . . . . 10.0 112.783 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.72 -37.11 65.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.518 -0.473 . . . . 10.0 110.876 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.74 -133.62 2.89 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.189 -1.005 . . . . 10.0 112.588 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.39 -31.58 29.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.641 0.258 . . . . 10.0 110.947 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.558 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 28.2 m95 -93.16 121.22 34.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -103.17 146.48 28.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.046 0.451 . . . . 10.0 111.634 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -95.23 119.51 33.87 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.01 159.13 42.48 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.291 0.567 . . . . 10.0 111.832 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -104.38 124.15 48.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.245 -0.889 . . . . 10.0 109.433 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.0 t -65.95 136.57 56.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.944 -0.391 . . . . 10.0 109.944 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.34 -2.71 58.81 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.2 m -97.15 -50.31 4.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.2 p -101.24 -28.07 12.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.94 0.4 . . . . 10.0 111.732 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.45 -6.03 77.73 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.977 -0.63 . . . . 10.0 112.233 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -69.03 149.32 48.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.945 0.403 . . . . 10.0 110.882 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.1 m -119.95 125.86 49.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.947 -0.569 . . . . 10.0 111.093 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -163.5 176.11 39.67 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.489 -0.644 . . . . 10.0 111.489 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -81.72 127.86 33.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.839 0.352 . . . . 10.0 110.5 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.0 pt -119.62 142.13 32.27 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.805 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.447 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 28.9 Cg_endo -69.01 110.9 2.51 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.171 1.914 . . . . 10.0 111.184 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 m -59.35 -19.55 47.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.887 -0.597 . . . . 10.0 112.579 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 30.7 p-10 -81.51 -8.8 59.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 10.0 110.87 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -103.03 -3.5 25.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.312 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.79 157.87 27.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.507 -0.315 . . . . 10.0 111.036 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -138.85 148.37 57.85 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.317 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 24.3 Cg_exo -63.38 136.53 55.59 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.546 2.164 . . . . 10.0 112.117 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.567 -0.73 . . . . 10.0 110.396 179.677 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ttt . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.561 0.22 . . . . 10.0 110.538 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.53 145.99 16.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.885 0.374 . . . . 10.0 111.009 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 6.1 m -93.72 119.8 33.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.625 -0.716 . . . . 10.0 109.45 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 32.8 t -86.87 130.34 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.984 0.421 . . . . 10.0 111.291 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -99.69 120.65 40.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.339 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -140.53 -174.22 3.9 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.609 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -125.54 142.97 51.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.068 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -125.52 98.84 5.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.968 0.413 . . . . 10.0 110.171 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm 56.8 31.64 19.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.189 -0.914 . . . . 10.0 112.264 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.45 -56.35 0.72 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.263 -0.97 . . . . 10.0 114.022 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -78.88 158.38 28.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.097 0.449 . . . . 10.0 111.842 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -97.1 141.79 29.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -136.9 152.1 49.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.443 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -126.18 111.9 15.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.21 -0.45 . . . . 10.0 109.796 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -129.59 142.13 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.803 0.335 . . . . 10.0 111.172 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.67 142.37 57.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.647 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 16.5 tt -63.13 -25.83 39.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.232 0.539 . . . . 10.0 110.616 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -11.38 60.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 10.0 111.362 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -99.5 2.68 45.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.122 0.487 . . . . 10.0 110.207 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 61.3 mt -96.91 134.34 34.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.075 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.26 -72.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.031 0.443 . . . . 10.0 110.434 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -120.99 147.02 46.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.096 -0.502 . . . . 10.0 111.155 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 t -124.16 116.01 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.659 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 5.1 m -120.65 112.55 19.02 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.128 0.49 . . . . 10.0 112.266 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.557 ' HD2' ' OE1' ' B' ' 48' ' ' GLU . 37.3 ttp85 -102.9 131.71 49.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.939 -0.393 . . . . 10.0 109.939 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -89.88 -25.48 20.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.311 0.577 . . . . 10.0 110.787 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.07 -4.14 16.3 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.716 -0.954 . . . . 10.0 110.716 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -134.17 -38.44 0.86 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -135.71 143.64 45.5 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.717 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mt -105.22 121.45 57.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -113.16 127.67 56.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.443 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -145.87 167.27 23.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.769 0.318 . . . . 10.0 110.608 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' ' 33' ' ' ARG . 6.2 ttt180 -126.46 129.93 49.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.106 -0.497 . . . . 10.0 109.742 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -119.48 162.99 17.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.224 0.535 . . . . 10.0 111.629 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.8 133.81 50.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.081 -0.963 . . . . 10.0 109.269 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 41.9 mt -112.5 140.01 47.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.815 0.341 . . . . 10.0 110.915 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.2 -7.49 45.07 Favored Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 115.829 -0.623 . . . . 10.0 112.839 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.07 8.89 59.18 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.916 -0.659 . . . . 10.0 111.975 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.1 47.93 16.98 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.913 -0.661 . . . . 10.0 112.372 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -163.02 99.28 1.04 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.552 0.215 . . . . 10.0 111.117 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.04 165.55 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.531 2.154 . . . . 10.0 110.874 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.76 -171.68 29.27 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 119.809 -1.186 . . . . 10.0 113.303 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 1.5 m-85 -124.49 158.42 32.91 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.813 -0.44 . . . . 10.0 109.813 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.69 132.7 6.16 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.627 -0.796 . . . . 10.0 111.584 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.27 125.82 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.254 0.55 . . . . 10.0 110.443 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 t -121.08 136.85 56.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.047 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 28.1 t -83.9 130.72 34.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.933 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.557 ' OE1' ' HD2' ' B' ' 25' ' ' ARG . 5.1 tt0 -93.97 4.44 53.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.338 0.589 . . . . 10.0 109.732 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -98.7 -46.09 5.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.793 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.03 79.85 1.89 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.23 0.538 . . . . 10.0 111.712 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.54 156.22 10.36 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.151 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.33 128.01 25.96 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.618 2.212 . . . . 10.0 112.55 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -63.42 -27.13 69.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.966 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' B' ' 58' ' ' LYS . 0.1 OUTLIER -57.88 -33.17 68.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.492 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.2 -38.18 19.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.252 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 61.9 mt -61.88 -47.08 86.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 10.0 111.142 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -76.83 -5.91 50.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.799 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' B' ' 54' ' ' GLU . 4.0 tttt -92.23 -22.92 19.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 10.0 110.369 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 29.3 mt -82.62 -54.56 5.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.736 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . 0.425 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 31.6 tt0 -92.15 94.16 9.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.103 0.478 . . . . 10.0 110.044 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -86.41 166.67 15.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.69 -0.686 . . . . 10.0 109.827 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -63.57 132.02 49.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.78 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.6 mttt 61.32 49.6 5.28 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.187 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.601 -0.714 . . . . 10.0 110.495 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 120.554 0.216 . . . . 10.0 110.735 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.7 mt -90.39 146.21 24.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.33 -0.396 . . . . 10.0 110.52 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -123.04 145.25 48.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.431 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.01 142.38 38.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.481 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.13 120.64 20.91 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.131 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 139' ' ' ALA . 50.7 mt -79.74 -32.99 41.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.366 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -144.45 164.28 31.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.734 -0.667 . . . . 10.0 109.748 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.02 152.34 38.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.407 -0.59 . . . . 10.0 109.407 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -119.29 128.92 54.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.896 0.379 . . . . 10.0 111.026 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.79 92.59 6.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.09 -0.505 . . . . 10.0 109.67 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.91 162.8 29.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.56 . . . . 10.0 111.499 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -126.11 -45.64 1.7 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.023 -0.535 . . . . 10.0 110.728 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.23 -177.82 3.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.864 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -87.47 -11.21 49.65 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.891 0.33 . . . . 10.0 111.891 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.96 -39.04 31.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.993 0.425 . . . . 10.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.13 124.0 29.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.117 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.2 tp -77.85 135.13 37.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.996 -0.547 . . . . 10.0 112.204 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.33 120.81 35.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.711 . . . . 10.0 109.897 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -136.55 166.23 24.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.852 0.358 . . . . 10.0 111.29 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -109.78 168.32 9.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.839 -0.619 . . . . 10.0 111.391 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -65.27 134.3 53.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.389 -0.823 . . . . 10.0 111.357 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.41 2.95 88.89 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.118 -0.563 . . . . 10.0 113.725 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -81.41 151.26 28.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.073 0.436 . . . . 10.0 110.968 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -116.43 143.66 45.29 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.06 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.38 158.72 43.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 10.0 110.861 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -97.68 113.99 25.87 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.55 116.77 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.148 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.6 mt -83.96 -63.33 1.37 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.906 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -117.73 98.27 6.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.179 0.514 . . . . 10.0 111.403 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.41 -17.1 35.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.683 -0.689 . . . . 10.0 110.386 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.59 14.36 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.765 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -70.07 -44.39 69.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.314 0.578 . . . . 10.0 110.324 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 153.3 -113.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.452 -0.794 . . . . 10.0 111.185 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.16 -45.68 6.44 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.435 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 29.4 m95 -92.4 110.68 22.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -96.52 150.25 20.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.843 0.354 . . . . 10.0 111.052 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -95.07 123.8 38.75 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.455 -0.943 . . . . 10.0 108.455 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.5 163.99 27.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.958 0.409 . . . . 10.0 111.345 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -114.58 128.4 56.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.834 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.1 t -68.88 147.7 51.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.919 0.39 . . . . 10.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.0 mt -94.52 -3.14 50.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.496 -0.557 . . . . 10.0 109.496 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 m -95.06 -66.36 0.92 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.363 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.0 p -90.18 -20.91 22.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 10.0 111.461 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.94 13.49 79.34 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.783 -0.723 . . . . 10.0 111.895 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.48 153.43 37.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 10.0 110.898 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.9 m -117.6 135.75 53.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.176 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -179.47 176.79 47.95 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.433 -0.889 . . . . 10.0 112.221 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -84.29 138.95 32.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.307 -0.257 . . . . 10.0 110.307 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.2 pt -126.41 139.98 36.04 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.019 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.589 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 37.3 Cg_endo -68.83 121.57 8.46 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.343 2.029 . . . . 10.0 111.415 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 p -66.46 -12.82 59.24 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.551 0.574 . . . . 10.0 112.551 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.589 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 35.4 p-10 -87.58 -8.31 56.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.859 0.361 . . . . 10.0 110.986 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -100.32 -17.66 17.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.021 0.439 . . . . 10.0 110.677 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 22.5 m -115.83 154.05 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.61 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 90' ' ' LEU . . . -137.82 145.24 47.59 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.407 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.46 124.76 12.88 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.219 1.946 . . . . 10.0 111.332 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.052 -0.975 . . . . 10.0 110.293 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 111.239 0.088 . . . . 10.0 111.239 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . 0.431 ' O ' HG22 ' B' ' 17' ' ' ILE . . . -169.66 169.67 8.46 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.683 0.278 . . . . 10.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 2.2 m -107.6 140.2 40.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.699 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 54.6 t -115.05 136.52 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.56 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -105.09 128.4 53.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.093 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -137.71 177.31 7.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.544 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -125.38 89.0 2.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.771 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -78.37 110.72 13.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.084 -0.507 . . . . 10.0 109.866 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm 58.28 24.21 11.28 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.027 0.441 . . . . 10.0 111.017 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.29 -14.7 59.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.821 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.51 127.44 34.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.857 0.361 . . . . 10.0 110.804 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.07 120.72 22.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.3 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -137.61 149.79 46.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.255 -0.429 . . . . 10.0 110.382 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -126.85 115.51 19.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.547 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 64.1 t -125.88 143.8 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.15 -0.477 . . . . 10.0 109.847 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 56.6 m-20 -64.42 135.04 55.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 10.0 110.076 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.431 HG22 ' O ' ' B' ' 2' ' ' ALA . 15.8 tt -59.94 -26.23 35.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.614 -0.721 . . . . 10.0 111.398 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -10.8 60.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.079 -0.509 . . . . 10.0 111.345 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -100.94 12.6 37.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.132 0.491 . . . . 10.0 110.337 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -99.6 132.22 45.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.049 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.98 -64.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.93 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -137.0 155.87 49.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.326 -0.397 . . . . 10.0 110.723 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' B' ' 59' ' ' LEU . 22.5 t -127.05 142.86 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.923 -0.581 . . . . 10.0 109.644 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 9.3 m -137.81 118.87 14.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.036 0.445 . . . . 10.0 111.577 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.462 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 57.4 ttp85 -111.59 116.12 30.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.11 0.481 . . . . 10.0 110.687 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -84.66 -21.3 30.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.331 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.82 12.63 15.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.556 -0.83 . . . . 10.0 111.497 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -138.56 -51.97 0.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.761 -0.829 . . . . 10.0 108.761 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -136.57 143.28 43.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.783 -1.099 . . . . 10.0 108.85 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 27.8 mt -97.32 122.35 48.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.654 -0.498 . . . . 10.0 109.654 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -113.26 136.78 52.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.521 -0.309 . . . . 10.0 110.508 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -148.28 169.41 20.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.782 0.325 . . . . 10.0 110.646 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -126.81 131.24 51.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.037 -0.528 . . . . 10.0 109.847 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -125.55 165.53 18.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.031 0.443 . . . . 10.0 111.375 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -134.63 122.02 21.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.678 -0.692 . . . . 10.0 110.218 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -90.27 147.48 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 10.0 111.59 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.49 -12.89 70.5 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.933 -0.576 . . . . 10.0 112.549 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.38 13.94 43.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.906 -0.664 . . . . 10.0 112.555 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.31 54.94 7.29 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.702 -0.761 . . . . 10.0 111.966 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -157.59 95.28 2.06 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.648 0.261 . . . . 10.0 110.813 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.72 143.06 18.43 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.346 2.031 . . . . 10.0 110.792 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.93 -173.46 18.92 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.84 -1.172 . . . . 10.0 113.136 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 7.2 m-85 -128.46 161.11 30.26 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.85 143.74 12.98 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.346 -0.931 . . . . 10.0 112.208 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 2.4 p -131.3 130.37 63.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.995 0.426 . . . . 10.0 110.004 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 26.4 t -122.57 133.95 67.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.848 -0.614 . . . . 10.0 110.134 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.39 136.67 53.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.047 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -87.86 -19.3 27.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.002 0.429 . . . . 10.0 110.946 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -108.35 -36.72 6.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.524 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -96.88 52.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.904 -0.589 . . . . 10.0 111.002 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -169.21 151.92 4.84 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.305 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.29 140.57 59.09 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.485 2.123 . . . . 10.0 111.803 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -60.96 -21.03 63.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.309 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -54.67 -46.15 73.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.252 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.28 -35.41 48.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.782 0.325 . . . . 10.0 110.743 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 30.8 mt -61.55 -43.47 98.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.001 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -74.33 -7.3 52.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.546 . . . . 10.0 111.949 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -91.97 -33.92 14.66 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.842 -0.429 . . . . 10.0 109.842 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.464 ' HB3' HG11 ' B' ' 23' ' ' VAL . 89.5 mt -82.26 -36.9 26.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.943 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . 0.462 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 8.8 tp10 -79.73 94.73 5.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.267 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -105.58 142.79 34.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.182 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -67.47 127.1 31.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 mttt 64.77 65.01 0.63 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.935 0.772 . . . . 10.0 109.845 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' B' ' 23' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.606 -0.724 . . . . 10.0 110.586 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 120.568 0.223 . . . . 10.0 110.774 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.0 mt -93.66 148.13 22.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.021 -0.363 . . . . 10.0 110.021 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -120.59 134.19 55.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.711 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.45 140.29 34.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.026 -0.533 . . . . 10.0 109.95 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 138' ' ' VAL . . . -71.22 124.77 25.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.191 -0.458 . . . . 10.0 111.633 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.6 mt -80.75 -34.12 34.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.172 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -140.71 164.08 31.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.533 -0.758 . . . . 10.0 110.008 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.79 147.41 39.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.829 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -129.48 137.73 51.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 10.0 111.243 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -98.31 130.98 44.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.946 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.411 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . . . -84.54 139.78 31.89 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.22 -0.289 . . . . 10.0 110.22 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -107.89 -28.32 9.69 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.848 -0.341 . . . . 10.0 111.444 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.3 p -132.25 -161.47 1.14 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.993 0.425 . . . . 10.0 110.878 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -102.31 8.72 40.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.482 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.55 -38.83 7.36 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.497 -0.557 . . . . 10.0 109.497 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 95' ' ' ALA . 16.3 p-10 -89.87 149.46 22.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.748 -0.834 . . . . 10.0 108.748 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.4 tp -117.1 134.4 54.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.089 0.471 . . . . 10.0 111.964 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.67 151.38 26.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.831 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -159.57 170.57 21.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.363 -0.38 . . . . 10.0 110.314 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.428 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 59.2 m-70 -113.4 165.28 12.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.252 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -62.32 121.05 12.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.406 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.37 -4.34 33.14 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.958 -0.639 . . . . 10.0 112.122 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 104' ' ' HIS . 3.7 tp10 -66.86 129.32 39.49 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 122.287 0.235 . . . . 10.0 111.225 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -94.19 124.47 38.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -118.72 138.04 52.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.228 0.537 . . . . 10.0 112.088 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -100.52 105.67 17.12 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.388 -0.967 . . . . 10.0 108.388 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.8 mm -65.87 119.31 10.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.057 -0.519 . . . . 10.0 110.848 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -96.29 -38.78 9.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.435 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 121' ' ' GLU . 18.3 t30 -137.23 101.62 4.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.194 0.521 . . . . 10.0 110.255 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.63 -13.44 16.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.17 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.69 3.01 27.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.993 -0.548 . . . . 10.0 111.802 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -65.94 -48.12 72.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 10.0 110.581 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.43 -124.47 1.27 Allowed Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.826 -0.702 . . . . 10.0 111.813 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -76.68 -58.08 3.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.055 -0.35 . . . . 10.0 110.055 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.406 ' NE1' ' HB3' ' B' ' 31' ' ' PHE . 29.4 m95 -78.72 137.92 38.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -112.94 150.24 32.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.13 0.49 . . . . 10.0 111.901 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 113' ' ' ASN . 5.3 mt-10 -89.96 112.61 24.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.496 -0.927 . . . . 10.0 108.496 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.69 154.91 44.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.234 0.54 . . . . 10.0 111.908 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 123' ' ' ARG . 36.2 ttt-85 -109.15 132.54 54.02 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.442 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 t -73.78 131.64 41.77 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.725 -0.472 . . . . 10.0 109.725 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.12 -10.75 57.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.208 0.528 . . . . 10.0 110.067 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -62.71 1.41 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.444 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.9 p -89.08 -31.26 18.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.743 0.306 . . . . 10.0 111.796 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.8 -3.0 58.69 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.635 -0.793 . . . . 10.0 112.439 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -69.19 153.55 43.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.74 0.305 . . . . 10.0 111.195 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.4 m -127.37 134.88 49.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.982 -0.554 . . . . 10.0 110.957 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.14 -176.37 44.29 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.851 -0.69 . . . . 10.0 111.945 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.502 ' CE1' ' HG3' ' A' ' 121' ' ' GLU . 41.3 m-85 -83.92 131.32 34.86 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.7 pt -122.55 141.39 34.89 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.041 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.18 111.05 1.32 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.495 2.13 . . . . 10.0 111.428 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.84 -18.86 63.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.693 -0.685 . . . . 10.0 112.232 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -83.07 -13.96 54.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.455 -0.339 . . . . 10.0 111.246 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.91 0.03 43.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.575 -0.284 . . . . 10.0 111.328 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 89' ' ' ALA . 15.7 m -123.33 161.23 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.823 0.344 . . . . 10.0 110.932 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -141.48 146.36 41.68 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.441 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 15.1 Cg_exo -67.35 135.61 37.29 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.478 2.119 . . . . 10.0 111.599 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.524 -0.751 . . . . 10.0 110.439 -179.74 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ttt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.41 0.148 . . . . 10.0 110.942 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.11 152.59 24.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.866 0.365 . . . . 10.0 111.447 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.66 133.56 36.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.371 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 t -110.74 135.41 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.734 0.302 . . . . 10.0 110.729 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -102.87 126.3 49.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.057 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -128.86 166.43 19.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.502 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.427 ' HG2' ' HG2' ' B' ' 12' ' ' GLU . 88.9 mttt -106.66 89.08 2.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.149 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -75.73 86.38 2.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.419 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm 54.85 35.36 24.11 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.3 -0.864 . . . . 10.0 111.294 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.48 -29.7 8.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.855 -0.688 . . . . 10.0 112.897 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -87.42 117.22 26.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.757 0.313 . . . . 10.0 111.121 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' B' ' 7' ' ' LYS . 34.8 mt-10 -83.51 114.34 21.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.998 0.428 . . . . 10.0 109.973 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -125.5 149.31 48.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.166 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -115.58 107.77 15.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.361 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.36 144.13 28.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.206 -0.452 . . . . 10.0 109.915 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.23 139.19 58.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.624 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.4 tt -63.29 -24.04 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.314 0.578 . . . . 10.0 110.732 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -16.01 62.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.932 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -98.93 15.93 24.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.34 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 72.9 mt -103.74 133.77 46.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.942 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.92 -71.62 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.472 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -128.94 147.0 50.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.709 -0.223 . . . . 10.0 110.844 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 27.9 t -125.53 127.69 71.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.1 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 63.1 m -129.8 118.21 21.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.081 0.467 . . . . 10.0 111.913 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 15.8 ttp85 -99.87 148.25 24.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.924 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -122.29 -25.47 4.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.965 0.357 . . . . 10.0 111.965 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.29 18.37 8.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.225 -0.988 . . . . 10.0 110.935 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -148.12 -50.65 0.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -148.7 134.0 18.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.854 -1.067 . . . . 10.0 109.647 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.4 mt -91.69 129.92 41.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.138 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.406 ' HB3' ' NE1' ' A' ' 119' ' ' TRP . 16.9 m-85 -115.61 135.27 54.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.481 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -150.15 171.08 17.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.673 0.273 . . . . 10.0 110.852 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -121.05 132.9 55.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.239 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -119.17 161.33 20.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.222 0.534 . . . . 10.0 111.455 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -133.09 128.79 36.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.542 -0.754 . . . . 10.0 109.751 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt -113.24 122.16 46.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.751 0.31 . . . . 10.0 110.613 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.2 -15.16 21.42 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.716 -0.675 . . . . 10.0 113.185 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.54 -14.48 67.11 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.286 -0.483 . . . . 10.0 112.437 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.55 40.84 2.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 10.0 113.009 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -159.93 89.9 1.85 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.066 0.46 . . . . 10.0 111.458 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -86.05 160.26 10.14 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.575 2.183 . . . . 10.0 110.836 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.94 -156.43 13.52 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.016 -1.088 . . . . 10.0 112.446 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -124.3 171.36 9.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.225 -0.287 . . . . 10.0 110.225 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.68 141.1 8.73 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.802 -0.713 . . . . 10.0 111.7 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.16 132.71 68.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.279 0.561 . . . . 10.0 111.015 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 71.0 t -128.14 126.09 65.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.476 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' B' ' 51' ' ' ALA . 28.7 t -68.84 146.96 52.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.93 7.37 43.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.104 0.478 . . . . 10.0 110.35 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -114.32 -50.86 2.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.936 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -101.49 31.71 3.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.828 0.347 . . . . 10.0 111.919 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -133.35 149.32 72.12 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.768 -0.196 . . . . 10.0 110.56 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 16.9 Cg_exo -66.47 142.56 65.84 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.784 2.323 . . . . 10.0 112.654 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -65.86 -24.36 66.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.771 -0.649 . . . . 10.0 110.31 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -56.69 -30.7 63.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.544 -0.753 . . . . 10.0 110.987 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.66 -37.25 11.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.387 . . . . 10.0 110.392 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 66.0 mt -63.64 -37.87 88.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 10.0 111.436 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -70.89 -16.32 62.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 10.0 111.242 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -86.33 -37.17 18.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 10.0 110.275 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.51 -41.13 80.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.931 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -85.62 100.16 11.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.156 0.503 . . . . 10.0 110.357 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -109.67 157.36 19.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.659 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -69.51 136.19 51.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.65 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 67.04 48.86 1.18 Allowed 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.758 0.662 . . . . 10.0 110.021 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.656 -0.688 . . . . 10.0 110.568 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.1 mt -109.59 145.32 36.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.961 0.41 . . . . 10.0 110.098 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -117.99 137.15 53.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.527 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.97 138.69 31.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.909 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.06 117.67 11.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.542 . . . . 10.0 110.932 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.36 -49.31 67.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.076 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -138.04 170.3 16.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.554 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.72 133.93 47.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.626 -0.509 . . . . 10.0 109.626 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.487 ' CE1' HG21 ' B' ' 24' ' ' THR . 32.6 t80 -110.84 120.99 44.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.009 0.433 . . . . 10.0 111.337 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -89.12 120.48 30.55 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.69 155.62 31.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.054 0.454 . . . . 10.0 111.181 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.514 HH21 ' HA ' ' B' ' 64' ' ' LYS . 6.5 ttm180 -110.32 -41.44 4.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.449 -0.796 . . . . 10.0 110.119 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.75 -160.86 0.86 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.072 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.5 -3.29 31.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.094 0.473 . . . . 10.0 110.145 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.58 -44.02 13.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.384 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.58 129.74 34.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.419 -0.81 . . . . 10.0 109.587 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.8 tp -80.68 125.26 29.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.672 -0.694 . . . . 10.0 111.947 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.46 131.49 34.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.402 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -147.26 167.61 23.81 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.983 0.42 . . . . 10.0 111.541 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -106.25 164.01 12.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.849 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.01 132.88 51.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.359 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.82 -5.23 66.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.629 -0.796 . . . . 10.0 113.962 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -78.32 155.04 30.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.07 0.435 . . . . 10.0 111.192 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -122.54 141.68 51.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.898 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.75 155.42 50.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.786 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -99.19 120.5 39.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.8 -0.636 . . . . 10.0 109.621 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.47 120.33 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.053 -0.522 . . . . 10.0 110.889 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.7 mt -93.53 -46.61 7.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.691 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -135.19 103.71 5.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.172 0.51 . . . . 10.0 111.05 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.92 -11.81 27.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.78 -0.645 . . . . 10.0 110.859 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.07 0.16 54.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.398 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.1 -32.9 74.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.218 0.532 . . . . 10.0 110.5 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 144.99 -110.03 0.54 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.913 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.09 -50.86 3.53 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.09 -0.337 . . . . 10.0 110.09 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.472 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 54.2 m95 -82.81 107.11 15.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.751 -1.203 . . . . 10.0 107.751 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -89.18 146.02 25.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.151 0.5 . . . . 10.0 111.553 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -86.69 115.91 24.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.83 154.94 41.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.112 0.482 . . . . 10.0 111.474 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.6 ttp85 -109.6 125.37 52.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.657 -0.701 . . . . 10.0 109.487 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.2 t -61.6 131.06 48.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.577 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.35 -6.22 58.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.832 -0.622 . . . . 10.0 109.783 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.26 -63.02 1.49 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.523 -0.762 . . . . 10.0 109.954 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.7 p -104.24 -61.14 1.48 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.691 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 149.83 -7.98 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.919 -0.582 . . . . 10.0 111.826 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.06 134.36 21.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.088 0.47 . . . . 10.0 111.879 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -116.69 132.45 56.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.306 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.24 -178.25 43.08 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.275 -0.964 . . . . 10.0 112.629 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -78.71 126.44 30.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.17 -0.307 . . . . 10.0 110.17 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.4 pt -112.84 135.69 21.63 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 10.0 111.127 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.454 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 34.8 Cg_endo -69.25 116.57 4.57 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.558 2.172 . . . . 10.0 111.518 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -14.36 60.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.695 -0.684 . . . . 10.0 112.35 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.513 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 38.4 p-10 -89.45 -3.34 58.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.452 -0.34 . . . . 10.0 111.032 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.448 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 11.2 m-85 -113.4 6.48 17.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.704 0.288 . . . . 10.0 111.223 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.5 m -129.64 150.58 34.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.937 0.399 . . . . 10.0 111.196 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.88 145.4 57.3 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.183 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.47 124.72 13.26 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.489 2.126 . . . . 10.0 111.82 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.403 -0.808 . . . . 10.0 110.158 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.638 0.256 . . . . 10.0 110.533 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.27 157.8 23.41 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.9 0.381 . . . . 10.0 110.922 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.9 m -96.74 131.35 43.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.684 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -103.38 138.32 28.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.07 0.462 . . . . 10.0 111.158 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -99.74 127.77 45.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.633 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -135.54 175.96 9.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.846 0.355 . . . . 10.0 111.002 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -120.97 106.48 11.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.571 . . . . 10.0 109.801 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -94.11 95.59 9.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.678 -0.489 . . . . 10.0 109.678 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 59.64 34.65 22.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.773 -0.649 . . . . 10.0 111.053 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.29 -24.82 29.83 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.808 -0.633 . . . . 10.0 112.49 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.96 111.32 18.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.75 0.31 . . . . 10.0 110.914 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -76.35 121.17 22.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.416 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -135.55 162.27 33.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.485 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -126.4 121.95 33.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.561 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 82.1 t -131.94 142.66 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 110.148 -0.315 . . . . 10.0 110.148 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 23.6 m-20 -70.1 141.79 52.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.898 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 tt -61.98 -26.2 39.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.961 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -17.93 64.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.094 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -99.87 3.16 44.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.681 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 65.1 mt -91.91 128.84 43.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.123 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 t -75.09 -63.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.097 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -138.6 152.51 48.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.471 -0.331 . . . . 10.0 110.86 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' B' ' 59' ' ' LEU . 18.8 t -131.33 138.49 53.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.3 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . 0.487 HG21 ' CE1' ' A' ' 93' ' ' TYR . 8.7 m -143.09 125.6 15.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.201 0.524 . . . . 10.0 111.25 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.499 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 40.9 ttp85 -105.39 155.64 18.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.939 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -121.77 -34.95 3.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.702 0.287 . . . . 10.0 111.742 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.85 27.23 1.95 Allowed Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 110.241 -1.144 . . . . 10.0 110.241 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -152.64 -57.82 0.14 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.161 -1.052 . . . . 10.0 108.161 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' B' ' 47' ' ' SER . 42.0 mt-30 -142.93 142.05 31.61 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.667 -1.151 . . . . 10.0 109.569 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -95.46 130.11 44.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 24.8 m-85 -114.23 139.58 49.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.546 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . 0.417 ' N ' ' HE1' ' A' ' 119' ' ' TRP . 42.8 p90 -152.0 160.85 43.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 10.0 111.149 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -123.13 132.92 54.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.362 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -126.12 167.43 15.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.945 0.402 . . . . 10.0 111.491 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -137.66 129.37 28.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.359 -0.837 . . . . 10.0 109.437 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 96.8 mt -101.44 143.85 30.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 10.0 111.077 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.51 -3.21 53.3 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.904 -0.589 . . . . 10.0 112.59 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.92 -8.57 87.55 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.933 -0.651 . . . . 10.0 112.068 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.72 42.5 3.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.265 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -163.77 114.7 0.99 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.711 0.291 . . . . 10.0 110.905 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.06 169.47 8.8 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.737 2.291 . . . . 10.0 111.311 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.51 -177.63 37.3 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.003 -1.094 . . . . 10.0 112.965 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 43.5 m-85 -132.23 164.5 26.23 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.87 150.43 22.09 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.488 -0.863 . . . . 10.0 112.183 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.52 139.2 28.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.101 0.477 . . . . 10.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.22 133.69 55.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.77 -0.65 . . . . 10.0 109.73 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.416 ' HA ' ' HG2' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -80.77 134.21 35.77 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.838 0.351 . . . . 10.0 110.516 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -77.7 41.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.769 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.27 -62.26 0.54 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.509 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -29.53 61.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.864 -0.607 . . . . 10.0 112.033 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -88.31 136.16 32.07 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.474 -0.33 . . . . 10.0 111.314 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 52.9 Cg_exo -56.75 144.17 87.83 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.832 2.355 . . . . 10.0 112.197 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -61.64 -26.04 67.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 10.0 112.074 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -33.57 71.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 10.0 110.064 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 mt -80.96 -39.57 25.82 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.185 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -64.05 -38.64 91.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.62 -0.718 . . . . 10.0 110.962 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -71.93 -15.07 62.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 10.0 111.032 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -81.82 -24.27 35.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.316 0.579 . . . . 10.0 109.47 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.479 ' HB3' HG11 ' B' ' 23' ' ' VAL . 64.0 mt -89.07 -52.5 5.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.33 -0.85 . . . . 10.0 111.352 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . 0.499 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 28.9 tt0 -86.38 106.08 17.17 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.337 0.589 . . . . 10.0 110.228 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -107.25 164.38 12.22 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.333 -0.849 . . . . 10.0 109.21 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -59.2 128.99 39.93 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.181 0.301 . . . . 10.0 110.906 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 66.95 75.88 0.3 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.372 -0.831 . . . . 10.0 110.676 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.514 ' HA ' HH21 ' A' ' 96' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.496 -0.764 . . . . 10.0 110.284 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 121.215 0.531 . . . . 10.0 110.809 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.0 mt -104.13 136.88 42.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.108 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.22 137.04 54.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.935 0.397 . . . . 10.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.16 140.78 31.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.353 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 119.91 17.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.026 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.462 ' O ' ' HE2' ' A' ' 105' ' ' LYS . 71.2 mt -72.0 -36.77 69.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.405 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -141.63 169.92 16.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.789 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.33 149.29 40.68 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -124.08 124.73 43.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.107 0.48 . . . . 10.0 111.985 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.43 98.12 9.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.308 -0.86 . . . . 10.0 109.097 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.49 155.51 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.608 -0.724 . . . . 10.0 112.191 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -114.4 -32.8 5.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.306 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.26 -166.52 1.66 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.272 -0.171 . . . . 10.0 110.844 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.4 -1.21 51.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 10.0 109.908 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.57 -42.45 16.76 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.065 -0.717 . . . . 10.0 109.065 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -91.82 138.41 31.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.946 -1.025 . . . . 10.0 109.894 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.1 tp -100.64 133.16 45.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.914 -0.585 . . . . 10.0 111.633 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.22 147.13 27.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.539 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -152.72 162.66 40.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.646 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -101.47 163.86 12.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.735 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 90' ' ' LEU . 57.7 tttm -60.97 118.71 7.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.767 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.92 -0.25 31.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.678 -0.773 . . . . 10.0 112.641 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 2.3 tp10 -68.4 141.31 55.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.584 0.23 . . . . 10.0 110.74 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -120.67 134.8 55.26 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 107' ' ' GLU . 0.5 OUTLIER -128.29 157.57 40.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.317 0.579 . . . . 10.0 111.919 -178.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -99.88 110.16 22.52 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.935 -1.135 . . . . 10.0 107.935 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.6 mm -64.35 116.64 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.299 -0.409 . . . . 10.0 111.651 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.6 mt -104.12 -57.7 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.563 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -117.65 112.9 21.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.355 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.58 -17.59 3.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.21 0.448 . . . . 10.0 112.21 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.2 m -83.14 -6.26 59.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.032 0.382 . . . . 10.0 112.032 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.11 -53.29 39.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 10.0 110.55 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.421 ' HA3' ' CD1' ' B' ' 43' ' ' PHE . . . -167.17 -159.14 12.25 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.451 -0.66 . . . . 10.0 111.451 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.69 -34.56 74.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.929 0.395 . . . . 10.0 110.689 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -86.07 112.69 21.5 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.781 -0.822 . . . . 10.0 108.781 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -91.17 145.7 24.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.927 -0.578 . . . . 10.0 111.471 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -108.66 115.85 30.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.075 -1.083 . . . . 10.0 108.075 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.1 164.64 26.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.064 0.459 . . . . 10.0 111.903 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.95 127.77 51.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.778 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.7 t -65.72 135.11 54.52 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.311 -0.404 . . . . 10.0 109.919 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.4 mt -82.3 -15.46 52.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.183 0.516 . . . . 10.0 109.806 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.8 m -79.85 -67.94 0.72 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.476 -0.784 . . . . 10.0 111.556 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 p -92.21 -34.68 14.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.151 0.426 . . . . 10.0 112.151 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.3 -4.97 35.45 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.628 -0.796 . . . . 10.0 112.071 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -63.75 141.61 58.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.681 0.277 . . . . 10.0 110.695 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.7 m -117.75 133.13 56.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.859 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -172.86 -178.57 42.99 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.799 -0.715 . . . . 10.0 112.093 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -78.66 131.39 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 10.0 110.498 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.0 pt -123.06 136.71 27.21 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.513 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 137' ' ' TYR . 26.4 Cg_endo -64.66 117.44 4.51 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.46 2.107 . . . . 10.0 111.563 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.72 -19.41 65.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 10.0 112.363 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.424 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 36.0 p-10 -87.05 0.46 55.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.405 -0.361 . . . . 10.0 111.338 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 13.2 m-85 -116.28 -0.08 12.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.697 0.284 . . . . 10.0 111.223 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.35 151.94 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.906 0.384 . . . . 10.0 111.451 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.45 150.17 62.86 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.266 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.14 142.63 97.45 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.686 2.257 . . . . 10.0 112.348 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.459 -0.782 . . . . 10.0 110.809 -179.667 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 20.3 ttt . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.571 0.224 . . . . 10.0 110.667 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.6 161.09 26.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.733 0.302 . . . . 10.0 110.952 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 7.1 m -100.73 133.28 45.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.388 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 21.0 t -115.42 138.8 44.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.002 0.43 . . . . 10.0 111.488 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -96.5 135.01 38.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.853 -0.612 . . . . 10.0 109.678 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.85 -179.51 6.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.816 0.341 . . . . 10.0 110.703 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.442 ' HE2' ' OE2' ' B' ' 12' ' ' GLU . 66.9 mttt -117.53 141.79 47.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.147 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -146.85 110.82 5.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.595 -0.275 . . . . 10.0 110.716 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm 67.5 1.89 2.71 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.937 0.773 . . . . 10.0 111.969 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.77 -52.57 0.82 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.668 -0.777 . . . . 10.0 112.096 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.49 145.35 47.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.866 0.365 . . . . 10.0 110.323 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.442 ' OE2' ' HE2' ' B' ' 7' ' ' LYS . 21.7 mt-10 -90.92 122.46 33.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.811 -0.631 . . . . 10.0 109.866 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -116.33 157.34 25.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.641 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -128.45 118.21 22.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.319 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 46.8 t -134.56 149.38 29.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.487 -0.56 . . . . 10.0 109.487 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 18.8 m-20 -68.26 138.38 55.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.715 0.293 . . . . 10.0 110.518 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 tt -62.54 -24.54 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 2.4 m -72.46 -9.2 58.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.082 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -106.6 11.8 30.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.338 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' B' ' 34' ' ' TYR . 67.6 mt -99.48 137.43 26.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 10.0 109.996 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 6.8 t -77.92 -74.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.777 0.322 . . . . 10.0 111.059 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -126.97 155.17 43.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.423 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.26 125.4 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.34 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -120.05 118.41 30.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.14 0.495 . . . . 10.0 111.464 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 40.5 ttp85 -104.81 144.17 32.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.142 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -115.36 -26.52 7.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.611 0.243 . . . . 10.0 111.131 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.71 14.57 8.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.401 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -145.24 -52.79 0.28 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.818 -0.808 . . . . 10.0 108.818 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -142.47 135.39 28.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.814 -1.085 . . . . 10.0 109.519 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 61.3 mt -93.02 133.52 33.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.212 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 53.3 m-85 -119.89 137.94 53.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.47 174.31 13.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.087 0.47 . . . . 10.0 111.383 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -126.95 126.45 43.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.315 -0.857 . . . . 10.0 109.399 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' B' ' 20' ' ' ILE . 53.9 p90 -116.12 159.03 22.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 10.0 111.223 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -126.26 115.83 20.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.434 -0.803 . . . . 10.0 109.775 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.41 137.41 32.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.005 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.36 -13.54 58.36 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.912 -0.586 . . . . 10.0 112.807 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.03 2.65 83.39 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.179 -0.534 . . . . 10.0 112.368 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.49 46.02 5.35 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.917 -0.659 . . . . 10.0 112.873 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -152.62 95.3 3.09 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.713 0.292 . . . . 10.0 111.211 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.49 150.88 25.33 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.931 2.421 . . . . 10.0 110.9 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.16 -170.9 22.59 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.044 -1.074 . . . . 10.0 112.885 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . 0.421 ' CD1' ' HA3' ' A' ' 117' ' ' GLY . 24.4 m-85 -126.6 165.8 18.5 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.56 -0.533 . . . . 10.0 109.56 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.45 149.48 20.08 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.251 -0.976 . . . . 10.0 112.553 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.1 p -125.53 138.1 55.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.092 0.473 . . . . 10.0 110.85 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 74.7 t -125.76 118.85 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.002 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 118.74 15.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.572 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.73 -7.93 43.6 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.648 0.61 . . . . 10.0 112.648 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -103.75 -24.18 13.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.84 0.311 . . . . 10.0 111.84 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.38 -42.37 6.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.361 0.504 . . . . 10.0 112.361 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.96 146.81 87.97 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.686 -0.233 . . . . 10.0 111.547 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.63 147.42 91.94 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.693 2.262 . . . . 10.0 111.467 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -60.61 -24.77 65.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -59.11 -44.16 91.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.872 0.368 . . . . 10.0 110.641 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 79.1 mt -72.45 -35.79 68.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.431 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.49 -42.0 92.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.745 -0.661 . . . . 10.0 111.487 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -78.05 -16.92 57.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 10.0 110.909 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -79.46 -45.92 18.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.551 -0.537 . . . . 10.0 109.551 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.79 -47.78 61.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.593 -0.73 . . . . 10.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -82.62 98.74 9.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.007 0.432 . . . . 10.0 110.453 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -96.22 144.2 26.63 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.844 -0.616 . . . . 10.0 109.919 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -61.89 130.88 47.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.968 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 67.58 97.38 0.06 Allowed 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.981 0.8 . . . . 10.0 111.23 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.637 -0.697 . . . . 10.0 110.302 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.632 0.253 . . . . 10.0 110.985 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.7 mt -108.49 140.23 42.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.559 -0.291 . . . . 10.0 110.361 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -112.33 130.05 56.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.209 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -109.1 140.38 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.234 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.26 121.36 19.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.84 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.6 -32.67 62.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.338 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.8 168.15 24.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.483 -0.781 . . . . 10.0 109.502 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.77 139.58 40.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.744 -0.465 . . . . 10.0 109.744 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -101.84 128.56 48.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.834 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -77.84 101.37 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.681 -0.69 . . . . 10.0 109.353 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.28 141.37 19.35 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.633 0.583 . . . . 10.0 111.661 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -106.93 -58.5 1.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.661 -0.7 . . . . 10.0 111.03 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 p -131.83 -165.86 1.64 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.958 -0.565 . . . . 10.0 110.346 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -89.32 -6.73 56.47 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.13 -0.693 . . . . 10.0 109.13 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -76.42 -45.14 32.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.045 -0.98 . . . . 10.0 110.006 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -82.5 152.86 25.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.466 -0.788 . . . . 10.0 110.149 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.406 HD11 ' HB2' ' A' ' 129' ' ' GLU . 22.8 tp -89.82 132.2 35.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.345 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 m -91.15 126.16 36.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.751 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -146.83 165.49 29.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.828 0.346 . . . . 10.0 111.218 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -118.33 166.51 12.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.166 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.2 tttm -66.52 132.25 47.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.942 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.56 -6.16 52.3 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.835 -0.698 . . . . 10.0 112.71 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -81.54 150.35 28.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 10.0 111.415 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -113.16 128.24 56.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.745 -0.662 . . . . 10.0 109.225 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -120.25 144.47 47.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.9 0.381 . . . . 10.0 111.216 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -99.08 110.66 23.22 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 16.9 mm -66.22 118.63 9.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.334 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.13 -37.72 18.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.083 -0.508 . . . . 10.0 109.896 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -153.57 112.37 3.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.968 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.47 2.59 47.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.274 0.559 . . . . 10.0 110.656 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.91 20.07 1.94 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.794 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.61 -42.89 17.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.274 0.559 . . . . 10.0 110.159 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 138.5 -70.79 0.46 Allowed Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.702 -0.681 . . . . 10.0 111.82 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -122.76 -69.0 0.85 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.709 -0.478 . . . . 10.0 109.709 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.499 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 40.0 m95 -78.35 100.84 6.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.444 -0.947 . . . . 10.0 108.444 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -88.34 156.26 19.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.057 -0.52 . . . . 10.0 111.941 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -84.56 122.9 29.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.404 -0.817 . . . . 10.0 109.028 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.25 153.13 43.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.238 0.542 . . . . 10.0 112.107 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -114.06 123.29 49.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.072 -0.967 . . . . 10.0 109.128 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 t -67.22 131.36 45.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.955 0.407 . . . . 10.0 110.016 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.4 mt -83.1 -21.28 33.73 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.31 -55.15 6.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.077 -0.965 . . . . 10.0 111.075 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.4 p -94.58 -67.17 0.87 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.766 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.29 -2.2 3.83 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.824 -0.91 . . . . 10.0 110.824 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.406 ' HB2' HD11 ' A' ' 101' ' ' LEU . 40.8 mt-10 -68.66 148.05 50.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.294 -0.453 . . . . 10.0 110.738 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.2 m -120.91 138.71 53.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.233 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.85 -175.05 47.49 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.571 -0.823 . . . . 10.0 112.159 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -88.79 135.7 33.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.615 0.245 . . . . 10.0 110.69 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.0 pt -125.78 143.96 46.84 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.192 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.513 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 56.9 Cg_endo -73.16 121.45 7.25 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.396 2.064 . . . . 10.0 111.347 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.18 -1.65 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.513 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 36.8 p-10 -96.33 0.55 50.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.794 0.33 . . . . 10.0 110.768 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -119.7 1.03 11.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.035 0.445 . . . . 10.0 111.202 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.63 154.33 36.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.37 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.15 147.13 42.83 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.804 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.29 142.85 42.23 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.438 2.092 . . . . 10.0 111.512 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.406 -0.807 . . . . 10.0 110.143 179.947 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.309 0.1 . . . . 10.0 110.828 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.03 171.23 11.26 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.751 0.31 . . . . 10.0 110.883 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m -107.72 129.16 55.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.34 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -102.85 137.39 31.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 10.0 110.722 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -101.94 137.32 40.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 10.0 110.417 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -145.55 168.13 21.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.254 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.45 85.14 2.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -67.77 96.38 0.56 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.356 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt 58.94 26.33 14.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.353 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.26 -27.23 9.66 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.973 -0.632 . . . . 10.0 112.703 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -76.87 114.03 15.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.693 0.283 . . . . 10.0 111.204 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.03 109.75 7.78 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.772 -0.455 . . . . 10.0 109.772 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -131.08 157.38 43.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.55 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -129.42 132.02 46.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.847 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 90.8 t -136.99 147.13 27.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.413 ' HB2' ' HD2' ' B' ' 19' ' ' LYS . 18.1 m-20 -61.16 135.99 57.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 10.0 110.783 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.4 tt -60.6 -31.4 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.492 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -5.49 39.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.165 -0.471 . . . . 10.0 111.584 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.413 ' HD2' ' HB2' ' B' ' 16' ' ' ASP . 80.9 mttt -105.29 9.99 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.21 0.529 . . . . 10.0 110.618 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 78.7 mt -95.55 121.7 46.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.39 -60.0 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.69 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.22 151.53 45.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.852 0.358 . . . . 10.0 111.318 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 t -127.02 138.41 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.278 -0.873 . . . . 10.0 109.564 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -136.91 118.6 15.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.977 0.418 . . . . 10.0 111.04 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 35.1 ttp85 -109.03 141.1 41.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.409 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -115.92 -26.06 7.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.339 -0.391 . . . . 10.0 111.168 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.64 29.76 2.81 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.748 . . . . 10.0 111.452 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -157.52 -53.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -139.23 129.88 25.95 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.283 -0.871 . . . . 10.0 109.806 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mt -88.98 117.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -104.97 139.12 40.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.688 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.81 166.19 32.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.724 0.297 . . . . 10.0 110.939 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -127.63 135.91 50.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.097 -0.501 . . . . 10.0 109.837 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -122.11 165.15 16.53 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.483 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -136.32 121.81 19.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.844 -0.616 . . . . 10.0 110.331 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 66.1 mt -98.11 142.38 29.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.875 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.38 -14.99 62.94 Favored Glycine 0 C--N 1.329 0.148 0 CA-C-N 116.095 -0.502 . . . . 10.0 112.815 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.64 11.94 54.2 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.659 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.3 51.1 6.28 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.889 -0.672 . . . . 10.0 111.766 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 tptt -138.93 90.46 12.2 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 121.072 -0.251 . . . . 10.0 110.987 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -89.05 110.02 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.771 2.314 . . . . 10.0 110.467 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.63 -177.86 15.18 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.124 -1.036 . . . . 10.0 112.897 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 23.0 m-85 -120.8 166.74 13.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.785 -0.45 . . . . 10.0 109.785 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.35 142.8 12.02 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.827 -0.702 . . . . 10.0 112.169 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.68 129.25 51.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.844 0.354 . . . . 10.0 110.43 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -126.07 127.19 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.204 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.15 127.94 34.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.457 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -83.73 26.06 0.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -137.69 -50.54 0.61 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -95.64 19.86 10.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.34 144.14 48.32 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.614 -0.267 . . . . 10.0 110.456 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.41 138.45 47.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.025 2.483 . . . . 10.0 112.248 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -60.7 -27.55 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.982 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.83 -38.1 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.716 0.293 . . . . 10.0 111.134 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.19 -39.85 78.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.382 . . . . 10.0 110.035 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 21.9 mt -67.84 -39.72 83.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.588 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -66.93 -31.61 72.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.266 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.42 -8.6 59.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.003 0.43 . . . . 10.0 110.748 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 25.5 mt -96.09 -45.56 6.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.791 0.293 . . . . 10.0 111.791 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -91.54 131.84 36.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 10.0 111.213 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -123.86 163.57 20.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 10.0 109.487 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -74.35 131.99 41.62 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.893 -0.323 . . . . 10.0 110.613 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 mttp 64.0 62.52 0.87 Allowed 'General case' 0 C--O 1.236 0.38 0 O-C-N 123.921 0.763 . . . . 10.0 110.746 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.496 -0.764 . . . . 10.0 110.254 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.753 0.311 . . . . 10.0 110.552 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.4 mt -88.09 160.79 17.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.309 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.18 135.92 55.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.505 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 p -111.05 139.29 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.553 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.99 124.63 25.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.162 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.411 ' O ' ' HE2' ' A' ' 105' ' ' LYS . 59.6 mt -83.51 -33.37 25.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.531 . . . . 10.0 110.607 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -139.61 154.57 47.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.962 -0.563 . . . . 10.0 109.812 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.01 150.42 42.43 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.619 -0.512 . . . . 10.0 109.619 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -138.02 133.93 34.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.629 0.252 . . . . 10.0 110.518 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.65 132.45 46.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.15 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.497 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -91.88 148.76 21.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.015 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 96' ' ' ARG . 5.4 ttm180 -119.8 -21.37 7.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.345 0.593 . . . . 10.0 109.968 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.55 -178.48 4.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.005 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -94.17 8.56 41.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.358 0.599 . . . . 10.0 110.143 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.69 -44.14 7.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.303 -0.862 . . . . 10.0 109.521 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 95' ' ' ALA . 15.9 p-10 -88.39 151.21 22.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.411 -0.813 . . . . 10.0 109.053 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 tp -112.0 129.12 56.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.984 0.421 . . . . 10.0 112.057 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.497 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -84.28 139.36 32.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.124 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.402 ' CB ' ' HZ ' ' A' ' 109' ' ' PHE . 31.3 p90 -155.2 170.81 20.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.841 0.353 . . . . 10.0 111.225 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -114.91 157.61 23.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.71 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 90' ' ' LEU . 54.8 tttm -62.32 131.99 51.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.664 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.71 -19.73 23.3 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.546 -0.835 . . . . 10.0 112.863 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -77.15 148.98 35.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.98 0.419 . . . . 10.0 110.834 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -114.68 144.09 43.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.122 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.402 ' HZ ' ' CB ' ' A' ' 103' ' ' PHE . 32.1 m-85 -129.51 153.91 47.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.963 0.411 . . . . 10.0 111.306 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -100.1 114.35 27.64 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 46.9 mm -69.35 119.15 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.904 0.383 . . . . 10.0 111.142 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.4 mt -85.37 -52.58 5.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.648 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -135.92 109.1 7.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.877 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.36 -8.08 39.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.225 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.27 21.22 9.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.45 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 119' ' ' TRP . 19.4 tp10 -67.59 -43.39 80.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.645 -0.707 . . . . 10.0 110.356 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 155.28 -106.54 0.3 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.833 -0.698 . . . . 10.0 111.887 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -99.4 -11.44 21.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.213 0.53 . . . . 10.0 109.971 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.482 ' O ' ' HB3' ' A' ' 116' ' ' GLU . 39.9 m95 -124.64 159.71 30.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.155 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -119.85 139.99 51.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.943 0.401 . . . . 10.0 111.88 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -90.23 116.11 27.97 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.786 -1.19 . . . . 10.0 107.786 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.91 160.61 30.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.643 0.735 . . . . 10.0 112.579 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -116.31 128.29 55.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.67 -1.15 . . . . 10.0 109.226 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t -66.43 133.16 49.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.81 0.338 . . . . 10.0 111.101 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.8 mt -92.04 -11.23 36.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.432 0.634 . . . . 10.0 109.362 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -50.47 8.48 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.347 -0.842 . . . . 10.0 110.537 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.0 p -111.05 -55.89 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.099 0.476 . . . . 10.0 111.298 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.1 -8.54 4.44 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.908 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -55.73 146.82 20.18 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.05 0.452 . . . . 10.0 111.843 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.83 142.62 46.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.329 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.92 173.47 42.51 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.419 -0.896 . . . . 10.0 112.076 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -84.79 131.34 34.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.019 0.438 . . . . 10.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.0 pt -115.51 144.53 32.61 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.547 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.469 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 19.6 Cg_exo -63.89 114.53 2.64 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.849 1.7 . . . . 10.0 111.141 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.1 -14.2 15.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.559 -0.746 . . . . 10.0 112.46 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.405 ' ND2' ' HB2' ' B' ' 26' ' ' TYR . 23.0 p-10 -104.27 12.88 33.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.424 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 134' ' ' PRO . 8.8 m-85 -120.82 3.34 10.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.747 0.308 . . . . 10.0 111.163 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 m -128.84 148.44 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.945 0.402 . . . . 10.0 111.12 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -128.9 141.44 41.71 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.292 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.02 137.02 43.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.654 2.236 . . . . 10.0 111.973 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 64.3 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.397 -0.811 . . . . 10.0 109.785 179.678 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.668 0.271 . . . . 10.0 110.398 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.52 147.58 28.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.863 0.364 . . . . 10.0 110.866 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.8 m -97.84 132.33 43.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.419 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 48.5 t -104.46 131.62 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.867 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -98.42 131.62 44.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.677 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -145.42 -174.07 4.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.742 0.306 . . . . 10.0 110.809 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -130.2 123.96 31.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.895 -0.593 . . . . 10.0 109.841 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . 0.481 ' O ' ' HG2' ' B' ' 11' ' ' GLU . 17.9 t80 -102.17 94.05 5.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.869 0.366 . . . . 10.0 110.122 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 60.44 13.4 4.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.639 -0.71 . . . . 10.0 112.156 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.68 -35.87 2.0 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.38 -0.914 . . . . 10.0 113.159 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' B' ' 8' ' ' TYR . 12.0 pt-20 -82.57 136.66 34.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.159 0.479 . . . . 10.0 111.062 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -83.62 138.59 33.28 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -148.3 150.48 33.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.894 0.378 . . . . 10.0 111.386 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -123.47 110.82 15.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.126 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . 0.436 HG11 ' HB2' ' B' ' 34' ' ' TYR . 60.2 t -125.44 141.51 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.162 -0.472 . . . . 10.0 109.835 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 29.9 m-20 -66.97 145.25 55.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.117 0.484 . . . . 10.0 111.786 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.6 tt -58.88 -30.14 42.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.401 -0.818 . . . . 10.0 112.318 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 5.8 m -74.04 -10.65 59.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.778 0.323 . . . . 10.0 111.417 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.3 2.58 39.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.237 0.541 . . . . 10.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -99.3 110.48 26.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.537 -0.756 . . . . 10.0 109.289 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.422 ' H ' HG23 ' B' ' 21' ' ' VAL . 2.9 t -62.19 -78.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.698 -0.683 . . . . 10.0 112.14 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -114.57 144.8 42.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 10.0 111.202 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 t -131.68 140.93 47.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 56.1 m -144.93 125.87 14.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.216 0.532 . . . . 10.0 111.376 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.452 ' HG3' ' OE1' ' B' ' 48' ' ' GLU . 27.6 ttp85 -108.42 152.59 24.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.373 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . 0.405 ' HB2' ' ND2' ' A' ' 136' ' ' ASN . 19.2 t80 -129.63 -18.31 3.53 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.874 -0.33 . . . . 10.0 111.745 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.46 3.14 25.8 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.316 -0.945 . . . . 10.0 111.325 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -128.02 -52.27 1.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.405 -0.591 . . . . 10.0 109.405 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -150.97 143.32 24.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.373 -0.83 . . . . 10.0 109.941 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mt -95.02 132.68 38.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.331 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -118.9 142.68 47.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.308 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -162.14 168.82 21.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.807 0.336 . . . . 10.0 111.193 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -123.9 133.56 53.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.476 -0.564 . . . . 10.0 109.476 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . 0.436 ' HB2' HG11 ' B' ' 15' ' ' VAL . 51.4 p90 -113.88 147.54 38.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.977 0.418 . . . . 10.0 110.739 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -122.94 121.76 36.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.641 -0.708 . . . . 10.0 109.531 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' B' ' 40' ' ' LYS . 96.5 mt -97.84 136.85 37.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.817 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.3 -18.18 64.88 Favored Glycine 0 C--N 1.33 0.202 0 CA-C-N 116.068 -0.515 . . . . 10.0 112.194 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.57 -8.63 87.56 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.793 -0.718 . . . . 10.0 111.913 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 64.85 1.05 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.76 -0.734 . . . . 10.0 112.471 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . 0.533 ' HB3' HD12 ' B' ' 36' ' ' LEU . 36.8 tttp -160.34 85.47 1.97 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.047 0.451 . . . . 10.0 110.371 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -84.34 136.07 6.46 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.668 2.245 . . . . 10.0 111.667 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.37 -176.92 29.97 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.532 -0.842 . . . . 10.0 112.101 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -113.13 168.83 9.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.303 -0.258 . . . . 10.0 110.303 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.03 138.77 7.08 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.463 -0.655 . . . . 10.0 111.463 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.44 135.28 64.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.88 0.372 . . . . 10.0 110.424 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 81.1 t -127.67 129.11 70.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.574 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.9 t -75.78 126.98 32.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.226 -0.443 . . . . 10.0 109.903 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' B' ' 25' ' ' ARG . 52.8 mt-10 -76.45 2.46 13.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.955 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -124.37 -34.71 2.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.595 -0.275 . . . . 10.0 111.497 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -84.47 -24.28 29.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.735 0.302 . . . . 10.0 111.557 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.35 146.87 32.07 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.747 0.308 . . . . 10.0 111.038 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.63 156.23 66.88 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.704 2.269 . . . . 10.0 111.759 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.401 ' HD3' HD12 ' B' ' 56' ' ' LEU . 74.3 mmtt -60.57 -25.96 66.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.375 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -51.39 -40.85 60.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.666 -0.697 . . . . 10.0 111.385 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.21 -40.53 14.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.027 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.401 HD12 ' HD3' ' B' ' 53' ' ' LYS . 54.8 mt -60.89 -37.18 81.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.7 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -74.52 -11.53 60.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.603 -0.271 . . . . 10.0 111.342 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -94.42 -19.16 20.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.097 0.475 . . . . 10.0 110.05 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -95.14 -7.94 37.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.229 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -79.92 71.35 6.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.616 -0.72 . . . . 10.0 109.781 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' B' ' 64' ' ' LYS . 82.3 mttt -72.39 102.71 3.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.589 -0.732 . . . . 10.0 110.076 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -70.68 150.96 45.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.401 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 67.59 33.85 4.86 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.739 0.78 . . . . 10.0 109.791 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' B' ' 61' ' ' LYS . 11.5 tptp . . . . . 0 C--O 1.251 1.172 0 CA-C-N 114.642 -1.163 . . . . 10.0 108.783 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.592 0.234 . . . . 10.0 110.553 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -107.86 137.94 44.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.964 0.411 . . . . 10.0 110.876 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -116.41 142.24 47.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.526 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.6 p -110.47 140.34 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.534 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.76 126.21 30.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.888 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.76 -31.95 35.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.019 0.438 . . . . 10.0 110.164 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -141.29 168.76 19.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.67 -0.696 . . . . 10.0 109.442 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.19 138.83 35.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.336 -0.393 . . . . 10.0 109.946 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -112.65 127.17 56.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.098 0.475 . . . . 10.0 111.67 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -95.94 118.09 31.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.371 -0.974 . . . . 10.0 108.371 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.87 153.26 36.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.98 0.419 . . . . 10.0 111.236 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -118.08 -35.9 3.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.946 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.44 171.79 7.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.985 0.421 . . . . 10.0 110.343 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -84.32 20.01 1.75 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.738 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.74 -36.04 3.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.161 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -83.3 141.05 32.11 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.923 -0.769 . . . . 10.0 108.923 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.0 tp -97.65 126.94 43.24 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.407 0.521 . . . . 10.0 112.407 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.4 146.97 25.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 10.0 109.839 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -155.61 168.39 27.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.674 0.274 . . . . 10.0 111.014 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -105.8 160.6 15.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.916 -0.583 . . . . 10.0 110.434 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -64.9 126.43 27.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.115 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.38 -9.07 38.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.641 -0.79 . . . . 10.0 113.278 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -77.8 151.45 33.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.269 0.534 . . . . 10.0 111.147 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -118.42 133.52 55.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.684 . . . . 10.0 109.971 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.26 152.56 45.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.784 0.326 . . . . 10.0 110.56 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -95.0 115.35 27.31 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.948 -0.76 . . . . 10.0 108.948 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.6 mm -69.5 120.18 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.862 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.1 mt -89.43 -55.93 3.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.148 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -134.74 108.63 8.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.34 4.71 41.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.642 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -95.4 8.53 42.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.031 -0.532 . . . . 10.0 111.541 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.21 74.55 3.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.312 0.577 . . . . 10.0 110.842 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.473 ' O ' ' HE2' ' B' ' 9' ' ' LYS . . . 68.04 -132.53 28.55 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.776 -0.726 . . . . 10.0 112.127 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -112.32 8.62 19.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.022 0.439 . . . . 10.0 110.798 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -120.44 104.76 10.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.262 -1.014 . . . . 10.0 108.262 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 4.6 m0 -83.35 135.56 34.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.869 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -92.41 112.56 24.55 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.462 -1.31 . . . . 10.0 107.462 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.75 169.26 11.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.012 0.434 . . . . 10.0 111.806 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -120.52 126.04 49.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.544 -0.753 . . . . 10.0 109.765 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.2 t -65.24 135.31 55.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.399 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.02 -12.38 44.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.056 0.455 . . . . 10.0 110.2 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.35 -48.02 11.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.693 -0.685 . . . . 10.0 111.126 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 80.8 p -105.98 -43.61 4.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.995 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.52 3.88 28.75 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.605 -0.807 . . . . 10.0 111.729 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -74.12 144.88 44.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 10.0 110.576 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -118.44 139.5 51.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.921 -0.582 . . . . 10.0 110.811 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.95 177.17 45.69 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.798 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.32 129.41 35.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.7 pt -113.67 136.78 22.03 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.719 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.57 107.16 0.82 Allowed 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.494 2.129 . . . . 10.0 111.752 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -7.69 10.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.791 -0.64 . . . . 10.0 112.227 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -96.11 1.22 52.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.833 0.349 . . . . 10.0 110.701 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -111.5 -14.45 13.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.093 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.6 m -114.1 160.62 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.108 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -143.42 152.66 57.63 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.448 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.12 144.56 87.43 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.272 1.981 . . . . 10.0 111.632 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.416 -0.802 . . . . 10.0 110.176 -179.982 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.524 0.202 . . . . 10.0 110.609 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.01 169.96 23.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.931 0.396 . . . . 10.0 111.48 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 7.4 m -104.95 136.01 45.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.895 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 44.3 t -109.86 132.47 58.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.763 0.316 . . . . 10.0 110.91 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -99.31 127.04 45.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.272 -0.64 . . . . 10.0 109.272 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.468 ' CD2' ' HZ ' ' B' ' 32' ' ' PHE . 41.3 p90 -141.96 175.88 9.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.441 -0.345 . . . . 10.0 111.009 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -109.72 146.91 34.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.88 92.78 2.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.473 ' HE2' ' O ' ' A' ' 117' ' ' GLY . 5.1 mmtm 61.57 30.35 18.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.287 -0.87 . . . . 10.0 111.668 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.83 -51.88 0.72 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.908 -0.663 . . . . 10.0 113.469 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -74.18 142.66 45.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.959 0.409 . . . . 10.0 111.198 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -92.94 130.49 38.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.953 -0.567 . . . . 10.0 109.79 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.47 157.26 35.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.568 -0.287 . . . . 10.0 110.916 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -129.32 113.28 14.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.549 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.14 149.5 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.273 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 5.1 m-20 -64.99 142.82 58.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.656 -0.247 . . . . 10.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 12.0 tt -65.96 -24.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.48 0.657 . . . . 10.0 110.041 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -4.06 33.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.322 -0.853 . . . . 10.0 111.068 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -110.97 15.08 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.539 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 71.3 mt -95.91 133.15 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.257 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -80.99 -52.58 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.066 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -152.15 155.3 37.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.367 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.59 125.83 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 123.547 0.529 . . . . 10.0 110.464 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 4.2 m -116.82 105.95 12.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.871 0.367 . . . . 10.0 111.453 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.552 ' HD2' ' OE2' ' B' ' 48' ' ' GLU . 0.3 OUTLIER -94.82 136.99 34.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.354 -0.384 . . . . 10.0 110.091 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -116.48 -21.47 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.887 0.375 . . . . 10.0 111.16 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.82 4.59 39.3 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.081 -0.808 . . . . 10.0 111.081 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -134.12 -47.41 0.78 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -149.44 132.69 16.43 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.988 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -87.17 123.65 40.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.245 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.81 132.67 53.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.86 -0.609 . . . . 10.0 109.612 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . 0.468 ' HZ ' ' CD2' ' B' ' 6' ' ' PHE . 43.4 p90 -150.77 169.46 21.61 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.431 -0.508 . . . . 10.0 111.985 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -122.04 138.87 54.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.357 -0.838 . . . . 10.0 109.459 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -133.67 165.65 24.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 10.0 111.697 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.32 121.38 15.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.707 -0.678 . . . . 10.0 110.112 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' B' ' 40' ' ' LYS . 24.9 mt -96.08 129.67 43.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.616 -0.265 . . . . 10.0 110.415 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.6 106.23 1.31 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.095 -0.574 . . . . 10.0 111.869 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.77 -7.83 1.73 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.976 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.54 36.27 3.84 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.52 -0.847 . . . . 10.0 112.991 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 79.5 tttt -135.42 67.72 67.18 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.113 0.457 . . . . 10.0 111.274 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -90.74 171.65 3.35 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.499 2.133 . . . . 10.0 112.015 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.8 -158.73 31.54 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.413 -0.898 . . . . 10.0 112.394 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -121.37 178.33 4.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.515 0.198 . . . . 10.0 110.517 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.51 150.5 19.68 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.654 -0.784 . . . . 10.0 111.957 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.55 130.8 69.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.188 0.518 . . . . 10.0 110.974 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 5.0 t -118.57 122.78 70.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.828 -0.623 . . . . 10.0 109.748 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.7 t -69.77 133.18 47.16 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.154 -0.313 . . . . 10.0 110.154 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.552 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 44.0 mt-10 -87.24 15.95 5.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.944 0.402 . . . . 10.0 110.389 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -122.92 -62.79 1.32 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.605 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.35 36.33 0.69 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 10.0 112.194 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.66 143.72 36.34 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.316 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.75 143.1 85.58 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.618 2.212 . . . . 10.0 112.095 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -59.79 -23.13 63.03 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.582 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -52.93 -50.88 63.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.685 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 75.6 mt -77.2 -34.86 56.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.695 0.283 . . . . 10.0 110.933 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.81 -42.0 98.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.391 -0.368 . . . . 10.0 111.553 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -73.9 -31.48 63.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.008 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -71.59 -33.78 69.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.462 -0.335 . . . . 10.0 110.394 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 20.5 mt -74.46 -44.54 51.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.677 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -79.19 87.43 4.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.177 0.513 . . . . 10.0 110.625 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -89.76 145.45 25.18 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.924 -0.58 . . . . 10.0 109.777 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -68.21 140.52 56.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.522 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.7 mttt 62.31 79.48 0.26 Allowed 'General case' 0 C--O 1.232 0.18 0 O-C-N 123.835 0.71 . . . . 10.0 110.233 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.221 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.833 0.349 . . . . 10.0 110.703 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.06 154.94 24.15 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.747 -0.464 . . . . 10.0 109.747 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -121.65 136.17 54.95 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.2 -0.296 . . . . 10.0 110.2 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.27 138.96 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.61 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.43 122.57 22.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.208 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.2 mt -77.78 -35.12 51.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.801 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -142.78 163.88 31.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 10.0 110.273 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.31 131.41 42.64 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -102.8 123.68 46.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.048 0.452 . . . . 10.0 111.688 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -88.29 105.81 17.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.802 -0.814 . . . . 10.0 108.802 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.99 156.99 37.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.355 0.598 . . . . 10.0 111.96 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -118.46 -44.08 2.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.67 -0.695 . . . . 10.0 111.059 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -121.89 -160.83 0.89 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.511 -0.313 . . . . 10.0 110.979 -178.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.404 ' H ' ' HB ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -98.35 -16.33 19.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.271 0.558 . . . . 10.0 109.54 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.86 -44.74 69.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.159 -0.928 . . . . 10.0 110.26 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.46 146.04 31.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.559 -0.746 . . . . 10.0 109.958 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.7 tp -96.77 124.9 40.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.31 -0.405 . . . . 10.0 111.816 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.24 129.42 34.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.297 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -144.29 164.53 30.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.892 0.377 . . . . 10.0 111.13 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -106.05 160.78 15.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.515 -0.766 . . . . 10.0 110.111 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -65.22 130.75 44.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.588 -0.278 . . . . 10.0 110.755 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.06 -15.34 51.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.681 -0.771 . . . . 10.0 113.175 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -71.43 152.22 43.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.899 0.381 . . . . 10.0 111.102 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -114.03 139.81 48.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.75 -0.659 . . . . 10.0 110.21 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.0 157.64 45.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 10.0 111.018 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -108.94 117.95 35.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.306 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.423 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . 23.8 mm -69.09 123.76 23.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.231 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 mt -98.17 -37.86 9.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.483 -0.326 . . . . 10.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -142.38 100.87 3.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.79 0.329 . . . . 10.0 111.364 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.75 -5.5 26.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.447 0.641 . . . . 10.0 110.34 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.78 8.71 24.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.078 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -72.9 -35.61 67.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.705 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 146.63 -127.26 2.68 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.719 -0.673 . . . . 10.0 111.454 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -49.74 22.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.933 0.396 . . . . 10.0 110.186 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.522 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 23.5 m95 -87.69 134.81 33.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.8 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 20.0 m0 -110.69 147.69 33.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.921 0.391 . . . . 10.0 111.18 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -99.03 120.57 39.67 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.423 ' HB2' ' HA ' ' A' ' 111' ' ' ILE . . . -139.89 166.37 24.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.846 0.355 . . . . 10.0 111.401 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -116.25 140.12 49.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.1 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.1 t -74.46 148.95 40.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.676 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.18 -24.7 18.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.568 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -45.08 48.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.729 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 p -104.35 -63.7 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.696 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.33 -13.01 5.72 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.748 -0.739 . . . . 10.0 112.037 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -57.15 144.42 34.97 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.858 0.361 . . . . 10.0 111.333 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.2 m -118.47 126.33 51.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.759 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -162.9 -174.58 32.97 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.564 -0.827 . . . . 10.0 111.675 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -82.19 130.1 35.0 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.145 -0.317 . . . . 10.0 110.145 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 pt -121.43 140.8 32.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.797 0.332 . . . . 10.0 110.821 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.56 119.64 6.68 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.666 2.244 . . . . 10.0 111.832 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.69 -18.97 65.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 10.0 111.749 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -88.92 7.09 36.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.389 -0.368 . . . . 10.0 111.422 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -123.85 8.04 8.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.179 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.2 m -131.33 151.72 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.992 0.425 . . . . 10.0 111.576 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -133.68 144.37 51.69 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.294 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.73 134.35 43.5 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.608 2.205 . . . . 10.0 112.41 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.434 -0.794 . . . . 10.0 110.445 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ttt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.525 0.203 . . . . 10.0 110.656 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.02 165.52 27.21 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.592 0.234 . . . . 10.0 110.673 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.92 137.75 32.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.903 -0.589 . . . . 10.0 110.958 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 88.2 t -108.55 128.74 63.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.358 -0.383 . . . . 10.0 110.159 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -93.82 121.95 35.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -132.09 170.97 14.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.486 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -117.44 97.07 5.69 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.193 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -80.98 72.47 8.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm 59.16 66.97 0.96 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.306 -0.861 . . . . 10.0 110.955 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.96 -46.3 2.27 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.832 -0.699 . . . . 10.0 113.02 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.32 117.88 19.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 10.0 111.333 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -88.53 116.36 26.71 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.274 -0.639 . . . . 10.0 109.274 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -124.24 160.1 28.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.885 0.374 . . . . 10.0 111.299 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -127.3 118.05 23.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.515 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.5 144.46 37.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.261 -0.427 . . . . 10.0 109.874 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.83 135.69 57.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.499 -0.318 . . . . 10.0 110.388 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 tt -63.75 -22.42 30.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.298 0.57 . . . . 10.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -9.45 59.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.935 -0.575 . . . . 10.0 111.131 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -101.47 11.23 39.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.303 0.573 . . . . 10.0 110.314 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 78.1 mt -98.73 129.95 48.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.34 -0.845 . . . . 10.0 109.654 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 7.2 t -76.65 -75.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.335 -0.393 . . . . 10.0 111.331 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -120.49 153.41 36.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.796 0.332 . . . . 10.0 110.781 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.34 129.2 56.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.869 -0.605 . . . . 10.0 110.511 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 19.5 m -121.44 112.13 18.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.197 0.522 . . . . 10.0 110.861 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.483 ' HG3' HG12 ' B' ' 30' ' ' ILE . 52.0 ttp85 -100.71 133.72 44.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.314 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -103.65 -19.01 14.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.984 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.96 -18.86 14.18 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.115 -0.794 . . . . 10.0 111.115 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -114.04 -61.4 1.75 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -118.67 143.57 46.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.368 -0.833 . . . . 10.0 109.523 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.483 HG12 ' HG3' ' B' ' 25' ' ' ARG . 1.9 mt -106.14 119.31 55.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.033 -0.531 . . . . 10.0 109.908 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -105.24 135.46 46.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.347 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -151.26 165.84 32.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.861 0.362 . . . . 10.0 111.438 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 133.55 54.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.409 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -123.73 166.2 15.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.517 -0.311 . . . . 10.0 110.699 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -139.6 115.81 10.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.164 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -82.55 145.53 29.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.837 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.47 -18.81 73.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.039 -0.601 . . . . 10.0 112.669 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.34 19.86 7.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.024 -0.608 . . . . 10.0 112.887 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.03 51.7 17.34 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.929 -0.653 . . . . 10.0 112.349 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -150.36 96.04 3.49 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.881 0.372 . . . . 10.0 111.286 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.84 154.13 13.24 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.412 2.074 . . . . 10.0 110.76 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.79 -172.11 31.85 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 119.573 -1.299 . . . . 10.0 113.034 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . 0.522 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 15.6 m-85 -133.07 166.89 21.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.685 -0.487 . . . . 10.0 109.685 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.66 146.43 14.48 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.628 -0.796 . . . . 10.0 111.767 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 3.6 p -129.68 127.63 64.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.303 0.573 . . . . 10.0 110.784 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.58 132.08 67.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.282 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 14.6 t -88.67 125.38 34.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.668 0.27 . . . . 10.0 110.388 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -68.97 -17.28 63.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.046 0.451 . . . . 10.0 111.587 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -100.47 16.75 23.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.671 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -133.26 -53.3 0.9 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.903 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.06 152.64 76.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.024 -0.534 . . . . 10.0 111.371 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.442 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 32.0 Cg_endo -63.4 154.08 70.54 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.82 2.346 . . . . 10.0 112.951 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -57.76 -34.12 69.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.459 -0.791 . . . . 10.0 112.082 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -54.15 -44.97 71.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.961 0.356 . . . . 10.0 111.961 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.6 -39.22 70.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 10.0 110.98 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 18.0 mt -65.21 -43.05 92.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.771 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -69.44 -18.39 63.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.818 -0.628 . . . . 10.0 111.685 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -80.67 -25.42 38.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.893 0.378 . . . . 10.0 110.614 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 82.0 mt -83.67 -42.9 16.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.452 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . 0.471 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 1.1 tp10 -86.64 92.39 8.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 10.0 110.342 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -108.88 -177.65 3.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.404 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -80.18 138.19 36.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.262 -0.273 . . . . 10.0 110.262 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 57.4 39.09 28.47 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.43 0.633 . . . . 10.0 110.018 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-N 115.168 -0.924 . . . . 10.0 110.886 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 120.849 0.357 . . . . 10.0 110.441 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -84.79 129.59 34.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.976 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -121.06 145.42 47.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.762 -0.654 . . . . 10.0 109.673 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.23 139.6 42.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.956 0.407 . . . . 10.0 110.647 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.95 123.52 24.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.894 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.4 mt -71.2 -50.93 27.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.429 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -129.01 178.61 6.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.846 -0.615 . . . . 10.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.06 142.87 28.41 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -126.37 130.2 50.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.996 0.426 . . . . 10.0 110.751 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -93.73 116.99 29.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.521 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 137.85 56.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.144 0.497 . . . . 10.0 111.304 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' B' ' 21' ' ' VAL . 14.6 ttt180 -94.09 -40.7 9.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.455 -0.793 . . . . 10.0 110.306 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.9 p -131.95 -163.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.887 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -93.84 -2.49 53.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.238 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.5 -41.43 16.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.907 -0.588 . . . . 10.0 109.874 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -89.49 154.51 19.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.5 -0.773 . . . . 10.0 109.153 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.3 tp -107.62 134.52 50.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.197 0.443 . . . . 10.0 112.197 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.56 146.36 25.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.528 -0.76 . . . . 10.0 110.555 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -162.65 166.06 24.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.821 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -113.53 168.34 9.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.493 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -61.7 115.54 4.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.852 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.09 -1.2 25.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.637 -0.792 . . . . 10.0 112.696 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -67.99 137.92 55.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 10.0 110.947 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -102.2 130.58 48.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -120.47 144.73 47.83 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.098 0.777 . . . . 10.0 113.098 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -108.28 106.07 16.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.7 114.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.101 0.477 . . . . 10.0 111.578 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 mt -86.0 -48.67 8.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.571 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -138.95 104.41 5.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 10.0 111.182 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -15.45 37.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.281 0.562 . . . . 10.0 110.458 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.87 13.45 5.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.811 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.17 -45.38 73.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 10.0 110.471 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.99 -119.12 0.93 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.2 -0.76 . . . . 10.0 111.2 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -93.51 -27.73 16.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.296 0.569 . . . . 10.0 110.052 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.442 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 29.2 m95 -110.63 114.99 28.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.145 -1.057 . . . . 10.0 108.145 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -95.31 143.12 26.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.164 0.507 . . . . 10.0 111.353 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -90.89 121.64 32.91 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.52 -0.919 . . . . 10.0 108.52 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.14 164.34 27.57 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.815 0.341 . . . . 10.0 111.582 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -112.04 137.64 49.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.522 -0.763 . . . . 10.0 110.708 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.1 t -76.45 141.12 41.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.148 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.8 mt -93.21 2.97 56.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.451 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -105.14 -58.48 1.88 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.888 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.1 p -91.47 -39.14 12.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.218 0.532 . . . . 10.0 110.875 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 103.17 6.96 44.5 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.698 -0.683 . . . . 10.0 111.671 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -73.24 146.11 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.321 . . . . 10.0 110.663 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 91.0 m -126.83 134.5 50.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.366 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.63 -176.0 43.5 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.903 -0.665 . . . . 10.0 111.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -76.26 122.65 24.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.757 0.313 . . . . 10.0 110.181 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.3 pt -114.39 141.15 26.07 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.734 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.38 110.3 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.45 2.1 . . . . 10.0 111.591 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -12.11 22.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.973 -0.558 . . . . 10.0 112.13 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -93.93 0.29 56.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.884 0.373 . . . . 10.0 110.66 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.26 5.07 14.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.915 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.2 m -129.78 153.45 38.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.376 -0.374 . . . . 10.0 110.947 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.57 147.92 61.65 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.214 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.84 130.03 20.98 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.537 2.158 . . . . 10.0 112.083 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.356 -0.831 . . . . 10.0 109.898 179.657 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ttt . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 120.711 0.291 . . . . 10.0 110.68 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.12 168.17 25.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.777 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 0.1 OUTLIER -101.44 146.38 27.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.382 -0.372 . . . . 10.0 110.952 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.94 132.12 68.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.155 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -103.22 129.33 50.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.031 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 26.5 p90 -139.19 165.06 28.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.736 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -110.0 77.7 1.07 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.086 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -69.58 99.92 1.36 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.551 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 57.2 32.48 21.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.156 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.88 -28.53 14.95 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.756 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -81.76 113.01 19.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.662 0.231 . . . . 10.0 110.89 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 7.2 mt-10 -74.88 115.71 14.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -125.2 156.01 39.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.857 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -124.36 116.6 22.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.336 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.5 145.03 36.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.577 -0.527 . . . . 10.0 109.577 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 11.5 m-20 -61.92 138.88 58.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.963 0.411 . . . . 10.0 111.099 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 15.2 tt -63.64 -24.51 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.677 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 8.0 m -77.0 -3.5 39.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.619 -0.719 . . . . 10.0 111.007 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -111.37 13.46 21.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.212 0.529 . . . . 10.0 110.021 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -99.01 126.88 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.732 -0.667 . . . . 10.0 109.767 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . 0.479 ' O ' ' HD3' ' A' ' 96' ' ' ARG . 3.5 t -75.18 -64.38 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.755 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -134.99 153.46 52.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.593 -0.276 . . . . 10.0 111.121 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -132.96 137.5 53.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.237 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -135.24 121.9 20.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.999 0.428 . . . . 10.0 111.023 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.46 ' HG3' HG12 ' B' ' 30' ' ' ILE . 53.6 ttp85 -109.0 146.12 34.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.257 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -127.19 -15.54 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.958 0.409 . . . . 10.0 111.613 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.76 16.76 23.17 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.39 -0.91 . . . . 10.0 111.072 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -140.9 -53.73 0.48 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -145.5 130.99 18.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.318 -0.855 . . . . 10.0 109.816 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 9.4 mt -86.42 121.26 37.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.67 -0.493 . . . . 10.0 109.67 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -109.06 135.78 49.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.722 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . 0.419 ' N ' ' HE1' ' A' ' 119' ' ' TRP . 51.2 p90 -155.69 169.4 24.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.664 0.269 . . . . 10.0 110.704 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -128.34 135.29 49.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.254 -0.43 . . . . 10.0 109.969 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -114.08 168.01 10.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.755 0.312 . . . . 10.0 110.414 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -138.4 112.45 8.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.935 -0.575 . . . . 10.0 109.859 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 82.7 mt -93.55 132.49 37.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.441 -0.345 . . . . 10.0 110.945 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.2 -11.17 61.01 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.91 -0.586 . . . . 10.0 112.469 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.52 -19.54 68.99 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.359 -0.448 . . . . 10.0 112.217 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.97 43.77 1.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.68 -0.771 . . . . 10.0 112.641 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -170.13 111.07 0.46 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.827 0.346 . . . . 10.0 110.738 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -86.27 179.11 3.71 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.513 2.142 . . . . 10.0 110.883 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.64 172.56 43.86 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.079 -1.058 . . . . 10.0 112.276 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 29.9 m-85 -108.1 168.32 9.38 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.38 144.95 12.7 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.938 -0.649 . . . . 10.0 111.888 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 4.2 p -136.78 131.47 47.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.092 0.472 . . . . 10.0 110.876 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.9 121.98 65.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.855 -0.611 . . . . 10.0 109.934 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.39 101.33 3.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.668 0.27 . . . . 10.0 110.662 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -74.1 65.15 1.11 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.585 0.707 . . . . 10.0 110.417 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -166.24 -50.02 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.885 -1.052 . . . . 10.0 109.21 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.47 -28.33 15.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.054 -0.975 . . . . 10.0 111.249 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.66 153.09 73.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.135 -0.484 . . . . 10.0 111.202 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.03 142.64 94.1 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.701 2.267 . . . . 10.0 111.994 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -60.86 -26.03 67.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.812 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -56.84 -48.51 77.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.807 0.337 . . . . 10.0 110.904 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 99.0 mt -65.62 -32.97 74.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.837 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -71.91 -44.0 64.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.792 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -69.52 -31.89 70.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.854 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -78.48 -23.39 46.45 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.051 -0.26 . . . . 10.0 110.999 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' B' ' 59' ' ' LEU . 13.0 mt -83.68 -47.59 11.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.968 0.413 . . . . 10.0 110.391 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . 0.415 ' OE1' ' HE3' ' B' ' 64' ' ' LYS . 2.9 tp10 -84.74 87.84 7.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.362 0.601 . . . . 10.0 109.938 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' B' ' 64' ' ' LYS . 46.9 mtmt -93.0 169.78 10.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.18 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.7 mm-40 -76.11 121.37 22.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.7 0.286 . . . . 10.0 110.572 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 mttt 59.24 43.74 16.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.681 -0.691 . . . . 10.0 110.942 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' B' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.581 -0.723 . . . . 10.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.9 mt -88.68 150.8 22.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.982 0.42 . . . . 10.0 110.862 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -122.8 141.21 52.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.806 -0.633 . . . . 10.0 110.196 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.2 p -109.27 140.04 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.613 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.2 123.81 25.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.588 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.8 mt -78.74 -24.47 44.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.28 170.57 22.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.31 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.27 130.25 35.07 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -104.99 132.03 51.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.971 0.415 . . . . 10.0 111.64 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -89.83 118.77 29.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.506 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.12 158.63 24.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.14 0.495 . . . . 10.0 111.57 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -120.01 -44.62 2.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.554 -0.748 . . . . 10.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.89 -167.59 1.61 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.886 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -93.2 -2.62 55.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.1 0.476 . . . . 10.0 110.671 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.16 -37.58 20.01 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.276 0.56 . . . . 10.0 110.021 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -91.28 146.64 23.65 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.397 -0.964 . . . . 10.0 108.397 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.9 tp -111.36 123.49 50.31 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.568 0.581 . . . . 10.0 112.568 -177.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.83 133.4 36.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.938 -0.573 . . . . 10.0 109.731 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -140.39 163.03 33.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.803 0.335 . . . . 10.0 111.342 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -95.75 158.26 15.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.911 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -64.46 124.95 23.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.503 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.25 -3.01 56.58 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.853 -0.689 . . . . 10.0 113.201 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -74.0 154.6 39.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.937 0.398 . . . . 10.0 111.219 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -117.55 141.26 48.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.779 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.06 152.66 51.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 10.0 111.006 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.405 ' HB2' HD21 ' A' ' 125' ' ' LEU . 5.9 tp-100 -100.3 115.59 30.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.432 HG21 ' HB3' ' A' ' 114' ' ' SER . 10.9 mm -71.96 112.13 7.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.328 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.6 mt -84.57 -40.05 18.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.121 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -140.07 103.39 4.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.72 0.295 . . . . 10.0 111.3 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.432 ' HB3' HG21 ' A' ' 111' ' ' ILE . 2.2 p -105.01 0.08 27.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.294 0.569 . . . . 10.0 110.552 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.21 10.04 20.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.37 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.1 -58.34 3.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.546 0.689 . . . . 10.0 109.977 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 167.59 -118.75 0.8 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.3 -0.72 . . . . 10.0 111.3 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -76.71 -51.16 11.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.083 -0.339 . . . . 10.0 110.083 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -88.47 134.35 33.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.876 -0.787 . . . . 10.0 108.876 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -115.04 148.51 38.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 10.0 111.045 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -86.97 117.27 25.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.73 156.76 45.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.226 0.536 . . . . 10.0 111.662 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -112.54 126.75 55.68 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.985 -0.746 . . . . 10.0 108.985 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.3 t -62.8 136.63 57.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.387 -0.37 . . . . 10.0 110.181 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 110' ' ' GLN . 83.8 mt -84.66 -10.98 56.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.191 0.52 . . . . 10.0 109.829 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.78 -67.92 0.76 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.488 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.7 p -86.86 -46.59 9.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.444 . . . . 10.0 111.476 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 116.35 6.09 15.95 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.895 -0.669 . . . . 10.0 111.865 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -72.21 149.31 44.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.729 0.3 . . . . 10.0 110.759 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -115.71 135.0 54.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.347 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -174.62 179.79 45.71 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.925 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -86.78 136.3 33.04 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.0 -0.37 . . . . 10.0 110.0 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.3 pt -121.15 136.14 25.47 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.08 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 137' ' ' TYR . 19.2 Cg_endo -63.05 122.62 10.92 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.761 2.307 . . . . 10.0 111.869 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -17.74 64.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.85 -0.614 . . . . 10.0 112.238 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.472 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 45.3 p-10 -87.44 -5.79 58.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.959 0.409 . . . . 10.0 111.057 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.476 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 0.8 OUTLIER -105.27 -6.16 19.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.969 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.1 m -124.31 152.38 30.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.125 0.488 . . . . 10.0 111.356 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.61 152.89 67.37 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.545 -0.752 . . . . 10.0 110.163 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.68 156.08 63.35 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.335 2.024 . . . . 10.0 111.622 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.323 -0.846 . . . . 10.0 110.097 179.703 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.732 0.301 . . . . 10.0 110.302 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.1 168.07 13.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.127 0.489 . . . . 10.0 112.23 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.7 m -110.69 145.84 37.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.541 -0.754 . . . . 10.0 109.927 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 45.0 t -111.23 130.3 64.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.717 0.294 . . . . 10.0 111.333 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -103.57 120.49 40.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.662 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -134.33 169.53 17.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.919 0.39 . . . . 10.0 111.259 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.41 ' HG3' ' HG2' ' B' ' 12' ' ' GLU . 1.7 mttt -117.37 63.25 0.74 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.522 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -59.32 112.96 1.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.889 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 58.83 21.81 9.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.305 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.4 -5.99 63.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.951 -0.642 . . . . 10.0 112.454 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -94.72 119.08 32.75 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.89 -0.182 . . . . 10.0 110.844 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.41 ' HG2' ' HG3' ' B' ' 7' ' ' LYS . 2.9 mt-10 -72.23 113.98 9.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.946 -0.39 . . . . 10.0 109.946 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt -134.38 153.02 52.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.788 0.327 . . . . 10.0 110.837 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 1.5 mt-30 -124.8 120.28 31.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.165 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.0 t -128.93 143.36 41.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.058 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.18 136.22 57.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.04 -0.356 . . . . 10.0 110.04 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.83 -22.9 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.131 0.491 . . . . 10.0 111.206 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -10.25 57.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.635 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -106.65 16.03 25.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.346 . . . . 10.0 111.072 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 73.2 mt -103.07 133.92 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.083 -0.508 . . . . 10.0 109.765 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.95 -63.12 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.199 -0.455 . . . . 10.0 111.286 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -134.29 152.27 51.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.494 -0.321 . . . . 10.0 110.878 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.51 129.24 70.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.779 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 8.3 m -123.92 127.43 47.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.015 0.436 . . . . 10.0 111.895 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.412 ' HG3' ' OE1' ' B' ' 48' ' ' GLU . 14.4 ttp85 -121.68 144.98 48.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -125.26 -16.64 5.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.675 0.274 . . . . 10.0 111.707 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.31 31.79 4.52 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.307 -0.949 . . . . 10.0 111.064 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 mmtm -155.33 -56.49 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.576 0.75 . . . . 10.0 109.179 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -143.8 138.38 28.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.859 -1.064 . . . . 10.0 109.691 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -95.48 131.81 41.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.808 -0.441 . . . . 10.0 109.808 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 49.4 m-85 -123.21 141.21 52.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.441 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -153.77 173.21 16.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.5 -0.318 . . . . 10.0 111.13 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -130.88 132.8 45.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.581 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -125.44 164.53 20.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.149 0.5 . . . . 10.0 111.249 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -138.08 125.82 22.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.986 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 54.6 mt -100.7 135.54 41.99 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.16 -27.05 62.11 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.223 -0.513 . . . . 10.0 112.887 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.04 8.54 15.64 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.292 -0.48 . . . . 10.0 112.803 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.73 54.35 3.48 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.368 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -147.74 78.35 9.9 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.919 0.39 . . . . 10.0 110.861 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -85.56 148.53 9.94 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.826 2.35 . . . . 10.0 110.863 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.79 -164.78 26.09 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 119.805 -1.188 . . . . 10.0 112.857 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -122.2 177.55 5.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.842 -0.429 . . . . 10.0 109.842 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.62 139.44 6.63 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.768 -0.73 . . . . 10.0 112.119 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.88 128.83 71.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.12 0.486 . . . . 10.0 110.392 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.93 119.61 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.034 -0.53 . . . . 10.0 109.841 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.0 t -68.68 125.86 27.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.732 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.412 ' OE1' ' HG3' ' B' ' 25' ' ' ARG . 52.2 mt-10 -75.68 -2.08 27.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.006 0.431 . . . . 10.0 110.967 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -111.27 -39.67 4.65 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.287 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -85.52 -27.81 25.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.147 0.425 . . . . 10.0 112.147 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.88 146.25 31.74 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.938 -0.305 . . . . 10.0 111.017 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.12 154.39 57.76 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.711 2.274 . . . . 10.0 111.639 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -63.0 -25.18 68.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.363 -0.381 . . . . 10.0 111.164 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -56.2 -44.14 79.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 10.0 110.61 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mt -69.93 -41.1 75.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.786 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.1 -37.66 88.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.054 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -73.37 -25.25 60.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.161 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -79.75 -36.06 37.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.437 -0.347 . . . . 10.0 110.419 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.68 -45.69 50.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.505 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.99 111.62 19.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.96 0.409 . . . . 10.0 110.48 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.25 165.2 15.14 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.64 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.474 ' OE1' ' HG3' ' B' ' 63' ' ' LYS . 1.0 OUTLIER -58.73 139.22 56.5 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.366 0.416 . . . . 10.0 110.398 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.474 ' HG3' ' OE1' ' B' ' 62' ' ' GLN . 43.6 mttp 63.06 79.98 0.24 Allowed 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 123.718 0.636 . . . . 10.0 110.159 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.262 -0.875 . . . . 10.0 109.997 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.676 0.274 . . . . 10.0 110.397 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.51 133.59 36.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.084 0.468 . . . . 10.0 110.83 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -116.7 140.2 49.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.179 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.48 139.04 39.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.855 0.359 . . . . 10.0 110.439 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.83 121.69 18.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.93 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.01 -40.15 63.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.431 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -143.1 164.05 31.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.186 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.85 147.4 39.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -126.92 126.19 42.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.815 0.341 . . . . 10.0 110.883 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.08 113.92 20.94 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.834 -0.621 . . . . 10.0 109.459 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.31 149.0 49.96 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.47 0.481 . . . . 10.0 111.089 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.405 ' HE ' ' C ' ' B' ' 64' ' ' LYS . 0.0 OUTLIER -109.69 -37.35 5.69 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.148 -0.478 . . . . 10.0 111.079 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 p -129.37 -164.11 1.37 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.961 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 98' ' ' GLU . 1.3 pp20? -99.63 6.77 45.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.138 0.494 . . . . 10.0 110.521 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.35 -36.73 11.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.502 -0.772 . . . . 10.0 109.611 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -89.78 145.35 25.25 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 129' ' ' GLU . 9.4 tp -98.74 135.25 40.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.187 0.517 . . . . 10.0 112.043 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.94 134.17 33.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.361 -0.836 . . . . 10.0 110.123 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -147.46 164.92 31.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.797 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -118.98 172.27 7.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.929 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -60.02 118.65 6.54 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.383 -0.826 . . . . 10.0 111.359 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.33 -1.84 43.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.476 -0.869 . . . . 10.0 113.351 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.57 133.7 54.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.839 0.352 . . . . 10.0 111.437 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -94.5 121.09 35.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.689 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -115.88 134.49 54.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.66 0.615 . . . . 10.0 112.66 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -102.9 104.37 14.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.904 -1.146 . . . . 10.0 107.904 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.3 mm -62.44 117.62 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.327 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 123' ' ' ARG . 70.9 mt -94.35 -35.87 12.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.321 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -145.1 99.89 3.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.28 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.79 0.26 46.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.238 0.542 . . . . 10.0 110.252 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -88.3 -0.0 56.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.995 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -63.17 -46.82 85.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.185 0.517 . . . . 10.0 110.333 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.99 -116.75 0.74 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.991 -0.843 . . . . 10.0 110.991 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.78 -28.5 17.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.234 0.54 . . . . 10.0 110.149 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.595 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 17.9 m95 -105.03 110.32 22.67 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.351 -0.981 . . . . 10.0 108.351 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -93.9 154.92 17.45 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.749 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -98.92 122.94 42.82 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -136.3 161.86 34.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.327 0.584 . . . . 10.0 111.602 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.416 ' HB2' HD11 ' A' ' 112' ' ' LEU . 6.0 ttp180 -114.03 133.76 55.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.19 -0.914 . . . . 10.0 109.345 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.5 t -69.45 140.82 54.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.954 0.407 . . . . 10.0 110.507 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 99.2 mt -96.84 2.05 51.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.376 0.608 . . . . 10.0 109.848 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.09 -48.84 3.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.492 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 66.4 p -101.06 -42.8 6.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 10.0 110.842 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.69 -0.73 34.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.059 -0.591 . . . . 10.0 112.42 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 101' ' ' LEU . 32.1 mt-10 -67.26 150.23 49.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.736 0.303 . . . . 10.0 110.905 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.2 m -122.77 133.91 54.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.709 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.1 178.83 46.7 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.61 -0.805 . . . . 10.0 111.995 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -81.47 133.48 35.4 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.276 -0.268 . . . . 10.0 110.276 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.8 pt -128.07 145.54 55.77 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.85 0.357 . . . . 10.0 111.426 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.498 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 47.3 Cg_endo -72.08 127.5 12.88 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.577 2.185 . . . . 10.0 111.672 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.0 p -69.81 -16.09 63.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.96 -0.564 . . . . 10.0 112.267 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.498 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 38.0 p-10 -85.55 -0.45 55.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.692 0.282 . . . . 10.0 111.465 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.433 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 1.9 m-85 -115.58 3.91 14.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.53 -0.304 . . . . 10.0 111.246 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.81 144.65 37.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 10.0 111.105 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -132.77 144.01 51.08 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.085 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.3 132.05 26.56 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.536 2.157 . . . . 10.0 112.305 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.1 t . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.151 -0.928 . . . . 10.0 110.121 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.619 0.247 . . . . 10.0 110.747 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' B' ' 16' ' ' ASP . . . -153.76 128.57 9.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.47 -0.332 . . . . 10.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.9 108.18 19.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.608 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.05 130.78 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.62 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -95.32 132.15 40.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.45 -0.341 . . . . 10.0 110.281 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -145.25 170.18 16.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.186 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.416 ' HG2' ' HG2' ' B' ' 12' ' ' GLU . 98.9 mttt -120.7 105.82 11.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.16 -0.473 . . . . 10.0 109.788 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -99.99 111.71 24.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.894 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt 54.27 34.13 19.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.69 -0.686 . . . . 10.0 112.13 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.52 4.36 68.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.023 -0.608 . . . . 10.0 113.409 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -109.94 123.18 49.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.884 0.342 . . . . 10.0 110.644 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' B' ' 7' ' ' LYS . 39.0 mt-10 -76.14 121.18 22.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -134.44 153.45 51.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.897 0.38 . . . . 10.0 110.972 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.46 114.06 15.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.72 -0.673 . . . . 10.0 109.773 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.04 144.24 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.55 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' B' ' 2' ' ' ALA . 6.9 t70 -64.26 138.27 58.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.387 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' B' ' 20' ' ' ILE . 21.4 tt -61.29 -22.58 27.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.935 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -70.71 -19.65 62.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.7 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -93.99 1.01 56.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.133 0.492 . . . . 10.0 110.517 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' B' ' 17' ' ' ILE . 70.8 mt -94.2 123.97 46.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.725 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.59 -77.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.549 -0.296 . . . . 10.0 111.383 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -113.13 151.63 30.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.011 0.434 . . . . 10.0 111.308 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 32.3 t -129.32 142.01 45.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.421 -0.808 . . . . 10.0 109.983 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.1 m -134.5 122.89 23.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 10.0 111.402 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.48 ' HD2' ' OE2' ' B' ' 48' ' ' GLU . 0.8 OUTLIER -109.98 143.26 40.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.511 . . . . 10.0 110.164 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -124.35 -20.58 5.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.648 0.24 . . . . 10.0 111.648 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.34 22.18 8.84 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.744 -0.943 . . . . 10.0 110.744 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -146.38 -54.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.721 -0.844 . . . . 10.0 108.721 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -146.88 138.59 24.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.008 -0.997 . . . . 10.0 109.433 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 52.0 mt -94.27 126.89 46.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.971 -0.381 . . . . 10.0 109.971 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 18.9 m-85 -111.19 139.29 46.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.38 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -154.4 171.83 18.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.991 0.424 . . . . 10.0 111.273 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -130.32 135.68 48.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.854 -0.612 . . . . 10.0 109.594 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -121.58 156.83 32.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.065 0.46 . . . . 10.0 111.139 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -127.35 117.39 22.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.419 -0.81 . . . . 10.0 109.32 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.52 139.37 31.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.835 0.35 . . . . 10.0 111.319 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.52 -9.39 61.53 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.588 -0.733 . . . . 10.0 112.095 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.83 -8.17 67.6 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.215 -0.517 . . . . 10.0 111.999 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.64 32.5 7.23 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.951 -0.643 . . . . 10.0 112.149 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -153.64 103.38 2.53 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.682 0.277 . . . . 10.0 111.086 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -86.14 168.93 8.91 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.826 2.35 . . . . 10.0 111.44 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.63 -172.0 36.53 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.115 -1.04 . . . . 10.0 113.143 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 6.6 m-85 -123.63 166.2 15.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.855 -0.424 . . . . 10.0 109.855 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.0 150.57 22.13 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.471 -0.871 . . . . 10.0 112.345 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 p -132.67 132.9 59.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.968 0.413 . . . . 10.0 110.451 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.44 136.38 55.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.441 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 26.9 t -74.11 131.29 41.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.391 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.48 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 45.1 mt-10 -84.45 3.64 35.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.964 0.411 . . . . 10.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -119.43 -44.25 2.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.969 0.414 . . . . 10.0 111.068 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -78.72 -49.43 13.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.634 . . . . 10.0 112.481 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -67.23 151.13 97.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.34 . . . . 10.0 111.886 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 32.2 Cg_exo -61.15 142.22 96.1 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.954 2.436 . . . . 10.0 112.296 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -62.93 -23.08 67.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.626 . . . . 10.0 110.704 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.4 -44.99 80.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.155 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.3 -35.47 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.551 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.0 mt -62.03 -42.94 99.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.872 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -72.63 -17.37 61.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 10.0 111.158 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -85.93 -38.56 17.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.635 -0.506 . . . . 10.0 109.635 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 51.6 mt -68.41 -41.77 79.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.085 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.15 85.74 7.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.545 0.688 . . . . 10.0 109.645 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -81.62 131.18 35.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.307 -0.86 . . . . 10.0 109.761 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' B' ' 63' ' ' LYS . 83.9 mm-40 -58.59 127.18 30.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.816 -0.439 . . . . 10.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' B' ' 62' ' ' GLN . 78.8 mttt 74.24 51.92 0.1 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 124.105 0.878 . . . . 10.0 110.122 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.405 ' C ' ' HE ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.359 -0.829 . . . . 10.0 110.945 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.683 0.278 . . . . 10.0 111.035 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.3 mt -88.16 161.18 17.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.295 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -131.07 126.03 34.76 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.1 p -108.63 141.05 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.874 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.3 126.5 31.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.317 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 139' ' ' ALA . 30.0 mt -90.72 -20.62 22.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.013 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.4 159.92 41.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.029 -0.532 . . . . 10.0 109.585 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -85.9 145.4 27.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 10.0 109.868 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -143.37 130.87 21.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.032 0.444 . . . . 10.0 111.41 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.2 124.36 44.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.587 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.83 140.29 58.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.983 0.421 . . . . 10.0 111.234 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -104.86 -23.84 12.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.364 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.1 -166.41 1.79 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.262 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -17.97 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.838 0.351 . . . . 10.0 110.451 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -69.9 -45.55 67.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -87.43 163.26 16.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.615 -0.72 . . . . 10.0 109.61 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.3 tp -130.59 145.46 51.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.757 0.313 . . . . 10.0 111.381 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -81.61 145.77 30.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.829 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -157.23 154.45 29.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -105.17 159.39 15.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.8 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -63.3 116.78 5.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.597 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.5 -4.82 26.42 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.78 -0.724 . . . . 10.0 112.171 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -78.58 150.44 32.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.579 0.228 . . . . 10.0 110.441 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -121.64 143.1 49.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 10.0 110.85 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 159.47 41.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.577 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -103.64 116.38 32.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.045 -0.724 . . . . 10.0 109.045 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.2 mm -68.36 121.13 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.943 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.1 mt -94.73 -40.78 9.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.249 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.586 ' ND2' ' HG3' ' A' ' 116' ' ' GLU . 55.2 t30 -146.39 106.26 3.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.013 0.435 . . . . 10.0 111.24 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.19 0.47 31.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 10.0 110.615 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.18 5.73 47.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.915 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.586 ' HG3' ' ND2' ' A' ' 113' ' ' ASN . 3.4 mt-10 -78.99 -34.47 44.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.689 0.28 . . . . 10.0 111.358 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 156.89 -126.79 1.82 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.349 -0.929 . . . . 10.0 112.37 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -87.42 -43.75 11.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 10.0 110.817 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.424 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 44.2 m95 -88.39 113.35 23.9 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.123 -1.066 . . . . 10.0 108.123 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -95.0 150.78 19.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.181 0.515 . . . . 10.0 112.152 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -88.03 117.07 26.66 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.53 -1.285 . . . . 10.0 107.53 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.3 146.23 49.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.238 0.542 . . . . 10.0 112.228 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -100.39 119.18 38.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.37 -0.832 . . . . 10.0 109.307 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.5 t -60.93 138.22 58.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.847 0.356 . . . . 10.0 110.556 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.0 mt -91.71 2.03 56.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.314 0.578 . . . . 10.0 109.541 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.1 -61.09 1.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.313 -0.858 . . . . 10.0 110.723 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.5 p -100.7 -29.21 12.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.34 . . . . 10.0 111.322 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.25 0.74 54.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.663 -0.779 . . . . 10.0 112.346 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -74.11 154.26 39.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.793 0.33 . . . . 10.0 111.204 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.17 -178.2 3.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.997 -0.547 . . . . 10.0 109.841 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 145.22 168.05 12.69 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.097 -1.049 . . . . 10.0 112.714 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -85.23 124.62 32.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.829 0.347 . . . . 10.0 110.38 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.9 pt -120.48 147.59 45.75 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.382 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.73 125.51 10.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.337 2.025 . . . . 10.0 111.359 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -67.14 -12.64 60.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.326 0.491 . . . . 10.0 112.326 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -96.27 -9.46 30.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.629 0.252 . . . . 10.0 110.814 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -88.04 -12.92 42.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.277 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.9 m -121.42 169.9 12.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.639 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.519 ' HB2' HD11 ' A' ' 90' ' ' LEU . . . -139.29 141.13 28.17 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.994 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.69 131.48 21.42 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.459 2.106 . . . . 10.0 112.336 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.3 t . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.111 -0.947 . . . . 10.0 109.713 179.368 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.403 ' HB3' HG21 ' B' ' 17' ' ' ILE . 7.9 ttt . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.753 0.311 . . . . 10.0 111.254 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.82 171.93 15.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.802 0.334 . . . . 10.0 110.857 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 142.26 32.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.575 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.04 124.87 63.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.928 0.394 . . . . 10.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.65 132.49 46.01 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.734 . . . . 10.0 109.417 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -149.2 173.62 13.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.857 0.36 . . . . 10.0 110.876 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -119.62 85.41 2.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.911 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -73.93 95.8 2.53 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt 61.82 23.89 14.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.459 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.59 -18.33 32.48 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.537 -0.756 . . . . 10.0 112.114 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.63 113.28 9.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.765 0.317 . . . . 10.0 111.015 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -73.29 94.76 2.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.938 -0.573 . . . . 10.0 109.523 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -109.76 153.23 24.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.206 0.526 . . . . 10.0 111.974 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -130.9 105.47 7.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -119.93 146.88 24.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.688 0.28 . . . . 10.0 110.674 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.1 139.59 51.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.839 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.419 HD11 ' O ' ' B' ' 58' ' ' LYS . 13.7 tt -65.95 -18.88 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.467 0.651 . . . . 10.0 110.377 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.6 -4.43 59.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.492 -0.777 . . . . 10.0 111.321 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.67 9.09 39.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.071 0.463 . . . . 10.0 110.519 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 81.7 mt -95.51 125.24 48.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.909 -0.587 . . . . 10.0 109.963 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 t -71.84 -60.95 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.088 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -133.86 151.58 51.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.683 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 t -119.46 115.08 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 10.0 109.722 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 13.7 m -117.34 120.41 38.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.035 0.445 . . . . 10.0 111.823 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.413 ' HD2' ' CD ' ' B' ' 48' ' ' GLU . 4.0 ttp85 -109.06 121.71 45.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -83.52 -39.46 20.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.691 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.2 -2.61 5.87 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.73 -0.948 . . . . 10.0 110.73 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -139.5 -40.29 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.04 141.52 36.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.37 -0.832 . . . . 10.0 109.644 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 55.7 mt -96.33 129.79 45.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.686 -0.487 . . . . 10.0 109.686 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -118.78 136.09 54.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.357 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -153.4 171.46 18.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.818 0.342 . . . . 10.0 110.953 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -125.04 133.98 52.73 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -123.46 166.77 14.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.024 0.44 . . . . 10.0 111.152 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -128.33 157.98 39.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.299 -0.864 . . . . 10.0 109.099 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 mt -133.89 145.29 49.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.829 0.347 . . . . 10.0 111.009 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.83 -15.25 66.59 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.939 -0.648 . . . . 10.0 112.592 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.12 4.51 70.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.254 -0.498 . . . . 10.0 112.874 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.58 38.5 32.33 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.771 -0.728 . . . . 10.0 112.885 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -149.17 88.07 5.17 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 122.552 -0.381 . . . . 10.0 110.663 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -74.98 177.9 7.98 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.374 2.049 . . . . 10.0 111.075 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.72 -169.95 37.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.653 -1.26 . . . . 10.0 112.711 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 28.5 m-85 -117.05 160.33 21.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.898 -0.408 . . . . 10.0 109.898 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.02 141.43 12.12 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.669 -0.777 . . . . 10.0 112.237 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 p -135.77 128.79 47.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.95 0.405 . . . . 10.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 t -128.03 129.89 69.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.027 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' B' ' 51' ' ' ALA . 30.2 t -74.31 133.87 42.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.413 ' CD ' ' HD2' ' B' ' 25' ' ' ARG . 54.0 mt-10 -81.01 -1.21 43.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.176 0.512 . . . . 10.0 110.437 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -116.39 -49.77 2.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.947 -0.569 . . . . 10.0 110.579 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -90.92 45.37 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.783 -0.644 . . . . 10.0 111.973 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' B' ' 47' ' ' SER . . . -162.63 151.06 12.14 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.581 -0.282 . . . . 10.0 110.798 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.24 136.29 74.53 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.86 2.374 . . . . 10.0 112.348 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.84 -29.92 71.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.218 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -59.25 -41.27 88.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.992 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.4 mt -67.55 -36.12 80.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.873 0.368 . . . . 10.0 110.518 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -68.38 -39.8 81.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.136 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -72.49 -21.47 61.2 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.851 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . 0.419 ' O ' HD11 ' B' ' 17' ' ' ILE . 79.3 mttt -81.51 -32.02 32.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.166 -0.679 . . . . 10.0 109.166 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 21.6 mt -75.87 -58.93 2.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.895 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -80.17 115.7 19.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.141 0.496 . . . . 10.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mtmm -129.15 170.31 13.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.731 -0.668 . . . . 10.0 109.547 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -69.49 134.9 49.45 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.347 0.404 . . . . 10.0 110.059 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 66.48 54.8 0.86 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.435 0.636 . . . . 10.0 110.312 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.919 0 CA-C-N 115.56 -0.746 . . . . 10.0 110.539 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 120.903 0.382 . . . . 10.0 110.769 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.72 153.64 20.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -114.68 129.4 56.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.782 0.325 . . . . 10.0 110.509 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.8 142.2 18.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.989 -0.55 . . . . 10.0 110.171 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 130.8 43.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.642 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.9 -45.29 18.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.915 -0.584 . . . . 10.0 109.799 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -137.02 173.56 11.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.657 -0.702 . . . . 10.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.88 141.25 36.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.145 -0.48 . . . . 10.0 109.938 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -131.25 123.55 28.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.73 0.3 . . . . 10.0 111.186 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -92.12 133.44 35.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.52 155.05 20.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.164 0.507 . . . . 10.0 111.991 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.2 ttm-85 -110.6 -36.32 5.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.48 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.77 -159.79 0.9 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.449 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -98.58 -10.36 23.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.92 -50.2 15.65 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.367 -0.833 . . . . 10.0 109.596 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -83.65 134.66 34.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.342 -0.845 . . . . 10.0 108.839 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 tp -97.74 134.1 41.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.189 0.519 . . . . 10.0 112.378 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.23 135.1 34.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.418 -0.81 . . . . 10.0 110.199 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -146.87 158.63 43.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.081 0.467 . . . . 10.0 111.377 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -102.29 164.42 11.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.807 -0.633 . . . . 10.0 111.054 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -62.07 113.41 2.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.738 -0.665 . . . . 10.0 110.5 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.61 -1.32 24.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 10.0 112.783 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.57 147.94 51.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.608 0.242 . . . . 10.0 110.469 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -116.74 131.13 57.03 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.1 -0.333 . . . . 10.0 110.1 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -119.18 142.71 47.74 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.553 0.575 . . . . 10.0 112.553 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.641 ' HB2' HD21 ' A' ' 125' ' ' LEU . 6.0 tp-100 -95.0 126.4 40.32 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.477 -0.934 . . . . 10.0 108.477 177.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.4 mm -70.27 115.17 9.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.262 0.553 . . . . 10.0 112.025 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 123' ' ' ARG . 27.1 mt -108.64 -67.09 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.717 -0.674 . . . . 10.0 109.425 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 22.0 t30 -107.38 95.62 5.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.764 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.1 p -99.87 -21.21 15.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.2 0.524 . . . . 10.0 110.813 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.5 m -83.09 20.11 1.3 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.134 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -70.84 -40.22 72.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.139 0.495 . . . . 10.0 109.94 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 137.21 -62.16 0.59 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.597 -0.811 . . . . 10.0 112.321 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.05 -66.11 0.68 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.472 ' HH2' ' HG1' ' B' ' 24' ' ' THR . 24.4 m95 -78.98 115.27 18.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.033 -0.729 . . . . 10.0 109.033 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -90.56 144.42 25.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.98 0.419 . . . . 10.0 111.427 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 113' ' ' ASN . 28.3 tt0 -95.49 109.95 22.08 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.256 -1.016 . . . . 10.0 108.256 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.6 168.8 13.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.929 0.395 . . . . 10.0 111.681 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.484 ' HB2' HD11 ' A' ' 112' ' ' LEU . 69.9 ttp85 -119.04 134.55 55.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.1 t -70.45 137.13 50.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.367 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 110' ' ' GLN . 43.8 mt -84.91 -10.16 57.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.059 0.457 . . . . 10.0 110.006 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.7 m -94.46 -57.5 2.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.609 -0.723 . . . . 10.0 111.607 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 46.6 p -89.0 -35.62 16.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.865 0.364 . . . . 10.0 111.53 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.78 5.85 58.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.658 -0.782 . . . . 10.0 112.096 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -78.1 146.84 34.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.562 0.22 . . . . 10.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.4 m -119.46 132.78 55.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.342 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -174.53 -178.06 44.14 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.687 -0.768 . . . . 10.0 112.12 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -82.46 132.92 35.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.873 0.368 . . . . 10.0 110.622 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 26.1 pt -122.6 142.65 37.97 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.048 -0.524 . . . . 10.0 110.842 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 133' ' ' ILE . 13.4 Cg_exo -69.15 122.12 8.96 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.61 2.207 . . . . 10.0 111.701 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -18.36 65.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.981 -0.554 . . . . 10.0 112.159 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -88.97 -1.84 58.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.478 -0.328 . . . . 10.0 111.232 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -115.51 5.41 14.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.67 0.271 . . . . 10.0 111.429 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.2 m -132.22 157.42 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.744 0.307 . . . . 10.0 110.78 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.57 143.22 19.36 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.314 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.96 143.29 72.09 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.357 2.038 . . . . 10.0 112.085 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.532 -0.747 . . . . 10.0 110.103 179.55 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.514 0.197 . . . . 10.0 111.033 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.67 168.82 18.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.938 0.399 . . . . 10.0 111.381 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.4 142.23 34.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.32 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 21.2 t -110.32 137.53 42.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.704 0.288 . . . . 10.0 110.781 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.73 121.53 42.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.582 -0.525 . . . . 10.0 109.582 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 33.6 p90 -130.88 171.47 13.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.059 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -114.41 93.0 4.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 10.0 109.998 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.16 94.65 6.69 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.982 -0.287 . . . . 10.0 110.227 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm 55.15 31.98 17.48 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.73 -0.668 . . . . 10.0 111.15 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.01 -24.69 20.74 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.903 -0.665 . . . . 10.0 112.719 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -85.92 108.87 18.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.859 0.33 . . . . 10.0 110.749 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 11.3 mt-10 -82.41 113.4 20.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.984 0.421 . . . . 10.0 110.853 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -132.61 157.09 45.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.391 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 52.4 mt-30 -115.9 127.54 55.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.86 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 91.0 t -131.78 147.15 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.33 139.04 57.39 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.683 -0.235 . . . . 10.0 110.556 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 20.6 tt -66.5 -21.11 28.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.381 0.61 . . . . 10.0 109.791 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.09 -15.17 60.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.538 -0.755 . . . . 10.0 110.663 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -95.37 0.49 53.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.158 0.504 . . . . 10.0 110.235 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mt -102.61 106.82 20.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.009 -0.541 . . . . 10.0 109.861 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -65.14 -78.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.774 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -110.1 141.41 43.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.042 0.449 . . . . 10.0 111.756 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.418 ' O ' ' HD3' ' B' ' 64' ' ' LYS . 58.7 t -125.79 114.89 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.327 -0.852 . . . . 10.0 109.247 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . 0.472 ' HG1' ' HH2' ' A' ' 119' ' ' TRP . 30.1 m -103.93 116.85 33.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.363 0.602 . . . . 10.0 111.973 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 33.8 ttp85 -107.56 137.72 45.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.593 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -111.79 -20.19 12.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.747 0.308 . . . . 10.0 111.678 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.1 -0.49 31.46 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.986 -0.846 . . . . 10.0 110.986 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -134.12 -42.25 0.81 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.158 -0.521 . . . . 10.0 109.89 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -147.82 133.78 19.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.205 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 68.0 mt -94.13 133.96 33.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.501 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -127.59 120.71 28.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.14 -0.482 . . . . 10.0 109.785 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -136.28 168.02 20.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.89 0.376 . . . . 10.0 111.336 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -122.96 126.46 47.24 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.933 -0.766 . . . . 10.0 108.933 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -122.02 156.65 33.04 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.072 0.463 . . . . 10.0 111.57 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -104.99 151.73 23.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.364 -0.834 . . . . 10.0 109.819 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 13.1 mt -135.88 133.93 38.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.781 0.324 . . . . 10.0 111.102 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.06 -10.69 69.13 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.764 -0.653 . . . . 10.0 112.624 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.94 -15.36 74.01 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.969 -0.634 . . . . 10.0 111.773 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.65 -3.02 45.71 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.749 -0.739 . . . . 10.0 112.991 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -131.56 94.32 26.34 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.728 0.299 . . . . 10.0 111.212 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.22 179.67 6.22 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.529 2.153 . . . . 10.0 111.096 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.1 -165.1 28.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.951 -1.119 . . . . 10.0 112.902 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -117.34 157.87 25.39 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.76 132.25 6.98 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.483 -0.865 . . . . 10.0 112.087 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.9 125.12 73.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.307 0.575 . . . . 10.0 110.617 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 91.6 t -126.84 120.95 57.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.766 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -71.84 129.87 39.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.311 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -86.75 18.38 3.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.101 0.477 . . . . 10.0 110.053 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -136.89 -39.27 0.62 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.866 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -94.23 7.67 44.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.631 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.02 153.64 81.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 122.348 -0.22 . . . . 10.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.82 149.58 90.39 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.851 2.367 . . . . 10.0 112.679 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -65.88 -23.3 66.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.735 -0.666 . . . . 10.0 111.307 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -54.76 -39.18 68.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 10.0 110.925 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.82 -37.38 30.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.649 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 28.2 mt -62.88 -42.08 99.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 10.0 111.122 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -66.71 -28.98 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.563 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -79.29 -29.85 42.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.783 0.325 . . . . 10.0 111.229 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 14.5 mt -85.07 -14.46 47.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.969 0.414 . . . . 10.0 110.929 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -70.63 90.88 0.77 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.345 0.593 . . . . 10.0 111.049 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -88.25 100.04 12.68 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.179 -0.675 . . . . 10.0 109.179 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -57.4 116.92 3.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.795 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 91.3 mttt 60.27 81.4 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.134 0.896 . . . . 10.0 110.674 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.418 ' HD3' ' O ' ' B' ' 23' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.401 -0.809 . . . . 10.0 110.284 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 120.718 0.294 . . . . 10.0 110.95 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.7 mt -87.96 155.59 19.76 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.846 -0.428 . . . . 10.0 109.846 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -116.9 136.45 52.94 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.514 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.7 p -111.29 140.29 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.64 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.98 123.67 22.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.559 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.78 -35.61 57.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.563 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.52 169.96 16.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.803 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -76.68 104.69 7.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.656 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.546 ' CE1' HG21 ' B' ' 24' ' ' THR . 86.8 t80 -81.58 128.2 33.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.003 0.43 . . . . 10.0 111.17 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -99.24 115.38 28.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.652 -0.703 . . . . 10.0 109.772 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.0 172.67 7.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.53 -0.304 . . . . 10.0 110.647 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -136.81 -41.63 0.6 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.572 -0.285 . . . . 10.0 111.087 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -172.92 2.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.58 -0.282 . . . . 10.0 110.608 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -92.35 -14.65 28.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.72 0.295 . . . . 10.0 111.336 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -43.75 34.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.023 0.44 . . . . 10.0 110.068 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.15 120.2 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.802 . . . . 10.0 109.762 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.4 tp -78.54 136.82 37.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 10.0 111.943 -178.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -95.0 124.73 39.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.435 -0.802 . . . . 10.0 109.698 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.59 155.01 45.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 10.0 111.805 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -94.43 158.29 15.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.358 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.36 133.18 53.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.817 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.9 -9.56 65.91 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.733 -0.746 . . . . 10.0 113.585 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.56 149.2 45.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.16 0.48 . . . . 10.0 111.094 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -110.66 137.71 47.99 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.093 -0.503 . . . . 10.0 109.928 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.66 155.92 45.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.936 0.398 . . . . 10.0 111.313 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -107.78 114.47 28.44 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 mm -71.21 118.04 15.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.474 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.91 -38.62 12.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.553 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -136.02 117.29 14.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.317 -0.401 . . . . 10.0 111.049 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.5 -15.05 15.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.128 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.5 m -83.19 13.04 4.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.42 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -76.8 -30.65 56.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.253 0.549 . . . . 10.0 110.483 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 128.73 -110.49 1.11 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.72 -0.673 . . . . 10.0 111.79 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.17 -57.43 2.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.277 0.56 . . . . 10.0 110.002 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -82.73 114.89 21.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.735 . . . . 10.0 109.026 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -93.61 144.15 25.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.972 0.415 . . . . 10.0 111.492 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.95 113.88 20.85 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.323 -0.991 . . . . 10.0 108.323 177.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.08 154.65 51.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.057 0.456 . . . . 10.0 111.613 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -111.8 128.18 56.03 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.219 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.2 t -69.22 134.26 48.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.135 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.3 mt -85.31 -3.25 58.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 10.0 109.941 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.55 -61.64 1.65 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.683 -0.689 . . . . 10.0 111.119 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 26.0 p -94.37 -21.71 18.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 10.0 111.723 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.22 15.43 66.82 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.665 -0.779 . . . . 10.0 112.071 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -91.34 154.83 18.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.669 0.271 . . . . 10.0 111.013 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.09 155.93 22.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.527 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.69 172.54 38.49 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.825 -0.702 . . . . 10.0 111.572 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -88.94 127.32 35.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.842 0.353 . . . . 10.0 110.351 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.7 pt -120.67 144.64 39.17 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.982 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.543 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 46.4 Cg_endo -73.04 131.35 16.65 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.448 2.099 . . . . 10.0 111.447 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 p -73.74 -1.65 20.07 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.605 0.595 . . . . 10.0 112.605 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.543 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 28.1 p-10 -105.15 13.79 30.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.848 0.356 . . . . 10.0 111.01 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.464 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 5.5 m-85 -126.4 7.87 7.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.686 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.7 m -133.15 155.86 41.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.893 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -135.4 144.16 48.35 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.19 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 13.8 Cg_exo -69.6 132.08 22.83 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.563 2.175 . . . . 10.0 111.686 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.666 -0.683 . . . . 10.0 110.522 -179.94 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ttt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.439 0.161 . . . . 10.0 111.067 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.05 130.68 7.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.773 0.32 . . . . 10.0 110.918 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.39 112.76 19.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.436 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 23.9 t -89.28 129.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.821 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -97.55 119.1 35.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.62 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -131.67 147.04 52.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.56 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -89.97 109.97 20.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.266 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -111.59 105.82 14.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.42 -0.355 . . . . 10.0 111.08 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt 56.67 38.15 29.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.666 -0.697 . . . . 10.0 111.878 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.4 -0.11 85.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.721 -0.752 . . . . 10.0 112.811 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . 0.415 ' CB ' ' HE2' ' B' ' 13' ' ' LYS . 49.4 mt-10 -111.87 117.34 32.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.728 0.264 . . . . 10.0 110.495 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -74.09 112.88 10.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.008 -0.367 . . . . 10.0 110.008 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.415 ' HE2' ' CB ' ' B' ' 11' ' ' GLU . 51.7 mmtt -109.68 147.4 33.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.159 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 8.4 pt20 -130.3 109.26 10.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.516 -0.55 . . . . 10.0 109.516 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.41 142.5 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.503 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -64.78 143.5 57.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.809 -0.441 . . . . 10.0 109.809 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 14.8 tt -56.41 -21.66 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.716 -0.675 . . . . 10.0 112.72 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.24 -14.22 47.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.392 0.516 . . . . 10.0 112.392 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -95.14 16.13 17.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.267 0.556 . . . . 10.0 111.461 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 47.5 mt -105.69 133.6 49.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.546 -0.752 . . . . 10.0 109.284 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.39 -72.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.563 -0.29 . . . . 10.0 110.833 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -133.44 154.77 50.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.601 -0.272 . . . . 10.0 110.3 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.36 126.33 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.402 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . 0.546 HG21 ' CE1' ' A' ' 93' ' ' TYR . 1.3 m -125.49 127.66 46.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.024 0.44 . . . . 10.0 110.67 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 48.2 ttp85 -108.46 138.48 44.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.496 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -101.44 -17.21 16.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.197 0.522 . . . . 10.0 111.354 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 14.18 24.56 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.101 -0.8 . . . . 10.0 111.101 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -146.86 -51.87 0.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.484 -0.932 . . . . 10.0 108.484 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -130.13 148.8 52.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.514 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mt -105.31 124.8 60.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.805 -0.443 . . . . 10.0 109.805 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -114.03 127.57 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.33 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -146.4 175.26 10.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.856 0.36 . . . . 10.0 111.033 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -136.95 128.41 28.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.903 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -111.01 158.2 19.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.718 0.295 . . . . 10.0 110.725 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -131.56 107.67 9.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.594 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -95.14 143.18 26.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.532 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.47 12.23 47.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.039 -0.601 . . . . 10.0 112.508 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.88 16.63 60.0 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.986 -0.626 . . . . 10.0 111.698 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.35 31.88 63.02 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.124 -0.56 . . . . 10.0 112.197 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -149.41 92.11 4.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.792 0.329 . . . . 10.0 111.492 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -90.49 177.88 2.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.781 2.32 . . . . 10.0 110.678 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.46 -172.25 45.29 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 119.979 -1.105 . . . . 10.0 112.807 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -117.38 -178.96 3.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.654 0.264 . . . . 10.0 110.406 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.35 143.17 10.05 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.465 -0.654 . . . . 10.0 111.465 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.02 125.16 28.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.089 0.471 . . . . 10.0 110.604 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 t -129.47 143.49 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.312 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.3 t -96.59 137.62 35.39 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.953 -0.388 . . . . 10.0 109.953 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -72.46 -12.28 61.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.737 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -100.31 -13.03 18.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.863 0.363 . . . . 10.0 110.744 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.13 -54.5 3.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.218 -0.447 . . . . 10.0 111.459 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -89.78 143.55 30.4 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.499 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.432 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 26.0 Cg_exo -62.74 155.74 57.51 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.601 2.201 . . . . 10.0 111.823 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.89 -27.4 63.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.261 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -53.18 -44.05 67.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.68 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 70.2 mt -80.16 -37.46 33.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.958 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 40.8 mt -60.84 -40.67 93.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.565 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -70.63 -22.63 62.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.034 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -75.76 -26.88 57.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.232 0.539 . . . . 10.0 110.037 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.87 -30.61 17.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.121 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.82 94.93 1.86 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.21 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -95.14 130.86 41.69 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.483 -0.78 . . . . 10.0 110.306 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -64.55 124.31 21.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.62 77.73 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.89 0.744 . . . . 10.0 110.045 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.379 -0.819 . . . . 10.0 110.301 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.713 0.292 . . . . 10.0 110.904 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.8 mt -113.21 154.49 26.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.257 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -113.82 125.27 53.89 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.86 142.24 17.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.442 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.417 ' HA ' HG12 ' A' ' 138' ' ' VAL . . . -74.14 123.8 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.423 -0.353 . . . . 10.0 110.675 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.25 -37.41 53.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.04 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -146.0 158.21 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.524 -0.762 . . . . 10.0 109.503 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.42 146.43 54.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.238 0.336 . . . . 10.0 110.272 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -127.66 131.86 49.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.947 0.403 . . . . 10.0 111.02 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -95.28 128.43 42.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.462 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.402 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -68.92 137.84 54.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 10.0 110.731 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -113.22 -31.85 6.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.272 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.3 -163.97 1.46 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.401 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -93.11 -19.1 21.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.835 0.35 . . . . 10.0 111.053 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.46 -37.09 60.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.857 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -93.56 151.54 19.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.254 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.9 tp -120.36 134.85 55.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.424 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 2.9 p -79.3 153.06 30.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.886 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -158.45 160.2 36.53 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.426 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -101.95 156.0 17.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.475 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -62.76 123.37 18.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.87 -12.24 22.63 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.767 -0.73 . . . . 10.0 112.95 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -72.15 150.12 44.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 10.0 111.472 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -111.47 137.32 49.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.349 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -124.39 150.94 45.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.218 0.532 . . . . 10.0 111.936 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -106.98 103.67 13.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.038 -0.983 . . . . 10.0 108.709 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 122' ' ' ALA . 26.1 mm -64.45 124.82 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.39 -0.368 . . . . 10.0 111.038 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.81 -39.85 8.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.295 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -130.96 122.56 27.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.36 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.3 p -133.65 19.09 3.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.243 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.76 -6.99 10.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.359 0.503 . . . . 10.0 112.359 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -84.29 -109.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.494 0.188 . . . . 10.0 110.598 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.518 ' HA2' ' OH ' ' B' ' 8' ' ' TYR . . . -73.19 -164.35 8.55 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.77 -0.729 . . . . 10.0 112.143 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -95.65 4.25 53.23 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.667 0.746 . . . . 10.0 110.044 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -105.06 155.73 18.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.513 -1.292 . . . . 10.0 107.513 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -106.45 129.57 54.4 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.084 -0.647 . . . . 10.0 112.671 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.26 115.03 27.16 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.16 -1.422 . . . . 10.0 107.16 177.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.551 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -137.33 161.83 35.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.442 0.639 . . . . 10.0 112.668 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 123' ' ' ARG . 31.4 ttp180 -106.78 120.93 43.33 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.117 -0.947 . . . . 10.0 109.318 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.2 t -69.67 134.73 49.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.9 mt -78.52 -11.05 59.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.864 0.364 . . . . 10.0 110.214 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -82.91 -56.61 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.558 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 p -92.76 -32.67 14.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.359 -0.382 . . . . 10.0 112.027 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.89 20.74 49.24 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.645 -0.788 . . . . 10.0 111.6 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -109.92 159.55 17.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.772 -0.214 . . . . 10.0 110.937 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.37 -179.48 4.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.705 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.58 157.32 7.73 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.185 -0.531 . . . . 10.0 111.778 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -80.76 116.38 20.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 37.6 pt -99.59 140.92 21.96 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.727 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 133' ' ' ILE . 27.0 Cg_exo -61.01 117.87 4.68 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.44 2.093 . . . . 10.0 111.465 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -6.5 11.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 10.0 112.538 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -107.18 3.63 25.86 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.743 0.275 . . . . 10.0 111.743 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.97 3.79 14.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.818 0.342 . . . . 10.0 111.036 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 89' ' ' ALA . 20.5 m -132.51 159.15 43.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.929 0.395 . . . . 10.0 111.037 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.7 141.23 34.5 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.725 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.87 130.29 13.27 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.441 2.094 . . . . 10.0 111.875 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.386 -0.816 . . . . 10.0 109.968 179.945 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ttt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.438 0.161 . . . . 10.0 110.605 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.04 169.53 24.35 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.618 0.247 . . . . 10.0 110.957 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.95 139.53 30.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.802 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -102.94 130.28 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.718 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -94.02 118.64 31.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.072 -0.513 . . . . 10.0 109.953 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -136.54 178.34 7.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.569 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . 0.421 ' HE2' ' OE2' ' B' ' 12' ' ' GLU . 66.6 mttt -123.1 137.94 54.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.871 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . 0.518 ' OH ' ' HA2' ' A' ' 117' ' ' GLY . 77.2 t80 -134.95 115.84 14.03 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.082 -0.71 . . . . 10.0 109.082 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm 59.34 24.02 12.53 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.512 0.507 . . . . 10.0 111.384 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.89 -0.6 67.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.905 -0.664 . . . . 10.0 112.77 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -103.13 136.13 43.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.686 -0.302 . . . . 10.0 110.426 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.421 ' OE2' ' HE2' ' B' ' 7' ' ' LYS . 20.3 mt-10 -86.52 126.19 34.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.54 -0.3 . . . . 10.0 110.238 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -139.11 153.38 48.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.616 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -125.7 124.52 41.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.412 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.2 t -134.62 146.83 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.079 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.71 140.44 56.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.623 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 tt -64.57 -26.57 40.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.912 -0.586 . . . . 10.0 110.6 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.91 -11.84 60.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.213 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -99.4 3.56 45.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.031 0.443 . . . . 10.0 110.482 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.4 mt -95.3 127.76 47.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.62 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.41 -88.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.339 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -100.11 149.86 23.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 10.0 110.93 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.1 t -127.12 116.1 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.715 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 1.2 m -108.72 104.22 13.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.142 0.496 . . . . 10.0 111.528 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -100.47 146.61 26.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.78 -0.646 . . . . 10.0 109.966 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -138.08 5.13 2.53 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.088 0.47 . . . . 10.0 111.165 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.47 20.55 68.84 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.569 -0.824 . . . . 10.0 111.281 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -138.83 -59.7 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.057 -0.72 . . . . 10.0 109.057 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -145.74 134.24 22.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.04 -0.982 . . . . 10.0 109.557 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 89.8 mt -91.37 117.94 35.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 123.302 0.376 . . . . 10.0 110.352 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -107.14 135.53 48.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.707 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -152.76 173.52 15.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.03 0.443 . . . . 10.0 111.388 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -131.91 141.65 49.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.496 -0.775 . . . . 10.0 109.668 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -133.36 173.72 11.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.82 0.343 . . . . 10.0 110.462 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -142.93 127.39 17.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.088 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt -100.51 142.2 32.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.723 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.97 -21.05 60.82 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 116.056 -0.52 . . . . 10.0 113.258 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.93 -3.7 75.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.911 -0.661 . . . . 10.0 112.38 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.43 34.41 8.62 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.914 -0.66 . . . . 10.0 112.052 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -125.43 77.36 68.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.739 0.305 . . . . 10.0 111.243 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.89 148.66 17.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.551 2.168 . . . . 10.0 111.442 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.86 -174.0 39.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.011 -1.09 . . . . 10.0 112.728 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -112.84 174.57 5.83 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.962 -0.384 . . . . 10.0 109.962 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.53 151.58 22.13 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.107 -0.797 . . . . 10.0 111.107 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.8 p -135.78 137.75 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.253 0.549 . . . . 10.0 111.263 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.36 132.97 70.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.782 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 13.6 t -73.5 128.44 35.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.591 -0.277 . . . . 10.0 110.358 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -84.97 6.94 22.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.929 0.395 . . . . 10.0 110.792 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -120.22 -39.47 2.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.269 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.66 -50.87 7.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.93 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -67.15 146.57 98.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.861 -0.609 . . . . 10.0 111.332 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 31.8 Cg_exo -59.23 148.72 84.76 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.54 2.16 . . . . 10.0 112.364 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -60.66 -26.84 67.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.058 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -53.33 -42.48 66.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.159 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 90.2 mt -74.44 -36.39 63.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 10.0 110.695 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 35.6 mt -65.72 -36.97 85.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.626 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -71.9 -14.49 61.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.111 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -96.26 -37.54 10.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.097 0.475 . . . . 10.0 109.831 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -70.53 -35.03 72.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.113 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -74.44 89.94 2.16 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.132 0.492 . . . . 10.0 110.35 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -70.23 109.17 4.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -50.85 123.38 8.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.293 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 65.64 58.58 0.8 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.346 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.533 -0.746 . . . . 10.0 110.622 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.856 0.36 . . . . 10.0 110.637 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.0 mt -81.6 128.1 33.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.278 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -117.82 127.42 53.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.656 -0.702 . . . . 10.0 109.478 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 p -99.79 135.06 36.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.891 0.377 . . . . 10.0 110.432 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.43 118.95 13.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.688 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.4 mt -70.14 -31.48 69.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.673 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -151.3 -178.2 6.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.064 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -87.47 159.99 18.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.16 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -141.12 125.61 17.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.858 0.361 . . . . 10.0 110.789 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -87.86 114.19 24.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.723 -0.672 . . . . 10.0 109.712 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.09 155.69 24.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.255 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -119.02 -20.03 8.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.885 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.6 -160.04 1.01 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.581 -0.282 . . . . 10.0 110.802 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -101.75 -19.88 15.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.983 0.42 . . . . 10.0 110.575 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.99 -48.03 59.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.516 -0.766 . . . . 10.0 109.418 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.83 129.04 34.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.279 -0.873 . . . . 10.0 109.362 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.48 138.69 31.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.903 -0.59 . . . . 10.0 112.319 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -92.2 136.82 32.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.615 -0.513 . . . . 10.0 109.615 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -153.54 178.46 9.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.821 0.343 . . . . 10.0 111.025 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.88 173.87 10.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.98 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -63.57 122.56 16.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.778 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.99 -4.13 33.85 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.836 -0.697 . . . . 10.0 112.524 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -66.33 131.93 47.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.741 0.305 . . . . 10.0 110.856 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -102.1 118.64 37.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.87 -0.419 . . . . 10.0 109.87 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -112.17 142.77 44.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.501 0.556 . . . . 10.0 112.501 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -108.22 104.3 13.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.513 -1.291 . . . . 10.0 107.513 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.64 123.96 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.522 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -102.82 -51.54 3.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.436 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -133.85 114.46 13.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.78 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -129.8 9.39 5.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.451 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.58 -0.98 51.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.435 -0.802 . . . . 10.0 111.897 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -87.72 -91.55 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.887 -0.325 . . . . 10.0 110.221 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.77 -162.57 28.96 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.603 -0.808 . . . . 10.0 111.627 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.53 -28.2 41.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.869 0.366 . . . . 10.0 110.19 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -81.32 145.59 30.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.551 -1.278 . . . . 10.0 107.551 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -106.6 142.5 36.15 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.794 0.665 . . . . 10.0 112.794 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.32 118.17 30.96 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 177.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.96 163.39 33.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.292 0.568 . . . . 10.0 111.64 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -114.79 138.32 50.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.423 -0.808 . . . . 10.0 110.08 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.9 t -73.22 133.49 44.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.273 -0.422 . . . . 10.0 110.434 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.6 mt -92.22 5.85 48.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 10.0 109.956 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.19 -51.11 3.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.703 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.0 p -103.73 -39.39 6.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.033 0.444 . . . . 10.0 110.83 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.7 -2.59 29.03 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.931 -0.652 . . . . 10.0 111.766 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -66.14 142.39 57.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.623 0.249 . . . . 10.0 110.826 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.5 m -117.58 144.6 44.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.539 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.02 179.01 42.68 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.173 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -85.22 135.96 33.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.896 0.379 . . . . 10.0 110.205 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.2 pt -122.47 145.48 44.82 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.294 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.444 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 31.9 Cg_endo -67.44 121.14 8.22 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.776 2.318 . . . . 10.0 111.497 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -4.93 14.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.628 -0.714 . . . . 10.0 112.736 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.444 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 36.0 p-10 -101.57 6.24 42.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.754 0.311 . . . . 10.0 110.977 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -124.96 14.12 8.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.298 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.29 146.52 30.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.471 -0.331 . . . . 10.0 110.755 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -130.9 142.97 47.49 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.557 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.23 131.71 19.67 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.356 2.038 . . . . 10.0 112.323 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.453 -0.784 . . . . 10.0 109.915 179.818 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.779 0.323 . . . . 10.0 110.405 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.74 151.07 26.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.747 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.3 m -94.98 123.16 38.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.242 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 20.6 t -98.75 132.96 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.999 0.428 . . . . 10.0 111.241 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -102.73 111.85 24.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.597 -0.729 . . . . 10.0 109.094 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -130.16 -174.41 3.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.441 . . . . 10.0 111.104 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -110.62 148.6 31.86 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.171 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.17 103.43 4.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.159 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 tptt 58.67 30.77 20.36 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.7 0.625 . . . . 10.0 110.703 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.49 -31.79 8.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.29 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -75.74 168.97 19.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.806 0.336 . . . . 10.0 110.515 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -114.37 129.73 56.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -132.64 148.1 52.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.833 0.349 . . . . 10.0 111.27 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -117.01 109.57 17.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.963 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 94.6 t -129.0 139.38 52.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 110.148 -0.315 . . . . 10.0 110.148 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 31.0 m-20 -66.9 141.17 57.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.861 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.08 -23.52 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.039 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.67 0.25 18.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.147 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -114.61 9.65 16.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.468 . . . . 10.0 110.244 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 63.9 mt -97.3 132.49 41.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.157 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 t -79.15 -59.99 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.367 -0.379 . . . . 10.0 111.658 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -141.03 155.14 46.23 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.245 -0.284 . . . . 10.0 110.824 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 68.1 t -123.54 122.91 66.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 O-C-N 123.512 0.508 . . . . 10.0 110.59 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 7.3 m -113.53 107.37 15.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.888 0.375 . . . . 10.0 110.969 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.496 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 8.0 ttp85 -102.65 149.9 23.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.254 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -125.84 -22.71 4.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.508 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.04 16.8 14.13 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.958 -0.857 . . . . 10.0 110.958 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -144.38 -51.34 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -145.08 136.02 24.7 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.384 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 52.7 mt -93.88 128.26 45.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.571 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 29.4 m-85 -119.16 130.52 55.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -143.8 172.02 13.41 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.71 -0.396 . . . . 10.0 111.677 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -128.98 136.41 50.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.706 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -131.11 166.84 20.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.891 0.377 . . . . 10.0 111.287 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -132.33 114.74 14.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.539 -0.755 . . . . 10.0 109.729 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 88.1 mt -88.0 135.6 33.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.979 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.75 -8.74 35.33 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.819 -0.628 . . . . 10.0 112.815 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.87 -11.76 83.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.979 -0.629 . . . . 10.0 112.258 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.05 16.34 19.25 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.92 -0.657 . . . . 10.0 112.702 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -138.2 104.03 8.0 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 120.885 -0.326 . . . . 10.0 111.62 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.47 171.42 7.44 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.733 2.289 . . . . 10.0 111.18 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.42 -173.76 44.87 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.66 -1.257 . . . . 10.0 112.966 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -113.42 169.51 8.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.537 0.208 . . . . 10.0 110.497 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.23 151.53 23.48 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.151 -0.547 . . . . 10.0 111.823 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.7 p -136.27 140.12 44.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 10.0 111.517 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.78 135.46 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.901 -0.59 . . . . 10.0 109.557 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.3 t -76.02 134.89 40.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.745 0.307 . . . . 10.0 110.714 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.459 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 45.0 mt-10 -89.79 8.95 29.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 10.0 110.048 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -132.22 -42.77 0.97 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.733 -0.667 . . . . 10.0 111.665 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.21 34.23 1.81 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.208 0.447 . . . . 10.0 112.208 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.98 154.66 34.55 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.705 -0.225 . . . . 10.0 110.574 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -59.48 134.71 60.03 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.77 2.313 . . . . 10.0 111.356 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -67.97 -16.65 64.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.219 -0.446 . . . . 10.0 112.165 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -59.61 -44.4 93.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.409 . . . . 10.0 110.366 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.97 -39.23 83.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.526 . . . . 10.0 110.008 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.9 -41.0 95.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.741 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -62.5 -38.12 88.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.323 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.69 -35.86 44.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.956 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.28 -56.33 22.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.857 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . 0.496 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 40.6 tt0 -86.81 89.77 8.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.335 0.588 . . . . 10.0 110.944 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -78.58 148.74 33.19 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -64.7 138.91 58.67 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.1 mttt 72.04 54.64 0.18 Allowed 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.983 0.802 . . . . 10.0 110.245 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.662 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 120.678 0.275 . . . . 10.0 110.507 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 73.1 mt -92.15 150.85 20.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -119.37 137.53 53.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.853 0.358 . . . . 10.0 110.942 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -111.86 140.01 33.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.335 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.74 122.8 22.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.921 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.9 mt -79.13 -38.32 36.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.462 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -134.19 161.39 35.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.36 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -77.23 121.54 23.81 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -112.22 117.92 33.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.075 0.464 . . . . 10.0 110.431 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -94.46 120.52 34.82 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.906 -0.588 . . . . 10.0 109.486 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.471 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -73.48 156.61 38.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.969 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.1 ttm105 -123.28 -26.42 4.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.85 -0.614 . . . . 10.0 110.676 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.48 -168.51 1.5 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.297 -0.41 . . . . 10.0 111.022 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -97.8 -3.17 39.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.018 0.437 . . . . 10.0 111.14 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.52 -43.29 9.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.04 -0.527 . . . . 10.0 110.385 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -81.16 147.43 30.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.552 -0.749 . . . . 10.0 109.91 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 62.2 tp -103.84 131.39 51.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.337 -0.392 . . . . 10.0 112.009 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.471 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -85.37 135.8 33.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.877 178.713 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -155.58 165.46 36.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.775 0.322 . . . . 10.0 110.664 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.493 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 36.5 m170 -110.22 165.23 11.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.959 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -61.82 126.1 26.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.558 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.35 -4.21 43.99 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.675 -0.774 . . . . 10.0 112.146 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 2.5 tp10 -68.11 148.12 51.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 122.204 0.202 . . . . 10.0 110.922 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -119.1 133.52 55.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.662 -0.495 . . . . 10.0 109.662 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 107' ' ' GLU . 0.4 OUTLIER -130.53 155.46 46.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.125 0.488 . . . . 10.0 111.582 -179.156 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -109.45 114.11 27.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.2 mm -63.2 128.77 25.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.143 -0.48 . . . . 10.0 111.065 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.03 -44.33 4.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.917 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 116' ' ' GLU . 30.1 t30 -138.81 108.55 6.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.812 0.339 . . . . 10.0 111.131 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.72 -11.32 19.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.163 0.506 . . . . 10.0 110.73 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.6 8.79 15.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.069 -0.514 . . . . 10.0 111.446 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.407 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 7.2 tp10 -77.98 -20.14 53.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.013 0.435 . . . . 10.0 110.806 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.34 -139.99 9.61 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.818 -0.706 . . . . 10.0 111.499 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.11 -35.28 49.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.98 -0.378 . . . . 10.0 109.98 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.466 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 20.4 m95 -92.18 126.01 37.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -103.55 146.99 27.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.882 0.372 . . . . 10.0 111.228 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -97.11 122.17 39.82 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.735 -0.839 . . . . 10.0 108.735 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.74 162.46 32.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.953 0.406 . . . . 10.0 111.543 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 123' ' ' ARG . 13.1 ttt-85 -109.53 128.08 54.93 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.453 -0.794 . . . . 10.0 109.599 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.3 t -67.3 134.16 51.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.163 -0.472 . . . . 10.0 109.749 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.9 mt -83.73 -10.66 57.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.864 0.364 . . . . 10.0 110.105 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.12 -62.77 1.37 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.761 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.2 p -87.36 -35.73 18.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.037 0.446 . . . . 10.0 111.546 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.89 2.01 52.17 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.72 -0.753 . . . . 10.0 111.87 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.99 144.7 48.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.802 0.334 . . . . 10.0 111.248 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.7 m -117.76 135.64 53.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.288 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -178.68 178.44 48.71 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.445 -0.883 . . . . 10.0 112.106 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -79.79 126.09 30.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.965 0.412 . . . . 10.0 109.971 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 31.2 pt -115.67 139.83 25.28 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.797 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.07 112.58 1.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.453 2.102 . . . . 10.0 111.34 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.67 -18.21 61.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.056 -0.52 . . . . 10.0 112.134 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -92.57 5.69 49.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.621 -0.263 . . . . 10.0 111.494 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -119.25 4.82 11.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.914 0.388 . . . . 10.0 110.748 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.93 149.07 32.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.152 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -129.39 142.65 45.96 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.218 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 6.7 Cg_exo -73.84 135.73 21.9 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.437 2.092 . . . . 10.0 111.773 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.367 -0.825 . . . . 10.0 110.682 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ttt . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.348 0.118 . . . . 10.0 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.35 174.08 13.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.75 0.309 . . . . 10.0 111.153 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 2.1 m -108.59 131.56 54.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.47 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.86 125.06 48.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.892 0.377 . . . . 10.0 110.893 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -103.86 111.44 23.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.272 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -121.94 176.99 5.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.978 -0.556 . . . . 10.0 111.036 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -121.06 94.72 4.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.469 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -80.88 92.02 6.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.059 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm 56.24 43.9 25.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.42 -0.809 . . . . 10.0 111.893 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.6 -16.43 59.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.852 -0.69 . . . . 10.0 113.586 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -94.75 117.79 30.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.168 0.484 . . . . 10.0 111.314 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -76.81 117.26 18.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -132.37 137.97 47.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.855 0.359 . . . . 10.0 110.877 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -112.48 116.28 30.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.137 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.3 t -124.08 140.34 47.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.775 -0.454 . . . . 10.0 109.775 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -57.51 137.21 56.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.594 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.8 tt -60.12 -26.94 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.983 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.27 2.16 16.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.434 -0.348 . . . . 10.0 111.821 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' B' ' 35' ' ' ASP . 95.4 mttt -112.01 8.27 20.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.775 0.321 . . . . 10.0 111.088 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -92.2 119.97 40.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.78 -70.32 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.888 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -128.49 148.98 50.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.73 0.3 . . . . 10.0 111.145 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.21 132.37 68.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.481 -0.781 . . . . 10.0 110.297 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 28.7 m -132.22 115.4 15.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.037 0.446 . . . . 10.0 110.851 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.546 ' HD2' ' OE1' ' B' ' 48' ' ' GLU . 68.5 ttp85 -116.32 144.26 44.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.309 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -119.89 7.62 10.97 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.132 0.491 . . . . 10.0 111.607 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.542 ' H ' ' HG2' ' B' ' 25' ' ' ARG . . . 90.53 16.56 54.89 Favored Glycine 0 C--O 1.231 -0.077 0 C-N-CA 120.462 -0.875 . . . . 10.0 112.203 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -140.0 -60.92 0.53 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.48 0.657 . . . . 10.0 109.343 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -131.46 147.05 52.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.162 -0.926 . . . . 10.0 109.699 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 61.7 mt -101.57 111.96 33.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.681 -0.69 . . . . 10.0 110.089 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -103.02 126.95 50.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.089 -0.505 . . . . 10.0 109.676 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -152.45 172.96 15.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.01 0.433 . . . . 10.0 111.133 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -129.16 134.41 48.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.785 -0.643 . . . . 10.0 109.739 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -110.98 168.83 9.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.239 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' B' ' 19' ' ' LYS . 21.8 t70 -131.65 153.09 50.32 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.312 -0.625 . . . . 10.0 109.312 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 51.0 mt -138.55 139.29 38.62 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.189 -0.3 . . . . 10.0 110.189 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.97 -20.93 60.68 Favored Glycine 0 C--N 1.33 0.218 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.33 -18.49 71.49 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.749 -0.54 . . . . 10.0 111.749 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.07 29.38 6.45 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.972 -0.632 . . . . 10.0 112.795 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -130.41 85.91 55.06 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.883 0.341 . . . . 10.0 111.56 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -91.33 76.94 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.138 2.559 . . . . 10.0 111.997 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.58 -167.47 43.69 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.927 -0.654 . . . . 10.0 113.027 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 62.1 m-85 -111.65 172.34 6.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.852 0.358 . . . . 10.0 110.727 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.22 151.59 23.05 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.358 -0.697 . . . . 10.0 111.358 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 14.6 p -141.57 140.49 31.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.13 0.49 . . . . 10.0 110.984 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.57 147.77 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.559 . . . . 10.0 109.651 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 22.2 t -93.0 136.67 33.05 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.168 -0.308 . . . . 10.0 110.168 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' GLU . . . . . 0.546 ' OE1' ' HD2' ' B' ' 25' ' ' ARG . 19.6 tt0 -80.66 -10.17 59.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.979 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -110.99 -26.01 9.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.157 0.428 . . . . 10.0 112.157 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -97.83 -15.16 20.37 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.465 0.543 . . . . 10.0 112.465 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.29 151.34 41.42 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.451 0.167 . . . . 10.0 111.226 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 25.7 Cg_exo -63.5 147.78 92.96 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.713 2.275 . . . . 10.0 111.836 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -64.31 -21.95 66.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.969 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.96 -45.93 71.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.918 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.2 mt -78.61 -36.26 44.42 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.898 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 36.4 mt -61.91 -39.38 91.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.203 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -69.08 -16.58 63.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 10.0 111.771 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -90.28 -20.24 23.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.167 0.508 . . . . 10.0 110.173 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 21.3 mt -93.08 -37.98 11.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.751 -0.659 . . . . 10.0 110.141 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -79.66 85.3 5.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.563 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' B' ' 64' ' ' LYS . 86.4 mttt -91.32 163.59 14.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.968 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -81.74 126.48 31.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 63.36 36.91 11.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.236 0.541 . . . . 10.0 109.736 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.174 -0.921 . . . . 10.0 111.673 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.475 0.783 0 CA-C-O 120.579 0.228 . . . . 10.0 110.69 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.5 mt -100.43 141.77 32.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.826 -0.435 . . . . 10.0 109.826 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -111.18 134.94 52.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.111 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 107' ' ' GLU . 12.6 p -109.42 138.61 36.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.453 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.84 123.46 26.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.862 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 86.2 mt -81.32 -34.64 31.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.338 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -133.54 154.99 50.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.003 -0.544 . . . . 10.0 110.259 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.76 145.48 30.45 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.066 -0.516 . . . . 10.0 110.242 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -150.85 130.0 12.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.53 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -97.06 132.18 43.12 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.949 -0.759 . . . . 10.0 108.949 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 143.96 57.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.97 0.414 . . . . 10.0 111.396 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.0 ttt-85 -97.01 -12.11 23.68 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.788 -0.642 . . . . 10.0 109.919 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.37 -166.49 2.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.028 -0.987 . . . . 10.0 109.434 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -98.35 -2.99 38.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -78.06 -47.84 17.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.002 -0.999 . . . . 10.0 108.827 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -87.64 155.68 19.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.192 -0.913 . . . . 10.0 108.818 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.1 tp -111.23 139.36 46.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.868 0.366 . . . . 10.0 111.86 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.9 m -81.44 140.04 34.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.665 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -152.2 166.22 32.39 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.967 0.413 . . . . 10.0 111.007 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -121.61 166.71 13.83 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.213 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -59.51 122.59 14.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.59 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.08 -1.43 44.2 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.733 -0.746 . . . . 10.0 112.611 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -67.15 140.94 57.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.644 0.259 . . . . 10.0 110.875 179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -112.27 124.83 53.32 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 107' ' ' GLU . 25.6 m-85 -116.94 146.07 43.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.292 0.568 . . . . 10.0 112.356 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -100.14 101.43 12.47 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.718 -1.216 . . . . 10.0 107.718 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.0 mm -60.77 116.28 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.374 -0.376 . . . . 10.0 111.316 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.8 mt -89.25 -53.51 4.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.307 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -133.25 104.57 6.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.376 -0.375 . . . . 10.0 111.008 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.75 -8.19 44.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.289 0.566 . . . . 10.0 110.497 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.63 10.57 27.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.215 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.86 -25.12 59.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.913 0.387 . . . . 10.0 110.317 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 143.42 -127.79 3.18 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.639 -0.584 . . . . 10.0 111.639 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -83.15 -47.74 11.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.484 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 25.8 m95 -88.5 127.68 35.53 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.531 -0.915 . . . . 10.0 108.531 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -107.52 139.96 41.24 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.835 0.35 . . . . 10.0 111.277 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -85.39 119.41 25.73 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.177 -1.045 . . . . 10.0 108.177 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.11 162.61 30.41 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.071 0.463 . . . . 10.0 111.818 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -112.91 122.09 46.62 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.378 -0.828 . . . . 10.0 108.922 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.4 t -62.25 144.34 55.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.883 0.373 . . . . 10.0 110.741 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.75 -16.17 37.19 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.235 -0.439 . . . . 10.0 110.176 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.3 m -93.05 -50.79 5.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.709 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 64.8 p -88.4 -41.25 12.93 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.284 0.564 . . . . 10.0 111.268 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.89 9.1 62.83 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.751 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.21 162.57 18.25 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.779 0.323 . . . . 10.0 110.724 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.13 150.97 33.33 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.463 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 168.79 168.75 31.29 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.911 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -79.79 134.41 36.35 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.823 0.344 . . . . 10.0 110.821 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 22.8 pt -120.53 137.5 26.31 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.588 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.581 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 37.6 Cg_endo -72.19 121.95 7.97 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.549 2.166 . . . . 10.0 111.437 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.93 -19.55 65.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.843 -178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.581 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 35.7 p-10 -80.63 -21.63 41.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.506 0.193 . . . . 10.0 111.446 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.473 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 4.6 m-85 -93.15 -11.99 31.45 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.081 0.4 . . . . 10.0 112.081 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.2 m -114.72 159.78 14.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.17 0.509 . . . . 10.0 111.675 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.72 137.59 18.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.376 -0.829 . . . . 10.0 109.716 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.64 137.14 32.25 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.343 2.029 . . . . 10.0 112.142 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.601 -0.714 . . . . 10.0 109.793 179.289 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ttm . . . . . 0 N--CA 1.478 0.97 0 CA-C-O 120.462 0.173 . . . . 10.0 111.061 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.28 162.24 37.77 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.446 0.641 . . . . 10.0 112.173 -178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 1.1 m -107.58 118.2 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.316 -0.856 . . . . 10.0 109.746 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 25.2 t -89.1 134.35 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.821 0.343 . . . . 10.0 111.682 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 55.8 tttt -98.58 139.25 34.58 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.487 -0.561 . . . . 10.0 109.487 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -148.07 176.35 10.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.85 0.357 . . . . 10.0 110.667 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -123.87 83.55 2.16 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.815 -0.63 . . . . 10.0 109.76 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -63.77 92.88 0.07 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.765 0.316 . . . . 10.0 110.535 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm 52.02 29.5 6.32 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.688 -0.687 . . . . 10.0 111.608 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.17 -16.65 22.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.839 -0.696 . . . . 10.0 112.806 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -88.83 101.68 14.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.779 0.323 . . . . 10.0 110.732 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -67.52 123.12 19.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.082 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.05 158.76 44.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.747 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -125.12 119.59 29.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.016 -0.538 . . . . 10.0 110.041 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 85.2 t -125.71 142.43 42.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.804 0.335 . . . . 10.0 110.43 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 1.4 m-20 -60.77 137.86 58.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.351 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.8 tt -60.96 -26.52 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.809 -0.632 . . . . 10.0 110.696 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -10.72 59.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.729 -0.669 . . . . 10.0 111.855 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -105.3 8.18 33.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.69 0.281 . . . . 10.0 111.484 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 63.3 mt -90.57 137.89 20.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.792 0.33 . . . . 10.0 110.273 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -88.95 -59.16 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.255 -0.43 . . . . 10.0 111.171 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -136.16 151.85 50.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.634 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 38.3 t -127.01 127.04 69.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.178 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . 0.405 ' HG1' ' HH2' ' A' ' 119' ' ' TRP . 8.1 m -123.43 101.78 7.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.886 0.374 . . . . 10.0 111.398 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.409 ' HG3' HG12 ' B' ' 30' ' ' ILE . 22.3 ttp85 -90.76 137.33 32.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.813 -0.44 . . . . 10.0 109.813 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.431 ' HB2' ' ND2' ' A' ' 136' ' ' ASN . 49.1 t80 -100.91 -20.49 15.44 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.06 0.457 . . . . 10.0 111.238 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.49 -4.58 37.44 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -135.17 -41.69 0.73 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.565 -0.817 . . . . 10.0 108.971 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -138.81 137.66 36.83 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.493 -0.776 . . . . 10.0 109.868 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.409 HG12 ' HG3' ' B' ' 25' ' ' ARG . 72.5 mt -102.98 125.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 110.279 -0.267 . . . . 10.0 110.279 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.441 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 17.7 m-85 -117.24 136.17 53.27 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.572 -0.529 . . . . 10.0 109.572 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -151.45 174.02 13.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.0 0.429 . . . . 10.0 111.227 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -130.24 140.88 50.67 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.96 -0.564 . . . . 10.0 109.805 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -124.41 152.52 43.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.926 0.393 . . . . 10.0 110.832 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.38 98.94 6.29 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.628 -0.714 . . . . 10.0 109.867 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' B' ' 40' ' ' LYS . 48.9 mt -75.81 144.42 41.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.793 0.33 . . . . 10.0 110.827 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.25 -5.87 87.55 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 116.071 -0.513 . . . . 10.0 112.201 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.3 23.05 10.38 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.899 -0.667 . . . . 10.0 112.441 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.84 43.42 97.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.45 -0.405 . . . . 10.0 112.834 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 86.0 tttt -159.79 95.68 1.61 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 120.717 0.294 . . . . 10.0 110.815 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -87.73 169.06 6.86 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.002 2.468 . . . . 10.0 111.235 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.63 -173.43 38.51 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.223 -0.989 . . . . 10.0 112.285 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 42.9 m-85 -118.56 166.89 12.17 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.66 138.25 6.42 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.372 -0.918 . . . . 10.0 112.531 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 p -124.33 127.73 73.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.078 0.466 . . . . 10.0 110.392 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 39.6 t -121.08 123.87 70.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 10.0 110.227 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -71.62 132.61 44.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.365 -0.38 . . . . 10.0 109.977 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -80.79 1.29 31.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.112 0.482 . . . . 10.0 110.791 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -116.3 -35.13 4.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.447 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -101.9 28.3 5.82 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.41 151.18 36.06 Favored Pre-proline 0 C--N 1.326 -0.427 0 C-N-CA 121.314 -0.154 . . . . 10.0 111.075 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.29 129.25 33.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.256 2.637 . . . . 10.0 112.418 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.449 ' HA ' HD12 ' B' ' 56' ' ' LEU . 97.3 mttt -64.31 -26.82 68.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.927 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -55.97 -42.62 76.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.392 -0.367 . . . . 10.0 110.971 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 73.8 mt -76.86 -30.67 56.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.729 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' B' ' 53' ' ' LYS . 62.1 mt -66.57 -32.09 73.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.413 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -74.42 -7.93 54.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.929 -0.578 . . . . 10.0 111.002 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -98.6 -26.92 14.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.907 -0.588 . . . . 10.0 110.11 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 52.3 mt -72.45 -61.95 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.865 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -101.03 110.33 22.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.208 0.528 . . . . 10.0 109.961 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -107.8 173.84 6.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.481 -0.781 . . . . 10.0 110.073 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -64.12 127.45 31.5 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.773 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 mttm 60.8 58.29 2.41 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.499 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.283 0 CA-C-N 115.954 -0.567 . . . . 10.0 111.061 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 120.929 0.395 . . . . 10.0 111.058 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.9 mt -92.57 158.84 15.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.09 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -121.08 134.61 55.27 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.2 p -112.27 140.34 32.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.921 0.391 . . . . 10.0 110.527 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 138' ' ' VAL . . . -72.13 123.37 22.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.97 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 139' ' ' ALA . 82.6 mt -83.28 -26.09 30.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.547 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.43 -175.3 4.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.922 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.87 149.8 27.05 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 123.282 0.364 . . . . 10.0 110.391 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -147.63 128.7 14.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.595 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -94.51 122.16 36.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.793 -0.639 . . . . 10.0 109.403 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.507 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -61.68 144.09 55.12 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.703 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -97.32 -38.61 9.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.354 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 98' ' ' GLU . 0.4 OUTLIER -124.36 -162.25 1.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.873 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' H ' ' HB ' ' A' ' 97' ' ' THR . 1.6 pt-20 -96.54 -8.58 31.57 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.911 0.386 . . . . 10.0 110.68 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.48 -38.78 25.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.232 0.539 . . . . 10.0 110.099 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -93.05 150.55 20.45 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.688 -0.856 . . . . 10.0 108.688 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 50.2 tp -113.63 142.46 45.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.888 0.375 . . . . 10.0 111.626 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.6 OUTLIER -81.92 148.51 28.7 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.799 179.006 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -154.85 158.96 40.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.102 0.477 . . . . 10.0 111.35 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -113.35 153.14 29.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.053 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -59.56 126.66 28.49 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.584 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 110.1 -17.64 29.24 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.884 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -68.4 143.14 55.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.733 0.302 . . . . 10.0 111.035 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -103.26 130.29 50.47 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.444 -0.576 . . . . 10.0 109.444 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -118.87 143.28 47.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.236 0.541 . . . . 10.0 112.089 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -103.19 104.14 14.26 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.69 -0.855 . . . . 10.0 108.69 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' A' ' 122' ' ' ALA . 20.3 mm -64.13 120.19 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 10.0 111.206 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 67.8 mt -82.74 -46.44 13.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.194 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -149.06 137.77 21.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.185 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.12 -12.44 10.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.173 -0.467 . . . . 10.0 111.29 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.9 m -86.82 47.21 1.46 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.919 0.39 . . . . 10.0 111.903 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -127.35 -3.72 6.15 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.97 0.414 . . . . 10.0 110.863 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 139.47 -145.47 16.62 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 121.014 -0.612 . . . . 10.0 111.729 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.05 -22.41 20.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.031 0.443 . . . . 10.0 110.611 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' B' ' 31' ' ' PHE . 23.2 m95 -98.38 119.56 37.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.961 -1.125 . . . . 10.0 107.961 177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -103.47 153.92 20.01 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.284 0.564 . . . . 10.0 112.187 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -90.29 124.6 35.03 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.672 -1.233 . . . . 10.0 107.672 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -140.69 146.71 38.19 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.629 0.728 . . . . 10.0 112.715 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 123' ' ' ARG . 30.0 ttt180 -99.68 122.28 42.47 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.854 -1.066 . . . . 10.0 109.646 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.7 t -66.79 131.23 45.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.3 mt -78.44 -9.43 59.29 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.85 0.357 . . . . 10.0 110.427 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.5 m -79.78 -63.65 1.37 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 10.0 111.427 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.3 p -102.09 -25.75 13.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.389 0.514 . . . . 10.0 112.389 -178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.12 1.59 57.01 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.552 -0.832 . . . . 10.0 111.704 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -69.2 146.33 52.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.83 0.348 . . . . 10.0 110.846 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.59 178.84 4.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.438 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 143.15 168.87 12.17 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.844 -0.693 . . . . 10.0 111.972 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -84.0 130.43 34.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.842 0.353 . . . . 10.0 110.44 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.8 pt -123.57 146.92 51.47 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.915 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.526 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 48.5 Cg_endo -74.23 115.05 4.18 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.666 2.244 . . . . 10.0 111.779 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.6 m -62.03 -15.06 41.73 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.945 0.72 . . . . 10.0 112.945 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 33.7 p-10 -83.41 -8.3 59.41 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.234 -0.291 . . . . 10.0 110.861 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.402 ' CE1' HG22 ' B' ' 24' ' ' THR . 2.5 m-85 -105.44 -0.16 26.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.414 -0.357 . . . . 10.0 111.167 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 89' ' ' ALA . 4.6 m -127.67 156.15 39.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.989 0.423 . . . . 10.0 111.206 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 90' ' ' LEU . . . -136.2 143.05 42.19 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.235 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.85 129.41 19.66 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.617 2.211 . . . . 10.0 112.06 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.7 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.29 -0.862 . . . . 10.0 110.261 -179.872 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.469 0.176 . . . . 10.0 110.708 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.4 169.24 25.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.821 0.343 . . . . 10.0 111.148 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.1 p -101.88 145.24 29.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 34.3 t -110.02 133.03 56.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.783 -0.451 . . . . 10.0 109.783 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -99.25 124.21 44.15 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.457 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 41.3 p90 -128.58 166.72 18.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.958 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -114.31 87.54 2.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.014 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -78.5 90.55 4.48 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.585 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 26.1 mmtm 53.54 38.21 27.61 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.108 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.01 -26.37 20.92 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.675 -0.774 . . . . 10.0 112.813 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -83.59 105.82 14.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.696 0.284 . . . . 10.0 110.882 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 26.7 mt-10 -80.16 116.93 20.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -130.92 157.44 42.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.612 0.244 . . . . 10.0 111.074 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -120.72 113.9 20.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.494 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . 0.497 HG11 ' HB2' ' B' ' 34' ' ' TYR . 48.8 t -124.42 143.02 39.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.857 -0.423 . . . . 10.0 109.857 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.26 141.69 45.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 10.0 111.314 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 7.4 tt -62.26 -32.68 55.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.174 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 15.2 m -80.98 2.16 28.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.372 -0.376 . . . . 10.0 111.549 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -104.62 12.47 32.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.522 0.677 . . . . 10.0 109.29 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 87.2 mt -104.15 133.86 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 115.063 -0.972 . . . . 10.0 109.324 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.1 t -83.76 -73.12 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.745 0.307 . . . . 10.0 111.568 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -118.85 152.18 36.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.72 0.295 . . . . 10.0 111.354 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.66 129.7 66.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.979 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . 0.402 HG22 ' CE1' ' A' ' 137' ' ' TYR . 1.5 m -134.46 121.4 21.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.901 0.381 . . . . 10.0 111.05 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 20.0 ttp85 -120.75 125.47 47.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.814 0.34 . . . . 10.0 110.844 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -89.05 -22.46 22.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.153 0.502 . . . . 10.0 110.684 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.17 -4.47 8.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.865 -0.683 . . . . 10.0 112.01 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -117.14 -57.96 2.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.302 -0.629 . . . . 10.0 109.302 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.68 149.89 52.12 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 29.6 mt -101.66 124.64 55.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.358 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.443 ' HB3' ' NE1' ' A' ' 119' ' ' TRP . 3.3 m-85 -104.5 132.55 50.63 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.665 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -152.38 156.65 39.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.938 0.399 . . . . 10.0 111.289 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -110.59 132.17 54.42 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.059 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.497 ' HB2' HG11 ' B' ' 15' ' ' VAL . 19.2 p90 -114.62 164.3 14.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.338 -0.392 . . . . 10.0 110.67 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -133.33 142.96 48.7 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.624 -0.717 . . . . 10.0 109.385 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 35.7 mt -126.5 142.42 51.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.018 0.437 . . . . 10.0 111.288 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.86 -13.48 78.74 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.696 -0.684 . . . . 10.0 112.212 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.52 7.9 37.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.962 -0.637 . . . . 10.0 112.1 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.89 45.46 16.51 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 121.201 -0.523 . . . . 10.0 112.618 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -160.49 90.45 1.7 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.891 0.377 . . . . 10.0 111.392 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.32 175.03 6.62 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.458 2.105 . . . . 10.0 110.917 178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 178.27 -166.5 36.54 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 119.881 -1.152 . . . . 10.0 112.462 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -120.65 156.57 31.42 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.681 0.277 . . . . 10.0 110.45 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.72 155.62 22.74 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.154 -0.778 . . . . 10.0 111.154 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -142.73 139.79 28.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.111 0.482 . . . . 10.0 111.262 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 20.4 m -132.31 152.48 36.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.763 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.416 ' HB3' ' HB2' ' B' ' 50' ' ' ASP . 19.5 t -91.16 141.34 28.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.112 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -82.6 -10.14 59.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.043 0.449 . . . . 10.0 110.636 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.64 -9.18 12.64 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.89 0.33 . . . . 10.0 111.89 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . 0.416 ' HB2' ' HB3' ' B' ' 47' ' ' SER . 24.1 m-20 -120.32 21.9 11.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.901 0.382 . . . . 10.0 111.48 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -145.71 141.65 17.05 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.164 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.51 142.86 69.78 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.779 2.319 . . . . 10.0 112.297 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -58.06 -30.48 66.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.214 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.4 -45.09 72.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 10.0 111.161 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 mt -71.74 -38.84 70.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 10.0 111.023 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.98 -41.67 97.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.015 -0.539 . . . . 10.0 111.045 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -74.53 -13.65 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.932 -0.577 . . . . 10.0 111.383 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 68.8 mttt -80.42 -37.11 32.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.018 0.437 . . . . 10.0 109.823 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 88.2 mt -74.44 -47.68 32.11 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.778 -0.646 . . . . 10.0 111.361 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -88.92 97.71 11.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.065 0.459 . . . . 10.0 110.43 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -104.01 -173.27 2.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.389 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -68.84 140.43 55.22 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 61.5 50.43 4.6 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.552 0.691 . . . . 10.0 109.892 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.177 0 CA-C-N 115.165 -0.925 . . . . 10.0 110.878 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.597 0.237 . . . . 10.0 110.721 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.2 mt -99.8 141.79 32.15 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.932 0.396 . . . . 10.0 110.723 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -119.56 140.35 50.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.76 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.86 140.15 30.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 120.959 0.409 . . . . 10.0 110.437 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.34 116.56 12.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.987 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 83.0 mt -69.24 -33.18 72.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.406 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -147.13 173.78 12.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.78 -0.645 . . . . 10.0 109.883 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.19 144.32 27.52 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.734 -0.469 . . . . 10.0 109.734 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -126.78 123.35 37.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.956 0.408 . . . . 10.0 111.112 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -84.93 116.85 23.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.606 -0.725 . . . . 10.0 109.579 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.94 148.67 51.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.092 0.472 . . . . 10.0 111.155 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.7 mtp-105 -115.15 -35.44 4.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.782 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.81 -165.09 1.48 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.551 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -96.0 -11.95 25.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.688 0.28 . . . . 10.0 111.262 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.35 -34.63 31.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.211 0.529 . . . . 10.0 110.611 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -90.23 149.76 22.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.58 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.6 tp -109.68 135.46 50.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.981 0.42 . . . . 10.0 111.916 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.91 147.72 24.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.883 -0.599 . . . . 10.0 110.204 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -156.77 163.59 39.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.779 0.323 . . . . 10.0 111.268 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -110.26 157.05 19.88 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.08 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -58.5 128.1 35.5 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.799 0.333 . . . . 10.0 110.419 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.38 -10.0 53.78 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.707 -0.758 . . . . 10.0 112.924 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -70.85 146.73 49.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 10.0 110.781 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.2 mttt -115.62 139.07 50.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.067 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -126.58 150.39 48.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.053 0.454 . . . . 10.0 111.818 -178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -97.91 111.5 23.78 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.2 mm -65.45 119.17 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.336 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 68.9 mt -102.7 -62.32 1.29 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.579 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -119.54 107.22 13.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.253 -0.431 . . . . 10.0 110.644 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.29 22.0 12.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.78 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -112.27 -1.08 15.26 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.783 0.66 . . . . 10.0 112.783 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -73.72 -37.11 65.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.518 -0.473 . . . . 10.0 110.876 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.74 -133.62 2.89 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.189 -1.005 . . . . 10.0 112.588 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.39 -31.58 29.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.641 0.258 . . . . 10.0 110.947 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.558 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 28.2 m95 -93.16 121.22 34.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -103.17 146.48 28.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.046 0.451 . . . . 10.0 111.634 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -95.23 119.51 33.87 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.01 159.13 42.48 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.291 0.567 . . . . 10.0 111.832 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -104.38 124.15 48.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.245 -0.889 . . . . 10.0 109.433 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.0 t -65.95 136.57 56.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.944 -0.391 . . . . 10.0 109.944 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.34 -2.71 58.81 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.761 -0.459 . . . . 10.0 109.761 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.2 m -97.15 -50.31 4.64 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.101 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.2 p -101.24 -28.07 12.85 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.94 0.4 . . . . 10.0 111.732 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.45 -6.03 77.73 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.977 -0.63 . . . . 10.0 112.233 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -69.03 149.32 48.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.945 0.403 . . . . 10.0 110.882 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.1 m -119.95 125.86 49.45 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.947 -0.569 . . . . 10.0 111.093 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -163.5 176.11 39.67 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.489 -0.644 . . . . 10.0 111.489 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -81.72 127.86 33.37 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.839 0.352 . . . . 10.0 110.5 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.0 pt -119.62 142.13 32.27 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.805 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.447 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 28.9 Cg_endo -69.01 110.9 2.51 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.171 1.914 . . . . 10.0 111.184 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 m -59.35 -19.55 47.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.887 -0.597 . . . . 10.0 112.579 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.447 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 30.7 p-10 -81.51 -8.8 59.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 10.0 110.87 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -103.03 -3.5 25.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.312 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.3 m -122.79 157.87 27.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.507 -0.315 . . . . 10.0 111.036 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -138.85 148.37 57.85 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.317 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 24.3 Cg_exo -63.38 136.53 55.59 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.546 2.164 . . . . 10.0 112.117 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.567 -0.73 . . . . 10.0 110.396 179.677 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ttt . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.561 0.22 . . . . 10.0 110.538 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.53 145.99 16.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.885 0.374 . . . . 10.0 111.009 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 6.1 m -93.72 119.8 33.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.625 -0.716 . . . . 10.0 109.45 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 32.8 t -86.87 130.34 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.984 0.421 . . . . 10.0 111.291 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -99.69 120.65 40.04 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.821 -0.627 . . . . 10.0 109.339 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -140.53 -174.22 3.9 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.609 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -125.54 142.97 51.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.068 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -125.52 98.84 5.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.968 0.413 . . . . 10.0 110.171 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 18.6 mmtm 56.8 31.64 19.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.189 -0.914 . . . . 10.0 112.264 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.45 -56.35 0.72 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.263 -0.97 . . . . 10.0 114.022 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -78.88 158.38 28.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.097 0.449 . . . . 10.0 111.842 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -97.1 141.79 29.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.469 -0.332 . . . . 10.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -136.9 152.1 49.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.443 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -126.18 111.9 15.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.21 -0.45 . . . . 10.0 109.796 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 59.2 t -129.59 142.13 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.803 0.335 . . . . 10.0 111.172 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.67 142.37 57.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.647 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 16.5 tt -63.13 -25.83 39.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.232 0.539 . . . . 10.0 110.616 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -11.38 60.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 10.0 111.362 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -99.5 2.68 45.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.122 0.487 . . . . 10.0 110.207 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 61.3 mt -96.91 134.34 34.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.075 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.26 -72.86 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.031 0.443 . . . . 10.0 110.434 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -120.99 147.02 46.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.096 -0.502 . . . . 10.0 111.155 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 30.2 t -124.16 116.01 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.659 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 5.1 m -120.65 112.55 19.02 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.128 0.49 . . . . 10.0 112.266 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.557 ' HD2' ' OE1' ' B' ' 48' ' ' GLU . 37.3 ttp85 -102.9 131.71 49.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.939 -0.393 . . . . 10.0 109.939 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -89.88 -25.48 20.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.311 0.577 . . . . 10.0 110.787 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.07 -4.14 16.3 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.716 -0.954 . . . . 10.0 110.716 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -134.17 -38.44 0.86 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.889 -0.782 . . . . 10.0 108.889 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -135.71 143.64 45.5 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.717 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mt -105.22 121.45 57.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -113.16 127.67 56.25 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.443 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -145.87 167.27 23.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.769 0.318 . . . . 10.0 110.608 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' B' ' 33' ' ' ARG . 6.2 ttt180 -126.46 129.93 49.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.106 -0.497 . . . . 10.0 109.742 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -119.48 162.99 17.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.224 0.535 . . . . 10.0 111.629 -178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.8 133.81 50.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.081 -0.963 . . . . 10.0 109.269 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 41.9 mt -112.5 140.01 47.59 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.815 0.341 . . . . 10.0 110.915 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.2 -7.49 45.07 Favored Glycine 0 N--CA 1.454 -0.158 0 CA-C-N 115.829 -0.623 . . . . 10.0 112.839 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.07 8.89 59.18 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.916 -0.659 . . . . 10.0 111.975 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 74.1 47.93 16.98 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.913 -0.661 . . . . 10.0 112.372 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -163.02 99.28 1.04 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.552 0.215 . . . . 10.0 111.117 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.04 165.55 23.92 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.531 2.154 . . . . 10.0 110.874 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.76 -171.68 29.27 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 119.809 -1.186 . . . . 10.0 113.303 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . 0.558 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 1.5 m-85 -124.49 158.42 32.91 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.813 -0.44 . . . . 10.0 109.813 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.69 132.7 6.16 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.627 -0.796 . . . . 10.0 111.584 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.27 125.82 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.254 0.55 . . . . 10.0 110.443 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 t -121.08 136.85 56.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.047 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 28.1 t -83.9 130.72 34.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.933 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.557 ' OE1' ' HD2' ' B' ' 25' ' ' ARG . 5.1 tt0 -93.97 4.44 53.91 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.338 0.589 . . . . 10.0 109.732 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -98.7 -46.09 5.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.793 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.03 79.85 1.89 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.23 0.538 . . . . 10.0 111.712 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.54 156.22 10.36 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.151 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.33 128.01 25.96 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.618 2.212 . . . . 10.0 112.55 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -63.42 -27.13 69.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.966 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' B' ' 58' ' ' LYS . 0.1 OUTLIER -57.88 -33.17 68.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.492 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.2 -38.18 19.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.252 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 61.9 mt -61.88 -47.08 86.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 10.0 111.142 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -76.83 -5.91 50.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.799 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' B' ' 54' ' ' GLU . 4.0 tttt -92.23 -22.92 19.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 10.0 110.369 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 29.3 mt -82.62 -54.56 5.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.736 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . 0.425 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 31.6 tt0 -92.15 94.16 9.07 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.103 0.478 . . . . 10.0 110.044 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -86.41 166.67 15.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.69 -0.686 . . . . 10.0 109.827 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -63.57 132.02 49.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.78 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 29.6 mttt 61.32 49.6 5.28 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.777 -0.647 . . . . 10.0 111.187 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.601 -0.714 . . . . 10.0 110.495 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 120.554 0.216 . . . . 10.0 110.735 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.7 mt -90.39 146.21 24.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.33 -0.396 . . . . 10.0 110.52 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -123.04 145.25 48.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.431 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.01 142.38 38.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.162 -0.472 . . . . 10.0 110.481 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.13 120.64 20.91 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.256 -0.429 . . . . 10.0 111.131 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 139' ' ' ALA . 50.7 mt -79.74 -32.99 41.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.006 -0.543 . . . . 10.0 110.366 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -144.45 164.28 31.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.734 -0.667 . . . . 10.0 109.748 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.02 152.34 38.7 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.407 -0.59 . . . . 10.0 109.407 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -119.29 128.92 54.59 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.896 0.379 . . . . 10.0 111.026 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.79 92.59 6.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.09 -0.505 . . . . 10.0 109.67 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.91 162.8 29.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.56 . . . . 10.0 111.499 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -126.11 -45.64 1.7 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.023 -0.535 . . . . 10.0 110.728 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.23 -177.82 3.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.864 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -87.47 -11.21 49.65 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 111.891 0.33 . . . . 10.0 111.891 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.96 -39.04 31.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.993 0.425 . . . . 10.0 110.065 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.13 124.0 29.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.117 178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.2 tp -77.85 135.13 37.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.996 -0.547 . . . . 10.0 112.204 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.33 120.81 35.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.637 -0.711 . . . . 10.0 109.897 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -136.55 166.23 24.01 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.852 0.358 . . . . 10.0 111.29 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -109.78 168.32 9.5 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.839 -0.619 . . . . 10.0 111.391 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -65.27 134.3 53.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.389 -0.823 . . . . 10.0 111.357 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.41 2.95 88.89 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.118 -0.563 . . . . 10.0 113.725 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -81.41 151.26 28.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 117.073 0.436 . . . . 10.0 110.968 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -116.43 143.66 45.29 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.06 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.38 158.72 43.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 10.0 110.861 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -97.68 113.99 25.87 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.55 116.77 12.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.148 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.6 mt -83.96 -63.33 1.37 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.906 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -117.73 98.27 6.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.179 0.514 . . . . 10.0 111.403 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.41 -17.1 35.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.683 -0.689 . . . . 10.0 110.386 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.59 14.36 7.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.932 -0.577 . . . . 10.0 110.765 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -70.07 -44.39 69.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.314 0.578 . . . . 10.0 110.324 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 153.3 -113.37 0.57 Allowed Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.452 -0.794 . . . . 10.0 111.185 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.16 -45.68 6.44 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.587 -0.523 . . . . 10.0 109.587 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.435 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 29.4 m95 -92.4 110.68 22.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -96.52 150.25 20.83 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.843 0.354 . . . . 10.0 111.052 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -95.07 123.8 38.75 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.455 -0.943 . . . . 10.0 108.455 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.5 163.99 27.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.958 0.409 . . . . 10.0 111.345 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -114.58 128.4 56.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.779 -0.646 . . . . 10.0 109.834 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.1 t -68.88 147.7 51.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.919 0.39 . . . . 10.0 110.603 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.0 mt -94.52 -3.14 50.41 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.496 -0.557 . . . . 10.0 109.496 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.4 m -95.06 -66.36 0.92 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.638 -0.71 . . . . 10.0 111.363 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.0 p -90.18 -20.91 22.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 10.0 111.461 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.94 13.49 79.34 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.783 -0.723 . . . . 10.0 111.895 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -75.48 153.43 37.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.879 0.371 . . . . 10.0 110.898 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.9 m -117.6 135.75 53.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.176 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -179.47 176.79 47.95 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.433 -0.889 . . . . 10.0 112.221 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -84.29 138.95 32.64 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.307 -0.257 . . . . 10.0 110.307 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.2 pt -126.41 139.98 36.04 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 116.364 -0.38 . . . . 10.0 111.019 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.589 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 37.3 Cg_endo -68.83 121.57 8.46 Favored 'Trans proline' 0 C--O 1.237 0.44 0 C-N-CA 122.343 2.029 . . . . 10.0 111.415 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 p -66.46 -12.82 59.24 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.551 0.574 . . . . 10.0 112.551 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.589 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 35.4 p-10 -87.58 -8.31 56.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.859 0.361 . . . . 10.0 110.986 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -100.32 -17.66 17.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.021 0.439 . . . . 10.0 110.677 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 22.5 m -115.83 154.05 17.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.61 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 90' ' ' LEU . . . -137.82 145.24 47.59 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.407 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.46 124.76 12.88 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.219 1.946 . . . . 10.0 111.332 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.052 -0.975 . . . . 10.0 110.293 -179.909 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 111.239 0.088 . . . . 10.0 111.239 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.431 ' O ' HG22 ' B' ' 17' ' ' ILE . . . -169.66 169.67 8.46 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.683 0.278 . . . . 10.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 2.2 m -107.6 140.2 40.97 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.699 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 54.6 t -115.05 136.52 51.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.56 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -105.09 128.4 53.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.114 -0.493 . . . . 10.0 110.093 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -137.71 177.31 7.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.544 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -125.38 89.0 2.97 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.771 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -78.37 110.72 13.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.084 -0.507 . . . . 10.0 109.866 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm 58.28 24.21 11.28 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.027 0.441 . . . . 10.0 111.017 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.29 -14.7 59.49 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.821 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.51 127.44 34.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.857 0.361 . . . . 10.0 110.804 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.07 120.72 22.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.3 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -137.61 149.79 46.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.255 -0.429 . . . . 10.0 110.382 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -126.85 115.51 19.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.131 -0.486 . . . . 10.0 110.547 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 64.1 t -125.88 143.8 38.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.15 -0.477 . . . . 10.0 109.847 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 56.6 m-20 -64.42 135.04 55.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.995 0.426 . . . . 10.0 110.076 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.431 HG22 ' O ' ' B' ' 2' ' ' ALA . 15.8 tt -59.94 -26.23 35.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.614 -0.721 . . . . 10.0 111.398 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.06 -10.8 60.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.079 -0.509 . . . . 10.0 111.345 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -100.94 12.6 37.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.132 0.491 . . . . 10.0 110.337 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -99.6 132.22 45.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.049 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.98 -64.83 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.93 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -137.0 155.87 49.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.326 -0.397 . . . . 10.0 110.723 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' B' ' 59' ' ' LEU . 22.5 t -127.05 142.86 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.923 -0.581 . . . . 10.0 109.644 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 9.3 m -137.81 118.87 14.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.036 0.445 . . . . 10.0 111.577 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.462 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 57.4 ttp85 -111.59 116.12 30.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.11 0.481 . . . . 10.0 110.687 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -84.66 -21.3 30.27 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.331 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.82 12.63 15.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.556 -0.83 . . . . 10.0 111.497 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -138.56 -51.97 0.58 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.761 -0.829 . . . . 10.0 108.761 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -136.57 143.28 43.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.783 -1.099 . . . . 10.0 108.85 179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 27.8 mt -97.32 122.35 48.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.654 -0.498 . . . . 10.0 109.654 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -113.26 136.78 52.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.521 -0.309 . . . . 10.0 110.508 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -148.28 169.41 20.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.782 0.325 . . . . 10.0 110.646 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -126.81 131.24 51.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.037 -0.528 . . . . 10.0 109.847 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -125.55 165.53 18.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.031 0.443 . . . . 10.0 111.375 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -134.63 122.02 21.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.678 -0.692 . . . . 10.0 110.218 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 82.4 mt -90.27 147.48 23.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 10.0 111.59 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.49 -12.89 70.5 Favored Glycine 0 C--N 1.33 0.229 0 CA-C-N 115.933 -0.576 . . . . 10.0 112.549 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.38 13.94 43.22 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.906 -0.664 . . . . 10.0 112.555 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.31 54.94 7.29 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.702 -0.761 . . . . 10.0 111.966 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -157.59 95.28 2.06 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.648 0.261 . . . . 10.0 110.813 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.72 143.06 18.43 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.346 2.031 . . . . 10.0 110.792 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.93 -173.46 18.92 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 119.84 -1.172 . . . . 10.0 113.136 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 7.2 m-85 -128.46 161.11 30.26 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.445 -0.576 . . . . 10.0 109.445 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.85 143.74 12.98 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.346 -0.931 . . . . 10.0 112.208 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 2.4 p -131.3 130.37 63.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.995 0.426 . . . . 10.0 110.004 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 26.4 t -122.57 133.95 67.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.848 -0.614 . . . . 10.0 110.134 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.39 136.67 53.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.047 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -87.86 -19.3 27.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.002 0.429 . . . . 10.0 110.946 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -108.35 -36.72 6.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.176 -0.466 . . . . 10.0 110.524 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -96.88 52.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.904 -0.589 . . . . 10.0 111.002 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -169.21 151.92 4.84 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.305 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.29 140.57 59.09 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.485 2.123 . . . . 10.0 111.803 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -60.96 -21.03 63.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.309 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -54.67 -46.15 73.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.252 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.28 -35.41 48.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.782 0.325 . . . . 10.0 110.743 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 30.8 mt -61.55 -43.47 98.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.001 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -74.33 -7.3 52.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.546 . . . . 10.0 111.949 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -91.97 -33.92 14.66 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.842 -0.429 . . . . 10.0 109.842 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.464 ' HB3' HG11 ' B' ' 23' ' ' VAL . 89.5 mt -82.26 -36.9 26.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.943 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . 0.462 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 8.8 tp10 -79.73 94.73 5.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.267 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -105.58 142.79 34.7 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.182 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -67.47 127.1 31.46 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 62.5 mttt 64.77 65.01 0.63 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.935 0.772 . . . . 10.0 109.845 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' B' ' 23' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.606 -0.724 . . . . 10.0 110.586 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 120.568 0.223 . . . . 10.0 110.774 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.0 mt -93.66 148.13 22.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.021 -0.363 . . . . 10.0 110.021 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -120.59 134.19 55.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.385 -0.37 . . . . 10.0 110.711 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.45 140.29 34.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.026 -0.533 . . . . 10.0 109.95 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 138' ' ' VAL . . . -71.22 124.77 25.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.191 -0.458 . . . . 10.0 111.633 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.6 mt -80.75 -34.12 34.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.172 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -140.71 164.08 31.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.533 -0.758 . . . . 10.0 110.008 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.79 147.41 39.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.829 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -129.48 137.73 51.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.963 0.411 . . . . 10.0 111.243 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -98.31 130.98 44.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.946 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.411 ' HA ' ' OD1' ' A' ' 100' ' ' ASP . . . -84.54 139.78 31.89 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.22 -0.289 . . . . 10.0 110.22 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -107.89 -28.32 9.69 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.848 -0.341 . . . . 10.0 111.444 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.3 p -132.25 -161.47 1.14 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.993 0.425 . . . . 10.0 110.878 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -102.31 8.72 40.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.482 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -102.55 -38.83 7.36 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.497 -0.557 . . . . 10.0 109.497 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 95' ' ' ALA . 16.3 p-10 -89.87 149.46 22.63 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.748 -0.834 . . . . 10.0 108.748 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.4 tp -117.1 134.4 54.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.089 0.471 . . . . 10.0 111.964 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.67 151.38 26.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.831 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -159.57 170.57 21.36 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.363 -0.38 . . . . 10.0 110.314 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.428 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 59.2 m-70 -113.4 165.28 12.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.252 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -62.32 121.05 12.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.406 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.37 -4.34 33.14 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.958 -0.639 . . . . 10.0 112.122 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 104' ' ' HIS . 3.7 tp10 -66.86 129.32 39.49 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 122.287 0.235 . . . . 10.0 111.225 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -94.19 124.47 38.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.675 -0.491 . . . . 10.0 109.675 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -118.72 138.04 52.92 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.228 0.537 . . . . 10.0 112.088 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -100.52 105.67 17.12 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.388 -0.967 . . . . 10.0 108.388 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.8 mm -65.87 119.31 10.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.057 -0.519 . . . . 10.0 110.848 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.3 mt -96.29 -38.78 9.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.435 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 121' ' ' GLU . 18.3 t30 -137.23 101.62 4.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.194 0.521 . . . . 10.0 110.255 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.63 -13.44 16.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.17 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.69 3.01 27.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.993 -0.548 . . . . 10.0 111.802 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -65.94 -48.12 72.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.942 0.401 . . . . 10.0 110.581 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.43 -124.47 1.27 Allowed Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.826 -0.702 . . . . 10.0 111.813 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -76.68 -58.08 3.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.055 -0.35 . . . . 10.0 110.055 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.406 ' NE1' ' HB3' ' B' ' 31' ' ' PHE . 29.4 m95 -78.72 137.92 38.01 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 19.5 m0 -112.94 150.24 32.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.13 0.49 . . . . 10.0 111.901 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 113' ' ' ASN . 5.3 mt-10 -89.96 112.61 24.06 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.496 -0.927 . . . . 10.0 108.496 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.69 154.91 44.75 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.234 0.54 . . . . 10.0 111.908 -178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 123' ' ' ARG . 36.2 ttt-85 -109.15 132.54 54.02 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.442 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.9 t -73.78 131.64 41.77 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.725 -0.472 . . . . 10.0 109.725 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 93.6 mt -84.12 -10.75 57.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.208 0.528 . . . . 10.0 110.067 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -62.71 1.41 Allowed 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.444 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.9 p -89.08 -31.26 18.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.743 0.306 . . . . 10.0 111.796 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.8 -3.0 58.69 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.635 -0.793 . . . . 10.0 112.439 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -69.19 153.55 43.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.74 0.305 . . . . 10.0 111.195 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.4 m -127.37 134.88 49.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.982 -0.554 . . . . 10.0 110.957 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -176.14 -176.37 44.29 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.851 -0.69 . . . . 10.0 111.945 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.502 ' CE1' ' HG3' ' A' ' 121' ' ' GLU . 41.3 m-85 -83.92 131.32 34.86 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.7 pt -122.55 141.39 34.89 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.041 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.18 111.05 1.32 Allowed 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.495 2.13 . . . . 10.0 111.428 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.84 -18.86 63.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.693 -0.685 . . . . 10.0 112.232 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -83.07 -13.96 54.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.455 -0.339 . . . . 10.0 111.246 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -98.91 0.03 43.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.575 -0.284 . . . . 10.0 111.328 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 89' ' ' ALA . 15.7 m -123.33 161.23 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.823 0.344 . . . . 10.0 110.932 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -141.48 146.36 41.68 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.441 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 15.1 Cg_exo -67.35 135.61 37.29 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.478 2.119 . . . . 10.0 111.599 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.524 -0.751 . . . . 10.0 110.439 -179.74 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ttt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 120.41 0.148 . . . . 10.0 110.942 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.11 152.59 24.65 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.866 0.365 . . . . 10.0 111.447 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.66 133.56 36.88 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.371 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 t -110.74 135.41 49.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.734 0.302 . . . . 10.0 110.729 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -102.87 126.3 49.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.246 -0.434 . . . . 10.0 110.057 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -128.86 166.43 19.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.502 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.427 ' HG2' ' HG2' ' B' ' 12' ' ' GLU . 88.9 mttt -106.66 89.08 2.91 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.854 -0.612 . . . . 10.0 110.149 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -75.73 86.38 2.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.419 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 17.0 mmtm 54.85 35.36 24.11 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.3 -0.864 . . . . 10.0 111.294 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.48 -29.7 8.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.855 -0.688 . . . . 10.0 112.897 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -87.42 117.22 26.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.757 0.313 . . . . 10.0 111.121 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' B' ' 7' ' ' LYS . 34.8 mt-10 -83.51 114.34 21.42 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.998 0.428 . . . . 10.0 109.973 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -125.5 149.31 48.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.969 -0.559 . . . . 10.0 110.166 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -115.58 107.77 15.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.361 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.36 144.13 28.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.206 -0.452 . . . . 10.0 109.915 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.23 139.19 58.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.624 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.4 tt -63.29 -24.04 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.314 0.578 . . . . 10.0 110.732 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -16.01 62.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.932 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -98.93 15.93 24.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.34 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 72.9 mt -103.74 133.77 46.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.942 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.92 -71.62 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.472 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -128.94 147.0 50.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.709 -0.223 . . . . 10.0 110.844 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 27.9 t -125.53 127.69 71.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.1 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 63.1 m -129.8 118.21 21.44 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.081 0.467 . . . . 10.0 111.913 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 15.8 ttp85 -99.87 148.25 24.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.924 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -122.29 -25.47 4.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.965 0.357 . . . . 10.0 111.965 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 111.29 18.37 8.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.225 -0.988 . . . . 10.0 110.935 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -148.12 -50.65 0.17 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -148.7 134.0 18.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.854 -1.067 . . . . 10.0 109.647 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 24.4 mt -91.69 129.92 41.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.298 -0.41 . . . . 10.0 110.138 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.406 ' HB3' ' NE1' ' A' ' 119' ' ' TRP . 16.9 m-85 -115.61 135.27 54.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.324 -0.398 . . . . 10.0 110.481 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -150.15 171.08 17.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.673 0.273 . . . . 10.0 110.852 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -121.05 132.9 55.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.239 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -119.17 161.33 20.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.222 0.534 . . . . 10.0 111.455 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -133.09 128.79 36.96 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.542 -0.754 . . . . 10.0 109.751 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt -113.24 122.16 46.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.751 0.31 . . . . 10.0 110.613 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.2 -15.16 21.42 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.716 -0.675 . . . . 10.0 113.185 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.54 -14.48 67.11 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.286 -0.483 . . . . 10.0 112.437 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.55 40.84 2.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 10.0 113.009 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -159.93 89.9 1.85 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.066 0.46 . . . . 10.0 111.458 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -86.05 160.26 10.14 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.575 2.183 . . . . 10.0 110.836 177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -173.94 -156.43 13.52 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.016 -1.088 . . . . 10.0 112.446 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -124.3 171.36 9.95 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.225 -0.287 . . . . 10.0 110.225 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -148.68 141.1 8.73 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.802 -0.713 . . . . 10.0 111.7 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -128.16 132.71 68.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.279 0.561 . . . . 10.0 111.015 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 71.0 t -128.14 126.09 65.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.476 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' B' ' 51' ' ' ALA . 28.7 t -68.84 146.96 52.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.512 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.93 7.37 43.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.104 0.478 . . . . 10.0 110.35 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -114.32 -50.86 2.79 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.144 -0.48 . . . . 10.0 111.936 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -101.49 31.71 3.64 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.828 0.347 . . . . 10.0 111.919 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -133.35 149.32 72.12 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.768 -0.196 . . . . 10.0 110.56 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 16.9 Cg_exo -66.47 142.56 65.84 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.784 2.323 . . . . 10.0 112.654 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -65.86 -24.36 66.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.771 -0.649 . . . . 10.0 110.31 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -56.69 -30.7 63.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.544 -0.753 . . . . 10.0 110.987 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 82.8 mt -94.66 -37.25 11.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.914 0.387 . . . . 10.0 110.392 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 66.0 mt -63.64 -37.87 88.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.139 -0.482 . . . . 10.0 111.436 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -70.89 -16.32 62.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 10.0 111.242 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -86.33 -37.17 18.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.903 0.382 . . . . 10.0 110.275 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 67.5 mt -68.51 -41.13 80.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.931 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -85.62 100.16 11.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.156 0.503 . . . . 10.0 110.357 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -109.67 157.36 19.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.858 -0.61 . . . . 10.0 109.659 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -69.51 136.19 51.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.428 -0.351 . . . . 10.0 110.65 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 67.04 48.86 1.18 Allowed 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.758 0.662 . . . . 10.0 110.021 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.656 -0.688 . . . . 10.0 110.568 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.1 mt -109.59 145.32 36.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.961 0.41 . . . . 10.0 110.098 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -117.99 137.15 53.06 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.527 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.97 138.69 31.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.909 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.06 117.67 11.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.009 -0.542 . . . . 10.0 110.932 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.36 -49.31 67.34 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.076 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -138.04 170.3 16.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.554 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.72 133.93 47.03 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.626 -0.509 . . . . 10.0 109.626 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.487 ' CE1' HG21 ' B' ' 24' ' ' THR . 32.6 t80 -110.84 120.99 44.21 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.009 0.433 . . . . 10.0 111.337 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -89.12 120.48 30.55 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.886 -0.783 . . . . 10.0 108.886 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -77.69 155.62 31.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.054 0.454 . . . . 10.0 111.181 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.514 HH21 ' HA ' ' B' ' 64' ' ' LYS . 6.5 ttm180 -110.32 -41.44 4.39 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.449 -0.796 . . . . 10.0 110.119 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.75 -160.86 0.86 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.072 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -100.5 -3.29 31.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.094 0.473 . . . . 10.0 110.145 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -85.58 -44.02 13.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.384 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -81.58 129.74 34.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.419 -0.81 . . . . 10.0 109.587 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.8 tp -80.68 125.26 29.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.672 -0.694 . . . . 10.0 111.947 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.46 131.49 34.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.402 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -147.26 167.61 23.81 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.983 0.42 . . . . 10.0 111.541 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -106.25 164.01 12.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.849 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.01 132.88 51.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.568 -0.742 . . . . 10.0 111.359 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.82 -5.23 66.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.629 -0.796 . . . . 10.0 113.962 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -78.32 155.04 30.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.07 0.435 . . . . 10.0 111.192 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -122.54 141.68 51.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.851 -0.613 . . . . 10.0 109.898 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.75 155.42 50.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.786 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -99.19 120.5 39.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.8 -0.636 . . . . 10.0 109.621 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.47 120.33 20.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.053 -0.522 . . . . 10.0 110.889 -179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 86.7 mt -93.53 -46.61 7.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.132 -0.486 . . . . 10.0 110.691 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -135.19 103.71 5.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.172 0.51 . . . . 10.0 111.05 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.92 -11.81 27.96 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.78 -0.645 . . . . 10.0 110.859 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.07 0.16 54.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.398 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -63.1 -32.9 74.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.218 0.532 . . . . 10.0 110.5 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 144.99 -110.03 0.54 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.881 -0.676 . . . . 10.0 111.913 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.09 -50.86 3.53 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.09 -0.337 . . . . 10.0 110.09 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.472 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 54.2 m95 -82.81 107.11 15.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.751 -1.203 . . . . 10.0 107.751 177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 9.1 m0 -89.18 146.02 25.04 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.151 0.5 . . . . 10.0 111.553 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -86.69 115.91 24.45 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.83 154.94 41.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.112 0.482 . . . . 10.0 111.474 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.6 ttp85 -109.6 125.37 52.49 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.657 -0.701 . . . . 10.0 109.487 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.2 t -61.6 131.06 48.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.577 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.35 -6.22 58.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.832 -0.622 . . . . 10.0 109.783 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.26 -63.02 1.49 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.523 -0.762 . . . . 10.0 109.954 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.7 p -104.24 -61.14 1.48 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.184 -0.462 . . . . 10.0 110.691 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 149.83 -7.98 0.81 Allowed Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.919 -0.582 . . . . 10.0 111.826 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -50.06 134.36 21.95 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.088 0.47 . . . . 10.0 111.879 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.1 m -116.69 132.45 56.69 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.849 -0.614 . . . . 10.0 110.306 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.24 -178.25 43.08 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.275 -0.964 . . . . 10.0 112.629 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -78.71 126.44 30.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.17 -0.307 . . . . 10.0 110.17 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.4 pt -112.84 135.69 21.63 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 10.0 111.127 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.454 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 34.8 Cg_endo -69.25 116.57 4.57 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.558 2.172 . . . . 10.0 111.518 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -14.36 60.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.695 -0.684 . . . . 10.0 112.35 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.513 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 38.4 p-10 -89.45 -3.34 58.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.452 -0.34 . . . . 10.0 111.032 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.448 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 11.2 m-85 -113.4 6.48 17.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.704 0.288 . . . . 10.0 111.223 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.5 m -129.64 150.58 34.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.937 0.399 . . . . 10.0 111.196 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -131.88 145.4 57.3 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.183 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -65.47 124.72 13.26 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.489 2.126 . . . . 10.0 111.82 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.403 -0.808 . . . . 10.0 110.158 179.854 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.638 0.256 . . . . 10.0 110.533 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.27 157.8 23.41 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.9 0.381 . . . . 10.0 110.922 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.9 m -96.74 131.35 43.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.684 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 t -103.38 138.32 28.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.07 0.462 . . . . 10.0 111.158 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 33.2 tttt -99.74 127.77 45.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.633 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -135.54 175.96 9.11 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.846 0.355 . . . . 10.0 111.002 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -120.97 106.48 11.64 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.943 -0.571 . . . . 10.0 109.801 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -94.11 95.59 9.09 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.678 -0.489 . . . . 10.0 109.678 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm 59.64 34.65 22.27 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.773 -0.649 . . . . 10.0 111.053 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.29 -24.82 29.83 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.808 -0.633 . . . . 10.0 112.49 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -82.96 111.32 18.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.75 0.31 . . . . 10.0 110.914 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -76.35 121.17 22.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.416 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -135.55 162.27 33.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.066 -0.515 . . . . 10.0 110.485 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -126.4 121.95 33.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.561 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 82.1 t -131.94 142.66 42.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 110.148 -0.315 . . . . 10.0 110.148 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 23.6 m-20 -70.1 141.79 52.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.898 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 12.9 tt -61.98 -26.2 39.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.961 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -17.93 64.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.975 -0.557 . . . . 10.0 111.094 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -99.87 3.16 44.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.681 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 65.1 mt -91.91 128.84 43.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.123 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 t -75.09 -63.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.045 -0.525 . . . . 10.0 111.097 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -138.6 152.51 48.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.471 -0.331 . . . . 10.0 110.86 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' B' ' 59' ' ' LEU . 18.8 t -131.33 138.49 53.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.3 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . 0.487 HG21 ' CE1' ' A' ' 93' ' ' TYR . 8.7 m -143.09 125.6 15.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.201 0.524 . . . . 10.0 111.25 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.499 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 40.9 ttp85 -105.39 155.64 18.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.939 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -121.77 -34.95 3.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.702 0.287 . . . . 10.0 111.742 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.85 27.23 1.95 Allowed Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 110.241 -1.144 . . . . 10.0 110.241 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 37.9 mmtm -152.64 -57.82 0.14 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.161 -1.052 . . . . 10.0 108.161 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . 0.416 ' HG2' ' HA ' ' B' ' 47' ' ' SER . 42.0 mt-30 -142.93 142.05 31.61 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.667 -1.151 . . . . 10.0 109.569 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -95.46 130.11 44.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 24.8 m-85 -114.23 139.58 49.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.546 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . 0.417 ' N ' ' HE1' ' A' ' 119' ' ' TRP . 42.8 p90 -152.0 160.85 43.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.91 0.386 . . . . 10.0 111.149 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -123.13 132.92 54.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.362 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -126.12 167.43 15.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.945 0.402 . . . . 10.0 111.491 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -137.66 129.37 28.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.359 -0.837 . . . . 10.0 109.437 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 96.8 mt -101.44 143.85 30.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 10.0 111.077 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.51 -3.21 53.3 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 115.904 -0.589 . . . . 10.0 112.59 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.92 -8.57 87.55 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.933 -0.651 . . . . 10.0 112.068 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.72 42.5 3.34 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.976 -0.631 . . . . 10.0 112.265 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -163.77 114.7 0.99 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.711 0.291 . . . . 10.0 110.905 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -86.06 169.47 8.8 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.737 2.291 . . . . 10.0 111.311 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.51 -177.63 37.3 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.003 -1.094 . . . . 10.0 112.965 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . 0.472 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 43.5 m-85 -132.23 164.5 26.23 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.87 150.43 22.09 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.488 -0.863 . . . . 10.0 112.183 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.52 139.2 28.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.101 0.477 . . . . 10.0 110.918 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.22 133.69 55.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.77 -0.65 . . . . 10.0 109.73 178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.416 ' HA ' ' HG2' ' B' ' 29' ' ' GLN . 0.2 OUTLIER -80.77 134.21 35.77 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.838 0.351 . . . . 10.0 110.516 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -77.7 41.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 10.0 110.769 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.27 -62.26 0.54 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.509 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.26 -29.53 61.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.864 -0.607 . . . . 10.0 112.033 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -88.31 136.16 32.07 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 116.474 -0.33 . . . . 10.0 111.314 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 52.9 Cg_exo -56.75 144.17 87.83 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.832 2.355 . . . . 10.0 112.197 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -61.64 -26.04 67.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 10.0 112.074 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -33.57 71.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.953 0.406 . . . . 10.0 110.064 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 mt -80.96 -39.57 25.82 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 115.91 -0.586 . . . . 10.0 110.185 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -64.05 -38.64 91.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.62 -0.718 . . . . 10.0 110.962 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -71.93 -15.07 62.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 10.0 111.032 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -81.82 -24.27 35.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.316 0.579 . . . . 10.0 109.47 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.479 ' HB3' HG11 ' B' ' 23' ' ' VAL . 64.0 mt -89.07 -52.5 5.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.33 -0.85 . . . . 10.0 111.352 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . 0.499 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 28.9 tt0 -86.38 106.08 17.17 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.337 0.589 . . . . 10.0 110.228 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -107.25 164.38 12.22 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.333 -0.849 . . . . 10.0 109.21 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -59.2 128.99 39.93 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.181 0.301 . . . . 10.0 110.906 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.5 mttt 66.95 75.88 0.3 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.372 -0.831 . . . . 10.0 110.676 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.514 ' HA ' HH21 ' A' ' 96' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.496 -0.764 . . . . 10.0 110.284 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 121.215 0.531 . . . . 10.0 110.809 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.0 mt -104.13 136.88 42.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.108 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -125.22 137.04 54.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.935 0.397 . . . . 10.0 110.907 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.16 140.78 31.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.716 -0.674 . . . . 10.0 110.353 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 119.91 17.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.026 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.462 ' O ' ' HE2' ' A' ' 105' ' ' LYS . 71.2 mt -72.0 -36.77 69.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.405 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -141.63 169.92 16.7 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.789 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.33 149.29 40.68 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.499 -0.556 . . . . 10.0 109.499 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -124.08 124.73 43.16 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.107 0.48 . . . . 10.0 111.985 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.43 98.12 9.99 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.308 -0.86 . . . . 10.0 109.097 178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.49 155.51 14.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.608 -0.724 . . . . 10.0 112.191 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -114.4 -32.8 5.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.306 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.26 -166.52 1.66 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.272 -0.171 . . . . 10.0 110.844 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.4 -1.21 51.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 10.0 109.908 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.57 -42.45 16.76 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.065 -0.717 . . . . 10.0 109.065 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -91.82 138.41 31.57 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.946 -1.025 . . . . 10.0 109.894 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.1 tp -100.64 133.16 45.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.914 -0.585 . . . . 10.0 111.633 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.22 147.13 27.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.539 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -152.72 162.66 40.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.646 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -101.47 163.86 12.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.735 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 90' ' ' LEU . 57.7 tttm -60.97 118.71 7.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.767 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 108.92 -0.25 31.8 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.678 -0.773 . . . . 10.0 112.641 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.4 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 2.3 tp10 -68.4 141.31 55.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.584 0.23 . . . . 10.0 110.74 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -120.67 134.8 55.26 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.4 ' CZ ' ' HB3' ' A' ' 107' ' ' GLU . 0.5 OUTLIER -128.29 157.57 40.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.317 0.579 . . . . 10.0 111.919 -178.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -99.88 110.16 22.52 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.935 -1.135 . . . . 10.0 107.935 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 49.6 mm -64.35 116.64 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.299 -0.409 . . . . 10.0 111.651 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 82.6 mt -104.12 -57.7 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.563 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.7 t30 -117.65 112.9 21.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.34 -0.391 . . . . 10.0 110.355 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.58 -17.59 3.25 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.21 0.448 . . . . 10.0 112.21 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.2 m -83.14 -6.26 59.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.032 0.382 . . . . 10.0 112.032 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -66.11 -53.29 39.7 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 10.0 110.55 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.421 ' HA3' ' CD1' ' B' ' 43' ' ' PHE . . . -167.17 -159.14 12.25 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.451 -0.66 . . . . 10.0 111.451 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.69 -34.56 74.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.929 0.395 . . . . 10.0 110.689 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -86.07 112.69 21.5 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.781 -0.822 . . . . 10.0 108.781 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -91.17 145.7 24.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.927 -0.578 . . . . 10.0 111.471 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -108.66 115.85 30.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.075 -1.083 . . . . 10.0 108.075 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.1 164.64 26.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.064 0.459 . . . . 10.0 111.903 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.95 127.77 51.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.457 -0.792 . . . . 10.0 109.778 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.7 t -65.72 135.11 54.52 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.311 -0.404 . . . . 10.0 109.919 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 82.4 mt -82.3 -15.46 52.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.183 0.516 . . . . 10.0 109.806 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.8 m -79.85 -67.94 0.72 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.476 -0.784 . . . . 10.0 111.556 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.3 p -92.21 -34.68 14.19 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.151 0.426 . . . . 10.0 112.151 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.3 -4.97 35.45 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.628 -0.796 . . . . 10.0 112.071 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -63.75 141.61 58.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.681 0.277 . . . . 10.0 110.695 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.7 m -117.75 133.13 56.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.859 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -172.86 -178.57 42.99 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.799 -0.715 . . . . 10.0 112.093 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -78.66 131.39 36.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 10.0 110.498 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.0 pt -123.06 136.71 27.21 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.513 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 137' ' ' TYR . 26.4 Cg_endo -64.66 117.44 4.51 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.46 2.107 . . . . 10.0 111.563 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.72 -19.41 65.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.798 -0.637 . . . . 10.0 112.363 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.424 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 36.0 p-10 -87.05 0.46 55.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.405 -0.361 . . . . 10.0 111.338 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 13.2 m-85 -116.28 -0.08 12.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.697 0.284 . . . . 10.0 111.223 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.1 m -126.35 151.94 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.906 0.384 . . . . 10.0 111.451 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.45 150.17 62.86 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.266 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.14 142.63 97.45 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.686 2.257 . . . . 10.0 112.348 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.459 -0.782 . . . . 10.0 110.809 -179.667 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 20.3 ttt . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.571 0.224 . . . . 10.0 110.667 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.6 161.09 26.57 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.733 0.302 . . . . 10.0 110.952 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 7.1 m -100.73 133.28 45.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.388 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 21.0 t -115.42 138.8 44.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.002 0.43 . . . . 10.0 111.488 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 70.2 tttt -96.5 135.01 38.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.853 -0.612 . . . . 10.0 109.678 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -147.85 -179.51 6.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.816 0.341 . . . . 10.0 110.703 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.442 ' HE2' ' OE2' ' B' ' 12' ' ' GLU . 66.9 mttt -117.53 141.79 47.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.147 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -146.85 110.82 5.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.595 -0.275 . . . . 10.0 110.716 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm 67.5 1.89 2.71 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.937 0.773 . . . . 10.0 111.969 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.77 -52.57 0.82 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.668 -0.777 . . . . 10.0 112.096 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.49 145.35 47.58 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.866 0.365 . . . . 10.0 110.323 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.442 ' OE2' ' HE2' ' B' ' 7' ' ' LYS . 21.7 mt-10 -90.92 122.46 33.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.811 -0.631 . . . . 10.0 109.866 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -116.33 157.34 25.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.347 -0.388 . . . . 10.0 110.641 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -128.45 118.21 22.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.319 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 46.8 t -134.56 149.38 29.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.487 -0.56 . . . . 10.0 109.487 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.546 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 18.8 m-20 -68.26 138.38 55.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.715 0.293 . . . . 10.0 110.518 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 tt -62.54 -24.54 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 2.4 m -72.46 -9.2 58.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.886 -0.597 . . . . 10.0 111.082 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -106.6 11.8 30.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.338 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' B' ' 34' ' ' TYR . 67.6 mt -99.48 137.43 26.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.816 -0.629 . . . . 10.0 109.996 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 6.8 t -77.92 -74.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.777 0.322 . . . . 10.0 111.059 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -126.97 155.17 43.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.423 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.26 125.4 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.34 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -120.05 118.41 30.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.14 0.495 . . . . 10.0 111.464 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 40.5 ttp85 -104.81 144.17 32.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.142 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -115.36 -26.52 7.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.611 0.243 . . . . 10.0 111.131 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.71 14.57 8.62 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.401 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -145.24 -52.79 0.28 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.818 -0.808 . . . . 10.0 108.818 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -142.47 135.39 28.36 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.814 -1.085 . . . . 10.0 109.519 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 61.3 mt -93.02 133.52 33.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.212 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 53.3 m-85 -119.89 137.94 53.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.47 174.31 13.54 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.087 0.47 . . . . 10.0 111.383 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -126.95 126.45 43.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.315 -0.857 . . . . 10.0 109.399 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' B' ' 20' ' ' ILE . 53.9 p90 -116.12 159.03 22.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.936 0.398 . . . . 10.0 111.223 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -126.26 115.83 20.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.434 -0.803 . . . . 10.0 109.775 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 72.3 mt -85.41 137.41 32.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.005 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.36 -13.54 58.36 Favored Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.912 -0.586 . . . . 10.0 112.807 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.03 2.65 83.39 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.179 -0.534 . . . . 10.0 112.368 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.49 46.02 5.35 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.917 -0.659 . . . . 10.0 112.873 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 58.4 tttt -152.62 95.3 3.09 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.713 0.292 . . . . 10.0 111.211 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.49 150.88 25.33 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.931 2.421 . . . . 10.0 110.9 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.16 -170.9 22.59 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.044 -1.074 . . . . 10.0 112.885 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . 0.421 ' CD1' ' HA3' ' A' ' 117' ' ' GLY . 24.4 m-85 -126.6 165.8 18.5 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.56 -0.533 . . . . 10.0 109.56 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.45 149.48 20.08 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.251 -0.976 . . . . 10.0 112.553 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.1 p -125.53 138.1 55.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.092 0.473 . . . . 10.0 110.85 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 74.7 t -125.76 118.85 53.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.747 -0.661 . . . . 10.0 110.002 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 118.74 15.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.572 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.73 -7.93 43.6 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.648 0.61 . . . . 10.0 112.648 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -103.75 -24.18 13.36 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 111.84 0.311 . . . . 10.0 111.84 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.38 -42.37 6.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.361 0.504 . . . . 10.0 112.361 -177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.96 146.81 87.97 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.686 -0.233 . . . . 10.0 111.547 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.63 147.42 91.94 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.693 2.262 . . . . 10.0 111.467 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -60.61 -24.77 65.75 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -59.11 -44.16 91.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.872 0.368 . . . . 10.0 110.641 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 79.1 mt -72.45 -35.79 68.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.431 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 68.0 mt -65.49 -42.0 92.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.745 -0.661 . . . . 10.0 111.487 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -78.05 -16.92 57.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 10.0 110.909 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -79.46 -45.92 18.48 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.551 -0.537 . . . . 10.0 109.551 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 83.1 mt -69.79 -47.78 61.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.593 -0.73 . . . . 10.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -82.62 98.74 9.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.007 0.432 . . . . 10.0 110.453 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -96.22 144.2 26.63 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.844 -0.616 . . . . 10.0 109.919 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -61.89 130.88 47.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.968 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 67.58 97.38 0.06 Allowed 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.981 0.8 . . . . 10.0 111.23 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.637 -0.697 . . . . 10.0 110.302 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.632 0.253 . . . . 10.0 110.985 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 69.7 mt -108.49 140.23 42.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.559 -0.291 . . . . 10.0 110.361 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -112.33 130.05 56.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.209 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.5 p -109.1 140.38 28.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.219 -0.446 . . . . 10.0 110.234 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.26 121.36 19.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.84 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.9 mt -74.6 -32.67 62.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.338 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -149.8 168.15 24.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.483 -0.781 . . . . 10.0 109.502 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -76.77 139.58 40.45 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.744 -0.465 . . . . 10.0 109.744 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -101.84 128.56 48.16 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.834 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -77.84 101.37 6.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.681 -0.69 . . . . 10.0 109.353 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -52.28 141.37 19.35 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.633 0.583 . . . . 10.0 111.661 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -106.93 -58.5 1.93 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.661 -0.7 . . . . 10.0 111.03 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.8 p -131.83 -165.86 1.64 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.958 -0.565 . . . . 10.0 110.346 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -89.32 -6.73 56.47 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.13 -0.693 . . . . 10.0 109.13 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -76.42 -45.14 32.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.045 -0.98 . . . . 10.0 110.006 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -82.5 152.86 25.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.466 -0.788 . . . . 10.0 110.149 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.406 HD11 ' HB2' ' A' ' 129' ' ' GLU . 22.8 tp -89.82 132.2 35.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.345 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.1 m -91.15 126.16 36.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.751 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -146.83 165.49 29.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.828 0.346 . . . . 10.0 111.218 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -118.33 166.51 12.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.166 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.2 tttm -66.52 132.25 47.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.942 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.56 -6.16 52.3 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.835 -0.698 . . . . 10.0 112.71 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -81.54 150.35 28.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.926 0.393 . . . . 10.0 111.415 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -113.16 128.24 56.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.745 -0.662 . . . . 10.0 109.225 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -120.25 144.47 47.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.9 0.381 . . . . 10.0 111.216 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -99.08 110.66 23.22 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 16.9 mm -66.22 118.63 9.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.334 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -86.13 -37.72 18.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.083 -0.508 . . . . 10.0 109.896 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -153.57 112.37 3.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.968 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.47 2.59 47.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.274 0.559 . . . . 10.0 110.656 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.91 20.07 1.94 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.931 -0.577 . . . . 10.0 111.794 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.61 -42.89 17.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.274 0.559 . . . . 10.0 110.159 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 138.5 -70.79 0.46 Allowed Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.702 -0.681 . . . . 10.0 111.82 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -122.76 -69.0 0.85 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.709 -0.478 . . . . 10.0 109.709 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.499 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 40.0 m95 -78.35 100.84 6.93 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.444 -0.947 . . . . 10.0 108.444 178.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -88.34 156.26 19.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.057 -0.52 . . . . 10.0 111.941 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -84.56 122.9 29.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.404 -0.817 . . . . 10.0 109.028 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.25 153.13 43.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.238 0.542 . . . . 10.0 112.107 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -114.06 123.29 49.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.072 -0.967 . . . . 10.0 109.128 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.6 t -67.22 131.36 45.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.955 0.407 . . . . 10.0 110.016 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.4 mt -83.1 -21.28 33.73 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.535 -0.543 . . . . 10.0 109.535 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.31 -55.15 6.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.077 -0.965 . . . . 10.0 111.075 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.4 p -94.58 -67.17 0.87 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.766 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.29 -2.2 3.83 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 110.824 -0.91 . . . . 10.0 110.824 -178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.406 ' HB2' HD11 ' A' ' 101' ' ' LEU . 40.8 mt-10 -68.66 148.05 50.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.294 -0.453 . . . . 10.0 110.738 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.2 m -120.91 138.71 53.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.914 -0.585 . . . . 10.0 110.233 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.85 -175.05 47.49 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.571 -0.823 . . . . 10.0 112.159 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -88.79 135.7 33.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.615 0.245 . . . . 10.0 110.69 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.0 pt -125.78 143.96 46.84 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.192 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.513 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 56.9 Cg_endo -73.16 121.45 7.25 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.396 2.064 . . . . 10.0 111.347 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.18 -1.65 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.59 0.589 . . . . 10.0 112.59 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.513 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 36.8 p-10 -96.33 0.55 50.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.794 0.33 . . . . 10.0 110.768 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -119.7 1.03 11.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.035 0.445 . . . . 10.0 111.202 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.7 m -126.63 154.33 36.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.37 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.15 147.13 42.83 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.804 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -71.29 142.85 42.23 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.438 2.092 . . . . 10.0 111.512 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.406 -0.807 . . . . 10.0 110.143 179.947 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.309 0.1 . . . . 10.0 110.828 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.03 171.23 11.26 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.751 0.31 . . . . 10.0 110.883 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.3 m -107.72 129.16 55.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.34 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 47.1 t -102.85 137.39 31.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 10.0 110.722 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -101.94 137.32 40.37 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.21 -0.45 . . . . 10.0 110.417 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -145.55 168.13 21.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.254 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.45 85.14 2.32 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.079 -0.341 . . . . 10.0 110.079 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -67.77 96.38 0.56 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.356 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt 58.94 26.33 14.85 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.353 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.26 -27.23 9.66 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.973 -0.632 . . . . 10.0 112.703 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -76.87 114.03 15.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.693 0.283 . . . . 10.0 111.204 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.03 109.75 7.78 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.772 -0.455 . . . . 10.0 109.772 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -131.08 157.38 43.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.55 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -129.42 132.02 46.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.434 -0.348 . . . . 10.0 110.847 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 90.8 t -136.99 147.13 27.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.413 ' HB2' ' HD2' ' B' ' 19' ' ' LYS . 18.1 m-20 -61.16 135.99 57.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 10.0 110.783 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 11.4 tt -60.6 -31.4 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.492 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -5.49 39.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.165 -0.471 . . . . 10.0 111.584 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.413 ' HD2' ' HB2' ' B' ' 16' ' ' ASP . 80.9 mttt -105.29 9.99 33.73 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.21 0.529 . . . . 10.0 110.618 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 78.7 mt -95.55 121.7 46.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -70.39 -60.0 2.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.69 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.22 151.53 45.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.852 0.358 . . . . 10.0 111.318 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 t -127.02 138.41 54.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.278 -0.873 . . . . 10.0 109.564 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -136.91 118.6 15.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.977 0.418 . . . . 10.0 111.04 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 35.1 ttp85 -109.03 141.1 41.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.228 -0.442 . . . . 10.0 110.409 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -115.92 -26.06 7.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.339 -0.391 . . . . 10.0 111.168 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 113.64 29.76 2.81 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.748 . . . . 10.0 111.452 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -157.52 -53.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -139.23 129.88 25.95 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.283 -0.871 . . . . 10.0 109.806 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mt -88.98 117.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.439 -0.578 . . . . 10.0 109.439 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -104.97 139.12 40.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.688 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -158.81 166.19 32.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.724 0.297 . . . . 10.0 110.939 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -127.63 135.91 50.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.097 -0.501 . . . . 10.0 109.837 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -122.11 165.15 16.53 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.483 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -136.32 121.81 19.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.844 -0.616 . . . . 10.0 110.331 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 66.1 mt -98.11 142.38 29.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.875 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.38 -14.99 62.94 Favored Glycine 0 C--N 1.329 0.148 0 CA-C-N 116.095 -0.502 . . . . 10.0 112.815 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.64 11.94 54.2 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.922 -0.656 . . . . 10.0 112.659 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.3 51.1 6.28 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.889 -0.672 . . . . 10.0 111.766 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 tptt -138.93 90.46 12.2 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 121.072 -0.251 . . . . 10.0 110.987 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -89.05 110.02 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 122.771 2.314 . . . . 10.0 110.467 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.63 -177.86 15.18 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.124 -1.036 . . . . 10.0 112.897 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 23.0 m-85 -120.8 166.74 13.32 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.785 -0.45 . . . . 10.0 109.785 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.35 142.8 12.02 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.827 -0.702 . . . . 10.0 112.169 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.68 129.25 51.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.844 0.354 . . . . 10.0 110.43 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 67.5 t -126.07 127.19 70.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.204 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.15 127.94 34.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.457 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -83.73 26.06 0.73 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -137.69 -50.54 0.61 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.347 0.499 . . . . 10.0 112.347 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -95.64 19.86 10.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.079 0.4 . . . . 10.0 112.079 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -126.34 144.14 48.32 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.614 -0.267 . . . . 10.0 110.456 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -51.41 138.45 47.15 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.025 2.483 . . . . 10.0 112.248 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -60.7 -27.55 67.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.982 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -59.83 -38.1 81.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.716 0.293 . . . . 10.0 111.134 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 94.5 mt -69.19 -39.85 78.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.382 . . . . 10.0 110.035 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 21.9 mt -67.84 -39.72 83.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.588 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -66.93 -31.61 72.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.266 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -80.42 -8.6 59.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.003 0.43 . . . . 10.0 110.748 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 25.5 mt -96.09 -45.56 6.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.791 0.293 . . . . 10.0 111.791 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -91.54 131.84 36.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.015 0.436 . . . . 10.0 111.213 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -123.86 163.57 20.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 10.0 109.487 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -74.35 131.99 41.62 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.893 -0.323 . . . . 10.0 110.613 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 mttp 64.0 62.52 0.87 Allowed 'General case' 0 C--O 1.236 0.38 0 O-C-N 123.921 0.763 . . . . 10.0 110.746 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.496 -0.764 . . . . 10.0 110.254 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.753 0.311 . . . . 10.0 110.552 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.4 mt -88.09 160.79 17.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.367 -0.379 . . . . 10.0 110.309 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -121.18 135.92 55.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.505 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 p -111.05 139.29 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.553 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.99 124.63 25.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.162 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.411 ' O ' ' HE2' ' A' ' 105' ' ' LYS . 59.6 mt -83.51 -33.37 25.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.216 0.531 . . . . 10.0 110.607 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -139.61 154.57 47.61 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.962 -0.563 . . . . 10.0 109.812 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.01 150.42 42.43 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.619 -0.512 . . . . 10.0 109.619 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -138.02 133.93 34.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.629 0.252 . . . . 10.0 110.518 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.65 132.45 46.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.15 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.497 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -91.88 148.76 21.98 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.015 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 96' ' ' ARG . 5.4 ttm180 -119.8 -21.37 7.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.345 0.593 . . . . 10.0 109.968 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.55 -178.48 4.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.005 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -94.17 8.56 41.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.358 0.599 . . . . 10.0 110.143 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.69 -44.14 7.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.303 -0.862 . . . . 10.0 109.521 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 95' ' ' ALA . 15.9 p-10 -88.39 151.21 22.74 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.411 -0.813 . . . . 10.0 109.053 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 55.9 tp -112.0 129.12 56.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.984 0.421 . . . . 10.0 112.057 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.497 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -84.28 139.36 32.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.124 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.402 ' CB ' ' HZ ' ' A' ' 109' ' ' PHE . 31.3 p90 -155.2 170.81 20.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.841 0.353 . . . . 10.0 111.225 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -114.91 157.61 23.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.591 -0.731 . . . . 10.0 109.71 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 90' ' ' LEU . 54.8 tttm -62.32 131.99 51.16 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.461 -0.336 . . . . 10.0 110.664 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 111.71 -19.73 23.3 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.546 -0.835 . . . . 10.0 112.863 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -77.15 148.98 35.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.98 0.419 . . . . 10.0 110.834 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -114.68 144.09 43.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.122 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.402 ' HZ ' ' CB ' ' A' ' 103' ' ' PHE . 32.1 m-85 -129.51 153.91 47.53 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.963 0.411 . . . . 10.0 111.306 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -100.1 114.35 27.64 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.135 -1.061 . . . . 10.0 108.135 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 46.9 mm -69.35 119.15 14.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.904 0.383 . . . . 10.0 111.142 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 66.4 mt -85.37 -52.58 5.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.648 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -135.92 109.1 7.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.877 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.36 -8.08 39.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.225 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.27 21.22 9.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.534 -0.757 . . . . 10.0 110.45 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 119' ' ' TRP . 19.4 tp10 -67.59 -43.39 80.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.645 -0.707 . . . . 10.0 110.356 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 155.28 -106.54 0.3 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.833 -0.698 . . . . 10.0 111.887 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -99.4 -11.44 21.15 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.213 0.53 . . . . 10.0 109.971 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.482 ' O ' ' HB3' ' A' ' 116' ' ' GLU . 39.9 m95 -124.64 159.71 30.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.155 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 46.8 m0 -119.85 139.99 51.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.943 0.401 . . . . 10.0 111.88 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -90.23 116.11 27.97 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.786 -1.19 . . . . 10.0 107.786 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.91 160.61 30.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.643 0.735 . . . . 10.0 112.579 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -116.31 128.29 55.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.67 -1.15 . . . . 10.0 109.226 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t -66.43 133.16 49.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.81 0.338 . . . . 10.0 111.101 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 87.8 mt -92.04 -11.23 36.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.432 0.634 . . . . 10.0 109.362 178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.07 -50.47 8.48 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.347 -0.842 . . . . 10.0 110.537 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.0 p -111.05 -55.89 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.099 0.476 . . . . 10.0 111.298 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 135.1 -8.54 4.44 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.908 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -55.73 146.82 20.18 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.05 0.452 . . . . 10.0 111.843 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -116.83 142.62 46.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.329 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.92 173.47 42.51 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.419 -0.896 . . . . 10.0 112.076 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -84.79 131.34 34.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.019 0.438 . . . . 10.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 27.0 pt -115.51 144.53 32.61 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.513 -0.767 . . . . 10.0 109.547 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.469 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 19.6 Cg_exo -63.89 114.53 2.64 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 121.849 1.7 . . . . 10.0 111.141 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.1 -14.2 15.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.559 -0.746 . . . . 10.0 112.46 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.405 ' ND2' ' HB2' ' B' ' 26' ' ' TYR . 23.0 p-10 -104.27 12.88 33.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.424 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 134' ' ' PRO . 8.8 m-85 -120.82 3.34 10.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.747 0.308 . . . . 10.0 111.163 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.9 m -128.84 148.44 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.945 0.402 . . . . 10.0 111.12 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -128.9 141.44 41.71 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.292 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.02 137.02 43.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.654 2.236 . . . . 10.0 111.973 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 64.3 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.397 -0.811 . . . . 10.0 109.785 179.678 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ttt . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 120.668 0.271 . . . . 10.0 110.398 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.52 147.58 28.36 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.863 0.364 . . . . 10.0 110.866 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.55 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.8 m -97.84 132.33 43.54 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.419 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 48.5 t -104.46 131.62 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.253 -0.43 . . . . 10.0 110.867 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 55.2 tttt -98.42 131.62 44.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.677 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -145.42 -174.07 4.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.742 0.306 . . . . 10.0 110.809 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 tttt -130.2 123.96 31.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.895 -0.593 . . . . 10.0 109.841 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . 0.481 ' O ' ' HG2' ' B' ' 11' ' ' GLU . 17.9 t80 -102.17 94.05 5.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.869 0.366 . . . . 10.0 110.122 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt 60.44 13.4 4.07 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.639 -0.71 . . . . 10.0 112.156 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.68 -35.87 2.0 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.38 -0.914 . . . . 10.0 113.159 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' B' ' 8' ' ' TYR . 12.0 pt-20 -82.57 136.66 34.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.159 0.479 . . . . 10.0 111.062 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -83.62 138.59 33.28 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -148.3 150.48 33.7 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.894 0.378 . . . . 10.0 111.386 -179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -123.47 110.82 15.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.891 -0.595 . . . . 10.0 110.126 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . 0.436 HG11 ' HB2' ' B' ' 34' ' ' TYR . 60.2 t -125.44 141.51 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.162 -0.472 . . . . 10.0 109.835 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.55 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 29.9 m-20 -66.97 145.25 55.62 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.117 0.484 . . . . 10.0 111.786 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 10.6 tt -58.88 -30.14 42.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.401 -0.818 . . . . 10.0 112.318 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 5.8 m -74.04 -10.65 59.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.778 0.323 . . . . 10.0 111.417 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -101.3 2.58 39.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.237 0.541 . . . . 10.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 56.9 mt -99.3 110.48 26.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.537 -0.756 . . . . 10.0 109.289 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.422 ' H ' HG23 ' B' ' 21' ' ' VAL . 2.9 t -62.19 -78.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.698 -0.683 . . . . 10.0 112.14 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -114.57 144.8 42.8 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.887 0.375 . . . . 10.0 111.202 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 t -131.68 140.93 47.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.349 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 56.1 m -144.93 125.87 14.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.216 0.532 . . . . 10.0 111.376 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.452 ' HG3' ' OE1' ' B' ' 48' ' ' GLU . 27.6 ttp85 -108.42 152.59 24.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.373 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . 0.405 ' HB2' ' ND2' ' A' ' 136' ' ' ASN . 19.2 t80 -129.63 -18.31 3.53 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.874 -0.33 . . . . 10.0 111.745 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.46 3.14 25.8 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.316 -0.945 . . . . 10.0 111.325 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 25.3 mmtt -128.02 -52.27 1.32 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.405 -0.591 . . . . 10.0 109.405 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -150.97 143.32 24.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.373 -0.83 . . . . 10.0 109.941 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 27.5 mt -95.02 132.68 38.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.331 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -118.9 142.68 47.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.308 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -162.14 168.82 21.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.807 0.336 . . . . 10.0 111.193 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -123.9 133.56 53.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.476 -0.564 . . . . 10.0 109.476 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.436 ' HB2' HG11 ' B' ' 15' ' ' VAL . 51.4 p90 -113.88 147.54 38.28 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.977 0.418 . . . . 10.0 110.739 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -122.94 121.76 36.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.641 -0.708 . . . . 10.0 109.531 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' B' ' 40' ' ' LYS . 96.5 mt -97.84 136.85 37.57 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.817 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.3 -18.18 64.88 Favored Glycine 0 C--N 1.33 0.202 0 CA-C-N 116.068 -0.515 . . . . 10.0 112.194 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.57 -8.63 87.56 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.793 -0.718 . . . . 10.0 111.913 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 64.85 1.05 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.76 -0.734 . . . . 10.0 112.471 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . 0.533 ' HB3' HD12 ' B' ' 36' ' ' LEU . 36.8 tttp -160.34 85.47 1.97 Allowed Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 121.047 0.451 . . . . 10.0 110.371 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -84.34 136.07 6.46 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.668 2.245 . . . . 10.0 111.667 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.37 -176.92 29.97 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.532 -0.842 . . . . 10.0 112.101 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -113.13 168.83 9.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 110.303 -0.258 . . . . 10.0 110.303 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.03 138.77 7.08 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.463 -0.655 . . . . 10.0 111.463 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.44 135.28 64.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.88 0.372 . . . . 10.0 110.424 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 81.1 t -127.67 129.11 70.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.574 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.9 t -75.78 126.98 32.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.226 -0.443 . . . . 10.0 109.903 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' B' ' 25' ' ' ARG . 52.8 mt-10 -76.45 2.46 13.63 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.262 -0.426 . . . . 10.0 111.955 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -124.37 -34.71 2.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.595 -0.275 . . . . 10.0 111.497 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -84.47 -24.28 29.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.735 0.302 . . . . 10.0 111.557 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.35 146.87 32.07 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-O 120.747 0.308 . . . . 10.0 111.038 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.63 156.23 66.88 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.704 2.269 . . . . 10.0 111.759 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.401 ' HD3' HD12 ' B' ' 56' ' ' LEU . 74.3 mmtt -60.57 -25.96 66.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.375 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -51.39 -40.85 60.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.666 -0.697 . . . . 10.0 111.385 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.21 -40.53 14.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.386 -0.37 . . . . 10.0 111.027 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.401 HD12 ' HD3' ' B' ' 53' ' ' LYS . 54.8 mt -60.89 -37.18 81.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.7 -178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -74.52 -11.53 60.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.603 -0.271 . . . . 10.0 111.342 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -94.42 -19.16 20.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.097 0.475 . . . . 10.0 110.05 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -95.14 -7.94 37.86 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.229 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -79.92 71.35 6.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.616 -0.72 . . . . 10.0 109.781 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.486 ' O ' ' HB3' ' B' ' 64' ' ' LYS . 82.3 mttt -72.39 102.71 3.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.589 -0.732 . . . . 10.0 110.076 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -70.68 150.96 45.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.401 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 67.59 33.85 4.86 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.739 0.78 . . . . 10.0 109.791 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' B' ' 61' ' ' LYS . 11.5 tptp . . . . . 0 C--O 1.251 1.172 0 CA-C-N 114.642 -1.163 . . . . 10.0 108.783 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 120.592 0.234 . . . . 10.0 110.553 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -107.86 137.94 44.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.964 0.411 . . . . 10.0 110.876 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -116.41 142.24 47.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.526 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.6 p -110.47 140.34 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.534 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.76 126.21 30.57 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.888 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.7 mt -80.76 -31.95 35.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.019 0.438 . . . . 10.0 110.164 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -141.29 168.76 19.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.67 -0.696 . . . . 10.0 109.442 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.19 138.83 35.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.336 -0.393 . . . . 10.0 109.946 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -112.65 127.17 56.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.098 0.475 . . . . 10.0 111.67 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -95.94 118.09 31.89 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.371 -0.974 . . . . 10.0 108.371 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.87 153.26 36.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.98 0.419 . . . . 10.0 111.236 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 62.9 ttt-85 -118.08 -35.9 3.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.202 -0.454 . . . . 10.0 110.946 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.44 171.79 7.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.985 0.421 . . . . 10.0 110.343 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -84.32 20.01 1.75 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.738 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.74 -36.04 3.77 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.161 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -83.3 141.05 32.11 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.923 -0.769 . . . . 10.0 108.923 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.0 tp -97.65 126.94 43.24 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.407 0.521 . . . . 10.0 112.407 -177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.4 146.97 25.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.379 -0.828 . . . . 10.0 109.839 178.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -155.61 168.39 27.31 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.674 0.274 . . . . 10.0 111.014 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -105.8 160.6 15.11 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.916 -0.583 . . . . 10.0 110.434 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -64.9 126.43 27.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 10.0 111.115 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.38 -9.07 38.4 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.641 -0.79 . . . . 10.0 113.278 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -77.8 151.45 33.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.269 0.534 . . . . 10.0 111.147 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -118.42 133.52 55.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.684 . . . . 10.0 109.971 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.26 152.56 45.96 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.784 0.326 . . . . 10.0 110.56 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -95.0 115.35 27.31 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.948 -0.76 . . . . 10.0 108.948 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.6 mm -69.5 120.18 16.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.225 -0.443 . . . . 10.0 110.862 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 55.1 mt -89.43 -55.93 3.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.148 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -134.74 108.63 8.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.34 4.71 41.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.642 179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.4 m -95.4 8.53 42.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.031 -0.532 . . . . 10.0 111.541 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -95.21 74.55 3.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.312 0.577 . . . . 10.0 110.842 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.473 ' O ' ' HE2' ' B' ' 9' ' ' LYS . . . 68.04 -132.53 28.55 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.776 -0.726 . . . . 10.0 112.127 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -112.32 8.62 19.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.022 0.439 . . . . 10.0 110.798 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -120.44 104.76 10.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.262 -1.014 . . . . 10.0 108.262 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 4.6 m0 -83.35 135.56 34.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.216 -0.447 . . . . 10.0 111.869 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -92.41 112.56 24.55 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.462 -1.31 . . . . 10.0 107.462 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -123.75 169.26 11.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.012 0.434 . . . . 10.0 111.806 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 44.1 ttt180 -120.52 126.04 49.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.544 -0.753 . . . . 10.0 109.765 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.2 t -65.24 135.31 55.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.399 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.02 -12.38 44.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.056 0.455 . . . . 10.0 110.2 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.35 -48.02 11.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.693 -0.685 . . . . 10.0 111.126 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 80.8 p -105.98 -43.61 4.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.995 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.52 3.88 28.75 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.605 -0.807 . . . . 10.0 111.729 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -74.12 144.88 44.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 10.0 110.576 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -118.44 139.5 51.32 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.921 -0.582 . . . . 10.0 110.811 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 176.95 177.17 45.69 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.798 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -77.32 129.41 35.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.7 pt -113.67 136.78 22.03 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.448 -0.342 . . . . 10.0 110.719 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -64.57 107.16 0.82 Allowed 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.494 2.129 . . . . 10.0 111.752 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.26 -7.69 10.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.791 -0.64 . . . . 10.0 112.227 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.6 p-10 -96.11 1.22 52.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.833 0.349 . . . . 10.0 110.701 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -111.5 -14.45 13.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.254 -0.43 . . . . 10.0 111.093 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 35.6 m -114.1 160.62 13.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.108 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -143.42 152.66 57.63 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.448 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.12 144.56 87.43 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.272 1.981 . . . . 10.0 111.632 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.416 -0.802 . . . . 10.0 110.176 -179.982 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.524 0.202 . . . . 10.0 110.609 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.01 169.96 23.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.931 0.396 . . . . 10.0 111.48 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 7.4 m -104.95 136.01 45.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.895 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 44.3 t -109.86 132.47 58.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.763 0.316 . . . . 10.0 110.91 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -99.31 127.04 45.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.272 -0.64 . . . . 10.0 109.272 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.468 ' CD2' ' HZ ' ' B' ' 32' ' ' PHE . 41.3 p90 -141.96 175.88 9.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.441 -0.345 . . . . 10.0 111.009 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -109.72 146.91 34.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.412 -0.588 . . . . 10.0 109.412 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.88 92.78 2.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.473 ' HE2' ' O ' ' A' ' 117' ' ' GLY . 5.1 mmtm 61.57 30.35 18.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.287 -0.87 . . . . 10.0 111.668 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.83 -51.88 0.72 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.908 -0.663 . . . . 10.0 113.469 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -74.18 142.66 45.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.959 0.409 . . . . 10.0 111.198 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -92.94 130.49 38.51 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.953 -0.567 . . . . 10.0 109.79 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -124.47 157.26 35.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.568 -0.287 . . . . 10.0 110.916 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -129.32 113.28 14.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.549 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 57.4 t -130.14 149.5 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.273 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 5.1 m-20 -64.99 142.82 58.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.656 -0.247 . . . . 10.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 12.0 tt -65.96 -24.35 33.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.48 0.657 . . . . 10.0 110.041 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.3 -4.06 33.96 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.322 -0.853 . . . . 10.0 111.068 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -110.97 15.08 21.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.539 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 71.3 mt -95.91 133.15 38.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.257 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 21.3 t -80.99 -52.58 13.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.287 -0.415 . . . . 10.0 111.066 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -152.15 155.3 37.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.367 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 86.6 t -125.59 125.83 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 O-C-N 123.547 0.529 . . . . 10.0 110.464 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 4.2 m -116.82 105.95 12.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.871 0.367 . . . . 10.0 111.453 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.552 ' HD2' ' OE2' ' B' ' 48' ' ' GLU . 0.3 OUTLIER -94.82 136.99 34.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.354 -0.384 . . . . 10.0 110.091 179.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -116.48 -21.47 9.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.887 0.375 . . . . 10.0 111.16 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 105.82 4.59 39.3 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.081 -0.808 . . . . 10.0 111.081 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 38.0 mmtm -134.12 -47.41 0.78 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.28 -0.637 . . . . 10.0 109.28 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -149.44 132.69 16.43 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.988 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -87.17 123.65 40.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.245 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.81 132.67 53.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.86 -0.609 . . . . 10.0 109.612 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . 0.468 ' HZ ' ' CD2' ' B' ' 6' ' ' PHE . 43.4 p90 -150.77 169.46 21.61 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.431 -0.508 . . . . 10.0 111.985 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -122.04 138.87 54.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.357 -0.838 . . . . 10.0 109.459 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -133.67 165.65 24.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.97 0.414 . . . . 10.0 111.697 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -139.32 121.38 15.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.707 -0.678 . . . . 10.0 110.112 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' B' ' 40' ' ' LYS . 24.9 mt -96.08 129.67 43.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.616 -0.265 . . . . 10.0 110.415 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.6 106.23 1.31 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.095 -0.574 . . . . 10.0 111.869 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . 144.77 -7.83 1.73 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.976 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.54 36.27 3.84 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.52 -0.847 . . . . 10.0 112.991 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' B' ' 36' ' ' LEU . 79.5 tttt -135.42 67.72 67.18 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 117.113 0.457 . . . . 10.0 111.274 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -90.74 171.65 3.35 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.499 2.133 . . . . 10.0 112.015 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 168.8 -158.73 31.54 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.413 -0.898 . . . . 10.0 112.394 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -121.37 178.33 4.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.515 0.198 . . . . 10.0 110.517 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.51 150.5 19.68 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.654 -0.784 . . . . 10.0 111.957 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.55 130.8 69.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.188 0.518 . . . . 10.0 110.974 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 5.0 t -118.57 122.78 70.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.828 -0.623 . . . . 10.0 109.748 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.7 t -69.77 133.18 47.16 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.154 -0.313 . . . . 10.0 110.154 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.552 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 44.0 mt-10 -87.24 15.95 5.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.944 0.402 . . . . 10.0 110.389 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -122.92 -62.79 1.32 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.066 -0.515 . . . . 10.0 111.605 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -86.35 36.33 0.69 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.062 0.458 . . . . 10.0 112.194 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.66 143.72 36.34 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.316 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.75 143.1 85.58 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.618 2.212 . . . . 10.0 112.095 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -59.79 -23.13 63.03 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.855 -0.612 . . . . 10.0 111.582 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -52.93 -50.88 63.11 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 10.0 111.685 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 75.6 mt -77.2 -34.86 56.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.695 0.283 . . . . 10.0 110.933 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.81 -42.0 98.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.391 -0.368 . . . . 10.0 111.553 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -73.9 -31.48 63.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.008 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -71.59 -33.78 69.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.462 -0.335 . . . . 10.0 110.394 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 20.5 mt -74.46 -44.54 51.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.677 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -79.19 87.43 4.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.177 0.513 . . . . 10.0 110.625 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -89.76 145.45 25.18 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.924 -0.58 . . . . 10.0 109.777 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -68.21 140.52 56.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.522 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 87.7 mttt 62.31 79.48 0.26 Allowed 'General case' 0 C--O 1.232 0.18 0 O-C-N 123.835 0.71 . . . . 10.0 110.233 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.221 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.833 0.349 . . . . 10.0 110.703 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.3 mt -83.06 154.94 24.15 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.747 -0.464 . . . . 10.0 109.747 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -121.65 136.17 54.95 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 110.2 -0.296 . . . . 10.0 110.2 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.8 p -106.27 138.96 29.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.61 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.43 122.57 22.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.208 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.2 mt -77.78 -35.12 51.88 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.98 -0.555 . . . . 10.0 110.801 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -142.78 163.88 31.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.149 -0.478 . . . . 10.0 110.273 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.31 131.41 42.64 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -102.8 123.68 46.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.048 0.452 . . . . 10.0 111.688 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -88.29 105.81 17.8 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.802 -0.814 . . . . 10.0 108.802 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.99 156.99 37.66 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.355 0.598 . . . . 10.0 111.96 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -118.46 -44.08 2.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.67 -0.695 . . . . 10.0 111.059 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -121.89 -160.83 0.89 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.511 -0.313 . . . . 10.0 110.979 -178.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.404 ' H ' ' HB ' ' A' ' 97' ' ' THR . 0.1 OUTLIER -98.35 -16.33 19.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.271 0.558 . . . . 10.0 109.54 179.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -69.86 -44.74 69.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.159 -0.928 . . . . 10.0 110.26 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.46 146.04 31.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.559 -0.746 . . . . 10.0 109.958 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 44.7 tp -96.77 124.9 40.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.31 -0.405 . . . . 10.0 111.816 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.24 129.42 34.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.297 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -144.29 164.53 30.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.892 0.377 . . . . 10.0 111.13 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -106.05 160.78 15.04 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.515 -0.766 . . . . 10.0 110.111 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.7 tttt -65.22 130.75 44.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.588 -0.278 . . . . 10.0 110.755 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.06 -15.34 51.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.681 -0.771 . . . . 10.0 113.175 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -71.43 152.22 43.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.899 0.381 . . . . 10.0 111.102 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -114.03 139.81 48.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.75 -0.659 . . . . 10.0 110.21 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.0 157.64 45.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.971 0.415 . . . . 10.0 111.018 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -108.94 117.95 35.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.306 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.423 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . 23.8 mm -69.09 123.76 23.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.212 -0.449 . . . . 10.0 111.231 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.0 mt -98.17 -37.86 9.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.483 -0.326 . . . . 10.0 110.59 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -142.38 100.87 3.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.79 0.329 . . . . 10.0 111.364 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.75 -5.5 26.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.447 0.641 . . . . 10.0 110.34 178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.78 8.71 24.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.078 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -72.9 -35.61 67.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.705 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 146.63 -127.26 2.68 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.719 -0.673 . . . . 10.0 111.454 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -49.74 22.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.933 0.396 . . . . 10.0 110.186 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.522 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 23.5 m95 -87.69 134.81 33.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.8 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 20.0 m0 -110.69 147.69 33.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.921 0.391 . . . . 10.0 111.18 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -99.03 120.57 39.67 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.423 ' HB2' ' HA ' ' A' ' 111' ' ' ILE . . . -139.89 166.37 24.81 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.846 0.355 . . . . 10.0 111.401 -178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.0 ptt180 -116.25 140.12 49.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.1 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.1 t -74.46 148.95 40.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.676 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.18 -24.7 18.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.568 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -45.08 48.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.087 -0.506 . . . . 10.0 110.729 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 p -104.35 -63.7 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.696 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.33 -13.01 5.72 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.748 -0.739 . . . . 10.0 112.037 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -57.15 144.42 34.97 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.858 0.361 . . . . 10.0 111.333 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.2 m -118.47 126.33 51.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.761 -0.654 . . . . 10.0 110.759 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -162.9 -174.58 32.97 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.564 -0.827 . . . . 10.0 111.675 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -82.19 130.1 35.0 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.145 -0.317 . . . . 10.0 110.145 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 40.1 pt -121.43 140.8 32.08 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.797 0.332 . . . . 10.0 110.821 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.56 119.64 6.68 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.666 2.244 . . . . 10.0 111.832 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.69 -18.97 65.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.742 -0.663 . . . . 10.0 111.749 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -88.92 7.09 36.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.389 -0.368 . . . . 10.0 111.422 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -123.85 8.04 8.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.179 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.2 m -131.33 151.72 36.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.992 0.425 . . . . 10.0 111.576 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -133.68 144.37 51.69 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.294 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.73 134.35 43.5 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.608 2.205 . . . . 10.0 112.41 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.434 -0.794 . . . . 10.0 110.445 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ttt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.525 0.203 . . . . 10.0 110.656 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.02 165.52 27.21 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.592 0.234 . . . . 10.0 110.673 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.92 137.75 32.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.903 -0.589 . . . . 10.0 110.958 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 88.2 t -108.55 128.74 63.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.358 -0.383 . . . . 10.0 110.159 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -93.82 121.95 35.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -132.09 170.97 14.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.486 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -117.44 97.07 5.69 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.193 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -80.98 72.47 8.0 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.508 -0.553 . . . . 10.0 109.508 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm 59.16 66.97 0.96 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.306 -0.861 . . . . 10.0 110.955 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.96 -46.3 2.27 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.832 -0.699 . . . . 10.0 113.02 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.32 117.88 19.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.831 0.348 . . . . 10.0 111.333 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -88.53 116.36 26.71 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.274 -0.639 . . . . 10.0 109.274 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 mttt -124.24 160.1 28.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.885 0.374 . . . . 10.0 111.299 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -127.3 118.05 23.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.733 -0.667 . . . . 10.0 110.515 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.5 144.46 37.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.261 -0.427 . . . . 10.0 109.874 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.83 135.69 57.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.499 -0.318 . . . . 10.0 110.388 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 19.3 tt -63.75 -22.42 30.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.298 0.57 . . . . 10.0 110.852 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.86 -9.45 59.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.935 -0.575 . . . . 10.0 111.131 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -101.47 11.23 39.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.303 0.573 . . . . 10.0 110.314 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 78.1 mt -98.73 129.95 48.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.34 -0.845 . . . . 10.0 109.654 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 7.2 t -76.65 -75.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.335 -0.393 . . . . 10.0 111.331 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -120.49 153.41 36.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.796 0.332 . . . . 10.0 110.781 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.34 129.2 56.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.869 -0.605 . . . . 10.0 110.511 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 19.5 m -121.44 112.13 18.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.197 0.522 . . . . 10.0 110.861 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.483 ' HG3' HG12 ' B' ' 30' ' ' ILE . 52.0 ttp85 -100.71 133.72 44.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.314 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -103.65 -19.01 14.49 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.984 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.96 -18.86 14.18 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.115 -0.794 . . . . 10.0 111.115 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -114.04 -61.4 1.75 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -118.67 143.57 46.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.368 -0.833 . . . . 10.0 109.523 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.483 HG12 ' HG3' ' B' ' 25' ' ' ARG . 1.9 mt -106.14 119.31 55.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.033 -0.531 . . . . 10.0 109.908 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -105.24 135.46 46.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.305 -0.407 . . . . 10.0 110.347 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -151.26 165.84 32.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.861 0.362 . . . . 10.0 111.438 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.99 133.55 54.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.409 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -123.73 166.2 15.96 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.517 -0.311 . . . . 10.0 110.699 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -139.6 115.81 10.45 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.164 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -82.55 145.53 29.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.837 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.47 -18.81 73.96 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.039 -0.601 . . . . 10.0 112.669 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.34 19.86 7.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.024 -0.608 . . . . 10.0 112.887 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.03 51.7 17.34 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.929 -0.653 . . . . 10.0 112.349 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -150.36 96.04 3.49 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 120.881 0.372 . . . . 10.0 111.286 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.84 154.13 13.24 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.412 2.074 . . . . 10.0 110.76 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.79 -172.11 31.85 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 119.573 -1.299 . . . . 10.0 113.034 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . 0.522 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 15.6 m-85 -133.07 166.89 21.37 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.685 -0.487 . . . . 10.0 109.685 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -154.66 146.43 14.48 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.628 -0.796 . . . . 10.0 111.767 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 3.6 p -129.68 127.63 64.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.303 0.573 . . . . 10.0 110.784 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 94.9 t -116.58 132.08 67.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.635 -0.711 . . . . 10.0 110.282 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 14.6 t -88.67 125.38 34.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.668 0.27 . . . . 10.0 110.388 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -68.97 -17.28 63.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.046 0.451 . . . . 10.0 111.587 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -100.47 16.75 23.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.312 -0.404 . . . . 10.0 110.671 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -133.26 -53.3 0.9 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.903 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.06 152.64 76.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.024 -0.534 . . . . 10.0 111.371 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.442 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 32.0 Cg_endo -63.4 154.08 70.54 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.82 2.346 . . . . 10.0 112.951 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -57.76 -34.12 69.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.459 -0.791 . . . . 10.0 112.082 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -54.15 -44.97 71.89 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.961 0.356 . . . . 10.0 111.961 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.6 -39.22 70.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 10.0 110.98 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 18.0 mt -65.21 -43.05 92.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.771 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -69.44 -18.39 63.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.818 -0.628 . . . . 10.0 111.685 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -80.67 -25.42 38.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.893 0.378 . . . . 10.0 110.614 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 82.0 mt -83.67 -42.9 16.13 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.452 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . 0.471 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 1.1 tp10 -86.64 92.39 8.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 10.0 110.342 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -108.88 -177.65 3.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.404 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -80.18 138.19 36.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.262 -0.273 . . . . 10.0 110.262 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 57.4 39.09 28.47 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.43 0.633 . . . . 10.0 110.018 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.964 0 CA-C-N 115.168 -0.924 . . . . 10.0 110.886 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 120.849 0.357 . . . . 10.0 110.441 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 mt -84.79 129.59 34.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.147 -0.479 . . . . 10.0 110.976 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -121.06 145.42 47.81 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.762 -0.654 . . . . 10.0 109.673 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.23 139.6 42.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.956 0.407 . . . . 10.0 110.647 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.95 123.52 24.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.894 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.4 mt -71.2 -50.93 27.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.429 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -129.01 178.61 6.28 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.846 -0.615 . . . . 10.0 110.115 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.06 142.87 28.41 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.825 -0.435 . . . . 10.0 109.825 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -126.37 130.2 50.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.996 0.426 . . . . 10.0 110.751 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -93.73 116.99 29.51 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.687 -0.688 . . . . 10.0 109.521 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 137.85 56.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.144 0.497 . . . . 10.0 111.304 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' B' ' 21' ' ' VAL . 14.6 ttt180 -94.09 -40.7 9.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.455 -0.793 . . . . 10.0 110.306 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.9 p -131.95 -163.35 1.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.887 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -93.84 -2.49 53.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.146 -0.479 . . . . 10.0 110.238 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -84.5 -41.43 16.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.907 -0.588 . . . . 10.0 109.874 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -89.49 154.51 19.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.5 -0.773 . . . . 10.0 109.153 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 28.3 tp -107.62 134.52 50.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.197 0.443 . . . . 10.0 112.197 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.56 146.36 25.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.528 -0.76 . . . . 10.0 110.555 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -162.65 166.06 24.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.821 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -113.53 168.34 9.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.493 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -61.7 115.54 4.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.998 -0.546 . . . . 10.0 110.852 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.09 -1.2 25.52 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.637 -0.792 . . . . 10.0 112.696 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -67.99 137.92 55.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 10.0 110.947 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -102.2 130.58 48.89 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -120.47 144.73 47.83 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.098 0.777 . . . . 10.0 113.098 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -108.28 106.07 16.06 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.7 114.96 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.101 0.477 . . . . 10.0 111.578 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.8 mt -86.0 -48.67 8.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.571 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -138.95 104.41 5.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 10.0 111.182 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -15.45 37.13 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.281 0.562 . . . . 10.0 110.458 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.87 13.45 5.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.811 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.17 -45.38 73.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.711 -0.677 . . . . 10.0 110.471 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.99 -119.12 0.93 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.2 -0.76 . . . . 10.0 111.2 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -93.51 -27.73 16.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.296 0.569 . . . . 10.0 110.052 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.442 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 29.2 m95 -110.63 114.99 28.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.145 -1.057 . . . . 10.0 108.145 178.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 23.6 m0 -95.31 143.12 26.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.164 0.507 . . . . 10.0 111.353 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -90.89 121.64 32.91 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.52 -0.919 . . . . 10.0 108.52 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.14 164.34 27.57 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.815 0.341 . . . . 10.0 111.582 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -112.04 137.64 49.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.522 -0.763 . . . . 10.0 110.708 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.1 t -76.45 141.12 41.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.148 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.8 mt -93.21 2.97 56.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.451 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -105.14 -58.48 1.88 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.888 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.1 p -91.47 -39.14 12.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.218 0.532 . . . . 10.0 110.875 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 103.17 6.96 44.5 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.698 -0.683 . . . . 10.0 111.671 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -73.24 146.11 45.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.557 -0.321 . . . . 10.0 110.663 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 91.0 m -126.83 134.5 50.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.366 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.63 -176.0 43.5 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.903 -0.665 . . . . 10.0 111.572 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -76.26 122.65 24.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.757 0.313 . . . . 10.0 110.181 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 14.3 pt -114.39 141.15 26.07 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.734 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.38 110.3 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.45 2.1 . . . . 10.0 111.591 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -12.11 22.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.973 -0.558 . . . . 10.0 112.13 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 -93.93 0.29 56.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.884 0.373 . . . . 10.0 110.66 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.26 5.07 14.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.915 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 15.2 m -129.78 153.45 38.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.376 -0.374 . . . . 10.0 110.947 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.57 147.92 61.65 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.214 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.84 130.03 20.98 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.537 2.158 . . . . 10.0 112.083 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.356 -0.831 . . . . 10.0 109.898 179.657 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ttt . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 120.711 0.291 . . . . 10.0 110.68 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.12 168.17 25.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.777 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 0.1 OUTLIER -101.44 146.38 27.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.382 -0.372 . . . . 10.0 110.952 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 69.4 t -117.94 132.12 68.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.411 -0.359 . . . . 10.0 110.155 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -103.22 129.33 50.12 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.244 -0.435 . . . . 10.0 110.031 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 26.5 p90 -139.19 165.06 28.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.736 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -110.0 77.7 1.07 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.086 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -69.58 99.92 1.36 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.551 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 57.2 32.48 21.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.156 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.88 -28.53 14.95 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.756 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -81.76 113.01 19.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.662 0.231 . . . . 10.0 110.89 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 7.2 mt-10 -74.88 115.71 14.79 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.586 -0.524 . . . . 10.0 109.586 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -125.2 156.01 39.13 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.857 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -124.36 116.6 22.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.336 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.5 145.03 36.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.577 -0.527 . . . . 10.0 109.577 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 11.5 m-20 -61.92 138.88 58.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.963 0.411 . . . . 10.0 111.099 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 15.2 tt -63.64 -24.51 36.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.677 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 8.0 m -77.0 -3.5 39.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.619 -0.719 . . . . 10.0 111.007 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -111.37 13.46 21.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.212 0.529 . . . . 10.0 110.021 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 69.8 mt -99.01 126.88 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.732 -0.667 . . . . 10.0 109.767 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . 0.479 ' O ' ' HD3' ' A' ' 96' ' ' ARG . 3.5 t -75.18 -64.38 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.755 -178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -134.99 153.46 52.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.593 -0.276 . . . . 10.0 111.121 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 36.5 t -132.96 137.5 53.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.237 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -135.24 121.9 20.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.999 0.428 . . . . 10.0 111.023 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.46 ' HG3' HG12 ' B' ' 30' ' ' ILE . 53.6 ttp85 -109.0 146.12 34.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.205 -0.452 . . . . 10.0 110.257 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -127.19 -15.54 5.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.958 0.409 . . . . 10.0 111.613 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.76 16.76 23.17 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.39 -0.91 . . . . 10.0 111.072 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -140.9 -53.73 0.48 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -145.5 130.99 18.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.318 -0.855 . . . . 10.0 109.816 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 9.4 mt -86.42 121.26 37.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.67 -0.493 . . . . 10.0 109.67 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -109.06 135.78 49.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.722 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . 0.419 ' N ' ' HE1' ' A' ' 119' ' ' TRP . 51.2 p90 -155.69 169.4 24.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.664 0.269 . . . . 10.0 110.704 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -128.34 135.29 49.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.254 -0.43 . . . . 10.0 109.969 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -114.08 168.01 10.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.755 0.312 . . . . 10.0 110.414 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -138.4 112.45 8.53 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.935 -0.575 . . . . 10.0 109.859 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 82.7 mt -93.55 132.49 37.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.441 -0.345 . . . . 10.0 110.945 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -68.2 -11.17 61.01 Favored Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.91 -0.586 . . . . 10.0 112.469 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.52 -19.54 68.99 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.359 -0.448 . . . . 10.0 112.217 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.97 43.77 1.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.68 -0.771 . . . . 10.0 112.641 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -170.13 111.07 0.46 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.827 0.346 . . . . 10.0 110.738 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -86.27 179.11 3.71 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.513 2.142 . . . . 10.0 110.883 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.64 172.56 43.86 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.079 -1.058 . . . . 10.0 112.276 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . 0.442 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 29.9 m-85 -108.1 168.32 9.38 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -149.38 144.95 12.7 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.938 -0.649 . . . . 10.0 111.888 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 4.2 p -136.78 131.47 47.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.092 0.472 . . . . 10.0 110.876 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 87.2 t -121.9 121.98 65.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.855 -0.611 . . . . 10.0 109.934 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.39 101.33 3.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.668 0.27 . . . . 10.0 110.662 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -74.1 65.15 1.11 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.585 0.707 . . . . 10.0 110.417 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -166.24 -50.02 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.885 -1.052 . . . . 10.0 109.21 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.47 -28.33 15.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.054 -0.975 . . . . 10.0 111.249 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.66 153.09 73.11 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.135 -0.484 . . . . 10.0 111.202 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.03 142.64 94.1 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.701 2.267 . . . . 10.0 111.994 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -60.86 -26.03 67.09 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.28 -0.418 . . . . 10.0 111.812 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -56.84 -48.51 77.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.807 0.337 . . . . 10.0 110.904 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 99.0 mt -65.62 -32.97 74.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.837 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.0 mt -71.91 -44.0 64.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.792 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -69.52 -31.89 70.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.854 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -78.48 -23.39 46.45 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.051 -0.26 . . . . 10.0 110.999 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' B' ' 59' ' ' LEU . 13.0 mt -83.68 -47.59 11.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.968 0.413 . . . . 10.0 110.391 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . 0.415 ' OE1' ' HE3' ' B' ' 64' ' ' LYS . 2.9 tp10 -84.74 87.84 7.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.362 0.601 . . . . 10.0 109.938 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.437 ' HB2' ' HB3' ' B' ' 64' ' ' LYS . 46.9 mtmt -93.0 169.78 10.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.833 -0.621 . . . . 10.0 110.18 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 55.7 mm-40 -76.11 121.37 22.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.7 0.286 . . . . 10.0 110.572 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.5 mttt 59.24 43.74 16.54 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.681 -0.691 . . . . 10.0 110.942 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' B' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.581 -0.723 . . . . 10.0 110.862 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 110.072 -0.344 . . . . 10.0 110.072 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.9 mt -88.68 150.8 22.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.982 0.42 . . . . 10.0 110.862 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -122.8 141.21 52.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.806 -0.633 . . . . 10.0 110.196 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.2 p -109.27 140.04 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.206 -0.452 . . . . 10.0 110.613 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.2 123.81 25.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.588 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 87.8 mt -78.74 -24.47 44.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.28 170.57 22.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.31 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -80.27 130.25 35.07 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.722 -0.473 . . . . 10.0 109.722 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -104.99 132.03 51.76 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.971 0.415 . . . . 10.0 111.64 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -89.83 118.77 29.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.678 -0.692 . . . . 10.0 109.506 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.12 158.63 24.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.14 0.495 . . . . 10.0 111.57 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -120.01 -44.62 2.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.554 -0.748 . . . . 10.0 110.277 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.89 -167.59 1.61 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.209 -0.451 . . . . 10.0 110.886 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -93.2 -2.62 55.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.1 0.476 . . . . 10.0 110.671 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.16 -37.58 20.01 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 121.276 0.56 . . . . 10.0 110.021 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -91.28 146.64 23.65 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.397 -0.964 . . . . 10.0 108.397 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.9 tp -111.36 123.49 50.31 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.568 0.581 . . . . 10.0 112.568 -177.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.83 133.4 36.28 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.938 -0.573 . . . . 10.0 109.731 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -140.39 163.03 33.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.803 0.335 . . . . 10.0 111.342 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.5 m170 -95.75 158.26 15.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.911 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -64.46 124.95 23.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.503 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 100.25 -3.01 56.58 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.853 -0.689 . . . . 10.0 113.201 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -74.0 154.6 39.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.937 0.398 . . . . 10.0 111.219 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -117.55 141.26 48.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.779 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.06 152.66 51.11 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.867 0.365 . . . . 10.0 111.006 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.405 ' HB2' HD21 ' A' ' 125' ' ' LEU . 5.9 tp-100 -100.3 115.59 30.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.432 HG21 ' HB3' ' A' ' 114' ' ' SER . 10.9 mm -71.96 112.13 7.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.328 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.6 mt -84.57 -40.05 18.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.121 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -140.07 103.39 4.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.72 0.295 . . . . 10.0 111.3 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.432 ' HB3' HG21 ' A' ' 111' ' ' ILE . 2.2 p -105.01 0.08 27.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.294 0.569 . . . . 10.0 110.552 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.21 10.04 20.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.951 -0.568 . . . . 10.0 111.37 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -75.1 -58.34 3.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.546 0.689 . . . . 10.0 109.977 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 167.59 -118.75 0.8 Allowed Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.3 -0.72 . . . . 10.0 111.3 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -76.71 -51.16 11.98 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.083 -0.339 . . . . 10.0 110.083 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -88.47 134.35 33.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.876 -0.787 . . . . 10.0 108.876 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 2.3 m0 -115.04 148.51 38.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.955 0.407 . . . . 10.0 111.045 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -86.97 117.27 25.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.73 156.76 45.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.226 0.536 . . . . 10.0 111.662 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -112.54 126.75 55.68 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.985 -0.746 . . . . 10.0 108.985 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 26.3 t -62.8 136.63 57.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.387 -0.37 . . . . 10.0 110.181 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 110' ' ' GLN . 83.8 mt -84.66 -10.98 56.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.191 0.52 . . . . 10.0 109.829 179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.78 -67.92 0.76 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.488 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.7 p -86.86 -46.59 9.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.033 0.444 . . . . 10.0 111.476 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 116.35 6.09 15.95 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.895 -0.669 . . . . 10.0 111.865 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -72.21 149.31 44.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.729 0.3 . . . . 10.0 110.759 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -115.71 135.0 54.46 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.347 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -174.62 179.79 45.71 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.925 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -86.78 136.3 33.04 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.0 -0.37 . . . . 10.0 110.0 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 30.3 pt -121.15 136.14 25.47 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.08 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 137' ' ' TYR . 19.2 Cg_endo -63.05 122.62 10.92 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.761 2.307 . . . . 10.0 111.869 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -17.74 64.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.85 -0.614 . . . . 10.0 112.238 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.472 ' HB3' ' CE1' ' B' ' 31' ' ' PHE . 45.3 p-10 -87.44 -5.79 58.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.959 0.409 . . . . 10.0 111.057 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.476 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 0.8 OUTLIER -105.27 -6.16 19.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.969 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.1 m -124.31 152.38 30.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.125 0.488 . . . . 10.0 111.356 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.61 152.89 67.37 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.545 -0.752 . . . . 10.0 110.163 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.68 156.08 63.35 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.335 2.024 . . . . 10.0 111.622 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 38.8 t . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.323 -0.846 . . . . 10.0 110.097 179.703 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.732 0.301 . . . . 10.0 110.302 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.1 168.07 13.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.127 0.489 . . . . 10.0 112.23 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.7 m -110.69 145.84 37.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.541 -0.754 . . . . 10.0 109.927 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 45.0 t -111.23 130.3 64.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.717 0.294 . . . . 10.0 111.333 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -103.57 120.49 40.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.98 -0.555 . . . . 10.0 109.662 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -134.33 169.53 17.08 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.919 0.39 . . . . 10.0 111.259 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.41 ' HG3' ' HG2' ' B' ' 12' ' ' GLU . 1.7 mttt -117.37 63.25 0.74 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.522 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -59.32 112.96 1.93 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.889 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 58.83 21.81 9.46 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.07 -0.514 . . . . 10.0 111.305 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.4 -5.99 63.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.951 -0.642 . . . . 10.0 112.454 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -94.72 119.08 32.75 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 122.89 -0.182 . . . . 10.0 110.844 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.41 ' HG2' ' HG3' ' B' ' 7' ' ' LYS . 2.9 mt-10 -72.23 113.98 9.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.946 -0.39 . . . . 10.0 109.946 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 18.1 mtmt -134.38 153.02 52.13 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.788 0.327 . . . . 10.0 110.837 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 1.5 mt-30 -124.8 120.28 31.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.165 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.0 t -128.93 143.36 41.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.299 -0.409 . . . . 10.0 110.058 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.18 136.22 57.99 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.04 -0.356 . . . . 10.0 110.04 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 13.3 tt -62.83 -22.9 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.131 0.491 . . . . 10.0 111.206 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -10.25 57.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 10.0 111.635 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -106.65 16.03 25.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.346 . . . . 10.0 111.072 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 73.2 mt -103.07 133.92 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.083 -0.508 . . . . 10.0 109.765 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.95 -63.12 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.199 -0.455 . . . . 10.0 111.286 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -134.29 152.27 51.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.494 -0.321 . . . . 10.0 110.878 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t -127.51 129.24 70.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.987 -0.551 . . . . 10.0 109.779 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 8.3 m -123.92 127.43 47.96 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.015 0.436 . . . . 10.0 111.895 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.412 ' HG3' ' OE1' ' B' ' 48' ' ' GLU . 14.4 ttp85 -121.68 144.98 48.46 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -125.26 -16.64 5.89 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.675 0.274 . . . . 10.0 111.707 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.31 31.79 4.52 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.307 -0.949 . . . . 10.0 111.064 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 23.5 mmtm -155.33 -56.49 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.576 0.75 . . . . 10.0 109.179 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -143.8 138.38 28.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.859 -1.064 . . . . 10.0 109.691 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -95.48 131.81 41.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.808 -0.441 . . . . 10.0 109.808 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 49.4 m-85 -123.21 141.21 52.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.441 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -153.77 173.21 16.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.5 -0.318 . . . . 10.0 111.13 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -130.88 132.8 45.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 10.0 109.581 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -125.44 164.53 20.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.149 0.5 . . . . 10.0 111.249 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -138.08 125.82 22.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.278 -0.874 . . . . 10.0 109.986 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 54.6 mt -100.7 135.54 41.99 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.204 -0.295 . . . . 10.0 110.204 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.16 -27.05 62.11 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.223 -0.513 . . . . 10.0 112.887 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.04 8.54 15.64 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.292 -0.48 . . . . 10.0 112.803 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.73 54.35 3.48 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.368 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 tptt -147.74 78.35 9.9 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.919 0.39 . . . . 10.0 110.861 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -85.56 148.53 9.94 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.826 2.35 . . . . 10.0 110.863 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.79 -164.78 26.09 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 119.805 -1.188 . . . . 10.0 112.857 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -122.2 177.55 5.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.842 -0.429 . . . . 10.0 109.842 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.62 139.44 6.63 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.768 -0.73 . . . . 10.0 112.119 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -126.88 128.83 71.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.12 0.486 . . . . 10.0 110.392 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 57.6 t -125.93 119.61 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.034 -0.53 . . . . 10.0 109.841 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 12.0 t -68.68 125.86 27.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.732 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.412 ' OE1' ' HG3' ' B' ' 25' ' ' ARG . 52.2 mt-10 -75.68 -2.08 27.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.006 0.431 . . . . 10.0 110.967 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -111.27 -39.67 4.65 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.248 -0.433 . . . . 10.0 111.287 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -85.52 -27.81 25.36 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.147 0.425 . . . . 10.0 112.147 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.88 146.25 31.74 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.938 -0.305 . . . . 10.0 111.017 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.12 154.39 57.76 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.711 2.274 . . . . 10.0 111.639 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -63.0 -25.18 68.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.363 -0.381 . . . . 10.0 111.164 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -56.2 -44.14 79.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.926 0.393 . . . . 10.0 110.61 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mt -69.93 -41.1 75.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.964 -0.562 . . . . 10.0 110.786 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.1 -37.66 88.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.906 -0.588 . . . . 10.0 111.054 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -73.37 -25.25 60.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.161 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -79.75 -36.06 37.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.437 -0.347 . . . . 10.0 110.419 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 13.2 mt -73.68 -45.69 50.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.505 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -82.99 111.62 19.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.96 0.409 . . . . 10.0 110.48 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.25 165.2 15.14 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.64 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.474 ' OE1' ' HG3' ' B' ' 63' ' ' LYS . 1.0 OUTLIER -58.73 139.22 56.5 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.366 0.416 . . . . 10.0 110.398 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.474 ' HG3' ' OE1' ' B' ' 62' ' ' GLN . 43.6 mttp 63.06 79.98 0.24 Allowed 'General case' 0 CA--C 1.52 -0.203 0 O-C-N 123.718 0.636 . . . . 10.0 110.159 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.262 -0.875 . . . . 10.0 109.997 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.676 0.274 . . . . 10.0 110.397 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 70.0 mt -79.51 133.59 36.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.084 0.468 . . . . 10.0 110.83 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -116.7 140.2 49.68 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.179 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 p -112.48 139.04 39.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.855 0.359 . . . . 10.0 110.439 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.83 121.69 18.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.089 -0.505 . . . . 10.0 110.93 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.4 mt -74.01 -40.15 63.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.431 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -143.1 164.05 31.18 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.082 -0.508 . . . . 10.0 110.186 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.85 147.4 39.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -126.92 126.19 42.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.815 0.341 . . . . 10.0 110.883 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -83.08 113.92 20.94 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.834 -0.621 . . . . 10.0 109.459 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.31 149.0 49.96 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.47 0.481 . . . . 10.0 111.089 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.405 ' HE ' ' C ' ' B' ' 64' ' ' LYS . 0.0 OUTLIER -109.69 -37.35 5.69 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.148 -0.478 . . . . 10.0 111.079 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.8 p -129.37 -164.11 1.37 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.961 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.404 ' H ' ' HG3' ' A' ' 98' ' ' GLU . 1.3 pp20? -99.63 6.77 45.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.138 0.494 . . . . 10.0 110.521 179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.35 -36.73 11.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.502 -0.772 . . . . 10.0 109.611 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -89.78 145.35 25.25 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 129' ' ' GLU . 9.4 tp -98.74 135.25 40.49 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.187 0.517 . . . . 10.0 112.043 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.94 134.17 33.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.361 -0.836 . . . . 10.0 110.123 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -147.46 164.92 31.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.613 -0.267 . . . . 10.0 110.797 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -118.98 172.27 7.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.929 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -60.02 118.65 6.54 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.383 -0.826 . . . . 10.0 111.359 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.33 -1.84 43.37 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.476 -0.869 . . . . 10.0 113.351 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.57 133.7 54.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.839 0.352 . . . . 10.0 111.437 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -94.5 121.09 35.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 10.0 109.689 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -115.88 134.49 54.93 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.66 0.615 . . . . 10.0 112.66 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -102.9 104.37 14.6 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.904 -1.146 . . . . 10.0 107.904 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 18.3 mm -62.44 117.62 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.327 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 123' ' ' ARG . 70.9 mt -94.35 -35.87 12.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.321 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -145.1 99.89 3.39 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.28 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.79 0.26 46.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.238 0.542 . . . . 10.0 110.252 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.6 m -88.3 -0.0 56.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.995 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -63.17 -46.82 85.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.185 0.517 . . . . 10.0 110.333 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.99 -116.75 0.74 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.991 -0.843 . . . . 10.0 110.991 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.78 -28.5 17.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.234 0.54 . . . . 10.0 110.149 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.595 ' HB2' ' CD2' ' B' ' 43' ' ' PHE . 17.9 m95 -105.03 110.32 22.67 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.351 -0.981 . . . . 10.0 108.351 178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -93.9 154.92 17.45 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.749 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -98.92 122.94 42.82 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -136.3 161.86 34.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.327 0.584 . . . . 10.0 111.602 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.416 ' HB2' HD11 ' A' ' 112' ' ' LEU . 6.0 ttp180 -114.03 133.76 55.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.19 -0.914 . . . . 10.0 109.345 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.5 t -69.45 140.82 54.09 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.954 0.407 . . . . 10.0 110.507 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 99.2 mt -96.84 2.05 51.35 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.376 0.608 . . . . 10.0 109.848 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -105.09 -48.84 3.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.677 -0.692 . . . . 10.0 110.492 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 66.4 p -101.06 -42.8 6.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.936 0.398 . . . . 10.0 110.842 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.69 -0.73 34.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.059 -0.591 . . . . 10.0 112.42 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.509 ' HB3' HD11 ' A' ' 101' ' ' LEU . 32.1 mt-10 -67.26 150.23 49.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.736 0.303 . . . . 10.0 110.905 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.2 m -122.77 133.91 54.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.709 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.1 178.83 46.7 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.61 -0.805 . . . . 10.0 111.995 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -81.47 133.48 35.4 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.276 -0.268 . . . . 10.0 110.276 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 11.8 pt -128.07 145.54 55.77 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.85 0.357 . . . . 10.0 111.426 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.498 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 47.3 Cg_endo -72.08 127.5 12.88 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.577 2.185 . . . . 10.0 111.672 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.0 p -69.81 -16.09 63.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.96 -0.564 . . . . 10.0 112.267 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.498 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 38.0 p-10 -85.55 -0.45 55.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.692 0.282 . . . . 10.0 111.465 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.433 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 1.9 m-85 -115.58 3.91 14.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.53 -0.304 . . . . 10.0 111.246 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.7 m -129.81 144.65 37.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.999 0.428 . . . . 10.0 111.105 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -132.77 144.01 51.08 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.806 -0.634 . . . . 10.0 110.085 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.3 132.05 26.56 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.536 2.157 . . . . 10.0 112.305 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.1 t . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.151 -0.928 . . . . 10.0 110.121 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.619 0.247 . . . . 10.0 110.747 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' B' ' 16' ' ' ASP . . . -153.76 128.57 9.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.47 -0.332 . . . . 10.0 110.515 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.9 108.18 19.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.608 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 28.0 t -88.05 130.78 37.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.62 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -95.32 132.15 40.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.45 -0.341 . . . . 10.0 110.281 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -145.25 170.18 16.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.186 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.416 ' HG2' ' HG2' ' B' ' 12' ' ' GLU . 98.9 mttt -120.7 105.82 11.12 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.16 -0.473 . . . . 10.0 109.788 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -99.99 111.71 24.0 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.894 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt 54.27 34.13 19.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.69 -0.686 . . . . 10.0 112.13 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.52 4.36 68.08 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.023 -0.608 . . . . 10.0 113.409 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -109.94 123.18 49.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.884 0.342 . . . . 10.0 110.644 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' B' ' 7' ' ' LYS . 39.0 mt-10 -76.14 121.18 22.47 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -134.44 153.45 51.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.897 0.38 . . . . 10.0 110.972 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -130.46 114.06 15.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.72 -0.673 . . . . 10.0 109.773 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.4 t -129.04 144.24 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.306 -0.406 . . . . 10.0 110.55 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.463 ' HA ' ' O ' ' B' ' 2' ' ' ALA . 6.9 t70 -64.26 138.27 58.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.387 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' B' ' 20' ' ' ILE . 21.4 tt -61.29 -22.58 27.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.935 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -70.71 -19.65 62.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.7 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -93.99 1.01 56.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.133 0.492 . . . . 10.0 110.517 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' B' ' 17' ' ' ILE . 70.8 mt -94.2 123.97 46.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.725 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 5.1 t -75.59 -77.37 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.549 -0.296 . . . . 10.0 111.383 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -113.13 151.63 30.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.011 0.434 . . . . 10.0 111.308 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 32.3 t -129.32 142.01 45.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.421 -0.808 . . . . 10.0 109.983 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 22.1 m -134.5 122.89 23.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 10.0 111.402 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.48 ' HD2' ' OE2' ' B' ' 48' ' ' GLU . 0.8 OUTLIER -109.98 143.26 40.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.077 -0.511 . . . . 10.0 110.164 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -124.35 -20.58 5.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.648 0.24 . . . . 10.0 111.648 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.34 22.18 8.84 Favored Glycine 0 N--CA 1.452 -0.252 0 N-CA-C 110.744 -0.943 . . . . 10.0 110.744 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -146.38 -54.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.721 -0.844 . . . . 10.0 108.721 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -146.88 138.59 24.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.008 -0.997 . . . . 10.0 109.433 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 52.0 mt -94.27 126.89 46.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.971 -0.381 . . . . 10.0 109.971 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 18.9 m-85 -111.19 139.29 46.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.38 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -154.4 171.83 18.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.991 0.424 . . . . 10.0 111.273 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -130.32 135.68 48.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.854 -0.612 . . . . 10.0 109.594 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -121.58 156.83 32.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.065 0.46 . . . . 10.0 111.139 -179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -127.35 117.39 22.11 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.419 -0.81 . . . . 10.0 109.32 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 90.9 mt -95.52 139.37 31.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.835 0.35 . . . . 10.0 111.319 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.52 -9.39 61.53 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.588 -0.733 . . . . 10.0 112.095 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.83 -8.17 67.6 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.215 -0.517 . . . . 10.0 111.999 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.64 32.5 7.23 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.951 -0.643 . . . . 10.0 112.149 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -153.64 103.38 2.53 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.682 0.277 . . . . 10.0 111.086 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -86.14 168.93 8.91 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.826 2.35 . . . . 10.0 111.44 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.63 -172.0 36.53 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.115 -1.04 . . . . 10.0 113.143 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' A' ' 119' ' ' TRP . 6.6 m-85 -123.63 166.2 15.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.855 -0.424 . . . . 10.0 109.855 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -155.0 150.57 22.13 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.471 -0.871 . . . . 10.0 112.345 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 p -132.67 132.9 59.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.968 0.413 . . . . 10.0 110.451 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.44 136.38 55.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.09 -0.505 . . . . 10.0 110.441 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 26.9 t -74.11 131.29 41.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.474 -0.33 . . . . 10.0 110.391 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.48 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 45.1 mt-10 -84.45 3.64 35.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.964 0.411 . . . . 10.0 111.298 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -119.43 -44.25 2.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.969 0.414 . . . . 10.0 111.068 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -78.72 -49.43 13.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.806 -0.634 . . . . 10.0 112.481 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -67.23 151.13 97.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.34 . . . . 10.0 111.886 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 32.2 Cg_exo -61.15 142.22 96.1 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.954 2.436 . . . . 10.0 112.296 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 35.2 tttt -62.93 -23.08 67.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.824 -0.626 . . . . 10.0 110.704 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -56.4 -44.99 80.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.155 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 92.4 mt -75.3 -35.47 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.551 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 60.0 mt -62.03 -42.94 99.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.872 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -72.63 -17.37 61.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.143 -0.48 . . . . 10.0 111.158 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -85.93 -38.56 17.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.635 -0.506 . . . . 10.0 109.635 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 51.6 mt -68.41 -41.77 79.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.085 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -85.15 85.74 7.44 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.545 0.688 . . . . 10.0 109.645 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -81.62 131.18 35.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.307 -0.86 . . . . 10.0 109.761 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' B' ' 63' ' ' LYS . 83.9 mm-40 -58.59 127.18 30.87 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.816 -0.439 . . . . 10.0 109.816 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' B' ' 62' ' ' GLN . 78.8 mttt 74.24 51.92 0.1 Allowed 'General case' 0 N--CA 1.465 0.291 0 O-C-N 124.105 0.878 . . . . 10.0 110.122 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.405 ' C ' ' HE ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.359 -0.829 . . . . 10.0 110.945 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.683 0.278 . . . . 10.0 111.035 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 86.3 mt -88.16 161.18 17.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.295 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -131.07 126.03 34.76 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.1 p -108.63 141.05 24.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.874 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.3 126.5 31.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.317 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 139' ' ' ALA . 30.0 mt -90.72 -20.62 22.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.013 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.4 159.92 41.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.029 -0.532 . . . . 10.0 109.585 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -85.9 145.4 27.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 10.0 109.868 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -143.37 130.87 21.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.032 0.444 . . . . 10.0 111.41 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.2 124.36 44.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.587 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.83 140.29 58.38 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.983 0.421 . . . . 10.0 111.234 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -104.86 -23.84 12.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.707 -0.679 . . . . 10.0 110.364 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.1 -166.41 1.79 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.262 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -17.97 22.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.838 0.351 . . . . 10.0 110.451 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -69.9 -45.55 67.35 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -87.43 163.26 16.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.615 -0.72 . . . . 10.0 109.61 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 31.3 tp -130.59 145.46 51.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.757 0.313 . . . . 10.0 111.381 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -81.61 145.77 30.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.829 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -157.23 154.45 29.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.077 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -105.17 159.39 15.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.8 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -63.3 116.78 5.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.027 -0.533 . . . . 10.0 110.597 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.5 -4.82 26.42 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.78 -0.724 . . . . 10.0 112.171 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -78.58 150.44 32.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.579 0.228 . . . . 10.0 110.441 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -121.64 143.1 49.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 10.0 110.85 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.3 159.47 41.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.577 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -103.64 116.38 32.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.045 -0.724 . . . . 10.0 109.045 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.2 mm -68.36 121.13 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.36 -0.382 . . . . 10.0 110.943 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.1 mt -94.73 -40.78 9.6 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.249 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.586 ' ND2' ' HG3' ' A' ' 116' ' ' GLU . 55.2 t30 -146.39 106.26 3.98 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.013 0.435 . . . . 10.0 111.24 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.19 0.47 31.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.859 -0.61 . . . . 10.0 110.615 179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.18 5.73 47.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.915 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.586 ' HG3' ' ND2' ' A' ' 113' ' ' ASN . 3.4 mt-10 -78.99 -34.47 44.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.689 0.28 . . . . 10.0 111.358 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 156.89 -126.79 1.82 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.349 -0.929 . . . . 10.0 112.37 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -87.42 -43.75 11.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.826 0.346 . . . . 10.0 110.817 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.424 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 44.2 m95 -88.39 113.35 23.9 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.123 -1.066 . . . . 10.0 108.123 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 44.3 m0 -95.0 150.78 19.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.181 0.515 . . . . 10.0 112.152 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -88.03 117.07 26.66 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.53 -1.285 . . . . 10.0 107.53 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.3 146.23 49.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.238 0.542 . . . . 10.0 112.228 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -100.39 119.18 38.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.37 -0.832 . . . . 10.0 109.307 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.5 t -60.93 138.22 58.18 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.847 0.356 . . . . 10.0 110.556 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 77.0 mt -91.71 2.03 56.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.314 0.578 . . . . 10.0 109.541 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.1 -61.09 1.54 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.313 -0.858 . . . . 10.0 110.723 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 17.5 p -100.7 -29.21 12.42 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.34 . . . . 10.0 111.322 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.25 0.74 54.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.663 -0.779 . . . . 10.0 112.346 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -74.11 154.26 39.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.793 0.33 . . . . 10.0 111.204 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.17 -178.2 3.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.997 -0.547 . . . . 10.0 109.841 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 145.22 168.05 12.69 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.097 -1.049 . . . . 10.0 112.714 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -85.23 124.62 32.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.829 0.347 . . . . 10.0 110.38 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.9 pt -120.48 147.59 45.75 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.382 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.73 125.51 10.6 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.337 2.025 . . . . 10.0 111.359 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -67.14 -12.64 60.55 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.326 0.491 . . . . 10.0 112.326 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -96.27 -9.46 30.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.629 0.252 . . . . 10.0 110.814 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -88.04 -12.92 42.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.041 -0.527 . . . . 10.0 110.277 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.9 m -121.42 169.9 12.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.639 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.519 ' HB2' HD11 ' A' ' 90' ' ' LEU . . . -139.29 141.13 28.17 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.534 -0.757 . . . . 10.0 109.994 178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.69 131.48 21.42 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.459 2.106 . . . . 10.0 112.336 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 18.3 t . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.111 -0.947 . . . . 10.0 109.713 179.368 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.403 ' HB3' HG21 ' B' ' 17' ' ' ILE . 7.9 ttt . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.753 0.311 . . . . 10.0 111.254 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.82 171.93 15.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.802 0.334 . . . . 10.0 110.857 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 142.26 32.93 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.575 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.04 124.87 63.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.928 0.394 . . . . 10.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.65 132.49 46.01 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.584 -0.734 . . . . 10.0 109.417 179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -149.2 173.62 13.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.857 0.36 . . . . 10.0 110.876 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -119.62 85.41 2.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.039 -0.528 . . . . 10.0 110.911 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -73.93 95.8 2.53 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt 61.82 23.89 14.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.723 -0.671 . . . . 10.0 110.459 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.59 -18.33 32.48 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.537 -0.756 . . . . 10.0 112.114 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -72.63 113.28 9.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.765 0.317 . . . . 10.0 111.015 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -73.29 94.76 2.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.938 -0.573 . . . . 10.0 109.523 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -109.76 153.23 24.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.206 0.526 . . . . 10.0 111.974 -178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -130.9 105.47 7.78 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.4 t -119.93 146.88 24.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.688 0.28 . . . . 10.0 110.674 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.1 139.59 51.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.839 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.419 HD11 ' O ' ' B' ' 58' ' ' LYS . 13.7 tt -65.95 -18.88 24.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.467 0.651 . . . . 10.0 110.377 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.6 -4.43 59.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.492 -0.777 . . . . 10.0 111.321 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -102.67 9.09 39.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.071 0.463 . . . . 10.0 110.519 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 81.7 mt -95.51 125.24 48.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.909 -0.587 . . . . 10.0 109.963 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 20.7 t -71.84 -60.95 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.381 -0.372 . . . . 10.0 111.088 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -133.86 151.58 51.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.31 -0.404 . . . . 10.0 110.683 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 35.1 t -119.46 115.08 46.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 10.0 109.722 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 13.7 m -117.34 120.41 38.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.035 0.445 . . . . 10.0 111.823 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.413 ' HD2' ' CD ' ' B' ' 48' ' ' GLU . 4.0 ttp85 -109.06 121.71 45.72 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -83.52 -39.46 20.43 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.691 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.2 -2.61 5.87 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.73 -0.948 . . . . 10.0 110.73 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -139.5 -40.29 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.04 141.52 36.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.37 -0.832 . . . . 10.0 109.644 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 55.7 mt -96.33 129.79 45.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.686 -0.487 . . . . 10.0 109.686 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -118.78 136.09 54.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.357 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -153.4 171.46 18.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.818 0.342 . . . . 10.0 110.953 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -125.04 133.98 52.73 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.135 -0.691 . . . . 10.0 109.135 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 44.7 p90 -123.46 166.77 14.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.024 0.44 . . . . 10.0 111.152 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -128.33 157.98 39.48 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.299 -0.864 . . . . 10.0 109.099 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 45.6 mt -133.89 145.29 49.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.829 0.347 . . . . 10.0 111.009 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.83 -15.25 66.59 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.939 -0.648 . . . . 10.0 112.592 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -81.12 4.51 70.91 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.254 -0.498 . . . . 10.0 112.874 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.58 38.5 32.33 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.771 -0.728 . . . . 10.0 112.885 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -149.17 88.07 5.17 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 122.552 -0.381 . . . . 10.0 110.663 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -74.98 177.9 7.98 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.374 2.049 . . . . 10.0 111.075 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.72 -169.95 37.28 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.653 -1.26 . . . . 10.0 112.711 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 28.5 m-85 -117.05 160.33 21.14 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.898 -0.408 . . . . 10.0 109.898 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.02 141.43 12.12 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.669 -0.777 . . . . 10.0 112.237 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.6 p -135.77 128.79 47.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.95 0.405 . . . . 10.0 110.291 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 t -128.03 129.89 69.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.027 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' B' ' 51' ' ' ALA . 30.2 t -74.31 133.87 42.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.93 -0.396 . . . . 10.0 109.93 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.413 ' CD ' ' HD2' ' B' ' 25' ' ' ARG . 54.0 mt-10 -81.01 -1.21 43.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.176 0.512 . . . . 10.0 110.437 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -116.39 -49.77 2.66 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.947 -0.569 . . . . 10.0 110.579 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -90.92 45.37 1.25 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.783 -0.644 . . . . 10.0 111.973 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' B' ' 47' ' ' SER . . . -162.63 151.06 12.14 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.581 -0.282 . . . . 10.0 110.798 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -56.24 136.29 74.53 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.86 2.374 . . . . 10.0 112.348 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.84 -29.92 71.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.027 -0.533 . . . . 10.0 111.218 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -59.25 -41.27 88.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.992 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 67.4 mt -67.55 -36.12 80.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.873 0.368 . . . . 10.0 110.518 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 22.1 mt -68.38 -39.8 81.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.136 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -72.49 -21.47 61.2 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.851 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . 0.419 ' O ' HD11 ' B' ' 17' ' ' ILE . 79.3 mttt -81.51 -32.02 32.58 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.166 -0.679 . . . . 10.0 109.166 178.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 21.6 mt -75.87 -58.93 2.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.895 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -80.17 115.7 19.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.141 0.496 . . . . 10.0 110.872 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mtmm -129.15 170.31 13.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.731 -0.668 . . . . 10.0 109.547 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -69.49 134.9 49.45 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.347 0.404 . . . . 10.0 110.059 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 83.8 mttt 66.48 54.8 0.86 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.435 0.636 . . . . 10.0 110.312 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.919 0 CA-C-N 115.56 -0.746 . . . . 10.0 110.539 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 120.903 0.382 . . . . 10.0 110.769 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.72 153.64 20.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.668 -0.493 . . . . 10.0 109.668 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -114.68 129.4 56.68 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.782 0.325 . . . . 10.0 110.509 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.9 p -104.8 142.2 18.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.989 -0.55 . . . . 10.0 110.171 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 130.8 43.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.642 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 90.3 mt -79.9 -45.29 18.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.915 -0.584 . . . . 10.0 109.799 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -137.02 173.56 11.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.657 -0.702 . . . . 10.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.88 141.25 36.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.145 -0.48 . . . . 10.0 109.938 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -131.25 123.55 28.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.73 0.3 . . . . 10.0 111.186 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -92.12 133.44 35.76 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.294 -0.632 . . . . 10.0 109.294 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.52 155.05 20.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.164 0.507 . . . . 10.0 111.991 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.2 ttm-85 -110.6 -36.32 5.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.48 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.77 -159.79 0.9 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.449 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -98.58 -10.36 23.52 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.61 -0.515 . . . . 10.0 109.61 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.92 -50.2 15.65 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 115.367 -0.833 . . . . 10.0 109.596 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -83.65 134.66 34.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.342 -0.845 . . . . 10.0 108.839 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.6 tp -97.74 134.1 41.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.189 0.519 . . . . 10.0 112.378 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.23 135.1 34.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.418 -0.81 . . . . 10.0 110.199 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -146.87 158.63 43.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.081 0.467 . . . . 10.0 111.377 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -102.29 164.42 11.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.807 -0.633 . . . . 10.0 111.054 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -62.07 113.41 2.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.738 -0.665 . . . . 10.0 110.5 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.61 -1.32 24.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.723 -0.751 . . . . 10.0 112.783 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -68.57 147.94 51.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.608 0.242 . . . . 10.0 110.469 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -116.74 131.13 57.03 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.1 -0.333 . . . . 10.0 110.1 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -119.18 142.71 47.74 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.553 0.575 . . . . 10.0 112.553 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.641 ' HB2' HD21 ' A' ' 125' ' ' LEU . 6.0 tp-100 -95.0 126.4 40.32 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.477 -0.934 . . . . 10.0 108.477 177.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 50.4 mm -70.27 115.17 9.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.262 0.553 . . . . 10.0 112.025 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 123' ' ' ARG . 27.1 mt -108.64 -67.09 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.717 -0.674 . . . . 10.0 109.425 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 121' ' ' GLU . 22.0 t30 -107.38 95.62 5.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.796 -0.638 . . . . 10.0 109.764 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.1 p -99.87 -21.21 15.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.2 0.524 . . . . 10.0 110.813 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.5 m -83.09 20.11 1.3 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.134 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 24.0 tp10 -70.84 -40.22 72.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.139 0.495 . . . . 10.0 109.94 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 137.21 -62.16 0.59 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.597 -0.811 . . . . 10.0 112.321 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.05 -66.11 0.68 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.777 -0.453 . . . . 10.0 109.777 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.472 ' HH2' ' HG1' ' B' ' 24' ' ' THR . 24.4 m95 -78.98 115.27 18.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.033 -0.729 . . . . 10.0 109.033 178.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -90.56 144.42 25.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.98 0.419 . . . . 10.0 111.427 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 113' ' ' ASN . 28.3 tt0 -95.49 109.95 22.08 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.256 -1.016 . . . . 10.0 108.256 178.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.6 168.8 13.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.929 0.395 . . . . 10.0 111.681 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.484 ' HB2' HD11 ' A' ' 112' ' ' LEU . 69.9 ttp85 -119.04 134.55 55.13 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.235 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.1 t -70.45 137.13 50.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.323 -0.399 . . . . 10.0 110.367 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 110' ' ' GLN . 43.8 mt -84.91 -10.16 57.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.059 0.457 . . . . 10.0 110.006 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 22.7 m -94.46 -57.5 2.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.609 -0.723 . . . . 10.0 111.607 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 46.6 p -89.0 -35.62 16.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.865 0.364 . . . . 10.0 111.53 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.78 5.85 58.47 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.658 -0.782 . . . . 10.0 112.096 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -78.1 146.84 34.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.562 0.22 . . . . 10.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.4 m -119.46 132.78 55.86 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.342 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -174.53 -178.06 44.14 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.687 -0.768 . . . . 10.0 112.12 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -82.46 132.92 35.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.873 0.368 . . . . 10.0 110.622 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 26.1 pt -122.6 142.65 37.97 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.048 -0.524 . . . . 10.0 110.842 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 133' ' ' ILE . 13.4 Cg_exo -69.15 122.12 8.96 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.61 2.207 . . . . 10.0 111.701 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -18.36 65.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.981 -0.554 . . . . 10.0 112.159 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -88.97 -1.84 58.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.478 -0.328 . . . . 10.0 111.232 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -115.51 5.41 14.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.67 0.271 . . . . 10.0 111.429 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 17.2 m -132.22 157.42 43.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.744 0.307 . . . . 10.0 110.78 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.57 143.22 19.36 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.156 -0.474 . . . . 10.0 110.314 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.96 143.29 72.09 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.357 2.038 . . . . 10.0 112.085 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.532 -0.747 . . . . 10.0 110.103 179.55 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.514 0.197 . . . . 10.0 111.033 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.67 168.82 18.9 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.938 0.399 . . . . 10.0 111.381 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.4 142.23 34.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.724 -0.671 . . . . 10.0 110.32 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 21.2 t -110.32 137.53 42.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.704 0.288 . . . . 10.0 110.781 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.73 121.53 42.23 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.582 -0.525 . . . . 10.0 109.582 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' B' ' 12' ' ' GLU . 33.6 p90 -130.88 171.47 13.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.29 -0.414 . . . . 10.0 111.059 -178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -114.41 93.0 4.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 10.0 109.998 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -81.16 94.65 6.69 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.982 -0.287 . . . . 10.0 110.227 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm 55.15 31.98 17.48 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.73 -0.668 . . . . 10.0 111.15 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.01 -24.69 20.74 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.903 -0.665 . . . . 10.0 112.719 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -85.92 108.87 18.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.859 0.33 . . . . 10.0 110.749 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' B' ' 6' ' ' PHE . 11.3 mt-10 -82.41 113.4 20.15 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.984 0.421 . . . . 10.0 110.853 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -132.61 157.09 45.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.599 -0.728 . . . . 10.0 110.391 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 52.4 mt-30 -115.9 127.54 55.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.86 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 91.0 t -131.78 147.15 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.33 139.04 57.39 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.683 -0.235 . . . . 10.0 110.556 179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 20.6 tt -66.5 -21.11 28.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.381 0.61 . . . . 10.0 109.791 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.09 -15.17 60.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.538 -0.755 . . . . 10.0 110.663 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -95.37 0.49 53.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.158 0.504 . . . . 10.0 110.235 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mt -102.61 106.82 20.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.009 -0.541 . . . . 10.0 109.861 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 2.3 t -65.14 -78.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.774 -178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -110.1 141.41 43.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.042 0.449 . . . . 10.0 111.756 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.418 ' O ' ' HD3' ' B' ' 64' ' ' LYS . 58.7 t -125.79 114.89 41.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.327 -0.852 . . . . 10.0 109.247 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . 0.472 ' HG1' ' HH2' ' A' ' 119' ' ' TRP . 30.1 m -103.93 116.85 33.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.363 0.602 . . . . 10.0 111.973 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 33.8 ttp85 -107.56 137.72 45.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 10.0 109.593 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -111.79 -20.19 12.16 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.747 0.308 . . . . 10.0 111.678 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.1 -0.49 31.46 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.986 -0.846 . . . . 10.0 110.986 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -134.12 -42.25 0.81 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.158 -0.521 . . . . 10.0 109.89 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -147.82 133.78 19.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.205 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 68.0 mt -94.13 133.96 33.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.139 -0.482 . . . . 10.0 110.501 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -127.59 120.71 28.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.14 -0.482 . . . . 10.0 109.785 179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -136.28 168.02 20.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.89 0.376 . . . . 10.0 111.336 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -122.96 126.46 47.24 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.933 -0.766 . . . . 10.0 108.933 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -122.02 156.65 33.04 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.072 0.463 . . . . 10.0 111.57 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -104.99 151.73 23.57 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.364 -0.834 . . . . 10.0 109.819 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 13.1 mt -135.88 133.93 38.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.781 0.324 . . . . 10.0 111.102 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.06 -10.69 69.13 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.764 -0.653 . . . . 10.0 112.624 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.94 -15.36 74.01 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.969 -0.634 . . . . 10.0 111.773 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.65 -3.02 45.71 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.749 -0.739 . . . . 10.0 112.991 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -131.56 94.32 26.34 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-O 120.728 0.299 . . . . 10.0 111.212 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -79.22 179.67 6.22 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.529 2.153 . . . . 10.0 111.096 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -172.1 -165.1 28.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 119.951 -1.119 . . . . 10.0 112.902 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -117.34 157.87 25.39 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.76 132.25 6.98 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.483 -0.865 . . . . 10.0 112.087 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.9 125.12 73.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.307 0.575 . . . . 10.0 110.617 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 91.6 t -126.84 120.95 57.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.974 -0.557 . . . . 10.0 109.766 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 28.0 t -71.84 129.87 39.66 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.311 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -86.75 18.38 3.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.101 0.477 . . . . 10.0 110.053 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -136.89 -39.27 0.62 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.706 -0.679 . . . . 10.0 110.866 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -94.23 7.67 44.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 10.0 111.631 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.02 153.64 81.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 122.348 -0.22 . . . . 10.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.82 149.58 90.39 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.851 2.367 . . . . 10.0 112.679 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -65.88 -23.3 66.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.735 -0.666 . . . . 10.0 111.307 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -54.76 -39.18 68.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 10.0 110.925 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 95.3 mt -80.82 -37.38 30.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.649 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 28.2 mt -62.88 -42.08 99.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 10.0 111.122 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -66.71 -28.98 68.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.563 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -79.29 -29.85 42.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.783 0.325 . . . . 10.0 111.229 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 14.5 mt -85.07 -14.46 47.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.969 0.414 . . . . 10.0 110.929 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -70.63 90.88 0.77 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.345 0.593 . . . . 10.0 111.049 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -88.25 100.04 12.68 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.179 -0.675 . . . . 10.0 109.179 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -57.4 116.92 3.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.795 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 91.3 mttt 60.27 81.4 0.18 Allowed 'General case' 0 C--N 1.331 -0.229 0 O-C-N 124.134 0.896 . . . . 10.0 110.674 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.418 ' HD3' ' O ' ' B' ' 23' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.401 -0.809 . . . . 10.0 110.284 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 120.718 0.294 . . . . 10.0 110.95 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 63.7 mt -87.96 155.59 19.76 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.846 -0.428 . . . . 10.0 109.846 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -116.9 136.45 52.94 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.514 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.7 p -111.29 140.29 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.115 -0.493 . . . . 10.0 110.64 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.98 123.67 22.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.559 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.78 -35.61 57.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.563 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -144.52 169.96 16.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.575 -0.284 . . . . 10.0 110.803 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -76.68 104.69 7.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.656 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.546 ' CE1' HG21 ' B' ' 24' ' ' THR . 86.8 t80 -81.58 128.2 33.67 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.003 0.43 . . . . 10.0 111.17 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -99.24 115.38 28.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.652 -0.703 . . . . 10.0 109.772 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.0 172.67 7.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.53 -0.304 . . . . 10.0 110.647 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -136.81 -41.63 0.6 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.572 -0.285 . . . . 10.0 111.087 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -172.92 2.45 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.58 -0.282 . . . . 10.0 110.608 -179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -92.35 -14.65 28.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.72 0.295 . . . . 10.0 111.336 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -43.75 34.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.023 0.44 . . . . 10.0 110.068 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.15 120.2 23.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.437 -0.802 . . . . 10.0 109.762 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.4 tp -78.54 136.82 37.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.369 0.604 . . . . 10.0 111.943 -178.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -95.0 124.73 39.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.435 -0.802 . . . . 10.0 109.698 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.59 155.01 45.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 10.0 111.805 -179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -94.43 158.29 15.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 10.0 110.358 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -63.36 133.18 53.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.878 -0.601 . . . . 10.0 110.817 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 96.9 -9.56 65.91 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.733 -0.746 . . . . 10.0 113.585 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -71.56 149.2 45.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.16 0.48 . . . . 10.0 111.094 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -110.66 137.71 47.99 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.093 -0.503 . . . . 10.0 109.928 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.66 155.92 45.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.936 0.398 . . . . 10.0 111.313 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -107.78 114.47 28.44 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 mm -71.21 118.04 15.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.262 -0.427 . . . . 10.0 110.474 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.91 -38.62 12.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.553 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -136.02 117.29 14.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.317 -0.401 . . . . 10.0 111.049 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.5 -15.05 15.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.128 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 19.5 m -83.19 13.04 4.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.976 -0.556 . . . . 10.0 111.42 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -76.8 -30.65 56.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.253 0.549 . . . . 10.0 110.483 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 128.73 -110.49 1.11 Allowed Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.72 -0.673 . . . . 10.0 111.79 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.17 -57.43 2.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.277 0.56 . . . . 10.0 110.002 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -82.73 114.89 21.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.583 -0.735 . . . . 10.0 109.026 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 50.5 m0 -93.61 144.15 25.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.972 0.415 . . . . 10.0 111.492 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.95 113.88 20.85 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.323 -0.991 . . . . 10.0 108.323 177.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.08 154.65 51.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.057 0.456 . . . . 10.0 111.613 -178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -111.8 128.18 56.03 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.219 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.2 t -69.22 134.26 48.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.135 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 91.3 mt -85.31 -3.25 58.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.16 0.505 . . . . 10.0 109.941 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.55 -61.64 1.65 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.683 -0.689 . . . . 10.0 111.119 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 26.0 p -94.37 -21.71 18.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 10.0 111.723 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.22 15.43 66.82 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.665 -0.779 . . . . 10.0 112.071 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -91.34 154.83 18.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.669 0.271 . . . . 10.0 111.013 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.09 155.93 22.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.527 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.69 172.54 38.49 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.825 -0.702 . . . . 10.0 111.572 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -88.94 127.32 35.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.842 0.353 . . . . 10.0 110.351 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.7 pt -120.67 144.64 39.17 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.982 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.543 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 46.4 Cg_endo -73.04 131.35 16.65 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.448 2.099 . . . . 10.0 111.447 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 p -73.74 -1.65 20.07 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.605 0.595 . . . . 10.0 112.605 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.543 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 28.1 p-10 -105.15 13.79 30.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.848 0.356 . . . . 10.0 111.01 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.464 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 5.5 m-85 -126.4 7.87 7.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.686 179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.7 m -133.15 155.86 41.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.893 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -135.4 144.16 48.35 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.947 -0.57 . . . . 10.0 110.19 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 13.8 Cg_exo -69.6 132.08 22.83 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.563 2.175 . . . . 10.0 111.686 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.1 t . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.666 -0.683 . . . . 10.0 110.522 -179.94 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ttt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.439 0.161 . . . . 10.0 111.067 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.05 130.68 7.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.773 0.32 . . . . 10.0 110.918 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.39 112.76 19.64 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.436 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 23.9 t -89.28 129.63 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.821 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -97.55 119.1 35.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.62 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -131.67 147.04 52.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.56 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -89.97 109.97 20.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.266 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -111.59 105.82 14.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.42 -0.355 . . . . 10.0 111.08 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 55.8 mmtt 56.67 38.15 29.34 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.666 -0.697 . . . . 10.0 111.878 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.4 -0.11 85.1 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.721 -0.752 . . . . 10.0 112.811 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . 0.415 ' CB ' ' HE2' ' B' ' 13' ' ' LYS . 49.4 mt-10 -111.87 117.34 32.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.728 0.264 . . . . 10.0 110.495 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -74.09 112.88 10.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.008 -0.367 . . . . 10.0 110.008 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.415 ' HE2' ' CB ' ' B' ' 11' ' ' GLU . 51.7 mmtt -109.68 147.4 33.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.159 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' B' ' 4' ' ' VAL . 8.4 pt20 -130.3 109.26 10.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.516 -0.55 . . . . 10.0 109.516 179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 58.0 t -125.41 142.5 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.503 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -64.78 143.5 57.89 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.809 -0.441 . . . . 10.0 109.809 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 14.8 tt -56.41 -21.66 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 115.716 -0.675 . . . . 10.0 112.72 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.24 -14.22 47.42 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.392 0.516 . . . . 10.0 112.392 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -95.14 16.13 17.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.267 0.556 . . . . 10.0 111.461 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 47.5 mt -105.69 133.6 49.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.546 -0.752 . . . . 10.0 109.284 178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.39 -72.83 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.563 -0.29 . . . . 10.0 110.833 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -133.44 154.77 50.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.601 -0.272 . . . . 10.0 110.3 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.36 126.33 44.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.402 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . 0.546 HG21 ' CE1' ' A' ' 93' ' ' TYR . 1.3 m -125.49 127.66 46.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.024 0.44 . . . . 10.0 110.67 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 48.2 ttp85 -108.46 138.48 44.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 10.0 110.496 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -101.44 -17.21 16.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.197 0.522 . . . . 10.0 111.354 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.42 14.18 24.56 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.101 -0.8 . . . . 10.0 111.101 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -146.86 -51.87 0.21 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.484 -0.932 . . . . 10.0 108.484 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -130.13 148.8 52.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.514 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 23.7 mt -105.31 124.8 60.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.805 -0.443 . . . . 10.0 109.805 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -114.03 127.57 56.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.33 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -146.4 175.26 10.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.856 0.36 . . . . 10.0 111.033 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -136.95 128.41 28.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.903 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -111.01 158.2 19.07 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.718 0.295 . . . . 10.0 110.725 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -131.56 107.67 9.02 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.594 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 79.5 mt -95.14 143.18 26.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.532 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.47 12.23 47.2 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.039 -0.601 . . . . 10.0 112.508 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.88 16.63 60.0 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.986 -0.626 . . . . 10.0 111.698 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.35 31.88 63.02 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.124 -0.56 . . . . 10.0 112.197 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -149.41 92.11 4.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.792 0.329 . . . . 10.0 111.492 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -90.49 177.88 2.19 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.781 2.32 . . . . 10.0 110.678 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . 175.46 -172.25 45.29 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 119.979 -1.105 . . . . 10.0 112.807 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -117.38 -178.96 3.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.654 0.264 . . . . 10.0 110.406 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.35 143.17 10.05 Favored Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.465 -0.654 . . . . 10.0 111.465 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.02 125.16 28.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.089 0.471 . . . . 10.0 110.604 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 1.2 t -129.47 143.49 40.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.312 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 1.3 t -96.59 137.62 35.39 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.953 -0.388 . . . . 10.0 109.953 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -72.46 -12.28 61.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.152 -0.476 . . . . 10.0 111.737 -179.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -100.31 -13.03 18.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.863 0.363 . . . . 10.0 110.744 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -97.13 -54.5 3.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.218 -0.447 . . . . 10.0 111.459 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -89.78 143.55 30.4 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.499 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.432 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 26.0 Cg_exo -62.74 155.74 57.51 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.601 2.201 . . . . 10.0 111.823 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.89 -27.4 63.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.261 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -53.18 -44.05 67.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.68 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 70.2 mt -80.16 -37.46 33.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.958 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 40.8 mt -60.84 -40.67 93.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 10.0 110.565 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -70.63 -22.63 62.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.034 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -75.76 -26.88 57.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.232 0.539 . . . . 10.0 110.037 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.87 -30.61 17.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.121 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.82 94.93 1.86 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.21 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -95.14 130.86 41.69 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.483 -0.78 . . . . 10.0 110.306 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 69.4 mm-40 -64.55 124.31 21.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.62 77.73 0.31 Allowed 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.89 0.744 . . . . 10.0 110.045 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.379 -0.819 . . . . 10.0 110.301 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.478 0.955 0 CA-C-O 120.713 0.292 . . . . 10.0 110.904 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.8 mt -113.21 154.49 26.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.348 -0.387 . . . . 10.0 110.257 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -113.82 125.27 53.89 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.86 142.24 17.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.442 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.417 ' HA ' HG12 ' A' ' 138' ' ' VAL . . . -74.14 123.8 25.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.423 -0.353 . . . . 10.0 110.675 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.25 -37.41 53.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.04 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -146.0 158.21 43.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.524 -0.762 . . . . 10.0 109.503 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.42 146.43 54.03 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 123.238 0.336 . . . . 10.0 110.272 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -127.66 131.86 49.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.947 0.403 . . . . 10.0 111.02 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -95.28 128.43 42.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.462 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.402 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -68.92 137.84 54.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.773 0.32 . . . . 10.0 110.731 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 29.6 ttt-85 -113.22 -31.85 6.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.388 -0.369 . . . . 10.0 111.272 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.3 -163.97 1.46 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.516 -0.311 . . . . 10.0 110.401 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -93.11 -19.1 21.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.835 0.35 . . . . 10.0 111.053 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.46 -37.09 60.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.022 -0.535 . . . . 10.0 110.857 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -93.56 151.54 19.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.254 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 32.9 tp -120.36 134.85 55.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.315 -0.402 . . . . 10.0 110.424 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 2.9 p -79.3 153.06 30.15 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.886 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -158.45 160.2 36.53 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.426 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -101.95 156.0 17.81 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.475 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -62.76 123.37 18.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.796 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 113.87 -12.24 22.63 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.767 -0.73 . . . . 10.0 112.95 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -72.15 150.12 44.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.988 0.423 . . . . 10.0 111.472 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -111.47 137.32 49.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.349 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -124.39 150.94 45.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.218 0.532 . . . . 10.0 111.936 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -106.98 103.67 13.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.038 -0.983 . . . . 10.0 108.709 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 122' ' ' ALA . 26.1 mm -64.45 124.82 20.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.39 -0.368 . . . . 10.0 111.038 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.81 -39.85 8.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.178 -0.465 . . . . 10.0 110.295 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -130.96 122.56 27.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.26 -0.427 . . . . 10.0 110.36 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.3 p -133.65 19.09 3.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.243 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.76 -6.99 10.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.359 0.503 . . . . 10.0 112.359 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -84.29 -109.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.494 0.188 . . . . 10.0 110.598 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.518 ' HA2' ' OH ' ' B' ' 8' ' ' TYR . . . -73.19 -164.35 8.55 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.77 -0.729 . . . . 10.0 112.143 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -95.65 4.25 53.23 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.667 0.746 . . . . 10.0 110.044 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -105.06 155.73 18.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.513 -1.292 . . . . 10.0 107.513 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 12.8 m0 -106.45 129.57 54.4 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.084 -0.647 . . . . 10.0 112.671 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.26 115.03 27.16 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.16 -1.422 . . . . 10.0 107.16 177.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.551 ' HB2' HD13 ' A' ' 111' ' ' ILE . . . -137.33 161.83 35.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.442 0.639 . . . . 10.0 112.668 -178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 123' ' ' ARG . 31.4 ttp180 -106.78 120.93 43.33 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.117 -0.947 . . . . 10.0 109.318 178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.2 t -69.67 134.73 49.03 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 81.9 mt -78.52 -11.05 59.94 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.864 0.364 . . . . 10.0 110.214 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.0 m -82.91 -56.61 3.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.558 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 p -92.76 -32.67 14.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.359 -0.382 . . . . 10.0 112.027 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.89 20.74 49.24 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.645 -0.788 . . . . 10.0 111.6 -178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -109.92 159.55 17.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.772 -0.214 . . . . 10.0 110.937 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.37 -179.48 4.37 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.705 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 150.58 157.32 7.73 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.185 -0.531 . . . . 10.0 111.778 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -80.76 116.38 20.74 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 37.6 pt -99.59 140.92 21.96 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.727 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 133' ' ' ILE . 27.0 Cg_exo -61.01 117.87 4.68 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.44 2.093 . . . . 10.0 111.465 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -6.5 11.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 10.0 112.538 -178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 38.5 p-10 -107.18 3.63 25.86 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.743 0.275 . . . . 10.0 111.743 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.97 3.79 14.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.818 0.342 . . . . 10.0 111.036 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 89' ' ' ALA . 20.5 m -132.51 159.15 43.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.929 0.395 . . . . 10.0 111.037 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.7 141.23 34.5 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.725 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.87 130.29 13.27 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.441 2.094 . . . . 10.0 111.875 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.5 t . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.386 -0.816 . . . . 10.0 109.968 179.945 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.2 ttt . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.438 0.161 . . . . 10.0 110.605 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.04 169.53 24.35 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.618 0.247 . . . . 10.0 110.957 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.95 139.53 30.81 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.802 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 39.2 t -102.94 130.28 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.718 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -94.02 118.64 31.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.072 -0.513 . . . . 10.0 109.953 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -136.54 178.34 7.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.569 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . 0.421 ' HE2' ' OE2' ' B' ' 12' ' ' GLU . 66.6 mttt -123.1 137.94 54.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.871 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . 0.518 ' OH ' ' HA2' ' A' ' 117' ' ' GLY . 77.2 t80 -134.95 115.84 14.03 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.082 -0.71 . . . . 10.0 109.082 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm 59.34 24.02 12.53 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.512 0.507 . . . . 10.0 111.384 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.89 -0.6 67.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.905 -0.664 . . . . 10.0 112.77 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -103.13 136.13 43.51 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.686 -0.302 . . . . 10.0 110.426 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.421 ' OE2' ' HE2' ' B' ' 7' ' ' LYS . 20.3 mt-10 -86.52 126.19 34.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.54 -0.3 . . . . 10.0 110.238 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 66.2 mttt -139.11 153.38 48.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.415 -0.357 . . . . 10.0 110.616 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -125.7 124.52 41.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.412 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 92.2 t -134.62 146.83 30.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.079 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.71 140.44 56.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 10.0 110.623 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 tt -64.57 -26.57 40.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.912 -0.586 . . . . 10.0 110.6 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.91 -11.84 60.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 10.0 111.213 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -99.4 3.56 45.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.031 0.443 . . . . 10.0 110.482 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 90.4 mt -95.3 127.76 47.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.781 -0.645 . . . . 10.0 109.62 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 11.5 t -80.41 -88.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.339 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -100.11 149.86 23.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 10.0 110.93 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 39.1 t -127.12 116.1 43.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.715 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 1.2 m -108.72 104.22 13.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.142 0.496 . . . . 10.0 111.528 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 2.4 ttp85 -100.47 146.61 26.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.78 -0.646 . . . . 10.0 109.966 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -138.08 5.13 2.53 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.088 0.47 . . . . 10.0 111.165 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.47 20.55 68.84 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.569 -0.824 . . . . 10.0 111.281 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 32.9 mmtm -138.83 -59.7 0.6 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.057 -0.72 . . . . 10.0 109.057 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -145.74 134.24 22.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.04 -0.982 . . . . 10.0 109.557 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 89.8 mt -91.37 117.94 35.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 123.302 0.376 . . . . 10.0 110.352 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -107.14 135.53 48.52 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.105 -0.498 . . . . 10.0 109.707 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -152.76 173.52 15.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.03 0.443 . . . . 10.0 111.388 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -131.91 141.65 49.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.496 -0.775 . . . . 10.0 109.668 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -133.36 173.72 11.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.82 0.343 . . . . 10.0 110.462 -179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -142.93 127.39 17.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.088 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 84.7 mt -100.51 142.2 32.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.174 -0.466 . . . . 10.0 110.723 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.97 -21.05 60.82 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 116.056 -0.52 . . . . 10.0 113.258 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.93 -3.7 75.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.911 -0.661 . . . . 10.0 112.38 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.43 34.41 8.62 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.914 -0.66 . . . . 10.0 112.052 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -125.43 77.36 68.68 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.739 0.305 . . . . 10.0 111.243 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.89 148.66 17.53 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.551 2.168 . . . . 10.0 111.442 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.86 -174.0 39.07 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.011 -1.09 . . . . 10.0 112.728 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -112.84 174.57 5.83 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.962 -0.384 . . . . 10.0 109.962 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.53 151.58 22.13 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.107 -0.797 . . . . 10.0 111.107 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.8 p -135.78 137.75 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.253 0.549 . . . . 10.0 111.263 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 59.8 t -124.36 132.97 70.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.782 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 13.6 t -73.5 128.44 35.5 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.591 -0.277 . . . . 10.0 110.358 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -84.97 6.94 22.99 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.929 0.395 . . . . 10.0 110.792 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -120.22 -39.47 2.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.269 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.66 -50.87 7.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.93 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' B' ' 52' ' ' PRO . . . -67.15 146.57 98.99 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.861 -0.609 . . . . 10.0 111.332 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 51' ' ' ALA . 31.8 Cg_exo -59.23 148.72 84.76 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.54 2.16 . . . . 10.0 112.364 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -60.66 -26.84 67.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.9 -0.591 . . . . 10.0 111.058 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -53.33 -42.48 66.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.159 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 90.2 mt -74.44 -36.39 63.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.921 0.391 . . . . 10.0 110.695 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 35.6 mt -65.72 -36.97 85.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.626 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -71.9 -14.49 61.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.111 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -96.26 -37.54 10.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.097 0.475 . . . . 10.0 109.831 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -70.53 -35.03 72.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.113 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -74.44 89.94 2.16 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.132 0.492 . . . . 10.0 110.35 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -70.23 109.17 4.52 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -50.85 123.38 8.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.293 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 65.64 58.58 0.8 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.346 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.533 -0.746 . . . . 10.0 110.622 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.856 0.36 . . . . 10.0 110.637 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.0 mt -81.6 128.1 33.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.278 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -117.82 127.42 53.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.656 -0.702 . . . . 10.0 109.478 178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.9 p -99.79 135.06 36.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.891 0.377 . . . . 10.0 110.432 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.43 118.95 13.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.688 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.4 mt -70.14 -31.48 69.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.473 -0.785 . . . . 10.0 110.673 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -151.3 -178.2 6.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.064 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -87.47 159.99 18.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.16 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -141.12 125.61 17.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.858 0.361 . . . . 10.0 110.789 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -87.86 114.19 24.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.723 -0.672 . . . . 10.0 109.712 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.09 155.69 24.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.255 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -119.02 -20.03 8.24 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.885 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.6 -160.04 1.01 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.581 -0.282 . . . . 10.0 110.802 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -101.75 -19.88 15.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.983 0.42 . . . . 10.0 110.575 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.99 -48.03 59.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.516 -0.766 . . . . 10.0 109.418 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -78.83 129.04 34.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.279 -0.873 . . . . 10.0 109.362 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.48 138.69 31.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.903 -0.59 . . . . 10.0 112.319 -177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.4 m -92.2 136.82 32.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.615 -0.513 . . . . 10.0 109.615 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -153.54 178.46 9.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.821 0.343 . . . . 10.0 111.025 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.88 173.87 10.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.98 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -63.57 122.56 16.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.778 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.99 -4.13 33.85 Favored Glycine 0 CA--C 1.518 0.236 0 C-N-CA 120.836 -0.697 . . . . 10.0 112.524 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -66.33 131.93 47.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.741 0.305 . . . . 10.0 110.856 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -102.1 118.64 37.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.87 -0.419 . . . . 10.0 109.87 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -112.17 142.77 44.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.501 0.556 . . . . 10.0 112.501 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -108.22 104.3 13.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.513 -1.291 . . . . 10.0 107.513 176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.64 123.96 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.522 -178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.5 mt -102.82 -51.54 3.27 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.436 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -133.85 114.46 13.36 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.992 -0.549 . . . . 10.0 110.78 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.2 p -129.8 9.39 5.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.451 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.58 -0.98 51.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.435 -0.802 . . . . 10.0 111.897 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -87.72 -91.55 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.887 -0.325 . . . . 10.0 110.221 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.77 -162.57 28.96 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.603 -0.808 . . . . 10.0 111.627 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.53 -28.2 41.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.869 0.366 . . . . 10.0 110.19 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -81.32 145.59 30.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.551 -1.278 . . . . 10.0 107.551 177.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 20.6 m0 -106.6 142.5 36.15 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.794 0.665 . . . . 10.0 112.794 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.32 118.17 30.96 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 177.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.96 163.39 33.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.292 0.568 . . . . 10.0 111.64 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -114.79 138.32 50.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.423 -0.808 . . . . 10.0 110.08 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.9 t -73.22 133.49 44.01 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.273 -0.422 . . . . 10.0 110.434 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.6 mt -92.22 5.85 48.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 10.0 109.956 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.19 -51.11 3.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.703 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.0 p -103.73 -39.39 6.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.033 0.444 . . . . 10.0 110.83 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.7 -2.59 29.03 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.931 -0.652 . . . . 10.0 111.766 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -66.14 142.39 57.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.623 0.249 . . . . 10.0 110.826 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.5 m -117.58 144.6 44.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.539 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.02 179.01 42.68 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.173 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -85.22 135.96 33.72 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.896 0.379 . . . . 10.0 110.205 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.2 pt -122.47 145.48 44.82 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.294 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.444 ' HB2' ' OD1' ' A' ' 136' ' ' ASN . 31.9 Cg_endo -67.44 121.14 8.22 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 122.776 2.318 . . . . 10.0 111.497 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -4.93 14.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.628 -0.714 . . . . 10.0 112.736 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.444 ' OD1' ' HB2' ' A' ' 134' ' ' PRO . 36.0 p-10 -101.57 6.24 42.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.754 0.311 . . . . 10.0 110.977 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -124.96 14.12 8.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.298 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.29 146.52 30.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.471 -0.331 . . . . 10.0 110.755 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -130.9 142.97 47.49 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.557 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.23 131.71 19.67 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.356 2.038 . . . . 10.0 112.323 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 15.8 t . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.453 -0.784 . . . . 10.0 109.915 179.818 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.779 0.323 . . . . 10.0 110.405 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.74 151.07 26.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.747 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' B' ' 16' ' ' ASP . 4.3 m -94.98 123.16 38.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.897 -0.592 . . . . 10.0 110.242 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 20.6 t -98.75 132.96 42.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.999 0.428 . . . . 10.0 111.241 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -102.73 111.85 24.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.597 -0.729 . . . . 10.0 109.094 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -130.16 -174.41 3.32 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.027 0.441 . . . . 10.0 111.104 -178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -110.62 148.6 31.86 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.171 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.17 103.43 4.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.614 -0.721 . . . . 10.0 109.159 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 21.3 tptt 58.67 30.77 20.36 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.7 0.625 . . . . 10.0 110.703 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.49 -31.79 8.3 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.679 -0.772 . . . . 10.0 112.29 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -75.74 168.97 19.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.806 0.336 . . . . 10.0 110.515 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -114.37 129.73 56.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -132.64 148.1 52.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.833 0.349 . . . . 10.0 111.27 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -117.01 109.57 17.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.963 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 94.6 t -129.0 139.38 52.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 110.148 -0.315 . . . . 10.0 110.148 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' B' ' 3' ' ' THR . 31.0 m-20 -66.9 141.17 57.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.238 -0.437 . . . . 10.0 110.861 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 17.3 tt -62.08 -23.52 31.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 10.0 111.039 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.67 0.25 18.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.193 -0.458 . . . . 10.0 111.147 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -114.61 9.65 16.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.082 0.468 . . . . 10.0 110.244 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 63.9 mt -97.3 132.49 41.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.748 -0.66 . . . . 10.0 110.157 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 16.3 t -79.15 -59.99 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.367 -0.379 . . . . 10.0 111.658 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -141.03 155.14 46.23 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 122.245 -0.284 . . . . 10.0 110.824 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 68.1 t -123.54 122.91 66.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 O-C-N 123.512 0.508 . . . . 10.0 110.59 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 7.3 m -113.53 107.37 15.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.888 0.375 . . . . 10.0 110.969 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.496 ' HE ' ' CD ' ' B' ' 60' ' ' GLU . 8.0 ttp85 -102.65 149.9 23.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.366 -0.379 . . . . 10.0 110.254 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -125.84 -22.71 4.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.508 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.04 16.8 14.13 Favored Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 110.958 -0.857 . . . . 10.0 110.958 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -144.38 -51.34 0.3 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -145.08 136.02 24.7 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.408 -0.815 . . . . 10.0 109.384 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 52.7 mt -93.88 128.26 45.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.481 -0.327 . . . . 10.0 110.571 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 136' ' ' ASN . 29.4 m-85 -119.16 130.52 55.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -143.8 172.02 13.41 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.71 -0.396 . . . . 10.0 111.677 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -128.98 136.41 50.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.682 -0.69 . . . . 10.0 109.706 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -131.11 166.84 20.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.891 0.377 . . . . 10.0 111.287 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -132.33 114.74 14.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.539 -0.755 . . . . 10.0 109.729 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 88.1 mt -88.0 135.6 33.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.979 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.75 -8.74 35.33 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.819 -0.628 . . . . 10.0 112.815 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.87 -11.76 83.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.979 -0.629 . . . . 10.0 112.258 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.05 16.34 19.25 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.92 -0.657 . . . . 10.0 112.702 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -138.2 104.03 8.0 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 120.885 -0.326 . . . . 10.0 111.62 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -86.47 171.42 7.44 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.733 2.289 . . . . 10.0 111.18 178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.42 -173.76 44.87 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.66 -1.257 . . . . 10.0 112.966 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -113.42 169.51 8.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.537 0.208 . . . . 10.0 110.497 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -151.23 151.53 23.48 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.151 -0.547 . . . . 10.0 111.823 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 7.7 p -136.27 140.12 44.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.883 0.373 . . . . 10.0 111.517 -179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.78 135.46 53.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.901 -0.59 . . . . 10.0 109.557 178.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 39.3 t -76.02 134.89 40.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.745 0.307 . . . . 10.0 110.714 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.459 ' OE2' ' HD2' ' B' ' 25' ' ' ARG . 45.0 mt-10 -89.79 8.95 29.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.139 0.495 . . . . 10.0 110.048 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -132.22 -42.77 0.97 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.733 -0.667 . . . . 10.0 111.665 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.21 34.23 1.81 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.208 0.447 . . . . 10.0 112.208 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.98 154.66 34.55 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 116.705 -0.225 . . . . 10.0 110.574 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -59.48 134.71 60.03 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.77 2.313 . . . . 10.0 111.356 178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -67.97 -16.65 64.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.219 -0.446 . . . . 10.0 112.165 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -59.61 -44.4 93.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.409 . . . . 10.0 110.366 179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.97 -39.23 83.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.526 . . . . 10.0 110.008 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 29.3 mt -64.9 -41.0 95.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.741 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -62.5 -38.12 88.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.323 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -78.69 -35.86 44.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.417 -0.356 . . . . 10.0 110.956 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.28 -56.33 22.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.857 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . 0.496 ' CD ' ' HE ' ' B' ' 25' ' ' ARG . 40.6 tt0 -86.81 89.77 8.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.335 0.588 . . . . 10.0 110.944 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -78.58 148.74 33.19 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -64.7 138.91 58.67 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.44 -0.578 . . . . 10.0 109.44 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 88.1 mttt 72.04 54.64 0.18 Allowed 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.983 0.802 . . . . 10.0 110.245 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.662 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 120.678 0.275 . . . . 10.0 110.507 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 73.1 mt -92.15 150.85 20.69 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -119.37 137.53 53.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.853 0.358 . . . . 10.0 110.942 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.4 p -111.86 140.01 33.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.335 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.74 122.8 22.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.921 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 80.9 mt -79.13 -38.32 36.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.462 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -134.19 161.39 35.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.36 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -77.23 121.54 23.81 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -112.22 117.92 33.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.075 0.464 . . . . 10.0 110.431 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -94.46 120.52 34.82 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 115.906 -0.588 . . . . 10.0 109.486 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.471 ' H ' ' HB3' ' A' ' 102' ' ' SER . . . -73.48 156.61 38.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.969 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.1 ttm105 -123.28 -26.42 4.29 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.85 -0.614 . . . . 10.0 110.676 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.48 -168.51 1.5 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.297 -0.41 . . . . 10.0 111.022 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -97.8 -3.17 39.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.018 0.437 . . . . 10.0 111.14 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.52 -43.29 9.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.04 -0.527 . . . . 10.0 110.385 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -81.16 147.43 30.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.552 -0.749 . . . . 10.0 109.91 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 62.2 tp -103.84 131.39 51.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.337 -0.392 . . . . 10.0 112.009 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.471 ' HB3' ' H ' ' A' ' 95' ' ' ALA . 0.0 OUTLIER -85.37 135.8 33.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.922 -0.581 . . . . 10.0 109.877 178.713 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -155.58 165.46 36.49 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.775 0.322 . . . . 10.0 110.664 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.493 ' O ' ' HB2' ' A' ' 107' ' ' GLU . 36.5 m170 -110.22 165.23 11.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.959 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -61.82 126.1 26.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.838 -0.619 . . . . 10.0 110.558 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 104.35 -4.21 43.99 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.675 -0.774 . . . . 10.0 112.146 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 109' ' ' PHE . 2.5 tp10 -68.11 148.12 51.37 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 122.204 0.202 . . . . 10.0 110.922 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -119.1 133.52 55.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.662 -0.495 . . . . 10.0 109.662 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 107' ' ' GLU . 0.4 OUTLIER -130.53 155.46 46.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.125 0.488 . . . . 10.0 111.582 -179.156 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -109.45 114.11 27.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.2 mm -63.2 128.77 25.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.143 -0.48 . . . . 10.0 111.065 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 76.3 mt -107.03 -44.33 4.42 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.416 -0.356 . . . . 10.0 110.917 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 116' ' ' GLU . 30.1 t30 -138.81 108.55 6.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.812 0.339 . . . . 10.0 111.131 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.72 -11.32 19.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.163 0.506 . . . . 10.0 110.73 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.6 8.79 15.57 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.069 -0.514 . . . . 10.0 111.446 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.407 ' HB2' ' ND2' ' A' ' 113' ' ' ASN . 7.2 tp10 -77.98 -20.14 53.17 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.013 0.435 . . . . 10.0 110.806 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.34 -139.99 9.61 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.818 -0.706 . . . . 10.0 111.499 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.11 -35.28 49.41 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.98 -0.378 . . . . 10.0 109.98 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.466 ' HB2' ' CE2' ' B' ' 43' ' ' PHE . 20.4 m95 -92.18 126.01 37.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -103.55 146.99 27.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.882 0.372 . . . . 10.0 111.228 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -97.11 122.17 39.82 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.735 -0.839 . . . . 10.0 108.735 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.74 162.46 32.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.953 0.406 . . . . 10.0 111.543 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 123' ' ' ARG . 13.1 ttt-85 -109.53 128.08 54.93 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.453 -0.794 . . . . 10.0 109.599 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.3 t -67.3 134.16 51.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.163 -0.472 . . . . 10.0 109.749 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 95.9 mt -83.73 -10.66 57.97 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.864 0.364 . . . . 10.0 110.105 179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.12 -62.77 1.37 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.761 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.2 p -87.36 -35.73 18.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.037 0.446 . . . . 10.0 111.546 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.89 2.01 52.17 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.72 -0.753 . . . . 10.0 111.87 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -71.99 144.7 48.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.802 0.334 . . . . 10.0 111.248 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.7 m -117.76 135.64 53.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.288 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -178.68 178.44 48.71 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.445 -0.883 . . . . 10.0 112.106 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -79.79 126.09 30.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.965 0.412 . . . . 10.0 109.971 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 31.2 pt -115.67 139.83 25.28 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.797 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.07 112.58 1.72 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.453 2.102 . . . . 10.0 111.34 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.67 -18.21 61.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.056 -0.52 . . . . 10.0 112.134 -178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 36.6 p-10 -92.57 5.69 49.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.621 -0.263 . . . . 10.0 111.494 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -119.25 4.82 11.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.914 0.388 . . . . 10.0 110.748 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.93 149.07 32.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.18 -0.464 . . . . 10.0 111.152 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -129.39 142.65 45.96 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.218 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 6.7 Cg_exo -73.84 135.73 21.9 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.437 2.092 . . . . 10.0 111.773 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.367 -0.825 . . . . 10.0 110.682 -179.966 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ttt . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.348 0.118 . . . . 10.0 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.35 174.08 13.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.75 0.309 . . . . 10.0 111.153 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 2.1 m -108.59 131.56 54.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.47 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.86 125.06 48.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.892 0.377 . . . . 10.0 110.893 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -103.86 111.44 23.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.792 -0.64 . . . . 10.0 110.272 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -121.94 176.99 5.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.978 -0.556 . . . . 10.0 111.036 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -121.06 94.72 4.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.984 -0.553 . . . . 10.0 110.469 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -80.88 92.02 6.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.226 -0.443 . . . . 10.0 110.059 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm 56.24 43.9 25.79 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.42 -0.809 . . . . 10.0 111.893 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.6 -16.43 59.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.852 -0.69 . . . . 10.0 113.586 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -94.75 117.79 30.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.168 0.484 . . . . 10.0 111.314 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -76.81 117.26 18.25 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -132.37 137.97 47.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.855 0.359 . . . . 10.0 110.877 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -112.48 116.28 30.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.137 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 69.3 t -124.08 140.34 47.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.775 -0.454 . . . . 10.0 109.775 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -57.51 137.21 56.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.185 -0.461 . . . . 10.0 110.594 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 9.8 tt -60.12 -26.94 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.983 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.27 2.16 16.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.434 -0.348 . . . . 10.0 111.821 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' B' ' 35' ' ' ASP . 95.4 mttt -112.01 8.27 20.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.775 0.321 . . . . 10.0 111.088 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 61.0 mt -92.2 119.97 40.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 110.042 -0.355 . . . . 10.0 110.042 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.78 -70.32 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.888 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -128.49 148.98 50.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.73 0.3 . . . . 10.0 111.145 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.21 132.37 68.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.481 -0.781 . . . . 10.0 110.297 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' THR . . . . . . . . . . . . . 28.7 m -132.22 115.4 15.63 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.037 0.446 . . . . 10.0 110.851 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.546 ' HD2' ' OE1' ' B' ' 48' ' ' GLU . 68.5 ttp85 -116.32 144.26 44.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.204 -0.453 . . . . 10.0 110.309 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -119.89 7.62 10.97 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.132 0.491 . . . . 10.0 111.607 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.542 ' H ' ' HG2' ' B' ' 25' ' ' ARG . . . 90.53 16.56 54.89 Favored Glycine 0 C--O 1.231 -0.077 0 C-N-CA 120.462 -0.875 . . . . 10.0 112.203 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -140.0 -60.92 0.53 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.48 0.657 . . . . 10.0 109.343 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -131.46 147.05 52.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.162 -0.926 . . . . 10.0 109.699 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' B' ' 45' ' ' VAL . 61.7 mt -101.57 111.96 33.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.681 -0.69 . . . . 10.0 110.089 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -103.02 126.95 50.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.089 -0.505 . . . . 10.0 109.676 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -152.45 172.96 15.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.01 0.433 . . . . 10.0 111.133 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -129.16 134.41 48.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.785 -0.643 . . . . 10.0 109.739 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -110.98 168.83 9.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.239 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' B' ' 19' ' ' LYS . 21.8 t70 -131.65 153.09 50.32 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.312 -0.625 . . . . 10.0 109.312 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 51.0 mt -138.55 139.29 38.62 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.189 -0.3 . . . . 10.0 110.189 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.97 -20.93 60.68 Favored Glycine 0 C--N 1.33 0.218 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.33 -18.49 71.49 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.749 -0.54 . . . . 10.0 111.749 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.07 29.38 6.45 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.972 -0.632 . . . . 10.0 112.795 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -130.41 85.91 55.06 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.883 0.341 . . . . 10.0 111.56 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -91.33 76.94 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.138 2.559 . . . . 10.0 111.997 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.58 -167.47 43.69 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.927 -0.654 . . . . 10.0 113.027 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 119' ' ' TRP . 62.1 m-85 -111.65 172.34 6.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.852 0.358 . . . . 10.0 110.727 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.22 151.59 23.05 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.358 -0.697 . . . . 10.0 111.358 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 30' ' ' ILE . 14.6 p -141.57 140.49 31.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.13 0.49 . . . . 10.0 110.984 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.57 147.77 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.559 . . . . 10.0 109.651 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 22.2 t -93.0 136.67 33.05 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.168 -0.308 . . . . 10.0 110.168 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.546 ' OE1' ' HD2' ' B' ' 25' ' ' ARG . 19.6 tt0 -80.66 -10.17 59.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.269 -0.423 . . . . 10.0 110.979 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -110.99 -26.01 9.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.157 0.428 . . . . 10.0 112.157 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -97.83 -15.16 20.37 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.465 0.543 . . . . 10.0 112.465 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.29 151.34 41.42 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.451 0.167 . . . . 10.0 111.226 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' B' ' 56' ' ' LEU . 25.7 Cg_exo -63.5 147.78 92.96 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.713 2.275 . . . . 10.0 111.836 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -64.31 -21.95 66.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.969 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.96 -45.93 71.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.918 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.2 mt -78.61 -36.26 44.42 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.161 -0.472 . . . . 10.0 110.898 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 52' ' ' PRO . 36.4 mt -61.91 -39.38 91.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.13 -0.486 . . . . 10.0 111.203 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -69.08 -16.58 63.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 10.0 111.771 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -90.28 -20.24 23.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.167 0.508 . . . . 10.0 110.173 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 21.3 mt -93.08 -37.98 11.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.751 -0.659 . . . . 10.0 110.141 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -79.66 85.3 5.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.563 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' B' ' 64' ' ' LYS . 86.4 mttt -91.32 163.59 14.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.774 -0.648 . . . . 10.0 110.968 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -81.74 126.48 31.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 77.6 mttt 63.36 36.91 11.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.236 0.541 . . . . 10.0 109.736 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-N 115.174 -0.921 . . . . 10.0 111.673 -179.451 . . . . . . . . 2 2 . 1 stop_ save_